Clustering O 0 1.6257041579592624e-07
of O 0 1.2221957668145933e-08
missense O 0 2.7556248483051604e-07
mutations O 0 2.1100805547291657e-09
in O 0 7.545507274553387e-11
the O 0 3.415411242713162e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 3.2629142054929616e-08
in O 0 1.5508865303104358e-09
a O 0 9.285709978712475e-09
sporadic B-Disease 0 2.600252173579065e-06
T I-Disease 0 4.316991908126511e-05
- I-Disease 0 2.8515301892184652e-05
cell I-Disease 0 4.784373686561594e-06
leukaemia I-Disease 0 0.003308998653665185
. O 0 1.0181160803313105e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.0074517376779113e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1678765593492457e-12
is O 0 4.092630097665695e-14
a O 0 5.794180781872049e-13
recessive B-Disease 0 2.2874235838798995e-09
multi I-Disease 0 4.535988409770653e-06
- I-Disease 1 0.9506995677947998
system I-Disease 0 9.639928066462744e-06
disorder I-Disease 0 0.21825164556503296
caused O 0 4.2839999991883815e-08
by O 0 6.276802688720551e-11
mutations O 0 2.554121913966867e-10
in O 0 1.1555448264921608e-10
the O 0 6.282268039115024e-10
ATM O 0 4.966759803437526e-08
gene O 0 9.177834187079625e-11
at O 0 1.8890844444285904e-09
11q22 O 0 3.7471986047421524e-07
- O 0 1.4412736959457106e-07
q23 O 0 2.1488979200512404e-06
( O 0 3.8713970917925167e-10
ref O 0 9.247413146340477e-08
. O 0 1.6184528717211322e-10
3 O 0 5.46001599488477e-09
) O 0 2.5445564058590442e-11
. O 0 1.3711505264524249e-09

The O 0 4.923006713397626e-08
risk O 0 9.724633400765015e-07
of O 0 2.6965005872625625e-07
cancer B-Disease 0 0.18174713850021362
, O 0 6.51325271494585e-10
especially O 0 1.3229354278720962e-09
lymphoid B-Disease 0 1.4698304767080117e-05
neoplasias I-Disease 1 0.9962880611419678
, O 0 1.003935545806911e-10
is O 0 3.1665746413889195e-12
substantially O 0 6.57398163683709e-11
elevated O 0 1.898968537972223e-09
in O 0 2.486765238174371e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.524732836827752e-09
and O 0 2.197069132528484e-12
has O 0 1.4942440730927875e-12
long O 0 2.645429014735967e-12
been O 0 1.9169564481787138e-13
associated O 0 3.948254050090139e-12
with O 0 4.4862991793737095e-11
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.8548951629782096e-05

By O 0 4.290629629366549e-09
analysing O 0 1.5147854526276205e-07
tumour B-Disease 1 1.0
DNA O 0 1.823193329641981e-08
from O 0 1.741454203063597e-10
patients O 0 3.3458071382885812e-12
with O 0 2.2574088052399605e-13
sporadic B-Disease 0 5.1772374831671186e-08
T I-Disease 0 1.2755665466102073e-06
- I-Disease 0 7.243475579343794e-07
cell I-Disease 0 1.3161837841835222e-07
prolymphocytic I-Disease 0 5.383461484598229e-06
leukaemia I-Disease 0 0.001008407911285758
( O 0 3.8778930067095985e-10
T B-Disease 0 5.142103987054725e-08
- I-Disease 0 5.153995275009038e-08
PLL I-Disease 0 3.254151081932832e-08
) O 0 2.0783388031409e-12
, O 0 6.102425422621627e-13
a O 0 1.0562408586656247e-11
rare O 0 2.0216177343268527e-10
clonal B-Disease 0 1.117685002327562e-07
malignancy I-Disease 0 6.705006398988189e-07
with O 0 1.7154514571002255e-12
similarities O 0 3.2713092651404097e-11
to O 0 7.942848045949802e-10
a O 0 8.931815842494473e-10
mature B-Disease 0 1.519608794353644e-08
T I-Disease 0 6.217117487494761e-08
- I-Disease 0 3.6471881514898996e-08
cell I-Disease 0 8.816251728660518e-09
leukaemia I-Disease 0 1.456656491427566e-06
seen O 0 2.1048780773913478e-10
in O 0 1.225649443048482e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.885165995003547e-10
we O 0 1.190262038236467e-11
demonstrate O 0 1.8829627527333637e-12
a O 0 6.375997819996204e-12
high O 0 1.3264669918022776e-10
frequency O 0 6.444005329342417e-10
of O 0 2.9388122491091906e-10
ATM O 0 1.1186655228812015e-06
mutations O 0 1.111065728309768e-08
in O 0 5.907931921456111e-09
T B-Disease 0 1.2846167919633444e-05
- I-Disease 0 6.332436896627769e-06
PLL I-Disease 0 6.467976163548883e-06
. O 0 2.122125586367929e-08

In O 0 4.56095294865122e-09
marked O 0 5.002387948316311e-10
contrast O 0 3.139166357413181e-11
to O 0 2.873791482560506e-10
the O 0 8.134522916369846e-11
ATM O 0 5.979342176942737e-08
mutation O 0 2.817218403006194e-10
pattern O 0 2.603514070997903e-10
in O 0 1.620887313258379e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 5.319299445361025e-10
the O 0 7.537049456773914e-11
most O 0 9.55368163052528e-13
frequent O 0 7.085910851134525e-12
nucleotide O 0 7.446797345433964e-11
changes O 0 6.925701765553294e-12
in O 0 6.399780445170977e-12
this O 0 2.828191014714321e-10
leukaemia B-Disease 0 1.5134530258364975e-05
were O 0 6.731631696510476e-09
missense O 0 1.0919495707639726e-06
mutations O 0 1.5885552784311585e-07
. O 0 4.1112006243793076e-08

These O 0 4.803598074865079e-10
clustered O 0 4.8673296504375685e-09
in O 0 1.7003893085232313e-11
the O 0 1.0591100912948903e-10
region O 0 7.950365921161051e-10
corresponding O 0 1.0880675249680394e-09
to O 0 1.394237347795979e-08
the O 0 4.5357082534280835e-09
kinase O 0 1.8207957452887058e-07
domain O 0 5.625210874882214e-08
, O 0 1.2459642692586037e-11
which O 0 1.0027882387311782e-12
is O 0 2.4264895648329343e-12
highly O 0 6.293271025831215e-12
conserved O 0 2.314702596262208e-11
in O 0 8.548610604119933e-12
ATM O 0 1.2347693711944885e-07
- O 0 2.2620175954557453e-08
related O 0 1.4055256958300788e-09
proteins O 0 2.277381408455348e-12
in O 0 4.8289098414366904e-12
mouse O 0 8.222345027064648e-11
, O 0 2.2561199436443857e-11
yeast O 0 1.9924644156787963e-09
and O 0 4.374393069994653e-10
Drosophila O 0 7.337661589446043e-09
. O 0 1.1128850063713003e-09

The O 0 4.755106601805892e-07
resulting O 0 1.4436302819831326e-07
amino O 0 3.201580796030612e-07
- O 0 3.836433393189509e-08
acid O 0 9.45656264406125e-09
substitutions O 0 1.0520437854211195e-09
are O 0 2.5251058188846542e-11
predicted O 0 1.4438113815629094e-08
to O 0 3.3462781434678845e-09
interfere O 0 6.49754783310641e-09
with O 0 4.1526480171194535e-11
ATP O 0 1.4872802012178e-06
binding O 0 1.703816820963766e-08
or O 0 6.143157094129492e-10
substrate O 0 7.128409151846427e-08
recognition O 0 1.7011337893890754e-09
. O 0 8.58489723754019e-09

Two O 0 7.64623386828589e-09
of O 0 5.8499967536818076e-08
seventeen O 0 4.247128231327224e-07
mutated O 0 2.500951978845478e-08
T B-Disease 0 2.6769427563522186e-07
- I-Disease 0 9.507731135727227e-08
PLL I-Disease 0 1.182652766829051e-07
samples O 0 1.5086151078369525e-11
had O 0 3.2255209787834804e-12
a O 0 3.716647215684654e-12
previously O 0 3.467537021406564e-11
reported O 0 1.2219851797112824e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 1.7280874544667313e-06
. O 0 2.7708900063316833e-08

In O 0 3.974493179015326e-09
contrast O 0 2.113633490452571e-09
, O 0 1.6901183785833496e-09
no O 0 4.791951280225248e-09
mutations O 0 3.1219011820127207e-09
were O 0 7.122585854446584e-10
detected O 0 1.4445846741040214e-09
in O 0 1.211005185020042e-10
the O 0 4.661139918482604e-09
p53 O 0 1.0100173142291169e-08
gene O 0 1.4660320180048814e-10
, O 0 2.8604018025707445e-12
suggesting O 0 2.5368365394462522e-11
that O 0 2.890367849575637e-12
this O 0 3.835946837948967e-10
tumour B-Disease 1 1.0
suppressor O 0 5.216672798269428e-05
is O 0 6.764162147065989e-11
not O 0 6.868530050274657e-12
frequently O 0 1.5981503230164118e-12
altered O 0 1.2950173051973213e-11
in O 0 5.60544926447859e-12
this O 0 3.4160460571364126e-10
leukaemia B-Disease 0 7.175529026426375e-05
. O 0 5.0056382150387435e-08

Occasional O 0 1.8251645315103815e-06
missense O 0 6.657995982095599e-06
mutations O 0 4.693706046055013e-08
in O 0 1.2619324474272275e-09
ATM O 0 2.3136569780035643e-06
were O 0 1.859052245478665e-09
also O 0 1.1971927789400372e-11
found O 0 2.5411209594872197e-12
in O 0 1.6301567734577915e-11
tumour B-Disease 1 0.9999982118606567
DNA O 0 3.6281890825051732e-09
from O 0 3.67964582415059e-11
patients O 0 9.653768669876106e-13
with O 0 1.1294037130212334e-13
B B-Disease 0 4.6333983760860065e-08
- I-Disease 0 1.762091272894395e-08
cell I-Disease 0 1.2366726309664955e-07
non I-Disease 0 1.0866383490792941e-05
- I-Disease 0 3.4155928005930036e-05
Hodgkins I-Disease 1 0.644398033618927
lymphomas I-Disease 0 1.0920415860482535e-07
( O 0 5.753338343933434e-12
B B-Disease 0 1.0067131128721485e-08
- I-Disease 0 1.4679019111341063e-09
NHL I-Disease 0 3.3139799793246993e-09
) O 0 2.998931940452476e-13
and O 0 1.0377685039433815e-12
a O 0 1.4753112620446984e-10
B B-Disease 0 1.4438421658269363e-07
- I-Disease 0 2.937475684916535e-08
NHL I-Disease 0 1.3391156983288965e-07
cell O 0 2.8258320128315972e-08
line O 0 8.856891042796633e-08
. O 0 1.0107727987929138e-08

The O 0 3.855945340802691e-09
evidence O 0 3.723568953173384e-10
of O 0 4.14412670846076e-11
a O 0 1.1609589158079192e-11
significant O 0 4.533333777811954e-11
proportion O 0 4.0196851402996003e-10
of O 0 1.7285952669254812e-09
loss O 0 7.023782888637697e-09
- O 0 1.3458397063459415e-07
of O 0 4.655491636640363e-07
- O 0 1.6108785416690807e-08
function O 0 9.12017822374267e-11
mutations O 0 1.0247785692946154e-12
and O 0 4.115479658450827e-14
a O 0 1.5560813271600638e-12
complete O 0 9.819522278631254e-11
absence O 0 7.113706290695632e-10
of O 0 3.8504022192853427e-10
the O 0 3.222737007813059e-11
normal O 0 2.2970399887745074e-11
copy O 0 1.600237303778229e-11
of O 0 5.373033962197127e-11
ATM O 0 9.977820347728539e-09
in O 0 4.014953300379709e-12
the O 0 1.85010097519811e-11
majority O 0 6.143724851775945e-12
of O 0 7.701821402861242e-10
mutated O 0 5.177731310368472e-08
tumours B-Disease 1 0.9999994039535522
establishes O 0 2.9046654859143928e-08
somatic O 0 4.3651127157318115e-08
inactivation O 0 6.207590672602237e-07
of O 0 1.420873418922497e-09
this O 0 2.7415203787684028e-11
gene O 0 1.7318730000451255e-12
in O 0 1.1984578910870236e-12
the O 0 4.610593851150924e-11
pathogenesis O 0 5.045186668439783e-08
of O 0 3.907976164896354e-08
sporadic B-Disease 0 0.00017808628035709262
T I-Disease 1 0.8191612958908081
- I-Disease 0 0.45553654432296753
PLL I-Disease 0 6.551543265231885e-06
and O 0 2.5400031036793003e-11
suggests O 0 9.198193422210732e-12
that O 0 7.123416982147968e-13
ATM O 0 8.631197090380738e-09
acts O 0 2.3912113955582015e-10
as O 0 8.485616376230354e-11
a O 0 3.2068649957750495e-09
tumour B-Disease 1 1.0
suppressor O 0 2.8349606509436853e-05
. O 0 5.6267879244842334e-08

As O 0 3.4320550845734488e-09
constitutional O 0 2.095598716778113e-08
DNA O 0 6.126202323208929e-10
was O 0 2.043774004201193e-11
not O 0 2.1559663776482552e-13
available O 0 1.3994904681739057e-13
, O 0 5.567948988156879e-13
a O 0 2.3810123317424825e-10
putative O 0 2.7488790692586917e-06
hereditary O 1 0.9999971389770508
predisposition O 1 0.9999978542327881
to O 1 0.981038510799408
T B-Disease 0 0.006631562951952219
- I-Disease 0 4.728214116767049e-05
PLL I-Disease 0 1.9014759118363145e-06
will O 0 3.7825315102324453e-10
require O 0 7.620572228805855e-11
further O 0 1.9879307922021638e-10
investigation O 0 4.891860250211266e-10
. O 0 6.28608831654276e-11
. O 0 1.0430386554460824e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 7.899758202256635e-06
kinase O 0 6.984068363635743e-07
is O 0 3.156486140173942e-12
involved O 0 8.467786340822167e-14
in O 0 7.2720888826764e-14
the O 0 1.575340118770141e-12
modulation O 0 7.76491457937789e-12
of O 0 5.227537500096524e-11
the O 0 6.122460871615942e-11
Ca2 O 0 6.172295452522292e-10
+ O 0 6.210738590084475e-09
homeostasis O 0 4.187777236097645e-09
in O 0 6.06465377916976e-10
skeletal O 0 3.916692890015838e-07
muscle O 0 1.654303218856512e-07
cells O 0 4.3312587649779744e-07
. O 0 7.532289458822561e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.7748706113707158e-06
DM B-Disease 1 1.0
) O 0 3.2177327469185e-10
, O 0 1.8589465904106373e-12
the O 0 2.6795651201366733e-12
most O 0 7.139277233628172e-13
prevalent O 0 1.507208047257791e-08
muscular B-Disease 0 7.697517867200077e-05
disorder I-Disease 0 2.821302587108221e-06
in O 0 2.0493218233497146e-10
adults O 0 2.0569630443389997e-09
, O 0 1.0377927683880017e-11
is O 0 1.826392509451935e-11
caused O 0 1.1373308961282191e-09
by O 0 2.666810661189345e-10
( O 0 2.4780024698856096e-09
CTG O 0 5.790527097815357e-07
) O 0 4.1617511520319894e-11
n O 0 6.674505392822994e-10
- O 0 1.4807951531636832e-09
repeat O 0 2.1273352523998312e-10
expansion O 0 6.586556994259141e-11
in O 0 3.331250639920791e-12
a O 0 2.7673469418787455e-11
gene O 0 1.376425666152481e-12
encoding O 0 1.0069996919659374e-11
a O 0 6.681867281699283e-10
protein O 0 6.405945107701427e-09
kinase O 0 1.0399902805602323e-07
( O 0 7.3155365098998e-10
DM B-Disease 1 0.9999890327453613
protein O 0 7.647969368917984e-09
kinase O 0 2.4464388292955164e-09
; O 0 2.549787204292331e-12
DMPK O 0 2.3535405091479333e-07
) O 0 3.1320641067679456e-13
and O 0 2.201862959539183e-13
involves O 0 2.419188113722548e-12
changes O 0 4.830420785584266e-12
in O 0 4.5138344451078893e-11
cytoarchitecture O 0 1.2157721585026593e-07
and O 0 4.705212219846544e-09
ion O 0 7.168943739088718e-06
homeostasis O 0 7.982424676811206e-07
. O 0 1.108572575958533e-07

To O 0 8.689129771255466e-08
obtain O 0 3.9710322141672805e-08
clues O 0 2.6563961696979277e-08
to O 0 2.7085172993324136e-10
the O 0 1.4377365964435285e-10
normal O 0 1.1726147830515288e-09
biological O 0 1.0603152800214843e-09
role O 0 1.630356544213285e-10
of O 0 1.3951384492116858e-09
DMPK O 0 0.0008378305356018245
in O 0 2.770757845382832e-08
cellular O 0 2.742371485453532e-08
ion O 0 6.963597570575075e-06
homeostasis O 0 5.90726983773493e-07
, O 0 4.2238335051791864e-10
we O 0 1.018153547582834e-10
have O 0 1.6617721738595992e-12
compared O 0 1.4717746119052855e-11
the O 0 1.9779525239904672e-11
resting O 0 1.100376387230817e-10
[ O 0 2.3115611855195617e-11
Ca2 O 0 5.5259415099317977e-11
+ O 0 7.107291422059347e-10
] O 0 5.039353379032718e-10
i O 0 9.160852632028593e-11
, O 0 1.4963004793533408e-12
the O 0 1.8408705549505244e-12
amplitude O 0 3.303210482918928e-11
and O 0 8.179431524452108e-13
shape O 0 5.2053822363618e-10
of O 0 6.616275860515941e-10
depolarization O 0 2.013476052553642e-09
- O 0 6.037154332005912e-09
induced O 0 3.748499111111414e-08
Ca2 O 0 1.6106126154991074e-10
+ O 0 2.5973043160654186e-10
transients O 0 1.383893333262165e-09
, O 0 1.7651007879707775e-13
and O 0 2.911586173982156e-13
the O 0 1.7641189073783203e-12
content O 0 1.405229405060382e-11
of O 0 1.2908231428188088e-10
ATP O 0 3.841749673938466e-08
- O 0 3.1865916572115793e-09
driven O 0 1.354186429658455e-09
ion O 0 6.4359508833433665e-09
pumps O 0 2.822456990347888e-10
in O 0 4.910224570692234e-12
cultured O 0 1.313521735823997e-09
skeletal O 0 5.4822648642982585e-09
muscle O 0 5.638148836695223e-10
cells O 0 1.0897456270697603e-09
of O 0 1.327345899859722e-09
wild O 0 6.97306448693702e-11
- O 0 1.0127319122199552e-11
type O 0 3.497827721909985e-11
and O 0 1.4013002563872945e-11
DMPK O 0 5.475560101331212e-06
[ O 0 2.0604234762799933e-08
- O 0 1.20998345209955e-06
/ O 0 3.583108991733752e-06
- O 0 1.1599087883951142e-05
] O 0 1.8876021101732476e-07
knockout O 0 1.0626516086631455e-05
mice O 0 6.242247962973124e-08
. O 0 4.111590623523398e-09

In O 0 5.5148628774759345e-08
vitro O 0 3.1490574770032254e-07
- O 0 4.814646459294636e-08
differentiated O 0 9.59239176978599e-09
DMPK O 0 1.536116724309977e-05
[ O 0 2.8563567511241672e-08
- O 0 1.0981235618601204e-06
/ O 0 1.3932452702647424e-06
- O 0 1.1750153134926222e-06
] O 0 7.289410852706624e-09
myotubes O 0 3.1354730367638695e-08
exhibit O 0 9.817794147104486e-12
a O 0 5.24263479850795e-11
higher O 0 1.8702768223022304e-09
resting O 0 1.7192635093365993e-09
[ O 0 2.9572777560105123e-10
Ca2 O 0 1.0709534370434426e-09
+ O 0 1.3645635732473238e-08
] O 0 8.731539935524779e-09
i O 0 1.0177172438119442e-09
than O 0 1.612087824343078e-10
do O 0 3.9664332929234547e-10
wild O 0 1.5288405263991223e-10
- O 0 1.324141490899322e-10
type O 0 7.105217525449348e-10
myotubes O 0 1.5049221246954403e-07
because O 0 2.0959753030402872e-11
of O 0 3.2629215301893666e-11
an O 0 1.2770031343131705e-12
altered O 0 3.5097497824709833e-11
open O 0 2.4674179366357407e-10
probability O 0 1.5981832524047945e-09
of O 0 6.253754736285089e-10
voltage O 0 1.163421075034421e-06
- O 0 5.7424415444984334e-08
dependent O 0 3.800642023321643e-09
l O 0 9.334351867840152e-12
- O 0 2.743120834647339e-11
type O 0 1.5136706124629917e-11
Ca2 O 0 1.0809610151429894e-11
+ O 0 4.2527311533424594e-11
and O 0 2.974615345707754e-11
Na O 0 6.664112039977965e-10
+ O 0 1.0411042861147024e-10
channels O 0 1.109007330413192e-09
. O 0 7.554209480176155e-10

The O 0 2.510918477582891e-07
mutant O 0 3.1342597139882855e-07
myotubes O 0 2.2977239950705552e-06
exhibit O 0 1.653276626711886e-09
smaller O 0 1.6864980245667738e-10
and O 0 3.476352816722539e-10
slower O 0 1.4524179192676456e-08
Ca2 O 0 1.664505977494457e-09
+ O 0 2.6895216609368333e-10
responses O 0 7.015711796232171e-12
upon O 0 1.1811214506440848e-10
triggering O 0 2.3709018082129774e-10
by O 0 8.556538290405147e-12
acetylcholine O 0 4.582648038820025e-09
or O 0 8.664644557399015e-10
high O 0 4.629146843626586e-09
external O 0 1.8142882751703837e-08
K O 0 9.011496615585202e-08
+ O 0 3.904718326452894e-09
. O 0 1.1255051335368194e-09

In O 0 8.951979602045412e-09
addition O 0 7.382524036536608e-10
, O 0 8.332484702222587e-10
we O 0 5.514762535518969e-10
observed O 0 9.833954484061991e-11
that O 0 6.182371780315277e-13
these O 0 1.7949235847636302e-12
Ca2 O 0 1.2185267239672726e-09
+ O 0 1.3163791834358562e-08
transients O 0 2.3048858821539397e-08
partially O 0 1.8074547414315134e-10
result O 0 2.4225588982768054e-12
from O 0 1.738439036821915e-12
an O 0 1.2597781975584588e-12
influx O 0 8.767503324909331e-13
of O 0 7.111908284507251e-12
extracellular O 0 3.8269561131176744e-11
Ca2 O 0 2.5368075695642034e-11
+ O 0 1.1893587677225259e-11
through O 0 5.733670916524547e-13
the O 0 9.861090242979653e-12
l O 0 3.622389064053544e-12
- O 0 2.2147539011085904e-11
type O 0 3.712879656503354e-11
Ca2 O 0 6.315555717284482e-11
+ O 0 2.4004284671086396e-10
channel O 0 3.0119620131330294e-09
. O 0 5.181440276835758e-10

Neither O 0 4.6223117777799416e-08
the O 0 6.286690612533619e-10
content O 0 9.409145684813325e-11
nor O 0 5.125794788618521e-10
the O 0 7.97487492709692e-11
activity O 0 2.9023752845525053e-10
of O 0 6.648978034817787e-10
Na O 0 3.1665492450372312e-09
+ O 0 7.40114913799772e-10
/ O 0 8.343780777408938e-09
K O 0 8.047616795181511e-09
+ O 0 1.2704061413959522e-10
ATPase O 0 1.6833485994016684e-10
and O 0 2.597085047018055e-11
sarcoplasmic O 0 6.905662708334148e-09
reticulum O 0 7.507845012355574e-09
Ca2 O 0 1.2079468536541071e-09
+ O 0 6.668804397591543e-10
- O 0 4.1091735569764865e-10
ATPase O 0 3.6405675696293827e-10
are O 0 9.03094805426545e-14
affected O 0 1.3822082584394324e-12
by O 0 9.96473910330753e-12
DMPK O 0 0.0007628919556736946
absence O 0 5.78288904762303e-07
. O 0 3.162850958915442e-08

In O 0 1.3277136723388594e-08
conclusion O 0 2.591997656509193e-07
, O 0 1.1670945321284876e-09
our O 0 2.1353437074100867e-10
data O 0 2.1050779175357803e-11
suggest O 0 4.83151088581657e-11
that O 0 8.831284661892091e-12
DMPK O 0 0.00011259759776294231
is O 0 5.970103578167851e-11
involved O 0 2.97611761623795e-12
in O 0 1.8128629023297926e-12
modulating O 0 1.3171740087525308e-10
the O 0 4.989464397198162e-11
initial O 0 8.26541335374742e-11
events O 0 2.6188313670405527e-12
of O 0 6.146259196038173e-11
excitation O 0 8.817264784966028e-08
- O 0 1.778252340045583e-06
contraction O 0 3.568454687297162e-08
coupling O 0 2.082333638853129e-09
in O 0 3.001385529000089e-10
skeletal O 0 3.7779059880449495e-08
muscle O 0 1.878908140184876e-09
. O 0 3.875617604620629e-09
. O 0 1.0374104242316662e-08

Constitutional O 0 2.1282568923197687e-05
RB1 O 0 0.0002850952441804111
- O 0 5.867758773092646e-06
gene O 0 5.727209817507628e-10
mutations O 0 7.688596981303419e-10
in O 0 1.786529084391031e-11
patients O 0 3.7912763206637834e-11
with O 0 2.5736507109491713e-12
isolated O 0 2.2623591178216884e-07
unilateral B-Disease 1 0.9999659061431885
retinoblastoma I-Disease 1 1.0
. O 0 5.825814150739461e-05

In O 0 1.1089062113001091e-08
most O 0 1.176687497439488e-10
patients O 0 3.059483916212358e-11
with O 0 6.152751376962973e-13
isolated O 0 3.0131815265121986e-08
unilateral B-Disease 1 0.9644413590431213
retinoblastoma I-Disease 1 0.9999998807907104
, O 0 1.3617456318115728e-07
tumor B-Disease 0 0.006789250299334526
development O 0 1.637213919991609e-08
is O 0 3.158710445982926e-11
initiated O 0 5.352916443435163e-10
by O 0 1.8155352221604915e-11
somatic O 0 3.1155127366844226e-09
inactivation O 0 6.396912510808761e-08
of O 0 3.81400189208847e-10
both O 0 1.5510093209769593e-11
alleles O 0 8.494085296240073e-11
of O 0 5.607668218665651e-10
the O 0 1.9175858678721625e-09
RB1 O 0 1.281059780922078e-06
gene O 0 6.641364347359513e-09
. O 0 6.995545032140171e-09

However O 0 1.7133327645524332e-08
, O 0 1.265014065721104e-10
some O 0 9.222014644982846e-12
of O 0 3.64156066412491e-10
these O 0 8.209631759126257e-12
patients O 0 1.7407226701737777e-11
can O 0 9.868225681053389e-11
transmit O 0 2.3185238617884352e-08
retinoblastoma B-Disease 0 3.72085596609395e-05
predisposition O 0 0.0004484795208554715
to O 0 1.9795875232375693e-06
their O 0 2.9086848485349037e-08
offspring O 0 6.38318908841029e-08
. O 0 1.7495226600772185e-08

To O 0 6.23767526519714e-09
determine O 0 3.8986289196962787e-10
the O 0 1.1039958010272688e-11
frequency O 0 1.0300844899280293e-10
and O 0 6.018298923451959e-13
nature O 0 4.8389809520488214e-11
of O 0 1.6868646757206562e-10
constitutional O 0 9.729136252190074e-08
RB1 O 0 2.6840543796424754e-06
- O 0 9.839596515348603e-08
gene O 0 8.126505024463881e-11
mutations O 0 1.1820004697238318e-10
in O 0 8.51050827033184e-12
patients O 0 1.4226699679431576e-11
with O 0 2.795846453657047e-12
isolated O 0 1.0145647877379815e-07
unilateral B-Disease 1 0.9992501139640808
retinoblastoma I-Disease 1 0.9999988079071045
, O 0 3.645901358595438e-08
we O 0 3.4934839465705636e-09
analyzed O 0 4.2661787991171707e-10
DNA O 0 5.07716257924784e-10
from O 0 3.5413949550644475e-11
peripheral O 0 5.7756226468086425e-09
blood O 0 3.494410316662311e-09
and O 0 3.172931917205801e-10
from O 0 1.0876489042743742e-08
tumor B-Disease 0 3.351366103743203e-06
tissue O 0 3.101264667293435e-07
. O 0 3.401472881137124e-08

The O 0 5.994939655806775e-09
analysis O 0 3.737486709010085e-10
of O 0 4.3384268622048694e-08
tumors B-Disease 1 1.0
from O 0 6.902004656694771e-08
54 O 0 4.0197811301823094e-08
( O 0 1.8281770194916724e-11
71 O 0 6.904043114985825e-09
% O 0 9.989045007818831e-11
) O 0 7.997364706233134e-13
of O 0 6.46668135706463e-11
76 O 0 4.942630749127375e-09
informative O 0 3.7224401339130964e-10
patients O 0 3.322191480248371e-11
showed O 0 7.208695446125901e-12
loss O 0 4.090466854123065e-11
of O 0 2.587346170646043e-10
constitutional O 0 1.1689663779179682e-06
heterozygosity O 0 9.992517152568325e-05
( O 0 2.86723000897382e-08
LOH O 1 0.9998248219490051
) O 0 7.483447195255621e-11
at O 0 4.220300109381014e-09
intragenic O 0 3.919495270565676e-07
loci O 0 3.8285239867263954e-08
. O 0 6.728371193531757e-09

Three O 0 2.7375740785373637e-08
of O 0 2.4699017941998136e-08
13 O 0 1.6683900128100504e-07
uninformative O 0 9.085471538128331e-05
patients O 0 1.5430387634296494e-08
had O 0 1.4631841516177246e-08
constitutional O 0 9.69802499639627e-07
deletions O 0 1.1510406920933747e-06
. O 0 2.9357235575844243e-07

For O 0 3.008094040524156e-08
39 O 0 2.7614626674221654e-07
randomly O 0 3.0549500706911203e-09
selected O 0 1.4856731844758997e-08
tumors B-Disease 1 1.0
, O 0 4.281900700675578e-08
SSCP O 1 0.999077320098877
, O 0 9.885269491860527e-08
hetero O 0 2.853210219200264e-07
- O 0 6.405237229500926e-09
duplex O 0 5.0347828128849414e-09
analysis O 0 1.0906849728931078e-10
, O 0 3.864745762999222e-12
sequencing O 0 7.928551912228521e-12
, O 0 4.9387121996147254e-12
and O 0 1.1326667034849969e-11
Southern O 0 2.56148036115178e-09
blot O 0 1.986921347452153e-07
analysis O 0 1.8119142297656765e-10
were O 0 1.5299775335542165e-11
used O 0 3.3354402139557093e-12
to O 0 4.623718075080774e-10
identify O 0 1.2557881401420445e-09
mutations O 0 1.7726222267810954e-08
. O 0 3.860966302227098e-08

Mutations O 0 3.638079988377285e-07
were O 0 1.9625845393278496e-09
detected O 0 7.123727163715898e-10
in O 0 1.5197456140758625e-11
21 O 0 1.1423312296088284e-09
( O 0 4.5971911173670055e-12
91 O 0 2.6042306089379963e-09
% O 0 5.977441458471233e-11
) O 0 4.062752738398512e-12
of O 0 1.287501882885067e-09
23 O 0 1.0073095836560242e-05
tumors B-Disease 1 1.0
with O 0 5.8186490292655435e-08
LOH O 1 1.0
. O 0 1.2076466191501822e-06

In O 0 6.5287539818825735e-09
6 O 0 6.699662691289632e-08
( O 0 5.167521965887545e-11
38 O 0 8.479767998892385e-09
% O 0 1.1569827040869285e-10
) O 0 5.769734516547498e-12
of O 0 6.959077758494914e-10
16 O 0 1.5221172589008347e-06
tumors B-Disease 1 1.0
without O 0 4.007978532172274e-06
LOH O 1 0.9999936819076538
, O 0 3.0183036625608395e-10
one O 0 6.465879914818728e-11
mutation O 0 9.68551454316735e-12
was O 0 1.4065279496655592e-10
detected O 0 4.3433385360502896e-11
, O 0 2.550632502516109e-13
and O 0 7.264301465047251e-13
in O 0 3.460276162825515e-11
9 O 0 3.71988129188594e-08
( O 0 5.8393415103275e-11
56 O 0 1.1436376290419048e-08
% O 0 9.285771457312464e-11
) O 0 6.393241405028283e-12
of O 0 6.178986211580195e-10
the O 0 5.242022993456885e-08
tumors B-Disease 1 1.0
without O 0 9.068047802429646e-06
LOH O 1 0.9999997615814209
, O 0 1.1954939260760966e-09
both O 0 2.4953078492373493e-10
mutations O 0 5.958559756713555e-10
were O 0 1.249403774883362e-10
found O 0 5.053307425284537e-11
. O 0 7.610640451183315e-10

Thus O 0 8.990205024872466e-09
, O 0 3.293748260246865e-11
a O 0 8.55778295449916e-11
total O 0 2.5987265117599634e-10
of O 0 1.956439038552915e-10
45 O 0 5.205424535859038e-09
mutations O 0 2.5222096633470414e-10
were O 0 1.338659322280833e-10
identified O 0 3.9096051396292353e-10
in O 0 8.889598501760076e-10
tumors B-Disease 1 1.0
of O 0 0.0002123997255694121
36 O 0 5.2561670599970967e-05
patients O 0 2.2758401385658544e-08
. O 0 6.936688379255429e-08

Thirty O 0 8.705301866029913e-07
- O 0 2.476449090238475e-08
nine O 0 1.0523246718463497e-09
of O 0 3.114239699453236e-10
the O 0 5.569762984158899e-10
mutations O 0 4.0787828670119097e-10
- O 0 2.1260015969915003e-09
including O 0 3.5920422886137615e-11
34 O 0 3.6159352845288595e-08
small O 0 5.199141117628869e-10
mutations O 0 1.4197960140904797e-08
, O 0 1.343250954910502e-09
2 O 0 6.727757977387228e-07
large O 0 4.327722180619276e-09
structural O 0 9.659497663960792e-07
alterations O 0 3.021828888449818e-06
, O 0 4.262748376504533e-09
and O 0 3.236878098888951e-09
hypermethylation O 0 0.0007870215340517461
in O 0 1.289278884542e-06
3 O 0 0.16808266937732697
tumors O 1 1.0
- O 0 1.1906553254448227e-06
were O 0 1.6191762375328267e-09
not O 0 2.3282441252714392e-10
detected O 0 2.9074284646490867e-10
in O 0 2.588212196646955e-12
the O 0 2.443573121624354e-11
corresponding O 0 1.735929316959428e-10
peripheral O 0 4.4767325846351014e-08
blood O 0 3.987981500586102e-08
DNA O 0 1.673474940844244e-07
. O 0 7.934252366226247e-09

In O 0 4.384301810489433e-09
6 O 0 4.951361276539501e-08
( O 0 3.622059249752674e-11
17 O 0 2.9626878728095107e-09
% O 0 5.184284945780604e-11
) O 0 7.106426449902947e-13
of O 0 4.302860845406542e-11
the O 0 2.470021964739999e-10
36 O 0 6.6562400036218605e-09
patients O 0 2.341219405843642e-11
, O 0 2.2631783599957878e-12
a O 0 3.9448930233554336e-10
mutation O 0 1.987939368675029e-09
was O 0 7.446208094563644e-09
detected O 0 3.8439887384278393e-10
in O 0 5.831525366761792e-12
constitutional O 0 4.115482177269314e-09
DNA O 0 2.9183471195182165e-09
, O 0 2.509361425248602e-12
and O 0 6.021792439692142e-12
1 O 0 2.8742933366743273e-08
of O 0 3.170796403217935e-10
these O 0 1.057327315978629e-11
mutations O 0 1.5188017510325835e-10
is O 0 1.7826954105612525e-12
known O 0 1.7989061846038212e-12
to O 0 1.617532496833718e-11
be O 0 5.4755054657018576e-12
associated O 0 1.824637663183637e-11
with O 0 8.140413256668699e-13
reduced O 0 5.511663125901123e-09
expressivity O 0 1.0572249493634445e-06
. O 0 7.258184098191123e-08

The O 0 1.8189547645874882e-09
presence O 0 1.9679502819003325e-11
of O 0 3.448212548828877e-11
a O 0 1.0352938124846833e-11
constitutional O 0 1.204231714346804e-09
mutation O 0 9.244913862227477e-11
was O 0 1.6398554389396303e-11
not O 0 3.0646671181702723e-13
associated O 0 3.0396228611374865e-13
with O 0 8.712682539411404e-15
an O 0 8.303185070925034e-13
early O 0 7.96357035870443e-10
age O 0 1.1929816023936723e-09
at O 0 5.670729996687385e-10
treatment O 0 1.2228269508085532e-09
. O 0 4.75068917538124e-09

In O 0 1.067165378287882e-08
1 O 0 4.304798494558781e-06
patient O 0 1.5089992189132317e-07
, O 0 1.5507446438078887e-09
somatic O 0 1.4925316236258368e-06
mosaicism O 0 6.467973435064778e-05
was O 0 1.3946124255426184e-08
demonstrated O 0 3.280619526035977e-11
by O 0 6.463521558253138e-12
molecular O 0 5.4762812340403144e-11
analysis O 0 9.716594933165124e-13
of O 0 1.2173314439811733e-11
DNA O 0 1.3801382779676796e-11
and O 0 1.7550238606139912e-12
RNA O 0 4.2070694150631027e-10
from O 0 5.6771441714342785e-11
peripheral O 0 1.880816391519602e-08
blood O 0 5.184549678460826e-08
. O 0 1.689970829943377e-08

In O 0 3.8805307411848844e-08
2 O 0 9.154443887382513e-07
patients O 0 2.735399962094931e-10
without O 0 9.177606591359577e-11
a O 0 7.418334280195893e-10
detectable O 0 6.558610721185687e-08
mutation O 0 3.883562638140603e-10
in O 0 3.267505363502288e-11
peripheral O 0 1.2310416686034387e-08
blood O 0 1.6045767381456244e-08
, O 0 2.2364297913579634e-10
mosaicism O 0 6.788896484977158e-07
was O 0 1.8195203121962322e-09
suggested O 0 1.3695085343545799e-10
because O 0 1.3001925924793767e-11
1 O 0 7.123064804659407e-09
of O 0 4.746970524993621e-11
the O 0 1.997805046394241e-11
patients O 0 6.280452286705485e-12
showed O 0 1.410253719358323e-10
multifocal O 1 0.9999997615814209
tumors B-Disease 1 1.0
and O 0 3.3128692678019434e-08
the O 0 1.3098147455536946e-08
other O 0 1.580448272253676e-11
later O 0 3.09178488366868e-10
developed O 0 2.822311828687418e-10
bilateral B-Disease 0 7.09855748937116e-06
retinoblastoma I-Disease 0 0.001453064731322229
. O 0 8.624714951110946e-07

In O 0 9.1759879694564e-09
conclusion O 0 9.115304777651545e-08
, O 0 3.0790381355672025e-10
our O 0 7.863165674137917e-11
results O 0 8.380456051337859e-11
emphasize O 0 1.5393275543118534e-10
that O 0 1.3650892482369725e-12
the O 0 1.309697836293644e-11
manifestation O 0 1.42886891207894e-09
and O 0 3.067208292906187e-11
transmissibility O 0 8.009841678813245e-08
of O 0 3.573886464547371e-10
retinoblastoma B-Disease 0 1.5738146785793106e-08
depend O 0 6.832343579787903e-10
on O 0 8.434034581839001e-10
the O 0 5.23713815370197e-11
nature O 0 5.927531382399209e-11
of O 0 9.519294380533339e-11
the O 0 7.333624679750628e-11
first O 0 1.8677946689305003e-10
mutation O 0 4.562113881112495e-11
, O 0 1.6091248342467446e-12
its O 0 3.929367248245441e-12
time O 0 4.943201056817337e-11
in O 0 1.1703323206380123e-11
development O 0 9.003379708438786e-10
, O 0 2.807465024345923e-11
and O 0 4.1577997988984094e-11
the O 0 3.938044335072277e-10
number O 0 1.1312287911957597e-11
and O 0 4.3873901907354185e-12
types O 0 9.048238547304521e-11
of O 0 8.269123163984204e-10
cells O 0 1.4471403242399816e-10
that O 0 4.005996055711503e-12
are O 0 1.5052916595495458e-12
affected O 0 5.4196081650248473e-11
. O 0 2.1880383616057486e-10
. O 0 1.0915165660208004e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
of I-Disease 0 0.008728424087166786
the I-Disease 0 2.6678976610128302e-06
fifth I-Disease 0 4.676035700867942e-07
component I-Disease 0 4.1761154534469824e-09
of I-Disease 0 1.2939230131792101e-08
complement I-Disease 0 4.971777989304371e-10
in O 0 1.661021187260303e-08
man O 0 5.231373506831005e-06
. O 0 1.472487980436199e-07

I O 0 0.022366099059581757
. O 0 2.421248382233898e-06

Clinical O 0 1.1062466001021676e-06
, O 0 7.836892246260163e-10
immunochemical O 0 4.815615466213785e-05
, O 0 2.8431308418674917e-09
and O 0 1.2996557163802436e-09
family O 0 2.7098778776490917e-09
studies O 0 2.3842310348243245e-09
. O 0 1.342186273234347e-08

The O 0 6.712524980301282e-10
first O 0 1.758670466200929e-11
recognized O 0 2.925509877751975e-12
human O 0 2.1479483122699428e-11
kindred O 0 5.634087862915749e-09
with O 0 2.0543067247302815e-11
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999998807907104
the I-Disease 0 0.00144273042678833
fifth I-Disease 0 4.7205682562889706e-07
component I-Disease 0 3.1119968824100397e-09
of I-Disease 0 1.3916567809246772e-07
complement I-Disease 0 1.8036441673530135e-08
( O 0 3.1268296840636367e-09
C5 O 1 0.9025509357452393
) O 0 2.1244482562021716e-10
is O 0 8.806293194663084e-11
described O 0 4.538026843192711e-09
. O 0 1.3500169870894752e-08

The O 0 1.1083822926138964e-07
proband O 0 1.2454691386665218e-05
, O 0 1.0289200741420146e-10
a O 0 1.4596537867284098e-10
20 O 0 3.150384397798689e-10
- O 0 3.131392367627939e-11
year O 0 2.5891221458462788e-11
- O 0 1.9680188034776336e-10
old O 0 1.4248187352183805e-10
black O 0 1.5568294266590788e-12
female O 0 2.0436782691493627e-13
with O 0 5.913703229366851e-13
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9994168281555176
age O 0 0.018649032339453697
11 O 0 9.773010134495053e-08
, O 0 3.683128455000961e-11
lacked O 0 3.6845373418969984e-09
serum O 0 4.0710825821577146e-09
hemolytic O 0 2.570958201886242e-07
complement O 0 5.926834023561867e-10
activity O 0 1.288686757305868e-08
, O 0 2.0076910620114852e-11
even O 0 1.4735226927520273e-10
during O 0 1.1649378350853112e-08
remission O 0 1.0011508067009345e-07
. O 0 5.205305075861588e-09

C5 O 0 0.0009785527363419533
was O 0 6.47174010737217e-06
undetectable O 0 1.7496203952305223e-07
in O 0 1.5168273581611658e-10
her O 0 2.9012724514498878e-11
serum O 0 4.675649450947006e-11
by O 0 2.5758410161780265e-12
both O 0 1.2270598426233903e-10
immunodiffusion O 0 1.8624836002345546e-06
and O 0 2.0006185152965372e-08
hemolytic O 0 0.016767801716923714
assays O 0 1.35182644953602e-05
. O 0 6.146304372123268e-07

Other O 0 1.9270995910147803e-10
complement O 0 1.545121669499494e-11
components O 0 1.225485823930228e-10
were O 0 1.903114645041004e-11
normal O 0 2.1329825405924652e-10
during O 0 2.5510207835033327e-10
remission O 0 6.2829781377615745e-09
of O 0 6.627466908604163e-10
lupus O 0 1.37955936452272e-07
, O 0 3.092999745213376e-10
but O 0 2.433946821867039e-09
C1 O 0 1.980210754481959e-06
, O 0 9.523046351489484e-09
C4 O 0 4.894879566563759e-06
, O 0 1.4912113766030188e-09
C2 O 0 1.1698413260319285e-07
, O 0 5.066860264690831e-10
and O 0 2.471201021592151e-09
C3 O 0 0.00038027914706617594
levels O 0 3.7729955693066586e-07
fell O 0 1.2899816283606924e-05
during O 0 5.425222227017912e-08
exacerbations O 0 1.4440626728173811e-05
. O 0 2.3319572051150317e-08

A O 0 1.1554873253771802e-06
younger O 0 1.6361587640290054e-08
half O 0 2.806921806097762e-09
- O 0 6.847179712110574e-09
sister O 0 8.608032509016539e-09
, O 0 4.877900861011142e-11
who O 0 3.6381661572271184e-10
had O 0 3.0606892575946176e-09
no O 0 1.4774246714921446e-08
underlying O 0 0.23931458592414856
disease O 1 0.9985842704772949
, O 0 7.29814320088451e-10
was O 0 1.7101990579249104e-07
also O 0 2.1177848363862495e-10
found O 0 2.727761905241266e-10
to O 0 1.0786065374190912e-08
lack O 0 3.3705737223499455e-07
immunochemically O 0 0.00017739500617608428
detectable O 0 0.018953407183289528
C5 O 0 0.02598501555621624
. O 0 1.0895050763792824e-06

By O 0 2.0876637307765122e-08
hemolytic O 0 0.0012850851053372025
assay O 0 1.2848870483139763e-06
, O 0 5.581482498406842e-10
she O 0 1.3973981694004323e-11
exhibited O 0 6.323942671609961e-12
1 O 0 4.296435651696129e-09
- O 0 1.7740350299888519e-09
2 O 0 1.526412063412863e-08
% O 0 1.5787315899018495e-10
of O 0 8.127264833346359e-11
the O 0 2.2344556760423018e-10
normal O 0 3.843492191180076e-09
serum O 0 2.1595432109222656e-09
C5 O 0 8.691333874821794e-08
level O 0 5.910366418504509e-09
and O 0 2.650177646779106e-11
normal O 0 1.7776458083318403e-09
concentrations O 0 1.7643192462557522e-10
of O 0 4.794293434473573e-12
other O 0 4.357332094966082e-13
complement O 0 1.2160874737765504e-11
components O 0 7.170170013282018e-10
. O 0 2.6373518924316386e-09

C5 O 0 0.00012723264808300883
levels O 0 4.0292228220550896e-08
of O 0 2.211105076810327e-09
other O 0 1.7702474902625553e-11
family O 0 2.821626786386755e-11
members O 0 1.031800079404066e-12
were O 0 1.2997733965514069e-11
either O 0 1.661447507350644e-10
normal O 0 8.243269178365153e-09
or O 0 2.6704755073936326e-10
approximately O 0 2.0579903059481097e-10
half O 0 4.5060258302420664e-10
- O 0 1.437874486143187e-09
normal O 0 2.2365076457475652e-09
, O 0 2.8558878352458184e-12
consistent O 0 2.2905080609980644e-11
with O 0 5.188285781901336e-13
autosomal O 0 1.3433950840635589e-08
codominant O 0 4.581474968290422e-07
inheritance O 0 2.3721119291053583e-08
of O 0 1.97046134964296e-09
the O 0 6.795977669504794e-10
gene O 0 2.0412398438196533e-09
determining O 0 4.046407866553636e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.011240394494962e-05

Normal O 0 4.999980956199579e-05
hemolytic O 0 0.003837981726974249
titers O 0 4.029533101856941e-06
were O 0 3.6429295691142727e-10
restored O 0 1.7099945071041844e-10
to O 0 3.046558005870281e-10
both O 0 5.823503484991832e-11
homozygous O 0 4.1731716748927283e-08
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 1.1900418428467674e-07
C5D B-Disease 1 1.0
) O 0 1.4313894514117464e-09
sera O 0 6.450550760206397e-09
by O 0 8.721901781534591e-13
addition O 0 4.38670410760067e-12
of O 0 4.3420400608340515e-10
highly O 0 7.38335503847054e-10
purified O 0 1.763059565007552e-08
human O 0 1.773345736921783e-08
C5 O 0 0.00010965005640173331
. O 0 2.1427635488180385e-07

In O 0 6.83940104551084e-09
specific O 0 1.0494829005835982e-08
C5 O 0 2.3653234165976755e-05
titrations O 0 5.13409759150818e-07
, O 0 1.4781390000884187e-10
however O 0 1.1730123816722227e-10
, O 0 1.3579069292612989e-11
it O 0 1.1903618715725095e-11
was O 0 1.1748714223713819e-09
noted O 0 1.8277410834821595e-11
that O 0 5.039730026530631e-13
when O 0 2.4642217519993403e-12
limited O 0 6.553471740972094e-12
amounts O 0 1.6492444909754767e-10
of O 0 2.0812216394716643e-09
C5 O 0 7.852173666833551e-07
were O 0 1.2516703229437098e-09
assayed O 0 6.596320378804421e-09
in O 0 6.47862926500542e-12
the O 0 6.859273999487714e-12
presence O 0 8.513166842478992e-13
of O 0 3.594256142713803e-11
low O 0 1.4833760886290293e-09
dilutions O 0 2.675377785976707e-08
of O 0 3.915545387922492e-10
either O 0 7.754699105078089e-09
C5D B-Disease 1 1.0
serum O 0 8.52085548785908e-08
, O 0 2.7637074920261462e-11
curving O 0 2.2932817866916366e-09
rather O 0 1.610962058196108e-11
than O 0 1.2210334306150816e-11
linear O 0 4.966094202529803e-09
dose O 0 2.3239694613153006e-08
- O 0 1.681426387012408e-10
response O 0 4.3663028921614444e-12
plots O 0 4.5225229117207277e-10
were O 0 2.0117659274565547e-11
consistently O 0 1.4034829722009423e-11
obtained O 0 1.869026808321017e-11
, O 0 7.61782217167939e-12
suggesting O 0 7.035171750713332e-11
some O 0 8.894643702128668e-12
inhibitory O 0 1.911098301832226e-08
effect O 0 5.115105494724048e-08
. O 0 1.596346876908683e-08

Further O 0 4.598533820399098e-08
studies O 0 2.516855890366543e-10
suggested O 0 2.1068061184514875e-10
that O 0 1.091700167765719e-11
low O 0 4.581127477365499e-09
dilutions O 0 2.7176727712685533e-07
of O 0 3.2782661918417944e-08
C5D B-Disease 1 1.0
serum O 0 1.0913479009388993e-08
contain O 0 1.0043448711583025e-11
a O 0 9.347643319113086e-12
factor O 0 6.756628243009821e-12
( O 0 1.7548119804044332e-13
or O 0 4.375392062549999e-11
factors O 0 2.932126763610654e-10
) O 0 2.5147134808528593e-12
interfering O 0 1.1139169586726894e-09
at O 0 1.073124922257307e-09
some O 0 2.079361639470423e-12
step O 0 6.037139677061987e-10
in O 0 3.7086878706960036e-12
the O 0 5.2796631649920656e-11
hemolytic O 0 4.155222086410504e-07
assay O 0 1.045331927684856e-07
of O 0 1.2719269193439686e-07
C5 O 0 4.593254561768845e-05
, O 0 3.5019931399205007e-11
rather O 0 6.736053121542129e-12
than O 0 2.395129884355529e-12
a O 0 7.531000129068488e-11
true O 0 6.955971909583525e-10
C5 O 0 6.444060431931575e-07
inhibitor O 0 5.2458037913538647e-08
or O 0 1.6686891868289422e-09
inactivator O 0 7.159638926168554e-07
. O 0 1.3466481263435526e-08

Of O 0 4.6325763491950056e-07
clinical O 0 4.774601052304206e-07
interest O 0 1.608520427964777e-08
are O 0 2.1869315386391364e-11
( O 0 1.3119480328505073e-11
a O 0 1.392755494267206e-10
) O 0 7.280892468791711e-13
the O 0 2.727650137007709e-12
documentation O 0 1.2776524282998025e-10
of O 0 2.746168847878039e-10
membranous O 0 5.612594759440981e-05
glomerulonephritis B-Disease 1 1.0
, O 0 1.148689854346685e-08
vasculitis B-Disease 1 1.0
, O 0 1.0039825859564644e-08
and O 0 6.777938921231907e-08
arthritis B-Disease 1 1.0
in O 0 5.711931905238998e-08
an O 0 9.117661070590088e-10
individual O 0 1.5936499342394939e-10
lacking O 0 1.7736917357069615e-07
C5 O 0 9.212688746629283e-05
( O 0 8.921459404565013e-11
and O 0 1.9537234677291515e-11
its O 0 4.754301119458404e-11
biologic O 0 1.9618884294914096e-09
functions O 0 3.9431042524011584e-13
) O 0 2.6409494572774903e-14
, O 0 5.601350614348362e-14
and O 0 6.28085636885517e-13
( O 0 5.861197811818375e-12
b O 0 3.3774075203218956e-10
) O 0 1.0651291589176826e-13
a O 0 5.9549522431201485e-12
remarkable O 0 1.4355136870869423e-11
propensity O 0 9.984255200379266e-09
to O 0 6.3805085659396354e-09
bacterial B-Disease 1 0.9999997615814209
infections I-Disease 1 0.9356090426445007
in O 0 2.3086442479947067e-11
the O 0 8.426039033171406e-11
proband O 0 1.6349170905982646e-08
, O 0 1.067163805240634e-11
even O 0 1.011729935940231e-11
during O 0 1.814840222547076e-10
periods O 0 1.105885383267946e-09
of O 0 8.43670133754415e-11
low O 0 6.023567755697457e-10
- O 0 1.0038187642225083e-10
dose O 0 2.2133023191983625e-10
or O 0 4.572548069348148e-12
alternate O 0 7.502054533148339e-11
- O 0 5.859616680758961e-10
day O 0 1.6872701846804006e-10
corticosteroid O 0 6.130520802116735e-08
therapy O 0 2.0537289646682666e-09
. O 0 4.91935048252401e-10

Other O 0 3.015019789387452e-09
observations O 0 3.0273124451696276e-08
indicate O 0 6.262014240476788e-10
that O 0 1.9896520195294976e-11
the O 0 1.222358325669859e-09
C5D B-Disease 1 1.0
state O 0 1.670179328172594e-09
is O 0 1.3515454380663705e-11
compatible O 0 7.946072272391191e-11
with O 0 2.8700637786510663e-12
normal O 0 3.897247857764796e-09
coagulation O 0 2.4462663006374896e-09
function O 0 1.7362669635367922e-10
and O 0 3.5846213150558803e-12
the O 0 1.9873991341512465e-11
capacity O 0 1.4185595406668305e-11
to O 0 5.124237839604362e-11
mount O 0 3.224690914294115e-08
a O 0 1.275287253577062e-08
neutrophilic O 0 0.00015893795352894813
leukocytosis O 0 9.245555702364072e-06
during O 0 1.071553086262611e-07
pyogenic B-Disease 0 1.7709950043354183e-05
infection I-Disease 0 8.986642541231049e-08
. O 0 2.8724161937887516e-10
. O 0 2.896564543775071e-09

Susceptibility O 0 1.172399970528204e-05
to O 0 2.5111414743150817e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 4.270182671461953e-06
twins O 0 4.986712909271773e-08
: O 0 9.604419039591083e-13
the O 0 6.6842829014868155e-12
role O 0 6.87406078239694e-12
of O 0 8.396311423908287e-11
genes O 0 1.9537420292703445e-11
, O 0 1.0407463953143736e-11
HLA O 0 2.022044753857699e-07
, O 0 5.263214170048158e-11
and O 0 5.954659682005925e-11
the O 0 8.73657057809396e-09
environment O 0 4.533738007239663e-08
. O 0 3.2589458243137415e-08

OBJECTIVE O 0 1.2689984032476787e-05
To O 0 2.875810700686543e-09
determine O 0 3.125999181730066e-10
the O 0 1.52987258278392e-11
relative O 0 1.3503717033458429e-09
effects O 0 8.17098122496418e-09
of O 0 2.297866119604919e-09
genetic O 0 6.745226599491616e-10
and O 0 2.3256453186848436e-12
environmental O 0 3.517344471237749e-10
factors O 0 1.6906066824251553e-11
in O 0 8.349175842879697e-13
susceptibility O 0 1.5000555464439458e-08
to O 0 2.2183182863955153e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 7.065828526719997e-07
AS B-Disease 1 1.0
) O 0 5.104847100589893e-10
. O 0 1.5119119289863647e-09

METHODS O 0 2.4061666863417486e-06
Twins O 0 1.5303475819905543e-08
with O 0 5.349488755614085e-13
AS B-Disease 1 0.9999994039535522
were O 0 1.6067143275566576e-12
identified O 0 5.6701456138848194e-14
from O 0 3.0924451232183445e-14
the O 0 2.4212920622483647e-13
Royal O 0 3.5905969170135776e-11
National O 0 1.1563252438895333e-10
Hospital O 0 3.170836038179914e-08
for O 0 1.8125753120656896e-09
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 2.6283601073373575e-07
. O 0 9.35661432777124e-08

Clinical O 0 1.179148625851667e-06
and O 0 1.0818221873876155e-09
radiographic O 0 3.176780438707283e-08
examinations O 0 6.119877582477784e-08
were O 0 4.683593443632894e-11
performed O 0 3.9224163196974193e-13
to O 0 5.799789468130534e-12
establish O 0 1.4756094957046884e-10
diagnoses O 0 1.1702150715109383e-07
, O 0 3.2686289785921474e-10
and O 0 1.581940445305463e-08
disease O 0 0.27885720133781433
severity O 0 0.002648596651852131
was O 0 5.182058515629251e-08
assessed O 0 2.1591726184766458e-09
using O 0 5.759530439380933e-12
a O 0 1.1252528422933672e-11
combination O 0 2.0305125636443933e-11
of O 0 1.409154043452432e-10
validated O 0 1.5146540688348864e-09
scoring O 0 1.3590328862278511e-09
systems O 0 1.8566010950848977e-08
. O 0 1.5709355594140106e-08

HLA O 0 4.411723239172716e-06
typing O 0 2.749713567951062e-09
for O 0 2.5449894969220566e-10
HLA O 0 9.237346887402964e-08
- O 0 1.8183902383839268e-08
B27 O 0 1.2260029791377747e-07
, O 0 3.1607834405367186e-11
HLA O 0 4.22330392879644e-09
- O 0 1.4050913765828454e-09
B60 O 0 4.590339841570312e-08
, O 0 7.969092399862099e-12
and O 0 7.913447674923191e-11
HLA O 0 1.9813884932773362e-07
- O 0 1.655768073760555e-07
DR1 O 0 3.556327646947466e-05
was O 0 3.490260302996262e-09
performed O 0 1.9319851708027302e-12
by O 0 2.0985184076560692e-12
polymerase O 0 1.274046645960425e-09
chain O 0 1.2802112148158074e-10
reaction O 0 2.7258453740713895e-12
with O 0 4.0542590985792604e-13
sequence O 0 8.062061435110124e-12
- O 0 1.070384753054654e-11
specific O 0 1.8416151850025875e-12
primers O 0 1.7852493094938637e-10
, O 0 1.536421922847253e-12
and O 0 5.642553698587127e-12
zygosity O 0 1.0700641439598257e-07
was O 0 2.8998092815868404e-09
assessed O 0 3.568017215016539e-09
using O 0 9.164837638797607e-11
microsatellite O 0 1.4474379383955238e-07
markers O 0 3.4489151090610903e-08
. O 0 6.796370577433208e-09

Genetic O 0 1.0501255474082427e-06
and O 0 1.4984247176386134e-09
environmental O 0 1.7396565965555055e-08
variance O 0 4.14502387968696e-09
components O 0 5.873827535474163e-10
were O 0 1.8407591423352798e-11
assessed O 0 5.927602297894907e-10
with O 0 2.5538842958819363e-13
the O 0 7.26548682328243e-11
program O 0 2.0588411184241373e-11
Mx O 0 2.760538686530367e-09
, O 0 1.2796754758279127e-12
using O 0 6.066356726848465e-13
data O 0 6.642186258475069e-13
from O 0 6.276401382128427e-13
this O 0 1.4211524210043514e-13
and O 0 1.176277093306935e-13
previous O 0 6.172890323896674e-12
studies O 0 2.3315034798632173e-12
of O 0 1.4682812257693634e-11
twins O 0 3.473867304926159e-10
with O 0 1.1930303966956046e-11
AS B-Disease 1 1.0
. O 0 9.70587450410676e-08

RESULTS O 0 1.8209799179658148e-07
Six O 0 7.64247243267846e-09
of O 0 2.072704674560555e-09
8 O 0 1.0647605819258388e-07
monozygotic O 0 1.9128530936995958e-07
( O 0 1.7237423710625421e-09
MZ O 0 7.233607902890071e-06
) O 0 4.795054631134832e-11
twin O 0 5.995728358243468e-09
pairs O 0 3.653825159100066e-11
were O 0 2.4681615085064834e-10
disease O 0 1.5545893461421656e-08
concordant O 0 1.992676885720357e-07
, O 0 1.6453506959668296e-11
compared O 0 3.1999087407585947e-11
with O 0 8.448914853333156e-13
4 O 0 3.257056846450723e-08
of O 0 1.4537530068636784e-09
15 O 0 9.554375068887566e-09
B27 O 0 3.7831850363545527e-07
- O 0 7.127427092967764e-09
positive O 0 7.28312132824982e-11
dizygotic O 0 4.2634091812487895e-08
( O 0 1.6139922731639444e-10
DZ O 0 1.763600039339508e-07
) O 0 2.072219132398523e-12
twin O 0 1.8503770737865466e-10
pairs O 0 4.815589658806185e-13
( O 0 6.280017738474752e-13
27 O 0 2.5200659337087927e-09
% O 0 4.9616769026705754e-11
) O 0 2.5580964213220425e-13
and O 0 4.441139730276822e-12
4 O 0 8.452219368848546e-09
of O 0 1.415771389012832e-09
32 O 0 1.3315837321670188e-08
DZ O 0 6.831619430158753e-07
twin O 0 3.3142582012146704e-09
pairs O 0 8.323263085696642e-12
overall O 0 1.0114969278829378e-10
( O 0 6.798032189253567e-12
12 O 0 2.329595627514891e-09
. O 0 3.69380775966377e-11
5 O 0 4.543310172522297e-09
% O 0 2.7782007250287677e-10
) O 0 3.9056081285737676e-11
. O 0 3.2166176389125667e-09

Nonsignificant O 0 9.702052921056747e-05
increases O 0 6.097539362315274e-09
in O 0 1.660933370006834e-11
similarity O 0 8.322390519788225e-12
with O 0 5.612986136538205e-14
regard O 0 2.2576092037485118e-11
to O 0 7.353458120196166e-11
age O 0 1.1452676584866595e-09
at O 0 2.8766322657247656e-10
disease O 0 1.164586205248952e-09
onset O 0 2.092231810024714e-08
and O 0 3.38100706286093e-12
all O 0 5.783087550503829e-12
of O 0 4.305487910638561e-11
the O 0 8.802129164431349e-11
disease O 0 1.334239829731132e-09
severity O 0 7.0296795051660865e-09
scores O 0 7.215934794135848e-11
assessed O 0 1.6064592989195603e-09
were O 0 2.7428070231705348e-11
noted O 0 3.327746758707839e-11
in O 0 1.4791826097315663e-10
disease O 0 1.8147977698390605e-07
- O 0 2.669170271474286e-07
concordant O 0 4.447476385394111e-05
MZ O 0 0.0002572457306087017
twins O 0 7.620609032699122e-09
compared O 0 3.6982653051076397e-10
with O 0 3.528874067959542e-11
concordant O 0 0.00012125330249546096
DZ O 0 0.11032473295927048
twins O 0 1.36765868319344e-06
. O 0 7.172994287429901e-08

HLA O 0 9.861925718723796e-06
- O 0 3.1433955882675946e-07
B27 O 0 8.152783834702859e-07
and O 0 5.840199157614023e-11
B60 O 0 9.619475349609274e-08
were O 0 6.4397718928244085e-12
associated O 0 3.5675763558618012e-12
with O 0 3.2780378346648764e-14
the O 0 1.1042196323973741e-10
disease O 0 5.104282552181871e-10
in O 0 1.1621596913979904e-11
probands O 0 3.2412606287834933e-07
, O 0 1.2320474501725798e-11
and O 0 6.199354831565307e-12
the O 0 3.2131083904651803e-10
rate O 0 1.0884001255817566e-08
of O 0 9.844506321243784e-10
disease O 0 1.0746207479428449e-08
concordance O 0 1.241692859643706e-09
was O 0 1.1923076415065736e-10
significantly O 0 2.396552400973917e-11
increased O 0 6.103723776407222e-11
among O 0 8.987414111538694e-12
DZ O 0 8.64845219439303e-07
twin O 0 9.412565837862985e-09
pairs O 0 2.691961670936438e-12
in O 0 5.539855683564521e-13
which O 0 3.59967237224465e-13
the O 0 3.083126809411141e-11
co O 0 1.9216084279349843e-10
- O 0 9.400648037782844e-10
twin O 0 8.558244113388014e-10
was O 0 1.2191025966501456e-10
positive O 0 2.6176115311762893e-13
for O 0 1.199255863885973e-12
both O 0 3.25299162606818e-11
B27 O 0 3.0904786854080157e-06
and O 0 8.270042428648594e-09
DR1 O 1 0.8262782096862793
. O 0 1.7858546641491557e-07

Additive O 0 8.023891950870166e-07
genetic O 0 6.54332978911043e-08
effects O 0 6.5625753720155444e-09
were O 0 5.439989778088794e-11
estimated O 0 6.5482237687763956e-12
to O 0 8.475098227378464e-12
contribute O 0 6.657969314760592e-12
97 O 0 9.334539807781539e-10
% O 0 7.192588885596152e-11
of O 0 1.5177699375090725e-11
the O 0 2.213398388184462e-11
population O 0 2.546968061803434e-12
variance O 0 7.640796440000486e-09
. O 0 1.0216814061436708e-08

CONCLUSION O 0 6.24313106527552e-05
Susceptibility O 0 4.3688596633728594e-05
to O 0 1.1901258289981342e-07
AS B-Disease 1 1.0
is O 0 2.1564673657881173e-10
largely O 0 6.266718394210002e-11
genetically O 0 8.588782463014866e-12
determined O 0 1.0831265051525207e-10
, O 0 2.6413149011722536e-12
and O 0 3.688828322662152e-12
the O 0 3.4948149929547867e-10
environmental O 0 6.552831610662224e-09
trigger O 0 1.9610586932117258e-08
for O 0 1.4066889320041298e-10
the O 0 3.8378679789730086e-08
disease O 0 3.75356171389285e-06
is O 0 5.604565075922885e-11
probably O 0 1.99072069939632e-09
ubiquitous O 0 1.042804509410189e-08
. O 0 1.7605726654323917e-08

HLA O 0 4.917071419185959e-05
- O 0 3.354149669121398e-07
B27 O 0 2.2105376729086856e-07
accounts O 0 7.754002518192693e-13
for O 0 6.015140100422423e-14
a O 0 1.7319522552239341e-12
minority O 0 1.979846408345365e-12
of O 0 2.4341115928416812e-11
the O 0 1.455322529153591e-10
overall O 0 8.289430808439135e-10
genetic O 0 2.0522653798593637e-08
susceptibility O 0 1.7180656868731603e-05
to O 0 2.4522702005924657e-05
AS B-Disease 1 1.0
. O 0 1.9040635379496962e-06

Cell O 0 3.2830862437549513e-06
cycle O 0 3.813176761013892e-07
- O 0 1.2543667438080774e-08
dependent O 0 1.2932248161234838e-08
colocalization O 0 4.2287226165171887e-07
of O 0 1.2620655631678801e-08
BARD1 O 0 0.0009229804272763431
and O 0 3.5280696142336865e-09
BRCA1 O 0 1.3401494358689092e-09
proteins O 0 1.0356552421209031e-11
in O 0 1.2411209213136765e-11
discrete O 0 4.401033315559744e-09
nuclear O 0 1.7300329773206613e-06
domains O 0 1.2618436358025065e-06
. O 0 4.990832991325078e-08

Germ O 0 1.335696561000077e-05
- O 0 8.772342141583067e-08
line O 0 2.1982597075975718e-08
mutations O 0 5.049937690237982e-10
of O 0 1.8316786976058097e-10
the O 0 1.9140219964519645e-10
BRCA1 O 0 4.6014242416347884e-10
gene O 0 4.9296611931426426e-11
predispose O 0 1.0514745518719337e-08
women O 0 9.70468497230037e-13
to O 0 2.3255888534357005e-11
early O 0 1.0481129919526211e-07
- O 0 3.917121375707211e-06
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 6.468405899795471e-08
compromising O 0 1.6763405596975645e-07
the O 0 1.183070796884067e-08
genes O 0 6.694854670641348e-10
presumptive O 0 2.0715475557153695e-08
function O 0 9.669055139882587e-11
as O 0 3.371405585261833e-12
a O 0 1.7535935203927266e-10
tumor B-Disease 0 1.817388692870736e-07
suppressor O 0 4.3989307414449286e-06
. O 0 9.908525555601955e-08

Although O 0 1.1995854976021292e-08
the O 0 9.651430765700297e-09
biochemical O 0 3.126014291865431e-08
properties O 0 7.153020220584949e-08
of O 0 7.247684408184796e-08
BRCA1 O 0 4.262124519982535e-08
polypeptides O 0 1.2203454913262135e-09
are O 0 7.070570799856679e-13
not O 0 3.857410918461923e-12
understood O 0 2.1303509303849388e-11
, O 0 1.1143403907953875e-12
their O 0 4.1601910718419566e-13
expression O 0 6.10335957121344e-12
pattern O 0 2.418323319375304e-10
and O 0 7.622312503396955e-12
subcellular O 0 3.486628941118397e-08
localization O 0 1.881813993520609e-08
suggest O 0 4.915252094228606e-10
a O 0 6.485234571584897e-11
role O 0 8.044968857756629e-11
in O 0 7.798790085944418e-11
cell O 0 7.506857357952867e-09
- O 0 3.372029411252697e-08
cycle O 0 5.192664787045942e-08
regulation O 0 1.077146905004156e-08
. O 0 4.331653258304868e-09

When O 0 4.456202020719502e-07
resting O 0 3.087091045017587e-06
cells O 0 2.2772328467368652e-09
are O 0 1.4428594603821399e-11
induced O 0 1.640821523096747e-08
to O 0 1.8468098161861235e-09
proliferate O 0 1.6287381443547133e-09
, O 0 5.122886923697445e-12
the O 0 4.9260612949852955e-11
steady O 0 5.205630371207803e-10
- O 0 8.421620345533398e-11
state O 0 7.183361544482736e-11
levels O 0 1.4841762541184522e-10
of O 0 8.989784611168616e-11
BRCA1 O 0 2.408224175631801e-10
increase O 0 6.445452505055016e-11
in O 0 3.0181582927335526e-11
late O 0 1.4526401059811178e-07
G1 O 0 4.022985056195694e-09
and O 0 1.228311397906412e-12
reach O 0 1.0583871279390422e-10
a O 0 6.626322320707478e-12
maximum O 0 1.1002425637229862e-09
during O 0 9.112149923495849e-10
S O 0 3.6076207265978155e-07
phase O 0 1.5552988941180956e-07
. O 0 1.0740737188541516e-08

Moreover O 0 1.9846223153763276e-07
, O 0 6.962184162517815e-10
in O 0 1.718948761109118e-09
S O 0 5.016810519009596e-06
phase O 0 1.4764634670427768e-06
cells O 0 1.5675823972216563e-09
, O 0 5.164309258010036e-11
BRCA1 O 0 9.338617656950987e-10
polypeptides O 0 3.483215660349259e-10
are O 0 3.5496705401427686e-12
hyperphosphorylated O 0 1.5291746535694983e-08
and O 0 1.7382054129377877e-10
accumulate O 0 5.036345784859009e-10
into O 0 1.5744194836742054e-10
discrete O 0 9.506458731323164e-09
subnuclear O 0 2.5212607397406828e-06
foci O 0 1.2190827192171128e-06
termed O 0 1.1462324778221955e-07
" O 0 4.472362746810177e-08
BRCA1 O 0 5.274618786188512e-08
nuclear O 0 2.397051048319554e-06
dots O 0 6.159360168567218e-07
. O 0 7.772901966518475e-08

" O 0 4.403379534778651e-06
BRCA1 O 0 2.421271801722469e-06
associates O 0 9.257454536282239e-08
in O 0 1.2346410560581944e-09
vivo O 0 5.030501792901987e-09
with O 0 2.7529523799474376e-12
a O 0 1.4391869029850568e-08
structurally O 0 7.806180519764894e-07
related O 0 1.2213396871629811e-07
protein O 0 4.295210601412691e-06
termed O 0 6.421578746085288e-06
BARD1 O 1 0.9988275170326233
. O 0 4.484227531520446e-07

Here O 0 5.2710181108750476e-08
we O 0 6.195164936606545e-10
show O 0 3.188795755226792e-11
that O 0 1.1517567498689485e-12
the O 0 2.902014045735868e-11
steady O 0 6.367557592312778e-10
- O 0 2.473019844462243e-10
state O 0 7.170002092049543e-11
levels O 0 8.206806900723507e-10
of O 0 2.3367546786445814e-10
BARD1 O 0 5.1499246183084324e-05
, O 0 2.4107875418177827e-11
unlike O 0 7.263806743595946e-12
those O 0 4.553166871312797e-12
of O 0 1.7625599590953556e-10
BRCA1 O 0 1.1584229131500479e-09
, O 0 9.24801294571731e-12
remain O 0 2.534930772235544e-11
relatively O 0 6.207803802255052e-12
constant O 0 1.8930079725976157e-10
during O 0 2.193709880415895e-09
cell O 0 7.867887319434885e-08
cycle O 0 1.3375712626384484e-07
progression O 0 4.8823299181322e-08
. O 0 3.3525195952677223e-09

However O 0 3.8300726146189845e-08
, O 0 7.572169002934004e-10
immunostaining O 0 1.0204232239630073e-05
revealed O 0 4.137474363119509e-08
that O 0 4.488518445810996e-10
BARD1 O 0 0.000490341626573354
resides O 0 6.2577907300465085e-09
within O 0 2.5838999828664555e-09
BRCA1 O 0 6.578654510036586e-09
nuclear O 0 5.68078121432336e-07
dots O 0 3.2831202201322185e-09
during O 0 1.958463613505046e-09
S O 0 1.7023875642507846e-08
phase O 0 6.201919422466062e-09
of O 0 1.490698675610247e-10
the O 0 1.4393225500342055e-10
cell O 0 3.298754602809595e-10
cycle O 0 7.046859207271439e-10
, O 0 7.463169622232146e-13
but O 0 2.420406540123987e-12
not O 0 2.2661166346193973e-11
during O 0 1.1464171834063563e-09
the O 0 7.499797449739276e-10
G1 O 0 7.569389026684803e-08
phase O 0 1.0530725802482266e-07
. O 0 3.716298602185475e-09

Nevertheless O 0 1.4861176396152587e-06
, O 0 8.553483255013816e-09
BARD1 O 0 0.0002821346861310303
polypeptides O 0 3.983913998695243e-08
are O 0 5.90626679508599e-12
found O 0 8.993376789806495e-13
exclusively O 0 3.063007204644197e-13
in O 0 1.7616844398202214e-12
the O 0 5.557980811699004e-11
nuclear O 0 5.138554826089603e-08
fractions O 0 2.9459186201563625e-09
of O 0 3.187423103234721e-10
both O 0 2.7431576107850297e-11
G1 O 0 5.6211217902557564e-09
- O 0 2.7017186265965165e-09
and O 0 1.7541823549294122e-10
S O 0 1.4089329170019482e-07
- O 0 1.4044785778821733e-08
phase O 0 5.040435269165755e-08
cells O 0 8.716460331292808e-10
. O 0 6.240623573461335e-10

Therefore O 0 9.536427114653634e-08
, O 0 6.261942631091699e-10
progression O 0 1.0642871473010018e-08
to O 0 1.3510751406542454e-09
S O 0 1.5575238876408548e-07
phase O 0 6.00316880650098e-08
is O 0 1.6652527880939294e-12
accompanied O 0 2.578318418142156e-12
by O 0 1.3624516011917498e-12
the O 0 7.254533779255112e-11
aggregation O 0 4.057862657003142e-10
of O 0 3.65539543079052e-10
nuclear O 0 8.272110108009656e-07
BARD1 O 0 0.00012282360694371164
polypeptides O 0 1.650936098940292e-08
into O 0 8.897981906841324e-09
BRCA1 O 0 2.0972741765490355e-08
nuclear O 0 4.943528892908944e-07
dots O 0 8.998340206289868e-08
. O 0 1.6882633957493454e-08

This O 0 5.727179619441358e-09
cell O 0 2.9393813605338437e-08
cycle O 0 2.5070796993986733e-08
- O 0 1.0992630139483595e-09
dependent O 0 1.721888964745233e-09
colocalization O 0 1.671363207833565e-07
of O 0 6.263450647026048e-09
BARD1 O 0 0.0015513069229200482
and O 0 1.744706712436539e-09
BRCA1 O 0 4.838782263760777e-09
indicates O 0 6.082467862711383e-11
a O 0 5.2167979137929255e-12
role O 0 7.19697652168394e-12
for O 0 1.2887978878550754e-11
BARD1 O 0 0.00035267602652311325
in O 0 1.2701094398437363e-08
BRCA1 O 0 2.82507841120605e-07
- O 0 2.335749286430655e-06
mediated O 0 0.0007111727027222514
tumor B-Disease 1 0.9941582679748535
suppression O 0 5.60154467166285e-06
. O 0 2.736237725287083e-08

Ethnic O 0 3.956192173859563e-08
differences O 0 8.804858175892605e-09
in O 0 3.187970165630105e-10
the O 0 3.976480034140195e-09
HFE O 0 8.205644917325117e-06
codon O 0 1.561628891977307e-06
282 O 0 4.3958846163150156e-07
( O 0 4.844157075467592e-09
Cys O 0 7.933229062473401e-05
/ O 0 4.1041835174837615e-06
Tyr O 0 3.6185992939863354e-06
) O 0 1.8645057719979263e-10
polymorphism O 0 2.279037225605407e-08
. O 0 7.148284630886792e-09

Recent O 0 2.856088254787892e-09
studies O 0 1.2290033574169357e-11
have O 0 1.2320369334115067e-13
shown O 0 7.004743464954222e-13
that O 0 1.8364712528473603e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.0231249802927778e-07
HH B-Disease 1 0.953399658203125
) O 0 3.927518379964745e-11
is O 0 6.95031532327306e-12
likely O 0 1.000145660734475e-10
to O 0 7.020319742201409e-11
be O 0 8.529981582183765e-11
caused O 0 1.1540096656048604e-10
by O 0 5.4586023201519396e-12
homozygosity O 0 1.8077011887385197e-08
for O 0 1.576726769980663e-11
a O 0 5.241627687446737e-10
Cys282Tyr O 0 2.2993103243607038e-07
mutation O 0 4.895501226620524e-10
in O 0 5.783376902379622e-11
the O 0 1.971874885597913e-09
HFE O 0 1.4002616808284074e-05
gene O 0 4.532628938846983e-09
located O 0 4.109356410708642e-09
4 O 0 3.8632470023003407e-07
. O 0 2.8735753332398417e-08

5 O 0 7.5313505476515274e-06
Mb O 0 1.060595332091907e-05
telomeric O 0 7.0521823545277584e-06
to O 0 6.19904199083976e-07
HLA O 0 9.404667252965737e-06
- O 0 1.9117588578865252e-07
A O 0 2.769754701148486e-07
. O 0 9.034882175740222e-09

Population O 0 5.154881729807492e-11
studies O 0 7.111948616828068e-12
of O 0 3.234990834238838e-12
this O 0 1.2846201966759674e-12
polymorphism O 0 2.172435703551301e-10
are O 0 7.306852063508618e-13
facilitated O 0 7.213330193572842e-12
by O 0 5.762846796986132e-13
the O 0 1.1313150936886895e-11
fact O 0 7.223129971749287e-13
that O 0 3.193454615330049e-13
the O 0 2.8837227744604732e-11
Cys282Tyr O 0 1.668472719984493e-07
mutation O 0 5.681158654624596e-09
creates O 0 5.140500802802705e-10
a O 0 3.0055460342737206e-09
Rsal O 0 3.0446142318396596e-06
restriction O 0 1.1470821448256174e-07
site O 0 2.204810378714228e-08
. O 0 5.473665520838722e-09

We O 0 7.487369657610543e-08
have O 0 9.01285920895667e-11
studied O 0 7.719925809723804e-10
the O 0 2.557846434658728e-10
codon O 0 1.017818629378553e-08
282 O 0 1.6207282627078712e-08
( O 0 1.7905290583541955e-09
Cys O 0 2.8117996407672763e-05
/ O 0 5.447400326374918e-07
Tyr O 0 1.5100199846074247e-07
) O 0 3.7739353742766157e-13
polymorphism O 0 5.161017880422891e-12
in O 0 5.938499881728496e-14
different O 0 1.3612397985879581e-14
ethnic O 0 1.9506059094342998e-12
groups O 0 6.873505670884628e-13
. O 0 2.7880106556743556e-10

In O 0 1.4464180964068873e-09
agreement O 0 2.337809235086752e-08
with O 0 8.185511296554537e-11
previous O 0 3.600134590442394e-08
observations O 0 1.2633468493561395e-08
the O 0 1.1806648991807833e-09
Tyr O 0 3.3377570929360445e-08
allele O 0 8.807473639294017e-10
appeared O 0 1.4854195651281543e-10
to O 0 3.505053539076819e-11
be O 0 1.4989549532162805e-11
rare O 0 2.7457485937687487e-11
or O 0 2.191242742810573e-09
absent O 0 3.0699517594712233e-08
in O 0 2.070901644612988e-10
Asiatic O 0 6.061523283307224e-09
( O 0 8.8128089895112e-12
Indian O 0 2.0677520806700045e-10
, O 0 6.100519828883266e-12
Chinese O 0 4.2353251981930295e-12
) O 0 5.550858384051338e-12
populations O 0 2.969354970239202e-11
. O 0 6.842320043887185e-10

The O 0 3.175986762471439e-08
highest O 0 1.7499866444836698e-08
allele O 0 2.2679685907078806e-10
frequency O 0 9.83613523963811e-10
( O 0 7.710367934399276e-12
7 O 0 1.026341123200325e-09
. O 0 4.385632915854254e-12
5 O 0 9.43664812957934e-10
% O 0 5.3381705306110305e-11
) O 0 1.477869801362608e-12
was O 0 5.250843648774151e-10
found O 0 1.9539692780456974e-11
in O 0 7.907503124515713e-11
Swedes O 0 6.252126638628397e-08
. O 0 2.014921740567388e-08

Saamis O 0 3.899788134731352e-05
( O 0 1.7005531427471965e-09
2 O 0 2.6659597551770275e-07
% O 0 6.536725050132475e-10
) O 0 1.5312874666190135e-12
and O 0 1.4081861544890106e-11
Mordvinians O 0 7.626371001379084e-08
( O 0 2.5712675044697875e-11
1 O 0 1.0690152763004335e-08
. O 0 2.612436829363407e-11
8 O 0 2.49415776920614e-09
% O 0 5.161729724201258e-11
) O 0 7.22770476281609e-13
had O 0 2.211663838180833e-11
significantly O 0 1.64841022776141e-11
lower O 0 8.943181611931195e-11
frequencies O 0 1.8740037299735945e-10
of O 0 1.2459150378063555e-10
the O 0 5.835881777827012e-10
Tyr O 0 4.567915539155365e-07
allele O 0 4.949010090626871e-08
. O 0 7.0619190495335715e-09

Comparisons O 0 1.4392472991175964e-08
with O 0 7.679634705937133e-12
allele O 0 1.238364549793758e-10
frequencies O 0 2.440829482974749e-11
based O 0 2.6138160646310693e-12
on O 0 4.036033729448718e-10
prevalence O 0 7.902200005460713e-10
estimates O 0 1.7023274456740012e-10
of O 0 1.8448101934964711e-09
HH B-Disease 0 0.00573982298374176
showed O 0 6.9874110941725576e-09
some O 0 3.932038028509055e-11
disagreements O 0 6.931725415881829e-09
with O 0 7.370571167286677e-12
the O 0 9.773001297119777e-10
RFLP O 0 2.9780656163325148e-08
data O 0 7.035574206559758e-11
, O 0 3.0449165324547556e-12
particularly O 0 3.043269108937707e-11
in O 0 5.980295147978154e-10
Finns O 0 5.386987567135293e-08
. O 0 2.1739591460345764e-08

The O 0 4.549017873500816e-08
newly O 0 1.5180647849888373e-08
described O 0 8.558559194682402e-09
HFE O 0 2.1436870156321675e-05
marker O 0 3.283867400227791e-08
provides O 0 1.0070879893908646e-11
a O 0 1.4808586648595856e-11
new O 0 6.8239233708133895e-12
approach O 0 6.913246364259606e-11
to O 0 2.7169086425082867e-11
the O 0 7.113169862155155e-12
screening O 0 3.110676299877824e-11
of O 0 8.730998563022396e-11
HH B-Disease 0 6.044913607183844e-05
as O 0 1.6274609437871845e-10
well O 0 6.99759000744038e-12
as O 0 3.015463746758318e-12
studies O 0 2.6140504691407607e-12
of O 0 2.1446232376792773e-12
the O 0 1.6753647080758327e-12
relationship O 0 3.3035113273377492e-12
between O 0 1.6922659107354576e-10
the O 0 1.5559175059465247e-09
HFE O 0 2.8214856229169527e-06
Tyr O 0 2.8662736895057606e-07
allele O 0 7.786575828561126e-10
and O 0 4.28451414971609e-12
different O 0 6.964382195939756e-12
disorders O 0 9.826643463384244e-07
including O 0 8.908375370708654e-09
cancer B-Disease 1 0.9999997615814209

Autosomal B-Disease 1 0.9999960660934448
dominant I-Disease 1 0.9999322891235352
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999891519546509
associated O 0 3.894677025328974e-09
with O 0 5.579060650962031e-12
a O 0 5.018519488864115e-10
missense O 0 1.486418721441396e-08
mutation O 0 5.043122586201321e-10
encoding O 0 2.132754806094539e-10
Gly23 O 0 2.3535001503205422e-07
- O 0 6.027434551469923e-08
- O 0 7.524965894845081e-08
> O 0 5.2918100124088596e-08
Val O 0 7.377333854918788e-09
in O 0 1.3132404885762838e-10
neurophysin O 0 7.199502078947262e-07
II O 0 0.0007492015138268471
. O 0 4.921153049508575e-07

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.2566641888488448e-09
ADNDI B-Disease 1 0.9999830722808838
) O 0 3.2361758672133645e-12
is O 0 1.3873481356785344e-12
an O 0 2.1512540360202337e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 3.033694326859404e-07
by O 0 3.6239269918247885e-10
progressive O 0 0.0008293097489513457
degeneration O 1 1.0
of O 0 9.053505345946178e-05
the O 0 2.8801497364838724e-07
magnocellular O 0 5.309016728460847e-07
neurons O 0 6.712377143003323e-08
of O 0 8.65470894950704e-08
the O 0 2.2057147219811668e-08
hypothalamus O 0 7.04862657130434e-08
leading O 0 1.5247884732616512e-08
to O 0 7.543715874192003e-09
decreased O 0 9.208950935146731e-09
ability O 0 6.944567837452453e-11
to O 0 2.7265982804891564e-09
produce O 0 2.265397425205151e-09
the O 0 1.3088109263037495e-08
hormone O 0 4.3906259183934537e-10
arginine O 0 7.230946064140653e-09
vasopressin O 0 3.323286179579554e-08
( O 0 2.1703163710640183e-09
AVP O 0 1.794179638636706e-06
) O 0 9.373141846014121e-11
. O 0 1.0708023356897911e-09

Affected O 0 3.3108605634879495e-08
individuals O 0 4.296759129052141e-11
are O 0 4.065651895007738e-12
not O 0 9.049618693302008e-11
symptomatic O 0 4.127566910483438e-08
at O 0 3.6981682161041363e-09
birth O 0 1.113993453039086e-09
, O 0 1.7512853146828267e-12
but O 0 5.405482918913185e-12
usually O 0 1.3243940666374243e-10
develop O 0 2.19518483390857e-07
diabetes B-Disease 1 0.9999998807907104
insipidus I-Disease 0 0.48854926228523254
at O 0 1.0091855529026361e-06
1 O 0 7.442785317834932e-06
- O 0 3.289736923761666e-06
6 O 0 5.373798103391891e-06
yr O 0 4.9734940148482565e-06
of O 0 4.802052089303288e-09
age O 0 3.029478534699592e-08
. O 0 3.639500700813869e-09

The O 0 4.095233041567781e-09
genetic O 0 5.400541680522508e-10
locus O 0 9.4403207473448e-10
of O 0 1.590155090935852e-10
the O 0 1.4750249910377988e-09
disease O 0 8.086754519354145e-07
is O 0 1.2396571269501777e-10
the O 0 9.639326670196624e-09
AVP O 0 1.1475593964860309e-05
- O 0 1.712841481094074e-06
neurophysin O 0 0.00013369049702305347
II O 1 0.998207688331604
( O 0 6.98109614560849e-09
NPII O 0 0.0005804201937280595
) O 0 1.3008157051519476e-10
gene O 0 2.857523939692186e-11
, O 0 3.4199284029701182e-12
and O 0 1.6172610126097275e-11
mutations O 0 4.061765090934699e-10
that O 0 6.609259667333944e-11
cause O 0 6.895530191286525e-07
ADNDI B-Disease 1 0.9990170001983643
have O 0 5.976076300484578e-10
been O 0 5.723701027027239e-11
found O 0 3.0950133948770553e-13
in O 0 1.7472339493198458e-13
both O 0 1.5831406281405225e-13
the O 0 5.514725395089348e-12
signal O 0 1.2028283924436778e-10
peptide O 0 2.855455039085797e-10
of O 0 1.4970078510145868e-09
the O 0 1.5536103514790511e-09
prepro O 0 4.222982170176692e-06
- O 0 2.2703032300341874e-05
AVP O 0 1.3501966350304428e-05
- O 0 3.9953596342456876e-07
NPII O 0 8.875441380951088e-06
precursor O 0 3.022343708636299e-09
and O 0 1.206762034050568e-11
within O 0 4.961054900221029e-10
NPII O 0 0.00016399267769884318
itself O 0 4.024144129033402e-09
. O 0 6.2790004307089475e-09

An O 0 2.81483503172808e-09
affected O 0 4.7345509734952884e-09
girl O 0 9.297584036005446e-09
who O 0 5.69795148563923e-11
presented O 0 4.793198477015537e-11
at O 0 5.219111809395827e-10
9 O 0 4.2798000698951455e-09
months O 0 3.6243280598924343e-10
of O 0 2.019336364789126e-10
age O 0 1.0740381917173636e-09
and O 0 8.288568616177105e-12
her O 0 8.60495008581097e-12
similarly O 0 3.706863375280145e-12
affected O 0 1.5218726279186967e-10
younger O 0 8.42639624742958e-10
brother O 0 1.3065561965674988e-08
and O 0 9.027763536728628e-10
father O 0 3.524916891706198e-08
were O 0 2.825214784341057e-10
all O 0 8.403244246280028e-12
found O 0 4.2535945469004965e-13
to O 0 1.8305175084054603e-12
have O 0 6.577935218006134e-14
a O 0 3.435252299635594e-12
novel O 0 3.371458667800198e-11
missense O 0 9.570608305864425e-09
mutation O 0 1.3906299445309855e-09
( O 0 3.8284087705564573e-11
G1758 O 0 1.3347856508971745e-07
- O 0 1.1403447786051402e-07
- O 0 4.4257421905058436e-07
> O 0 4.9982158856209935e-08
T O 0 1.6277722503232894e-09
) O 0 1.8576306671288373e-13
encoding O 0 5.049872195753147e-13
the O 0 3.965849176834624e-11
amino O 0 3.386934135929387e-11
acid O 0 4.084103281259965e-12
substitution O 0 4.536324007403669e-12
Gly23 O 0 1.0920850002094085e-08
- O 0 8.810334684028476e-09
- O 0 3.307994589363261e-08
> O 0 6.363617188753778e-08
Val O 0 1.3213472982442909e-08
within O 0 3.399823755856346e-09
NPII O 0 5.681377660948783e-05
. O 0 2.6863355984119153e-08

The O 0 2.756810602022597e-07
mutation O 0 5.369074962402465e-09
was O 0 1.1361558360789559e-09
confirmed O 0 1.5815760159854086e-11
by O 0 3.3630947419288626e-12
restriction O 0 1.169068508666271e-09
endonuclease O 0 1.068461159547951e-07
analysis O 0 1.946598660040877e-09
. O 0 5.369423128342987e-09

A O 0 9.084622433874756e-05
T1 O 0 0.0008063118439167738
- O 0 8.399476882914314e-07
weighted O 0 1.28402506405223e-08
magnetic O 0 5.287287052624379e-09
resonance O 0 2.1056862919976993e-09
imaging O 0 7.222870834766582e-08
of O 0 5.316928231025031e-09
the O 0 3.284318239593631e-08
fathers O 0 1.3368742202146677e-06
pituitary O 0 2.250162469863426e-05
gland O 0 1.7220694417119375e-06
demonstrates O 0 3.828040551212553e-09
an O 0 7.097767928954113e-10
attenuated O 0 1.056463929671736e-06
posterior O 0 0.004649174865335226
pituitary O 1 0.9941440224647522
bright O 0 6.107085209805518e-05
spot O 0 5.233464980847202e-05
. O 0 2.0365398256672052e-07

This O 0 3.249908075986241e-08
mutation O 0 3.509233081899765e-08
may O 0 7.499687093570628e-09
be O 0 1.1804661415037998e-10
valuable O 0 1.2040811923907935e-11
for O 0 5.563384497010715e-13
developing O 0 8.176705840190479e-12
models O 0 5.374520273271344e-11
of O 0 2.087519268556548e-09
dominantly B-Disease 0 1.0586652933852747e-05
inherited I-Disease 0 0.20563694834709167
neurodegeneration I-Disease 1 1.0
, O 0 5.662674495976461e-11
as O 0 9.62330584143578e-13
the O 0 6.04434308593832e-13
early O 0 1.7780542663214938e-11
age O 0 2.033776272392096e-11
of O 0 8.962318734373476e-12
onset O 0 8.881300345819909e-06
of O 0 5.2621683011011555e-08
symptoms O 0 2.4584815037087537e-06
suggests O 0 1.1654055498411253e-10
that O 0 1.962222268350744e-12
this O 0 2.641588163487807e-11
mutation O 0 1.4986475393996557e-09
may O 0 1.885718470262532e-09
be O 0 1.1914801090195937e-10
particularly O 0 4.996530619805206e-11
deleterious O 0 1.2726196985113347e-07
to O 0 1.9916218008120268e-08
the O 0 1.1335718141936013e-08
magnocellular O 0 1.9712128107585158e-07
neuron O 0 4.267168378646602e-07
. O 0 4.125132679888566e-09
. O 0 2.4694635669675336e-08

Frequent O 0 6.174926880930798e-08
inactivation O 0 1.0618827218422666e-05
of O 0 3.23057065543253e-07
PTEN O 0 0.3907201886177063
/ O 0 0.00010495409514987841
MMAC1 O 1 0.9999929666519165
in O 0 6.039333300122962e-08
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00013718107948079705

Sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 2.1590232790913433e-05
the O 0 2.1028418117907677e-08
most O 0 1.1765499165206084e-11
common O 0 2.5498869682394343e-10
male B-Disease 0 1.782520381299335e-10
cancer I-Disease 0 4.4127229648083244e-10
in O 0 4.129661022866937e-12
the O 0 3.565047562714696e-11
Western O 0 1.3999177372880922e-09
world O 0 2.2021003076577728e-11
, O 0 8.928906333922904e-13
yet O 0 3.195649907888898e-12
many O 0 3.0374133926352326e-14
of O 0 4.1502070877164066e-12
the O 0 4.313853961546155e-12
major O 0 3.5609497989197436e-11
genetic O 0 6.1010202966060856e-12
events O 0 1.5335637219750925e-13
involved O 0 9.944589639612755e-13
in O 0 2.0838918698279363e-12
the O 0 6.376292549514773e-11
progression O 0 4.284291588163569e-09
of O 0 3.016730962257519e-11
this O 0 2.7481326242417836e-11
often O 0 3.769703993405926e-10
fatal O 0 1.7778567780624144e-05
cancer B-Disease 0 0.0024472486693412066
remain O 0 2.6401062669378916e-08
to O 0 9.330200612112094e-09
be O 0 1.3073637283866901e-08
elucidated O 0 2.3752779725327855e-06
. O 0 3.55363383164331e-08

Numerous O 0 1.1437663260949193e-08
cytogenetic O 0 5.518362740986049e-06
and O 0 8.377779359136639e-09
allelotype O 0 1.7891385141410865e-05
studies O 0 2.787980069030027e-09
have O 0 2.2803033766782832e-11
reported O 0 1.6752449427670513e-10
frequent O 0 2.2435478475024695e-10
loss O 0 5.345305309489845e-10
of O 0 6.678061215126263e-09
heterozygosity O 0 1.5500555718972464e-06
on O 0 7.932974767754786e-06
chromosomal O 0 4.4491822336567566e-05
arm O 0 1.6382939065806568e-05
10q O 0 0.0005088532925583422
in O 0 7.060453555141066e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7497313618659973

Deletion O 0 2.634734755702084e-06
mapping O 0 4.0505899079334995e-08
studies O 0 3.315014929228255e-10
have O 0 4.902092620717724e-12
unambiguously O 0 1.957827650000965e-10
identified O 0 1.1854497418417598e-11
a O 0 1.703953991794016e-11
region O 0 3.227729195032225e-09
of O 0 1.6551295445310643e-08
chromosome O 0 8.965292181528639e-06
10q23 O 0 1.7312480849795975e-05
to O 0 2.6829343191536736e-09
be O 0 2.995116307746848e-11
the O 0 4.1356931768099514e-11
minimal O 0 7.2305597065280836e-09
area O 0 2.935269094450632e-08
of O 0 7.764156428891056e-09
loss O 0 1.8614096575220174e-07
. O 0 2.533838028284663e-07

A O 0 1.2464889778129873e-06
new O 0 1.099789948000307e-08
tumor B-Disease 0 1.333956021198901e-07
suppressor O 0 8.496139258795665e-08
gene O 0 2.4737842330146975e-10
, O 0 3.9361729153863934e-11
PTEN O 0 3.3715361951180967e-06
/ O 0 4.1344401324749924e-06
MMAC1 O 1 0.999963641166687
, O 0 2.5626334387851557e-09
was O 0 1.457986371633524e-07
isolated O 0 1.5174654421912237e-08
recently O 0 1.2767997770168904e-10
at O 0 4.5609831883508534e-11
this O 0 1.6583493476010625e-12
region O 0 1.4222671929076114e-09
of O 0 6.453430234643065e-09
chromosome O 0 2.3002232865110273e-06
10q23 O 0 1.6666877854731865e-05
and O 0 4.1597530975323593e-10
found O 0 1.6113676365447915e-11
to O 0 3.215252716848305e-11
be O 0 2.6471906264258216e-12
inactivated O 0 6.751307412428131e-12
by O 0 1.0211923537686851e-12
mutation O 0 1.228270540831744e-10
in O 0 5.397730595824157e-10
three O 0 3.2297018037752423e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.0948997437953949
lines O 0 1.108443143493787e-06
. O 0 1.0218143842166683e-07

We O 0 1.1868789897562237e-06
screened O 0 2.304467670910526e-06
80 O 0 1.2068982186974608e-06
prostate B-Disease 0 0.01907671056687832
tumors I-Disease 1 1.0
by O 0 7.806413293565129e-10
microsatellite O 0 1.3915859575774903e-08
analysis O 0 1.6248462297863142e-10
and O 0 2.2649371961280806e-11
found O 0 6.230416182972931e-11
chromosome O 0 1.4678499837827985e-07
10q23 O 0 8.244710443250369e-07
to O 0 4.31061941696953e-09
be O 0 4.873467740473814e-10
deleted O 0 1.6067434882582887e-10
in O 0 1.7545360997406334e-11
23 O 0 3.18616022454421e-09
cases O 0 6.564784826856851e-11
. O 0 2.7621187559390137e-09

We O 0 2.7674886382555997e-08
then O 0 3.363944955925291e-10
proceeded O 0 9.332131595263249e-11
with O 0 2.9227837462569503e-15
sequence O 0 1.42574076459831e-13
analysis O 0 1.1111646542119602e-13
of O 0 2.9589900408383274e-12
the O 0 3.390715139217626e-11
entire O 0 4.331653258304868e-09
PTEN O 0 9.438157576369122e-05
/ O 0 6.962203769944608e-06
MMAC1 O 0 0.00032267821370624006
coding O 0 1.469341555093706e-07
region O 0 1.3154905609269463e-08
and O 0 4.8921752066055646e-11
tested O 0 6.766304183614125e-11
for O 0 2.154102417273318e-11
homozygous O 0 9.404176048999346e-11
deletion O 0 1.0620639923075714e-09
with O 0 2.4370821116379005e-13
new O 0 1.00806099578854e-10
intragenic O 0 5.81789947773359e-07
markers O 0 1.9279164931162995e-09
in O 0 6.506594568689295e-11
these O 0 3.682803628030085e-12
23 O 0 6.511936545550157e-10
cases O 0 2.5727967933181217e-12
with O 0 4.941934882152221e-12
10q23 O 0 8.409222209593281e-05
loss O 0 3.537553254773229e-07
of O 0 4.344515673437854e-06
heterozygosity O 0 0.0008530013146810234
. O 0 1.224278889822017e-06

The O 0 4.041302292812077e-10
identification O 0 2.6425557922427068e-11
of O 0 8.402463447243491e-11
the O 0 6.483774628307515e-11
second O 0 1.6538412861422103e-09
mutational O 0 1.4261802050441474e-07
event O 0 1.7345201941409982e-09
in O 0 2.6726920676622967e-10
10 O 0 1.079374190027238e-08
( O 0 2.460584513919173e-10
43 O 0 3.332179119297507e-07
% O 0 3.053017749721221e-08
) O 0 1.1429115431838e-08
tumors B-Disease 1 1.0
establishes O 0 7.945413926790934e-07
PTEN O 0 0.0008212629472836852
/ O 0 1.560445161885582e-05
MMAC1 O 0 0.0004408599925227463
as O 0 5.2665281857766644e-11
a O 0 1.6853974812991446e-11
main O 0 1.1228329377388491e-10
inactivation O 0 1.6342552866532856e-09
target O 0 4.764034722271049e-10
of O 0 1.6584270068342732e-10
10q O 0 1.3503060472430661e-05
loss O 0 2.1323141652374034e-07
in O 0 1.6721666895591625e-07
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.0786558252439136e-06
. O 0 5.8251448109558623e-08

Risk O 0 4.150519089307636e-06
reversals O 0 1.6178456974103028e-07
in O 0 7.884069785912828e-11
predictive O 0 3.182959007475006e-09
testing O 0 6.992873502476016e-10
for O 0 1.4315642005158224e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 7.37962352559407e-07

The O 0 2.144614263954736e-09
first O 0 3.142341248318914e-11
predictive O 0 1.7845139255179276e-10
testing O 0 8.057315231679851e-11
for O 0 2.4262053477386303e-10
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.080213029083012e-10
HD B-Disease 0 9.133401590588619e-07
) O 0 8.754139774191927e-12
was O 0 4.852271015542975e-11
based O 0 4.734625452113006e-12
on O 0 2.0030181679953074e-10
analysis O 0 1.495516557814547e-11
of O 0 5.34816808894778e-11
linked O 0 4.2763703689274735e-10
polymorphic O 0 1.223776524561515e-09
DNA O 0 2.528009357405381e-09
markers O 0 2.325784009826748e-11
to O 0 7.882743069398401e-12
estimate O 0 1.2092232770655187e-10
the O 0 1.1719472614579729e-11
likelihood O 0 1.2755736467084944e-09
of O 0 6.102240046601537e-09
inheriting O 0 1.315691946501829e-07
the O 0 1.0164450614524867e-08
mutation O 0 1.4540136872298604e-09
for O 0 7.498295873098471e-10
HD B-Disease 0 3.647616904345341e-05
. O 0 6.882470415803255e-08

Limits O 0 1.0541758399540413e-07
to O 0 2.1084394230541648e-09
accuracy O 0 2.0190602523229018e-09
included O 0 1.0090915950056178e-11
recombination O 0 4.503428532864895e-11
between O 0 3.744086429779969e-10
the O 0 6.913487005100194e-10
DNA O 0 1.8939613766200125e-10
markers O 0 2.2823441053754223e-11
and O 0 3.4640712607419966e-12
the O 0 9.108912929489676e-11
mutation O 0 3.900547662638587e-10
, O 0 1.926532544604953e-11
pedigree O 0 9.432437053646936e-10
structure O 0 8.130727202626531e-10
, O 0 4.846600898389397e-11
and O 0 5.3753813900048186e-11
whether O 0 2.250799824299321e-10
DNA O 0 2.794511011483536e-10
samples O 0 7.705894299395166e-13
were O 0 4.034347115817842e-14
available O 0 1.140380650153927e-13
from O 0 1.7701361210153976e-11
family O 0 4.689814508962442e-11
members O 0 3.093718337066065e-11
. O 0 2.356732586861199e-09

With O 0 1.705772606497291e-10
direct O 0 7.415989600190187e-09
tests O 0 1.3736155268784245e-10
for O 0 1.1975307030731575e-11
the O 0 4.2771533537155904e-10
HD B-Disease 0 2.4098821995721664e-06
mutation O 0 8.120641048492416e-09
, O 0 6.448046957485687e-11
we O 0 3.401662285185125e-11
have O 0 2.2618879425700955e-12
assessed O 0 2.8338928426130394e-10
the O 0 2.071090174360357e-11
accuracy O 0 3.8311209760166776e-10
of O 0 9.236805764700762e-11
results O 0 3.889949560381689e-12
obtained O 0 2.4523041583512928e-11
by O 0 1.2486597693317503e-11
linkage O 0 1.6650457679290298e-09
approaches O 0 2.203703441949756e-09
when O 0 1.1078708263279058e-11
requested O 0 2.0950650936324422e-10
to O 0 3.719005103874906e-10
do O 0 3.4969936668627355e-11
so O 0 7.41866258095053e-13
by O 0 5.315629663868449e-13
the O 0 1.4287094077247708e-11
test O 0 5.346605103095925e-12
individuals O 0 2.6538536992970485e-12
. O 0 3.8026577442451526e-09

For O 0 6.134691088455213e-10
six O 0 1.8101825594030174e-11
such O 0 9.292135745748997e-14
individuals O 0 1.3667982761214614e-12
, O 0 1.7949039823883517e-11
there O 0 9.929242324180354e-12
was O 0 8.617622171414041e-10
significant O 0 5.165836508558286e-11
disparity O 0 6.85950352075082e-10
between O 0 1.6919988743424597e-09
the O 0 1.5414560294857438e-08
tests O 0 2.704972024147878e-09
. O 0 3.819376370728378e-09

Three O 0 3.307281914999294e-08
went O 0 9.02404906355514e-09
from O 0 4.824862037677846e-11
a O 0 1.7083448544674695e-10
decreased O 0 1.8804353629775505e-09
risk O 0 2.8666293297452405e-11
to O 0 1.058390614733229e-11
an O 0 2.000099304927394e-12
increased O 0 6.64050897603019e-11
risk O 0 9.7247299102321e-10
, O 0 8.904483595785495e-13
while O 0 6.761265809382411e-13
in O 0 7.344199575744226e-13
another O 0 1.4079551760581843e-11
three O 0 4.622372797025154e-12
the O 0 2.281208034971005e-11
risk O 0 2.399622722748518e-10
was O 0 4.800440489560742e-09
decreased O 0 4.470912884357858e-08
. O 0 9.958958990807787e-09

Knowledge O 0 7.503009413767359e-08
of O 0 2.0990510662954875e-08
the O 0 9.855947169512547e-10
potential O 0 7.528174195137183e-10
reasons O 0 1.1628056156842703e-10
for O 0 2.714710834600398e-12
these O 0 3.5191980080929997e-13
changes O 0 2.8395387170060404e-12
in O 0 2.4317852419242225e-12
results O 0 1.163461601366711e-11
and O 0 8.162152377588772e-12
impact O 0 5.168975913960594e-09
of O 0 5.002654956953734e-10
these O 0 3.91466026261611e-12
risk O 0 9.993771088456782e-11
reversals O 0 5.003695235927808e-10
on O 0 3.69865305049899e-10
both O 0 8.339658174108533e-13
patients O 0 5.51382886831292e-13
and O 0 8.512842123928333e-13
the O 0 5.855747831073899e-11
counseling O 0 1.2937039460536592e-11
team O 0 1.400165926127364e-13
can O 0 8.514936802525574e-13
assist O 0 1.2378843609883727e-11
in O 0 5.7955649827856615e-12
the O 0 5.680783968231573e-11
development O 0 1.385641185125408e-10
of O 0 5.555956389402539e-11
strategies O 0 1.4340414272728808e-11
for O 0 1.2534219539020452e-12
the O 0 2.847078475753939e-11
prevention O 0 5.428443111687997e-11
and O 0 4.183760813920162e-13
, O 0 3.359553846053742e-13
where O 0 2.354082857466966e-12
necessary O 0 2.4059287895283887e-10
, O 0 1.7117947684330836e-11
management O 0 3.6244524048711924e-10
of O 0 1.8853904548699063e-10
a O 0 1.3419296784888957e-09
risk O 0 2.4727757619302793e-09
reversal O 0 5.686229265222664e-10
in O 0 6.284478579893227e-12
any O 0 4.0323227395999695e-11
predictive O 0 1.4009347848453757e-10
testing O 0 2.967130013908914e-11
program O 0 2.0409993140013682e-12
. O 0 2.689005918973808e-12
. O 0 3.0964472652605934e-10

A O 0 1.7630661375278578e-08
novel O 0 7.64738217196026e-10
common O 0 4.4669362653237954e-10
missense O 0 1.7174052402424422e-07
mutation O 0 5.431183058846045e-09
G301C O 0 6.259488571913607e-08
in O 0 2.4891649505476288e-11
the O 0 3.2915895009644203e-10
N O 0 6.64053061427694e-08
- O 0 4.168445855157188e-08
acetylgalactosamine O 0 5.966970206827682e-07
- O 0 2.454634397963673e-07
6 O 0 1.550318700083153e-07
- O 0 1.0938193462095569e-08
sulfate O 0 8.56532000881316e-09
sulfatase O 0 3.6123783075936444e-08
gene O 0 3.026424597041277e-11
in O 0 1.7221475634432437e-10
mucopolysaccharidosis B-Disease 0 3.1748069886816666e-05
IVA I-Disease 1 0.9999456405639648
. O 0 3.134189682896249e-06

Mucopolysaccharidosis B-Disease 1 0.9717123508453369
IVA I-Disease 1 1.0
( O 0 1.1529588164194138e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 4.8061429835932756e-11
is O 0 4.720882539055449e-12
an O 0 8.587738159482328e-11
autosomal B-Disease 1 0.9999967813491821
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.00010025875963037834
by O 0 4.646793227980339e-10
a O 0 1.299755126638047e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 7.334317597695872e-09
N O 0 1.4244362489534979e-07
- O 0 2.7034209537646348e-08
acetylgalactosamine O 0 1.321628815276199e-07
- O 0 7.475611596419185e-08
6 O 0 7.202785212712115e-08
- O 0 8.849879939987204e-09
sulfate O 0 1.1007594835632517e-08
sulfatase O 0 5.48360574725848e-08
( O 0 7.53972370648448e-11
GALNS O 0 5.17117132403655e-06
) O 0 1.3173598323312774e-10
. O 0 3.416803950884173e-09

In O 0 1.951357653240393e-08
previous O 0 3.732041164994371e-08
studies O 0 2.578602664726759e-09
, O 0 2.916330024693714e-11
we O 0 3.2774109814948105e-11
have O 0 1.8877993786248215e-12
found O 0 6.533200087692481e-13
two O 0 1.3050385696145722e-13
common O 0 2.7948014996032056e-12
mutations O 0 1.278159383888422e-10
in O 0 8.701970394264791e-11
Caucasians O 0 2.489576100828117e-09
and O 0 5.149221674050075e-11
Japanese O 0 5.7081601667619e-09
, O 0 9.972597053709009e-11
respectively O 0 1.2713479158321661e-08
. O 0 2.1096431268574634e-08

To O 0 1.3825847133830393e-07
characterize O 0 2.1647615255915298e-07
the O 0 7.140953162121377e-09
mutational O 0 1.478747435612604e-07
spectrum O 0 4.839003864276492e-09
in O 0 1.7524147280859048e-12
various O 0 7.053141707832888e-13
ethnic O 0 7.856730023514391e-12
groups O 0 9.928745109064052e-13
, O 0 1.248278065114905e-12
mutations O 0 1.7576074276548503e-11
in O 0 8.451965689826313e-12
the O 0 1.588912057481906e-10
GALNS O 0 2.4607359137007734e-06
gene O 0 1.3080002359000531e-11
in O 0 2.56943390175568e-11
Colombian O 0 5.147795718585257e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.8876296909174926e-08
were O 0 4.3512093927944306e-10
investigated O 0 2.388873987513307e-09
, O 0 2.9618599239888965e-11
and O 0 1.0616502815752327e-10
genetic O 0 1.5682941612027435e-09
backgrounds O 0 1.8763283982092815e-10
were O 0 1.1222420215339923e-10
extensively O 0 5.802046777053649e-12
analyzed O 0 1.6251770762476525e-11
to O 0 1.5709392120477617e-11
identify O 0 3.0323760863426585e-11
racial O 0 2.7499100219152695e-11
origin O 0 5.720860417335327e-12
, O 0 2.596408873491163e-13
based O 0 4.988281489259894e-12
on O 0 3.2665490312666634e-09
mitochondrial O 0 1.2255425563267863e-09
DNA O 0 8.457924360882885e-10
( O 0 1.4138971243804477e-11
mtDNA O 0 1.3444448332400327e-10
) O 0 2.2533114263367793e-11
lineages O 0 6.448899192434965e-10
. O 0 4.0450504057432113e-10

Three O 0 4.60606264240937e-09
novel O 0 1.2196665899466552e-08
missense O 0 6.368805770762265e-06
mutations O 0 3.997356827767362e-07
never O 0 1.6550727011122035e-08
identified O 0 7.312118688318492e-10
previously O 0 5.408207909285423e-11
in O 0 5.1672828342563815e-12
other O 0 2.480604263666031e-12
populations O 0 1.1013369036194653e-12
and O 0 1.1270115700054428e-12
found O 0 5.941518978203053e-12
in O 0 1.9194684036660803e-11
16 O 0 6.070255409440506e-10
out O 0 1.0941015454735137e-11
of O 0 4.4345062344408603e-11
19 O 0 1.7087303794127706e-09
Colombian O 0 3.078304757764272e-07
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
unrelated O 0 1.806814475813212e-09
alleles O 0 1.712872552128708e-11
account O 0 2.545190837602296e-12
for O 0 2.8027783219308766e-11
84 O 0 8.119312866483597e-08
. O 0 2.5327938857344634e-08

2 O 0 4.830522470911092e-07
% O 0 1.4491133848437698e-09
of O 0 2.617071281907357e-10
the O 0 2.236796581289724e-10
alleles O 0 6.728621132490176e-11
in O 0 2.4822477406871712e-11
this O 0 9.040355269940292e-11
study O 0 5.142962167248299e-10
. O 0 1.91288429540748e-09

The O 0 3.53162732835699e-07
G301C O 0 1.736378726491239e-05
and O 0 1.0771325165137569e-08
S162F O 0 5.959297595836688e-06
mutations O 0 1.4117588209572318e-09
account O 0 2.8637658217034456e-11
for O 0 2.2380002018262957e-10
68 O 0 2.569967989529687e-07
. O 0 1.463881904584241e-08

4 O 0 3.325796114950208e-06
% O 0 1.0130057681578819e-08
and O 0 3.364509504333313e-10
10 O 0 3.5333446390950485e-08
. O 0 1.0431148389500322e-08

5 O 0 5.383648726819956e-07
% O 0 6.948297937015013e-09
of O 0 2.4319144475981602e-09
mutations O 0 1.2458776232904256e-09
, O 0 4.1078081908230146e-11
respectively O 0 1.0963085994575295e-09
, O 0 2.1131154118170237e-11
whereas O 0 2.48979309391828e-10
the O 0 1.5339821635151907e-09
remaining O 0 2.1941378491874275e-08
F69V O 0 1.4669484698970336e-05
is O 0 1.7560024614948766e-11
limited O 0 2.63253329725599e-12
to O 0 1.9062099121391896e-11
a O 0 1.9142118445891754e-10
single O 0 5.24447762995095e-10
allele O 0 5.8736770114364845e-08
. O 0 2.2711569513944596e-08

The O 0 1.3526099351679477e-08
skewed O 0 4.866644687240296e-08
prevalence O 0 4.4332018944714946e-08
of O 0 5.029923144661552e-10
G301C O 0 3.9143102981142874e-07
in O 0 6.360138110617086e-11
only O 0 9.044529014623492e-11
Colombian O 0 1.1314678083351737e-08
patients O 0 3.6563908151210356e-11
and O 0 2.2920844909568583e-12
haplotype O 0 4.555473498424334e-10
analysis O 0 2.2589176622983542e-12
by O 0 3.7261494345748603e-13
restriction O 0 4.296021524630156e-11
fragment O 0 3.965798245353369e-10
length O 0 2.1688710549749857e-10
polymorphisms O 0 2.7864477392114395e-10
in O 0 1.9817666604970974e-11
the O 0 4.882399484706923e-10
GALNS O 0 6.933599070180207e-05
gene O 0 1.0151736118402255e-09
suggest O 0 2.3473731292078526e-10
that O 0 1.3802120037154086e-11
G301C O 0 1.1368103258746487e-07
originated O 0 2.0135816625188596e-11
from O 0 1.3535111399731736e-11
a O 0 3.04882334656309e-11
common O 0 1.4292389494130475e-10
ancestor O 0 2.1429183760801607e-08
. O 0 8.137914342398744e-09

Investigation O 0 2.913583330155234e-07
of O 0 7.960991865729738e-09
the O 0 5.839667638340984e-10
genetic O 0 4.226853589361923e-11
background O 0 1.4735062399840598e-13
by O 0 4.454439746746919e-13
means O 0 6.743374192375029e-10
of O 0 3.6972938044499415e-09
mtDNA O 0 2.0221819774235428e-09
lineages O 0 5.054897472822617e-11
indicate O 0 1.582777138520175e-11
that O 0 1.3452949691739047e-12
all O 0 7.276814567580558e-12
our O 0 1.0316786487607477e-11
patients O 0 4.335793605658028e-13
are O 0 2.0919740210414116e-14
probably O 0 7.328773005133016e-11
of O 0 3.435288720154972e-10
native O 0 2.4531054965137855e-10
American O 0 4.9555537451340115e-09
descent O 0 4.701502257375978e-05

Low O 0 4.2772151687131554e-07
frequency O 0 1.2793876180694497e-08
of O 0 4.988422563911854e-09
BRCA1 O 0 3.3445633818018905e-08
germline O 0 9.598873873528646e-08
mutations O 0 1.6052884022066394e-10
in O 0 1.0742661100959783e-12
45 O 0 1.8141975699492718e-09
German O 0 0.0019882461056113243
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.054038183516241e-07
. O 0 5.34501474191984e-08

In O 0 2.7546582792581376e-09
this O 0 6.165868510210615e-11
study O 0 3.2774734315399456e-11
we O 0 1.1445017026115445e-12
investigated O 0 4.625382715728321e-11
45 O 0 2.762645445741896e-09
German O 0 0.005633768625557423
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.2957250262199977e-09
for O 0 9.935768874314022e-10
germline O 0 2.5722778218550957e-07
mutations O 0 1.421049611316505e-09
in O 0 4.3410633421281375e-10
the O 0 3.572456996892015e-09
BRCA1 O 0 2.9096005604856146e-08
gene O 0 4.109442564015353e-09
. O 0 5.568130401201188e-09

We O 0 2.5660927605031247e-08
identified O 0 2.5796111913223285e-09
four O 0 2.7025004456504576e-10
germline O 0 8.269903162272385e-08
mutations O 0 1.3058080172712039e-09
in O 0 2.817947958311251e-11
three O 0 1.2782422342816346e-10
breast B-Disease 0 3.794396661760402e-06
cancer I-Disease 1 0.649781346321106
families O 0 3.2000077587746034e-10
and O 0 5.601145242062344e-11
in O 0 7.681902225442627e-09
one O 1 0.5519206523895264
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.9679400793393143e-05
. O 0 3.9891490111187977e-10
among O 0 8.56914257434116e-13
these O 0 3.0618273216299896e-13
were O 0 2.1978820673174138e-12
one O 0 1.637888284201916e-12
frameshift O 0 1.5596850477805901e-09
mutation O 0 2.1992976884099846e-10
, O 0 1.0540391476299149e-11
one O 0 3.940928139378741e-11
nonsense O 0 9.851799376292547e-09
mutation O 0 9.956485635953527e-10
, O 0 2.4348669781792953e-12
one O 0 2.3728131005179565e-12
novel O 0 4.429298941510673e-11
splice O 0 2.7977498096021236e-09
site O 0 2.6307639400258154e-10
mutation O 0 4.506444523100228e-11
, O 0 2.318014920635325e-12
and O 0 1.6206577746480377e-11
one O 0 1.5756400628674783e-09
missense O 0 1.0350669981562532e-05
mutation O 0 1.3102143384458032e-05
. O 0 7.669606247873162e-07

The O 0 1.761915626730115e-07
missense O 0 9.511482517154946e-07
mutation O 0 8.475034007915383e-08
was O 0 8.260677475391276e-09
also O 0 2.2374612579367792e-11
found O 0 6.847522115299709e-12
in O 0 6.317266848521186e-11
2 O 0 7.001333983680524e-07
. O 0 4.183165103199826e-08

8 O 0 1.8244336388306692e-06
% O 0 1.4357816269239265e-08
of O 0 8.249431138196428e-10
the O 0 3.416893434859958e-10
general O 0 9.907255460461784e-09
population O 0 2.2903725790945906e-11
, O 0 2.2078274538456233e-12
suggesting O 0 3.4420293004711056e-11
that O 0 3.530277470093629e-13
it O 0 5.104898166512217e-13
is O 0 3.340986124908407e-12
not O 0 3.4689942585153233e-10
disease O 0 2.079234917573558e-08
associated O 0 4.259456787281124e-09
. O 0 6.380012251838707e-08

The O 0 7.098228671509332e-10
average O 0 2.592646930477116e-10
age O 0 2.109412644557551e-09
of O 0 6.618472436770162e-10
disease O 0 1.1169938716193428e-06
onset O 0 1.5962661564117298e-05
in O 0 4.745639992087547e-11
those O 0 3.6122486946066346e-11
families O 0 8.689531733052647e-11
harbouring O 0 1.8312125149577696e-08
causative O 0 7.872387186580454e-09
mutations O 0 4.950621690369417e-09
was O 0 3.3564224732884895e-09
between O 0 8.98708485408406e-09
32 O 0 2.8286692099754873e-07
. O 0 1.9973775522430515e-08

3 O 0 6.294643299042946e-06
and O 0 7.483111907902185e-09
37 O 0 9.009896189127176e-07
. O 0 1.658169246354646e-08

4 O 0 5.9085032262373716e-06
years O 0 5.170297079359898e-09
, O 0 1.5084452784086544e-11
whereas O 0 1.430381646461143e-10
the O 0 1.4993645214289586e-10
family O 0 3.378649443552817e-11
harbouring O 0 5.348550935480034e-09
the O 0 4.3276537908809587e-10
missense O 0 9.381056820245703e-09
mutation O 0 4.270860332056259e-10
had O 0 4.5456020891787574e-11
an O 0 2.938942221097224e-13
average O 0 8.386463398735167e-12
age O 0 4.199629255463577e-10
of O 0 9.56096979365384e-10
onset O 0 8.88361973920837e-05
of O 0 6.735866122653533e-07
51 O 0 3.524087787809549e-06
. O 0 5.144772430298872e-08

2 O 0 6.450608634622768e-05
years O 0 3.0906622328075173e-07
. O 0 8.965772479996303e-08

These O 0 6.07769279348247e-10
findings O 0 1.0304243569514426e-10
show O 0 1.594789404701924e-11
that O 0 1.1876399386503977e-12
BRCA1 O 0 5.313491868719211e-09
is O 0 1.4871992526366284e-11
implicated O 0 2.823426215048386e-10
in O 0 3.5036214381112263e-12
a O 0 1.3692726640035513e-11
small O 0 6.9894528532954414e-12
fraction O 0 8.379532623337127e-10
of O 0 2.334540113224648e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.370355911551769e-09
suggesting O 0 3.743256399291184e-11
the O 0 1.860313118828838e-11
involvement O 0 3.591473646258336e-11
of O 0 6.46801362469418e-11
another O 0 1.1936591992611767e-10
susceptibility O 0 1.8995489625694972e-08
gene O 0 2.4659463360166e-09
( O 0 1.416411543608831e-09
s O 0 1.5419523151649628e-06
) O 0 4.091416982987539e-08

Paternal O 0 3.183315129717812e-06
transmission O 0 2.693624446692411e-05
of O 0 0.0001039267226587981
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9985839128494263

We O 0 7.319241746017724e-08
report O 0 6.21086237995172e-11
a O 0 1.1024955254290703e-11
rare O 0 6.411717511090043e-12
case O 0 9.672743855881905e-11
of O 0 4.092935157462563e-10
paternally O 0 0.0008634515106678009
transmitted O 1 0.9999982118606567
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.8787942508424749e-06
DM B-Disease 1 1.0
) O 0 4.485551041710778e-09
. O 0 1.0968864039284654e-08

The O 0 3.753407185058677e-08
proband O 0 6.881241915834835e-06
is O 0 2.8460088452586518e-11
a O 0 6.323246093398183e-11
23 O 0 6.994314571961979e-10
year O 0 1.4072517456886757e-11
old O 0 7.280681058041694e-10
, O 0 7.415006109123823e-11
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.3032380365984864e-06
who O 0 3.4529367809454925e-08
suffers O 1 0.9999933242797852
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999973773956299

He O 0 4.5635197842841535e-09
presented O 0 1.6112710055082857e-09
with O 0 3.0202501610787635e-10
respiratory O 0 0.19784316420555115
and O 0 6.46772733148282e-08
feeding O 0 3.014941114543035e-07
difficulties O 0 6.341166169931967e-08
at O 0 3.5998880321130855e-07
birth O 0 3.480543568912253e-07
. O 0 7.581120797794938e-08

His O 0 7.481202146664145e-07
two O 0 4.522734542433682e-08
sibs O 1 0.9998562335968018
suffer O 0 6.620297881454462e-06
from O 0 2.439521153974056e-07
childhood O 1 0.9991071820259094
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 5.4765409004176036e-05

Their O 0 1.5711985046351629e-09
late O 0 2.8596718948392663e-07
father O 0 4.563302180571327e-09
had O 0 5.1546652363176904e-11
the O 0 1.1053079024964108e-12
adult O 0 5.799963374159001e-13
type O 0 2.3588707376287488e-11
of O 0 2.013061495276247e-09
DM B-Disease 1 1.0
, O 0 1.0015261953100207e-09
with O 0 7.675859947653407e-11
onset O 0 0.00069797522155568
around O 0 1.8480114105656753e-09
30 O 0 1.7167019805697237e-08
years O 0 1.3992584868560698e-09
. O 0 3.6467202590984016e-09

Only O 0 6.054275414335564e-10
six O 0 1.0280543777385631e-11
other O 0 3.828505573547428e-14
cases O 0 9.391721070544506e-14
of O 0 4.170123447944096e-12
paternal O 0 8.107208238072872e-09
transmission O 0 6.2871558839106e-06
of O 0 0.0006216857582330704
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.0001203426145366393
been O 0 1.3193377057518774e-08
reported O 0 2.0213182239103844e-09
recently O 0 1.114975667348972e-09
. O 0 1.881601319198012e-09

We O 0 3.191488184839386e-09
review O 0 4.769562522710658e-10
the O 0 8.134953648208931e-12
sex O 0 7.528909678859719e-13
related O 0 1.4028506004418184e-12
effects O 0 5.895577082082326e-11
on O 0 1.0364150648811687e-09
transmission O 0 6.18694073750703e-08
of O 0 7.436120341708374e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0002200301387347281

Decreased O 0 4.871084001933923e-06
fertility O 0 1.5117974427880654e-08
of O 0 4.532071246066138e-11
males O 0 3.8784860739715654e-13
with O 0 7.999507902877595e-15
adult O 0 1.0806502220850334e-10
onset O 0 7.64354808779899e-06
DM B-Disease 1 1.0
and O 0 2.051059100338648e-09
contraction O 0 3.1092099561647046e-08
of O 0 1.1081742190555133e-09
the O 0 8.895360142924247e-11
repeat O 0 3.612496760063699e-11
upon O 0 1.4320379083943013e-11
male O 0 1.6302056276076837e-12
transmission O 0 1.4040336818524346e-12
contribute O 0 1.7645150477470922e-13
to O 0 7.477508195963267e-12
the O 0 1.149810368444859e-11
almost O 0 3.8955349362934655e-11
absent O 0 5.731799479491428e-10
occurrence O 0 1.6401252578290837e-10
of O 0 2.5451047519498005e-11
paternal O 0 2.1240369463271236e-08
transmission O 0 4.897831331618363e-07
of O 0 3.974586775257194e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 4.7476296458626166e-05

Also O 0 1.6986956286046961e-09
the O 0 1.054983433945722e-09
fathers O 0 6.430882937280558e-09
of O 0 6.139560526641219e-10
the O 0 2.051339792474849e-10
reported O 0 4.999071379074849e-09
congenitally O 0 0.00023309762764256448
affected O 0 3.3165740376261965e-08
children O 0 1.1705901803438223e-09
showed O 0 2.434493440173213e-10
, O 0 2.2078833553096366e-11
on O 0 3.17226955814931e-08
average O 0 3.1037805658939988e-09
, O 0 1.8182946814881973e-10
shorter O 0 5.12184215040179e-07
CTG O 0 1.5686706319684163e-05
repeat O 0 1.7808979180244933e-08
lengths O 0 1.3119205277689616e-07
and O 0 4.983754728349332e-12
hence O 0 8.040136612041948e-11
less O 0 1.1343796041396459e-10
severe O 0 1.6815266690173303e-07
clinical O 0 3.455157226994743e-08
symptoms O 0 8.343807866850739e-10
than O 0 7.354544490772996e-13
the O 0 1.083361525489046e-11
mothers O 0 7.583343675232612e-13
of O 0 8.015491482354919e-13
children O 0 2.4566475156223566e-12
with O 0 9.969421121969191e-11
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9735925793647766

We O 0 6.753185566310549e-09
conclude O 0 1.1216182649320672e-08
that O 0 9.107115018711087e-13
paternal O 0 6.781168959690831e-09
transmission O 0 1.651481795761356e-07
of O 0 7.227804417198058e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 2.5716596496749844e-07
rare O 0 1.8524879547010542e-11
and O 0 1.6489974533420715e-12
preferentially O 0 8.345901227058139e-12
occurs O 0 1.3290843035515532e-12
with O 0 3.9550333223292017e-14
onset O 0 1.5891265547907096e-07
of O 0 1.711079455901654e-08
DM B-Disease 1 1.0
past O 0 8.67199361209714e-08
30 O 0 2.165697399192368e-09
years O 0 6.846229312629237e-12
in O 0 3.0426158012346327e-13
the O 0 5.898543806170942e-12
father O 0 1.3722617486777722e-10
. O 0 9.257512117999411e-11
. O 0 2.4633233230986207e-09

The O 0 2.4369725792894315e-07
RB1 O 0 2.819793962771655e-06
gene O 0 1.3085449390715098e-10
mutation O 0 1.0122341853602279e-10
in O 0 6.8894438765010335e-12
a O 0 9.281880264389031e-10
child O 0 9.900950459496016e-08
with O 0 7.666971058029048e-09
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.0004941067891195416

The O 0 3.8280504099930113e-07
RB1 O 0 4.8140223043446895e-06
gene O 0 6.340567515472628e-10
mutation O 0 7.829735193531917e-10
was O 0 2.7262017643359115e-10
investigated O 0 1.3003692567181702e-10
in O 0 1.0911713373140675e-11
a O 0 1.081785105938593e-09
child O 0 5.9085884629439533e-08
with O 0 1.211137412582275e-09
ectopic B-Disease 1 0.9999771118164062
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 0 4.869557960773818e-05
using O 0 1.0455564192213274e-09
DNA O 0 5.050698748121363e-10
obtained O 0 1.033764567004436e-11
from O 0 4.0256040688413375e-12
both O 0 7.300304566588978e-13
the O 0 1.8617685518251825e-11
pineal B-Disease 0 5.446465252134658e-07
and I-Disease 0 1.7884810299406695e-09
retinal I-Disease 0 0.1153084859251976
tumours I-Disease 1 1.0
of O 0 0.007953494787216187
the O 0 2.8087551982025616e-06
patient O 0 5.179954314371571e-07
. O 0 5.214679177356629e-08

A O 0 2.307434215254034e-06
nonsense O 0 1.5312941741285613e-06
mutation O 0 5.9801843477202965e-09
in O 0 6.301120181184672e-10
exon O 0 1.8544136892728602e-08
17 O 0 2.8278538621862026e-08
( O 0 4.585039292681614e-11
codon O 0 6.103928029688177e-09
556 O 0 2.0495534158726514e-09
) O 0 5.76354198741913e-12
of O 0 2.1451654341753112e-10
the O 0 1.3864878134484115e-09
RB1 O 0 5.154486757419363e-07
gene O 0 1.799251025946802e-10
was O 0 6.199775692827814e-10
found O 0 7.304984525266511e-13
to O 0 4.174389132971523e-12
be O 0 4.547863387965867e-12
present O 0 5.901416161302464e-11
homozygously O 0 2.0152308479737258e-06
in O 0 7.770285526120801e-10
both O 0 3.241071300230658e-10
the O 0 1.1346100947662308e-08
retinal B-Disease 0 1.9125386643281672e-06
and I-Disease 0 1.1011126588300613e-07
the I-Disease 0 1.4552736047335202e-06
pineal I-Disease 1 0.9999434947967529
tumours I-Disease 1 1.0
. O 0 1.4016430213814601e-05

The O 0 2.8199400592399115e-09
same O 0 4.5281076110903484e-10
mutation O 0 2.1515002279759443e-10
was O 0 1.1283288886554388e-10
present O 0 1.4560299146926248e-11
heterozygously O 0 2.2843336111577628e-08
in O 0 4.280367033038246e-11
the O 0 5.892879240132487e-11
DNA O 0 9.175991563803443e-12
from O 0 5.74390578503281e-13
the O 0 1.1371947220700784e-12
constitutional O 0 2.1288287799237082e-10
cells O 0 3.453162061850534e-11
of O 0 3.042160620636558e-11
the O 0 4.985430818171821e-11
patient O 0 2.6246144146924166e-10
, O 0 7.257630260659731e-12
proving O 0 3.261977354895862e-10
it O 0 8.531307713229019e-13
to O 0 2.768212915837953e-11
be O 0 9.76863590018695e-11
of O 0 8.120327743554867e-10
germline O 0 2.266077387957921e-07
origin O 0 7.579643579447293e-09
. O 0 1.0171394393410083e-08

The O 0 1.9201230827547988e-08
initial O 0 8.775450588416334e-09
mutation O 0 1.6429406723972306e-09
was O 0 6.967046384254161e-10
shown O 0 3.2236143008429474e-12
to O 0 9.033821607440373e-11
have O 0 4.352018745379382e-12
occurred O 0 2.9837482484751376e-10
in O 0 3.0469964659024518e-12
the O 0 4.606163714337974e-11
paternally O 0 1.9883261703768085e-09
derived O 0 6.737203572804162e-10
RB1 O 0 1.2176662949059391e-06
allele O 0 1.0481550560825781e-07
. O 0 1.722612630317144e-08

The O 0 7.3586146065451885e-09
mutation O 0 2.795273457145697e-10
is O 0 8.959306278637225e-13
in O 0 4.990534352954101e-13
an O 0 1.5352619349429109e-12
area O 0 1.212558942143005e-09
of O 0 9.990078764232635e-10
the O 0 1.6713839201543124e-09
gene O 0 2.4213773347492307e-11
that O 0 1.494113860411872e-11
encodes O 0 6.839690272486543e-12
the O 0 7.61577346325426e-12
protein O 0 1.0525002744343759e-11
- O 0 3.1268564126829546e-11
binding O 0 5.0208800672635334e-08
region O 0 5.756422751801438e-07
known O 0 2.6507567252309627e-09
as O 0 8.38541250325342e-11
the O 0 1.3194194348198351e-10
pocket O 0 5.174017587705748e-06
region O 0 8.554202963750868e-07
and O 0 2.597315473806816e-09
has O 0 6.149287745671472e-10
been O 0 4.810767895158108e-10
detected O 0 5.037777417449263e-10
in O 0 7.59861899964076e-13
other O 0 2.718517956318972e-13
cases O 0 2.902820778888371e-12
of O 0 3.523595859533657e-10
retinoblastoma B-Disease 0 7.719063432887197e-07
. O 0 7.262931145390894e-09
. O 0 5.54027117516398e-08

Low O 0 3.53053655999247e-06
levels O 0 3.4416587357810613e-09
of O 0 6.334789914852479e-10
beta O 0 1.065945198774898e-07
hexosaminidase O 0 4.965746143170691e-07
A O 0 3.2353721923783496e-09
in O 0 7.688618838819217e-12
healthy O 0 1.7223066505964169e-12
individuals O 0 7.517584102965935e-14
with O 0 2.1768674102889962e-12
apparent O 0 0.006931885611265898
deficiency O 1 0.9999812841415405
of O 0 0.00017234281403943896
this O 0 1.165824059512488e-07
enzyme O 0 8.750247957323154e-07
. O 0 4.7151150539548325e-08

Appreciable O 0 1.1577382792893331e-05
beta O 0 1.9354688447492663e-06
hexosaminidase O 0 1.0621521141729318e-05
A O 0 3.809131385423825e-06
( O 0 6.309626598977047e-09
hex O 0 1.4786278370593209e-06
A O 0 8.079693429863255e-07
) O 0 2.5127550040693336e-10
activity O 0 1.0545032402831112e-08
has O 0 1.2906090085529343e-10
been O 0 5.054196505760444e-10
detected O 0 1.0554488838465659e-08
in O 0 2.753207384298406e-10
cultured O 0 1.7023721454734186e-07
skin O 0 4.824661914426542e-07
fibroblasts O 0 9.296700653749213e-08
and O 0 2.3937465343237818e-08
melanoma B-Disease 0 0.002541949739679694
tissue O 0 1.152548492200367e-07
from O 0 6.746619263253706e-09
healthy O 0 3.3365191165479757e-10
individuals O 0 7.166853482204472e-12
previously O 0 2.6944765862957354e-10
reported O 0 2.2508643560126274e-10
as O 0 1.9147596008739498e-10
having O 0 5.3487960727238715e-09
deficiency B-Disease 0 1.98315319721587e-05
of I-Disease 0 5.966963726677932e-06
hex I-Disease 0 2.0139571006438928e-06
A I-Disease 0 1.3775894203149619e-08
activity O 0 1.7922673067882755e-10
indistinguishable O 0 5.673850712178963e-12
from O 0 1.550161773033673e-13
that O 0 1.1699711193618751e-14
of O 0 5.361307643496349e-13
patients O 0 8.779585131818424e-13
with O 0 2.34286451350485e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.392395697687789e-08
TSD B-Disease 0 0.0004841108457185328
) O 0 2.0628487806817475e-09
. O 0 3.877068621704893e-08

Identification O 0 6.566243548888906e-09
and O 0 1.2094037993293227e-09
quantitation O 0 6.627663969993591e-05
of O 0 1.2406644600559957e-05
hex O 0 3.4445714845787734e-05
A O 0 1.3433627827907912e-06
, O 0 1.672473826097587e-10
amounting O 0 3.890267219475163e-09
to O 0 1.3322646985614028e-08
3 O 0 1.9310623429191764e-06
. O 0 4.433413280935383e-08

5 O 0 2.126973640770302e-06
% O 0 7.276009483803136e-08
- O 0 1.995598069015614e-07
6 O 0 1.5380984450530377e-06
. O 0 3.690912109277633e-08

9 O 0 7.762617997286725e-07
% O 0 3.6634728584061804e-09
of O 0 1.7890338099846304e-09
total O 0 6.513575789846016e-10
beta O 0 5.7799674380021315e-08
hexosaminidase O 0 2.2735672189355682e-07
activity O 0 1.011625272440142e-08
, O 0 4.926859961673635e-11
has O 0 1.4361190188438844e-11
been O 0 1.5723301133308e-11
obtained O 0 3.434599132878802e-11
by O 0 1.0843956982364844e-10
cellulose O 0 9.528895894561629e-09
acetate O 0 6.354442527722881e-10
gel O 0 2.5551465387962935e-09
electrophoresis O 0 6.677102759589104e-10
, O 0 3.266957190883879e-11
DEAE O 0 1.6101371329568792e-06
- O 0 8.551758412522759e-08
cellulose O 0 4.399231201546172e-08
ion O 0 4.818081933422036e-08
- O 0 4.322517010990623e-09
exchange O 0 1.6738979091712736e-09
chromatography O 0 2.2474890837287376e-09
, O 0 2.4612308718863218e-11
radial O 0 1.274173655474442e-08
immunodiffusion O 0 8.703676712684683e-08
, O 0 4.043674770026762e-11
and O 0 2.0795225263992023e-10
radioimmunoassay O 0 1.6050187696237117e-05
. O 0 1.1231836793967886e-07

Previous O 0 1.9709336811502e-06
family O 0 3.1783182752320727e-09
studies O 0 3.193459385819608e-10
suggested O 0 2.408904187234384e-10
that O 0 1.2295209338500368e-12
these O 0 1.2146120426711343e-13
individuals O 0 4.938775625441816e-13
may O 0 7.871527318847882e-10
be O 0 1.387323034229837e-10
compound O 0 2.3838570006873283e-10
heterozygotes O 0 2.9808797791242014e-11
for O 0 1.1054154553519213e-12
the O 0 1.1567085830832546e-11
common O 0 7.993972150899253e-11
mutant O 0 6.209471159479563e-09
TSD B-Disease 0 4.2618404449967784e-07
gene O 0 2.129928351746191e-11
and O 0 2.2114773120390785e-12
a O 0 7.215949365813046e-11
rare O 0 9.626326819001108e-11
( O 0 6.490211701404291e-10
allelic O 0 9.885741292237071e-08
) O 0 5.536557878826898e-10
mutant O 0 9.526842426055282e-09
gene O 0 1.1886863715560025e-09
. O 0 1.5991253876634914e-09

Thus O 0 8.076082025354481e-08
, O 0 4.189772417895199e-10
the O 0 1.1415406397929928e-09
postulated O 0 6.567348265207329e-08
rate O 0 1.316622721958538e-08
mutant O 0 1.3640423235372623e-09
gene O 0 9.125463405756928e-12
appears O 0 1.9602583445355037e-12
to O 0 1.0709109380530046e-12
code O 0 1.071363999035832e-13
for O 0 3.264213172763514e-13
the O 0 2.0042390056623782e-12
expression O 0 4.466804096742161e-12
of O 0 9.334908540603593e-11
low O 0 1.3295731182694226e-09
amounts O 0 1.4198107967100526e-10
of O 0 5.867023311623143e-09
hex O 0 4.1805874388956e-06
A O 0 1.542049403724377e-06
. O 0 4.3990969089691134e-08

Heterozygotes O 0 4.994150458514923e-06
for O 0 5.646933143310662e-09
the O 0 5.500478295061839e-09
rare O 0 4.249384455423666e-10
mutant O 0 3.573902063180867e-09
may O 0 8.646747762242057e-10
be O 0 2.1764950952629647e-11
indistinguishable O 0 7.516233468951583e-11
from O 0 5.8060318705588365e-12
heterozygotes O 0 4.019899690899109e-10
for O 0 3.476477092312358e-11
the O 0 5.436383010426482e-10
common O 0 2.0911228304498763e-08
TSD B-Disease 0 4.679771518567577e-05
mutant O 0 4.6430722022705595e-07
. O 0 1.3233853124461348e-08

However O 0 5.758034493652531e-09
, O 0 6.85564105484815e-11
direct O 0 1.7140803221238343e-09
visualization O 0 2.9563953063416193e-08
and O 0 1.9647230509178826e-09
quantitation O 0 2.552646037656814e-05
of O 0 1.3094621635900694e-06
hex O 0 1.01731973245478e-06
A O 0 6.671517560619122e-09
by O 0 5.841622324753715e-12
the O 0 2.4508452559079963e-11
methods O 0 5.562795710178925e-11
described O 0 1.16857235693546e-11
may O 0 1.0074113071523172e-10
prevent O 0 3.9846320687431103e-10
false O 0 5.856331530829095e-10
- O 0 5.098272026771156e-09
positive O 0 7.102179261364583e-11
prenatal O 0 4.4974438395684047e-08
diagnosis O 0 3.879450360955161e-08
of O 0 1.4477927745559782e-09
TSD B-Disease 0 7.246976110764081e-06
in O 0 3.2512086356462078e-09
fetuses O 0 1.2449707931239118e-08
having O 0 2.963385786758366e-11
the O 0 6.253488699092813e-11
incomplete O 0 3.5818179533464445e-09
hex B-Disease 0 2.425656020932365e-06
A I-Disease 0 2.8591857699211687e-06
deficiency I-Disease 0 0.04161786660552025
of O 0 6.563291066186139e-08
the O 0 6.336529634332067e-10
type O 0 1.0116812276805831e-08
described O 0 4.26156748778439e-10
in O 0 2.424751198437658e-11
the O 0 4.760056238062305e-10
four O 0 1.0052423476958339e-10
healthy O 0 6.933397606045943e-11
individuals O 0 6.083074044482828e-10

The O 0 7.548684379798942e-07
tumor B-Disease 0 3.4173122003267054e-06
suppressor O 0 8.586011972511187e-07
gene O 0 5.4811040151037105e-09
Smad4 O 0 1.2340929060883354e-06
/ O 0 1.3710210566841852e-07
Dpc4 O 0 5.341112228052225e-07
is O 0 1.8711596508347306e-11
required O 0 5.7099838746133e-11
for O 0 2.7311394465434624e-11
gastrulation O 0 5.119993318203342e-09
and O 0 4.765565546349659e-12
later O 0 8.303605719683915e-11
for O 0 6.114009038632462e-12
anterior O 0 1.6751691589433904e-07
development O 0 2.4966244183133313e-08
of O 0 5.832179184039887e-09
the O 0 8.903206505372907e-10
mouse O 0 3.2922065074103557e-09
embryo O 0 6.559011467288656e-08
. O 0 1.928542836537872e-08

Mutations O 0 2.0111900767005864e-07
in O 0 1.349310996268116e-09
the O 0 1.4487104849081334e-08
SMAD4 O 1 0.9997583031654358
/ O 0 0.003005348378792405
DPC4 O 1 0.9979791045188904
tumor B-Disease 0 5.1522336434572935e-05
suppressor O 0 3.116412017334369e-07
gene O 0 1.6392338875181878e-10
, O 0 3.2104343055533446e-12
a O 0 1.0839035224918803e-10
key O 0 7.649209265991885e-09
signal O 0 2.5742108888948678e-08
transducer O 0 6.694170906484942e-08
in O 0 9.800517064562086e-10
most O 0 1.726248449740453e-10
TGFbeta O 0 2.8580134312505834e-06
- O 0 2.1013568130001659e-07
related O 0 1.6945866931905584e-08
pathways O 0 7.962263626204447e-10
, O 0 6.492579369098139e-13
are O 0 1.7015870388604505e-14
involved O 0 5.233667774336148e-13
in O 0 1.5446552457248908e-12
50 O 0 4.959522792447046e-10
% O 0 1.4483838572942886e-09
of O 0 3.0372081738505585e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0007152569596655667

Homozygous O 0 2.4005923933145823e-06
Smad4 O 0 0.00015728306607343256
mutant O 0 1.5049134844957734e-06
mice O 0 1.2846183494730212e-07
die O 0 1.3859602177035413e-07
before O 0 1.5259863372918403e-09
day O 0 8.06642663775392e-09
7 O 0 3.23020088899284e-07
. O 0 1.692861495428133e-08

5 O 0 1.0583190487523098e-05
of O 0 3.8712391869921703e-07
embryogenesis O 0 2.5260862912546145e-06
. O 0 1.4547862292602076e-07

Mutant O 0 5.651946253237838e-07
embryos O 0 2.8851854239064778e-08
have O 0 6.340129116155779e-11
reduced O 0 5.906677924549797e-10
size O 0 1.2707526697575133e-10
, O 0 2.487736405765162e-11
fail O 0 1.3701891177220205e-08
to O 0 6.5418421790752745e-09
gastrulate O 0 1.4295451364887413e-06
or O 0 8.498546311130895e-10
express O 0 1.5585452373123587e-10
a O 0 1.194686433114711e-10
mesodermal O 0 9.21265819187056e-09
marker O 0 3.3389335740707793e-09
, O 0 1.4886238075551006e-11
and O 0 5.548892595408361e-11
show O 0 2.2186417147906923e-09
abnormal O 0 1.072784172606589e-07
visceral O 0 1.579355853209563e-06
endoderm O 0 0.00014890207967255265
development O 0 6.423153081414057e-06
. O 0 1.5470826042474073e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 6.0173755628056824e-05
the O 0 3.291817620265647e-06
Smad4 O 0 0.002452095737680793
- O 0 1.588924351381138e-05
deficient O 0 1.3403102627762564e-07
embryos O 0 3.727768926875541e-10
results O 0 2.19552431790504e-11
from O 0 1.5909529249569232e-10
reduced O 0 1.2221770262499376e-08
cell O 0 5.020255322563116e-09
proliferation O 0 1.2074545807649883e-08
rather O 0 3.0417952878725174e-11
than O 0 3.88906094828112e-11
increased O 0 1.4954268934275206e-09
apoptosis O 0 1.0935048777582779e-07
. O 0 1.1908587893572076e-08

Aggregation O 0 2.467955084739515e-07
of O 0 3.0114694737903847e-08
mutant O 0 1.1924798570817075e-07
Smad4 O 0 1.8784552594297566e-05
ES O 0 4.421904577611713e-06
cells O 0 1.7150246500730049e-10
with O 0 7.30490104169923e-13
wild O 0 6.845044669967493e-11
- O 0 7.509670663097268e-11
type O 0 1.52926715735191e-09
tetraploid O 0 2.2981710117164766e-06
morulae O 0 8.885705938155297e-06
rescues O 0 2.2763485674204276e-07
the O 0 6.359367699104723e-09
gastrulation B-Disease 0 4.485960744204931e-06
defect I-Disease 0 1.4026164535607677e-05
. O 0 1.9963155750701844e-07

These O 0 1.686466744033055e-09
results O 0 8.152358788038327e-10
indicate O 0 5.38628364132876e-10
that O 0 6.756898859872074e-12
Smad4 O 0 3.3957945788642974e-08
is O 0 2.047163220192383e-12
initially O 0 2.6375240966963753e-12
required O 0 9.977419281395616e-13
for O 0 3.648904366593958e-13
the O 0 1.3334243431639692e-11
differentiation O 0 1.0752039536487956e-10
of O 0 1.0395644761684864e-10
the O 0 1.842063168666641e-10
visceral O 0 3.039617446631837e-09
endoderm O 0 3.8655937117937356e-08
and O 0 1.9350800475881336e-11
that O 0 1.9332825271223264e-12
the O 0 3.431829126432362e-11
gastrulation B-Disease 0 1.3916230834354337e-08
defect I-Disease 0 1.8070246410317736e-09
in O 0 3.924588518749994e-12
the O 0 4.1825366087211435e-11
epiblast O 0 9.972873193930809e-09
is O 0 5.345993613070643e-12
secondary O 0 4.037804535172995e-10
and O 0 1.7881961536514446e-11
non O 0 1.0115620341366593e-07
- O 0 2.1269979697535746e-06
cell O 0 1.259866849068203e-06
autonomous O 0 1.3246285561763216e-06
. O 0 7.075080077356688e-08

Rescued O 0 5.042842531111091e-06
embryos O 0 2.175568525331073e-08
show O 0 1.0655417659322097e-09
severe O 0 5.35743708951486e-07
anterior O 0 0.00037374949897639453
truncations O 0 0.005112356040626764
, O 0 3.91296417490139e-09
indicating O 0 1.7989028933129703e-08
a O 0 1.2105069169265903e-09
second O 0 2.2285744361028037e-09
important O 0 1.0170485981175759e-11
role O 0 3.498040745952835e-11
for O 0 8.113542476761992e-11
Smad4 O 0 2.2233082290767925e-06
in O 0 9.461993855097717e-09
anterior O 0 0.0007013982976786792
patterning O 0 0.0015029229689389467
during O 0 0.00021522051247302443
embryogenesis O 0 5.777718001809262e-07
. O 0 3.253344260656377e-08

Prevalence O 0 8.169601642293856e-06
of O 0 2.2796283971615594e-08
p16 O 0 2.992163672388415e-07
and O 0 5.611437536856556e-09
CDK4 O 1 0.9980656504631042
germline O 0 7.503489905502647e-05
mutations O 0 3.21191677699062e-08
in O 0 6.259434637279071e-10
48 O 0 3.6236477285456203e-07
melanoma B-Disease 0 0.3409467339515686
- O 0 7.082087449816754e-07
prone O 0 3.763852873817086e-07
families O 0 7.418698294570092e-11
in O 0 1.6291513693644788e-09
France O 0 3.6312169982011255e-07
. O 0 2.8129261409048922e-06

The O 0 2.8459099965516543e-08
French O 0 9.909373375194264e-07
Familial B-Disease 1 0.9982878565788269
Melanoma I-Disease 1 0.9999998807907104
Study O 0 1.138332450523194e-07
Group O 0 1.8155153769239263e-10
. O 0 1.5591496982381159e-09

Germline O 0 0.00014697067672386765
mutations O 0 1.032580243531811e-07
in O 0 6.339757607776164e-10
the O 0 1.6534248414856734e-09
p16 O 0 2.540791754768179e-08
and O 0 1.0409796358246126e-09
CDK4 O 1 0.587786853313446
genes O 0 8.009455321200676e-09
have O 0 1.9102280521265946e-11
been O 0 1.589754022868206e-11
reported O 0 8.545708411744624e-12
in O 0 8.588188211804126e-13
a O 0 2.1248440507104505e-11
subset O 0 8.226620273887875e-09
of O 0 1.3501972873086743e-08
melanoma B-Disease 0 6.139340257504955e-05
pedigrees O 0 9.802334055564188e-09
, O 0 3.493240766094807e-11
but O 0 2.515194302832313e-11
their O 0 4.108575979433482e-11
prevalence O 0 3.87063847639979e-09
is O 0 1.6455129359799203e-12
not O 0 2.5750809470870273e-11
well O 0 6.238573546646364e-11
known O 0 5.681873638252455e-09
. O 0 4.0917679910990046e-08

We O 0 2.6877806647007674e-08
searched O 0 3.478895171937779e-09
for O 0 3.6620647486662605e-11
such O 0 1.0782660181396508e-10
germline O 0 1.218750185216777e-06
mutations O 0 2.3319697284307495e-09
in O 0 1.9961378383559492e-10
48 O 0 2.6532061880857327e-08
French O 0 1.3380638108628773e-07
melanoma B-Disease 1 0.9942150712013245
- O 0 9.162094443126989e-07
prone O 0 7.642504584737253e-08
families O 0 7.498703047392752e-12
selected O 0 8.251574879110379e-13
according O 0 7.00148435322373e-13
to O 0 1.0892271459783665e-11
two O 0 1.4393595907172263e-12
major O 0 1.5700592215228681e-10
criteria O 0 9.674704370965514e-10
families O 0 6.380702173222619e-13
with O 0 1.4834098847286287e-13
at O 0 1.2741122601411803e-09
least O 0 9.653464833059289e-11
three O 0 1.236178520658271e-11
affected O 0 4.697558661503898e-11
members O 0 3.237929238966708e-12
( O 0 7.321391756742734e-12
n O 0 1.5062503466722887e-09
= O 0 4.1135886363896645e-10
20 O 0 1.3831538692166134e-10
) O 0 3.431922037137533e-14
or O 0 3.4655037086522844e-13
families O 0 1.6446266142564406e-14
with O 0 3.621927705535965e-15
two O 0 2.86715123214501e-13
affected O 0 6.567549021979646e-12
members O 0 1.9044236131658676e-13
, O 0 1.1471329528639496e-12
one O 0 9.036575307486139e-12
of O 0 2.805420479257137e-11
them O 0 1.1062669741856643e-13
affected O 0 1.8484562838705365e-12
before O 0 2.5903766978641052e-11
the O 0 1.9919722121786165e-11
age O 0 2.066758431062965e-10
of O 0 7.333107038265396e-11
50 O 0 1.4640118284336978e-10
( O 0 5.387881113483317e-12
n O 0 1.8799259926538525e-09
= O 0 1.0373782943773335e-09
28 O 0 1.9182844201992566e-09
) O 0 5.295936215607422e-13
, O 0 2.543631538037827e-13
and O 0 1.207647263440359e-13
one O 0 7.39337735998491e-13
additional O 0 2.8070245780553726e-12
minor O 0 2.350089012281842e-09
criterion O 0 5.8214959608449135e-06
. O 0 4.0841115378498216e-08

Sixteen O 0 1.1361106544427457e-06
different O 0 3.3351719164187443e-09
p16 O 0 7.513706918871321e-07
germline O 0 2.5888107302307617e-06
mutations O 0 4.113708484965173e-09
were O 0 1.7092173162924773e-11
found O 0 2.030440973774944e-13
in O 0 7.756824154346587e-14
21 O 0 3.764837400166421e-11
families O 0 3.9341495556080575e-13
, O 0 1.4626901035860729e-12
while O 0 2.6134981331860097e-11
one O 0 6.155718712541614e-10
germline O 0 3.6410062875802396e-07
mutation O 0 3.006545412631567e-08
, O 0 3.7476016734316886e-10
Arg24His O 0 4.855398401559796e-06
, O 0 1.1680878486686197e-09
was O 0 5.0131671258668575e-08
detected O 0 2.7132396329676567e-09
in O 0 5.994281460086626e-11
the O 0 2.4757109695627832e-09
CDK4 O 0 0.00012648424308281392
gene O 0 1.827559259481859e-08
. O 0 2.4101476370219643e-08

The O 0 2.5312917983910665e-08
frequency O 0 2.7996195584023553e-08
of O 0 5.07589703602207e-09
p16 O 0 1.0072451317455489e-08
gene O 0 6.060395935092444e-11
mutation O 0 4.8141435282644807e-11
in O 0 1.7649535262106997e-12
our O 0 4.9090913625815524e-12
sample O 0 4.2531324057244746e-13
( O 0 5.294320754370418e-13
44 O 0 3.0120755889484485e-10
% O 0 3.208672910703925e-11
) O 0 2.968972181820184e-13
is O 0 3.6394097371189593e-13
among O 0 3.045738371254027e-14
the O 0 1.678108606933959e-12
highest O 0 3.863880049248536e-10
rates O 0 9.492184815940163e-12
yet O 0 6.4526205559301e-12
reported O 0 2.3039814847636286e-11
and O 0 6.568313167670814e-12
the O 0 3.4961816774981003e-10
CDK4 O 0 4.885291673417669e-06
mutation O 0 6.115216111268751e-10
is O 0 8.11781024345759e-12
the O 0 9.908379672296519e-11
second O 0 4.891564486797506e-09
mutation O 0 1.5907899442169082e-09
detected O 0 9.163286240898572e-10
in O 0 5.067222249438563e-12
this O 0 9.921125726508606e-11
gene O 0 8.947911855905488e-10
worldwide O 0 1.2807956917271213e-09
. O 0 1.3710988788773193e-08

In O 0 1.3920099517505946e-09
summary O 0 2.7055513385221275e-08
, O 0 7.643222166286989e-11
our O 0 2.1140264885866067e-11
results O 0 1.1750046248482082e-11
show O 0 3.2261608749056814e-12
frequent O 0 1.9794688891489054e-12
involvement O 0 1.230101576155107e-10
of O 0 8.954553765150308e-10
the O 0 7.263343260177635e-10
p16 O 0 2.1001711481005714e-09
gene O 0 2.3948159427744642e-11
in O 0 3.857802619022799e-11
familial B-Disease 0 1.890996259135136e-06
melanoma I-Disease 0 0.1081356406211853
and O 0 1.848021180528292e-10
confirm O 0 6.975928168451162e-10
the O 0 1.7939327801030913e-10
role O 0 8.314414434718032e-11
of O 0 4.0546441204547534e-10
the O 0 1.2561715001524476e-09
CDK4 O 0 0.00031992411823011935
gene O 0 3.677290416614909e-10
as O 0 6.576138245062424e-11
a O 0 3.8574312632988494e-09
melanoma B-Disease 0 9.498425788478926e-05
- O 0 4.816502041649073e-06
predisposing O 0 6.64473702727264e-07
gene O 0 1.3116642216814967e-09
. O 0 1.0640550662799342e-09
. O 0 1.2270611193798686e-08

Progression O 0 0.0001441263739252463
of O 0 3.2189993817155482e-06
somatic O 0 3.267271677032113e-05
CTG O 0 6.653214950347319e-05
repeat O 0 2.069849180941219e-08
length O 0 4.031540379312304e-10
heterogeneity O 0 1.511295089073883e-09
in O 0 4.835195611951892e-12
the O 0 8.362695952390808e-12
blood O 0 9.884006807459045e-12
cells O 0 9.863295596934663e-11
of O 0 1.4194920794352583e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0007772419485263526
. O 0 9.22270601222408e-07

The O 0 1.0733809396867855e-09
genetic O 0 2.3046155261940982e-10
basis O 0 7.960502257375879e-10
of O 0 3.3098486174054642e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.837841309310534e-08
DM B-Disease 1 1.0
) O 0 1.4050042379532002e-11
is O 0 5.677593269658165e-13
the O 0 3.744354219042956e-12
expansion O 0 2.876226479209265e-10
of O 0 5.425278559734181e-10
an O 0 9.988059268550842e-10
unstable O 0 4.589138552546501e-05
CTG O 0 3.3249878470087424e-05
repeat O 0 1.552947637151192e-08
in O 0 6.103945127122756e-11
the O 0 5.925205881496254e-10
34 O 0 7.580467809020774e-09
UTR O 0 1.0046167062682798e-06
of O 0 1.6506456201881292e-09
the O 0 6.958550180513612e-09
DM B-Disease 1 1.0
protein O 0 3.2417734274758914e-08
kinase O 0 5.772351929778097e-09
gene O 0 1.5864099964235656e-11
on O 0 1.1788985343486047e-09
chromosome O 0 2.0092039676455897e-07
19 O 0 3.033237305771763e-07
. O 0 5.030348138035379e-09

One O 0 3.520547853241851e-09
of O 0 6.804616314859402e-10
the O 0 1.3975534618460017e-10
principal O 0 8.021927566659315e-10
features O 0 2.412340075960695e-13
of O 0 1.08173289770086e-10
the O 0 2.8304694144054565e-09
DM B-Disease 1 1.0
mutation O 0 7.029306914319022e-08
is O 0 1.1597483390302088e-11
an O 0 1.844842421189208e-12
extraordinarily O 0 2.939540832969101e-10
high O 0 2.057415393608153e-08
level O 0 4.391895345179364e-07
of O 0 2.1830636853792384e-07
somatic O 0 1.457143844163511e-05
mosaicism O 0 0.0006477169808931649
, O 0 1.4698313399730267e-10
due O 0 2.0788848420494332e-09
to O 0 2.161807712008912e-11
an O 0 6.204924269705148e-13
extremely O 0 1.9450183651181785e-12
high O 0 1.806058080866535e-11
degree O 0 3.40897932105122e-09
of O 0 3.9090530812302404e-10
somatic O 0 3.296606720937234e-08
instability O 0 1.4650802349081005e-08
both O 0 3.5764809083044247e-12
within O 0 1.463226588505062e-11
and O 0 1.2608743259548416e-12
between O 0 8.69294636274276e-11
different O 0 7.191792994465374e-11
tissues O 0 3.638556345109123e-09
. O 0 2.603793403110899e-09

This O 0 1.1187552217961638e-08
instability O 0 2.271634684802848e-06
appears O 0 8.800269957198736e-10
to O 0 8.32382357485173e-11
be O 0 4.071876082839543e-12
biased O 0 4.967623534746224e-11
towards O 0 1.0016418250380354e-11
further O 0 3.4917199340234184e-12
expansion O 0 2.019928495300416e-11
and O 0 1.0300342393257389e-12
continuous O 0 6.985618333787968e-11
throughout O 0 7.323287484241325e-13
the O 0 7.338504803833246e-12
life O 0 3.536330950293376e-12
of O 0 1.3490259256898618e-12
an O 0 5.499513062827421e-13
individual O 0 6.501051731449756e-14
, O 0 3.6029764783652996e-13
features O 0 3.973285527089816e-14
that O 0 1.218766027769741e-13
could O 0 2.2176357972192307e-12
be O 0 8.391531827051102e-13
associated O 0 1.3457235542926882e-12
with O 0 1.659543711490536e-14
the O 0 9.547984798630171e-12
progressive O 0 1.3973202150907582e-08
nature O 0 9.488266838886261e-10
of O 0 5.714347661722741e-09
the O 0 2.9537238432908453e-08
disease O 0 1.482531956753519e-06
. O 0 2.0992551696963346e-08

Although O 0 9.874439460544338e-11
increasing O 0 5.0585726579788215e-11
measured O 0 1.1245733511078271e-10
allele O 0 1.3145110000500893e-10
size O 0 1.560225039443086e-11
between O 0 1.5920366414068354e-10
patients O 0 1.390560305791766e-10
clearly O 0 9.589048305391756e-12
correlates O 0 7.773390438281513e-12
with O 0 3.3225773681303493e-15
an O 0 6.854911603626501e-14
increased O 0 3.041457060162789e-12
severity O 0 1.695058671202787e-08
of O 0 2.5065177711169895e-10
symptoms O 0 1.7873821867020467e-10
and O 0 2.7935263152180367e-13
an O 0 2.2214235930340803e-13
earlier O 0 5.6715923624217623e-11
age O 0 2.5490312638432044e-10
of O 0 6.77812320160065e-11
onset O 0 1.0035311248657308e-07
, O 0 6.0204714477651855e-12
this O 0 1.0383511758749187e-11
correlation O 0 2.130551152168536e-10
is O 0 3.4910939156890253e-12
not O 0 6.3771895750242e-12
precise O 0 1.4722696672908597e-10
and O 0 3.776846890790608e-12
measured O 0 9.13893197229676e-11
allele O 0 8.345781843388522e-10
length O 0 8.233114745515024e-10
cannot O 0 6.342306541062825e-11
be O 0 4.6711367412966e-12
used O 0 2.414954900550187e-13
as O 0 5.028138685579317e-14
an O 0 2.5494250062278213e-14
accurate O 0 3.0011493290516e-11
predictor O 0 5.69359279722903e-08
of O 0 2.24680232752128e-10
age O 0 3.809381965425018e-08
of O 0 2.7704039951004233e-08
onset O 0 0.001118843094445765
. O 0 8.391264572082946e-08

In O 0 1.0520437854211195e-09
order O 0 3.003217952102233e-10
to O 0 2.1687014684079742e-10
further O 0 1.620670819768577e-10
characterize O 0 1.879417865779942e-08
the O 0 1.3215886163209234e-09
dynamics O 0 1.1644002206878667e-08
of O 0 4.430285684975388e-07
DM B-Disease 1 1.0
CTG O 0 0.0004389335517771542
repeat O 0 1.6989176288007002e-07
somatic O 0 1.7792535800253972e-07
instability O 0 6.991372742959356e-07
, O 0 8.11307757087043e-11
we O 0 3.826598413136928e-11
have O 0 1.691012130669578e-12
studied O 0 5.5503743962015406e-11
repeat O 0 1.7329247412045667e-11
length O 0 5.607427282922073e-12
changes O 0 2.6511559332413615e-13
over O 0 7.962130846132787e-13
time O 0 2.4628120723346747e-12
in O 0 1.1674311690967887e-12
111 O 0 2.589393375274085e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.1539023070383791e-09
with O 0 8.051222991252438e-13
varying O 0 1.7905760207881372e-10
clinical O 0 7.548365488219133e-09
severity O 0 2.131575001840247e-06
and O 0 1.9934107697849868e-09
CTG O 0 1.1142254834339838e-06
repeat O 0 8.523676209293285e-10
size O 0 1.738002276818751e-11
over O 0 1.8209871111007914e-11
time O 0 3.503168935492518e-11
intervals O 0 1.4440852680319693e-10
of O 0 2.4463056580437126e-11
1 O 0 3.999985231928349e-09
- O 0 4.427073818646932e-09
7 O 0 4.904543615680268e-08
years O 0 3.2493487900353557e-09
. O 0 2.5202007147839822e-09

We O 0 3.449152075063466e-08
have O 0 7.416148424532754e-12
found O 0 2.0145284095399174e-13
a O 0 2.8425718267936773e-13
direct O 0 4.855882015930568e-11
progression O 0 1.4615488819202938e-09
of O 0 1.4179867002805935e-10
the O 0 1.8594556450146627e-10
size O 0 6.942399433107482e-10
heterogeneity O 0 2.5395562985863762e-08
over O 0 2.4690665068050066e-09
time O 0 4.98037922014305e-09
related O 0 8.561051867417291e-10
to O 0 1.1674112343484921e-08
initial O 0 4.467452185963339e-08
CTG O 0 1.26090537833079e-06
repeat O 0 1.2163253737540458e-09
size O 0 6.23412502176457e-11
and O 0 1.1880845265932471e-11
the O 0 6.743242075835099e-11
time O 0 1.5420897891971208e-10
interval O 0 3.180960772564134e-10
and O 0 2.983335583781055e-12
always O 0 6.472996617878923e-12
biased O 0 2.688977929210523e-10
towards O 0 2.457577752412732e-10
further O 0 4.184844415444644e-10
expansion O 0 3.639391366050404e-08
. O 0 3.4600240894633316e-08

Attempts O 0 7.512991118119317e-08
to O 0 4.95303975611705e-09
mathematically O 0 1.3853412639264207e-08
model O 0 8.927932282354334e-10
the O 0 2.5632298505939843e-09
dynamics O 0 3.297072126429157e-08
have O 0 1.3282999700159337e-10
proved O 0 1.2844358909802622e-09
only O 0 1.9566659056891034e-11
partially O 0 3.073604704084687e-10
successful O 0 7.898816149765064e-12
suggesting O 0 1.1122551447570461e-12
that O 0 1.5692477970275648e-14
individual O 0 4.713839571907378e-15
specific O 0 1.982408378078948e-12
genetic O 0 5.573437197869957e-11
and O 0 1.1814589237491013e-11
/ O 0 1.9058570899233018e-07
or O 0 2.5703105421825967e-08
environmental O 0 1.423398714450741e-07
factors O 0 6.877136082827917e-10
also O 0 6.087080709274439e-13
play O 0 4.281050340615433e-12
a O 0 1.1904777511007048e-11
role O 0 3.6228259975290555e-11
in O 0 1.3893886041671522e-10
somatic O 0 1.2502708557349251e-07
mosaicism O 0 1.4448671208810993e-05
. O 0 4.115843221796922e-09
. O 0 1.5716608459115378e-08

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 5.1855160165814596e-09
Palestinian O 0 1.683798586782359e-06
Arabs O 0 2.156838263545069e-07
. O 0 1.8184769245976895e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.8539842367172241
AGU B-Disease 1 1.0
) O 0 2.1887772150286366e-10
is O 0 9.264131128894348e-12
a O 0 5.861738178181142e-11
rare O 0 2.8046902578182653e-09
disorder B-Disease 1 0.9472508430480957
of I-Disease 0 9.627622057450935e-05
glycoprotein I-Disease 0 5.238298399490304e-05
metabolism I-Disease 1 0.5184535384178162
caused O 0 1.6144070968948654e-07
by O 0 1.5203407977004701e-10
the O 0 4.312463985911563e-08
deficiency B-Disease 0 4.3839514546561986e-05
of I-Disease 0 1.98373800230911e-06
the I-Disease 0 1.4602949249820085e-07
lysosomal I-Disease 0 2.6731288471637527e-06
enzyme I-Disease 0 5.367746425122277e-08
aspartylglucosaminidase I-Disease 0 1.2326321439104504e-06
( O 0 4.952772636457325e-10
AGA O 0 2.251211526527186e-06
) O 0 1.4459926311882754e-10
. O 0 1.5410291931416964e-09

AGU B-Disease 1 1.0
is O 0 1.1433568403163008e-07
inherited O 0 4.4325511794340855e-07
as O 0 6.715021871883664e-10
an O 0 3.047069263573121e-10
autosomal O 0 1.8061731452689855e-06
recessive O 0 1.7918757293955423e-05
trait O 0 3.179069896219744e-09
and O 0 2.8649020655802104e-11
occurs O 0 1.002522891091484e-11
with O 0 3.658952277990103e-14
a O 0 1.5747852674663498e-11
high O 0 6.118424655809918e-10
frequency O 0 8.95940543976792e-10
in O 0 1.8405556592715477e-11
Finland O 0 2.527106857108663e-10
because O 0 5.850055162515133e-11
of O 0 7.990287320680522e-10
a O 0 2.1848991504924697e-09
founder O 0 3.462096742623544e-08
effect O 0 1.2686149375440436e-07
. O 0 1.909353031237515e-08

While O 0 2.2054368997714846e-08
very O 0 3.326783848400794e-10
few O 0 2.5704843809037925e-10
patients O 0 3.969443870821543e-11
with O 0 1.1212663436621639e-10
AGU B-Disease 1 1.0
have O 0 1.8738475215940298e-09
been O 0 4.5712073015735655e-11
reported O 0 2.0218624951356956e-12
from O 0 5.505938587002657e-12
non O 0 1.8758990194545078e-10
- O 0 7.702287418975828e-11
Finnish O 0 8.252862282454032e-10
origin O 0 1.3129450304738555e-10
, O 0 9.909830768484174e-12
we O 0 3.2676256145336424e-10
diagnosed O 0 2.1996973373461515e-05
the O 0 4.862096503188695e-09
disorder O 0 1.434938781130768e-07
in O 0 9.22483339715896e-11
8 O 0 4.720856594531142e-08
patients O 0 2.3425226602230564e-12
originating O 0 4.170584884388706e-12
from O 0 1.3450544497639605e-11
3 O 0 1.5267199726665126e-09
unrelated O 0 3.6746099218998296e-11
families O 0 1.4126449576074007e-13
, O 0 2.7969424329756312e-14
all O 0 7.819630630945956e-14
Palestinian O 0 3.722667174521632e-10
Arabs O 0 8.543768990898482e-12
from O 0 2.7679265129920694e-12
the O 0 2.4097796241101532e-12
region O 0 1.40723627195527e-10
of O 0 1.0039470643707915e-10
Jerusalem O 0 1.8205420246886206e-06
. O 0 2.2859243387074457e-08

The O 0 3.1022893143273222e-09
clinical O 0 1.5493261784627066e-08
diagnosis O 0 0.10254021733999252
of O 0 0.00024152504920493811
AGU B-Disease 1 1.0
is O 0 2.8403462692949688e-08
often O 0 2.9891238789714336e-11
difficult O 0 2.7586741224716604e-10
, O 0 4.5457973323059786e-13
in O 0 3.1565147631112955e-13
particular O 0 6.394960515992976e-12
early O 0 1.4829991401565934e-10
in O 0 9.43262070014772e-13
the O 0 5.568206486172844e-12
course O 0 4.1696507357968926e-10
of O 0 6.016112608087099e-11
the O 0 6.221916315496401e-10
disease O 0 1.048402520353875e-08
, O 0 1.555808325053032e-12
and O 0 1.8216600103371228e-12
most O 0 1.4906062495434469e-12
of O 0 1.273803007517671e-10
the O 0 1.0254092713823937e-10
patients O 0 9.425415309349816e-12
are O 0 1.0850007958057573e-12
diagnosed O 0 2.858311809461611e-09
after O 0 4.3001555094512867e-10
the O 0 9.121135097212019e-11
age O 0 5.064367258889035e-10
of O 0 2.190042452943075e-10
5 O 0 1.104650504402116e-08
years O 0 1.6200968344648459e-09
. O 0 4.3278705064153655e-09

However O 0 1.2681275052273122e-07
, O 0 1.6678110004164637e-09
since O 0 9.116779331463931e-09
these O 0 7.037184723834855e-11
patients O 0 7.712872007736848e-11
excrete O 0 1.521695547346269e-10
early O 0 1.0677099482325758e-10
large O 0 6.424130324922395e-12
amounts O 0 8.569707443673025e-11
of O 0 1.738501453907304e-09
aspartylglucosamine O 0 7.902325478426064e-07
in O 0 7.246160560470116e-09
urine O 0 2.721224634516517e-10
, O 0 2.0910747092206527e-12
biochemical O 0 2.47595902114206e-11
screening O 0 9.899898262277773e-11
is O 0 2.825583734003545e-12
easy O 0 5.506750264117066e-11
by O 0 1.1907622110562954e-10
urine O 0 2.1816871920155023e-10
chromatography O 0 3.727144815002248e-09
. O 0 1.3890685268691527e-09
. O 0 1.0894219748536216e-08

Detection O 0 3.806287907082151e-08
of O 0 2.2719517933644795e-10
heterozygous O 0 4.648534595447229e-12
carriers O 0 2.190595795037442e-12
of O 0 1.1389193754762772e-10
the O 0 1.771554103413564e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.8392709932868456e-07
ATM O 0 8.311829878948629e-05
) O 0 6.392025103663102e-11
gene O 0 1.4019919123212099e-12
by O 0 4.303655088550018e-12
G2 O 0 4.187220170592809e-08
phase O 0 1.2755114653373312e-07
chromosomal O 0 2.5793131044338224e-06
radiosensitivity O 0 6.593520083697513e-06
of O 0 3.525005070059706e-07
peripheral O 0 3.047704740311019e-05
blood O 0 2.877634187825606e-06
lymphocytes O 0 3.529182777128881e-07
. O 0 7.205341034932644e-08

In O 0 2.9681996238650754e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.5058994853898184e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.575236218189559e-10
patients O 0 8.043587323980361e-11
, O 0 2.9338469587775196e-12
mutations O 0 5.176289084862784e-12
in O 0 2.5698445108024437e-12
a O 0 2.2572216665239786e-11
single O 0 1.769356362812946e-11
gene O 0 1.082163113459711e-12
, O 0 4.877877073615478e-13
ATM O 0 6.228592752677287e-09
, O 0 9.495131460604544e-13
result O 0 2.842638234176742e-12
in O 0 8.454964159354539e-12
an O 0 1.1742788075252975e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 7.488068831662531e-07
embraces O 0 1.0852653220538855e-09
a O 0 1.601721533184275e-11
variety O 0 1.4594462791062135e-12
of O 0 8.53788827831492e-12
clinical O 0 7.0691850810600254e-12
features O 0 4.481392131840643e-14
and O 0 8.448560319222753e-13
manifests O 0 4.4485519434811494e-11
extreme O 0 3.841581275310091e-08
radiosensitivity O 0 2.7861003104590054e-07
and O 0 2.290766742962802e-10
a O 0 1.946390604246062e-09
strong O 0 1.0175366105258377e-09
pre O 0 2.451168029438122e-06
- O 0 4.2008832679130137e-07
disposition O 0 3.652427267297753e-06
to O 0 6.243569714570185e-07
malignancy B-Disease 0 0.00011572252697078511
. O 0 3.8597885776425755e-08

Heterozygotes O 0 2.8487403369581443e-07
for O 0 1.5745014181334227e-09
the O 0 4.221491600731042e-09
ATM O 0 6.192914838720753e-07
gene O 0 3.9829736731000764e-11
have O 0 1.1016456843981892e-12
no O 0 8.194906342059993e-13
clinical O 0 3.6277543469243057e-12
expression O 0 5.7936203577690915e-12
of O 0 6.792962192747609e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 6.369027527597382e-10
may O 0 4.517645812995852e-09
be O 0 9.768305053725612e-10
cancer B-Disease 0 2.4271193055369622e-08
prone O 0 3.225610611945484e-10
with O 0 6.567955814634763e-14
a O 0 8.266690110225738e-11
moderate O 0 9.031388259472806e-08
increase O 0 6.693733567431082e-09
in O 0 3.1133264855043308e-09
in O 0 1.852130360191495e-08
vitro O 0 2.2457177237811266e-06
radiosensitivity O 0 1.8147393348044716e-05
. O 0 1.120696992984449e-07

We O 0 1.1942211131099612e-07
performed O 0 7.919944700063297e-10
a O 0 1.0928721261294072e-09
blind O 0 3.005192183991312e-08
chromosomal O 0 1.518663452770852e-07
analysis O 0 3.789275837551287e-10
on O 0 1.8242646504518234e-08
G2 O 0 3.0333641376500964e-08
- O 0 1.6222799770204688e-09
phase O 0 1.0479187295686643e-08
lymphocytes O 0 1.309243338742938e-11
from O 0 1.3127240613974855e-11
7 O 0 7.212182517868371e-10
unrelated O 0 1.8645600619038305e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.186106709689e-10
, O 0 2.7171869355219203e-12
13 O 0 2.005713234387585e-10
obligate O 0 2.205954530154486e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 3.27131255417612e-09
( O 0 1.7117842516720105e-12
parents O 0 3.1408176840580504e-12
of O 0 9.003009275587726e-12
the O 0 7.772426799390608e-12
patients O 0 7.60050334301654e-13
) O 0 2.9495443630914164e-13
, O 0 4.622884106769698e-12
and O 0 7.134384055751397e-11
14 O 0 6.597279167408487e-08
normal O 0 6.5497829382366035e-09
controls O 0 8.39764424664935e-10
following O 0 8.09354180897337e-11
X O 0 8.313981680885263e-08
- O 0 8.382286864616617e-09
irradiation O 0 2.0059705008179662e-09
with O 0 1.5010598016299004e-12
1 O 0 1.5222401117398476e-08
Gy O 0 2.152750333550557e-08
in O 0 1.573451330165454e-12
order O 0 3.966081369571883e-12
to O 0 1.2913766410382888e-11
evaluate O 0 1.3517464057810624e-11
this O 0 3.148837310687491e-12
cytogenetic O 0 1.0789254822896055e-08
method O 0 3.162437256509776e-10
as O 0 8.881008992447925e-13
a O 0 2.611210076289283e-12
tool O 0 1.3373525897808491e-10
for O 0 5.1433488544583295e-12
detection O 0 5.867940799930693e-09
of O 0 6.545212372088827e-09
ATM O 0 7.454405476892134e-06
carriers O 0 1.0908192571434938e-08
. O 0 2.3761149492429468e-08

Both O 0 1.1303121993933019e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 2.237963144580135e-06
and O 0 1.0452108623049128e-10
heterozygotes O 0 1.190413101426202e-09
showed O 0 1.2380969513503537e-11
significantly O 0 9.843594689362689e-12
increased O 0 3.843048448914921e-11
levels O 0 1.1703932267792538e-10
of O 0 1.4025147709872954e-10
radiation O 0 1.2591973245434929e-05
- O 0 8.318738196066988e-07
induced O 0 4.730501132144127e-06
chromatid O 0 1.3125265923008556e-06
damage O 0 3.3289577316963914e-08
relative O 0 2.0294692593125774e-09
to O 0 1.1324598897521909e-10
that O 0 4.310596584539139e-12
of O 0 1.3935713694124274e-10
normal O 0 3.726562169958925e-09
controls O 0 1.6104083400136915e-08
. O 0 5.0066479850841006e-09

These O 0 1.1074092753915465e-09
results O 0 5.067962161042772e-10
show O 0 2.392867570755186e-10
that O 0 5.052880423100925e-12
the O 0 1.8648685373712226e-10
G2 O 0 2.3294724371680786e-08
- O 0 1.5827071209173482e-08
phase O 0 2.870650632758043e-07
chromosomal O 0 2.2065653126901452e-07
radiosensitivity O 0 1.9038370169255359e-07
assay O 0 1.4389061053776686e-09
can O 0 4.083954962402769e-12
be O 0 1.0197981239849774e-13
used O 0 1.814050991399193e-14
for O 0 1.6460262514984836e-14
the O 0 2.7063551052974866e-13
detection O 0 1.8804557910812036e-10
of O 0 8.587153210726228e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 6.446079169108998e-06
. O 0 5.9588501244434156e-08

In O 0 1.3223810491069798e-08
combination O 0 7.589465944590756e-09
with O 0 2.9710162108287363e-10
molecular O 0 9.95987434748713e-08
genetic O 0 7.095930509848358e-09
analyses O 0 2.196044873725711e-10
, O 0 1.4264106389105802e-12
this O 0 1.1417108577993496e-12
test O 0 6.668365078871252e-12
may O 0 7.123692261079562e-12
be O 0 1.1011142084932368e-12
of O 0 1.3344262760756065e-12
value O 0 4.008355604899483e-13
in O 0 1.4674397222531887e-13
studies O 0 1.052881198025657e-12
of O 0 1.14399592229808e-11
familial B-Disease 0 2.972570856130119e-09
and I-Disease 0 8.019602204534237e-10
sporadic I-Disease 0 4.5046084551358945e-07
cancers I-Disease 0 3.4066979424096644e-06
aimed O 0 2.968933099367632e-09
at O 0 2.9395633149853495e-10
determination O 0 1.0762667840280571e-10
of O 0 5.072475772749385e-11
the O 0 1.7695588050425926e-11
potential O 0 1.936660554147096e-11
involvement O 0 2.560575362853257e-10
of O 0 9.03368824189954e-10
ATM O 0 1.727924200167763e-06
mutations O 0 3.129174475091645e-09
in O 0 2.696548262459686e-10
tumor B-Disease 0 1.4575608474842738e-05
risk O 0 2.4368837614474614e-08
or O 0 1.13578091376354e-09
development O 0 1.1785708409206563e-08
. O 0 1.3042548152597533e-09
. O 0 1.2893063505714508e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 9.150780133637682e-10
identification O 0 6.467076180127762e-11
and O 0 4.482465180283279e-12
detection O 0 2.9115030386606122e-09
of O 0 1.0269873840229593e-09
founder O 0 1.8143264668424308e-08
- O 0 9.214854657102478e-09
effect O 0 1.3812022814363445e-07
mutations O 0 4.0981373850002e-10
in O 0 9.625463620599461e-11
the O 0 1.2890990497282928e-09
ATM O 0 3.018894574324804e-07
gene O 0 4.449977539233707e-11
in O 0 2.2627823226262223e-11
ethnic O 0 6.696208032508366e-10
populations O 0 3.147993810070915e-10
. O 0 2.0860306815251306e-09

To O 0 3.810702864370796e-09
facilitate O 0 3.152620386970284e-10
the O 0 2.081022437705471e-10
evaluation O 0 8.9940432879132e-10
of O 0 1.192442367070612e-09
ATM O 0 9.81961647994467e-07
heterozygotes O 0 6.882887149117778e-09
for O 0 2.2060785143107609e-10
susceptibility O 0 5.532847779932126e-08
to O 0 3.96488530896022e-09
other O 0 1.93580096397028e-10
diseases O 0 1.9579236720801418e-07
, O 0 6.610492535308321e-12
such O 0 1.2310773060686397e-11
as O 0 3.714429297474453e-08
breast B-Disease 0 0.21361075341701508
cancer I-Disease 1 0.9999837875366211
, O 0 2.7429563065339835e-09
we O 0 5.66574565041833e-10
have O 0 3.706170353251492e-12
attempted O 0 2.5919200119517427e-10
to O 0 3.502620762874109e-11
define O 0 1.5038238709852436e-10
the O 0 6.994574190677394e-12
most O 0 2.066794543668926e-13
common O 0 5.48591727600467e-12
mutations O 0 1.93668987097384e-11
and O 0 6.798067425824172e-13
their O 0 1.8721503026227632e-13
frequencies O 0 6.530540691551678e-11
in O 0 2.166849061291387e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 6.886185133225808e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.0902919112563154e-11
homozygotes O 0 7.585959638234385e-10
from O 0 1.2042097354003634e-11
10 O 0 9.328056382873484e-11
ethnic O 0 3.9616004920972614e-11
populations O 0 3.7771511612882946e-11
. O 0 7.197505369482826e-10

Both O 0 1.727659970640616e-08
genomic O 0 6.230590798850244e-08
mutations O 0 6.739005797840036e-09
and O 0 5.126838190094851e-11
their O 0 3.7706369276913065e-11
effects O 0 1.0007834561065465e-09
on O 0 4.773077932895831e-09
cDNA O 0 3.6724698837531378e-09
were O 0 4.633541467180535e-11
characterized O 0 5.395517366224567e-10
. O 0 4.456828239796096e-09

Protein O 0 1.4310899132397026e-08
- O 0 3.7588141488242854e-09
truncation O 0 1.791889658875334e-08
testing O 0 1.242298625081517e-10
of O 0 3.759907316047695e-11
the O 0 5.567827102148648e-11
entire O 0 1.0544985995508682e-09
ATM O 0 4.767612082900996e-08
cDNA O 0 5.8063513996842175e-09
detected O 0 2.2703934288159644e-09
92 O 0 8.897350634029522e-10
( O 0 6.560362496299543e-12
66 O 0 3.574651907811699e-09
% O 0 5.105915690251095e-11
) O 0 5.213962508271441e-12
truncating O 0 2.119181097270939e-08
mutations O 0 3.2640562475094725e-10
in O 0 2.997390877168549e-11
140 O 0 6.788243855915255e-10
mutant O 0 6.153441645118107e-10
alleles O 0 3.8756894915614737e-10
screened O 0 4.786150586966187e-09
. O 0 2.625837547398646e-09

The O 0 5.6506213041984665e-08
haplotyping O 0 0.0004048491537105292
of O 0 2.2332399396418623e-07
patients O 0 8.493765135675346e-10
with O 0 7.251929525636802e-12
identical O 0 8.577516474872482e-09
mutations O 0 4.777137405653775e-07
indicates O 0 2.366440554624205e-08
that O 0 1.9442255097534833e-11
almost O 0 4.574277415181349e-11
all O 0 1.72972053347209e-12
of O 0 5.247481594215786e-13
these O 0 9.815083214768667e-15
represent O 0 5.600989507262288e-13
common O 0 3.206005599887263e-11
ancestry O 0 2.3422300210462765e-10
and O 0 2.234011413360104e-11
that O 0 1.6428011728741865e-11
very O 0 4.649875970375028e-11
few O 0 2.519142117130002e-10
spontaneously O 0 2.330582393739178e-09
recurring O 0 1.4653624980098812e-08
ATM O 0 1.3911785572418012e-05
mutations O 0 1.4812725623869483e-07
exist O 0 4.993450986034986e-08
. O 0 2.5167144812598963e-08

Assays O 0 1.2277324401566148e-07
requiring O 0 7.789372702404762e-09
minimal O 0 6.286456510906646e-08
amounts O 0 5.639205546970061e-09
of O 0 1.0399977767860946e-08
genomic O 0 8.23165424712613e-10
DNA O 0 2.2922004572212273e-10
were O 0 2.1356539854720108e-13
designed O 0 1.3306410552409165e-13
to O 0 3.2630319887066994e-12
allow O 0 2.0520421299685676e-12
rapid O 0 5.51491447994823e-12
screening O 0 2.0518033886501863e-12
for O 0 6.063800178125744e-13
common O 0 1.3781871477380747e-10
ethnic O 0 4.276486720300454e-09
mutations O 0 3.11524708251909e-08
. O 0 1.2850197350644521e-08

These O 0 1.3521146868811229e-08
rapid O 0 4.392724406443449e-08
assays O 0 4.726613767047638e-08
detected O 0 4.005774911775006e-08
mutations O 0 1.2587178521705766e-10
in O 0 8.04459623915399e-12
76 O 0 2.566918899660209e-09
% O 0 1.9540187523592323e-10
of O 0 2.5130425518327115e-10
Costa O 0 1.9315123722662975e-07
Rican O 0 1.4739057405677158e-06
patients O 0 7.389145406655473e-10
( O 0 6.498021305062496e-12
3 O 0 1.8914063648622914e-09
) O 0 3.893933515474596e-13
, O 0 2.976638304331286e-13
50 O 0 1.010617024094218e-11
% O 0 2.7113576141213347e-12
of O 0 5.619847903010067e-12
Norwegian O 0 3.757669020387766e-08
patients O 0 2.23407958799271e-11
( O 0 1.3611736520910411e-12
1 O 0 3.8856100559314655e-09
) O 0 4.2334492573840865e-13
, O 0 3.9835471618392126e-13
25 O 0 3.406284976303908e-11
% O 0 2.927519121218025e-12
of O 0 3.657002652091013e-12
Polish O 0 6.340740377197562e-09
patients O 0 1.582403513777919e-10
( O 0 5.92520000078367e-12
4 O 0 3.3485254569143308e-09
) O 0 4.514673140540437e-13
, O 0 4.466349978662215e-13
and O 0 5.006485135315708e-13
14 O 0 1.1578834419045947e-10
% O 0 7.784191694004683e-12
of O 0 6.370697806096226e-12
Italian O 0 1.5221898186368321e-09
patients O 0 5.668034097627839e-11
( O 0 9.712449594578842e-12
1 O 0 3.348201857988897e-07
) O 0 6.860730039637275e-11
, O 0 1.5128740274428232e-11
as O 0 6.607794606622308e-12
well O 0 9.80293212056449e-13
as O 0 6.723290001987847e-13
in O 0 8.574864451306452e-13
patients O 0 1.6204405439007585e-12
of O 0 3.881458002230609e-11
Amish O 0 1.4047812690876071e-08
/ O 0 4.424940058811444e-08
Mennonite O 0 1.6871366526061138e-08
and O 0 5.698407717913412e-11
Irish O 0 2.3604920795783357e-10
English O 0 3.9413058927628697e-10
backgrounds O 0 2.1642438952085286e-09
. O 0 5.888143750354402e-09

Additional O 0 1.496189838690043e-07
mutations O 0 1.7204223823341636e-08
were O 0 1.7936395702022878e-09
observed O 0 4.094949657140745e-10
in O 0 8.122689153233775e-12
Japanese O 0 4.800300712481942e-10
, O 0 2.657233461045294e-11
Utah O 0 2.1625108370670887e-09
Mormon O 0 6.037240152245715e-11
, O 0 2.00143016309412e-13
and O 0 4.4716010408341056e-13
African O 0 3.261030334655857e-11
American O 0 8.907482390574373e-11
patients O 0 7.788621830817632e-11
. O 0 2.0918478060849566e-09

These O 0 7.709254068455351e-11
assays O 0 2.248207175981065e-11
should O 0 5.382681063023642e-13
facilitate O 0 6.028098484787969e-13
screening O 0 3.831007559795818e-12
for O 0 2.244222689629094e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.1241991277065608e-08
in O 0 5.7488659666038444e-11
the O 0 4.7243532003138355e-11
populations O 0 1.2296828052343889e-12
studied O 0 6.029243077021462e-11
. O 0 6.966975607536341e-11
. O 0 4.546786502857003e-09

The O 0 1.0505683576411684e-06
von B-Disease 1 1.0
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.9999991655349731
Lindau I-Disease 1 0.9968346953392029
tumor I-Disease 0 0.00015464772877749056
suppressor O 0 6.506976291120736e-08
gene O 0 1.1776656906603566e-11
is O 0 2.6363609103956243e-13
required O 0 3.86062015689248e-12
for O 0 1.7770269630790203e-11
cell O 0 2.200557513987178e-09
cycle O 0 1.2401833338060442e-08
exit O 0 2.4237272189253645e-09
upon O 0 2.9738736473383653e-10
serum O 0 4.134648179388023e-09
withdrawal O 0 1.9974582698978338e-07
. O 0 3.965030614949683e-08

The O 0 1.055380494108249e-08
inactivation O 0 5.035533831687644e-06
of O 0 2.00441885311875e-08
the O 0 1.9935029627049516e-08
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 1.5296405990739004e-06
VHL I-Disease 1 0.999853253364563
) I-Disease 0 2.893764783351571e-09
tumor I-Disease 0 0.0005244668573141098
suppressor O 0 5.627492100757081e-06
gene O 0 1.1380903996993652e-09
predisposes O 0 1.753635459067482e-08
affected O 0 4.709589315754492e-11
individuals O 0 2.357469417162833e-13
to O 0 1.7479233338502098e-10
the O 0 9.055320937534361e-10
human O 0 1.0498216340693034e-07
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.700949464085056e-10
is O 0 1.002144374429026e-11
associated O 0 6.560979537439948e-11
with O 0 3.480564100821759e-11
sporadic B-Disease 0 0.00012147364031989127
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 1.327255063188204e-06
RCC B-Disease 1 0.9699753522872925
) O 0 9.118344301839443e-09
and O 0 2.202574300724791e-08
brain B-Disease 0 0.011256091296672821
hemangioblastomas I-Disease 0 0.000423679273808375
. O 0 5.6556456229373e-07

VHL O 0 0.005137777887284756
- O 0 6.804047006880865e-05
negative O 0 2.235137117168051e-06
786 O 0 5.462348781293258e-06
- O 0 2.0502993720583618e-06
0 O 0 1.8609020457915904e-07
RCC B-Disease 0 2.1226373974059243e-06
cells O 0 1.2435895868634361e-08
are O 0 3.468674653062109e-11
tumorigenic O 0 8.965428150986554e-07
in O 0 7.679221702971972e-09
nude O 0 1.6325029150721093e-07
mice O 0 3.4172389917763724e-10
which O 0 1.2127237148523706e-12
is O 0 9.388018791176012e-13
suppressed O 0 7.971145445095917e-12
by O 0 1.105685313272653e-12
the O 0 1.4871573417174488e-10
reintroduction O 0 3.2386335391265675e-08
of O 0 3.0018107999296717e-09
VHL B-Disease 0 4.382813858683221e-05
. O 0 2.5982092211052077e-07

Remarkably O 0 3.014567369064025e-07
, O 0 5.848950490605631e-11
this O 0 1.0923312601662793e-11
occurs O 0 3.6750304188704064e-11
without O 0 2.6710038694699456e-11
affecting O 0 3.3093718737609024e-11
the O 0 1.7525593823397578e-11
growth O 0 3.441865195630278e-11
rate O 0 7.725829004323614e-11
and O 0 1.0481730934597255e-11
cell O 0 4.778926143700346e-09
cycle O 0 2.957753153509657e-09
profile O 0 5.86649912676096e-12
of O 0 3.522237015940455e-11
these O 0 1.3652349650089546e-12
cells O 0 7.27731416794164e-12
in O 0 6.196530268065548e-12
culture O 0 1.2637262070125388e-10
. O 0 1.0112120030214555e-09

The O 0 4.5469923293239844e-07
786 O 0 1.6361201460313168e-06
- O 0 3.58008179546232e-07
0 O 0 3.290249850351756e-08
cell O 0 4.2996739502143555e-09
line O 0 3.625062250378619e-09
, O 0 6.344762215615418e-11
like O 0 1.1598146054669911e-11
many O 0 1.7782204528304923e-11
cancer B-Disease 0 3.579659901831178e-09
cells O 0 1.1343948003172954e-10
, O 0 1.0194199651092362e-11
fails O 0 1.4554064620142526e-09
to O 0 1.5736336678173757e-09
exit O 0 1.5819102472391933e-08
the O 0 1.032230745323659e-09
cell O 0 2.5570234818417248e-09
cycle O 0 9.720039217953058e-10
upon O 0 7.459463602366156e-11
serum O 0 9.356285746164872e-10
withdrawal O 0 5.879415709841851e-08
. O 0 2.343009875005464e-08

Here O 0 2.721694869478597e-08
, O 0 2.228746701082862e-11
it O 0 5.746930166992958e-13
is O 0 1.7631020612658005e-13
shown O 0 7.247856286494991e-14
that O 0 2.428673852739732e-13
reintroduction O 0 2.3492734424479522e-09
of O 0 4.928514193980327e-11
the O 0 2.50369863730171e-10
wild O 0 8.181549882024797e-10
- O 0 6.53293952268541e-09
type O 0 9.067306905308214e-08
VHL B-Disease 0 1.785211861715652e-05
gene O 0 1.0107029657646649e-09
restores O 0 9.211967855193848e-10
the O 0 4.2823269236214045e-11
ability O 0 1.7979054009464868e-11
of O 0 6.697357668450366e-10
VHL O 0 1.0866569027712103e-05
- O 0 1.653224171604961e-05
negative O 0 3.6062240837964055e-07
RCC B-Disease 0 4.492499283514917e-05
cancer I-Disease 0 1.2540386933324044e-06
cells O 0 2.4448798541243377e-10
to O 0 1.008726990825437e-09
exit O 0 1.414265371479928e-09
the O 0 1.2070434929345453e-10
cell O 0 1.417978512385787e-10
cycle O 0 2.1850313225435514e-10
and O 0 6.100228829020171e-12
enter O 0 9.221325036889993e-09
G0 O 0 4.20165088144131e-05
/ O 0 3.3465146316302707e-06
quiescence O 0 3.243578248657286e-06
in O 0 2.7890543208286545e-09
low O 0 6.17432647231908e-08
serum O 0 5.528804525312125e-09
. O 0 1.7592695078505471e-09

Both O 0 1.4401622649984347e-07
VHL O 0 0.0007818134035915136
- O 0 5.688957571692299e-06
positive O 0 1.1181445769281595e-09
and O 0 8.11348488394259e-10
VHL O 0 3.3246924431296065e-06
- O 0 1.8199486362391326e-07
negative O 0 6.020147935714704e-09
RCC B-Disease 0 2.0429123992471432e-07
cells O 0 2.351990380233815e-09
exit O 0 3.93944388221712e-09
the O 0 1.360583173903862e-10
cell O 0 1.9874758783178237e-10
cycle O 0 1.3571568868719908e-10
by O 0 1.6183464074046028e-12
contact O 0 6.060101753746494e-09
inhibition O 0 2.406519286068942e-07
. O 0 1.52829187527459e-07

The O 0 3.2308189474861138e-06
cyclin O 0 1.540796915833198e-06
- O 0 1.494390318157457e-07
dependent O 0 4.007792497873197e-08
kinase O 0 5.222711862984397e-08
inhibitor O 0 2.071626603594723e-08
, O 0 9.107453680101685e-11
p27 O 0 2.291302436674414e-08
, O 0 3.8461703440184625e-12
accumulates O 0 3.302542614380677e-11
upon O 0 6.097343983879622e-12
serum O 0 1.0911317856188152e-11
withdrawal O 0 1.7780256156285645e-09
, O 0 2.3168613295238005e-12
only O 0 2.5601085921339584e-12
in O 0 1.2541704870819292e-12
the O 0 1.0350035932471524e-11
presence O 0 1.4433575862282666e-11
of O 0 1.0768320679588328e-09
VHL B-Disease 0 2.331491941731656e-06
, O 0 1.8313319610774315e-11
as O 0 1.152721472962026e-12
a O 0 4.043395826491825e-12
result O 0 1.7724301193400294e-11
of O 0 1.4534355489981277e-11
the O 0 7.397442901291296e-12
stabilization O 0 4.419084209672519e-09
of O 0 1.3496824102787741e-08
the O 0 1.0894261492921942e-08
protein O 0 5.795576996092677e-08
. O 0 3.3112632635834416e-09

We O 0 6.412620212614684e-09
propose O 0 5.868679764375884e-09
that O 0 2.4390796674045312e-11
the O 0 1.691042861295955e-10
loss O 0 1.5548494713968353e-09
of O 0 6.2020020230590944e-09
wild O 0 1.9568768827582517e-09
- O 0 4.0668060030668585e-09
type O 0 5.617716070105416e-08
VHL B-Disease 0 2.4673013285791967e-06
gene O 0 5.3611899641925476e-11
results O 0 3.7445418293868826e-11
in O 0 9.537282422145132e-12
a O 0 5.2207616701993587e-11
specific O 0 3.1984823123387685e-10
cellular O 0 8.006462159926286e-09
defect O 0 2.2146897649122366e-08
in O 0 5.264652602754438e-10
serum O 0 1.261588966627869e-08
- O 0 7.863176421096796e-08
dependent O 0 3.394758252284191e-08
growth O 0 6.059474033648371e-10
control O 0 8.514965954553588e-10
, O 0 7.325802291180405e-13
which O 0 1.4725827978886996e-12
may O 0 7.74058261931998e-10
initiate O 0 2.597792558844958e-08
tumor B-Disease 0 3.252925750985014e-07
formation O 0 2.9067937390436782e-08
. O 0 2.8754723047086372e-08

This O 0 1.1720669990111787e-09
is O 0 5.778966541414299e-11
corrected O 0 3.821851723984082e-10
by O 0 4.639278544660286e-12
the O 0 1.601746790758085e-10
reintroduction O 0 1.6850014716851547e-08
of O 0 3.994433117604501e-10
wild O 0 1.0348526480186138e-09
- O 0 1.398170734745463e-08
type O 0 2.8130657483416144e-06
VHL B-Disease 1 0.9994348883628845
, O 0 4.014854226852549e-08
implicating O 0 0.00015442020958289504
VHL B-Disease 0 0.01989101618528366
as O 0 1.400356541836345e-08
the O 0 3.421486427512832e-09
first O 0 7.014059888454938e-10
tumor B-Disease 0 7.906847621086399e-09
suppressor O 0 7.867043905207538e-09
involved O 0 6.172740790733044e-11
in O 0 6.12801909910532e-12
the O 0 1.3937201392977272e-10
regulation O 0 5.57870472039923e-10
of O 0 1.6708581185298499e-09
cell O 0 2.0142829626479397e-09
cycle O 0 8.405533158395428e-09
exit O 0 1.4887672206143066e-09
, O 0 6.160971255733672e-13
which O 0 4.614108032284514e-13
is O 0 2.250102231274309e-12
consistent O 0 2.0100131628564277e-11
with O 0 8.014509195186648e-14
its O 0 2.5051493865446695e-11
gatekeeper O 0 5.195594621199007e-09
function O 0 1.2097855703330218e-11
in O 0 8.121325660581658e-12
the O 0 4.023980870737631e-10
kidney O 0 1.6486052345499047e-07
. O 0 1.6760001164684013e-09
. O 0 1.6030993421622952e-08

Piebaldism B-Disease 1 1.0
with O 0 0.005141600966453552
deafness B-Disease 1 1.0
: O 0 1.2412547789608652e-07
molecular O 0 1.6969023519664006e-08
evidence O 0 6.079208664244717e-11
for O 0 2.2211917635045486e-12
an O 0 2.9207723045709955e-11
expanded O 0 2.3758794043260423e-08
syndrome O 1 0.9999874830245972
. O 0 1.5859002360230079e-06

In O 0 2.2081497741410772e-10
a O 0 1.3564217804518108e-10
South O 0 1.8941563595387123e-10
African O 0 8.010608842923261e-11
girl O 0 4.0288652969344696e-10
of O 0 6.627096788003328e-11
Xhosa O 0 5.399339197964537e-09
stock O 0 1.4479624964314208e-11
with O 0 3.140742603057606e-14
severe O 0 1.7973961519146542e-07
piebaldism B-Disease 0 0.0001111449018935673
and O 0 2.108379959508966e-08
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 3.1048868549987674e-05
identified O 0 3.73807845788221e-10
a O 0 1.0187104632075616e-11
novel O 0 2.2494337989509283e-11
missense O 0 3.0135018924681845e-09
substitution O 0 8.571934273504667e-10
at O 0 1.6130421442994702e-09
a O 0 3.187307362484404e-10
highly O 0 2.521949593603523e-10
conserved O 0 4.94975305187495e-09
residue O 0 9.161755798459126e-08
in O 0 7.249650879614933e-11
the O 0 5.156506888148726e-10
intracellular O 0 1.0760825563949084e-09
kinase O 0 5.2375856540720633e-08
domain O 0 7.587048322932333e-09
of O 0 1.3047972702295851e-09
the O 0 4.6222542460228055e-10
KIT O 0 8.695214859244516e-08
proto O 0 1.0045976068795426e-06
- O 0 3.9838425891502993e-07
oncogene O 0 5.728132350668602e-07
, O 0 2.6759772175921626e-10
R796G O 0 3.064931433982565e-06
. O 0 1.2240247038164398e-08

Though O 0 1.8020747916125401e-07
auditory B-Disease 0 0.04816660284996033
anomalies I-Disease 1 0.9166542291641235
have O 0 3.359990286000425e-09
been O 0 5.384928059015692e-10
observed O 0 3.964769346165298e-10
in O 0 1.6615955139576144e-11
mice O 0 2.2620573816856115e-11
with O 0 5.764781013661846e-13
dominant O 0 3.963365191594903e-09
white O 0 9.797900268893045e-10
spotting O 0 6.299779897744884e-08
( O 0 2.3378081692726482e-09
W O 0 2.5974217351176776e-05
) O 0 1.1572078018051712e-10
due O 0 1.6992634854773314e-08
to O 0 5.293402161044014e-09
KIT O 0 4.5364760126176407e-07
mutations O 0 1.1873177641064103e-07
, O 0 1.0606256495293565e-07
deafness B-Disease 1 1.0
is O 0 3.758670708009504e-09
not O 0 2.1600610189409508e-10
typical O 0 1.5615871928886804e-09
in O 0 1.1657480536442222e-10
human O 0 3.756203403870728e-10
piebaldism B-Disease 0 1.3581754956248915e-06
. O 0 5.008254433391812e-08

Thus O 0 3.47751516471817e-09
, O 0 1.340590225634708e-11
the O 0 2.095859423512092e-11
occurrence O 0 8.551037211645962e-09
of O 0 7.651240139239235e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 3.570814078557305e-05
this O 0 1.3187091951749608e-07
patient O 0 2.9218242048045795e-08
extends O 0 4.871321124255701e-10
considerably O 0 3.720294558529069e-11
the O 0 1.0458046754979744e-11
phenotypic O 0 2.1412410733390175e-10
range O 0 3.0336750889148334e-09
of O 0 6.635764715490211e-10
piebaldism B-Disease 0 5.105991931486642e-07
due O 0 1.3382565100528154e-07
to O 0 1.3398075537907062e-08
KIT O 0 1.1581920489334152e-07
gene O 0 3.677421908654388e-11
mutation O 0 1.1002902755574695e-10
in O 0 6.5858507883320705e-12
humans O 0 2.940352475389041e-11
and O 0 1.4512056487059333e-11
tightens O 0 3.8947642333475585e-10
the O 0 3.4628161883071273e-12
clinical O 0 3.267069254020427e-11
similarity O 0 1.1051671730544221e-11
between O 0 6.022599779997861e-11
piebaldism B-Disease 0 8.109531535183123e-08
and O 0 1.2649741280498783e-12
the O 0 6.747622751344939e-13
various O 0 3.156488945547063e-14
forms O 0 3.178982077578496e-11
of O 0 2.2027915047573288e-09
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999876022338867
. O 0 1.2682720651469026e-08
. O 0 2.549884925429069e-08

Cycloheximide O 0 1.7855589248938486e-05
facilitates O 0 9.641127896031776e-09
the O 0 1.5754145765711769e-09
identification O 0 5.945243741756201e-10
of O 0 7.536711699174248e-09
aberrant O 0 5.015271398178811e-08
transcripts O 0 4.6528992214689424e-08
resulting O 0 1.517085568281118e-09
from O 0 6.928625728708226e-11
a O 0 1.3557235889471997e-10
novel O 0 3.346359578326741e-10
splice O 0 4.146874399424405e-09
- O 0 3.249867597254763e-10
site O 0 4.3510084424269735e-11
mutation O 0 6.9755356005285485e-12
in O 0 5.0209849299098774e-12
COL17A1 O 0 0.05365324392914772
in O 0 1.6775120181833358e-10
a O 0 1.6430379279341878e-09
patient O 0 1.3251407082748301e-08
with O 0 2.3092355805331977e-10
generalized O 1 0.9999356269836426
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9961471557617188
. O 0 2.176039060941548e-06

Patients O 0 2.8056609835402924e-07
with O 0 4.575763379310871e-10
generalized O 1 0.9996883869171143
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9986379742622375
often O 0 7.780904254239829e-10
show O 0 9.352836560783118e-11
decreased O 0 2.609011895415847e-10
expression O 0 3.0330470773831664e-11
of O 0 1.9621117230972374e-10
type O 0 1.1469865057733841e-08
XVII O 0 1.640659502299968e-05
collagen O 0 4.040720469333792e-08
, O 0 7.202064500333449e-10
a O 0 1.3366934226155536e-08
transmembrane O 0 8.596327347731858e-07
hemidesmosomal O 0 1.9718595467566047e-07
protein O 0 2.86439011398798e-10
encoded O 0 1.678352010321682e-12
by O 0 7.417166707213152e-12
COL17A1 O 0 2.464479985064827e-05
. O 0 5.25668077955288e-08

This O 0 2.4482780247581104e-09
report O 0 2.7777754055269277e-11
documents O 0 2.2344929725970353e-11
a O 0 5.5554158495674244e-11
novel O 0 1.44468312313073e-10
splice O 0 4.630321459586639e-09
- O 0 6.49893194815121e-10
site O 0 1.5123091667845756e-10
mutation O 0 1.4280937543631467e-11
in O 0 1.4457270450241033e-11
COL17A1 O 1 0.9997088313102722
in O 0 1.5935563979496692e-09
a O 0 2.5278950488427654e-08
patient O 0 1.5855553670007794e-07
with O 0 5.262494329194567e-10
generalized O 1 0.9997521042823792
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999988079071045
bullosa I-Disease 0 0.0011281660990789533
, O 0 1.396713994461507e-10
and O 0 4.100228837011777e-12
applies O 0 8.701937781463442e-11
a O 0 2.225951367673673e-11
new O 0 5.072463282740358e-12
methodology O 0 3.6697773292404534e-11
to O 0 5.041081094225852e-11
define O 0 5.900023802851706e-10
and O 0 1.765041932055844e-11
characterize O 0 7.624389120053365e-09
the O 0 4.5310363794293096e-10
resulting O 0 4.0018607871949996e-10
mRNA O 0 8.882822477573882e-09
splice O 0 2.4952440114134333e-08
variants O 0 2.640027918499044e-10
. O 0 8.725875022541629e-10

Mutational O 0 2.7286969270789996e-06
analysis O 0 1.2853378361654677e-09
of O 0 1.1073084671409106e-08
COL17A1 O 1 0.9989153146743774
identified O 0 1.4987856289394585e-08
a O 0 1.5249185247867558e-09
maternally O 0 2.8647590966102143e-08
inherited O 0 7.558395509477123e-08
G O 0 1.599828607368181e-07
- O 0 6.34549763844916e-08
to O 0 1.9859363931118423e-07
- O 0 6.143553036963567e-06
T O 0 1.1072899042119388e-07
transversion O 0 1.1030003577161551e-07
at O 0 6.422041787246258e-10
the O 0 1.4615279472773857e-11
- O 0 7.787848838036737e-11
1 O 0 2.209338934022753e-09
position O 0 2.4771944495682874e-09
of O 0 1.0821235019164988e-09
exon O 0 7.258665224441074e-09
32 O 0 3.3191749793104464e-08
. O 0 4.382955776094377e-09

This O 0 1.8081175445772146e-09
acceptor O 0 9.448246629517598e-10
splice O 0 1.0066017352983181e-08
- O 0 5.966873661833461e-10
site O 0 1.7396416251980185e-10
mutation O 0 2.0503841680064028e-11
led O 0 1.7158253984295158e-11
to O 0 1.529488063978235e-10
the O 0 5.875419040179963e-10
formation O 0 1.1365161256549072e-08
of O 0 7.145491736082477e-07
aberrant O 0 1.3696904943572008e-07
transcripts O 0 6.370563454538569e-08
present O 0 1.740558586149632e-09
at O 0 1.3401039389293601e-08
extremely O 0 1.1959021550822513e-09
low O 0 1.1012618017502973e-07
levels O 0 1.0276129280839541e-08
. O 0 6.778233085924512e-09

Based O 0 6.6804943799070315e-09
on O 0 1.3221823280673561e-07
our O 0 3.835463890933255e-10
recent O 0 1.2616302967616289e-11
finding O 0 5.1565925140995006e-11
that O 0 2.226816387534969e-12
cycloheximide O 0 1.5276332021585404e-07
stabilized O 0 7.559338541796023e-07
mutant O 0 4.185719149063516e-08
COL17A1 O 0 6.3490724642178975e-06
transcripts O 0 3.0785991533832657e-09
in O 0 1.0765850017024903e-10
keratinocytes O 0 9.504608655674929e-09
homozygous O 0 5.3248492420943094e-11
for O 0 9.661012441430916e-12
a O 0 3.0514601956355136e-10
frameshift O 0 1.1746410564228427e-06
mutation O 0 1.6655038237445297e-08
, O 0 3.150743554947155e-11
the O 0 3.5143604693033126e-10
effects O 0 2.3432511042642545e-08
of O 0 8.078435698166686e-09
the O 0 4.713494039521038e-09
splice O 0 1.016654493923852e-08
- O 0 1.3311691748896237e-09
site O 0 3.1506727782293353e-10
mutation O 0 3.98241162269386e-11
on O 0 1.8010580804528331e-09
splicing O 0 5.004945902165048e-10
of O 0 2.7056377138734433e-09
COL17A1 O 0 5.469954885484185e-06
transcripts O 0 2.17285247572363e-08
were O 0 1.616422828920605e-10
determined O 0 1.3150727729005496e-10
using O 0 1.4372314102728545e-11
reverse O 0 7.719793693183874e-10
transcriptase O 0 9.173563991771161e-11
polymerase O 0 1.7124325568662613e-10
chain O 0 5.701103825139775e-11
reaction O 0 8.558431741079175e-12
of O 0 4.453478141819289e-10
total O 0 7.599307988437332e-11
RNA O 0 4.5656308594876904e-11
from O 0 1.7588616327279816e-11
keratinocytes O 0 4.117003127301899e-10
incubated O 0 6.975556243737913e-10
for O 0 1.7925706058408153e-11
2 O 0 3.699821249369961e-08
. O 0 4.413297727268173e-09

5 O 0 1.0979098306052038e-06
h O 0 1.9349306601412763e-09
in O 0 1.1396140975339364e-11
the O 0 5.014881218623479e-11
presence O 0 3.303916168428955e-11
or O 0 1.3147198885121725e-09
absence O 0 2.9451785010792264e-08
of O 0 1.3528834941212153e-08
10 O 0 8.241571869405107e-09
microg O 0 1.510396003823189e-07
cycloheximide O 0 2.633661893014505e-07
per O 0 3.281024874013383e-08
ml O 0 2.3852697950133006e-07
. O 0 4.6397810038456555e-09

Using O 0 1.9685142405023726e-10
this O 0 2.653748748526752e-11
approach O 0 1.3831122913643412e-09
, O 0 7.010605290735938e-11
an O 0 4.185331248240942e-10
abnormally O 0 1.5740488024107435e-08
spliced O 0 4.4996895098847745e-09
transcript O 0 2.2650267439416893e-08
was O 0 3.3829923307138188e-09
identified O 0 3.4960132011541134e-11
that O 0 2.7472281719474745e-13
contains O 0 1.967085213249939e-13
an O 0 6.961592760590385e-12
extra O 0 1.825275486311284e-10
264 O 0 1.17073750693919e-09
bases O 0 2.965467871263172e-10
upstream O 0 7.540047697318641e-09
from O 0 7.905109344896744e-10
exon O 0 5.6908104895114775e-09
32 O 0 1.401328386663181e-09
, O 0 2.9290831912720527e-12
resulting O 0 4.6874268355701076e-11
in O 0 5.755624102321555e-11
a O 0 5.14828402131684e-09
premature O 0 6.183602181408787e-07
termination O 0 1.785276936061564e-06
codon O 0 2.584853746157023e-06
27 O 0 2.4060291252681054e-06
bp O 0 2.8484956260399485e-07
downstream O 0 3.2464200216963945e-08
from O 0 1.2524774550826123e-09
the O 0 1.9840606935161986e-09
cryptic O 0 4.5324327402340714e-08
splice O 0 1.0026911212435152e-07
site O 0 7.241628630083596e-09
. O 0 3.1362250574318296e-09

Three O 0 3.219134070420182e-09
other O 0 5.804027831263214e-12
splice O 0 9.639449238818543e-10
variants O 0 6.855441127967543e-12
, O 0 5.594082055221383e-13
including O 0 4.92808376571785e-14
one O 0 1.4736223309316787e-12
derived O 0 2.7563255497464745e-12
from O 0 8.071712742641068e-11
the O 0 1.428568513484052e-10
skipping O 0 1.4640292311796088e-09
of O 0 8.042180810186039e-10
exon O 0 4.677652043483249e-09
32 O 0 9.563017044911248e-09
, O 0 4.0193074563044107e-11
were O 0 2.2804567956224986e-10
also O 0 1.3753614913625256e-10
identified O 0 4.038684497942313e-09
. O 0 8.290352404571877e-09

These O 0 6.930651053060899e-10
results O 0 4.052116142627682e-10
indicate O 0 3.507570067728949e-10
the O 0 1.251760362031007e-10
usefulness O 0 1.5326602209597695e-09
of O 0 1.1443499620122921e-10
cycloheximide O 0 1.0378263937127485e-07
treatment O 0 1.0376077774765236e-09
in O 0 2.1978035710801258e-11
evaluating O 0 1.6845658201702918e-10
the O 0 1.2901223422900898e-09
abnormal O 0 1.1610825190189189e-08
processing O 0 4.175844559028974e-09
of O 0 3.606435150516063e-09
mRNA O 0 3.4893350431275394e-09
due O 0 1.1441722236327223e-08
to O 0 1.5357680682726027e-09
splice O 0 6.192203194643753e-09
- O 0 1.2847911623481423e-09
site O 0 2.0749582607670902e-10
mutations O 0 2.807679436167554e-11
, O 0 9.638208633977463e-12
because O 0 2.3310345320659565e-10
( O 0 6.719929057652507e-10
i O 0 4.0008731616580917e-07
) O 0 7.723298667272616e-10
aberrant O 0 4.330892977577605e-09
splicing O 0 3.429939665622328e-10
often O 0 1.2126682037011394e-12
generates O 0 7.983176294502903e-13
a O 0 2.080195911358107e-11
premature O 0 5.545596870604186e-09
termination O 0 5.150408100007553e-08
codon O 0 1.734309407197543e-08
, O 0 1.1090912910294293e-10
( O 0 5.1982855520105176e-11
ii O 0 6.038319355639032e-08
) O 0 5.706935618521314e-11
transcripts O 0 2.7811486447149036e-10
with O 0 3.1692695343088495e-12
premature O 0 1.4360608702190802e-08
termination O 0 6.702538968283989e-08
codons O 0 1.1731656535118873e-08
can O 0 3.45428380343904e-10
occur O 0 4.375978746029574e-10
at O 0 1.0499209279757338e-09
low O 0 4.985122092904248e-09
or O 0 1.3149230593256789e-09
undetectable O 0 2.2351997586156358e-08
levels O 0 5.0800597062306e-10
due O 0 1.3291978628870993e-09
to O 0 4.2335687733263683e-10
nonsense O 0 9.898166730692992e-10
- O 0 1.8628422415734036e-10
mediated O 0 2.486913341925856e-09
mRNA O 0 1.440809249686481e-09
decay O 0 3.721093211339621e-09
, O 0 9.985905873900747e-14
and O 0 1.48884078893588e-13
( O 0 1.5398191619345192e-12
iii O 0 1.0821983309483585e-08
) O 0 3.358916964013581e-11
the O 0 3.039940521532003e-10
levels O 0 3.699224537800916e-10
of O 0 9.052415761434673e-11
these O 0 3.0267693733321277e-12
transcripts O 0 6.991190265592806e-11
can O 0 5.333791568140622e-12
be O 0 1.1752355165428607e-11
increased O 0 1.6990957252271954e-11
by O 0 9.373141846014121e-11
cycloheximide O 0 1.0057794497697614e-05
. O 0 7.328447537702232e-08

A O 0 3.716158971656114e-07
deletion O 0 1.0628735935824807e-07
mutation O 0 6.113781703120935e-10
in O 0 4.9316713907066045e-12
COL17A1 O 0 1.214669373439392e-05
in O 0 1.676906530301281e-11
five O 0 2.0339273668068536e-11
Austrian O 0 1.1055842463747467e-08
families O 0 2.167364725191856e-11
with O 0 2.2080391334777794e-11
generalized O 1 0.999636173248291
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999991655349731
bullosa I-Disease 0 0.0004081693768966943
represents O 0 6.630476168112409e-10
propagation O 0 9.905272158050593e-09
of O 0 3.4272076288033304e-09
an O 0 1.988241793426937e-10
ancestral O 0 1.4070016263190155e-08
allele O 0 5.918570877838647e-08
. O 0 1.7862761936271454e-08

Patients O 0 1.574346697452711e-07
with O 0 4.005464848688689e-10
generalized O 1 0.9452555775642395
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.8697369694709778
, O 0 4.503809269973402e-10
a O 0 1.1013694817263442e-10
usually O 0 3.196163472773961e-11
nonlethal O 0 4.843953682609481e-09
form O 0 1.0434565433925513e-09
of O 0 4.973746854375349e-07
junctional B-Disease 1 0.9998316764831543
epidermolysis I-Disease 1 0.9993537068367004
bullosa I-Disease 0 0.0009071273962035775
, O 0 3.3246144726106763e-10
have O 0 1.7657524747916042e-11
generalized O 0 3.2158693485939693e-09
blistering B-Disease 0 5.1645344001372e-07
, O 0 6.549754627549476e-10
nail B-Disease 1 0.5101949572563171
dystrophy I-Disease 1 0.9999430179595947
, O 0 1.2848037158619263e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 4.355795226729242e-06
and O 0 0.2576470375061035
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9999998807907104

Skin B-Disease 1 0.9999963045120239
fragility I-Disease 0 0.00010977267811540514
in O 0 5.456827212313442e-10
most O 0 8.825625993913455e-12
cases O 0 8.288979745640912e-12
is O 0 3.03007337103256e-12
due O 0 5.374259259838254e-09
to O 0 4.347163518048092e-09
mutations O 0 2.7062352359052966e-10
in O 0 1.9002610596174918e-10
the O 0 3.2494648638525803e-10
gene O 0 1.1252806846051566e-11
encoding O 0 5.567444769094543e-11
type O 0 2.110476060579458e-08
XVII O 0 1.6495881936862133e-05
collagen O 0 6.572925030923216e-07
( O 0 4.221153204753136e-09
COL17A1 O 0 0.0002443529956508428
) O 0 9.86034809358216e-10
. O 0 4.850656765142958e-09

Recently O 0 1.0340879441628203e-07
, O 0 1.547098144039083e-10
we O 0 3.659446357051621e-11
reported O 0 1.3837968965146885e-11
five O 0 1.357611072172471e-12
Austrian O 0 2.166935936243064e-10
families O 0 9.170686128892602e-13
with O 0 3.809751993044674e-12
generalized O 1 0.995407223701477
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9997835755348206
who O 0 5.1515649523992124e-09
share O 0 3.037454177068355e-10
the O 0 3.3093416895724204e-10
same O 0 1.2090486389837451e-09
COL17A1 O 0 0.01587441749870777
mutation O 0 3.093876728144096e-07
. O 0 3.19091171263608e-08

Affected O 0 1.2133507532041676e-08
individuals O 0 1.577797788254731e-11
in O 0 3.983232146897997e-11
three O 0 3.133316175962797e-11
families O 0 2.5821276540549665e-12
are O 0 6.879368494132343e-13
homozygous O 0 1.9932061643551657e-12
for O 0 5.091578634403016e-12
4003delTC O 0 3.730224573672558e-09
, O 0 1.129501787239251e-11
whereas O 0 9.320195309969748e-11
those O 0 6.10713259477369e-12
in O 0 2.993802775130838e-11
two O 0 2.4703314047136438e-11
others O 0 2.124398400249472e-11
are O 0 1.3293783391807312e-12
compound O 0 2.6086699467242624e-09
heterozygotes O 0 8.229791070846204e-09
. O 0 9.767620490208628e-09

To O 0 8.849829313817281e-09
determine O 0 2.173207613864747e-09
if O 0 6.622712100945449e-11
the O 0 6.305157090880087e-11
occurrence O 0 5.108314327095798e-10
of O 0 2.102807511450422e-10
4003delTC O 0 2.6224540317087985e-09
in O 0 4.562607670149932e-12
these O 0 3.837960494117859e-13
unrelated O 0 8.691652952919071e-11
families O 0 1.490023490875736e-12
signifies O 0 5.2546883511084275e-11
propagation O 0 7.558449865996408e-09
of O 0 4.634233552458511e-10
an O 0 6.99020286099028e-11
ancestral O 0 1.5211913950707867e-09
allele O 0 2.1183796938828436e-09
or O 0 6.90834667249618e-10
a O 0 1.147345329854943e-08
mutational O 0 9.677177331468556e-06
hot O 0 6.828663572377991e-06
spot O 0 1.4251482127747295e-07
, O 0 3.9995236289502856e-11
haplotypes O 0 2.145713745571598e-10
were O 0 2.1694574955932744e-11
determined O 0 1.3278035615460482e-10
for O 0 1.911241130636565e-11
polymorphisms O 0 1.7479576674972463e-09
both O 0 1.25183668986395e-10
within O 0 4.378552187489504e-09
and O 0 7.097713528025906e-10
flanking O 0 5.956848781352164e-06
COL17A1 O 1 0.9990936517715454
. O 0 1.0039194648925331e-06

Five O 0 2.398049616658682e-07
intragenic O 0 4.303349669498857e-06
polymorphisms O 0 3.3862864512457236e-08
were O 0 3.312234375663081e-10
chosen O 0 7.620063607882699e-11
based O 0 6.80985823287017e-11
on O 0 6.715307421245598e-09
their O 0 2.6327870439324386e-10
informativeness O 0 1.4323167079055565e-06
. O 0 5.6633748357626246e-08

One O 0 6.337816671475593e-08
of O 0 4.445121160046028e-09
these O 0 8.36540732518376e-12
, O 0 1.1587334390605886e-11
not O 0 1.10643751105588e-10
previously O 0 1.812533040324027e-10
reported O 0 1.8978668636648877e-10
, O 0 6.344529068780247e-12
was O 0 3.896742928333197e-09
2988 O 0 6.035832456063872e-08
A O 0 9.659684963025938e-08
or O 0 3.112833768526002e-09
C O 0 1.8812631878972752e-06
that O 0 8.061246115076415e-12
introduces O 0 6.27913476422548e-12
a O 0 2.366268856204834e-12
new O 0 2.3153284844923405e-12
restriction O 0 5.764896893190041e-11
site O 0 3.6074636333705e-11
for O 0 1.5460294502944727e-11
Eco0109 O 0 1.391304704156937e-05
I O 0 3.0908366170478985e-05
. O 0 1.344059370467221e-07

All O 0 3.0676499118698075e-09
the O 0 2.589301273392408e-10
4003delTC O 0 8.260834682971563e-09
alleles O 0 1.0248422249725664e-10
showed O 0 1.2518934673633186e-11
the O 0 3.4728569846265156e-12
same O 0 7.899630602437036e-12
haplotype O 0 6.615017866806738e-09
for O 0 1.332756266458901e-10
these O 0 4.30507712811945e-11
five O 0 3.7598302249364224e-10
polymorphic O 0 1.5035041656119574e-08
markers O 0 3.619164345991521e-08
. O 0 4.655109719919892e-08

Fourteen O 0 1.3714394242470007e-07
microsatellite O 0 4.290370014814471e-08
polymorphisms O 0 3.900743283935526e-09
were O 0 4.277901990978883e-11
selected O 0 1.1174350290563129e-12
based O 0 2.784856113074996e-12
on O 0 1.1626796192487632e-09
their O 0 1.399286415904033e-11
high O 0 2.201069548846135e-09
heterozygosity O 0 2.482464722675104e-08
and O 0 7.921995698323414e-11
their O 0 1.9077739388251302e-11
location O 0 5.780160239332588e-10
within O 0 5.195492924769951e-10
10q23 O 0 3.2266282232740195e-06
- O 0 7.181693604252359e-07
q25 O 0 8.11710469861282e-06
near O 0 2.505182692402741e-07
COL17A1 O 0 0.00019259423424955457
. O 0 7.327329143436145e-08

Three O 0 4.963544575353751e-10
families O 0 1.593016864254171e-11
shared O 0 7.921814593192522e-11
microsatellite O 0 1.6631999244509643e-07
polymorphisms O 0 2.756342496468278e-07
covering O 0 4.7413180936928256e-07
at O 0 4.408386899967809e-08
most O 0 3.709800522333495e-11
19 O 0 3.026941586270482e-09
cM O 0 4.229698546964755e-08
, O 0 4.206615958346482e-12
whereas O 0 8.680354351975339e-11
the O 0 2.975848178987661e-10
others O 0 8.912241084013672e-11
shared O 0 8.229307860152524e-12
smaller O 0 2.470091145512221e-11
regions O 0 4.485908033924346e-10
consistent O 0 2.971543289209677e-10
with O 0 8.574079488933573e-13
cross O 0 1.5815715403988406e-09
- O 0 4.976277168111665e-09
over O 0 1.8184820316236028e-10
events O 0 1.4359045636541667e-12
during O 0 3.7677881647990574e-12
passage O 0 5.418943939405896e-12
of O 0 1.3393858504934242e-12
this O 0 1.1123548913569148e-12
mutation O 0 7.191268414086238e-12
through O 0 4.0754968844147754e-12
several O 0 1.0276721314206316e-11
generations O 0 2.3685742256418507e-10
. O 0 2.2166917190702407e-09

These O 0 2.1853534537541464e-09
results O 0 5.14104925297687e-10
indicate O 0 5.643290834633774e-10
that O 0 6.133164288935067e-12
4003delTC O 0 2.9760709452375522e-09
occurs O 0 3.5577384788210153e-11
on O 0 8.336725060287264e-11
a O 0 3.130735254375239e-11
single O 0 6.57936274905957e-11
ancestral O 0 2.1443716247127043e-10
allele O 0 1.89123317007045e-09
. O 0 5.848428408228301e-10
. O 0 6.546635678006396e-09

The O 0 5.077255877949938e-07
haptoglobin O 0 7.091074621712323e-06
- O 0 2.5067743081308436e-07
gene O 0 2.9108521149012745e-10
deletion O 0 1.1011164424701292e-08
responsible O 0 1.8143531121950218e-09
for O 0 3.6869118869020667e-10
anhaptoglobinemia B-Disease 0 0.0001616901863599196
. O 0 2.178809154429473e-06

We O 0 5.1624464703081685e-08
have O 0 2.1153290924447177e-11
found O 0 2.971625116116039e-12
an O 0 6.287784420737352e-13
allelic O 0 4.804257547341706e-10
deletion O 0 6.74601441374989e-09
of O 0 4.548616594490795e-09
the O 0 5.332314589878706e-09
haptoglobin O 0 1.2607393955477164e-06
( O 0 6.333315538675777e-10
Hp O 0 3.2158815610472402e-09
) O 0 7.832594815793126e-12
gene O 0 2.799857784854809e-13
from O 0 1.0669881861727348e-12
an O 0 3.065403562495933e-13
individual O 0 5.077860197209502e-14
with O 0 7.765329178288649e-12
anhaptoglobinemia B-Disease 0 0.0004312306991778314
. O 0 1.2133575637562899e-06

The O 0 5.737197383837156e-08
Hp O 0 1.3000680532115894e-08
gene O 0 1.0028327127042935e-11
cluster O 0 1.2221570977466456e-10
consists O 0 9.227675047684958e-13
of O 0 3.8934251656019825e-11
coding O 0 4.030543010458132e-09
regions O 0 5.879639886074983e-08
of O 0 4.5499464818021806e-07
the O 0 2.592002488199796e-07
alpha O 0 1.2411244654231268e-07
chain O 0 1.7223282522405015e-10
and O 0 3.72622982816595e-12
beta O 0 2.43706854696768e-09
chain O 0 9.243537879566333e-11
of O 0 4.450758511742592e-11
the O 0 9.689547081359606e-11
haptoglobin O 0 9.165196601657044e-09
gene O 0 2.0972629882765048e-11
( O 0 3.0121183325348966e-12
Hp O 0 6.773457489339663e-11
) O 0 8.502408304321418e-13
and O 0 4.839255298566547e-12
of O 0 1.9380766436150054e-10
the O 0 5.791139789934618e-10
alpha O 0 8.464416723086288e-09
chain O 0 2.8212931990623247e-11
and O 0 1.1931685023683358e-12
beta O 0 3.0686739815877218e-09
chain O 0 6.112450129380775e-11
of O 0 5.983495383193871e-12
the O 0 1.6544295447507018e-11
haptoglobin O 0 3.4607829491051234e-08
- O 0 2.9857820660339485e-09
related O 0 1.196436172357096e-09
gene O 0 1.5404280281905436e-11
( O 0 2.915755744486992e-12
Hpr O 0 4.743979431509615e-09
) O 0 4.948461779230584e-12
, O 0 3.4819701375671253e-12
in O 0 3.176351542899525e-11
tandem O 0 1.761734202965215e-09
from O 0 3.0039297715944713e-09
the O 0 6.106093852764616e-09
5 O 0 6.0516711641867e-08
side O 0 2.638470242288804e-08
. O 0 5.0469672885355976e-08

Southern O 0 9.351740573038114e-07
blot O 0 4.604774858307792e-06
and O 0 1.5202400449609854e-09
PCR O 0 1.7992384249154725e-09
analyses O 0 4.2495224006344756e-10
have O 0 2.4733947528998712e-12
indicated O 0 1.9277380039484093e-11
that O 0 1.15182860536793e-13
the O 0 3.893577084010391e-13
individual O 0 3.1604514503776136e-15
with O 0 1.4617717843459777e-13
anhaptoglobinemia B-Disease 0 6.099414662230629e-08
was O 0 1.213841560598894e-08
homozygous O 0 2.7880199884866563e-11
for O 0 1.01744437527862e-11
the O 0 6.459531520786044e-11
gene O 0 4.486434227596314e-12
deletion O 0 1.4976582474179878e-10
and O 0 3.954751023188541e-12
that O 0 2.3353710458529076e-12
the O 0 5.7137423264963516e-11
gene O 0 4.4335399067285675e-12
deletion O 0 6.49003850661245e-10
was O 0 1.9912020643442219e-10
included O 0 6.610753611191456e-13
at O 0 1.6470273062063612e-11
least O 0 1.7752712277649407e-12
from O 0 8.679621257834391e-12
the O 0 5.108097972383874e-11
promoter O 0 9.560941549580093e-08
region O 0 4.298192024521086e-08
of O 0 6.842626731895507e-08
Hp O 0 1.1751858153274952e-08
to O 0 3.584239038900705e-08
Hpr O 0 1.9057262079513748e-07
alpha O 0 1.6227108545763258e-08
but O 0 1.5192182581391656e-11
not O 0 1.0553788745704118e-11
to O 0 5.735725228106503e-10
Hpr O 0 5.460102414645007e-08
beta O 0 1.6574837502503215e-07
( O 0 2.7511232181254286e-10
Hpdel O 0 6.157198413347942e-07
) O 0 3.3778196906197877e-10
. O 0 3.768677814264265e-09

In O 0 1.5404972852905985e-09
addition O 0 4.617616705671068e-11
, O 0 7.117448991289521e-11
we O 0 2.681376128077506e-11
found O 0 7.775077240021466e-13
seven O 0 1.857499614191238e-13
individuals O 0 1.1202843996099983e-15
with O 0 6.433377864722284e-15
hypohaptoglobinemia B-Disease 0 1.4226260169891702e-08
in O 0 1.582499409291671e-11
three O 0 5.712398869900381e-12
families O 0 8.084431019593497e-13
, O 0 2.302933505785726e-13
and O 0 1.5770929484223983e-12
the O 0 2.132795606790694e-10
genotypes O 0 2.0630885888550665e-09
of O 0 4.0465648609711025e-09
six O 0 6.914990802187049e-10
of O 0 6.231939964074229e-10
the O 0 7.390959372299832e-11
seven O 0 2.2250003922641426e-11
individuals O 0 5.27549033103869e-13
were O 0 2.85766011548505e-11
found O 0 5.753952869724799e-12
to O 0 1.9021575980993077e-10
be O 0 6.711577960061277e-10
Hp2 O 0 2.638706791913137e-05
/ O 0 3.7727975723100826e-05
Hpdel O 0 0.0006423508748412132
. O 0 4.748291075884481e-07

The O 0 2.5852473939380616e-08
phenotypes O 0 3.90671495154038e-09
and O 0 5.005640346666951e-11
genotypes O 0 2.0347832307976432e-09
in O 0 1.201474943840486e-11
one O 0 1.0155928181765361e-11
of O 0 2.2145004580087502e-11
these O 0 6.969477891940329e-14
three O 0 2.8745327515858343e-13
families O 0 1.918075615871262e-13
showed O 0 9.172753702435532e-12
the O 0 6.229441268379432e-11
father O 0 4.713779366838367e-10
to O 0 1.3385961228351562e-09
be O 0 1.2590137821177905e-09
hypohaptoglobinemic B-Disease 0 9.987769544750336e-07
( O 0 6.53925635862862e-10
Hp2 O 0 1.6241032199104666e-06
) O 0 2.6741438924338112e-11
and O 0 1.1302976610227944e-10
Hp2 O 0 1.532920464342169e-06
/ O 0 2.0159370706096524e-07
Hpdel O 0 3.690300218295306e-06
, O 0 1.463006799040656e-10
the O 0 5.971700911544531e-10
mother O 0 1.5790448115726718e-10
to O 0 1.1913620090453492e-10
be O 0 1.191898246766243e-10
Hp2 O 0 8.486405533858488e-08
- O 0 6.739635516339604e-09
1 O 0 4.101316264382149e-08
and O 0 1.167944629898443e-10
Hp1 O 0 3.7732328905804025e-07
/ O 0 2.984308977715955e-08
Hp2 O 0 6.307330977506354e-07
, O 0 8.230438032497123e-12
one O 0 8.396579438685325e-12
of O 0 2.900691492557783e-11
the O 0 1.8468291132500703e-11
two O 0 1.4348532128075075e-12
children O 0 3.2559057446673867e-13
to O 0 2.2568428029168253e-11
be O 0 4.5765316536439116e-10
hypohaptoglobinemic B-Disease 0 2.8774859401892172e-06
( O 0 2.5641002654452905e-09
Hp2 O 0 2.5805925361055415e-06
) O 0 1.3340247309590048e-11
and O 0 3.828036498898513e-11
Hp2 O 0 8.466275289720215e-07
/ O 0 9.821146562671856e-08
Hpdel O 0 3.2293614822265226e-06
, O 0 6.065877661276531e-11
and O 0 1.116468462819542e-11
the O 0 5.33440479288938e-11
other O 0 2.2091078966113287e-12
child O 0 1.2550684450052252e-11
to O 0 3.162363426678638e-11
be O 0 1.37021907709034e-10
Hp1 O 0 3.69961696833343e-07
and O 0 6.263161100861225e-10
Hp1 O 0 3.5187498724553734e-05
/ O 0 8.583985618315637e-06
Hpdel O 0 2.7853622668772005e-05
, O 0 4.3893843421072276e-11
showing O 0 2.2869938581804305e-11
an O 0 2.367778022260847e-11
anomalous O 0 3.678960354136507e-07
inheritance O 0 9.596720929039293e-07
of O 0 6.380474815159687e-07
Hp O 0 1.888350631418234e-08
phenotypes O 0 3.421301852934988e-10
in O 0 1.6018497292491496e-11
the O 0 1.135685018249788e-10
child O 0 1.8110332677956364e-10
with O 0 5.610016357709968e-12
Hp1 O 0 2.581060653028544e-05
. O 0 3.355906414981291e-07

The O 0 7.369433063786346e-08
Hp2 O 0 4.1649651393527165e-05
/ O 0 3.251451062169508e-06
Hpdel O 0 6.035209935362218e-06
individuals O 0 4.705046421915604e-11
had O 0 6.506001848372023e-10
an O 0 5.066584304880273e-12
extremely O 0 7.216182512648217e-11
low O 0 7.79826248020754e-09
level O 0 1.3457750469569874e-08
of O 0 1.2307293850710721e-08
Hp O 0 6.898711824021575e-09
( O 0 1.5705924061304444e-10
mean O 0 1.985197073395284e-08
+ O 0 1.0230049030113264e-09
/ O 0 3.1525619892391887e-09
- O 0 9.314641502555787e-09
SD O 0 7.57493481273741e-08
= O 0 8.07362621202401e-10
0 O 0 1.1007205563684508e-10
. O 0 2.0303721811471e-12
049 O 0 1.7754907544187404e-09
+ O 0 1.1881985673145579e-10
/ O 0 1.0600240685221252e-09
- O 0 1.9779697879585e-09
0 O 0 3.448332730471293e-10
. O 0 4.782930995705925e-12
043 O 0 1.0560605723242134e-09
mg O 0 3.7545561104579406e-10
/ O 0 5.278193160318523e-11
ml O 0 5.833798027987669e-11
; O 0 1.106617943981425e-12
n O 0 4.556296312463459e-11
= O 0 3.048660629501043e-11
6 O 0 8.896412079240079e-11
) O 0 4.07410955286739e-14
, O 0 2.7462366690607365e-14
compared O 0 1.686151354174728e-13
with O 0 3.3586553812659306e-14
the O 0 3.265499329274668e-11
level O 0 8.505616211351708e-10
( O 0 8.714889053462738e-12
1 O 0 1.0756994406335707e-08
. O 0 2.812567713450509e-11
64 O 0 3.5760822081343235e-10
+ O 0 7.575992611030813e-11
/ O 0 5.246178491624676e-10
- O 0 2.012547017926636e-09
1 O 0 3.2199507504770963e-09
. O 0 1.2506261651279438e-11
07 O 0 3.254035652044962e-10
mg O 0 8.607108914482353e-10
/ O 0 1.3388380681877976e-10
ml O 0 4.322091989861221e-11
) O 0 3.997305687408054e-14
obtained O 0 3.5857634136243766e-12
from O 0 3.3570465851617826e-11
52 O 0 4.334396841443322e-09
healthy O 0 8.443152427206613e-12
volunteers O 0 5.750976409500674e-13
having O 0 1.2057542464471993e-11
phenotype O 0 4.96778973513301e-09
Hp2 O 0 4.7183721108012833e-07
, O 0 2.2271786845329267e-11
whereas O 0 7.912979993474067e-11
the O 0 1.0728685301275576e-10
serum O 0 4.2727016369425996e-10
Hp O 0 6.838989097257553e-11
level O 0 1.247679598526119e-10
of O 0 2.2301487913323204e-12
an O 0 1.8917777500765398e-13
individual O 0 1.9172555185717303e-14
with O 0 5.500207927999767e-12
Hp1 O 0 4.215738226776011e-05
/ O 0 1.7267400835407898e-05
Hpdel O 0 4.060080391354859e-05
was O 0 3.856153796277795e-07
0 O 0 1.1590108073278316e-07
. O 0 3.774648593690699e-09

50 O 0 4.322634197251318e-07
mg O 0 1.5082541438005137e-07
/ O 0 1.0842892805840165e-08
ml O 0 3.884468746662151e-09
, O 0 7.62416985013864e-13
which O 0 1.2826903168089432e-13
was O 0 1.4104171823514644e-11
approximately O 0 1.0052720374881252e-12
half O 0 5.112968642223548e-12
the O 0 7.096609758172612e-12
level O 0 7.295011816843555e-10
of O 0 1.9165719011837723e-10
Hp O 0 2.0705936965015326e-10
in O 0 6.005599489933289e-11
control O 0 6.212337755329145e-09
sera O 0 4.703059275357191e-09
from O 0 1.619301220889824e-11
the O 0 1.6597931362660745e-11
Hp1 O 0 2.9984459359866378e-09
phenotype O 0 5.773612143933349e-11
( O 0 7.998722127353086e-13
1 O 0 9.201150952264925e-10
. O 0 8.514373234236317e-12
26 O 0 1.7925178008582066e-09
+ O 0 1.1033943203564434e-10
/ O 0 6.421343456963768e-10
- O 0 2.9720153005285965e-09
0 O 0 3.506941126385499e-10
. O 0 5.241212845674692e-12
33 O 0 1.300275026538955e-10
mg O 0 2.1595336630042539e-10
/ O 0 6.400455165866958e-11
ml O 0 4.503462880389719e-11
; O 0 1.2859733894074465e-12
n O 0 9.701567327269345e-11
= O 0 7.576426985789197e-11
9 O 0 5.28139809663486e-10
) O 0 4.547896347711911e-13
, O 0 8.938652769352462e-13
showing O 0 1.450466743241341e-11
a O 0 2.7352645148859267e-10
gene O 0 4.3090864210171276e-11
- O 0 1.3397251086288975e-09
dosage O 0 1.3173561796975264e-08
effect O 0 3.33920908701657e-08
. O 0 5.584275264425287e-09

The O 0 8.791114503026165e-09
other O 0 1.713650402135336e-11
allele O 0 1.0493342861295218e-09
( O 0 1.6573574110334555e-11
Hp2 O 0 1.1024534529724406e-07
) O 0 1.6316272334962467e-12
of O 0 1.5792610275067176e-11
individuals O 0 7.709702559526022e-13
with O 0 6.074870207567473e-12
Hp2 O 0 2.144187965313904e-05
/ O 0 4.137493306188844e-06
Hpdel O 0 1.611724655958824e-05
was O 0 2.4489331451604812e-08
found O 0 3.1361961638776137e-12
to O 0 1.6069234484716866e-11
have O 0 1.2744919052412595e-12
, O 0 6.56790865184026e-13
in O 0 5.108855179181138e-12
all O 0 4.02054951831321e-11
exons O 0 2.0412631585031704e-09
, O 0 3.399171916163013e-11
no O 0 2.4177004842584893e-10
mutation O 0 8.878342505624914e-11
, O 0 2.8862912494070914e-12
by O 0 1.8750039715298428e-11
DNA O 0 1.360729195987176e-09
sequencing O 0 2.012685129670899e-09
. O 0 1.6695359539298238e-09

On O 0 2.891410488814472e-08
the O 0 7.762963882829155e-11
basis O 0 4.686008248100393e-10
of O 0 4.264671601972303e-11
the O 0 1.3756127313635513e-11
present O 0 6.5759095217721164e-12
study O 0 5.518944676263793e-12
, O 0 4.64373819345637e-13
the O 0 8.02998726540105e-12
mechanism O 0 1.2527970327802507e-10
of O 0 1.5835750766246548e-10
anhaptoglobinemia B-Disease 0 2.7597504725918043e-08
and O 0 1.7329939566712582e-11
the O 0 4.2738569627776e-11
mechanism O 0 2.5438295914170794e-10
of O 0 1.762076040634497e-10
anomalous O 0 3.779402106829366e-07
inheritance O 0 7.820427185833978e-07
of O 0 8.96731151556196e-08
Hp O 0 1.4907172385392187e-08
phenotypes O 0 1.5795518226724425e-09
were O 0 1.9296374220711954e-10
well O 0 4.0783917909514855e-11
explained O 0 1.2746590449808082e-09
. O 0 2.9961477743256637e-09

However O 0 2.5216333465749585e-09
, O 0 3.104784138119321e-11
the O 0 3.326553615901062e-11
mechanism O 0 7.658227940687823e-10
of O 0 1.498396073884578e-09
hypohaptoglobinemia B-Disease 0 0.00137743738014251
remains O 0 5.117686896483065e-07
unknown O 0 1.4804338661633665e-06

ATM O 0 0.00010552985622780398
mutations O 0 2.493740502984565e-08
and O 0 4.979291978735034e-11
phenotypes O 0 1.0843037578922576e-08
in O 0 3.420435712442327e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 3.990459962466275e-09
in O 0 2.4061615547243953e-11
the O 0 1.8061269493885312e-11
British O 0 9.646060859791472e-12
Isles O 0 9.429774738833885e-10
: O 0 7.608012662788446e-14
expression O 0 4.314674431540183e-13
of O 0 1.0367205358075005e-11
mutant O 0 1.070903435373971e-11
ATM O 0 7.334873819431209e-10
and O 0 5.877696875218608e-13
the O 0 6.32992790128295e-12
risk O 0 1.0938475125676916e-10
of O 0 6.397480323272475e-10
leukemia B-Disease 1 0.9999994039535522
, O 0 1.2823848010157235e-06
lymphoma B-Disease 1 1.0
, O 0 0.1278916597366333
and O 0 0.4990825951099396
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9657498002052307

We O 0 4.02204936023054e-09
report O 0 1.8855405084505783e-11
the O 0 1.0860676941115699e-11
spectrum O 0 1.7464013568613268e-09
of O 0 1.9004542384237766e-09
59 O 0 3.407076576422696e-08
ATM O 0 9.418663466931321e-07
mutations O 0 1.4155498995194193e-09
observed O 0 3.2167388197557045e-10
in O 0 2.587459690950311e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.276062787132105e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.327179058462917e-11
patients O 0 2.949861275386434e-12
in O 0 1.2245967044230421e-12
the O 0 3.8537652236048103e-11
British O 0 3.322775943281897e-10
Isles O 0 3.320676285056834e-07
. O 0 2.5896842004158316e-08

Of O 0 1.8158759758080123e-06
51 O 0 3.992186066170689e-06
ATM O 0 1.9724759113159962e-05
mutations O 0 1.1187850645910657e-08
identified O 0 1.2853566822013107e-10
in O 0 1.523347073484338e-11
families O 0 1.5935031072444872e-11
native O 0 3.057866026362488e-12
to O 0 1.0557781038311731e-10
the O 0 6.924041201505915e-11
British O 0 8.700527104332778e-11
Isles O 0 1.8109451715986324e-08
, O 0 4.544414844431799e-11
11 O 0 2.3473833987708304e-09
were O 0 4.1300746156380796e-10
founder O 0 1.0912874159885178e-08
mutations O 0 1.6733800456414372e-10
, O 0 1.1488151575866912e-11
and O 0 6.083222120478737e-11
2 O 0 1.8403378021503158e-07
of O 0 2.4624495775782407e-09
these O 0 7.644997482292304e-12
11 O 0 6.012261244414674e-10
conferred O 0 1.2686462991240433e-09
a O 0 9.358244040802433e-11
milder O 0 2.6151777632321682e-08
clinical O 0 1.119142556404995e-10
phenotype O 0 2.9589348332637044e-11
with O 0 1.79728211073581e-14
respect O 0 1.0314365680996751e-11
to O 0 6.160781329533904e-10
both O 0 1.6321184403977895e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 2.1026510239607887e-06
cellular O 0 1.122937263176027e-07
features O 0 2.2553894862831214e-10
. O 0 5.008290671071336e-09

We O 0 3.913964263801972e-09
report O 0 1.0782203255232936e-11
, O 0 9.52171352289373e-14
in O 0 2.461589959645849e-13
two O 0 8.576848432861883e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 7.373331112336956e-11
, O 0 1.3254438779169986e-12
an O 0 1.6323347187818804e-11
ATM O 0 1.9715287180588348e-07
mutation O 0 1.2385752423682561e-09
( O 0 2.968494200450422e-11
7271T O 0 9.53555456817412e-08
- O 0 1.3288182998394404e-08
- O 0 2.6234710404082762e-08
> O 0 1.5124953733902657e-08
G O 0 2.6964468435863864e-09
) O 0 1.0616608639305372e-13
that O 0 3.808512885486795e-14
may O 0 7.419175516998333e-12
be O 0 1.3952933860389427e-12
associated O 0 6.109634282866483e-13
with O 0 3.616625702802627e-15
an O 0 1.655077984386022e-13
increased O 0 3.1800555244654305e-11
risk O 0 1.3819677624482551e-09
of O 0 5.2865235744548045e-08
breast B-Disease 1 0.9992554783821106
cancer I-Disease 1 0.7319980263710022
in O 0 1.4001321879675288e-08
both O 0 3.22743365366307e-09
homozygotes O 0 7.924515443846758e-08
and O 0 2.8620963932191046e-10
heterozygotes O 0 5.3402331445795426e-09
( O 0 4.0504214565695307e-11
relative O 0 7.017984415824685e-09
risk O 0 6.385460493696371e-10
12 O 0 9.944978868192678e-11
. O 0 1.9322835432405983e-12
7 O 0 5.20199772147123e-10
; O 0 1.993868785354902e-11
P O 0 9.917466741171665e-07
= O 0 5.806037872702063e-10
. O 0 1.8047117619768294e-11
0025 O 0 4.320612756458786e-09
) O 0 1.9620190075484573e-13
, O 0 1.0574572765825394e-13
although O 0 9.699369535624489e-14
there O 0 1.6202975918443163e-13
is O 0 5.733494191570432e-14
a O 0 9.130438375845595e-13
less O 0 1.1583650011415259e-10
severe O 1 0.9687876105308533
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 4.118746732562073e-10
in O 0 5.912888315908957e-14
terms O 0 1.8166012314205227e-12
of O 0 7.814804033924594e-13
the O 0 2.728184702888853e-13
degree O 0 9.717722182500665e-10
of O 0 9.470348949491836e-10
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
. O 0 6.017171017447254e-06

This O 0 1.5742821490860592e-09
mutation O 0 2.487358097269521e-10
( O 0 4.676913804152472e-12
7271T O 0 3.0302356179845447e-08
- O 0 3.4941567417234864e-09
- O 0 5.275209602473296e-09
> O 0 4.771512074341899e-09
G O 0 7.79240005854831e-10
) O 0 7.410141531145106e-15
also O 0 1.6086436805691886e-15
allows O 0 2.5062150603796535e-15
expression O 0 5.673025525905484e-13
of O 0 9.476392760776609e-12
full O 0 2.303164256534096e-11
- O 0 1.1579187608745656e-10
length O 0 1.1885838147041028e-10
ATM O 0 1.878020405854386e-08
protein O 0 1.2598683207798445e-10
at O 0 2.5222081367903826e-11
a O 0 5.936150009044905e-12
level O 0 1.962373874508927e-10
comparable O 0 4.245388415813345e-11
with O 0 3.99617215403672e-13
that O 0 2.6410024341061433e-12
in O 0 1.507585202509265e-11
unaffected O 0 7.651602906832977e-09
individuals O 0 4.2245561215903393e-11
. O 0 2.2030111068715996e-08

In O 0 1.9637451664777927e-09
addition O 0 7.126604861795727e-11
, O 0 6.443644923193048e-11
we O 0 4.67315283692038e-11
have O 0 1.4637003631703949e-12
studied O 0 4.445091517091271e-11
18 O 0 4.7739519004608155e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 9.4298790997982e-11
, O 0 4.4528572859135404e-14
in O 0 7.702540184449311e-14
15 O 0 2.47720611384894e-11
families O 0 7.343317035175823e-13
, O 0 3.009855385760485e-12
who O 0 6.51454168387744e-11
developed O 0 3.316004892894853e-08
leukemia B-Disease 1 1.0
, O 0 0.00010557503264863044
lymphoma B-Disease 1 1.0
, O 0 2.1847934476681985e-05
preleukemic O 1 0.9626113176345825
T O 0 3.93427535527735e-06
- O 0 4.150350889631227e-07
cell O 0 1.3798824305411017e-08
proliferation O 0 9.516802634834676e-08
, O 0 8.05168865608552e-12
or O 0 1.8973331350480294e-08
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.4505879991920665e-07
mostly O 0 1.7733238488748526e-10
in O 0 1.3334792159369613e-09
childhood O 0 2.275155793540762e-06
. O 0 3.3664971965663426e-07

A O 0 7.67180836191983e-07
wide O 0 1.6326360707807908e-08
variety O 0 7.381394107053296e-11
of O 0 1.866371057701599e-09
ATM O 0 1.125509811572556e-06
mutation O 0 1.8108405885897128e-09
types O 0 3.134722481590302e-10
, O 0 8.356541153498043e-12
including O 0 1.9738821688264352e-11
missense O 0 1.0265334822179284e-06
mutations O 0 5.094959476537042e-08
and O 0 1.6787762846526277e-10
in O 0 1.7908832750102022e-10
- O 0 2.699637402514554e-09
frame O 0 2.4619706273654174e-09
deletions O 0 3.232442313816364e-09
, O 0 8.543300789032315e-11
were O 0 3.1911195907952106e-11
seen O 0 4.3280563161163244e-11
in O 0 5.536562961566682e-12
these O 0 1.3476685913060837e-11
patients O 0 1.1189504184327959e-10
. O 0 1.0299342712016823e-08

We O 0 5.770139033245414e-09
also O 0 2.09199216109901e-12
show O 0 4.1144846319070283e-13
that O 0 7.770947920522284e-15
25 O 0 4.884080119504919e-12
% O 0 2.025826988799606e-12
of O 0 4.293136159072564e-12
all O 0 2.3535107196437366e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.457688355749781e-10
carried O 0 3.3325722823690507e-12
in O 0 6.603709007575731e-13
- O 0 6.112484823850295e-11
frame O 0 6.011252606796802e-10
deletions O 0 2.3137161075936774e-09
or O 0 6.045693279332909e-09
missense O 0 1.6808113514343859e-06
mutations O 0 2.1845715991730685e-07
, O 0 1.3107724974870116e-11
many O 0 1.0366403238202745e-13
of O 0 5.924725553912991e-12
which O 0 6.326194451101996e-13
were O 0 1.4088839686912658e-12
also O 0 1.204750817336564e-13
associated O 0 1.0975706021126852e-12
with O 0 1.1036325661944318e-13
expression O 0 8.712865845472706e-11
of O 0 1.3275769816800675e-08
mutant O 0 1.1141513489576482e-08
ATM O 0 1.6823139503685525e-06
protein O 0 1.9844331689000683e-07
. O 0 5.420999205085764e-09

The O 0 6.808594577023541e-08
DMPK O 1 0.7497544884681702
gene O 0 8.64839755365665e-10
of O 0 5.670805491853059e-10
severely O 0 9.055533882929012e-05
affected O 0 0.038695115596055984
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9840376377105713
is O 0 4.462152869422198e-09
hypermethylated O 0 1.599168058419309e-06
proximal O 0 2.693909664230887e-05
to O 0 2.5834390271484153e-07
the O 0 2.0804886702308067e-08
largely O 0 1.0526699512070081e-09
expanded O 0 2.6336119951508863e-09
CTG O 0 9.360393050883431e-06
repeat O 0 9.70209868000893e-08
. O 0 1.6738477270905605e-08

Using O 0 2.246504493541579e-08
methylation O 0 1.4707364925925503e-07
- O 0 5.5588373015780235e-08
sensitive O 0 7.341959928908182e-09
restriction O 0 1.9461754430238898e-09
enzymes O 0 1.8665304024612084e-10
, O 0 1.7932263746828214e-12
we O 0 2.4485125298817634e-12
characterized O 0 1.1794550579258267e-11
the O 0 8.722642746983311e-11
methylation O 0 1.5690840848847643e-09
pattern O 0 1.51640577872314e-09
on O 0 2.431737922137245e-09
the O 0 1.29917923641365e-10
5 O 0 1.6299719352019792e-09
side O 0 1.0380036830071049e-09
of O 0 4.744830306435688e-09
the O 0 7.988705696959642e-09
CTG O 0 3.2676218779670307e-06
repeat O 0 1.5449757029273314e-09
in O 0 1.4202000686580618e-11
the O 0 1.2645268165911716e-10
DMPK O 0 2.5271922368119704e-06
gene O 0 9.382116611389435e-12
of O 0 1.3522931906206903e-11
normal O 0 7.416349478983619e-11
individuals O 0 1.73060418534772e-13
and O 0 2.871142342972255e-12
of O 0 2.4530164011160593e-10
patients O 0 3.381118302003827e-11
affected O 0 2.478098976022025e-11
with O 0 2.202395626982323e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 3.886492017102228e-09
showing O 0 2.9688693170548675e-10
expansions O 0 3.456104291643669e-09
of O 0 3.82452247649212e-09
the O 0 4.064852010543518e-09
repetitive O 0 1.5224113525391658e-08
sequence O 0 2.4733795012110704e-09
. O 0 2.5654944835196147e-09

The O 0 2.5136066028608184e-07
gene O 0 1.0079193035750222e-09
segment O 0 2.5563406946815803e-09
analyzed O 0 1.2192746812189625e-10
corresponds O 0 8.428325259934866e-10
to O 0 2.0797932265281815e-09
the O 0 2.3718393915572733e-09
genomic O 0 4.38994405271842e-08
SacI O 0 7.09946561983088e-07
- O 0 4.567238143238228e-09
HindIII O 0 1.9335592682523384e-08
fragment O 0 2.100688067940837e-09
carrying O 0 8.069987733616557e-11
exons O 0 2.6341795411610747e-09
11 O 0 1.6331522800783205e-09
- O 0 4.205627401887568e-09
15 O 0 1.3372187801508062e-08
. O 0 3.742889109759062e-09

There O 0 1.1753248152501783e-08
is O 0 4.309795575974107e-10
constitutive O 0 1.11763171162238e-07
methylation O 0 2.8047057298863365e-07
in O 0 1.1115660392135851e-08
intron O 0 8.994562676889473e-07
12 O 0 5.7343971349155254e-08
at O 0 5.817477610747801e-10
restriction O 0 1.3311710067576144e-10
sites O 0 6.414155317990833e-11
of O 0 1.0197958449920108e-10
SacII O 0 2.352826982132683e-07
and O 0 4.695492328288253e-10
HhaI O 0 7.434711278619943e-06
, O 0 4.4274936494836936e-10
localized O 0 7.935587831298108e-08
1 O 0 4.6251426510934834e-07
, O 0 5.151087889565531e-11
159 O 0 1.6721045659195966e-09
- O 0 6.7292700300924935e-09
1 O 0 6.847274391930114e-08
, O 0 1.8934556700322958e-10
232 O 0 1.4439153206424749e-09
bp O 0 2.0657594745898678e-08
upstream O 0 1.742957955741531e-08
of O 0 1.5132564090691858e-09
the O 0 7.164773663248525e-09
CTG O 0 3.4890820188593352e-06
repeat O 0 1.152220452382835e-08
, O 0 6.647085659672314e-11
whereas O 0 1.5260320784804549e-10
most O 0 3.465353438231178e-12
, O 0 2.2006801762841643e-12
if O 0 7.63884615284649e-12
not O 0 1.3804068131617608e-11
all O 0 5.840708559162744e-12
, O 0 2.3376396304786162e-12
of O 0 1.9745977422602756e-11
the O 0 1.2554323899904851e-11
other O 0 3.516996806632311e-13
sites O 0 1.6026444060734946e-11
of O 0 1.2051708242477588e-10
SacII O 0 6.541495167766698e-07
, O 0 2.5267260506112166e-10
HhaI O 0 6.2460276240017265e-06
, O 0 1.9963891650931487e-10
and O 0 2.253385672501551e-10
HpaII O 0 5.305976628733333e-06
in O 0 1.0294735897087293e-10
this O 0 9.997317557131069e-11
region O 0 6.592999923782372e-09
are O 0 1.0953710161132335e-11
unmethylated O 0 4.49372006272597e-09
, O 0 1.906921669181383e-12
in O 0 1.7035730465186916e-12
normal O 0 3.0504301862244176e-10
individuals O 0 4.915497804798552e-13
and O 0 3.922627847541271e-12
most O 0 3.955807036104542e-12
of O 0 1.916118652633969e-10
the O 0 6.137898522773355e-10
patients O 0 7.358803844059736e-11
. O 0 3.1081883733463656e-09

In O 0 6.617550951659723e-10
a O 0 3.2878372246969434e-10
number O 0 3.180061422525249e-11
of O 0 2.3265395165950054e-10
young O 0 1.4220757384164617e-11
and O 0 3.387018096545624e-11
severely O 0 7.753780664643273e-05
affected O 0 8.570994936007992e-08
patients O 0 2.7051783035858534e-09
, O 0 7.78167252857287e-11
however O 0 6.897142301731662e-10
, O 0 6.748002850942569e-11
complete O 0 1.4196056552506775e-09
methylation O 0 6.872575841754269e-09
of O 0 7.459381445862334e-10
these O 0 1.9185451838321654e-12
restriction O 0 2.079855732084468e-10
sites O 0 4.922651869465611e-11
was O 0 1.5290504973286545e-10
found O 0 1.9044499050685504e-12
in O 0 1.6760039536767302e-12
the O 0 4.173993442546653e-11
mutated O 0 1.8793371026060157e-10
allele O 0 2.621265160485109e-08
. O 0 1.488711198760484e-08

In O 0 2.0330492844777837e-09
most O 0 3.094709905004933e-11
of O 0 5.469881839137436e-11
these O 0 2.4798273243892277e-13
patients O 0 6.617376460162083e-13
, O 0 3.7775629792204807e-14
the O 0 2.7600081508455387e-12
onset O 0 5.457212637338671e-07
of O 0 7.028593707048003e-09
the O 0 3.405848403303935e-08
disease O 1 0.9174333810806274
was O 0 0.00028739747358486056
congenital O 1 1.0
. O 0 0.0006873930688016117

Preliminary O 0 8.49555817694636e-06
in O 0 4.795592758455314e-07
vivo O 0 6.194998150022002e-06
footprinting O 0 3.3263638670177897e-06
data O 0 3.897082656578732e-10
gave O 0 1.9625984171156574e-10
evidence O 0 7.110853572633857e-11
for O 0 1.7175641117694873e-11
protein O 0 9.186240657044209e-11
- O 0 4.919087914778686e-10
DNA O 0 1.9903893810901963e-10
contact O 0 3.4341815502436646e-10
in O 0 2.572966284475342e-10
normal O 0 5.031108685216168e-08
genes O 0 7.885212621738802e-11
at O 0 8.175259774700905e-11
an O 0 5.786419520620312e-12
Sp1 O 0 1.3881706895091384e-09
consensus O 0 2.755456973702053e-09
binding O 0 8.332873591143652e-08
site O 0 3.835979711652726e-08
upstream O 0 2.5338422915410774e-08
of O 0 7.277820013307235e-10
the O 0 1.483299705284935e-09
CTG O 0 1.0691742318158504e-06
repeat O 0 3.406221971147261e-10
and O 0 1.8610990298786184e-13
for O 0 1.6072038177324804e-13
a O 0 3.832944378556746e-12
significant O 0 1.1183567093231428e-11
reduction O 0 2.799863896285615e-09
of O 0 2.0498690245229767e-10
this O 0 2.511110243352821e-11
interaction O 0 1.429694279631022e-10
in O 0 4.93729258865816e-11
cells O 0 7.322788209140896e-12
with O 0 1.0363200776035766e-13
a O 0 4.6355769223183074e-10
hypermethylated O 0 1.1216267239433364e-06
DMPK O 0 4.164742858847603e-05
gene O 0 8.007542962040759e-10
. O 0 4.1849645970870597e-10
. O 0 2.7521060985691292e-09

The O 0 3.0353137844940647e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.9561761988029502e-08
product O 0 8.091817771394005e-10
complexes O 0 4.448840601467552e-11
with O 0 2.3026272728821073e-12
the O 0 3.592852959588555e-10
transferrin O 0 7.267673396427199e-08
receptor O 0 2.393043985193799e-07
and O 0 4.087801486196696e-10
lowers O 0 3.697997186247193e-10
its O 0 3.9641154941927326e-12
affinity O 0 4.168453776598469e-12
for O 0 1.3938569265806167e-12
ligand O 0 7.08697267537417e-10
binding O 0 1.2628461831809545e-07
. O 0 1.3689143152362249e-08

We O 0 7.724101891426471e-08
recently O 0 1.3637380114062125e-09
reported O 0 1.0655860221975288e-10
the O 0 1.8146767075122305e-11
positional O 0 1.4800631553679722e-10
cloning O 0 4.0253737842999016e-12
of O 0 8.695060188350368e-13
a O 0 1.899313388856183e-12
candidate O 0 2.2950177869240918e-10
gene O 0 1.9557899744171436e-10
for O 0 1.509106617447742e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999992847442627
HFE O 1 0.9999301433563232
. O 0 2.0663583200075664e-06

The O 0 4.1086742896823125e-09
gene O 0 3.1344620909229404e-12
product O 0 4.045709513927909e-12
, O 0 2.5864146978651914e-13
a O 0 4.806381334598875e-11
member O 0 9.863808658749917e-10
of O 0 3.526764436045937e-09
the O 0 1.5718998325198186e-09
major O 0 9.333297690261588e-09
histocompatibility O 0 6.255364723983803e-07
complex O 0 1.117537440364913e-08
class O 0 1.8643883659130722e-10
I O 0 2.980747737524325e-08
- O 0 1.363524737563182e-09
like O 0 4.9221048244174614e-12
family O 0 5.051251951437852e-12
, O 0 1.1560616830150194e-12
was O 0 3.373074874968296e-10
found O 0 2.6513088599577905e-12
to O 0 4.066918329881375e-11
have O 0 8.59740403869047e-12
a O 0 4.189740221427485e-10
mutation O 0 1.8953860703163627e-09
, O 0 2.4053689595682215e-10
Cys O 0 5.839161190124287e-07
- O 0 2.9589236305582745e-07
282 O 0 4.592275004711155e-08
- O 0 2.3551953631795186e-07
- O 0 3.2958467954813386e-07
> O 0 8.20756582697868e-08
Tyr O 0 1.7657727369169152e-07
( O 0 6.050344253383244e-12
C282Y O 0 3.8143692648873184e-08
) O 0 1.9223461527034108e-13
, O 0 8.2676866654946e-14
in O 0 1.2893504623343044e-12
85 O 0 3.950743898695208e-10
% O 0 6.726055129524511e-11
of O 0 3.899803813212088e-10
patient O 0 3.005089155294627e-08
chromosomes O 0 2.2751919459551573e-07
. O 0 5.566986160943088e-08

This O 0 4.126218478006649e-09
mutation O 0 2.938169041399874e-09
eliminates O 0 1.1594050164376313e-08
the O 0 9.93637047641549e-11
ability O 0 5.437562206056512e-11
of O 0 1.445982333869722e-09
HFE O 0 4.484365490498021e-06
to O 0 1.121417181337847e-08
associate O 0 2.1154322737970688e-09
with O 0 2.250085100879984e-12
beta2 O 0 4.254378382029245e-06
- O 0 2.1130717868800275e-06
microglobulin O 0 3.855025170196313e-06
( O 0 5.169712991026643e-10
beta2m O 0 1.0478117928869324e-06
) O 0 1.0902310304539142e-11
and O 0 5.2235708813963555e-11
prevents O 0 6.907740490724734e-10
cell O 0 4.888003957148612e-08
- O 0 1.444064690048208e-08
surface O 0 1.0446562725974218e-07
expression O 0 4.065844549927533e-09
. O 0 2.2032843105534994e-08

A O 0 1.204186105496774e-06
second O 0 1.0676605199932965e-07
mutation O 0 1.6310603978553218e-09
that O 0 3.5969150834896935e-12
has O 0 1.0929163390266394e-12
no O 0 1.8491263208131326e-12
effect O 0 2.610933691471473e-10
on O 0 1.6796611879144052e-09
beta2m O 0 3.413985609768133e-07
association O 0 1.4096594724843925e-10
, O 0 1.0056987881368329e-10
H63D O 0 0.0006196585018187761
, O 0 1.828299872608241e-10
was O 0 1.6557980542231121e-09
found O 0 5.998724737429906e-13
in O 0 4.2272524998672456e-13
eight O 0 3.2363918402861236e-12
out O 0 1.4254370253596882e-12
of O 0 8.431469064595909e-12
nine O 0 6.123407336744435e-11
patients O 0 1.479564951459289e-12
heterozygous O 0 5.696361785045845e-12
for O 0 4.488524829593388e-11
the O 0 1.0664003013971524e-08
C282Y O 0 3.776750236283988e-05
mutant O 0 5.706975798602798e-07
. O 0 4.642262041443246e-08

In O 0 3.3263984899889465e-09
this O 0 2.570905988097394e-10
report O 0 3.750932203727686e-11
, O 0 1.354993808128091e-11
we O 0 9.072501083728923e-11
demonstrate O 0 2.2586094106102905e-10
in O 0 3.586587693504839e-10
cultured O 0 3.1059972371849653e-08
293 O 0 6.566246213424165e-08
cells O 0 1.0241709702540902e-08
overexpressing O 0 6.56296563761316e-08
wild O 0 5.088243715256624e-10
- O 0 2.148523164935412e-10
type O 0 4.344724302551839e-10
or O 0 2.1451911358383313e-09
mutant O 0 4.483609039596104e-09
HFE O 0 1.524024497712162e-07
proteins O 0 2.782589046332329e-12
that O 0 1.1350618253462563e-13
both O 0 6.302120283963042e-13
the O 0 4.8925301310287495e-11
wild O 0 1.1294873369926961e-10
- O 0 3.817218485746565e-10
type O 0 2.9794562372842393e-09
and O 0 2.2328932036685956e-09
H63D O 0 0.0014015816850587726
HFE O 0 7.890210326877423e-06
proteins O 0 1.2330801657522983e-10
form O 0 1.8122000428055784e-11
stable O 0 2.1410694051038348e-10
complexes O 0 4.898083241083873e-12
with O 0 3.3587593969118534e-13
the O 0 2.8361640813656663e-10
transferrin O 0 5.6919422064538594e-08
receptor O 0 8.229637415979596e-08
( O 0 3.731766839987216e-10
TfR O 0 3.790118086044458e-08
) O 0 1.649234221412499e-11
. O 0 3.7731209823199663e-10

The O 0 2.382878108164732e-07
C282Y O 0 3.26946574205067e-05
mutation O 0 8.409799079345248e-09
nearly O 0 1.0958982332720524e-10
completely O 0 8.176148647009995e-11
prevents O 0 1.4439303051838603e-11
the O 0 1.1145875021545404e-11
association O 0 1.3169522763978314e-11
of O 0 6.197989899092704e-10
the O 0 4.850240209464118e-09
mutant O 0 1.0116137261206859e-08
HFE O 0 1.1022195849363925e-06
protein O 0 1.4592619335118684e-09
with O 0 1.8582553031054605e-12
the O 0 8.407196605553224e-10
TfR O 0 1.0678270427888492e-06
. O 0 1.6147483350437142e-08

Studies O 0 1.005500305240048e-08
on O 0 1.497456914023587e-08
cell O 0 1.8076520280629893e-09
- O 0 5.639546607483226e-10
associated O 0 7.05145386525885e-11
transferrin O 0 4.234598449670557e-08
at O 0 5.743468367569449e-09
37 O 0 6.294153531705149e-10
degrees O 0 6.184958323274259e-08
C O 0 7.825352810186814e-08
suggest O 0 6.194938312331644e-11
that O 0 2.386456700656514e-12
the O 0 2.4822019439874055e-10
overexpressed O 0 3.6677749903901713e-07
wild O 0 3.5260652175850282e-09
- O 0 5.5534083998054484e-09
type O 0 1.9583525912025834e-08
HFE O 0 2.245366658826242e-06
protein O 0 1.6649822631720212e-09
decreases O 0 1.0249223691971565e-10
the O 0 1.3933280527608782e-12
affinity O 0 5.844678907518386e-11
of O 0 2.764083129047634e-10
the O 0 3.988920860287237e-10
TfR O 0 7.727708251081822e-09
for O 0 2.6469647654292494e-11
transferrin O 0 4.33453976711462e-07
. O 0 5.024328686431545e-08

The O 0 4.071526291227201e-06
overexpressed O 0 0.00014906258729752153
H63D O 1 0.6295354962348938
protein O 0 6.410874107132258e-07
does O 0 1.8493258313601046e-10
not O 0 2.2051350329066466e-11
have O 0 3.2707509118636013e-13
this O 0 3.630570236806685e-13
effect O 0 1.3648744634497945e-10
, O 0 4.903371545600388e-13
providing O 0 4.100156087046003e-13
the O 0 1.1160803184417922e-12
first O 0 1.2604367419580265e-12
direct O 0 8.735158429917789e-12
evidence O 0 3.112728174173296e-12
for O 0 1.870751004193899e-13
a O 0 1.0739265379755558e-11
functional O 0 2.178041969003175e-09
consequence O 0 7.569269655505195e-09
of O 0 1.6070416108959762e-09
the O 0 6.468057645037106e-09
H63D O 0 0.00036087099579162896
mutation O 0 3.9559063225169666e-07
. O 0 2.1418561146901993e-08

Addition O 0 2.0884202811544128e-08
of O 0 5.475019975165196e-07
soluble O 0 3.307356109871762e-06
wild O 0 2.2907254759729767e-08
- O 0 6.476995384474549e-09
type O 0 5.272174519177497e-08
HFE O 0 0.001590503379702568
/ O 0 2.0756071535288356e-05
beta2m O 0 1.4664393347629812e-05
heterodimers O 0 2.6681090048441547e-07
to O 0 2.1301143959817637e-08
cultured O 0 1.5919493501215243e-09
cells O 0 7.736253998524845e-11
also O 0 7.305179681657559e-13
decreased O 0 3.535496201356736e-11
the O 0 2.9320567241503115e-12
apparent O 0 2.411036925664689e-10
affinity O 0 2.855640168775153e-10
of O 0 1.697260887389973e-09
the O 0 4.820081001000176e-10
TfR O 0 3.627289579810622e-09
for O 0 1.1785684190732115e-12
its O 0 3.4345712038308385e-12
ligand O 0 1.7475433600200319e-10
under O 0 6.591537871081243e-10
steady O 0 2.1371129310665538e-09
- O 0 1.0021868751541874e-10
state O 0 3.2569773267265845e-11
conditions O 0 1.2742464861048575e-08
, O 0 3.668473944756778e-12
both O 0 3.5865774326154787e-12
in O 0 3.41983871776641e-11
293 O 0 4.178655199638115e-10
cells O 0 2.6405454212063972e-11
and O 0 2.4456619021617776e-11
in O 0 1.0852818643769524e-09
HeLa O 0 3.6535800518322503e-07
cells O 0 4.0180925253707755e-09
. O 0 4.527203056881035e-09

Furthermore O 0 2.3418035510758273e-08
, O 0 1.8664735035311963e-10
at O 0 1.0710106135292108e-09
4 O 0 4.430756650464218e-09
degrees O 0 6.524822993014823e-07
C O 0 4.805760909221135e-07
, O 0 2.7764089638449008e-11
the O 0 2.69021943610781e-10
added O 0 1.3535770282402382e-09
soluble O 0 5.879726927560114e-09
complex O 0 1.1992462578547247e-09
of O 0 1.8176229410471478e-09
HFE O 0 1.1949122381338384e-05
/ O 0 2.595104149349936e-07
beta2m O 0 2.906229212840117e-07
inhibited O 0 8.031527110041736e-10
binding O 0 2.0844397319308428e-09
of O 0 2.9216165042811326e-09
transferrin O 0 7.0152168518689e-08
to O 0 4.270579267995345e-08
HeLa O 0 6.157098937364935e-07
cell O 0 9.901833131209514e-09
TfR O 0 2.687621680763641e-08
in O 0 1.448763591732627e-11
a O 0 5.969218452861469e-10
concentration O 0 1.3799318310248054e-07
- O 0 1.4458313657428334e-08
dependent O 0 6.251229311970974e-09
manner O 0 8.98513086156072e-09
. O 0 2.856656422522974e-08

Scatchard O 0 5.5694727052468807e-05
plots O 0 1.6791353800726938e-06
of O 0 1.515184209210929e-07
these O 0 1.4500663170213812e-10
data O 0 2.754940719995602e-10
indicate O 0 7.260212986359704e-10
that O 0 1.048077163251504e-11
the O 0 1.2979457786332915e-10
added O 0 8.388435779327352e-11
heterodimer O 0 1.0593591559526772e-09
substantially O 0 2.3848664709724687e-10
reduced O 0 3.44303557886505e-10
the O 0 1.9095067541052835e-11
affinity O 0 2.7608321184757756e-10
of O 0 1.0360434732348267e-09
TfR O 0 1.666352389406711e-08
for O 0 6.477741953947458e-11
transferrin O 0 7.036449005681789e-07
. O 0 3.325499164930079e-08

These O 0 9.755197760696888e-10
results O 0 3.8229747145734905e-10
establish O 0 1.571027641311673e-09
a O 0 1.3414331867522833e-09
molecular O 0 8.250411021037962e-09
link O 0 1.5853437451696095e-09
between O 0 1.10024318544788e-08
HFE O 0 3.9281621866393834e-05
and O 0 8.088731351385547e-10
a O 0 5.872732966594185e-09
key O 0 2.2617069106445342e-08
protein O 0 4.881570148107528e-10
involved O 0 7.959800180090681e-11
in O 0 5.43208880654511e-11
iron O 0 1.538050184990425e-07
transport O 0 4.315366286533617e-09
, O 0 4.610769752111388e-11
the O 0 1.3212483329638758e-09
TfR O 0 2.7876200903165227e-08
, O 0 5.1627903341344705e-12
and O 0 3.5866663371936225e-12
raise O 0 1.5088057192524928e-10
the O 0 1.1927533960509606e-10
possibility O 0 7.531448797948315e-10
that O 0 1.801286550473513e-11
alterations O 0 6.250272521768352e-10
in O 0 3.0287096615400078e-12
this O 0 1.6510366207880822e-12
regulatory O 0 3.402910175864804e-10
mechanism O 0 2.784789898679918e-10
may O 0 4.29444847738214e-11
play O 0 6.9320716701570806e-12
a O 0 4.052474935484218e-12
role O 0 1.6607074873262184e-12
in O 0 2.472365302937096e-13
the O 0 7.92020875967081e-12
pathogenesis O 0 4.311756640618114e-08
of O 0 8.424925823646845e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 8.263206837000325e-06
. O 0 9.995024186082446e-08

Genomic O 0 5.274055325799054e-08
organization O 0 2.4422894817632823e-09
of O 0 5.950351322780989e-09
the O 0 1.541553196204859e-08
UBE3A O 0 0.00016241318371612579
/ O 0 9.180521374219097e-06
E6 O 0 1.9205614080419764e-05
- O 0 2.7920609682041686e-06
AP O 0 7.724645456619328e-07
gene O 0 2.032457709078006e-11
and O 0 3.3727688610735163e-12
related O 0 5.702237571014734e-10
pseudogenes O 0 9.091048980280902e-08
. O 0 3.015274074869012e-08

The O 0 7.918741857793066e-07
UBE3A O 0 3.146333256154321e-05
gene O 0 1.800426030484914e-09
encodes O 0 1.0332978916949287e-10
the O 0 2.439243529384072e-10
E6 O 0 1.6195731689094828e-07
- O 0 5.985561557508845e-08
AP O 0 2.1253667625842354e-07
ubiquitin O 0 1.0400607042271304e-09
- O 0 1.2308978281083682e-09
protein O 0 3.272345242000263e-11
ligase O 0 1.7010208346046607e-12
and O 0 2.7112023563702348e-12
has O 0 8.45933132570531e-13
recently O 0 3.1865870619290915e-12
been O 0 3.336475789660759e-13
shown O 0 1.0125025275663224e-14
to O 0 2.824035764351779e-13
be O 0 1.6026855407039187e-13
mutated O 0 2.957202885345289e-11
in O 0 5.595829910554073e-10
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 6.18437334196642e-05
who O 0 3.932027148323414e-09
lack O 0 7.230094212218319e-08
15q11 O 0 6.984441370150307e-06
- O 0 4.632943273463752e-07
q13 O 0 1.7840344526121044e-06
deletions O 0 8.322815325811916e-09
or O 0 2.4455617531060625e-09
chromosome O 0 1.145075771091797e-06
15 O 0 2.2276329048054322e-07
paternal O 0 1.8507462300476618e-06
uniparental B-Disease 0 0.0006667746929451823
disomy I-Disease 0 0.0008322439971379936
. O 0 2.2211361283552833e-06

Previous O 0 6.946802955098974e-07
UBE3A O 0 3.2264865694742184e-06
cDNA O 0 2.3090782619306083e-09
analysis O 0 1.4183835529701927e-11
has O 0 9.255238312940242e-14
shown O 0 4.283610955096301e-14
a O 0 2.839917970925976e-12
coding O 0 1.5417788157279233e-09
region O 0 1.199121069106468e-08
of O 0 4.581704349249094e-09
approximately O 0 4.697437994138909e-09
2 O 0 4.1305605691377423e-07
. O 0 1.95438225603084e-08

6 O 0 3.567053863662295e-05
kb O 0 2.4396290427830536e-06
and O 0 2.742944482658771e-10
a O 0 1.3397563947137314e-08
3 O 0 1.5255933476510108e-06
- O 0 5.857655196450651e-07
untranslated O 0 4.480682036955841e-05
region O 0 4.705528766635325e-08
( O 0 2.122014230998559e-10
UTR O 0 1.9258541215094738e-06
) O 0 4.589991928205528e-11
of O 0 3.276620530456853e-09
< O 0 8.418242600782833e-07
50 O 0 9.79925030009099e-09
bp O 0 3.263236347805787e-09
, O 0 6.807127344438113e-12
whereas O 0 3.392429392956586e-11
Northern O 0 3.766160994178591e-10
analysis O 0 7.183714560710097e-12
has O 0 9.442414298371782e-13
indicated O 0 1.3596668062276773e-11
mRNA O 0 3.739773768440813e-11
sizes O 0 1.480573476320135e-11
of O 0 4.955330937250757e-11
5 O 0 8.2864941575167e-09
- O 0 3.7460331725469587e-08
8 O 0 1.6181481043986423e-07
kb O 0 8.324881264343276e-07
. O 0 1.4693396721554564e-08

We O 0 7.758910101074434e-07
have O 0 4.4551601297015964e-10
analyzed O 0 1.9453282040782227e-10
additional O 0 2.826393459554044e-11
cDNA O 0 5.945405501250889e-09
clones O 0 6.720287659689461e-10
and O 0 1.6926837535791162e-12
provide O 0 3.462213426109334e-13
evidence O 0 2.3554257502778064e-12
for O 0 3.0005295123536335e-12
an O 0 3.992397384910973e-11
additional O 0 4.69810801373427e-10
0 O 0 1.380514760285223e-07
. O 0 2.2903586582856406e-08

5 O 0 3.5060063510172768e-06
kb O 0 3.011997932844679e-06
of O 0 1.0274820283484587e-07
5 O 0 4.025897055726091e-07
- O 0 9.001532674801638e-08
UTR O 0 7.082302545313723e-06
and O 0 1.0970861719084013e-10
> O 0 2.1909471570324968e-08
2 O 0 3.357218147925778e-08
kb O 0 8.516322935747667e-08
of O 0 6.430318499894838e-09
3 O 0 3.862278106225858e-07
- O 0 5.965923719486455e-07
UTR O 0 8.428537694271654e-05
. O 0 2.245082519891639e-08

We O 0 5.0056736533576895e-09
have O 0 3.7617920931043436e-12
established O 0 3.5018177593770794e-12
the O 0 2.451461126110055e-12
genomic O 0 1.3679570497193705e-11
organization O 0 1.3371324880662172e-11
of O 0 1.3927209385755646e-10
UBE3A O 0 4.5686169869441073e-07
and O 0 1.7924816145264977e-11
the O 0 1.0203814182485615e-10
sequence O 0 8.323426670120426e-11
of O 0 4.030894507067728e-10
intron O 0 8.14543383853561e-08
- O 0 3.16603802730242e-07
exon O 0 1.2259130244274274e-07
borders O 0 3.6692927807280284e-08
. O 0 5.769867073013302e-08

We O 0 1.3361348010221263e-06
have O 0 1.1331475757714315e-09
also O 0 1.7385470840736161e-10
mapped O 0 5.501202604563105e-09
two O 0 2.545746669024851e-10
highly O 0 2.4637825113416056e-10
homologous O 0 2.829939060866593e-10
processed O 0 2.157673817393402e-09
pseudogenes O 0 1.7504264704371053e-09
, O 0 5.2913982223623535e-11
UBE3AP1 O 0 5.735584181820741e-06
and O 0 1.9695369779526573e-09
UBE3AP2 O 0 6.692636088700965e-05
, O 0 2.0572406278507316e-10
to O 0 1.800027793485981e-09
chromosomes O 0 8.364299253216245e-10
2 O 0 1.762345824829481e-09
and O 0 6.221482530543998e-12
21 O 0 1.5440743128536383e-09
, O 0 4.631206876326566e-12
respectively O 0 9.942322659606262e-11
, O 0 5.271490275543522e-12
and O 0 4.689454553841177e-12
determined O 0 5.949758463685839e-10
their O 0 7.766603332681754e-12
genomic O 0 4.568159184259457e-10
organization O 0 3.339218623832352e-10
. O 0 1.8185454253583089e-09

These O 0 2.7446764305771865e-10
results O 0 8.016417391010222e-11
will O 0 3.768815988458574e-12
form O 0 1.0650688230667837e-12
the O 0 6.3372245819037776e-12
basis O 0 8.309494585467814e-12
for O 0 1.6010295574107186e-13
studies O 0 3.7352451860706015e-12
of O 0 5.851457773181634e-12
mutation O 0 8.836069896600574e-12
and O 0 1.6232376554015104e-11
imprinting O 0 1.1664857169080278e-07
of O 0 1.6352795739749126e-07
UBE3A O 0 0.00035639017005451024
. O 0 8.142669116750767e-08

Mutation O 0 8.531442574621906e-08
spectrum O 0 7.537937563029118e-08
and O 0 3.4840064166985485e-10
genotype O 0 1.2962355810941517e-07
- O 0 3.5564141853683395e-08
phenotype O 0 1.5264753905341877e-09
analyses O 0 6.777244043743025e-11
in O 0 4.033582062107355e-12
Cowden B-Disease 0 0.00012122473708586767
disease I-Disease 0 9.727539662662821e-08
and O 0 4.427003763574078e-10
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.0284947882819324e-09
two O 0 6.230184812494599e-09
hamartoma B-Disease 1 0.9998683929443359
syndromes I-Disease 0 0.011968454346060753
with O 0 1.9832771158689866e-07
germline O 1 0.9998712539672852
PTEN O 1 0.9999170303344727
mutation O 0 6.350553303491324e-05
. O 0 6.951269142518868e-07

The O 0 9.883203347271774e-06
tumour B-Disease 1 1.0
suppressor O 0 0.0014728022506460547
gene O 0 5.058845999883488e-07
PTEN O 0 8.854719635564834e-05
, O 0 2.1491255997041492e-10
which O 0 1.3425143809142615e-11
maps O 0 1.0152471086044557e-09
to O 0 3.862955466615858e-08
10q23 O 0 0.00029519229428842664
. O 0 1.4911657331140304e-07

3 O 0 1.8833850390365114e-06
and O 0 1.1037506464361968e-09
encodes O 0 2.477429372760298e-10
a O 0 1.1512598652174688e-09
403 O 0 8.176542776183737e-10
amino O 0 1.1110440345518668e-09
acid O 0 3.2315466969023987e-10
dual O 0 4.0280428992289785e-10
specificity O 0 5.973597438924116e-08
phosphatase O 0 3.163045039400458e-05
( O 0 2.752378991388582e-09
protein O 0 6.708739341831915e-09
tyrosine O 0 7.151462089183269e-09
phosphatase O 0 1.3433182566302548e-08
; O 0 1.3033184774469131e-11
PTPase O 0 2.755563599521338e-08
) O 0 1.5269855692390255e-12
, O 0 1.3711431079074798e-12
was O 0 2.1949435324852828e-10
shown O 0 4.8289835671844195e-12
recently O 0 2.974189644566749e-11
to O 0 1.5282712595432457e-11
play O 0 4.227915760546264e-12
a O 0 7.912915982177804e-12
broad O 0 6.24433837970173e-10
role O 0 1.159558699059815e-10
in O 0 3.3748431133018286e-11
human O 0 4.726620428385786e-09
malignancy B-Disease 0 4.519088543020189e-05
. O 0 1.448445186014169e-08

Somatic O 0 0.0002198468428105116
PTEN O 0 0.00030777123174630105
deletions O 0 2.7715830697161437e-07
and O 0 5.201186592529439e-09
mutations O 0 2.1346646672526504e-09
were O 0 4.548611834409577e-11
observed O 0 1.7084483133755768e-11
in O 0 1.9459754987960487e-12
sporadic B-Disease 0 5.421549786888136e-08
breast I-Disease 1 0.7972599864006042
, I-Disease 0 9.141751888819272e-08
brain I-Disease 1 1.0
, I-Disease 0 5.609344498225255e-06
prostate I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.0008569516940042377
lines O 0 5.3104347585986034e-08
and O 0 6.457043233432103e-11
in O 0 1.048307014112071e-11
several O 0 1.7915450373218178e-11
primary O 0 7.699375714764756e-08
tumours B-Disease 1 1.0
such O 0 2.8472482704877677e-10
as O 0 1.4068693587887537e-07
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999997615814209
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9982022047042847

In O 0 3.4599563214499085e-09
addition O 0 8.025722864068996e-10
, O 0 2.490715855785197e-09
PTEN O 1 0.777481734752655
was O 0 1.0686078866228854e-07
identified O 0 2.5073401688224806e-10
as O 0 2.3049869304903048e-12
the O 0 1.5397084648927084e-11
susceptibility O 0 1.313521735823997e-09
gene O 0 1.221054420769141e-11
for O 0 2.3337649521226744e-11
two O 0 1.2825900341795204e-09
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
( O 0 2.843812685338065e-10
CD B-Disease 0 6.052733851902303e-07
; O 0 1.943831762218906e-08
MIM O 0 9.877072443487123e-05
158350 O 0 4.6393321895266126e-07
) O 0 1.1317251823184105e-11
and O 0 1.3391010522667557e-10
Bannayan B-Disease 0 0.0002550475182943046
- I-Disease 0 0.0016509771812707186
Zonana I-Disease 0 0.00019576222985051572
( I-Disease 0 1.0459373367410763e-09
BZS I-Disease 0 6.343195764202392e-06
) I-Disease 0 2.1249362946312855e-12
or I-Disease 0 1.4605497367092823e-11
Ruvalcaba I-Disease 0 3.17473300981419e-08
- I-Disease 0 8.691131370142102e-09
Riley I-Disease 0 4.475142478810312e-09
- I-Disease 0 1.5914635014269152e-06
Smith I-Disease 0 1.1311764183119521e-06
syndrome I-Disease 1 0.9999997615814209
( O 0 1.7479649727647484e-08
MIM O 0 0.0013523863162845373
153480 O 0 8.695446922502015e-06
) O 0 4.4013079292248847e-10
. O 0 1.0027233265930136e-08

Constitutive O 0 2.524831188566168e-07
DNA O 0 1.5680047482646842e-08
from O 0 5.845975370455392e-10
37 O 0 2.2261190668615427e-09
CD B-Disease 0 1.2944704197437318e-09
families O 0 1.9478965315733454e-11
and O 0 4.543392051470363e-11
seven O 0 1.8257256817477696e-09
BZS B-Disease 0 4.5803840293956455e-06
families O 0 7.859712880531333e-12
was O 0 3.152247629589766e-10
screened O 0 5.572270422860015e-10
for O 0 5.075700970635921e-10
germline O 0 6.854721141280606e-05
PTEN O 0 0.002098941942676902
mutations O 0 7.561000074929325e-06
. O 0 1.4749812748959812e-07

PTEN O 0 0.0015202021459117532
mutations O 0 9.984867688217491e-08
were O 0 2.0183776872073622e-10
identified O 0 6.859051087521051e-12
in O 0 2.3488665439747036e-12
30 O 0 3.162956008218032e-10
of O 0 1.8029612525172212e-10
37 O 0 2.4877626625396942e-09
( O 0 1.2390088087455009e-11
81 O 0 5.3724966697643595e-09
% O 0 4.826859398288086e-11
) O 0 2.4673812255501804e-13
CD B-Disease 0 2.0146045942581736e-10
families O 0 4.4656201479698066e-12
, O 0 2.4683894251503746e-12
including O 0 4.68856941118756e-12
missense O 0 6.821620246455495e-08
and O 0 1.03208697144197e-09
nonsense O 0 3.632740970260784e-07
point O 0 5.504846853909839e-07
mutations O 0 3.4474120780281226e-10
, O 0 2.1909396172303808e-11
deletions O 0 2.04644790002817e-09
, O 0 1.9516274707420678e-10
insertions O 0 2.7609914354798093e-09
, O 0 1.036630087325463e-10
a O 0 5.252188461923879e-09
deletion O 0 1.770284825397539e-07
/ O 0 2.3041702945647557e-07
insertion O 0 1.0003625305898822e-07
and O 0 8.030841769368635e-09
splice O 0 1.6199729770960403e-06
site O 0 4.505720951897274e-08
mutations O 0 5.1254772870379384e-08
. O 0 2.286430245135307e-08

These O 0 6.192699686380365e-09
mutations O 0 2.3221338185663853e-09
were O 0 2.5936211511812246e-10
scattered O 0 4.028924763255226e-11
over O 0 3.085972883482002e-12
the O 0 5.095581075142963e-12
entire O 0 1.9806632028940285e-11
length O 0 2.9318682898127335e-11
of O 0 6.090129789360077e-11
PTEN O 0 2.940248577942839e-07
, O 0 1.026243651690295e-12
with O 0 1.2877098001730543e-14
the O 0 2.8778969225068396e-12
exception O 0 6.517123646299083e-12
of O 0 4.413882453979667e-11
the O 0 1.170222946322852e-11
first O 0 7.217353104049806e-11
, O 0 1.3564935633092468e-11
fourth O 0 2.3652391156758767e-09
and O 0 8.053013117459429e-11
last O 0 1.6179181727693503e-07
exons O 0 2.3243123905558605e-06
. O 0 9.502836206820575e-08

A O 0 5.804912871099077e-05
hot O 0 2.3384227461065166e-05
spot O 0 1.8672785984108486e-07
for O 0 8.492874736809597e-10
PTEN O 0 1.5557568985968828e-05
mutation O 0 2.5336377440510205e-09
in O 0 1.837406754523485e-10
CD B-Disease 0 1.4433515715950307e-08
was O 0 2.530500076147746e-08
identified O 0 4.0095468611944796e-10
in O 0 5.29796241599545e-11
exon O 0 4.019587329651131e-09
5 O 0 3.119163372033995e-09
that O 0 1.526531288528754e-12
contains O 0 1.6587605854850862e-12
the O 0 7.534319002022727e-11
PTPase O 0 2.5290989924542373e-07
core O 0 3.422700345367957e-09
motif O 0 1.602351064333707e-11
, O 0 1.8903854989617969e-13
with O 0 2.976205436613921e-14
13 O 0 8.11206157802502e-10
of O 0 2.1536762651042096e-10
30 O 0 1.5471519621002017e-09
( O 0 9.73849386548542e-12
43 O 0 1.589888998232425e-09
% O 0 1.4291101288477215e-11
) O 0 6.719534325662357e-13
CD B-Disease 0 9.540567225130303e-10
mutations O 0 1.7547979735965669e-10
identified O 0 1.2717631635295046e-11
in O 0 3.689707827464472e-12
this O 0 1.7718158884516555e-10
exon O 0 7.751138753064879e-08
. O 0 1.3265821330321614e-08

Seven O 0 5.7008954001958045e-08
of O 0 5.31891641841753e-09
30 O 0 1.1322062398733124e-08
( O 0 2.5385983246084542e-11
23 O 0 9.533622780111273e-09
% O 0 1.0725187404858616e-10
) O 0 2.378476105305283e-13
were O 0 1.864824050387681e-12
within O 0 7.807939191029067e-12
the O 0 1.6504833957875498e-11
core O 0 5.486568491197552e-11
motif O 0 2.605309848066617e-12
, O 0 4.370764546731548e-14
the O 0 3.6476797602401356e-13
majority O 0 1.9968964361846003e-13
( O 0 4.61964060755049e-12
five O 0 1.993626513874247e-10
of O 0 1.875433974785068e-10
seven O 0 6.705445226851126e-11
) O 0 7.954980532805245e-13
of O 0 2.21176514603183e-11
which O 0 7.872014672061223e-12
were O 0 2.566251655622409e-10
missense O 0 6.904242866312416e-08
mutations O 0 4.0584295923906666e-09
, O 0 6.40153858741388e-12
possibly O 0 3.2472155520046897e-10
pointing O 0 3.636570489184976e-10
to O 0 1.9338672330171391e-10
the O 0 8.944904539287535e-11
functional O 0 2.024192369276534e-09
significance O 0 2.908254748135164e-10
of O 0 4.0809228218918747e-10
this O 0 1.0469028421944415e-10
region O 0 7.574386273745404e-08
. O 0 4.8899718052553e-08

Germline O 0 0.005174585152417421
PTEN O 0 0.00048684669309295714
mutations O 0 4.350948401565802e-08
were O 0 4.152141477864468e-11
identified O 0 2.2278531016522996e-12
in O 0 1.9031999554889462e-13
four O 0 3.1559366123028176e-13
of O 0 1.3014107153042076e-11
seven O 0 4.892109981002868e-11
( O 0 1.7786003572717313e-11
57 O 0 8.105124749135939e-08
% O 0 4.297009414955255e-09
) O 0 5.122188229123026e-10
BZS B-Disease 0 9.275026968680322e-05
families O 0 6.107418459855296e-10
studied O 0 1.8391441258813757e-08
. O 0 1.7071412727887036e-08

Interestingly O 0 2.942287551377376e-07
, O 0 6.429959342746372e-10
none O 0 1.1097520680181105e-09
of O 0 9.70805213995618e-10
these O 0 1.6875074254629752e-11
mutations O 0 4.1095185587813887e-10
was O 0 1.4102544687588647e-09
observed O 0 1.0279940787505382e-10
in O 0 3.799462047066049e-12
the O 0 5.861852114819044e-10
PTPase O 0 6.942841991985915e-06
core O 0 3.527830187977088e-07
motif O 0 1.0113942039424728e-07
. O 0 1.3171752577534335e-08

It O 0 2.22786372683359e-10
is O 0 4.0268018954014995e-12
also O 0 4.764172997079319e-13
worthy O 0 1.165314372775228e-10
of O 0 3.281670768462419e-11
note O 0 6.310711935658686e-12
that O 0 3.8013735497062495e-13
a O 0 3.204477308504927e-11
single O 0 8.072636309419678e-11
nonsense O 0 1.7589851353250197e-08
point O 0 5.3265438282323885e-08
mutation O 0 2.7891275400371285e-10
, O 0 3.193671022083677e-11
R233X O 0 1.0628953077684855e-06
, O 0 1.558789070044142e-10
was O 0 1.1254327247911533e-08
observed O 0 2.6331384295197324e-10
in O 0 2.1245848830231395e-11
the O 0 2.3185832420669072e-10
germline O 0 1.2201924803889597e-08
DNA O 0 5.188105500764095e-10
from O 0 1.4002530038248473e-11
two O 0 5.275068034292507e-13
unrelated O 0 3.955988314707781e-12
CD B-Disease 0 2.648452124276446e-09
families O 0 3.233610601505177e-11
and O 0 1.2509011881878251e-10
one O 0 8.381279670288677e-09
BZS B-Disease 0 0.010245535522699356
family O 0 6.250466810797661e-09
. O 0 2.479781358033506e-08

Genotype O 0 9.74973431766557e-07
- O 0 1.3393417930274154e-07
phenotype O 0 3.892382416381679e-09
studies O 0 2.79237327704962e-11
were O 0 1.607014651558436e-12
not O 0 1.1029513890745135e-12
performed O 0 1.0965180586436363e-12
on O 0 1.167747929603502e-11
this O 0 3.9284211734297303e-13
small O 0 3.0267810827155905e-12
group O 0 1.4583006677226784e-11
of O 0 3.733449105425279e-09
BZS B-Disease 0 0.20643548667430878
families O 0 6.616052594665689e-09
. O 0 1.354381424789608e-07

However O 0 5.370877964594456e-09
, O 0 1.6457721296880834e-10
genotype O 0 7.736305818184519e-09
- O 0 2.709118263055643e-09
phenotype O 0 7.140241176095685e-10
analysis O 0 2.931202849887349e-11
inthe O 0 2.382345698492827e-08
group O 0 2.5536129200781632e-12
of O 0 1.6468042207673506e-11
CD B-Disease 0 6.008011421698711e-09
families O 0 2.5587722912723265e-11
revealed O 0 8.08261929607923e-11
two O 0 1.4034064708956517e-13
possible O 0 6.31567324479998e-12
associations O 0 8.888312720382874e-13
worthy O 0 6.343301439670768e-10
of O 0 2.0545283252459967e-09
follow O 0 5.575396255785847e-10
- O 0 6.743567371181314e-10
up O 0 4.986457774469599e-11
in O 0 8.794807764000989e-12
independent O 0 1.9592136246693315e-10
analyses O 0 1.1371075192556646e-09
. O 0 7.075684926860504e-09

The O 0 4.792928720576128e-09
first O 0 1.4231402167830254e-10
was O 0 6.09043426802458e-10
an O 0 6.9915462308500764e-12
association O 0 1.4232263804980771e-11
noted O 0 2.5179398496777416e-11
in O 0 6.292634815996401e-12
the O 0 1.0950333001469303e-10
group O 0 1.8631600168933504e-12
of O 0 1.1501613030040492e-11
CD B-Disease 0 5.085435361706914e-08
families O 0 3.119554614627873e-10
with O 0 4.1111984927511e-09
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 8.711549526196904e-06

A O 0 2.0118540078328806e-07
correlation O 0 1.1099219321408782e-08
was O 0 4.199549041850048e-10
observed O 0 9.687139979064341e-12
between O 0 8.066936875439357e-12
the O 0 2.499965859326103e-11
presence O 0 2.8296353107859495e-11
/ O 0 4.4042349145456683e-07
absence O 0 1.3172783752679607e-08
of O 0 1.1940515243225036e-09
a O 0 1.6732530916385713e-09
PTEN O 0 1.4192673916113563e-06
mutation O 0 2.4854751590197566e-10
and O 0 2.71769369161734e-13
the O 0 6.384658969051105e-13
type O 0 7.185061573489193e-11
of O 0 3.664260561642152e-10
breast O 0 8.985688850771112e-07
involvement O 0 9.915224836731795e-07
( O 0 3.731962650022069e-08
unaffected O 0 2.7172187401447445e-05
versus O 0 7.978476787684485e-05
benign O 1 0.9992994070053101
versus O 0 0.0008553470834158361
malignant O 1 0.9998619556427002
) O 0 1.2947962702014593e-09
. O 0 6.949875341888401e-09

Specifically O 0 7.822734127138631e-10
and O 0 2.5770991243789787e-12
more O 0 3.139329074475228e-14
directly O 0 3.589965130723627e-12
, O 0 6.017013059675391e-13
an O 0 3.323127580404095e-12
association O 0 1.140924021925116e-10
was O 0 1.841299201998936e-08
also O 0 1.7061753052050044e-11
observed O 0 1.6570538344251595e-11
between O 0 1.7554532480423823e-11
the O 0 2.5795051858401585e-11
presence O 0 2.523664870829334e-12
of O 0 5.966961647008162e-11
a O 0 1.2930292392354659e-09
PTEN O 0 0.023332010954618454
mutation O 0 7.746275514364243e-06
and O 0 3.4306046359233733e-07
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.0860809197765775e-05

Secondly O 0 5.4128751798998564e-05
, O 0 9.58149382057627e-09
there O 0 2.910974239433983e-10
appeared O 0 2.352814887363053e-10
to O 0 2.126619887132808e-11
be O 0 6.857377079366733e-12
an O 0 1.4501570083647053e-11
interdependent O 0 2.660680920030245e-08
association O 0 5.006024483833471e-10
between O 0 2.261029067085474e-06
mutations O 0 1.2111771866329946e-05
upstream O 0 5.29610645116918e-07
and O 0 2.1582149262178163e-11
within O 0 2.640445917467815e-10
the O 0 3.085640076783136e-10
PTPase O 0 5.626412189485563e-07
core O 0 8.8132257047846e-09
motif O 0 5.139108583129826e-10
, O 0 1.9448661431331615e-12
the O 0 4.806654206601646e-12
core O 0 3.247963703545409e-11
motif O 0 6.534658339614474e-13
containing O 0 3.457992737166131e-15
the O 0 1.1137362462398243e-13
majority O 0 9.07757687919862e-14
of O 0 8.048682553774e-11
missense O 0 2.3845915464448808e-08
mutations O 0 1.2193706044882902e-09
, O 0 7.271233311637038e-13
and O 0 8.725974180419718e-14
the O 0 1.9804355638058935e-12
involvement O 0 7.513051986096642e-11
of O 0 1.918100539510803e-10
all O 0 4.6932219395501296e-12
major O 0 2.2064404470167887e-10
organ O 0 6.268759733529805e-08
systems O 0 2.1219977952569025e-06
( O 0 2.798637055434483e-08
central O 1 0.9999884366989136
nervous O 0 1.9759172573685646e-05
system O 0 2.0475677047215868e-06
, O 0 3.115740199177708e-08
thyroid O 1 1.0
, O 0 4.4092027451370086e-07
breast O 1 0.9999994039535522
, O 0 3.47383593179984e-06
skin O 1 1.0
and O 0 0.0003482959873508662
gastrointestinal O 1 1.0
tract O 1 0.9999963045120239
) O 0 2.8783043148905563e-07
. O 0 1.0896037565544248e-06

However O 0 1.3647553487317055e-07
, O 0 1.090772916434446e-09
these O 0 4.8862441870412e-11
observations O 0 8.518203031826488e-09
would O 0 6.301384969376045e-10
need O 0 1.6439147265678855e-10
to O 0 2.113882263676814e-10
be O 0 2.488206342354804e-11
confirmed O 0 1.2251952924424714e-11
by O 0 2.5129572901738673e-13
studying O 0 1.3704477006340476e-12
a O 0 2.8918111395076496e-13
larger O 0 7.353240737660582e-13
number O 0 1.4600978846118773e-12
of O 0 3.4282375549476996e-11
CD B-Disease 0 3.688927563416655e-08
families O 0 1.947928263135168e-09
. O 0 3.293363803891225e-08

Molecular O 0 0.00067293387837708
defects O 1 0.9969815611839294
leading O 0 1.756815848352744e-08
to O 0 4.2105854913820906e-10
human O 0 6.950730269128513e-11
complement B-Disease 0 2.839857460301687e-09
component I-Disease 0 0.4682942032814026
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.803625165885947e-10
an O 0 6.838594360930594e-12
African O 0 5.893685713076469e-12
- O 0 6.671752733611314e-11
American O 0 8.006007315430885e-12
family O 0 2.4572907944553357e-11
. O 0 1.217404621556284e-09

Complement B-Disease 0 6.066139945914983e-08
component I-Disease 0 3.4630684240255505e-05
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.5027830368996575e-10
C6D B-Disease 0 1.3400319403444882e-05
) O 0 6.5955804186279554e-12
was O 0 3.6733525110577148e-09
diagnosed O 0 7.160852799614759e-09
in O 0 2.8671529126583772e-12
a O 0 2.6062704078233523e-11
16 O 0 1.645627661917004e-10
- O 0 1.4524073783939162e-11
year O 0 1.820247425010635e-11
- O 0 1.4661606650978598e-10
old O 0 1.7261628237896787e-10
African O 0 1.4795366537825871e-12
- O 0 1.3106518908373443e-12
American O 0 2.0573474835642452e-13
male O 0 1.0625075580646126e-13
with O 0 6.437628614864785e-14
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.7961297089641448e-06

The O 0 3.956207095257014e-08
patients O 0 2.2038588731732034e-09
father O 0 3.950158422583172e-09
and O 0 6.508803912508299e-11
two O 0 8.790602967767569e-11
brothers O 0 7.779546251640568e-08
also O 0 2.0670895550800594e-10
had O 0 9.776362830393737e-09
C6D B-Disease 0 0.10390999168157578
, O 0 1.687887329904214e-11
but O 0 1.7545284886413826e-12
gave O 0 8.16602948455758e-12
no O 0 7.145410998998791e-12
history O 0 1.0106304682011569e-11
of O 0 1.0640302527953338e-10
meningitis B-Disease 1 1.0
or O 0 1.4802303827110563e-09
other O 0 2.1372341396652672e-10
neisserial B-Disease 0 3.9381739043165e-05
infection I-Disease 0 7.80418031354202e-06
. O 0 1.062413517161076e-07

By O 0 6.172766742196245e-10
using O 0 5.046009166065346e-10
exon O 0 2.5674671277897687e-09
- O 0 5.645465761539015e-10
specific O 0 4.071629491897433e-11
polymerase O 0 1.0930513161255817e-09
chain O 0 2.16166848310273e-10
reaction O 0 1.5382936244257017e-11
( O 0 9.123005085751035e-13
PCR O 0 2.6120331592105472e-11
) O 0 9.42677576623585e-13
/ O 0 4.051534108207022e-11
single O 0 8.312681272493183e-12
- O 0 5.30431185086222e-11
strand O 0 5.6718411217682174e-11
conformation O 0 7.105400035706255e-12
polymorphism O 0 3.376605202040639e-12
as O 0 1.2995911313241904e-13
a O 0 8.333551947473095e-13
screening O 0 3.98306257767822e-12
step O 0 5.0179714550235843e-11
and O 0 2.0644200324909656e-12
nucleotide O 0 2.8741793667297344e-11
sequencing O 0 1.2130249929520609e-11
of O 0 7.882806907222317e-11
target O 0 2.8594513423740864e-09
exons O 0 4.8622261772379716e-09
, O 0 2.0469377928766797e-11
we O 0 1.3576117660618614e-11
determined O 0 1.1341416000787419e-10
that O 0 1.0965871223220236e-12
the O 0 2.0333146624751386e-11
proband O 0 1.849998021441479e-08
was O 0 4.2504952335598034e-10
a O 0 2.825994646626917e-11
compound O 0 2.0781981691087026e-10
heterozygote O 0 1.2745078603604298e-10
for O 0 1.9823261088181e-11
two O 0 2.1896540136623344e-10
C6 O 0 3.1839510484132916e-05
gene O 0 8.406226470469846e-08
mutations O 0 2.988234086842567e-07
. O 0 4.162122024808923e-08

The O 0 2.2046380721008063e-08
first O 0 1.0873496547603168e-09
, O 0 1.8115779709670932e-11
1195delC O 0 9.32568156031266e-09
located O 0 1.8635210041750838e-10
in O 0 1.5129612840336648e-10
exon O 0 5.786704448951241e-09
7 O 0 6.828285137316925e-08
, O 0 3.664285021243163e-12
is O 0 3.9124861119996246e-13
a O 0 4.702926416355613e-12
novel O 0 4.012191967550649e-11
mutation O 0 9.115339559551128e-12
, O 0 2.153960603629157e-13
while O 0 6.497212707082256e-13
the O 0 1.5913648870879982e-11
second O 0 3.138797000090676e-10
, O 0 1.058798448222431e-11
1936delG O 0 4.027061795142117e-09
in O 0 1.178224073861145e-09
exon O 0 9.426021740921442e-09
12 O 0 3.9217976421923595e-08
, O 0 3.08780535862585e-11
has O 0 1.4540482533298427e-11
been O 0 8.167571653727723e-12
described O 0 1.1652605963474727e-11
before O 0 2.942995153132344e-11
to O 0 1.3328173287252554e-10
cause O 0 1.628009016485521e-08
C6D B-Disease 0 0.00012411300849635154
in O 0 9.667081718456316e-11
an O 0 1.4866547229375193e-11
unrelated O 0 3.296175832279147e-10
African O 0 1.29000851667449e-10
- O 0 2.653031405674966e-10
American O 0 7.044813343792811e-11
individual O 0 8.872210258137336e-12
. O 0 9.639381737258645e-09

Both O 0 1.7769279381241176e-08
mutations O 0 1.4132440995240358e-08
result O 0 1.7119434758683383e-09
in O 0 7.294608805885616e-10
premature O 0 3.74952946913254e-07
termination O 0 5.318337571225129e-06
codons O 0 7.960910011206579e-07
and O 0 1.0586365561948696e-08
C6 O 0 8.33966532809427e-06
null O 0 5.902431894355686e-06
alleles O 0 1.2347689093417102e-08
. O 0 4.378100992852296e-09

Allele O 0 6.558220633223755e-09
- O 0 3.200179010676152e-10
specific O 0 1.0876722265906746e-11
PCR O 0 5.006490014225484e-11
indicated O 0 1.2723163668459936e-11
that O 0 4.217827327093922e-14
the O 0 2.6428770196623708e-12
probands O 0 2.2109249542268117e-08
two O 0 4.466065364749916e-11
brothers O 0 3.7198371050095602e-09
also O 0 4.7460743668459315e-11
inherited O 0 6.515965100817311e-09
the O 0 5.467279518001078e-09
1195delC O 0 1.4021846794776138e-08
mutation O 0 2.766778472995668e-10
from O 0 8.611455992735273e-11
their O 0 1.218876475445052e-11
heterozygous O 0 1.644698092995167e-11
mother O 0 6.476454355447414e-12
and O 0 1.2943054831029976e-12
the O 0 4.443294343570159e-11
1936delG O 0 7.712023242234523e-10
mutation O 0 7.063178514288282e-11
from O 0 2.3361265699683997e-10
their O 0 1.5522352847519016e-10
homozygous O 0 1.2042149222235565e-10
father O 0 1.4796575076303498e-09
. O 0 2.1674236017066306e-10
. O 0 1.8629140452475212e-09

PAX6 O 0 0.0024605081416666508
mutations O 0 1.45827448250202e-06
reviewed O 0 3.731834965492453e-07
. O 0 6.973925792408409e-08

Mutations O 0 2.1368292379975173e-07
in O 0 1.8526523648532134e-09
PAX6 O 0 5.266689640848199e-06
are O 0 1.9946145429772244e-11
responsible O 0 2.6116606099968465e-10
for O 0 6.57692927896747e-11
human O 0 2.3608007992947933e-08
aniridia B-Disease 1 1.0
and O 0 1.0940055261698944e-07
have O 0 5.597228236453589e-10
also O 0 8.492347450261839e-12
been O 0 4.537016162070584e-12
found O 0 4.101647949235343e-14
in O 0 1.9667166522739296e-14
patients O 0 1.4347259206961942e-14
with O 0 1.1266949694185499e-13
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 7.933120116376813e-08
with O 0 3.179442501277663e-05
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 4.787810667039594e-06
with O 0 5.958619819779187e-09
autosomal B-Disease 1 0.9841296672821045
dominant I-Disease 1 0.9820603132247925
keratitis I-Disease 1 0.9999982118606567
, O 0 9.437908232712289e-10
and O 0 9.452569282863976e-11
with O 0 4.5684031557691185e-10
isolated B-Disease 1 0.9999983310699463
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9997010231018066

No O 0 2.03848635749182e-08
locus O 0 2.340516225274314e-09
other O 0 8.972851216378086e-13
than O 0 8.167977579021102e-12
chromosome O 0 2.6562628363535623e-07
11p13 O 0 1.546199018775951e-05
has O 0 9.778888809819364e-11
been O 0 4.1079178253466964e-11
implicated O 0 2.962505518677716e-10
in O 0 1.7578398459061617e-10
aniridia B-Disease 1 1.0
, O 0 1.6021814985833771e-09
and O 0 7.458286210848541e-10
PAX6 O 0 8.201288437703624e-05
is O 0 2.457821723922393e-10
clearly O 0 2.3158960860136801e-10
the O 0 2.063835352617005e-10
major O 0 1.2035082930239582e-09
, O 0 1.1192273670357356e-11
if O 0 3.457313949017937e-11
not O 0 3.514197613463388e-11
only O 0 7.04360389458536e-11
, O 0 3.6015645327180934e-11
gene O 0 3.004111681637056e-10
responsible O 0 1.6206973540988656e-08
. O 0 3.937102022177896e-08

Twenty O 0 3.0880991630510835e-07
- O 0 2.8368377869014694e-08
eight O 0 6.869951829635568e-10
percent O 0 9.095133535197419e-10
of O 0 1.4809441173380122e-10
identified O 0 1.6126022739371138e-09
PAX6 O 0 1.2304545862207306e-06
mutations O 0 6.243198402700045e-09
are O 0 1.1404344829601953e-10
C O 0 1.2055168554070406e-05
- O 0 1.245783732883865e-05
T O 0 3.58681802481442e-07
changes O 0 5.849778439426245e-10
at O 0 2.2862982618221395e-09
CpG O 0 3.758843014622926e-09
dinucleotides O 0 1.7301069021868898e-08
, O 0 4.2499823105224266e-11
20 O 0 1.323743115122511e-09
% O 0 1.1014640588502544e-10
are O 0 1.8597445632095866e-12
splicing O 0 5.741745412457533e-10
errors O 0 5.890514298556582e-09
, O 0 3.37627061725021e-12
and O 0 8.531714289043701e-13
more O 0 1.1511345804522677e-13
than O 0 3.128310110955823e-12
30 O 0 5.639933520207308e-10
% O 0 3.8834126886433395e-11
are O 0 6.979271761214934e-13
deletion O 0 3.397559733553379e-10
or O 0 8.145981805762759e-11
insertion O 0 2.4042328128359713e-09
events O 0 1.646035807656432e-10
. O 0 2.9775815146848572e-09

There O 0 1.8336510088090563e-09
is O 0 1.0712102732624018e-10
a O 0 8.889394775835058e-10
noticeably O 0 2.7412735192910986e-08
elevated O 0 4.5087642064345346e-08
level O 0 1.4808835935298248e-08
of O 0 2.121064435200992e-09
mutation O 0 6.10155037605864e-10
in O 0 5.506782183029024e-11
the O 0 1.427010870580503e-10
paired O 0 2.193619765000765e-11
domain O 0 1.9351291402625037e-10
compared O 0 8.216509070346767e-12
with O 0 4.480135812573276e-14
the O 0 2.6479847828331238e-11
rest O 0 1.9615206681145025e-10
of O 0 1.4940176873423638e-10
the O 0 5.728422181050519e-10
gene O 0 8.290316766412786e-10
. O 0 3.068504117464954e-09

Increased O 0 4.323731062072511e-08
mutation O 0 1.4940754189396444e-09
in O 0 5.5887020705691626e-11
the O 0 2.8541100038914635e-10
homeodomain O 0 4.110118467792745e-08
is O 0 3.1619411949845855e-11
accounted O 0 2.9093684059122715e-11
for O 0 7.220071437420705e-13
by O 0 2.8585050992901984e-11
the O 0 7.664485934810727e-09
hypermutable O 0 2.8823912998632295e-06
CpG O 0 5.954390189799597e-07
dinucleotide O 0 1.3982352697894385e-07
in O 0 1.996976584095478e-09
codon O 0 1.0294672136978988e-07
240 O 0 2.5361147848457222e-08
. O 0 3.5319143165679634e-09

Very O 0 1.3172732238331264e-08
nearly O 0 6.231491767039188e-09
all O 0 8.379369420552507e-11
mutations O 0 1.6207883646313093e-10
appear O 0 1.3058372438923271e-10
to O 0 5.713930439910087e-10
cause O 0 2.3299618590044702e-07
loss O 0 1.055040783626282e-07
of O 0 5.694178994986032e-08
function O 0 6.939752106305264e-10
of O 0 1.086391976379275e-09
the O 0 1.5633327965502986e-10
mutant O 0 6.25728358016886e-11
allele O 0 1.8733675721804843e-10
, O 0 8.65193116802998e-13
and O 0 9.324288438800413e-14
more O 0 6.263733428419835e-14
than O 0 2.723849574712278e-12
80 O 0 1.2174296293299136e-10
% O 0 4.738440195772853e-11
of O 0 1.4669269965406073e-10
exonic O 0 1.3385080421812745e-07
substitutions O 0 5.110692424814545e-10
result O 0 1.646318359416199e-10
in O 0 3.7149427978278027e-10
nonsense O 0 1.3216099148394278e-07
codons O 0 3.056105981613655e-07
. O 0 9.233257713958665e-09

In O 0 1.1103327146599895e-08
a O 0 4.0729619676938e-09
gene O 0 1.756035941657963e-11
with O 0 4.0430693190075806e-13
such O 0 2.2755805920149363e-11
extraordinarily O 0 5.3669072741513446e-08
high O 0 1.07141616467743e-07
sequence O 0 1.990018372310942e-09
conservation O 0 4.362810668290251e-10
throughout O 0 8.69750278742476e-12
evolution O 0 9.95526508451583e-11
, O 0 5.260662131606475e-12
there O 0 2.4221626440668054e-11
are O 0 1.0046979220801333e-10
presumed O 0 4.473609351407504e-06
undiscovered O 0 1.8544953491073102e-05
missense O 0 8.095327075352543e-07
mutations O 0 8.760270020502503e-08
, O 0 7.282232455940729e-11
these O 0 5.64733416280605e-12
are O 0 8.182478132556792e-12
hypothesized O 0 4.376531581584686e-09
to O 0 1.076150391021713e-09
exist O 0 4.3731918086820087e-10
in O 0 7.490501274798333e-11
as O 0 7.64949353859734e-11
- O 0 3.3865303894486942e-09
yet O 0 3.149255023426889e-10
unidentified O 0 1.3439120927216663e-09
phenotypes O 0 2.372896878988229e-10
. O 0 5.3733316407456044e-11
. O 0 1.960691164981654e-09

Genetic O 0 3.653573230621987e-07
heterogeneity O 0 9.317648164142156e-08
and O 0 1.7885484759894155e-10
penetrance O 0 2.1834630103967356e-08
analysis O 0 3.089089400942768e-11
of O 0 6.139502239932426e-10
the O 0 4.964765820680839e-10
BRCA1 O 0 5.520637724742983e-09
and O 0 8.455247058059001e-10
BRCA2 O 0 5.78061793987672e-08
genes O 0 2.333540249921384e-09
in O 0 1.0173581976857804e-09
breast B-Disease 0 0.09783060103654861
cancer I-Disease 1 0.9999812841415405
families O 0 3.299664683709125e-07
. O 0 2.425582124487846e-06

The O 0 5.5237251217477024e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 4.5310673158383e-05
Consortium O 0 1.4730568409504485e-07
. O 0 2.8103196214601667e-08

The O 0 2.0265604749880595e-09
contribution O 0 2.2800317189819452e-09
of O 0 2.7232720523073795e-09
BRCA1 O 0 9.26600041140091e-09
and O 0 4.009409193539426e-10
BRCA2 O 0 3.5185902902412636e-07
to O 0 1.8043301679426804e-05
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.00261112698353827
assessed O 0 3.231932055314246e-08
by O 0 8.645820170904983e-11
linkage O 0 1.6758849863407477e-09
and O 0 1.2877388391729916e-11
mutation O 0 4.757146933320744e-12
analysis O 0 1.1096572879315536e-12
in O 0 6.338961473784099e-13
237 O 0 1.4534965245283082e-11
families O 0 2.1375082422375041e-13
, O 0 2.6342849342858576e-13
each O 0 1.8300275574437141e-13
with O 0 7.05577564148567e-14
at O 0 9.316533655656656e-11
least O 0 6.5379776245655385e-12
four O 0 1.1446981600451989e-12
cases O 0 4.396571648412895e-12
of O 0 9.47987244259707e-10
breast B-Disease 0 4.055409590364434e-06
cancer I-Disease 0 7.2316794330618e-07
, O 0 3.350023383696943e-11
collected O 0 8.303126415587503e-12
by O 0 1.0199723010639872e-11
the O 0 1.271382359391282e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 2.4035657588683534e-06
Consortium O 0 5.12768743021752e-08
. O 0 3.0114350124677e-08

Families O 0 2.8922952921561773e-10
were O 0 2.2385883077791213e-11
included O 0 1.2300298583498015e-12
without O 0 4.1851380000457183e-11
regard O 0 2.719694192077071e-10
to O 0 1.6043701089873963e-10
the O 0 1.5223981797429786e-10
occurrence O 0 3.484501576167531e-08
of O 0 2.5845133677648846e-06
ovarian B-Disease 1 1.0
or I-Disease 1 0.9757307767868042
other I-Disease 0 1.5267856724676676e-05
cancers I-Disease 1 1.0
. O 0 5.7682223996380344e-05

Overall O 0 1.4062969967199024e-05
, O 0 1.404365264079388e-07
disease O 0 0.005608023144304752
was O 0 1.8537815549279912e-07
linked O 0 2.808026344780501e-08
to O 0 3.8017603287698876e-08
BRCA1 O 0 2.60903321169792e-09
in O 0 2.657375361425629e-11
an O 0 1.7518767469679175e-12
estimated O 0 2.1330669869312757e-11
52 O 0 1.2004976179813553e-10
% O 0 1.829998132196753e-11
of O 0 2.4286853778088258e-11
families O 0 6.5664843354462654e-12
, O 0 1.4958275937337895e-11
to O 0 2.1753516765699032e-09
BRCA2 O 0 2.1152990470341138e-09
in O 0 6.170751409850794e-11
32 O 0 6.121611551002104e-10
% O 0 2.251107807105246e-11
of O 0 6.83669050191571e-12
families O 0 9.141190408790134e-13
, O 0 1.2699736011076435e-12
and O 0 2.6037598726408318e-12
to O 0 1.6667957292160196e-10
neither O 0 1.4421421001831192e-10
gene O 0 2.4317249602834323e-12
in O 0 8.619964984857287e-12
16 O 0 5.033685690492007e-10
% O 0 3.318644664629389e-11
( O 0 2.099142908107421e-12
95 O 0 3.2986366971243797e-09
% O 0 1.0059717503452248e-09
confidence O 0 2.7385336220930867e-09
interval O 0 4.888693894145035e-08
[ O 0 1.714411546061001e-08
CI O 0 1.3206011999500333e-06
] O 0 5.041276285311369e-10
6 O 0 6.991086598517882e-10
% O 0 1.533720372925984e-11
- O 0 7.326018958142555e-11
28 O 0 6.054713952430291e-10
% O 0 1.913108560458454e-11
) O 0 3.0065834262342495e-13
, O 0 2.113799586755949e-12
suggesting O 0 1.743421795818989e-10
other O 0 5.188884738549504e-11
predisposition O 0 6.400631718861405e-06
genes O 0 6.112854578077531e-08
. O 0 1.8646641564146194e-08

The O 0 2.4537569753846356e-09
majority O 0 3.046015870089569e-11
( O 0 1.0717043572028295e-11
81 O 0 2.271485000093776e-09
% O 0 3.763013858848474e-11
) O 0 2.6571697316415954e-13
of O 0 4.3660717402582705e-11
the O 0 1.9708981113808477e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.935509790802371e-08
were O 0 5.46614031815551e-10
due O 0 1.0370463598974311e-08
to O 0 2.4568200807095764e-09
BRCA1 O 0 1.0304918030001886e-09
, O 0 1.208880868672213e-12
with O 0 3.449674153646089e-14
most O 0 2.7001020776878937e-12
others O 0 4.238428184810683e-12
( O 0 1.1123914289701275e-11
14 O 0 9.621949459415191e-09
% O 0 2.1887396062236775e-10
) O 0 8.792694003445511e-12
due O 0 2.734901904943854e-08
to O 0 1.8199382623151905e-07
BRCA2 O 0 3.23518770528608e-06
. O 0 9.914272425248782e-08

Conversely O 0 1.7572523347553215e-07
, O 0 3.690955874269264e-11
the O 0 2.3329461626420134e-11
majority O 0 2.8652724724104184e-12
of O 0 2.4292413566828763e-11
families O 0 2.426994152524009e-12
with O 0 1.320412420895145e-12
male B-Disease 0 8.894041059193114e-10
and I-Disease 0 1.935712284906188e-10
female I-Disease 0 4.134238285047331e-09
breast I-Disease 0 4.498097041505389e-06
cancer I-Disease 0 0.0004759602015838027
were O 0 3.154319827558538e-08
due O 0 5.512303687282838e-06
to O 0 4.994280402570439e-07
BRCA2 O 0 6.04745977739185e-08
( O 0 2.7462213059159524e-10
76 O 0 1.3824832478803728e-07
% O 0 1.000762472891381e-09
) O 0 8.093820058618917e-11
. O 0 2.622704275978549e-09

The O 0 1.771648783233104e-08
largest O 0 5.579633199914724e-09
proportion O 0 1.524222692506072e-10
( O 0 8.530952853857965e-12
67 O 0 7.489651565606437e-09
% O 0 8.903881798527635e-11
) O 0 5.399730142185977e-13
of O 0 4.669624409370243e-11
families O 0 1.261615985292952e-11
due O 0 1.5581843371137438e-08
to O 0 4.71630023923808e-09
other O 0 3.833662901020496e-11
genes O 0 1.642071374707843e-11
was O 0 1.9057228017871353e-11
found O 0 1.2408610854867767e-14
in O 0 1.3526470728545369e-14
families O 0 8.022366781025147e-15
with O 0 3.05218031092778e-15
four O 0 9.571720586271093e-13
or O 0 1.2010580030530349e-11
five O 0 3.592191214624174e-12
cases O 0 2.397730885367322e-12
of O 0 7.804626944718507e-10
female O 0 3.2535845129189056e-09
breast B-Disease 0 2.3357659301836975e-05
cancer I-Disease 0 0.09868694096803665
only O 0 1.0446487976878416e-06
. O 0 1.855848836385121e-06

These O 0 4.7022874483104715e-09
estimates O 0 2.0286808677383306e-08
were O 0 8.061404321857424e-11
not O 0 4.67536391546286e-11
substantially O 0 4.296007438675531e-10
affected O 0 3.273531445913136e-11
either O 0 9.830423801371335e-12
by O 0 7.616848124447628e-12
changing O 0 3.4038838414574e-10
the O 0 1.238036201334225e-10
assumed O 0 8.997457223713923e-10
penetrance O 0 1.5339930714564076e-10
model O 0 3.986528555183222e-12
for O 0 1.1750427887646797e-11
BRCA1 O 0 4.4490461315049856e-10
or O 0 1.6729579527252625e-11
by O 0 2.047936690022234e-12
including O 0 2.0718557078303057e-12
or O 0 2.076447902510381e-09
excluding O 0 4.143618781426994e-08
BRCA1 O 0 1.245682739181575e-07
mutation O 0 8.01381432324888e-08
data O 0 5.839848160604788e-09
. O 0 1.4593629416026488e-08

Among O 0 1.2568657226097457e-10
those O 0 1.2632677889867772e-11
families O 0 1.6053427684403765e-11
with O 0 1.5357196417320473e-11
disease O 0 4.089614321856061e-06
due O 0 1.4145044588076416e-05
to O 0 4.191581865597982e-06
BRCA1 O 0 6.99269335768804e-08
that O 0 8.528587280842714e-10
were O 0 2.3256953654571255e-11
tested O 0 5.048658431421049e-13
by O 0 1.4618414443355598e-13
one O 0 1.2295959606403728e-12
of O 0 2.386238125498541e-12
the O 0 5.814140943867507e-13
standard O 0 2.256686807908248e-12
screening O 0 2.886049038641758e-12
methods O 0 5.932462854296716e-11
, O 0 2.8895479758928033e-11
mutations O 0 4.01352562295898e-10
were O 0 2.760284500968879e-10
detected O 0 3.481435695285029e-10
in O 0 6.923958368459937e-12
the O 0 2.0444132498020906e-11
coding O 0 1.6322421192427328e-10
sequence O 0 1.9943024662238962e-11
or O 0 3.804378687077836e-12
splice O 0 1.4207887644168693e-10
sites O 0 1.3065460172101417e-12
in O 0 8.84972298350814e-14
an O 0 2.925753714820567e-13
estimated O 0 3.7757390963788495e-11
63 O 0 1.1546068545698063e-09
% O 0 4.829502076031389e-11
( O 0 9.59091400049017e-12
95 O 0 1.764253632074997e-08
% O 0 3.5494187589080184e-09
CI O 0 3.3429344625801605e-07
51 O 0 1.6105397016019651e-09
% O 0 5.015818316245202e-11
- O 0 3.174100149383463e-10
77 O 0 8.188169586809124e-10
% O 0 7.866375606457865e-11
) O 0 1.0523276694485162e-11
. O 0 9.709829607018605e-10

The O 0 4.0174356286115653e-08
estimated O 0 5.6155919914147034e-09
sensitivity O 0 3.447775398512931e-09
was O 0 1.5082540771871322e-09
identical O 0 1.4214032728609993e-11
for O 0 9.985553182934037e-12
direct O 0 4.915570728236673e-10
sequencing O 0 1.6571401195708546e-10
and O 0 2.1426331195395498e-11
other O 0 9.685384438906652e-12
techniques O 0 2.1388257831489454e-09
. O 0 3.478543453283578e-09

The O 0 8.25762498379845e-08
penetrance O 0 2.9781192552036373e-06
of O 0 1.430522758028019e-07
BRCA2 O 0 2.230185742746471e-07
was O 0 7.511196109533103e-09
estimated O 0 3.487541505586833e-11
by O 0 1.6118157156186363e-12
maximizing O 0 2.9583795413401504e-09
the O 0 1.4601306830286376e-09
LOD O 0 3.620302231865935e-05
score O 0 6.087833015477884e-10
in O 0 3.130478515300794e-11
BRCA2 O 0 4.015778820587457e-09
- O 0 7.624156417307404e-09
mutation O 0 2.2857825354716255e-10
families O 0 3.2778658259902116e-12
, O 0 2.015586482440046e-12
over O 0 5.2529144228818936e-11
all O 0 3.0319250582389046e-11
possible O 0 2.8466142776295555e-09
penetrance O 0 3.7970283983668196e-07
functions O 0 4.8078532266515595e-09
. O 0 6.8107617323676095e-09

The O 0 2.538416810082822e-09
estimated O 0 4.2388528798120717e-10
cumulative O 0 1.362037926888604e-09
risk O 0 5.66228086640308e-09
of O 0 2.147386446438304e-08
breast B-Disease 0 0.00029185853782109916
cancer I-Disease 0 2.733142173383385e-05
reached O 0 7.184713467722759e-06
28 O 0 2.1009900308399665e-07
% O 0 1.3628662087761256e-10
( O 0 1.420882075192642e-12
95 O 0 2.686569855470111e-09
% O 0 5.02060670815041e-10
CI O 0 5.16855465093613e-08
9 O 0 1.0934808614138092e-09
% O 0 1.1245899177170227e-11
- O 0 2.6043472933778844e-11
44 O 0 1.7826896209216514e-11
% O 0 3.394082703691431e-13
) O 0 7.017891902337309e-16
by O 0 2.7435614002001285e-14
age O 0 4.063281655586337e-11
50 O 0 1.5603619091253407e-11
years O 0 3.8370409280452655e-12
and O 0 8.986312670551666e-13
84 O 0 3.287737027068971e-10
% O 0 1.009045364624983e-11
( O 0 1.6718756370645571e-12
95 O 0 1.5509989959028303e-09
% O 0 1.7889340009347166e-10
CI O 0 4.884276449956815e-08
43 O 0 2.4878657467475307e-10
% O 0 2.8379037401299323e-12
- O 0 6.492681826203439e-12
95 O 0 3.962454322992137e-11
% O 0 1.598540418958072e-12
) O 0 5.590460650558692e-15
by O 0 1.7206640843051013e-13
age O 0 1.0851100018527404e-09
70 O 0 7.261085066545547e-10
years O 0 1.4936642200868988e-10
. O 0 1.2919174618986062e-09

The O 0 6.464545094786445e-07
corresponding O 1 0.9997497200965881
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9906967878341675
were O 0 9.85341941373008e-08
0 O 0 1.2157141782154213e-07
. O 0 3.899315093036648e-09

4 O 0 1.7508867813376128e-06
% O 0 4.848593970763204e-09
( O 0 5.0652732008771295e-11
95 O 0 2.887651717742301e-08
% O 0 3.1513658349524576e-09
CI O 0 2.0627128094474756e-07
0 O 0 4.933050079536372e-10
% O 0 6.933606033071582e-12
- O 0 1.550411882211833e-11
1 O 0 1.3897569206555715e-10
% O 0 6.405236042082707e-13
) O 0 7.547618366616268e-16
by O 0 9.270286022654804e-15
age O 0 1.5635498104571433e-11
50 O 0 6.707449266146748e-12
years O 0 5.033044293833999e-13
and O 0 1.6039180075234916e-13
27 O 0 3.6012434700971596e-10
% O 0 1.9385895666523822e-11
( O 0 2.1425706261263278e-12
95 O 0 1.298530727389391e-09
% O 0 2.0538375167244993e-10
CI O 0 1.8363154552503147e-08
0 O 0 1.2188329512330398e-10
% O 0 4.251074318950554e-12
- O 0 1.3047984567804427e-11
47 O 0 5.528419388944883e-11
% O 0 9.050334266735849e-13
) O 0 4.636794302058074e-15
by O 0 2.6639901764581586e-13
age O 0 9.022874669639691e-10
70 O 0 1.0222442892171557e-09
years O 0 9.789942190252532e-10
. O 0 2.5761790478640023e-09

The O 0 1.143871042330602e-08
lifetime O 0 1.1942393030039966e-07
risk O 0 5.319121783031733e-07
of O 0 3.7129957490833476e-06
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 6.850488176723957e-08
similar O 0 7.281621139387795e-11
to O 0 8.073014257092836e-09
the O 0 2.9824411829082464e-09
risk O 0 7.513198951869526e-10
in O 0 2.8675589680560165e-11
BRCA1 O 0 1.685186157285301e-10
carriers O 0 1.3660014959449018e-11
, O 0 3.1432987723095662e-12
but O 0 1.986829754538344e-12
there O 0 2.0896513686086138e-12
was O 0 4.996311350757843e-11
some O 0 6.742897933802519e-14
suggestion O 0 6.738562485786304e-11
of O 0 7.483775404937276e-11
a O 0 1.5875367687101516e-10
lower O 0 2.258206954763864e-08
risk O 0 9.307409287728774e-10
in O 0 1.6959235404900852e-10
BRCA2 O 0 1.6248038470223491e-09
carriers O 0 1.7914572603139334e-10
< O 0 8.800546424936329e-08
50 O 0 5.044661910424963e-10
years O 0 2.041401249430752e-11
of O 0 2.1642087427720114e-11
age O 0 4.227809213830369e-09
. O 0 3.008459703579547e-09

Eye B-Disease 1 0.9984721541404724
movement I-Disease 0 2.616266101540532e-06
abnormalities I-Disease 0 3.1202889658743516e-06
correlate O 0 8.708201382212621e-10
with O 0 1.544313396779906e-12
genotype O 0 3.112413793360247e-08
in O 0 9.234079612063795e-10
autosomal O 0 0.010074913501739502
dominant O 1 0.9049293994903564
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 1.4946325563869323e-06

We O 0 3.683899763018417e-08
compared O 0 1.8623502739956166e-08
horizontal O 0 2.214416781498585e-06
eye O 0 7.934478344395757e-05
movements O 0 4.292653699167204e-08
( O 0 5.935272828772042e-10
visually O 0 7.821704950394803e-10
guided O 0 1.3264525033918062e-09
saccades O 0 2.0145033374774357e-07
, O 0 1.0328662924941057e-10
antisaccades O 0 1.3810284826831776e-07
, O 0 4.702283007418373e-11
and O 0 3.377296359241555e-11
smooth O 0 8.73630001674286e-10
pursuit O 0 2.377927188490503e-09
) O 0 3.9323288548998026e-12
in O 0 8.174756878365219e-12
control O 0 3.261716174929319e-10
subjects O 0 8.537860002322262e-11
( O 0 5.9854014106131e-12
n O 0 5.529371405188499e-10
= O 0 4.1603323563954575e-10
14 O 0 1.9691902275464912e-10
) O 0 8.449941728315771e-14
and O 0 6.672735145462835e-14
patients O 0 4.226073362242032e-14
with O 0 2.722639178183179e-16
three O 0 7.366459872648612e-14
forms O 0 1.0870831144982329e-11
of O 0 9.151617796909761e-10
autosomal O 0 3.546694642864168e-05
dominant O 0 0.00016064810915850103
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999914169311523
type I-Disease 1 0.9995200634002686
I I-Disease 1 0.8235252499580383
spinocerebellar B-Disease 0 0.0008397743222303689
ataxias I-Disease 0 4.043269655085169e-05
1 I-Disease 0 3.2073551210487494e-06
and I-Disease 0 5.063507946267976e-10
2 I-Disease 0 8.137856610801464e-08
( O 0 2.454767222825893e-10
SCA1 B-Disease 0 4.315748446970247e-05
, O 0 3.600282016957834e-10
n O 0 1.2364886892157756e-09
= O 0 2.8253441253234257e-10
11 O 0 3.027285019885362e-11
; O 0 7.194241946964497e-13
SCA2 B-Disease 0 2.744201310633798e-07
, O 0 1.0398059149818728e-11
n O 0 8.746500052003725e-11
= O 0 6.449682454778838e-11
10 O 0 1.4512693130575016e-11
) O 0 1.0315869930195912e-13
and O 0 1.7036226596101045e-11
SCA3 B-Disease 1 1.0
/ O 0 2.54229198617395e-05
Machado B-Disease 0 8.829819364564173e-08
- I-Disease 0 1.597641485773238e-08
Joseph I-Disease 0 8.827966979652047e-08
disease I-Disease 0 2.1821181306336257e-08
( O 0 5.399962074714715e-11
MJD B-Disease 1 1.0
) O 0 4.5526241110316334e-10
( O 0 1.6196881336139057e-10
n O 0 3.435193818290827e-08
= O 0 1.3666446641025232e-08
16 O 0 8.530543382789801e-09
) O 0 4.491436389475467e-11
. O 0 1.3165893930633388e-09

In O 0 2.3446152397355036e-07
SCA1 B-Disease 0 0.001071765087544918
, O 0 3.539710524691486e-09
saccade O 0 2.2497383156405704e-07
amplitude O 0 9.448071658368917e-09
was O 0 3.398266112952797e-10
significantly O 0 4.8153647735915683e-11
increased O 0 5.46897388487011e-11
, O 0 3.9739869381327786e-12
resulting O 0 7.78746303553568e-11
in O 0 3.746801202630934e-10
hypermetria B-Disease 0 6.636746093136026e-06
. O 0 1.4551152105468645e-07

The O 0 5.264667635174192e-08
smooth O 0 2.5974358663916064e-08
pursuit O 0 1.1457614590426601e-07
gain O 0 2.466827879743505e-07
was O 0 2.577301643214014e-07
decreased O 0 1.515493437409532e-07
. O 0 1.2528555082269577e-08

In O 0 1.5234184047585586e-07
SCA2 B-Disease 0 0.0009567778324708343
, O 0 1.0422258611697544e-08
saccade O 0 1.015706629914348e-06
velocity O 0 4.911747168989677e-07
was O 0 1.7312622446752357e-08
markedly O 0 3.468620590751925e-08
decreased O 0 4.2155878787752954e-08
. O 0 3.810360915679212e-09

The O 0 8.641348614446542e-08
percentage O 0 3.532917389748036e-07
of O 0 1.7358681603241166e-08
errors O 0 8.25120514491573e-06
in O 0 4.997529501338249e-08
antisaccades O 1 0.9949467778205872
was O 0 3.0448302368313307e-07
greatly O 0 1.0468349104231223e-10
increased O 0 1.533782406637485e-10
and O 0 4.314512289105288e-12
was O 0 6.368708338477802e-11
significantly O 0 6.973208035304657e-12
correlated O 0 1.6727081959128087e-12
with O 0 9.524947155873167e-14
age O 0 2.7184350326336926e-09
at O 0 1.3416691757583976e-08
disease O 0 1.3677339438800118e-07
onset O 0 3.875090442306828e-06
. O 0 5.008216419355449e-08

In O 0 1.674594130030016e-09
addition O 0 9.619755686474107e-11
, O 0 2.920955838314754e-11
a O 0 1.1849145276077166e-10
correlation O 0 3.3873684412988325e-10
between O 0 6.364267446379301e-10
smooth O 0 3.109415613877786e-09
pursuit O 0 3.5209910542732814e-09
gain O 0 2.4983763946551107e-09
and O 0 4.717102142920426e-12
the O 0 5.855301660195877e-11
number O 0 2.2860430562432477e-11
of O 0 6.966487942072774e-10
trinucleotide O 0 7.054960633467999e-07
repeats O 0 7.871801877001872e-09
was O 0 1.2674571614468277e-08
found O 0 2.1682755591001523e-10
. O 0 1.2933548676485884e-09

In O 0 8.699624345354096e-07
SCA3 B-Disease 1 1.0
, O 0 5.730241809942527e-07
gaze B-Disease 0 0.00015887462359387428
- I-Disease 0 6.070527547308302e-07
evoked I-Disease 0 2.8791491857305118e-08
nystagmus I-Disease 0 6.929427058821602e-07
was O 0 1.9730639344572865e-09
often O 0 7.946897805609365e-13
present O 0 2.127965989182079e-12
as O 0 2.158946849420418e-12
was O 0 1.3126044695610517e-10
saccade O 0 1.1815194156383768e-08
hypometria O 0 5.114881673762284e-08
and O 0 2.009607757980092e-10
smooth O 0 3.1806969502667926e-08
pursuit O 0 1.4117144075953547e-07
gain O 0 2.9840987281204434e-07
was O 0 4.9767546528300954e-08
markedly O 0 1.8377519950263377e-08
decreased O 0 1.784263758963789e-08
. O 0 3.1301412573014886e-09

Three O 0 2.2184216685872116e-09
major O 0 4.969249456365787e-09
criteria O 0 4.59525217877399e-09
, O 0 2.2663934964861632e-11
saccade O 0 2.8637101578965485e-08
amplitude O 0 6.124032392307299e-09
, O 0 2.7914146688567953e-11
saccade O 0 3.079228960700675e-08
velocity O 0 7.288774384051067e-08
, O 0 1.2578484261116518e-11
and O 0 1.2587820542864225e-11
presence O 0 1.5228628080787843e-10
of O 0 1.281157935295596e-08
gaze B-Disease 0 2.8843437576142605e-06
- I-Disease 0 5.97715299477386e-08
evoked I-Disease 0 5.005387659906546e-09
nystagmus I-Disease 0 1.2884017408509862e-08
, O 0 1.468123582773484e-12
permitted O 0 1.5469734868100993e-11
the O 0 1.110724468129931e-12
correct O 0 8.897901512816553e-12
assignment O 0 2.98151676958458e-11
of O 0 1.7060417314973542e-11
90 O 0 1.8323739747749812e-10
% O 0 2.059485394723115e-11
of O 0 1.5296857530655572e-11
the O 0 1.1257085541505063e-10
SCA1 B-Disease 0 3.0928081287129316e-06
, O 0 1.5394381949751512e-11
90 O 0 5.38924349591241e-10
% O 0 1.7438599175800817e-11
of O 0 9.911833506737189e-12
the O 0 5.269049779821344e-11
SCA2 B-Disease 0 1.201727627631044e-06
, O 0 7.611707271426571e-12
and O 0 6.120332539383266e-12
93 O 0 5.740913300300576e-10
% O 0 3.4633528683825077e-11
of O 0 1.9910111753729254e-11
the O 0 5.064480779193303e-11
patients O 0 1.0825435166339492e-11
with O 0 8.607773348268122e-12
SCA3 B-Disease 1 1.0
to O 0 5.535491141017701e-07
their O 0 2.6178051393266344e-10
genetically O 0 3.7549695991456744e-11
confirmed O 0 4.480911822146716e-11
patient O 0 3.7861547230733095e-10
group O 0 5.1177690557624445e-12
and O 0 8.909109561194839e-12
, O 0 4.6789322416529444e-11
therefore O 0 9.818258206450992e-09
, O 0 5.03076746927178e-10
may O 0 1.6274307768071594e-07
help O 0 1.886111711257854e-08
orient O 0 2.6859652280109003e-05
diagnoses O 0 3.3001242627506144e-07
of O 0 5.90653783660855e-08
SCA1 B-Disease 0 0.0005014693015255034
, O 0 3.6180150542186595e-10
SCA2 B-Disease 0 8.27627009130083e-05
, O 0 8.640643756052668e-11
and O 0 6.047166101197377e-10
SCA3 B-Disease 1 1.0
at O 0 1.204423369927099e-07
early O 0 5.867784036439616e-09
clinical O 0 3.220937960790593e-10
stages O 0 1.4031149575544077e-09
of O 0 6.132222507559959e-10
the O 0 7.740025509406223e-09
diseases O 0 3.9847279253990564e-07
. O 0 1.0993614907306437e-09
. O 0 1.775647362478594e-08

Genetic O 0 5.193612651055446e-09
basis O 0 3.8227634946430555e-10
and O 0 2.4835537272560604e-12
molecular O 0 2.029205137255019e-10
mechanism O 0 2.803251408778351e-09
for O 0 2.850060276671229e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999914169311523

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.5344685912132263
more O 0 2.4407328935716066e-10
than O 0 5.882177384064491e-11
300 O 0 3.785228727681833e-11
, O 0 1.1598937955936695e-12
000 O 0 2.652955355397779e-10
sudden O 0 3.214935262452201e-10
deaths O 0 1.859578810381457e-11
each O 0 1.0340658451041262e-12
year O 0 5.950277770505608e-11
in O 0 1.9977823215167057e-11
the O 0 8.386184524589169e-10
USA O 0 1.832431806292334e-08
alone O 0 3.2496214608102036e-09
. O 0 5.96717253387169e-09

In O 0 6.9340391206651475e-09
approximately O 0 1.217265399588996e-09
5 O 0 7.0650041372744e-09
- O 0 2.8190152434603988e-09
12 O 0 2.2071782179722277e-09
% O 0 1.0006244444138446e-10
of O 0 1.7924534469540565e-12
these O 0 8.652867783181736e-14
cases O 0 1.146056990627975e-12
, O 0 5.981563443342719e-13
there O 0 4.938163593315448e-13
are O 0 3.10327718383574e-13
no O 0 8.176397753301146e-11
demonstrable O 0 1.6878034330147784e-06
cardiac O 0 3.88623375329189e-05
or O 0 6.647576356044738e-08
non O 0 0.0009230354917235672
- O 1 0.8063293695449829
cardiac O 1 0.9999858140945435
causes O 0 6.60668533214448e-08
to O 0 1.5075524162355691e-09
account O 0 4.566804399919189e-12
for O 0 8.721807130684933e-12
the O 0 1.4077786159027994e-10
episode O 0 1.7534329543877902e-10
, O 0 2.2937614942196774e-14
which O 0 7.051574273363994e-15
is O 0 7.872607459599029e-14
therefore O 0 1.2038836941230535e-11
classified O 0 1.631121765433008e-10
as O 0 9.61360235862685e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 8.918780622479971e-06
IVF B-Disease 1 1.0
) O 0 2.3188717612754317e-09
. O 0 8.563669773309357e-09

A O 0 1.026005378435002e-07
distinct O 0 5.467349906140839e-10
group O 0 1.7342680069809546e-10
of O 0 7.194766737939062e-08
IVF B-Disease 1 1.0
patients O 0 5.559247438213788e-05
has O 0 1.2938181082056133e-10
been O 0 8.495587046353226e-12
found O 0 4.663941216738465e-13
to O 0 1.9438055765680362e-12
present O 0 3.2289047737638077e-13
with O 0 3.370476234264633e-14
a O 0 8.556950981120082e-11
characteristic O 0 2.0045860527062587e-09
electrocardiographic O 0 4.697486019722419e-06
pattern O 0 2.2979124878474977e-06
. O 0 9.735966699508936e-08

Because O 0 1.311603909925907e-07
of O 0 1.978906460919916e-08
the O 0 5.371049160984853e-10
small O 0 1.7428889928505775e-11
size O 0 1.843986074945292e-10
of O 0 2.7274291158896347e-10
most O 0 6.018692488840571e-12
pedigrees O 0 1.82497177092511e-11
and O 0 8.473865597928565e-13
the O 0 9.0567284574683e-12
high O 0 2.2811321720439537e-09
incidence O 0 1.2656131787025515e-07
of O 0 2.058792247794372e-09
sudden B-Disease 0 1.1502118013595464e-07
death I-Disease 0 1.1360917540059745e-07
, O 0 2.7000004662602883e-11
however O 0 5.918956297312761e-11
, O 0 8.684643282297344e-11
molecular O 0 1.730785847975369e-09
genetic O 0 6.892578729988941e-10
studies O 0 7.108250099641111e-11
of O 0 2.580546221153668e-09
IVF B-Disease 1 1.0
have O 0 4.928175922902511e-11
not O 0 1.093398548784874e-11
yet O 0 3.1422871249464635e-11
been O 0 1.2350473074795865e-11
done O 0 6.491446963297065e-11
. O 0 9.515197518794594e-10

Because O 0 1.4333265880850377e-06
IVF B-Disease 1 1.0
causes O 1 0.9311002492904663
cardiac O 1 1.0
rhythm O 1 0.9965848922729492
disturbance O 1 0.5781204104423523
, O 0 3.5009395382701314e-10
we O 0 2.4404162024538323e-10
investigated O 0 1.1173812985987297e-09
whether O 0 5.0887971614344e-10
malfunction O 0 6.14181544733583e-07
of O 0 5.368724353971288e-10
ion O 0 6.57822774030592e-09
channels O 0 1.476026967317523e-09
could O 0 4.3157510898339524e-10
cause O 0 1.6757100596009877e-08
the O 0 5.072952058426949e-10
disorder O 0 2.584751579437494e-10
by O 0 4.1148399791690604e-12
studying O 0 1.1808488908915393e-10
mutations O 0 6.406574576400814e-11
in O 0 7.007289887228652e-11
the O 0 2.686149747077593e-09
cardiac O 0 1.2391836889946717e-07
sodium O 0 4.629979599712897e-08
channel O 0 2.56345913385303e-07
gene O 0 1.2784874492410836e-08
SCN5A O 0 3.314414425403811e-05
. O 0 4.7669477254430603e-08

We O 0 5.860092144871487e-08
have O 0 8.216827218632261e-11
now O 0 1.3728082039199396e-11
identified O 0 2.5698455516365293e-11
a O 0 6.148194453547973e-11
missense O 0 5.247244772021986e-08
mutation O 0 1.4644118140338946e-09
, O 0 3.540096818119287e-12
a O 0 4.206610060286664e-11
splice O 0 1.086953638207433e-09
- O 0 8.941326568034924e-10
donor O 0 9.222621000226638e-10
mutation O 0 5.680277914699161e-10
, O 0 2.8300549837628752e-12
and O 0 5.821356851426485e-12
a O 0 4.841734235760953e-10
frameshift O 0 5.359542001315276e-07
mutation O 0 8.031297293875639e-10
in O 0 2.5831732586301115e-11
the O 0 5.474818862150066e-11
coding O 0 5.872125563577413e-10
region O 0 1.8318577765796817e-09
of O 0 2.396029152862411e-09
SCN5A O 0 4.9285026761936024e-05
in O 0 1.1076711770030556e-09
three O 0 2.682166710954448e-09
IVF B-Disease 1 1.0
families O 0 3.72278791127556e-10
. O 0 1.750366407371473e-09

We O 0 5.788925960814595e-08
show O 0 2.3587143349601547e-10
that O 0 1.5276876985659271e-12
sodium O 0 1.1496129569132929e-11
channels O 0 7.800629933663039e-12
with O 0 7.80118767436562e-14
the O 0 1.1248672132646576e-10
missense O 0 6.447773159834469e-08
mutation O 0 8.342284196771743e-09
recover O 0 7.135860791152027e-09
from O 0 4.739202363879258e-10
inactivation O 0 2.854911542726768e-07
more O 0 2.7328107225083054e-12
rapidly O 0 1.2638316608526434e-11
than O 0 9.011543681408662e-13
normal O 0 4.378923612602392e-11
and O 0 3.602488316337138e-13
that O 0 5.222031032418861e-13
the O 0 4.1871502792778514e-11
frameshift O 0 5.662435142994582e-08
mutation O 0 6.00597216404708e-09
causes O 0 1.257849713276471e-09
the O 0 2.4523241770602056e-10
sodium O 0 1.6535185720645273e-10
channel O 0 4.198011382960942e-10
to O 0 6.200576857517959e-11
be O 0 8.406967483276517e-11
non O 0 1.1079358763765867e-08
- O 0 1.6806041003292194e-08
functional O 0 5.515252254895131e-08
. O 0 5.917562884150129e-09

Our O 0 7.240043942147167e-08
results O 0 2.273504717820174e-09
indicate O 0 1.1988436909859956e-09
that O 0 5.556581583743281e-11
mutations O 0 6.279452513524575e-10
in O 0 4.1127179439826023e-10
cardiac O 0 3.6571496053738883e-08
ion O 0 1.8403588342152943e-07
- O 0 6.287824305672984e-08
channel O 0 2.0161518676786727e-08
genes O 0 4.9935364003494964e-12
contribute O 0 1.0207599739422979e-12
to O 0 2.4027162637968447e-12
the O 0 6.401807035871787e-12
risk O 0 4.989254842602264e-11
of O 0 1.5767334660132803e-10
developing O 0 1.983410768957583e-08
IVF B-Disease 1 1.0
. O 0 4.95544005829629e-09
. O 0 3.4886096234032493e-09

Molecular O 0 3.4437556450939155e-07
heterogeneity O 0 1.1252893017399401e-07
in O 0 1.0560262664327524e-09
mucopolysaccharidosis B-Disease 0 0.36589452624320984
IVA I-Disease 1 1.0
in O 0 6.023007870226138e-09
Australia O 0 2.1869220843961923e-12
and O 0 2.8119959702768704e-13
Northern O 0 3.949809646019986e-10
Ireland O 0 3.105577947581928e-11
: O 0 7.54647863296376e-13
nine O 0 2.172637590669435e-11
novel O 0 1.5703160993751908e-11
mutations O 0 2.1317898835082616e-11
including O 0 1.2657416347677808e-12
T312S O 0 7.990246331246453e-07
, O 0 1.9818070795540876e-12
a O 0 4.616645607469216e-12
common O 0 7.51359217898706e-12
allele O 0 1.6518730827641548e-10
that O 0 9.32075488839501e-13
confers O 0 2.299838097741258e-10
a O 0 5.383469781072847e-10
mild O 0 9.18005071071093e-07
phenotype O 0 1.565713137097191e-05
. O 0 2.65469765281523e-07

Mucopolysaccharidosis B-Disease 1 0.9942618608474731
IVA I-Disease 1 1.0
( O 0 1.7165633607874042e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 8.728633787979945e-11
is O 0 1.2431845483606985e-11
an O 0 1.5968476541061705e-10
autosomal B-Disease 1 0.9999909400939941
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.0005001790123060346
by O 0 9.658995825390093e-10
a O 0 3.2940033634076826e-06
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 3.9271796481443744e-08
N O 0 5.689944373443723e-07
- O 0 5.55467174478963e-08
acetylgalactosamine O 0 5.423793254522025e-07
- O 0 2.291827456701867e-07
6 O 0 1.8682975166939286e-07
- O 0 2.0736704797741368e-08
sulfate O 0 2.2247364839245165e-08
sulfatase O 0 1.5767975014568947e-07
( O 0 1.1301057312174123e-10
GALNS O 0 7.045090114843333e-06
) O 0 2.6751761916798955e-10
. O 0 6.705387800565177e-09

Previous O 0 1.5765726502081634e-08
studies O 0 1.1213754230743334e-10
of O 0 7.145796454555153e-11
patients O 0 1.2726846486399435e-12
from O 0 5.908223671587109e-13
a O 0 2.5425028835762697e-12
British O 0 1.612065515799177e-11
- O 0 4.2424522228579065e-10
Irish O 0 1.3303835463829294e-11
population O 0 6.293444633704084e-14
showed O 0 3.9167325253334356e-14
that O 0 5.778693224888637e-14
the O 0 6.527751256202308e-11
I113F O 0 6.345237011373683e-07
mutation O 0 1.9875983081618642e-09
is O 0 3.346375043386529e-12
the O 0 1.1117079479205927e-12
most O 0 1.1779200153520884e-14
common O 0 2.6559283201540995e-13
single O 0 4.334175379705485e-12
mutation O 0 5.22022647331255e-10
among O 0 1.6495872723343297e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.1730062254855511e-07
and O 0 4.3714632608216064e-11
produces O 0 4.4321216835507826e-11
a O 0 3.0086760860470463e-10
severe O 0 2.137074943675543e-06
clinical O 0 4.519332890140504e-07
phenotype O 0 2.0440402295207605e-06
. O 0 9.380308796380632e-08

We O 0 8.319724287275676e-08
studied O 0 1.1200789629128849e-08
mutations O 0 7.052506356686195e-10
in O 0 1.2979748352515141e-11
the O 0 1.2186050779572355e-10
GALNS O 0 1.532405917714641e-06
gene O 0 5.7723760667205415e-12
from O 0 9.333069907191405e-12
23 O 0 1.698558793616911e-10
additional O 0 1.6732651375583885e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 7.656508316244981e-09
( O 0 7.808877676429571e-12
15 O 0 6.714317435374539e-10
from O 0 2.9145227897764414e-11
Australia O 0 3.3936230019702973e-13
, O 0 3.158458466556019e-14
8 O 0 3.600486228605426e-11
from O 0 4.954241877852539e-12
Northern O 0 5.199557451263104e-10
Ireland O 0 2.2728693926943322e-11
) O 0 6.327848401516123e-13
, O 0 2.1421243685121327e-13
with O 0 1.782251680493372e-14
various O 0 4.258167169562954e-12
clinical O 0 6.473105162996262e-09
phenotypes O 0 1.6163321348017234e-08
( O 0 3.898762979126502e-10
severe O 0 9.654348832555115e-05
, O 0 1.8295208403795726e-10
16 O 0 5.105733058563544e-10
cases O 0 1.4254314959286085e-12
; O 0 2.0521830762509907e-12
intermediate O 0 2.8746811597812894e-09
, O 0 3.122659032392394e-12
4 O 0 1.7534806939778491e-09
cases O 0 6.478060709386169e-12
; O 0 2.2566492077769063e-11
mild O 0 2.778056114038918e-07
, O 0 9.621338170617832e-10
3 O 0 4.091869598710218e-08
cases O 0 1.2492845646860928e-10
) O 0 1.178789843514494e-10
. O 0 5.317263074289258e-09

We O 0 8.948755692017585e-08
found O 0 9.238426690316714e-11
two O 0 3.3923046663386636e-12
common O 0 2.3417507516443337e-11
mutations O 0 2.9648894450673424e-11
that O 0 1.0386160247816134e-12
together O 0 3.50098747735339e-13
accounted O 0 8.38505653799615e-12
for O 0 4.474759972283859e-12
32 O 0 2.266378196225105e-09
% O 0 2.3497742640543606e-10
of O 0 7.138903357351012e-11
the O 0 1.7677043162578343e-10
44 O 0 2.0091948105260826e-09
unrelated O 0 1.1800767307779125e-10
alleles O 0 5.2547383111445356e-11
in O 0 2.921563338476041e-11
these O 0 3.16623810503458e-11
patients O 0 1.8870525975156482e-10
. O 0 5.458100194033477e-09

One O 0 5.898304955564981e-09
is O 0 1.511072239557265e-10
the O 0 1.1837066882236513e-09
T312S O 0 2.6034381335193757e-06
mutation O 0 3.845457285933662e-09
, O 0 2.9662908414274103e-12
a O 0 2.4078005214644982e-11
novel O 0 2.1048780773913478e-10
mutation O 0 5.912054734658057e-10
found O 0 5.909669888864988e-12
exclusively O 0 1.7465785762116326e-12
in O 0 6.240260044809709e-12
milder O 0 4.722306584881153e-06
patients O 0 5.9511492622732476e-08
. O 0 1.7211205260991846e-07

The O 0 2.1456830978650032e-08
other O 0 1.3474322352324819e-11
is O 0 7.542366904644826e-12
the O 0 3.114404567572393e-11
previously O 0 2.939427173886955e-11
described O 0 1.3498946405121615e-10
I113F O 0 5.358938892641163e-07
that O 0 6.073746540435909e-12
produces O 0 1.7683915096156078e-11
a O 0 1.002481875289618e-09
severe O 0 2.0682353351730853e-05
phenotype O 0 2.5723422368173487e-05
. O 0 4.564149094221648e-07

The O 0 3.6737401387654245e-07
I113F O 0 2.6423076633363962e-05
and O 0 6.979472111368068e-09
T312S O 0 3.6916485441906843e-06
mutations O 0 8.810951968030167e-10
accounted O 0 4.096393016461697e-11
for O 0 1.6811135816752198e-12
8 O 0 7.608275121029351e-10
( O 0 2.5112334087196153e-12
18 O 0 1.4819000471177901e-09
% O 0 1.0687893278737981e-11
) O 0 6.89585243291227e-14
and O 0 1.1529920898242785e-12
6 O 0 7.478684893591492e-10
( O 0 2.763758839841035e-12
14 O 0 4.090047744931269e-10
% O 0 3.489775959528152e-12
) O 0 1.6025081381234457e-13
of O 0 5.98439700572051e-12
44 O 0 5.116093312884651e-11
unrelated O 0 1.1351884710020244e-11
alleles O 0 1.6651837894676724e-11
, O 0 1.9792433317289415e-11
respectively O 0 2.780736307883558e-09
. O 0 8.913694671264238e-09

The O 0 1.2672497007315542e-07
relatively O 0 4.7374237865938085e-09
high O 0 4.4856559355821446e-08
residual O 0 4.5437154767569155e-05
GALNS O 1 0.9992708563804626
activity O 0 8.285834240950862e-08
seen O 0 2.91070223479295e-10
when O 0 9.084219487753842e-12
the O 0 4.439059189675909e-11
T312S O 0 2.1657067250657747e-08
mutant O 0 2.833849821470835e-10
cDNA O 0 6.96630197971615e-10
is O 0 4.251625961015915e-12
overexpressed O 0 5.855382290143041e-10
in O 0 1.848443099972119e-11
mutant O 0 1.4894481481508848e-10
cells O 0 2.1530828335503127e-12
provides O 0 1.4556833792837495e-14
an O 0 5.629326079717098e-14
explanation O 0 1.7371871302573894e-11
for O 0 6.641531508783105e-12
the O 0 1.6160837945644602e-10
mild O 0 4.599854150910687e-07
phenotype O 0 2.508434135961579e-07
in O 0 2.1934495886277716e-10
patients O 0 8.20211953911354e-12
with O 0 1.7991694017862464e-13
this O 0 1.0833785257791106e-10
mutation O 0 1.1151378487284092e-08
. O 0 1.747788402894912e-08

The O 0 1.8878130170207896e-09
distribution O 0 5.4621147882460974e-11
and O 0 9.893357834356298e-13
relative O 0 1.791477799439889e-10
frequencies O 0 3.296515282968926e-10
of O 0 2.154087047623321e-10
the O 0 1.8865775608389868e-10
I113F O 0 7.670353596722634e-08
and O 0 1.8518175881609977e-10
T312S O 0 1.1005663509422448e-06
mutations O 0 3.252112190654799e-10
in O 0 6.725384572164872e-12
Australia O 0 8.314527587477763e-14
corresponded O 0 3.762758876181549e-13
to O 0 1.497940139982834e-11
those O 0 1.0617465023496364e-12
observed O 0 2.8698024859274973e-11
in O 0 2.580955848346944e-12
Northern O 0 9.67343094515627e-10
Ireland O 0 7.181868294514615e-11
and O 0 6.087060543114031e-12
are O 0 9.50897889075153e-13
unique O 0 1.012565357082218e-12
to O 0 1.1411111638937044e-10
these O 0 2.104892215387677e-12
two O 0 4.3533549161367535e-12
populations O 0 1.1537685954202126e-12
, O 0 1.1480917128450785e-12
suggesting O 0 4.037463419148679e-11
that O 0 2.0271768638724375e-11
both O 0 1.7016003883707498e-10
mutations O 0 1.0069277633917295e-09
were O 0 5.981296014034854e-11
probably O 0 1.2921847619695725e-11
introduced O 0 8.740937119076919e-13
to O 0 1.160815020495587e-11
Australia O 0 3.9495452264573516e-14
by O 0 2.6090664595164806e-14
Irish O 0 3.5781544394097864e-11
migrants O 0 1.7072884772595387e-11
during O 0 2.547016850901196e-12
the O 0 2.7622409567995554e-12
19th O 0 2.4856081082269554e-10
century O 0 4.42500569519666e-09
. O 0 1.192024523533064e-08

Haplotype O 0 1.5629786958015757e-06
analysis O 0 2.146664401792009e-09
using O 0 5.985966722299452e-10
6 O 0 1.1242509856401739e-07
RFLPs O 0 2.1542871309065958e-07
provides O 0 5.950194763987282e-12
additional O 0 4.958552665690341e-12
data O 0 2.8031617825552413e-12
that O 0 3.214378362006304e-13
the O 0 5.472010691787155e-11
I113F O 0 6.776969030397595e-08
mutation O 0 7.922161537887717e-11
originated O 0 3.24664904335914e-12
from O 0 8.018855761696142e-13
a O 0 7.103178288614398e-12
common O 0 4.861340496820077e-11
ancestor O 0 2.4601598980211747e-08
. O 0 9.975878789703074e-09

The O 0 4.8146834075168954e-08
other O 0 6.969647775578736e-11
9 O 0 1.1897418161765927e-08
novel O 0 3.25563742631374e-10
mutations O 0 5.485755738554587e-10
identified O 0 6.355251741529955e-11
in O 0 1.0398494565411198e-11
these O 0 6.5471998482447e-12
23 O 0 8.539301710186464e-09
patients O 0 1.581177896947672e-11
were O 0 3.250912126301353e-12
each O 0 1.094656158252827e-12
limited O 0 1.6555144841806646e-12
to O 0 4.061399133670207e-11
a O 0 2.88002510728802e-10
single O 0 1.4435628248321564e-09
family O 0 2.789680708659148e-10
. O 0 1.0498633074007557e-08

These O 0 1.0624084945121126e-09
data O 0 3.034696452464125e-11
provide O 0 1.3919042784679703e-12
further O 0 4.738808737775324e-12
evidence O 0 3.979068810555653e-12
for O 0 9.22264218120028e-13
extensive O 0 1.1470160238280513e-10
allelic O 0 6.8794614449529945e-09
heterogeneity O 0 2.715788482987591e-08
in O 0 1.627703971607275e-09
MPS B-Disease 1 0.9999997615814209
IVA I-Disease 1 1.0
in O 0 1.0396219995989497e-10
British O 0 1.9016968555440883e-10
- O 0 2.4808635146200686e-09
Irish O 0 1.3348068483853837e-10
patients O 0 3.3554253126011346e-12
and O 0 3.576336004684072e-13
provide O 0 9.322425643942811e-13
evidence O 0 5.0838760284888096e-11
for O 0 5.7733259145598126e-11
their O 0 6.81474390806791e-11
transmission O 0 1.1995431037359339e-10
to O 0 2.1554586240868367e-11
Australia O 0 4.582391662844888e-14
by O 0 1.9762827035670408e-14
British O 0 2.526030773442045e-11
- O 0 1.8040594573776048e-09
Irish O 0 9.328518513207484e-11
migrants O 0 2.6785185180955295e-11
. O 0 3.7310584309613315e-12
. O 0 2.380975971938426e-10

Identification O 0 5.730946828208516e-10
of O 0 1.0408665040984033e-09
constitutional O 0 3.7196053881416447e-07
WT1 O 0 0.0006469948566518724
mutations O 0 1.1451682979668476e-07
, O 0 2.0912912027104547e-11
in O 0 5.735358802466672e-12
patients O 0 9.894229532902976e-12
with O 0 2.302978771226427e-12
isolated O 0 5.5239970606635325e-06
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 8.221534009145159e-10
and O 0 4.639986311838484e-12
analysis O 0 4.386921381716036e-12
of O 0 3.516968660743913e-10
genotype O 0 1.2699446827468819e-08
/ O 0 1.1679807698783407e-07
phenotype O 0 2.88494161893027e-09
correlations O 0 4.617284332653071e-10
by O 0 8.689191401990704e-13
use O 0 1.3604502073494285e-11
of O 0 7.602193180522576e-11
a O 0 1.0883700191088863e-10
computerized O 0 6.2183600491039215e-09
mutation O 0 4.995239777372262e-09
database O 0 3.876127419033537e-09
. O 0 6.398618523917321e-09

Constitutional O 0 6.373265478032408e-06
mutations O 0 1.0024100305372485e-07
of O 0 2.3327002551809528e-08
the O 0 4.913089046709729e-09
WT1 O 0 5.453586027215351e-07
gene O 0 1.3147267996505008e-10
, O 0 5.936353405372463e-12
encoding O 0 2.0948402734699556e-11
a O 0 9.09590180953046e-09
zinc O 0 1.9790732608271355e-07
- O 0 1.448150328542397e-07
finger O 0 2.6549076892479206e-07
transcription O 0 5.799856950261528e-08
factor O 0 2.9853379768240984e-09
involved O 0 2.3269466215003476e-11
in O 0 4.979655021664087e-10
renal O 1 0.9999895095825195
and O 0 2.4860523240022303e-07
gonadal O 1 0.9999064207077026
development O 0 0.0004680047568399459
, O 0 6.40478114988241e-10
are O 0 4.796927612071844e-12
found O 0 5.114119631249858e-12
in O 0 3.2215660803087964e-13
most O 0 8.939023295444909e-14
patients O 0 1.0165685567636862e-13
with O 0 1.757277185094122e-13
Denys B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.7017504205796286e-07
DDS B-Disease 1 1.0
) O 0 9.051932120529571e-11
, O 0 1.0463353274092757e-11
or O 0 6.533637186834085e-09
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 3.033341045011184e-08
DMS B-Disease 0 2.3938368940434884e-06
) O 0 6.22029283550013e-13
associated O 0 4.6648860989317864e-12
with O 0 2.3509642583380286e-12
pseudohermaphroditism B-Disease 1 1.0
and O 0 8.403837625792221e-08
/ O 0 1.6796988347778097e-05
or O 0 1.000184852273378e-06
Wilms B-Disease 0 0.01576400361955166
tumor I-Disease 0 5.4734398872824386e-05
( O 0 2.990039327244176e-09
WT B-Disease 1 0.9998955726623535
) O 0 2.0279437851211668e-10
. O 0 2.587485559146785e-09

Most O 0 2.824763312148093e-09
mutations O 0 1.0691416640895568e-08
in O 0 3.686407623604282e-09
DDS B-Disease 1 1.0
patients O 0 5.077297373645706e-06
lie O 0 2.1188066057220567e-06
in O 0 2.4027611011945282e-09
exon O 0 2.562297396480062e-08
8 O 0 5.6140635251722415e-08
or O 0 2.620054173618769e-09
exon O 0 2.2319831316508498e-08
9 O 0 1.4123151004241663e-07
, O 0 2.442823998638488e-10
encoding O 0 1.2382358249851677e-08
zinc O 0 3.0346022867888678e-06
finger O 0 4.723297752207145e-05
2 O 0 1.0578578439890407e-05
or O 0 3.573093465547572e-07
zinc O 0 1.6964936548902187e-06
finger O 0 5.653202492794662e-07
3 O 0 1.300532233017293e-07
, O 0 2.0693212768319036e-11
respectively O 0 1.003663749332695e-10
, O 0 2.1822552445649457e-12
with O 0 5.669715456672886e-13
a O 0 8.744589941045433e-09
hot O 0 7.654261366951687e-07
spot O 0 9.467738237844969e-08
( O 0 4.180608359494187e-10
R394W O 0 1.0609954870233196e-06
) O 0 2.7955492087894385e-11
in O 0 3.848581175969201e-10
exon O 0 2.9764869680093398e-08
9 O 0 1.3661005482390465e-07
. O 0 1.0483866219601623e-08

We O 0 1.1534496913157e-08
analyzed O 0 1.962793122478601e-10
a O 0 2.08123553113726e-11
series O 0 1.0690747766217701e-11
of O 0 2.2393868009951134e-11
24 O 0 4.5636854295594276e-09
patients O 0 3.921447888632912e-11
, O 0 1.4157483345378363e-11
10 O 0 2.2238655361661586e-09
with O 0 8.846090526759554e-11
isolated B-Disease 0 3.1364204915007576e-05
DMS I-Disease 0 0.23194728791713715
( O 0 1.995477383331945e-08
IDMS B-Disease 0 4.849705146625638e-05
) O 0 7.452679445796306e-11
, O 0 8.458189877658118e-12
10 O 0 6.991789786026104e-11
with O 0 2.8196991182921627e-12
DDS B-Disease 1 1.0
, O 0 1.0471744305018404e-10
and O 0 1.7539939986543907e-11
4 O 0 4.397819441948059e-09
with O 0 1.4827777894410588e-11
urogenital B-Disease 0 6.794182809244376e-06
abnormalities I-Disease 0 9.228242561221123e-05
and O 0 7.122768153067227e-08
/ O 0 3.18056445394177e-05
or O 0 6.957283039810136e-05
WT B-Disease 1 1.0
. O 0 1.042534449879895e-07

We O 0 6.902202187575313e-08
report O 0 7.012721514598752e-10
WT1 O 0 5.770548341388348e-07
heterozygous O 0 4.4975939639257945e-10
mutations O 0 6.376657535334118e-11
in O 0 1.4887714325229062e-11
16 O 0 1.3350976990622598e-09
patients O 0 1.5826321156375833e-11
, O 0 3.7632271430998454e-12
4 O 0 3.67537253964656e-08
of O 0 2.2153350265341487e-09
whom O 0 3.6366812339316823e-10
presented O 0 8.803409667912376e-10
with O 0 2.342337157568153e-10
IDMS B-Disease 1 0.9403056502342224
. O 0 5.335003265827254e-07

One O 0 6.8452994383960686e-09
male O 0 1.4472784082286694e-10
and O 0 4.839015039365124e-12
two O 0 2.0260791308568393e-11
female O 0 6.687936870974909e-10
IDMS B-Disease 0 0.00019607756985351443
patients O 0 4.5401566950431516e-09
with O 0 5.154176530020038e-10
WT1 O 0 0.11543691903352737
mutations O 0 0.0015006691683083773
underwent O 0 0.0018433217192068696
normal O 0 0.0007023286307230592
puberty O 0 0.0005195955163799226
. O 0 3.011423643783928e-08

Two O 0 3.683632954221139e-08
mutations O 0 2.5379533141745014e-08
associated O 0 9.691623059637777e-10
with O 0 6.104736854917192e-11
IDMS B-Disease 1 0.7440148591995239
are O 0 1.81523060471811e-11
different O 0 4.285934129301394e-13
from O 0 6.2212214546608635e-12
those O 0 7.4516770792038e-13
described O 0 2.1059773716580743e-11
in O 0 3.6497310729188825e-10
DDS B-Disease 1 1.0
patients O 0 1.3449916025365383e-07
. O 0 6.17477411424261e-08

No O 0 1.951938656929997e-06
WT1 O 0 5.005156708648428e-05
mutations O 0 1.1199213645340933e-07
were O 0 4.4819570277354615e-10
detected O 0 2.350993566491155e-10
in O 0 2.1866176404261584e-12
the O 0 3.48713592723815e-11
six O 0 7.962625003798962e-11
other O 0 3.6277911230619964e-11
IDMS B-Disease 1 0.9999992847442627
patients O 0 1.3933600939708413e-08
, O 0 5.336174904724267e-11
suggesting O 0 8.979935683939289e-10
genetic O 0 3.578446694518789e-08
heterogeneity O 0 1.3530284093121736e-07
of O 0 2.817296618218279e-08
this O 0 6.11750863299676e-08
disease O 0 0.00011200198787264526
. O 0 6.400818364227234e-08

We O 0 6.5873962284968e-08
analyzed O 0 4.097834516159082e-09
genotype O 0 8.800362394367767e-08
/ O 0 1.3203376170167758e-07
phenotype O 0 5.108219625071797e-09
correlations O 0 2.1795214522057904e-09
, O 0 4.993171674738672e-13
on O 0 8.472884720223117e-12
the O 0 2.907540473575526e-13
basis O 0 7.102473123521413e-12
of O 0 8.201161646494148e-13
the O 0 7.252755254011367e-13
constitution O 0 4.578901927759782e-12
of O 0 5.226939367442007e-11
a O 0 2.2076779293556115e-10
WT1 O 0 2.628986806030298e-07
mutation O 0 1.0951444195939075e-09
database O 0 1.2248010938797904e-10
of O 0 7.018315373308326e-10
84 O 0 2.327274017943637e-08
germ O 0 1.9045975250264746e-06
- O 0 6.058532449060294e-07
line O 0 6.258186999730242e-07
mutations O 0 1.2566578888595359e-09
, O 0 4.621227012169271e-12
to O 0 5.71525743398027e-11
compare O 0 2.356020066540676e-11
the O 0 5.400343019990039e-11
distribution O 0 4.4476356625411384e-11
and O 0 1.0326190857251616e-12
type O 0 7.032143756191545e-10
of O 0 6.4017684486827875e-09
mutations O 0 2.557817291304332e-10
, O 0 1.1783346650848237e-12
according O 0 6.927389434654985e-13
to O 0 7.377017052778712e-11
the O 0 5.075998649184399e-11
different O 0 4.2109368075804454e-11
symptoms O 0 1.383822052503092e-07
. O 0 2.0084986118718007e-08

This O 0 4.920588936307979e-10
demonstrated O 0 1.3608947302401475e-10
( O 0 1.3981659580108996e-11
1 O 0 2.7510946409847747e-08
) O 0 1.817218142456667e-12
the O 0 1.2533652067603374e-11
association O 0 4.865818251792442e-12
between O 0 3.939892856408278e-10
mutations O 0 3.615421018121623e-10
in O 0 4.3992243875523585e-11
exons O 0 1.0496585822750149e-09
8 O 0 1.4013177285221445e-09
and O 0 8.077837877762395e-12
9 O 0 7.01186975149426e-09
and O 0 9.212279550308011e-11
DMS B-Disease 0 1.757798742119121e-07
; O 0 4.6411572501847687e-11
( O 0 1.2672213278719369e-10
2 O 0 7.302551097154719e-08
) O 0 1.4070048078018704e-11
among O 0 1.5717836103837368e-12
patients O 0 3.1713858969495412e-12
with O 0 1.9274211133374353e-12
DMS B-Disease 0 4.076617585724307e-07
, O 0 1.1633750386652597e-11
a O 0 2.5639851353176368e-11
higher O 0 1.3105756757614273e-10
frequency O 0 1.4753449850690714e-10
of O 0 1.3008827348670593e-10
exon O 0 4.236128947621154e-10
8 O 0 2.4862210068476998e-09
mutations O 0 5.2619093110495285e-11
among O 0 5.440596432572387e-13
46 O 0 1.132808291615106e-09
, O 0 8.143433843921244e-11
XY O 0 2.8880409445264377e-05
patients O 0 1.0642388012516157e-11
with O 0 3.918152152553034e-14
female O 0 1.9777441403329155e-12
phenotype O 0 3.2297210045273417e-11
than O 0 3.595858853733258e-12
among O 0 1.327705848909455e-12
46 O 0 4.564451483446419e-09
, O 0 2.457521686149988e-10
XY O 0 0.03661481291055679
patients O 0 4.4723051650930046e-11
with O 0 1.364901030739829e-13
sexual O 0 4.893799254723774e-11
ambiguity O 0 7.885036512611521e-10
or O 0 1.431495200154842e-10
male O 0 1.4011505497513177e-11
phenotype O 0 4.899739641794909e-11
; O 0 3.858316010435514e-12
and O 0 6.594602641740721e-11
( O 0 4.0263914424798486e-10
3 O 0 2.6313796297472436e-07
) O 0 4.637387349126776e-11
statistically O 0 3.526761174765802e-11
significant O 0 3.7371126158924906e-12
evidence O 0 7.42059469427403e-11
that O 0 5.302610347340808e-12
mutations O 0 4.3269748895014004e-11
in O 0 1.002450761289353e-10
exons O 0 1.4619008226191e-08
8 O 0 2.4334001480497136e-08
and O 0 7.862955425652629e-11
9 O 0 1.2270072957676348e-08
preferentially O 0 2.2808188671064045e-09
affect O 0 3.1938267586184566e-09
amino O 0 4.29441815441578e-10
acids O 0 1.9011292106546618e-12
with O 0 3.38639071279412e-15
different O 0 2.3497603670219643e-14
functions O 0 3.280104703476394e-12
. O 0 1.1867618866789886e-11
. O 0 6.323730983304188e-10

The O 0 9.327321492946794e-08
185delAG O 0 8.399100579481455e-07
BRCA1 O 0 2.5971187866957735e-08
mutation O 0 4.370089845551206e-10
originated O 0 3.5875831385506762e-12
before O 0 1.50888481396938e-12
the O 0 2.612588693561707e-13
dispersion O 0 2.1009634310065195e-10
of O 0 2.9306605753287585e-11
Jews O 0 3.415054350419666e-11
in O 0 2.032782362576535e-12
the O 0 9.45020190573631e-12
diaspora O 0 1.1359336214711302e-11
and O 0 2.533445458627326e-12
is O 0 4.236100619586791e-12
not O 0 1.6538079933292593e-11
limited O 0 2.7886261008691626e-11
to O 0 7.419781233863887e-09
Ashkenazim O 0 9.553734344081022e-06
. O 0 1.312771615857855e-07

The O 0 4.3471906963077345e-08
185delAG O 0 5.422510866992525e-07
mutation O 0 1.1931779120288866e-08
in O 0 6.930439555574708e-10
BRCA1 O 0 1.626705348201085e-08
is O 0 3.2046729853130174e-11
detected O 0 9.90692458624487e-11
in O 0 3.7042760352157256e-12
Ashkenazi O 0 1.620541922875418e-09
Jews O 0 6.1378013782587e-11
both O 0 1.4025884403565114e-12
in O 0 3.8412897862549755e-11
familial B-Disease 1 0.7536040544509888
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.236467426224408e-07
in O 0 6.097617966105418e-10
the O 0 4.70189109869068e-10
general O 0 5.647458611868217e-10
population O 0 1.791899636484351e-12
. O 0 4.037727374672784e-10

All O 0 1.953845618629657e-08
tested O 0 3.560213235331844e-09
Ashkenazi O 0 1.1526688936669416e-08
mutation O 0 5.1138884793466843e-11
carriers O 0 1.2460421149745882e-12
share O 0 3.6781003590058425e-12
the O 0 6.158178567777783e-12
same O 0 1.2730494609869414e-11
allelic O 0 5.952576653811548e-09
pattern O 0 2.467499093938841e-09
at O 0 1.3686839439586151e-09
the O 0 1.3384575392461073e-10
BRCA1 O 0 2.575098356771832e-09
locus O 0 5.973529226821483e-08
. O 0 3.6644092205051493e-09

Our O 0 3.1343793693849875e-07
previous O 0 2.0385018117963227e-08
study O 0 8.914009114180388e-11
showed O 0 2.1481889617841476e-12
that O 0 1.451065694468498e-13
this O 0 1.4515682926485862e-11
Ashkenazi O 0 1.2625519296705079e-08
mutation O 0 2.2420119927257787e-10
also O 0 6.137444068590736e-13
occurs O 0 1.3321095528734395e-12
in O 0 8.214405718132145e-13
Iraqi O 0 2.9484073515995135e-10
Jews O 0 2.4306412785279896e-11
with O 0 2.955084161854367e-14
a O 0 1.2637208987587023e-11
similar O 0 1.323529653929345e-11
allelic O 0 5.9149591891127784e-08
pattern O 0 6.378758854452826e-08
. O 0 1.5503283989914962e-08

We O 0 3.331422249175375e-08
extended O 0 8.183161703811948e-09
our O 0 6.005462099833991e-11
analysis O 0 1.6904058448147241e-12
to O 0 1.9236612303075162e-11
other O 0 6.140936283788312e-12
non O 0 3.639951673406472e-09
- O 0 9.842333170695383e-09
Ashkenazi O 0 1.3405385246301194e-08
subsets O 0 8.427634701213549e-10
354 O 0 6.83022943759326e-11
of O 0 4.656849992429324e-12
Moroccan O 0 4.2377878983757e-09
origin O 0 7.337584012612197e-11
, O 0 8.805684480195364e-12
200 O 0 1.189721758609874e-11
Yemenites O 0 8.584434274538921e-10
and O 0 2.035513901529895e-12
150 O 0 2.3032915852372327e-11
Iranian O 0 2.0267227895942597e-09
Jews O 0 3.0306328557827555e-09
. O 0 1.5423582411244752e-09

Heteroduplex O 0 1.2900394722237252e-05
analysis O 0 1.2167709062538279e-09
complemented O 0 7.374737626131278e-11
by O 0 5.2363963859436424e-12
direct O 0 6.976833555327744e-10
DNA O 0 1.9403858519950745e-09
sequencing O 0 2.847992397470023e-10
of O 0 6.339358482598811e-10
abnormally O 0 1.8405995616532778e-09
migrating O 0 1.8940037038728263e-11
bands O 0 1.0578764947366537e-10
were O 0 6.35256083847402e-11
employed O 0 1.362269075322331e-09
. O 0 4.250529705984718e-09

Four O 0 6.86801282512306e-10
of O 0 5.138098835288929e-10
Moroccan O 0 2.3866071785505483e-08
origin O 0 1.1201462674081952e-10
( O 0 7.011841736577484e-13
1 O 0 5.0592890987744e-10
. O 0 1.2694504735594192e-12
1 O 0 8.192418410324365e-10
% O 0 1.0753367814253512e-11
) O 0 1.0684417353678047e-13
and O 0 1.1913038914720953e-12
none O 0 7.848990207781625e-11
of O 0 3.8287978343376494e-10
the O 0 4.946296705554687e-10
Yemenites O 0 6.008538555590803e-09
or O 0 1.5239146056167385e-10
Iranians O 0 2.6116908635742675e-10
was O 0 3.306614704268185e-11
a O 0 2.1347550463457488e-12
carrier O 0 4.009259937931553e-12
of O 0 2.2146019393320948e-11
the O 0 1.0127710475815732e-10
185delAG O 0 3.6083978471879163e-08
mutation O 0 3.682234961388531e-08
. O 0 1.836805907373673e-08

BRCA1 O 0 1.428787300028489e-06
allelic O 0 9.962838731780721e-08
patterns O 0 2.6305582712105036e-10
were O 0 3.9035359146455395e-12
determined O 0 2.11187439064231e-11
for O 0 8.614667139361654e-13
four O 0 6.865540037523377e-13
of O 0 2.099463181429173e-12
these O 0 1.7541652538085456e-14
individuals O 0 3.1564049198786956e-14
and O 0 9.783954245737303e-13
for O 0 1.3436031801039583e-11
12 O 0 2.7039044336873985e-09
additional O 0 1.0805718819728583e-10
non O 0 1.7633420057450166e-08
- O 0 9.387590260701018e-09
Ashkenazi O 0 2.991106029526236e-09
185delAG O 0 6.410876690621237e-11
mutation O 0 1.3925497040212509e-12
carriers O 0 1.217112565246592e-12
who O 0 2.4543724691517e-11
had O 0 9.723681415607643e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.042667996138334274

Six O 0 4.105417517052956e-08
non O 0 1.0566518682253445e-07
- O 0 2.4720083757756584e-08
Ashkenazi O 0 1.0083235579827488e-08
individuals O 0 2.0575475188650688e-13
shared O 0 9.69678547527164e-13
the O 0 1.0088529837914972e-11
common O 0 7.041790067718878e-11
Ashkenazi O 0 2.1678724593243714e-08
haplotype O 0 2.719723397603957e-07
, O 0 2.656332653838689e-10
four O 0 3.9618495983884117e-11
had O 0 2.0129913014255152e-10
a O 0 9.35517028427535e-12
closely O 0 1.7003169705542831e-12
related O 0 8.887169472560075e-11
pattern O 0 4.4448245084538485e-09
, O 0 9.635708030086843e-12
and O 0 2.3140447891201177e-11
the O 0 4.85177631404099e-09
rest O 0 4.5246220103933865e-09
( O 0 3.858275643420228e-10
n O 0 2.4177174395845213e-07
= O 0 1.1646705644352551e-07
6 O 0 3.531889092300844e-08
) O 0 1.0377289305640858e-12
displayed O 0 1.683902366503287e-12
a O 0 3.0555124402864564e-11
distinct O 0 3.7420143372823844e-11
BRCA1 O 0 1.9521170457892367e-08
allelic O 0 1.256059931620257e-07
pattern O 0 8.936492434941101e-08
. O 0 9.672605827404368e-09

We O 0 4.148236953938067e-08
conclude O 0 7.248375055723955e-08
that O 0 8.632008302589256e-12
the O 0 7.643616295460731e-11
185delAG O 0 1.1951617473471288e-08
BRCA1 O 0 3.367042467061765e-08
mutation O 0 2.7932280932674303e-09
occurs O 0 3.2973564850768966e-11
in O 0 1.000201874448714e-12
some O 0 5.269218221470862e-12
non O 0 3.461984476871294e-08
- O 0 4.202269963116123e-07
Ashkenazi O 0 1.0281681284141087e-07
populations O 0 8.54339429062767e-12
at O 0 6.672449051614571e-12
rates O 0 1.7355964755660924e-12
comparable O 0 2.7812465872023573e-12
with O 0 1.7390484939681233e-13
that O 0 7.981387772915127e-11
of O 0 7.382288114143876e-09
Ashkenazim O 0 5.179537311050808e-06
. O 0 2.1908510561274852e-08

The O 0 4.0283523183859415e-09
majority O 0 3.190322658830347e-11
of O 0 4.399394459841943e-10
Jewish O 0 3.3999403292739316e-09
185delAG O 0 6.619286097020449e-08
mutation O 0 1.4017293992196755e-09
carriers O 0 6.555647084210969e-12
have O 0 2.428405241651499e-13
a O 0 2.595078449005306e-12
common O 0 2.3593208983707648e-11
allelic O 0 1.2552612282945574e-09
pattern O 0 2.735900950234793e-10
, O 0 3.460714787656416e-13
supporting O 0 9.562710866217738e-12
the O 0 2.1625674861969202e-10
founder O 0 2.0365265029909096e-09
effect O 0 6.746825764736286e-09
notion O 0 4.810676301758576e-10
, O 0 2.3725687213482782e-12
but O 0 7.120156786215304e-13
dating O 0 1.1531970690870086e-11
the O 0 1.006166417544252e-11
mutations O 0 2.223336315401725e-12
origin O 0 3.3451035994988554e-13
to O 0 4.823994068786641e-12
an O 0 4.678570356651812e-13
earlier O 0 2.299301721242486e-11
date O 0 1.2978399466234691e-09
than O 0 1.1962705999402079e-11
currently O 0 2.3352344363791744e-11
estimated O 0 1.0093390567789129e-09
. O 0 1.55970667492511e-08

However O 0 6.540869179616493e-09
, O 0 2.987613628713248e-11
the O 0 1.1269518304657389e-11
different O 0 1.4001134236371615e-12
allelic O 0 5.18480414157807e-09
pattern O 0 4.270903186665009e-09
at O 0 1.2785842384843704e-09
the O 0 1.1801802590749588e-10
BRCA1 O 0 1.6416783488182318e-09
locus O 0 1.516342162943829e-09
even O 0 4.423859282370879e-12
in O 0 5.377847689738702e-13
some O 0 2.2188785639594422e-13
Jewish O 0 1.808775490497183e-10
mutation O 0 7.267302731817082e-11
carriers O 0 5.001629319045797e-12
, O 0 1.85252941459213e-12
might O 0 7.684414909947535e-11
suggest O 0 1.1944882583048155e-10
that O 0 3.5745781334917126e-12
the O 0 5.077228221184171e-11
mutation O 0 1.9739800072304803e-11
arose O 0 2.7120364981536582e-11
independently O 0 4.274378767599174e-11
. O 0 6.934270518899055e-11
. O 0 3.4646450153275055e-09

Crystal O 0 2.686853576960857e-06
structure O 0 1.5001661779479036e-07
of O 0 6.323632078419905e-06
the O 0 1.753090873535257e-05
hemochromatosis B-Disease 1 1.0
protein O 0 0.0004229559563100338
HFE O 0 0.00010553962056292221
and O 0 7.967185799984122e-10
characterization O 0 3.196972997443481e-08
of O 0 1.3054102687704017e-08
its O 0 1.700789092895505e-10
interaction O 0 8.660971939633555e-11
with O 0 2.6471199364441755e-12
transferrin O 0 2.161733050343173e-07
receptor O 0 7.708881639700849e-07
. O 0 3.919808477803599e-08

HFE O 1 0.910476803779602
is O 0 8.93969431814412e-09
an O 0 4.915092777224572e-10
MHC O 0 1.7127467799582519e-06
- O 0 2.5957676825782983e-06
related O 0 3.605549281360254e-08
protein O 0 4.276063059194257e-09
that O 0 6.184211671401985e-13
is O 0 8.001342915054527e-14
mutated O 0 2.750043573938876e-13
in O 0 4.64271958551532e-13
the O 0 6.566963639542678e-11
iron B-Disease 0 0.16929566860198975
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.8989710211753845

HFE O 0 7.666867168154567e-05
binds O 0 2.3121996761688024e-08
to O 0 1.794701276480737e-08
transferrin O 0 2.3194995435460442e-07
receptor O 0 4.2980119019375707e-08
( O 0 1.0262114075176854e-10
TfR O 0 1.696925089333945e-08
) O 0 5.677095078759908e-13
and O 0 1.0711356931633609e-12
reduces O 0 3.241792945196664e-11
its O 0 2.349673190391033e-12
affinity O 0 1.522171555468077e-10
for O 0 2.2616269967912217e-10
iron O 0 7.425589387821674e-08
- O 0 5.172259953667435e-09
loaded O 0 4.910807524516336e-11
transferrin O 0 4.749067361586867e-09
, O 0 2.1019323434567916e-11
implicating O 0 1.4036939610662102e-08
HFE O 0 1.0738138371380046e-05
in O 0 6.56519461017524e-08
iron O 0 0.0014454699121415615
metabolism O 0 7.257240213220939e-05
. O 0 2.4644248242111644e-07

The O 0 1.4406692798729637e-06
2 O 0 1.454841549275443e-05
. O 0 1.4812090398663713e-07

6 O 0 3.832299626083113e-05
A O 0 9.59136855271936e-07
crystal O 0 1.8915553710030508e-06
structure O 0 1.8193065898230998e-07
of O 0 1.1341966228428646e-06
HFE O 0 0.12951338291168213
reveals O 0 9.02997232543612e-09
the O 0 7.012879166268249e-11
locations O 0 2.7244029254802626e-10
of O 0 1.0396963290304484e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 1.6859759170984034e-06
and O 0 3.796758463181504e-09
a O 0 2.9305196491691277e-08
patch O 0 0.00987797137349844
of O 0 0.00014593701052945107
histidines O 0 0.00022404691844712943
that O 0 8.617803137767055e-10
could O 0 2.3651893776843735e-09
be O 0 9.998309125069937e-11
involved O 0 5.329411217891433e-11
in O 0 1.968262774987295e-10
pH O 0 1.2643921763810795e-05
- O 0 6.1196901697258e-06
dependent O 0 7.170949061219289e-07
interactions O 0 9.592248773060419e-08
. O 0 4.154349753093811e-08

We O 0 3.3298854873464734e-07
also O 0 8.256798023076328e-10
demonstrate O 0 5.764394517271398e-10
that O 0 1.3366513451629203e-10
soluble O 0 1.3295958467551827e-07
TfR O 0 1.0743075762320586e-07
and O 0 9.692208841061145e-11
HFE O 0 2.131811953631768e-07
bind O 0 7.637455112785574e-10
tightly O 0 2.1204080158376826e-10
at O 0 1.5703079114803842e-10
the O 0 2.8144080815861727e-11
basic O 0 3.3967625934216983e-10
pH O 0 6.156804488455236e-08
of O 0 3.5812099952181597e-09
the O 0 4.301125677841355e-09
cell O 0 6.993864598570099e-09
surface O 0 2.7638066057988908e-08
, O 0 6.469617896964763e-11
but O 0 6.291341753117408e-11
not O 0 4.3036019192754793e-10
at O 0 3.867922426792347e-09
the O 0 1.7607734159597044e-09
acidic O 0 8.750581628191867e-07
pH O 0 4.415473995322827e-06
of O 0 2.3848105001889053e-07
intracellular O 0 3.4632199685802334e-07
vesicles O 0 3.385619947948726e-06
. O 0 1.0552077611691857e-07

TfR O 0 0.0002552637888584286
HFE O 0 0.00015107363287825137
stoichiometry O 0 1.1810877822426846e-06
( O 0 2.36835373534916e-09
2 O 0 4.5868964093642717e-07
1 O 0 1.4579376284018508e-07
) O 0 7.043411860696569e-12
differs O 0 4.407866779909675e-11
from O 0 2.0018264823562504e-10
TfR O 0 1.563748774913165e-08
transferrin O 0 7.78040387672263e-09
stoichiometry O 0 1.1295008262024453e-09
( O 0 3.515927479713632e-11
2 O 0 9.600463535264225e-09
2 O 0 5.251988177690237e-09
) O 0 2.5824034750876468e-12
, O 0 2.0334027430596313e-12
implying O 0 3.5175640178408685e-11
a O 0 6.551997226017514e-12
different O 0 9.385041707535638e-14
mode O 0 2.178505119354579e-11
of O 0 2.527147545047792e-12
binding O 0 3.0564872854910163e-10
for O 0 1.190930271066648e-10
HFE O 0 1.0831791996679385e-06
and O 0 3.2965341567603446e-10
transferrin O 0 2.2714125691436493e-08
to O 0 5.623759680162266e-09
TfR O 0 4.9270930446709826e-08
, O 0 5.259297771592619e-12
consistent O 0 4.2878766509657495e-11
with O 0 6.01439742193427e-13
our O 0 1.0654742366167369e-10
demonstration O 0 1.243389002869577e-10
that O 0 1.3669919363135108e-11
HFE O 0 6.561538725691207e-07
, O 0 6.497838378471954e-11
transferrin O 0 2.425615264201042e-08
, O 0 1.0296601765658053e-10
and O 0 7.041991295642092e-11
TfR O 0 1.6313599360273656e-08
form O 0 3.535078479943721e-11
a O 0 9.758882590915618e-10
ternary O 0 9.338143769355156e-08
complex O 0 1.0806908790073066e-07
. O 0 3.9051521127930755e-08

Identification O 0 1.0760374813401086e-09
of O 0 6.641741046031768e-10
three O 0 1.4805422512975674e-11
novel O 0 6.385749568016408e-11
mutations O 0 1.5028912142556194e-11
and O 0 7.351277247526211e-13
a O 0 1.3109200357186435e-11
high O 0 5.551669124415071e-10
frequency O 0 1.3585715885611194e-09
of O 0 1.5612409975940267e-10
the O 0 1.322001397241479e-10
Arg778Leu O 0 1.414148016465333e-07
mutation O 0 1.4872084119765816e-10
in O 0 1.5002018724508126e-11
Korean O 0 1.2496808032835816e-09
patients O 0 7.839365441519863e-12
with O 0 1.7909976886970602e-12
Wilson B-Disease 0 1.4815353210906324e-07
disease I-Disease 0 8.953944075074105e-07
. O 0 1.4913714707631698e-08

Four O 0 1.939380211979369e-08
mutations O 0 1.4762971956017168e-09
- O 0 5.0491979486366745e-09
- O 0 1.691415540960861e-08
R778L O 0 7.253851777022646e-07
, O 0 2.9488106401132086e-11
A874V O 0 1.446954769335207e-07
, O 0 2.689017584989184e-11
L1083F O 0 7.685071068408433e-08
, O 0 9.660440850045582e-12
and O 0 7.43166812811058e-12
2304delC O 0 3.7205536429496533e-09
- O 0 7.83771803014588e-09
- O 0 1.635073054728764e-08
in O 0 1.0234948444320935e-09
the O 0 8.941894336089717e-09
copper O 0 2.6492973148606325e-08
- O 0 6.915996664247359e-09
transporting O 0 7.293732284807675e-10
enzyme O 0 1.3530007669793065e-10
, O 0 1.708617622386832e-11
P O 0 9.712912429904463e-08
- O 0 8.553772690156336e-10
type O 0 4.42404946010555e-10
ATPase O 0 2.0960773117195686e-09
( O 0 2.1705738335181524e-12
ATP7B O 0 1.5987686197149742e-07
) O 0 3.365017953952526e-13
, O 0 1.038831428648232e-13
were O 0 2.5251708276469165e-13
identified O 0 9.531639800358649e-13
in O 0 5.679402260982958e-13
Korean O 0 1.6415148407222802e-10
Patients O 0 9.133404102468212e-12
with O 0 1.6159528142684065e-12
Wilson B-Disease 0 2.2853635073261103e-06
disease I-Disease 0 0.0005971199716441333
. O 0 3.6852392781838716e-07

Arg778Leu O 0 0.0021262275986373425
, O 0 2.161967493918837e-08
the O 0 4.215440885246835e-09
most O 0 1.4159022912463293e-11
frequently O 0 1.295921616545348e-11
reported O 0 1.6540350686322647e-11
mutation O 0 1.680543898485709e-11
of O 0 7.352518593961577e-11
this O 0 2.0415726401101786e-11
enzyme O 0 1.4877957199566083e-10
, O 0 4.476416199522548e-12
was O 0 1.6504622668556124e-10
found O 0 2.0280798524938137e-13
in O 0 2.5047265693814436e-13
six O 0 5.69718751342041e-12
of O 0 2.3111292393740435e-11
eight O 0 3.41278810767065e-11
unrelated O 0 6.641462380052587e-10
patients O 0 1.0780598636017658e-11
studied O 0 4.913946333173769e-11
, O 0 6.244519333044318e-13
an O 0 8.289703016910177e-13
allele O 0 3.190352843018829e-11
frequency O 0 4.6565906686169e-09
of O 0 5.469000807778457e-09
37 O 0 9.09401407511723e-08
. O 0 7.093034604110926e-09

5 O 0 5.100281669001561e-06
% O 0 4.649803031497868e-08
, O 0 1.31939598135844e-11
which O 0 4.806250449712612e-12
is O 0 3.4981995598870608e-12
considerably O 0 6.605693769756726e-11
higher O 0 1.5039615386402971e-10
than O 0 3.2292144219042695e-12
those O 0 1.1239545535599027e-12
in O 0 5.203322581831538e-12
other O 0 4.906133659055012e-12
Asian O 0 1.6720719253626726e-10
populations O 0 2.6610678938165933e-11
. O 0 1.0987619702973461e-09

The O 0 1.5695510446889216e-09
novel O 0 2.038297725048821e-10
single O 0 8.68572019863123e-11
nucleotide O 0 4.489820182307369e-10
deletion O 0 2.013698985336987e-09
, O 0 4.736197111582241e-12
2304delC O 0 5.389019896995251e-09
, O 0 8.577753091154605e-11
was O 0 5.915125278477262e-09
found O 0 1.8197303039424462e-11
in O 0 1.3812890935216426e-11
one O 0 1.2864113940747046e-10
patient O 0 6.604339297666684e-09
. O 0 3.251365043865917e-08

Since O 0 8.613357493914009e-08
a O 0 6.908455585374895e-09
mutation O 0 2.6924125151595035e-09
at O 0 2.768669737918117e-09
cDNA O 0 6.503152238934717e-09
nucleotide O 0 5.506811362465669e-08
2302 O 0 1.0172867632718408e-06
( O 0 7.722937740706204e-12
2302insC O 0 3.569392115210235e-09
) O 0 1.8556246816903155e-11
had O 0 2.384721031756243e-10
been O 0 1.3815736749078766e-11
previously O 0 8.078994070959133e-12
described O 0 5.389114501874737e-12
, O 0 1.6730518880014866e-13
this O 0 9.973652763048402e-13
region O 0 1.5794191510209998e-09
of O 0 2.4888162641900635e-09
the O 0 1.6406993097461964e-08
ATP7B O 1 0.994763195514679
gene O 0 3.955360483587356e-09
may O 0 1.607385691215768e-08
be O 0 7.544676550175211e-10
susceptible O 0 3.0945138007609785e-08
to O 0 6.100135863107425e-08
gene O 0 3.688617766783864e-08
rearrangements O 0 0.00127401074860245
causing O 1 0.999942421913147
Wilson B-Disease 0 0.023136453703045845
disease I-Disease 1 0.9938653111457825
. O 0 8.765966867940733e-07

Disruption O 0 4.321765300119296e-05
of O 0 2.3542139615528868e-07
splicing O 0 1.4390267866204454e-09
regulated O 0 8.462982918622242e-12
by O 0 2.2345161474184722e-13
a O 0 1.7255761056156338e-11
CUG O 0 2.4371354356844677e-07
- O 0 5.569752437040165e-10
binding O 0 4.1128060956907575e-09
protein O 0 1.3240315510643086e-08
in O 0 8.207589607955867e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.000109958513348829

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.5778549595779623e-06
DM B-Disease 1 1.0
) O 0 1.6106196376597381e-09
is O 0 7.206211322108302e-11
caused O 0 1.3032128709511426e-09
by O 0 4.6132767744788694e-11
a O 0 6.1142517715495615e-09
CTG O 0 2.0637294255720917e-06
expansion O 0 1.8293682124692623e-09
in O 0 2.2697935544990777e-11
the O 0 1.3988654679053525e-10
3 O 0 1.6027691174258507e-08
untranslated O 0 1.9480094124446623e-06
region O 0 6.975173327816719e-09
of O 0 4.343085890923248e-09
the O 0 4.80590287565974e-08
DM B-Disease 1 1.0
gene O 0 6.752376435770202e-08
. O 0 1.0183818233144848e-08

One O 0 5.147122728033082e-10
model O 0 3.291175110220479e-10
of O 0 2.0488158725129324e-08
DM B-Disease 1 1.0
pathogenesis O 0 0.0019842658657580614
suggests O 0 1.1693004342561153e-09
that O 0 2.2152186335278046e-11
RNAs O 0 7.068774454666027e-10
from O 0 6.18617657099918e-11
the O 0 1.122348481513713e-11
expanded O 0 1.4973196293954771e-12
allele O 0 1.809689030574102e-11
create O 0 2.0546151585643102e-12
a O 0 8.340558105279783e-11
gain O 0 1.329796983640108e-08
- O 0 1.158653439858881e-08
of O 0 4.893860428012431e-09
- O 0 7.3519652588061035e-09
function O 0 7.610230501331472e-11
mutation O 0 1.3704999591787614e-12
by O 0 7.227149380253234e-14
the O 0 2.669984025538419e-12
inappropriate O 0 3.7377344275224544e-11
binding O 0 8.771702475485199e-09
of O 0 7.4067592059634535e-09
proteins O 0 8.670206913530265e-12
to O 0 4.1741546330520407e-10
the O 0 1.8676673541051514e-09
CUG O 0 0.00022032340348232538
repeats O 0 4.3980148234368244e-07
. O 0 2.202465054779168e-08

Data O 0 8.139777740723275e-09
presented O 0 2.209262994767869e-09
here O 0 1.5196688352148158e-09
indicate O 0 2.1687398543690506e-09
that O 0 2.974621243767572e-11
the O 0 3.4225683398503293e-10
conserved O 0 2.930160558634043e-09
heterogeneous O 0 1.9128076900187807e-09
nuclear O 0 2.3170134682004573e-06
ribonucleoprotein O 0 4.973234695171413e-07
, O 0 2.909553153962463e-10
CUG O 0 5.02923342082795e-07
- O 0 9.301517334137088e-10
binding O 0 4.179015800076513e-09
protein O 0 3.110897373037602e-10
( O 0 6.727228366379401e-13
CUG O 0 3.2093026902657584e-07
- O 0 9.33098398547827e-09
BP O 0 2.0032727832131059e-07
) O 0 4.912032152554202e-12
, O 0 2.66958677386242e-12
may O 0 5.922143886394338e-10
mediate O 0 1.2722907172246778e-07
the O 0 6.7206245013551325e-09
trans O 0 1.905609359198479e-08
- O 0 8.35594793358041e-09
dominant O 0 1.1071981109722628e-09
effect O 0 9.02454910800543e-09
of O 0 8.093145043019945e-10
the O 0 7.064838714043731e-10
RNA O 0 1.9566872566656457e-08
. O 0 8.550004593210758e-10

CUG O 0 0.03529799357056618
- O 0 0.0003439581487327814
BP O 0 0.0006431845831684768
was O 0 8.871685253097894e-08
found O 0 6.460908197336579e-12
to O 0 1.32893279713997e-11
bind O 0 1.4591964789256728e-11
to O 0 1.4972439954519245e-10
the O 0 2.680544120003958e-10
human O 0 2.7282889281110556e-09
cardiac O 0 3.023221142939292e-05
troponin O 0 4.0181770600611344e-05
T O 0 1.5116469512577169e-05
( O 0 6.735134672197773e-10
cTNT O 0 1.6292553084440442e-07
) O 0 2.56157525746481e-11
pre O 0 1.4029498451861855e-08
- O 0 7.526695933179894e-10
messenger O 0 4.3202622035387606e-11
RNA O 0 9.054090810423077e-11
and O 0 1.5102783390216756e-12
regulate O 0 3.0420139063985774e-12
its O 0 6.890780806199925e-13
alternative O 0 7.832360454651521e-11
splicing O 0 7.640952315313143e-10
. O 0 4.4219738981610135e-10

Splicing O 0 3.6161008409862916e-08
of O 0 9.303580128516842e-09
cTNT O 0 4.435783466760768e-06
was O 0 9.893380337189228e-08
disrupted O 0 1.8272181989686942e-07
in O 0 3.796953862433838e-09
DM B-Disease 1 1.0
striated O 0 6.829782250861172e-07
muscle O 0 7.251750133718815e-08
and O 0 1.6214013465187804e-09
in O 0 4.873655701231883e-09
normal O 0 4.532056721018307e-07
cells O 0 1.426255114012065e-09
expressing O 0 6.338557456686544e-11
transcripts O 0 8.219668279352277e-10
that O 0 4.745803056094289e-11
contain O 0 1.3221483907699394e-09
CUG O 0 5.514330405276269e-05
repeats O 0 9.655298072175356e-07
. O 0 1.7642840077769506e-08

Altered O 0 9.611149209831638e-08
expression O 0 4.854164625811563e-09
of O 0 2.3538136773026963e-08
genes O 0 6.107068739602539e-10
regulated O 0 5.108489742333688e-10
posttranscriptionally O 0 2.8314051547795316e-08
by O 0 5.461991969823998e-10
CUG O 0 0.006092584691941738
- O 0 1.1854054719151463e-05
BP O 0 9.092051186598837e-06
therefore O 0 1.2024529150167496e-09
may O 0 4.037850609428517e-10
contribute O 0 2.3130442006191743e-10
to O 0 1.0114212045664317e-07
DM B-Disease 1 1.0
pathogenesis O 0 9.405115633853711e-06
. O 0 1.0104254100085086e-09
. O 0 4.622044968982664e-09

Identification O 0 9.72721680980726e-10
of O 0 5.143628856174587e-10
a O 0 8.325554134991364e-11
novel O 0 3.352403077361288e-10
nonsense O 0 8.61297611010059e-09
mutation O 0 1.3419083899623985e-10
and O 0 1.942930842255275e-12
a O 0 2.803772838899654e-11
missense O 0 5.0348982760795025e-09
substitution O 0 6.497569149388482e-10
in O 0 4.224999516910799e-11
the O 0 1.332903787343298e-10
vasopressin O 0 3.771309486921837e-09
- O 0 2.7961293724843017e-08
neurophysin O 0 6.536999421768996e-07
II O 0 1.2919391338073183e-05
gene O 0 1.2070335182745584e-11
in O 0 1.3978052656321571e-12
two O 0 4.4991915466689736e-13
Spanish O 0 1.3302826895600361e-10
kindreds O 0 2.395555220857659e-08
with O 0 1.0203478686965362e-11
familial B-Disease 0 0.005030580330640078
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 3.4293002499907743e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.4044304386118256e-08
FNDI B-Disease 1 1.0
) O 0 1.613819147761042e-11
is O 0 1.9989095014633085e-12
an O 0 1.6698465526987505e-11
autosomal B-Disease 1 0.9912441968917847
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.183049607789144e-05
by O 0 8.246603400152708e-09
deficiency O 1 0.9999862909317017
in O 0 2.3603472527611302e-06
the O 0 9.57935208134586e-06
antidiuretic O 0 1.9856521760175383e-07
hormone O 0 1.1564808666264526e-08
arginine O 0 3.427928874089048e-08
vasopressin O 0 4.371494810584409e-08
( O 0 4.0072381524147715e-10
AVP O 0 3.769937606534768e-08
) O 0 5.54594246232349e-14
encoded O 0 8.637330488423661e-15
by O 0 3.4649813942556895e-13
the O 0 1.1015417744619782e-10
AVP O 0 3.586650052511686e-07
- O 0 3.720938579476751e-08
neurophysin O 0 2.4371220206376165e-06
II O 0 0.0007099361391738057
( O 0 2.0083835039486075e-08
AVP O 0 1.3226960618339945e-05
- O 0 4.935897095492692e-07
NPII O 0 1.8453816664987244e-05
) O 0 3.8993409195997586e-11
gene O 0 2.5697083350095795e-11
on O 0 2.5924651314568337e-09
chromosome O 0 2.609416242194129e-06
20p13 O 0 6.902065797476098e-05
. O 0 1.7145512742899882e-07

In O 0 1.252587988886944e-08
this O 0 1.2109088176615046e-09
study O 0 1.4174844631398287e-09
, O 0 3.1350734508439615e-11
we O 0 4.547570653379296e-11
analyzed O 0 2.2571958191441865e-11
two O 0 6.883424494459611e-13
families O 0 1.3159020314373882e-12
with O 0 7.996865322712488e-12
FNDI B-Disease 1 1.0
using O 0 1.0545554651741895e-08
direct O 0 5.5491337747071157e-08
automated O 0 1.4090829836277408e-08
fluorescent O 0 2.0070038964092873e-09
, O 0 8.468509921089051e-11
solid O 0 8.868462630928775e-10
phase O 0 2.3725192477286328e-08
, O 0 2.43893533841133e-11
single O 0 8.710539234346726e-11
- O 0 1.3552019506590796e-09
stranded O 0 1.9756460356568084e-10
DNA O 0 1.5486850083595849e-12
sequencing O 0 5.489378483020113e-13
of O 0 4.02652564068795e-12
PCR O 0 4.899779471045917e-10
- O 0 1.914180813855637e-08
amplified O 0 3.258740832734475e-08
AVP O 0 7.946156870275445e-07
- O 0 3.0607608891841664e-08
NPII O 0 3.4836491522582946e-06
DNA O 0 1.1139983158159339e-08
. O 0 6.802993723908912e-10

In O 0 7.971396320805013e-10
one O 0 3.1458675942008796e-11
of O 0 3.445937632462481e-11
the O 0 8.974635271052911e-12
families O 0 9.563180325758425e-13
, O 0 3.391125542265977e-13
affected O 0 1.308528697722966e-12
individuals O 0 1.0906375900055637e-13
presented O 0 1.0403241462730861e-10
a O 0 1.7957781095478964e-10
novel O 0 1.2949610828094649e-10
nonsense O 0 9.846196080687264e-10
mutation O 0 2.995824768814437e-11
in O 0 5.393752285087761e-12
exon O 0 1.246128894516474e-10
3 O 0 2.330244663895087e-09
of O 0 2.2387174059002035e-10
the O 0 9.874627504569133e-11
gene O 0 1.3767564562353063e-12
, O 0 4.276902454154047e-13
consisting O 0 2.0900409224491878e-13
in O 0 1.3207254734304286e-11
a O 0 7.46929451622691e-09
G O 0 1.2891141523141414e-06
to O 0 4.545609328943101e-07
T O 0 1.648301690693188e-06
transition O 0 9.830573333147186e-08
at O 0 1.2255782166903373e-08
nucleotide O 0 3.06154146478832e-09
2101 O 0 5.577465600481446e-08
, O 0 7.632172346373756e-13
which O 0 1.0224468976549952e-13
produces O 0 2.2155459975317648e-13
a O 0 1.1116066400695956e-11
stop O 0 2.979460289598279e-10
signal O 0 1.1317262682553064e-09
in O 0 1.4377805890308792e-10
codon O 0 2.25645884199821e-08
82 O 0 7.394016421358174e-08
( O 0 6.258145668347481e-10
Glu O 0 1.0518981241602887e-07
) O 0 1.6541613565013158e-11
of O 0 8.347023627841565e-10
NPII O 0 0.000466334808152169
. O 0 6.158636267628026e-08

The O 0 2.0505463282916025e-07
premature O 0 3.300034222775139e-06
termination O 0 2.1318394374247873e-06
eliminates O 0 1.0266161609706614e-07
part O 0 2.966046297459002e-09
of O 0 1.8738948170948788e-08
the O 0 4.457092028786747e-09
C O 0 3.862617177219363e-07
- O 0 4.723916369187009e-09
terminal O 0 3.64323016199819e-09
domain O 0 1.1498291208056344e-09
of O 0 1.7119199113846406e-10
NPII O 0 9.044383091350028e-07
, O 0 1.6911033337563275e-11
including O 0 1.8726227166143694e-12
a O 0 4.134220465967786e-10
cysteine O 0 1.8898872744532724e-10
residue O 0 7.2499211078991266e-09
in O 0 1.3102325648051139e-11
position O 0 1.9241512827505858e-09
85 O 0 2.785205621691489e-09
, O 0 2.2345088019487536e-12
which O 0 6.924562377490229e-13
could O 0 4.7102721029146366e-11
be O 0 3.773521772831856e-11
involved O 0 1.2363035942208889e-11
in O 0 6.318878580102716e-12
the O 0 1.0170491532290882e-10
correct O 0 1.667143934014348e-08
folding O 0 8.827424125001926e-09
of O 0 1.7984010947103002e-09
the O 0 1.5023575272721246e-08
prohormone O 0 7.827483932487667e-05
. O 0 1.425263747023564e-07

In O 0 2.4286233024639614e-09
the O 0 1.2969837426268782e-09
second O 0 7.3027424107863226e-09
family O 0 3.246545046686755e-11
, O 0 3.2389236691993117e-12
a O 0 8.603116136152167e-11
G279A O 0 6.330857615921559e-08
substitution O 0 9.55528101087566e-10
at O 0 2.6940718544921083e-09
position O 0 2.9697202474920914e-09
- O 0 2.742673643751914e-09
1 O 0 1.1007725220224529e-07
of O 0 8.607683454897597e-10
the O 0 1.3884851601808634e-10
signal O 0 5.966259153389331e-10
peptide O 0 9.40132416360484e-11
was O 0 3.535727544079492e-10
observed O 0 6.910329513470925e-12
in O 0 9.33630560015497e-13
all O 0 1.2635731220025925e-12
affected O 0 9.560577156342287e-12
individuals O 0 1.5144214007833945e-11
. O 0 1.161241947045255e-08

This O 0 2.8110862970720518e-08
missense O 0 3.674052322821808e-06
mutation O 0 1.3463044012951286e-07
, O 0 9.347201485043755e-11
which O 0 7.767569920602568e-11
replaces O 0 5.4443887620436726e-08
Ala O 0 2.6478505787963513e-07
with O 0 1.0438123282385803e-10
Thr O 0 5.835854040014965e-07
, O 0 2.7332707278060475e-11
is O 0 5.458050678086579e-12
frequent O 0 1.9710541532269588e-10
among O 0 7.285650555077794e-11
FNDI B-Disease 1 1.0
patients O 0 2.436457009480364e-07
and O 0 4.669618025587852e-10
is O 0 3.806922832527704e-10
thought O 0 2.892786565844574e-10
to O 0 1.346960765147287e-09
reduce O 0 2.205086779838439e-09
the O 0 2.447763103319289e-10
efficiency O 0 4.768889727557735e-10
of O 0 2.604909898895613e-10
cleavage O 0 2.159938672363637e-09
by O 0 1.882925065865848e-10
signal O 0 1.0445068454600914e-07
peptidases O 0 2.9936794021523383e-07
. O 0 1.0744050094046997e-09
. O 0 2.656146635970913e-09

Genetic O 0 2.867277260065748e-07
heterogeneity O 0 3.866579163513961e-07
of O 0 4.931079544689965e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.041836643153829e-09
due O 0 1.088991893993807e-06
to O 0 7.901317644609662e-08
TWIST O 0 7.702026778133586e-06
and O 0 1.0486145285426574e-08
FGFR O 0 0.005923713557422161
mutations O 0 5.387880719354143e-07
. O 0 9.814180401690464e-08

Thirty O 0 3.10875861941895e-06
- O 0 1.1725487070179952e-07
two O 0 2.5068511502746027e-11
unrelated O 0 1.4461423170075705e-09
patients O 0 1.3889818115120356e-12
with O 0 2.9599225411040255e-15
features O 0 1.9479799446674856e-13
of O 0 1.6525136814493635e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.98284503935853e-11
a O 0 4.866693506522246e-11
common O 0 2.999464232544824e-09
autosomal B-Disease 0 5.218726528255502e-06
dominant I-Disease 0 2.7784912163042463e-05
condition I-Disease 1 0.9267368912696838
of O 1 0.7409496307373047
craniosynostosis B-Disease 1 1.0
and O 1 0.9920868277549744
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999985694885254
, O 0 2.8351379022240053e-09
were O 0 4.741661507878803e-10
screened O 0 7.623687237057197e-10
for O 0 2.7192310902979244e-11
mutations O 0 8.621250935370028e-11
in O 0 1.4337822595855698e-10
TWIST O 0 1.3737266044699936e-06
, O 0 3.876709508965348e-10
FGFR2 O 0 0.0001366989890811965
, O 0 5.432692629092628e-10
and O 0 2.397267939713288e-09
FGFR3 O 1 0.9144618511199951
. O 0 6.398096275006537e-07

Nine O 0 1.636820456951682e-08
novel O 0 4.268107811622457e-10
and O 0 4.455013441484468e-11
three O 0 4.472902256913436e-11
recurrent O 0 3.317305470318388e-07
TWIST O 0 1.9364440959179774e-05
mutations O 0 2.4958008992825853e-08
were O 0 8.638056936405292e-11
found O 0 1.661135205083264e-12
in O 0 4.377242925762692e-12
12 O 0 5.784350776139036e-10
families O 0 6.481796349655511e-11
. O 0 9.062617323252198e-09

Seven O 0 1.7419809594798608e-08
families O 0 1.0559190327663615e-10
were O 0 1.1231821028800937e-10
found O 0 4.650281895668407e-12
to O 0 4.0608336138170387e-11
have O 0 4.314660174281615e-12
the O 0 1.0354444385241024e-10
FGFR3 O 0 3.858559466607403e-06
P250R O 0 8.131973459057917e-07
mutation O 0 8.798575201751646e-10
, O 0 4.472814479905551e-12
and O 0 2.0071539916233228e-12
one O 0 6.6063456788389985e-12
individual O 0 1.451346096255357e-12
was O 0 5.784243750639462e-09
found O 0 1.854934608691572e-11
to O 0 1.2347299571668913e-10
have O 0 7.27235979769425e-12
an O 0 1.7541956776057077e-10
FGFR2 O 0 0.0002727076062001288
VV269 O 0 2.4661161660333164e-05
- O 0 8.213170303861261e-07
270 O 0 9.163958480939982e-08
deletion O 0 1.4471466158738622e-07
. O 0 8.856128275169795e-09

To O 0 8.6368174834206e-08
date O 0 6.97177711117547e-07
, O 0 1.7315379685634014e-10
our O 0 4.4029432877401575e-11
detection O 0 4.4031972512570405e-10
rate O 0 2.17693519460882e-11
for O 0 4.901201514952158e-13
TWIST O 0 5.1579974069682066e-08
or O 0 3.0592184341315942e-09
FGFR O 0 5.339143899618648e-05
mutations O 0 5.897706212287801e-10
is O 0 3.5812386042777256e-12
68 O 0 1.9954907171104708e-10
% O 0 3.1623735748109727e-12
in O 0 3.5678464306229674e-13
our O 0 6.753667763925719e-11
Saethre B-Disease 1 0.9666635990142822
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.1991142301326363e-08
, O 0 6.09791384054148e-12
including O 0 5.3028120089448905e-12
our O 0 2.9763094211432417e-09
five O 0 2.8929741935357356e-10
patients O 0 8.107226695530656e-12
elsewhere O 0 2.57410880805109e-11
reported O 0 1.322889298105423e-10
with O 0 2.912039012703538e-11
TWIST O 0 3.843989907181822e-05
mutations O 0 7.121314524738409e-07
. O 0 1.3964948664124677e-07

More O 0 1.9049968547069085e-10
than O 0 4.73968746195208e-11
35 O 0 5.019237248049535e-10
different O 0 4.0189734678251765e-13
TWIST O 0 3.910153267838723e-08
mutations O 0 1.3576597623909947e-09
are O 0 3.3349362225758294e-13
now O 0 7.870314643054765e-13
known O 0 7.928351443246828e-13
in O 0 1.3625035344758119e-12
the O 0 1.3327862251333311e-11
literature O 0 1.5156820243333868e-10
. O 0 1.4657084435043544e-09

The O 0 4.487906579697665e-08
most O 0 1.8640033960792834e-11
common O 0 1.005487273303407e-11
phenotypic O 0 2.6323149215912167e-10
features O 0 8.102121404340856e-13
, O 0 3.1128942739461207e-12
present O 0 5.82916744387707e-12
in O 0 7.403297267762066e-13
more O 0 1.959747942810279e-14
than O 0 2.8007232492389955e-13
a O 0 1.574355749933698e-11
third O 0 7.963069093008812e-10
of O 0 1.7593558554462874e-10
our O 0 3.1832415176014095e-11
patients O 0 5.326143714436127e-13
with O 0 5.226914279003736e-13
TWIST O 0 2.143500523743569e-06
mutations O 0 3.2825333562414016e-08
, O 0 5.968509020348733e-11
are O 0 1.5118123766755254e-11
coronal B-Disease 0 0.0001874458830570802
synostosis I-Disease 0 3.816609751083888e-05
, O 0 2.47161485722458e-10
brachycephaly B-Disease 0 2.5968024601752404e-06
, O 0 4.587306923209411e-10
low B-Disease 0 6.522385774587747e-06
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 1.2284667150197492e-07
facial B-Disease 1 0.8572250604629517
asymmetry I-Disease 1 0.9999274015426636
, O 0 3.224174349725217e-08
ptosis B-Disease 1 0.9572117924690247
, O 0 7.568894844212082e-09
hypertelorism B-Disease 0 3.697785359690897e-05
, O 0 1.9307133669599352e-09
broad B-Disease 0 2.1662497601937503e-05
great I-Disease 0 0.0026831207796931267
toes I-Disease 1 0.9699021577835083
, O 0 3.734160980428669e-09
and O 0 6.493955151398723e-09
clinodactyly B-Disease 0 0.0024739662185311317
. O 0 2.6355087356932927e-06

Significant O 0 2.0281063370930497e-06
intra O 0 0.0005230114329606295
- O 0 2.364736246818211e-06
and O 0 9.821849999980259e-10
interfamilial O 0 9.675992487245821e-07
phenotypic O 0 5.052428164731282e-08
variability O 0 4.678667266944103e-07
is O 0 1.5375066671208248e-12
present O 0 1.0539662675598804e-12
for O 0 1.4573794645048044e-12
either O 0 4.161649636014175e-10
TWIST O 0 8.776506774665904e-07
mutations O 0 1.4018637806145762e-08
or O 0 7.0433689991489246e-09
FGFR O 0 0.0004980314988642931
mutations O 0 1.8369676979546057e-07
. O 0 1.9783779947601943e-08

The O 0 5.374785061462717e-08
overlap O 0 1.5978974587937955e-08
in O 0 1.2072459698586613e-10
clinical O 0 6.684851006077963e-10
features O 0 3.8503374750684105e-13
and O 0 6.169064824951276e-12
the O 0 5.492306609511388e-11
presence O 0 6.9176483118160714e-12
, O 0 9.981454681881607e-13
in O 0 1.746308718290901e-12
the O 0 1.5258334526424555e-11
same O 0 2.865743926883102e-11
genes O 0 6.839533713692836e-12
, O 0 1.6306223949227872e-12
of O 0 3.759757088994675e-11
mutations O 0 9.145414460454138e-12
for O 0 4.659797396035226e-13
more O 0 4.4276112995140365e-14
than O 0 5.442269898625618e-12
one O 0 4.647535134516545e-11
craniosynostotic B-Disease 0 3.551175211669033e-07
condition I-Disease 0 1.5902212169294216e-07
- O 0 6.118031414814595e-09
such O 0 6.203282245514918e-12
as O 0 1.5224736749086532e-10
Saethre B-Disease 0 1.1056205551085441e-07
- I-Disease 0 1.7338463109695113e-08
Chotzen I-Disease 0 3.7709810385422315e-07
, I-Disease 0 3.246823990221692e-11
Crouzon I-Disease 0 4.2976284930773545e-06
, I-Disease 0 9.28342125394721e-10
and I-Disease 0 7.075549923740709e-09
Pfeiffer I-Disease 0 0.00434613972902298
syndromes I-Disease 0 1.539284312457312e-05
- O 0 7.699036359554157e-07
support O 0 1.8056576678304737e-08
the O 0 8.263737782954195e-08
hypothesis O 0 4.412020260247118e-08
that O 0 1.0545619932855743e-11
TWIST O 0 1.746272282332484e-08
and O 0 3.891390681909357e-11
FGFRs O 0 3.1772408704000554e-08
are O 0 1.3397868968770266e-12
components O 0 4.1165456460268146e-11
of O 0 9.595932382033823e-11
the O 0 7.227284742894469e-11
same O 0 8.626975522840752e-11
molecular O 0 3.320900499037549e-10
pathway O 0 1.205766320122592e-10
involved O 0 3.337367003846542e-13
in O 0 4.808684646220168e-14
the O 0 4.4954513202244417e-13
modulation O 0 6.591797940824762e-11
of O 0 6.977871058744256e-10
craniofacial O 0 0.04221407696604729
and O 0 8.259578976321791e-08
limb O 1 1.0
development O 0 1.290907903239713e-06
in O 0 6.517009154549669e-09
humans O 0 9.621705654438983e-10
. O 0 1.8408725932506087e-10
. O 0 2.3174657748370464e-09

Mutation O 0 2.9375695209665764e-09
analysis O 0 2.757757217031198e-11
of O 0 7.979550353809373e-10
UBE3A O 1 0.99997878074646
in O 0 5.086590681457892e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.19494295120239258
. O 0 1.0862391945920535e-06

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.202021505581797e-06
AS B-Disease 1 1.0
) O 0 2.8096253101850266e-10
is O 0 2.4071898988009544e-11
caused O 0 5.104671685352002e-10
by O 0 9.156118224717957e-11
chromosome O 0 5.027443876315374e-06
15q11 O 0 4.914516830467619e-05
- O 0 6.71979364597064e-07
q13 O 0 7.708337648182351e-07
deletions O 0 1.2440729557638974e-09
of O 0 5.75852587836323e-10
maternal O 0 4.6135717468587245e-09
origin O 0 4.0861310862672084e-11
, O 0 1.0443848477009743e-12
by O 0 7.034040884479342e-12
paternal O 0 9.42543863402534e-07
uniparental B-Disease 0 0.0010710825445130467
disomy I-Disease 0 0.0006567410891875625
( O 0 3.354517019715786e-08
UPD B-Disease 1 1.0
) O 0 2.9421770575410733e-10
15 O 0 1.762480272837763e-09
, O 0 8.888736643432316e-13
by O 0 2.0591238783507215e-11
imprinting O 0 2.1681304133380763e-05
defects O 0 0.0013860856415703893
, O 0 4.452150800804411e-11
and O 0 9.43577507794835e-12
by O 0 4.9599171991765445e-11
mutations O 0 1.3998137093906848e-09
in O 0 3.02349656422507e-09
the O 0 7.051665562585185e-08
UBE3A O 0 1.8337716028327122e-05
gene O 0 6.97108006875169e-08
. O 0 3.807544146638975e-08

UBE3A O 0 0.0023886985145509243
encodes O 0 7.61824381356746e-08
a O 0 7.771624233043894e-09
ubiquitin O 0 6.831307075572113e-08
- O 0 5.742430886357397e-08
protein O 0 8.428358011514092e-10
ligase O 0 8.817251789805525e-11
and O 0 2.2945745997704492e-11
shows O 0 1.0392631893951787e-10
brain O 0 3.910623291858428e-08
- O 0 6.3103247072149315e-09
specific O 0 2.1401560523770513e-09
imprinting O 0 2.2765273115510354e-06
. O 0 3.654854907608751e-08

Here O 0 1.1774793051699817e-07
we O 0 3.4674609850071647e-09
describe O 0 2.4976865020676087e-08
UBE3A O 0 2.9125074433977716e-05
coding O 0 1.3526636166716344e-06
- O 0 1.3506862615031423e-06
region O 0 4.762576679695485e-07
mutations O 0 8.212824198494673e-09
detected O 0 1.2808005767084296e-09
by O 0 3.5798727263808283e-12
SSCP O 0 7.163320674408169e-07
analysis O 0 1.6761326701586476e-11
in O 0 3.69200286662319e-12
13 O 0 1.0990093279872326e-09
AS B-Disease 1 0.9999716281890869
individuals O 0 4.660652939969534e-12
or O 0 3.159983108513842e-10
families O 0 3.9010986108145573e-10
. O 0 6.9941581415378096e-09

Two O 0 9.32710442214102e-09
identical O 0 4.589225888196324e-09
de O 0 6.472601512541587e-07
novo O 0 4.22272432842874e-06
5 O 0 3.6882879612676334e-06
- O 0 3.738710177003668e-07
bp O 0 2.0605577333299152e-07
duplications O 0 1.2663768700349465e-08
in O 0 3.483237476231693e-09
exon O 0 1.392244364240014e-08
16 O 0 1.3870333326337914e-08
were O 0 1.447156977585351e-10
found O 0 3.1643923592561407e-10
. O 0 2.214300076630593e-09

Among O 0 4.656048879780883e-09
the O 0 1.2142299388173683e-09
other O 0 3.0880471790784014e-11
11 O 0 1.1763333640502083e-09
unique O 0 1.8075398816597144e-11
mutations O 0 1.2366513368888832e-09
, O 0 1.929258419686164e-10
8 O 0 7.5261425536155e-08
were O 0 4.33130392663017e-10
small O 0 7.596134138365684e-11
deletions O 0 1.4964881556167597e-09
or O 0 1.096698110103489e-08
insertions O 0 3.33365370863703e-08
predicted O 0 2.992060785800277e-07
to O 0 4.8150504028399155e-08
cause O 0 4.39157020082348e-06
frameshifts O 0 4.4446951505960897e-05
, O 0 2.550394340161688e-09
1 O 0 4.772251713802689e-07
was O 0 1.1257332843683798e-08
a O 0 3.9785946759351987e-10
mutation O 0 1.010355479835745e-10
to O 0 2.236267698796368e-10
a O 0 2.828643985708368e-10
stop O 0 1.6289494197962995e-09
codon O 0 2.9238740317794054e-09
, O 0 2.5987845556074696e-11
1 O 0 8.187829969585891e-09
was O 0 1.948032180010273e-09
a O 0 6.078597625247539e-10
missense O 0 8.925825412120503e-09
mutation O 0 4.853143997785025e-10
, O 0 1.3364085012235183e-11
and O 0 1.4896861522117888e-11
1 O 0 9.85872006253885e-08
was O 0 2.902084794698112e-08
predicted O 0 2.0632315411717173e-08
to O 0 6.792167939195792e-10
cause O 0 6.264621266183212e-09
insertion O 0 9.047263382910842e-09
of O 0 5.6732645248303015e-09
an O 0 5.135051828197845e-10
isoleucine O 0 2.194002348687718e-07
in O 0 7.65416410808406e-11
the O 0 4.1223935376422105e-10
hect O 0 2.1001727645852952e-07
domain O 0 2.417315769775996e-08
of O 0 3.855055386026152e-09
the O 0 3.382760072057067e-09
UBE3A O 0 1.2265999203009414e-06
protein O 0 5.297765781620001e-09
, O 0 1.1868201733877815e-12
which O 0 3.255781603518637e-13
functions O 0 1.3953226594975998e-12
in O 0 1.7578790853511883e-11
E2 O 0 1.1712183223266948e-08
binding O 0 4.015786370104024e-09
and O 0 1.5863078905997696e-10
ubiquitin O 0 4.717020107847247e-09
transfer O 0 1.8960855641125818e-07
. O 0 1.4468300335579443e-08

Eight O 0 3.6218711585433994e-08
of O 0 1.157702822496276e-09
the O 0 1.1180714687419879e-10
cases O 0 6.1003571985573934e-12
were O 0 6.715799444334536e-11
familial O 0 1.2970958529479049e-08
, O 0 4.492587135640491e-10
and O 0 3.0220423385962647e-10
five O 0 2.3360784418002822e-09
were O 0 5.545033876508398e-10
sporadic O 0 3.283353677829837e-08
. O 0 4.516855156566635e-08

In O 0 5.375264233720145e-09
two O 0 2.3628976553169423e-10
familial O 0 1.2220971257193014e-07
cases O 0 6.861076151665202e-09
and O 0 8.51132497814433e-11
one O 0 5.6312027957305943e-11
sporadic O 0 7.299841842112187e-10
case O 0 3.0836927455979435e-10
, O 0 2.937409690484394e-11
mosaicism O 0 3.7138065067665593e-07
for O 0 5.540258030123368e-09
UBE3A O 0 2.3892363969935104e-05
mutations O 0 1.6459495100207278e-08
was O 0 2.3963353523726028e-09
detected O 0 3.790958172378289e-11
in O 0 1.3337968967144787e-13
the O 0 9.501110835585802e-13
mother O 0 2.9539827615249203e-12
of O 0 9.235215023273291e-12
three O 0 1.3836359141761179e-11
AS B-Disease 1 1.0
sons O 0 1.890930301229332e-09
, O 0 2.563224697597899e-13
in O 0 4.903361787780836e-13
the O 0 1.4129078115820981e-11
maternal O 0 2.581934444023659e-09
grandfather O 0 4.326632829787513e-09
of O 0 1.0904656733146112e-08
two O 0 5.208312114923785e-10
AS B-Disease 1 1.0
first O 0 2.0062844718893302e-09
cousins O 0 5.928348922878968e-10
, O 0 1.1879117481350399e-12
and O 0 4.202780159480446e-13
in O 0 2.117132641074604e-12
the O 0 5.84209347564979e-11
mother O 0 2.5829465302718013e-11
of O 0 7.141708752156362e-11
an O 0 1.0416604384611006e-10
AS B-Disease 1 1.0
daughter O 0 7.8489028965123e-06
. O 0 3.4984472563337476e-07

The O 0 3.871216236461805e-08
frequencies O 0 2.2729584880920584e-09
with O 0 3.0523944916788226e-12
which O 0 2.929531617290593e-11
we O 0 1.665222820745882e-10
detected O 0 2.5459412356099165e-10
mutations O 0 7.942144338024537e-12
were O 0 3.4918064533567827e-12
5 O 0 1.0637380559730403e-10
( O 0 1.5895773195981344e-12
14 O 0 4.3287437523353844e-10
% O 0 1.440112785966452e-11
) O 0 3.2741027228798403e-13
of O 0 1.6758353385548652e-11
35 O 0 2.1643913050706232e-10
in O 0 1.6535106617254769e-12
sporadic O 0 1.3143731936171577e-10
cases O 0 2.7042096860385723e-12
and O 0 1.9362200644884586e-12
8 O 0 5.527072688416013e-10
( O 0 2.422762077763929e-12
80 O 0 1.0048263610062946e-10
% O 0 4.586908977644022e-12
) O 0 8.711390305947073e-14
of O 0 3.767090805961715e-12
10 O 0 2.5118861851636254e-11
in O 0 5.4706512757352055e-12
familial O 0 9.456779359595657e-09
cases O 0 3.4279123983793625e-10
. O 0 4.921827945203461e-10
. O 0 5.3031543600923214e-09

The O 0 3.848346750601195e-06
hemochromatosis B-Disease 1 0.9999998807907104
845 O 0 7.396176897600526e-06
G O 0 1.4764871991701511e-07
- O 0 9.24707421745552e-09
- O 0 2.9203461870963565e-09
> O 0 1.3704236634382028e-09
A O 0 4.979996970355671e-10
and O 0 1.1915742914939131e-12
187 O 0 7.92876354849259e-12
C O 0 7.04161950970672e-10
- O 0 3.8449565753495563e-10
- O 0 1.4934429248825154e-09
> O 0 1.193064047555481e-08
G O 0 1.674850480526402e-08
mutations O 0 8.861728711950789e-11
: O 0 1.3285260478529404e-13
prevalence O 0 4.57518502250398e-11
in O 0 3.1818070313910374e-12
non O 0 1.7266652108105518e-08
- O 0 9.062482320132403e-08
Caucasian O 0 2.950886823782639e-07
populations O 0 1.6357147858414578e-09
. O 0 2.1006598682760114e-09

Hemochromatosis B-Disease 0 0.00031043108901940286
, O 0 1.4543687365531355e-09
the O 0 1.946141594544315e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999991655349731
, O 0 1.4072027987310776e-08
leads O 0 2.8160503262597558e-08
, O 0 9.301801551231392e-10
if O 0 4.405318918543344e-07
untreated O 0 0.009956497699022293
, O 0 1.6616747908204665e-11
to O 0 2.974205770556182e-08
progressive O 0 0.33308789134025574
iron B-Disease 1 0.9999972581863403
overload I-Disease 0 0.13133826851844788
and O 0 1.544219969673577e-07
premature B-Disease 0 7.421877671731636e-05
death I-Disease 0 1.3247714377939701e-05
. O 0 1.282695194504413e-07

The O 0 1.563297519169282e-05
hemochromatosis B-Disease 1 1.0
gene O 0 9.220164542966813e-07
, O 0 2.134449950119688e-08
HFE O 1 0.9958712458610535
, O 0 2.3896864931316486e-08
recently O 0 6.597326684953941e-09
has O 0 3.5590686647823944e-11
been O 0 2.5059810129790527e-11
identified O 0 1.6479637099386935e-11
, O 0 4.5334498958646274e-13
and O 0 1.208396663981981e-12
characterization O 0 1.50379597663175e-09
of O 0 2.6805146990938056e-09
this O 0 5.438477446162437e-10
gene O 0 9.436320475009197e-11
has O 0 3.950091989612936e-12
shown O 0 3.159043935729161e-13
that O 0 1.782646838303925e-13
it O 0 1.9148005121587264e-13
contains O 0 2.0857240359741652e-13
two O 0 3.7570094604810755e-12
mutations O 0 1.9343568413709988e-11
that O 0 7.901167567436751e-12
result O 0 6.4549782186063e-10
in O 0 4.952869669949678e-09
amino O 0 2.0540669609658835e-08
acid O 0 1.3855467884127393e-09
substitutions O 0 3.5170404782958187e-11
- O 0 1.595958643019202e-10
cDNA O 0 1.587070613817687e-10
nucleotides O 0 8.002541337925884e-12
845 O 0 6.999729268430954e-11
G O 0 2.8461446741068208e-11
- O 0 2.473537520641944e-11
- O 0 4.1776491987999265e-11
> O 0 1.6226318899636993e-10
A O 0 8.968757958527362e-10
( O 0 5.329327690956065e-12
C282Y O 0 1.394912985119845e-08
) O 0 1.2423111042485224e-13
and O 0 3.7788191629625767e-13
187 O 0 1.0138161143924407e-11
C O 0 7.337839780241495e-10
- O 0 3.7027400590083914e-10
- O 0 2.121331332816112e-09
> O 0 1.0445004861026064e-08
G O 0 1.939291571773083e-08
( O 0 3.512093740831723e-11
H63D O 0 4.980770427209791e-06
) O 0 1.225219370404318e-10
. O 0 3.315737462372681e-09

Although O 0 1.1351927753366908e-07
hemochromatosis B-Disease 1 1.0
is O 0 1.4880631171720893e-09
common O 0 3.5856986824178705e-10
in O 0 4.996476010710182e-10
Caucasians O 0 1.5447820800318368e-08
, O 0 7.776894406230639e-11
affecting O 0 3.789369651396868e-10
> O 0 2.5964551397805735e-08
= O 0 4.607732417838406e-09
1 O 0 2.8325125356332137e-08
/ O 0 8.312182608882779e-10
300 O 0 1.8856546098872107e-12
individuals O 0 3.301675136090955e-14
of O 0 6.405223573757723e-13
northern O 0 1.7661197157514685e-11
European O 0 1.4409404225368405e-10
origin O 0 1.160521193033226e-10
, O 0 1.3688410214346414e-12
it O 0 2.0597737925009962e-13
has O 0 7.940984024859543e-14
not O 0 1.8381260055710946e-13
been O 0 2.903893488517828e-13
recognized O 0 5.686089619982848e-13
in O 0 1.7221425023875025e-12
other O 0 2.261900736155731e-12
populations O 0 5.2849429693635486e-11
. O 0 1.4355782118613547e-09

The O 0 1.537896139325312e-07
present O 0 4.1609773404616135e-09
study O 0 1.452067494023268e-10
used O 0 3.899986236732822e-12
PCR O 0 5.325946281220517e-11
and O 0 2.138725654909912e-11
restriction O 0 1.344250488699572e-09
- O 0 1.4451937424553307e-09
enzyme O 0 1.7382675160382277e-11
digestion O 0 1.196684279447524e-10
to O 0 5.630042959614556e-11
analyze O 0 1.904124080631675e-11
the O 0 4.356843878727812e-12
frequency O 0 1.9082843638607017e-10
of O 0 2.0980710224716148e-11
the O 0 3.747099852624558e-11
845 O 0 9.684231194739823e-10
G O 0 5.358044563585906e-10
- O 0 5.220326393384767e-10
- O 0 5.015897697191463e-10
> O 0 2.596843573510199e-10
A O 0 3.170469720092939e-10
and O 0 1.7116634715499957e-12
187 O 0 6.319601526111329e-12
C O 0 2.339194116185439e-10
- O 0 1.9861191857817317e-10
- O 0 7.507468535727924e-10
> O 0 4.033934519753757e-09
G O 0 5.535451652605161e-09
mutations O 0 2.8762906986723458e-11
in O 0 1.5234894942817157e-11
HLA O 0 6.933824070465278e-10
- O 0 6.253822459889591e-11
typed O 0 8.101445729546963e-12
samples O 0 3.815776701229269e-14
from O 0 1.8885763721117332e-13
non O 0 1.3308308621784448e-10
- O 0 1.8197797435615115e-10
Caucasian O 0 1.4644508938843614e-09
populations O 0 2.848396648755247e-12
, O 0 1.8775679253534017e-13
comprising O 0 7.439775791956427e-13
Australian O 0 6.300035493289613e-11
Aboriginal O 0 5.2808920431024475e-11
, O 0 1.6782654909883177e-12
Chinese O 0 7.739659607652882e-12
, O 0 1.0719496471023326e-11
and O 0 2.988601033315774e-10
Pacific O 0 3.8566761872971256e-07
Islanders O 0 1.541220200351745e-07
. O 0 1.8593508954722893e-08

Results O 0 4.865160008193925e-08
showed O 0 1.0301419717251292e-09
that O 0 2.828771938911956e-11
the O 0 1.9690325758769944e-10
845 O 0 5.634904542972663e-09
G O 0 8.812351737219615e-09
- O 0 2.130332799055168e-09
- O 0 2.0449029136671015e-09
> O 0 1.4750812793451473e-09
A O 0 1.381166736535988e-09
mutation O 0 6.935685359366062e-11
was O 0 1.4415088046837443e-11
present O 0 7.868318084754133e-13
in O 0 1.2320491848960557e-12
these O 0 7.571103032705251e-13
populations O 0 8.477179461868767e-13
( O 0 1.4043203449068398e-12
allele O 0 1.1320128862069012e-10
frequency O 0 9.735086070605803e-10
0 O 0 2.434372703419285e-10
. O 0 1.2932493617667795e-12
32 O 0 7.968489063037154e-11
% O 0 1.348481222518405e-11
) O 0 5.48758846523334e-13
, O 0 1.1875085333470925e-12
and O 0 2.754181431530167e-12
, O 0 9.907562617539334e-12
furthermore O 0 7.22758866644746e-11
, O 0 3.646443390292742e-12
it O 0 3.901928259664178e-12
was O 0 1.5127341601584021e-09
always O 0 2.552026645563643e-11
seen O 0 1.4713424922874196e-11
in O 0 6.102018304705858e-13
conjunction O 0 2.878535257377912e-11
with O 0 2.981903265975028e-11
HLA O 0 2.352015144424513e-06
haplotypes O 0 7.2787962324127875e-09
common O 0 2.8890922987301337e-10
in O 0 2.9682067914649224e-10
Caucasians O 0 1.0749548806643361e-08
, O 0 2.0345366016916167e-11
suggesting O 0 2.2127283338946313e-10
that O 0 4.698553698889718e-11
845 O 0 2.1660040872006903e-08
G O 0 9.948976043006041e-08
- O 0 5.864161778390553e-08
- O 0 1.451440994060249e-07
> O 0 8.967294462536302e-08
A O 0 1.3308834923009272e-07
may O 0 2.827372558300567e-09
have O 0 2.080186934164119e-12
been O 0 4.1582077950179375e-13
introduced O 0 1.581320930319277e-13
into O 0 2.731923303030126e-13
these O 0 3.611704017862606e-15
populations O 0 8.385875205504066e-15
by O 0 4.1595405505384653e-13
Caucasian O 0 2.5381179824535138e-08
admixture O 0 4.0163749304156227e-07
. O 0 6.508167871288606e-08

187 O 0 1.7621079706486853e-08
C O 0 2.752784844517464e-08
- O 0 3.6317755469639224e-09
- O 0 2.6686233223216504e-09
> O 0 5.021375759639568e-09
G O 0 3.0390261418489217e-09
was O 0 3.2725700621627496e-11
present O 0 8.158318855547297e-13
at O 0 9.845359770499496e-12
an O 0 3.3025708903733353e-13
allele O 0 2.3229067974694928e-11
frequency O 0 2.240320151614128e-09
of O 0 1.3486779470994747e-09
2 O 0 4.3209405475863605e-07
. O 0 2.630375384171657e-08

68 O 0 1.4447350622504018e-06
% O 0 2.3196635723365944e-09
in O 0 1.4116740762459834e-11
the O 0 6.622030007674695e-11
two O 0 1.0374346347263863e-11
populations O 0 2.523525225589518e-12
analyzed O 0 1.875465234502105e-11
( O 0 7.1016335173590406e-12
Australian O 0 2.4760593575479106e-10
Aboriginal O 0 3.228908113106499e-11
and O 0 2.443432175341931e-12
Chinese O 0 6.725923203804163e-12
) O 0 2.0341757792086135e-11
. O 0 1.345320077561496e-09

In O 0 7.132486157246376e-09
the O 0 4.500170458499042e-09
Australian O 0 6.653862461014626e-10
Aboriginal O 0 3.7312170714232096e-11
samples O 0 3.7672759334826666e-13
, O 0 8.670181136623614e-14
187 O 0 1.4785839219655372e-11
C O 0 1.7880513736301396e-09
- O 0 1.1606368088834529e-09
- O 0 5.325687446600114e-09
> O 0 1.0404263228736e-08
G O 0 5.876878983457345e-09
was O 0 1.0171170850004074e-10
found O 0 1.1339344583747787e-13
to O 0 9.493501904739299e-13
be O 0 1.5083985492950203e-12
associated O 0 3.270629253537827e-11
with O 0 1.70808991950544e-11
HLA O 0 1.5383950085379183e-05
haplotypes O 0 6.6273058152432895e-09
common O 0 3.646808688362313e-10
in O 0 2.219288225413507e-10
Caucasians O 0 2.4278230981167326e-08
, O 0 3.27503024699638e-11
suggesting O 0 1.2584849828911615e-10
that O 0 9.503470926874868e-12
it O 0 4.504457137149975e-12
was O 0 2.7750112971403063e-11
introduced O 0 6.745473320537987e-13
by O 0 1.472273691849324e-12
recent O 0 7.111857630581753e-11
admixture O 0 7.177795247059748e-09
. O 0 1.569246599331109e-08

In O 0 2.499349704976339e-08
the O 0 6.592358214874139e-09
Chinese O 0 5.980452244536139e-11
samples O 0 1.545191492119402e-12
analyzed O 0 1.6477869416164914e-12
, O 0 2.2521834928696666e-13
187 O 0 6.868293694201055e-12
C O 0 3.3054559089862323e-10
- O 0 9.127557043520085e-11
- O 0 2.5628568711688615e-10
> O 0 6.548055986321799e-10
G O 0 3.9726874567769244e-10
was O 0 6.77390608883055e-12
present O 0 4.1649385221047275e-13
in O 0 9.652055630443579e-13
association O 0 1.674572264707963e-12
with O 0 1.543358539926598e-13
a O 0 3.603167209043079e-10
wide O 0 3.21666648872565e-09
variety O 0 3.100986134541017e-10
of O 0 2.1688443041512073e-08
HLA O 0 8.393326993427763e-07
haplotypes O 0 5.297998040276752e-09
, O 0 1.0937259778409647e-11
showing O 0 4.3455816202409014e-12
this O 0 7.381108745041498e-12
mutation O 0 1.4541898067654824e-11
to O 0 8.396872086535723e-11
be O 0 2.5005763085172994e-11
widespread O 0 6.552750009269914e-11
and O 0 2.6045957057796443e-11
likely O 0 3.734510034547611e-09
to O 0 1.559549112073455e-08
predate O 0 6.694604053336661e-07
the O 0 1.7846850663971736e-09
more O 0 1.1206371768046619e-11
genetically O 0 7.454983158572404e-11
restricted O 0 6.131167101797175e-11
845 O 0 5.0129065343185175e-09
G O 0 1.5868875991031928e-08
- O 0 1.7958518228056164e-08
- O 0 2.8066555302075358e-08
> O 0 1.5586985924187502e-08
A O 0 3.972343165514758e-08
mutation O 0 6.083703762982395e-09
. O 0 6.835693122653197e-10

Genotype O 0 6.897786079207435e-06
- O 0 6.941260153325857e-07
phenotype O 0 5.2662144867099414e-08
correlations O 0 1.9536075512860407e-07
in O 0 1.1200683047718485e-08
attenuated B-Disease 1 0.9999587535858154
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 1.2601464732142631e-05

Germ O 0 5.87814865866676e-05
- O 0 1.0195088862019475e-06
line O 0 1.4782540347368922e-07
mutations O 0 7.37211536261384e-09
of O 0 4.4360731754622407e-10
the O 0 1.5656186069801237e-10
tumor B-Disease 0 4.331985792305204e-08
suppressor O 0 6.548299325004336e-07
APC O 0 2.5132894876378487e-08
are O 0 5.144565762976727e-12
implicated O 0 1.8648409483290607e-09
in O 0 3.6801830471944186e-09
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.225814791425364e-06
AAPC B-Disease 1 1.0
) O 0 2.9340930726706738e-12
, O 0 4.124170555302835e-14
a O 0 4.32012580006344e-13
variant O 0 8.146114005569416e-09
of O 0 2.5198251023539342e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.3432790524348093e-07
FAP B-Disease 0 1.394542294974599e-07
) O 0 1.0479236922655844e-10
. O 0 1.6839145633440467e-09

AAPC B-Disease 1 1.0
is O 0 7.134537405306673e-10
recognized O 0 5.200167119828736e-12
by O 0 3.708333987106904e-12
the O 0 1.3023523925959068e-10
occurrence O 0 2.5443307460903952e-09
of O 0 8.9439584627371e-09
< O 0 1.6855510693858378e-05
100 O 0 1.7526790685451488e-08
colonic B-Disease 0 1.5054631603561575e-06
adenomas I-Disease 0 1.211214737395494e-07
and O 0 2.933214652070526e-12
a O 0 1.1006381570033419e-11
later O 0 4.379276941079979e-10
onset O 0 2.4914570531109348e-05
of O 0 2.5789786377572455e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 7.67419461311647e-10
age O 0 5.958304427622352e-08
> O 0 2.6501007610590932e-08
40 O 0 3.251580782404062e-09
years O 0 2.1256398030633505e-10
) O 0 2.4156112873874314e-11
. O 0 1.029711760303087e-09

The O 0 2.4897765626974433e-08
aim O 0 8.849089994100723e-08
of O 0 1.841898966681299e-09
this O 0 5.142625561505021e-11
study O 0 5.7088622024137337e-11
was O 0 1.1179648873316239e-10
to O 0 1.2621942380164342e-10
assess O 0 4.963953692538325e-09
genotype O 0 3.01211912301369e-07
- O 0 9.18357102364098e-07
phenotype O 0 1.043282367163556e-07
correlations O 0 2.327354593489872e-07
in O 0 1.1272931921268992e-08
AAPC B-Disease 1 1.0
families O 0 2.9310507798641083e-08
. O 0 4.026656696964892e-08

By O 0 1.182691811152381e-08
protein O 0 8.556028774364677e-09
- O 0 2.758454353823936e-09
truncation O 0 2.5351088339675698e-08
test O 0 3.2187534859673406e-09
( O 0 3.0763655511911736e-11
PTT O 0 4.395876018747913e-08
) O 0 4.0286746378140337e-13
assay O 0 3.131846171289254e-11
, O 0 1.036840088070555e-13
the O 0 3.3678688635650766e-13
entire O 0 2.7564476742791832e-11
coding O 0 3.784104696258339e-10
region O 0 3.1209368422935313e-09
of O 0 4.206413439789003e-09
the O 0 4.520352092640678e-09
APC B-Disease 0 1.4560070482616538e-08
gene O 0 1.1871738835045331e-11
was O 0 2.167856692769643e-11
screened O 0 1.4660089114881814e-11
in O 0 2.062777710145139e-13
affected O 0 4.765338297574306e-12
individuals O 0 4.128337862535636e-12
from O 0 2.0075601625535455e-08
11 O 0 3.326244041090831e-05
AAPC B-Disease 1 1.0
kindreds O 0 9.608923392079305e-06
, O 0 1.4937326375807913e-10
and O 0 2.5435226841397096e-11
their O 0 1.539221007595959e-11
phenotypic O 0 4.093303918040192e-09
differences O 0 7.137385349409442e-09
were O 0 1.5017378451886998e-09
examined O 0 1.2169618202051424e-08
. O 0 1.5471822933932344e-08

Five O 0 1.3158745204577826e-08
novel O 0 3.638452428234018e-09
germ O 0 7.556578225376143e-07
- O 0 4.097602257502331e-08
line O 0 6.60485852677084e-08
APC B-Disease 0 1.2775806190745698e-08
mutations O 0 7.50142836736245e-10
were O 0 2.023151958463476e-11
identified O 0 2.5053407265440697e-11
in O 0 4.661277613893233e-11
seven O 0 2.9649038779666625e-09
kindreds O 0 2.2882072698848788e-06
. O 0 1.0579122999843094e-07

Mutations O 0 9.7546852373398e-08
were O 0 1.1729676951954815e-10
located O 0 4.581575136636262e-12
in O 0 3.911672418269174e-13
three O 0 6.79262080068542e-14
different O 0 9.055298896246296e-15
regions O 0 7.43657774249229e-11
of O 0 9.204731976630853e-10
the O 0 4.6280788090768965e-09
APC B-Disease 0 2.6797530860989127e-09
gene O 0 1.3949641788912892e-11
( O 0 4.083090636430864e-12
1 O 0 1.9413194607409423e-08
) O 0 4.8250153872331225e-12
at O 0 2.5222526844892457e-10
the O 0 2.5022220406789586e-11
5 O 0 6.182039324897914e-10
end O 0 1.5865568858686174e-09
spanning O 0 1.0346276058115222e-09
exons O 0 9.98207960734021e-10
4 O 0 7.280611113991142e-10
and O 0 2.714182611301963e-12
5 O 0 7.384960420964148e-10
, O 0 8.317803910917743e-12
( O 0 7.745449247253955e-12
2 O 0 1.1344927219880674e-09
) O 0 7.626482995473638e-13
within O 0 1.840576649425607e-11
exon O 0 6.989216150277144e-11
9 O 0 3.680447890896943e-10
, O 0 1.1608720712139031e-12
and O 0 4.160875637093664e-12
( O 0 7.297583370924343e-11
3 O 0 4.5431391981765046e-08
) O 0 1.6179460549103908e-11
at O 0 4.217240168191694e-10
the O 0 3.0898731490092146e-11
3 O 0 2.528207199148369e-09
distal O 0 7.833536841417299e-08
end O 0 6.004233199519149e-08
of O 0 6.500200822046054e-09
the O 0 6.764182103324856e-09
gene O 0 1.8742727370124612e-09
. O 0 9.087022689868718e-09

Variability O 0 9.807106835069135e-06
in O 0 2.4152302380286983e-10
the O 0 5.096966182449592e-10
number O 0 3.2962513274448213e-10
of O 0 2.1029305230513273e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.926489858306013e-06
most O 0 7.020383406552977e-12
apparent O 0 3.4328584419540675e-10
in O 0 1.0794213830059296e-12
individuals O 0 1.9382954442870304e-13
with O 0 4.800695973562752e-13
mutations O 0 6.474706881753889e-10
in O 0 3.0678313223120313e-09
region O 0 1.810759044929e-06
1 O 1 0.7725355625152588
, O 0 1.2056589060449596e-09
and O 0 3.0639835113532854e-09
upper O 1 0.9932087063789368
- O 1 0.7568653225898743
gastrointestinal O 0 7.039811407594243e-06
manifestations O 0 1.0929540621873457e-05
were O 0 4.765597916289721e-10
more O 0 2.6187314036002496e-12
severe O 0 1.0793082871884963e-08
in O 0 1.3378680108200314e-10
them O 0 6.309704148055317e-11
. O 0 1.8823371750187334e-09

In O 0 2.6607241410125937e-10
individuals O 0 6.429204824770496e-12
with O 0 1.9272519777985275e-12
mutations O 0 1.6605034014460784e-10
in O 0 4.241147363859277e-11
either O 0 7.928832035375422e-10
region O 0 5.261896873776095e-08
2 O 0 2.4642977791700105e-07
or O 0 4.262610264760269e-09
region O 0 1.1559696844187783e-07
3 O 0 1.3290608080751554e-07
, O 0 4.22909519903758e-11
the O 0 1.0008534973016125e-10
average O 0 3.0986743726479915e-10
number O 0 9.358030322870192e-11
of O 0 3.159882355774357e-09
adenomas B-Disease 0 1.9177111880708253e-06
tended O 0 1.4126694258820294e-09
to O 0 2.901085760509403e-10
be O 0 3.19834644879613e-11
lower O 0 1.9175992738151848e-10
than O 0 7.867508185731287e-13
those O 0 4.992074394377481e-14
in O 0 1.1538228597389455e-13
individuals O 0 6.820389928828205e-14
with O 0 5.258803917503052e-13
mutations O 0 5.6062970238413e-11
in O 0 3.103682935656771e-11
region O 0 2.242795948959042e-09
1 O 0 4.513324469712643e-08
, O 0 1.9419526750552585e-12
although O 0 1.4261903290291311e-12
age O 0 3.3248048758593995e-10
at O 0 2.1319780663109356e-10
diagnosis O 0 5.076226550215779e-09
was O 0 1.708432839642171e-10
similar O 0 1.430132661600636e-11
. O 0 4.009380383251937e-09

In O 0 3.754473709705053e-08
all O 0 3.7352172910232184e-08
AAPC B-Disease 1 1.0
kindreds O 0 3.4596391742525157e-06
, O 0 6.770198984762388e-12
a O 0 2.764624640327895e-11
predominance O 0 2.867049531118937e-08
of O 0 8.47112318069776e-08
right O 1 0.9999794960021973
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999902248382568
rectal B-Disease 1 1.0
polyp I-Disease 1 0.998286783695221
sparing O 0 5.783352321486745e-07
was O 0 1.2884734701401612e-07
observed O 0 4.997412261786849e-09
. O 0 2.7277582415052848e-09

No O 0 9.067328937817365e-05
desmoid B-Disease 1 1.0
tumors I-Disease 1 1.0
were O 0 4.902663519601447e-08
found O 0 1.0484875467842159e-10
in O 0 3.085314989603738e-11
these O 0 5.768856919941001e-11
kindreds O 0 8.7359399003617e-07
. O 0 3.470440290698207e-08

Our O 0 8.278820473606174e-08
data O 0 2.6360530425151296e-10
suggest O 0 1.4331534570199977e-10
that O 0 2.950907747323317e-12
, O 0 8.902280822231656e-12
in O 0 2.980471980329469e-10
AAPC B-Disease 1 1.0
families O 0 1.3034284762625248e-10
, O 0 7.85881342640904e-12
the O 0 4.3635161456334615e-11
location O 0 2.028022194622281e-09
of O 0 1.6348664644283417e-09
the O 0 1.2949352701241423e-08
APC B-Disease 0 3.461899495960097e-07
mutation O 0 5.2580244158662026e-08
may O 0 1.7617013625681466e-08
partially O 0 1.8748709251781293e-08
predict O 0 1.7293412923891083e-08
specific O 0 4.392535779551565e-10
phenotypic O 0 4.788454432969047e-08
expression O 0 9.27056209576449e-09
. O 0 3.875360476968126e-08

This O 0 1.0883663970062685e-09
should O 0 3.653645719303711e-10
help O 0 6.298806962123926e-12
in O 0 6.288792186656678e-13
the O 0 1.4560596652002378e-12
design O 0 6.966002861347187e-12
of O 0 1.5546107803854348e-11
tailored O 0 6.098847815660946e-11
clinical O 0 2.0350161555882096e-09
- O 0 1.0814699358263624e-08
management O 0 2.246013930395918e-10
protocols O 0 5.206285957903845e-10
in O 0 7.529602809308589e-12
this O 0 9.693941829813646e-12
subset O 0 1.363363422157704e-09
of O 0 8.404647533488685e-10
FAP B-Disease 0 1.5564229016717945e-08
patients O 0 1.3644033125537192e-10
. O 0 2.4319596336752625e-10
. O 0 4.47654224799976e-09

Wilms B-Disease 1 0.9994389414787292
' I-Disease 0 3.921739698853344e-05
tumor I-Disease 0 1.3552044038078748e-05
1 O 0 1.4891536466166144e-06
and O 0 2.9474922502714662e-09
Dax O 0 1.4445502529270016e-05
- O 0 3.019078747001913e-07
1 O 0 1.0973258213198278e-06
modulate O 0 4.203157377702382e-09
the O 0 1.4630103795099103e-09
orphan O 0 3.975539453193733e-09
nuclear O 0 9.18460685284117e-08
receptor O 0 6.081942416358288e-08
SF O 0 1.5280194929800928e-05
- O 0 1.3493322015278864e-08
1 O 0 1.0577236864151018e-09
in O 0 8.001866313653294e-13
sex O 0 6.965826570073941e-13
- O 0 7.550999213921938e-13
specific O 0 3.1647552417232716e-13
gene O 0 8.559358191835564e-13
expression O 0 3.846803084406325e-11
. O 0 9.992823235549508e-10

Products O 0 7.1932824141640594e-09
of O 0 1.083648282218519e-08
steroidogenic O 0 3.848787400784204e-06
factor O 0 8.658403771732992e-09
1 O 0 3.066967124709663e-08
( O 0 5.256422380695014e-11
SF O 0 7.477524195564911e-05
- O 0 9.9111878171243e-07
1 O 0 3.6848632589681074e-07
) O 0 1.4984917820481947e-11
and O 0 1.7913139027658787e-10
Wilms B-Disease 0 1.2442925253708381e-05
tumor I-Disease 0 1.2947002687724307e-06
1 O 0 1.4623255140122637e-07
( O 0 1.336070143409529e-10
WT1 O 0 1.194266729953597e-07
) O 0 1.4658356126129313e-11
genes O 0 4.306093676076372e-12
are O 0 1.1419803904594295e-13
essential O 0 1.7087016480551998e-12
for O 0 2.395212283720638e-12
mammalian O 0 2.120700282048915e-09
gonadogenesis O 0 2.627893103124279e-08
prior O 0 1.54252888240336e-09
to O 0 1.4709905515886135e-09
sexual O 0 4.748765825013379e-10
differentiation O 0 8.268433049352097e-09
. O 0 5.622279974915045e-09

In O 0 2.6368640604346183e-09
males O 0 1.075953326434842e-09
, O 0 2.084311473415923e-10
SF O 0 0.0005902174161747098
- O 0 4.621078460331773e-06
1 O 0 6.699726782244397e-07
participates O 0 6.568203619883306e-11
in O 0 2.379266705529459e-12
sexual O 0 2.843321715226277e-12
development O 0 2.8311780003731357e-12
by O 0 1.0208301218228577e-12
regulating O 0 3.806850112919591e-10
expression O 0 5.4645531155639304e-11
of O 0 3.2218228085412193e-10
the O 0 4.6005291243211843e-10
polypeptide O 0 2.358316564254892e-08
hormone O 0 1.1118447135194387e-10
Mullerian O 0 2.9168278903313194e-09
inhibiting O 0 2.7003055347307736e-10
substance O 0 1.2590497533437883e-09
( O 0 1.333463200969831e-10
MIS O 0 1.1336796887917444e-05
) O 0 9.794755284620038e-11
. O 0 1.239151781184944e-09

Here O 0 7.359347620194967e-08
, O 0 5.03694141951172e-10
we O 0 1.9293282249588373e-10
show O 0 2.5514913098989567e-11
that O 0 4.47735555228479e-12
WT1 O 0 1.7104680409829598e-06
- O 0 9.000955856208748e-07
KTS O 0 5.770951975136995e-05
isoforms O 0 1.1848224623633996e-09
associate O 0 9.601998085528862e-10
and O 0 3.1182426432629917e-12
synergize O 0 1.375425218164139e-09
with O 0 8.640507580259804e-12
SF O 0 5.067621168564074e-05
- O 0 3.275938524893718e-07
1 O 0 1.2202930577132065e-07
to O 0 4.59362192728463e-09
promote O 0 5.0324397982137725e-09
MIS O 0 2.830778612405993e-05
expression O 0 8.366281889493621e-09
. O 0 1.507414992829581e-08

In O 0 4.179637969059513e-09
contrast O 0 8.31981505911017e-09
, O 0 4.14549816696308e-09
WT1 O 0 2.7309586585033685e-05
missense O 0 1.6824568547235685e-06
mutations O 0 6.870924718072047e-09
, O 0 1.1128747662986216e-12
associated O 0 1.7027381024256605e-12
with O 0 1.9690297298462917e-13
male B-Disease 0 6.199751823032784e-10
pseudohermaphroditism I-Disease 1 1.0
in O 0 8.686060759544034e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.150339059563521e-07
fail O 0 1.900375536934007e-06
to O 0 1.120979220559093e-07
synergize O 0 5.446070758807764e-07
with O 0 1.254775283676679e-09
SF O 1 0.9994663596153259
- O 0 0.0001228444161824882
1 O 0 1.358908320980845e-05
. O 0 2.4191006531282255e-08

Additionally O 0 2.4199591663887077e-08
, O 0 3.955522367982134e-11
the O 0 5.891710036509679e-11
X O 0 1.5470075140910922e-06
- O 0 4.1587028931644454e-07
linked O 0 1.499237356483718e-08
, O 0 6.892256296936461e-12
candidate O 0 5.17594855864445e-10
dosage O 0 5.274900161111873e-08
- O 0 5.4616831057785475e-09
sensitive O 0 4.834649569573912e-09
sex O 0 1.2778619828957005e-10
- O 0 9.80309611264829e-10
reversal O 0 3.2371623159832552e-09
gene O 0 1.3281682698096375e-10
, O 0 8.997109307573581e-11
Dax O 0 2.159294581360882e-06
- O 0 1.8647551769390702e-07
1 O 0 1.7172117168229306e-06
, O 0 1.7030549193108868e-10
antagonizes O 0 5.627772470262471e-09
synergy O 0 1.1924758402948044e-10
between O 0 4.646405038499779e-09
SF O 0 2.5832154278759845e-05
- O 0 1.468144006366856e-07
1 O 0 4.998158331659397e-08
and O 0 3.208881077521042e-11
WT1 O 0 6.301438304490148e-08
, O 0 3.6466103574273045e-12
most O 0 3.4799764524022503e-13
likely O 0 1.2236493068806809e-11
through O 0 7.994878630651625e-13
a O 0 1.2175032683414688e-11
direct O 0 1.776851582535599e-10
interaction O 0 2.381471131407409e-10
with O 0 1.6982606987347992e-10
SF O 1 0.8613259792327881
- O 0 6.881902663735673e-05
1 O 0 1.2326589967415202e-05
. O 0 2.797340314941721e-08

We O 0 4.6814747634016385e-08
propose O 0 7.791604872409152e-08
that O 0 4.79610906545247e-10
WT1 O 0 3.868385647365358e-06
and O 0 1.2707466190420291e-08
Dax O 0 7.5388520599517506e-06
- O 0 2.1415454298789882e-08
1 O 0 4.167714706682091e-08
functionally O 0 3.2298583252377e-10
oppose O 0 5.018057844252688e-11
each O 0 2.1443205284327194e-12
other O 0 5.078831235780235e-13
in O 0 6.577665929291543e-12
testis O 0 8.27479151865873e-09
development O 0 2.0869519654076463e-11
by O 0 1.7831996296235886e-11
modulating O 0 2.023463707701012e-08
SF O 0 8.122616418404505e-05
- O 0 5.474315116771322e-07
1 O 0 1.7018236064814118e-07
- O 0 5.417525983375526e-09
mediated O 0 5.246063849995153e-08
transactivation O 0 2.3312509256356861e-07
. O 0 1.3042342206226465e-10
. O 0 4.3451803266592037e-10

A O 0 8.312962762602183e-09
mouse O 0 2.178791869145158e-11
model O 0 2.6398555216800013e-11
for O 0 3.106065127322921e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999990463256836
- O 1 0.999935507774353
centre O 0 8.711538157513132e-07
mutations O 0 7.169615656721362e-08
. O 0 2.5694870231518507e-08

Imprinting O 0 3.00251076623681e-06
in O 0 1.2317432629416203e-09
the O 0 3.294518435836835e-09
15q11 O 0 7.614910828124266e-06
- O 0 2.8994963940931484e-07
q13 O 0 2.2422852907766355e-06
region O 0 8.906025916743943e-10
involves O 0 2.3373109003799186e-11
an O 0 1.8900773307573004e-11
imprinting O 0 3.2703159291713746e-08
centre O 0 5.997329743934188e-09
( O 0 2.1630945298833915e-11
IC O 0 1.3793054165489593e-07
) O 0 2.474991045442465e-11
, O 0 3.720221613406904e-12
mapping O 0 5.27581762999052e-11
in O 0 2.7776893198744323e-12
part O 0 1.3104274609876398e-11
to O 0 3.5730685077339785e-10
the O 0 1.9717083521442191e-10
promoter O 0 4.023816302378691e-08
and O 0 5.53097151412274e-11
first O 0 2.394119569260056e-09
exon O 0 1.9746195789593912e-08
of O 0 3.6959843185968566e-08
SNRPN O 0 0.07648928463459015
. O 0 4.1127660210804606e-07

Deletion O 0 8.633520565126673e-07
of O 0 4.583347479325539e-09
this O 0 4.344674620071487e-10
IC O 0 3.7553513720922638e-06
abolishes O 0 4.005477194368723e-07
local O 0 4.254039343010163e-10
paternally O 0 5.284199189325989e-10
derived O 0 2.908263040113379e-12
gene O 0 3.5861583342657044e-13
expression O 0 6.415882229790157e-14
and O 0 2.2632362902731164e-14
results O 0 7.456823786916589e-13
in O 0 1.7925304296451117e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.302567842591088e-06
PWS B-Disease 1 1.0
) O 0 6.175620015369532e-09
. O 0 3.428517203474257e-08

We O 0 1.7153372056100125e-08
have O 0 8.148308416888739e-12
created O 0 3.740729948020771e-11
two O 0 1.6028010862978448e-10
deletion O 0 2.1412841277879124e-08
mutations O 0 3.3233480412064864e-09
in O 0 2.1996710009020148e-10
mice O 0 6.346193570649916e-10
to O 0 1.393269055682822e-09
understand O 0 2.918348762648293e-08
PWS B-Disease 1 1.0
and O 0 1.1441454450533683e-09
the O 0 4.8488507653488e-10
mechanism O 0 1.0781905368517641e-09
of O 0 1.172292124484997e-10
this O 0 1.7101704774535875e-10
IC O 0 1.0160622878174763e-05
. O 0 8.048418465023133e-08

Mice O 0 5.777779733762145e-06
harbouring O 0 1.106191689359548e-06
an O 0 1.1716891901158988e-09
intragenic O 0 6.106776254455326e-06
deletion O 0 3.344867138821428e-07
in O 0 2.4795103747976555e-09
Snrpn O 0 5.122920629219152e-05
are O 0 4.5939002601969037e-10
phenotypically O 0 9.012258601615031e-07
normal O 0 1.4990534680237033e-07
, O 0 1.7898852539000032e-11
suggesting O 0 1.2774281632488282e-10
that O 0 1.4560548947106788e-11
mutations O 0 1.2042844499404737e-09
of O 0 7.3956347712567094e-09
SNRPN O 0 7.365149940596893e-05
are O 0 1.0266827318861083e-11
not O 0 7.282232455940729e-11
sufficient O 0 5.967032423725982e-10
to O 0 5.725519169885729e-09
induce O 0 9.557506928103976e-06
PWS B-Disease 1 1.0
. O 0 4.169411113252863e-06

Mice O 0 4.9955087177977475e-08
with O 0 2.124263438763041e-12
a O 0 3.860548339340575e-11
larger O 0 1.1634223445744496e-10
deletion O 0 1.0131276262370648e-08
involving O 0 8.555531283427342e-11
both O 0 6.4223539680829944e-12
Snrpn O 0 2.446646192311164e-07
and O 0 4.864298894236008e-11
the O 0 1.1815030065420729e-09
putative O 0 2.085552068820107e-06
PWS O 1 1.0
- O 0 1.711705408524722e-05
IC O 0 8.976192475529388e-06
lack O 0 5.222031695950591e-09
expression O 0 1.197307530897973e-10
of O 0 2.701943946359364e-10
the O 0 1.7021650755566498e-10
imprinted O 0 1.1205207872677647e-09
genes O 0 4.1606895706536307e-10
Zfp127 O 0 8.929371375643314e-08
( O 0 1.8560281783708277e-11
mouse O 0 6.753877457299495e-10
homologue O 0 6.561939613902723e-08
of O 0 5.421702198304956e-09
ZNF127 O 0 0.00013122610107529908
) O 0 6.019593712380811e-10
, O 0 6.279369246797728e-10
Ndn O 0 1.749040848153527e-06
and O 0 2.946829003036555e-09
Ipw O 0 8.379156923865594e-08
, O 0 9.068763795472279e-11
and O 0 5.057955096421374e-11
manifest O 0 1.2358191137096242e-09
several O 0 8.551773872378376e-12
phenotypes O 0 4.452577750946318e-10
common O 0 3.021010663850632e-10
to O 0 1.063372906173754e-06
PWS B-Disease 1 1.0
infants O 0 0.0007505464018322527
. O 0 3.2826059737089963e-07

These O 0 2.1415186290951738e-10
data O 0 2.971768664483676e-11
demonstrate O 0 1.5933481964380825e-11
that O 0 2.4036225483928253e-13
both O 0 4.800568037706399e-13
the O 0 1.2341312867480969e-11
position O 0 1.2663031734305719e-10
of O 0 1.422230389014345e-11
the O 0 8.629554536232487e-12
IC O 0 1.2371499380492423e-08
and O 0 2.016447555805434e-12
its O 0 3.886967570726485e-12
role O 0 1.7870393749855329e-12
in O 0 4.103559397665435e-13
the O 0 2.8785337828629576e-12
coordinate O 0 1.786494910338554e-11
expression O 0 5.2944971323798384e-11
of O 0 1.887773493081113e-09
genes O 0 9.23300186306264e-11
is O 0 2.5496074435721328e-12
conserved O 0 1.739100009834349e-11
between O 0 1.2313614537740047e-11
mouse O 0 7.622258380024505e-11
and O 0 1.1980104408504388e-11
human O 0 2.107552674046609e-11
, O 0 1.6420893507798628e-12
and O 0 1.0855658819780567e-12
indicate O 0 2.9401283491159447e-11
that O 0 5.261292161488906e-13
the O 0 7.917732441908854e-12
mouse O 0 1.4753948063273015e-11
is O 0 3.182594433218805e-13
a O 0 1.1381147760336496e-12
suitable O 0 1.1240586239580352e-10
model O 0 7.361046668041826e-12
system O 0 3.6369015438131314e-11
in O 0 6.28706852204286e-12
which O 0 4.186325331528851e-12
to O 0 1.2015169414958393e-10
investigate O 0 3.130080084012832e-10
the O 0 4.448670598566906e-11
molecular O 0 2.663445575201706e-10
mechanisms O 0 2.7785929113122165e-10
of O 0 7.916421684850405e-11
imprinting O 0 2.675626387116381e-09
in O 0 1.3618176681814975e-12
this O 0 8.734254638986805e-13
region O 0 3.1684144197186015e-10
of O 0 2.0156883107080859e-10
the O 0 8.055025396691562e-11
genome O 0 7.26516832805224e-11
. O 0 9.42563457839718e-11
. O 0 2.3527890746777302e-09

Mutations O 0 1.3412373789378762e-07
of O 0 2.4187871261460714e-08
the O 0 7.754772823886924e-09
ATM O 0 7.690224265388679e-06
gene O 0 3.8291339543583547e-10
detected O 0 7.220536946128675e-10
in O 0 7.908887086904848e-12
Japanese O 0 5.057382622908335e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 6.480723868662608e-07
: O 0 1.7182806826693264e-12
possible O 0 1.0575355174902157e-10
preponderance O 0 7.572937832378557e-09
of O 0 6.973237959284617e-11
the O 0 1.8572074433897967e-11
two O 0 2.309656155566331e-12
founder O 0 4.173631218407081e-09
mutations O 0 7.19781123592611e-09
4612del165 O 0 3.0387261631403817e-06
and O 0 1.0739323208497353e-08
7883del5 O 0 0.00035800531622953713
. O 0 3.9419833797182946e-07

The O 0 9.649315124704572e-09
ATM O 0 1.9117922420264222e-05
( O 0 4.528310881823927e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 7.885999075973871e-10
mutated O 0 4.814969603583741e-11
) O 0 1.721268960697131e-12
gene O 0 1.5478699051663103e-12
on O 0 2.5017368732171974e-10
human O 0 3.303237405827275e-10
chromosome O 0 2.0332925032562343e-06
11q22 O 0 9.722232789499685e-05
. O 0 1.0082008117251462e-07

3 O 0 4.50027764600236e-05
has O 0 6.299197830017533e-10
recently O 0 3.941576509625122e-10
been O 0 1.7189175430254444e-11
identified O 0 4.09602343362514e-12
as O 0 1.2820297666353564e-13
the O 0 1.658974878044478e-13
gene O 0 3.650211236787618e-14
responsible O 0 3.646747617422341e-13
for O 0 1.0515762251857991e-13
the O 0 4.5291676659120483e-11
human O 0 1.4813467785756984e-08
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0002061292325379327
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.349102050189458e-09
. O 0 2.0933734745653965e-08

In O 0 4.761018801424655e-10
order O 0 8.510642884873576e-11
to O 0 3.5584580421188505e-11
define O 0 2.648703201213465e-10
the O 0 7.247767056656196e-12
types O 0 4.4157011380718814e-11
of O 0 4.6414783128057024e-10
disease O 0 2.656315167826051e-08
- O 0 2.648886665568284e-09
causing O 0 3.176051865949603e-09
ATM O 0 2.71608968205328e-07
mutations O 0 8.824384972738741e-11
in O 0 8.127881180597374e-12
Japanese O 0 1.5921870044621755e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.507704431944148e-09
as O 0 1.6193817120591092e-11
well O 0 1.5469608016446812e-12
as O 0 1.0024382582698999e-12
to O 0 1.0230917675546625e-11
look O 0 2.7462186170945646e-12
for O 0 2.955549433664162e-12
possible O 0 4.686546706267336e-09
mutational O 0 1.4939299717298127e-06
hotspots O 0 6.535285024256154e-08
, O 0 5.6900015948935234e-11
reverse O 0 1.8234184162579936e-09
- O 0 6.723442358413934e-10
transcribed O 0 3.390320663099189e-11
RNA O 0 2.4114038890687972e-11
derived O 0 1.535720877722524e-13
from O 0 2.92754020895028e-13
ten O 0 1.2691745441065216e-12
patients O 0 1.970268261421767e-14
belonging O 0 9.964672451978976e-14
to O 0 7.911090185719338e-12
eight O 0 1.1202268279664196e-11
unrelated O 0 8.329556488995138e-11
Japanese O 0 8.33150650692005e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 5.841750971846693e-10
was O 0 1.6872389041466818e-09
analyzed O 0 9.684336665927162e-11
for O 0 8.95514218335336e-12
mutations O 0 5.289831073174156e-12
by O 0 5.1327848221705e-12
the O 0 8.401421225379124e-11
restriction O 0 6.965236026834631e-11
endonuclease O 0 2.204914251180412e-09
fingerprinting O 0 8.822201857938694e-10
method O 0 2.1648300929655306e-09
. O 0 8.627210612566216e-10

As O 0 2.4405025556006876e-08
has O 0 1.128514018344795e-10
been O 0 1.8220711398009293e-11
reported O 0 9.608271643590793e-12
by O 0 2.0944277128592814e-12
others O 0 2.9776351523347344e-11
, O 0 1.8004483320899212e-11
mutations O 0 1.182929726395443e-10
that O 0 2.2728098569846367e-10
lead O 0 9.61908108720877e-10
to O 0 2.7391566348455854e-08
exon O 0 8.516598626329142e-08
skipping O 0 2.6683557052820106e-07
or O 0 5.384923085216542e-08
premature O 0 3.6569650774254114e-07
protein O 0 1.1046588532792612e-08
truncation O 0 8.326486522491905e-08
were O 0 5.6963433969769994e-11
also O 0 3.95144854337115e-12
predominant O 0 1.2661148518500198e-10
in O 0 9.265067879571376e-12
our O 0 1.838914437390926e-10
mutants O 0 2.438546919947271e-09
. O 0 2.17162887672373e-09

Six O 0 6.0647034061389604e-09
different O 0 4.040990198711514e-12
mutations O 0 6.507661770571715e-11
were O 0 5.835987075542004e-12
identified O 0 9.129607660141037e-12
on O 0 3.4490035827339227e-10
12 O 0 3.4796499015499194e-10
of O 0 3.789490596317613e-11
the O 0 1.184702197454257e-10
16 O 0 5.5747184646293135e-09
alleles O 0 6.273874197937346e-10
examined O 0 2.3004412597060764e-08
. O 0 2.1164664687489676e-08

Four O 0 2.047878133737413e-08
were O 0 3.879165322295819e-10
deletions O 0 2.898465689682439e-09
involving O 0 1.1229014940106197e-10
a O 0 5.085779575253468e-10
loss O 0 8.12178679865383e-09
of O 0 4.3543522565414605e-08
a O 0 9.041174031665378e-09
single O 0 6.704416133374025e-09
exon O 0 1.607637223344227e-08
exon O 0 5.94861830904847e-08
7 O 0 4.567401674648863e-07
, O 0 3.195128883692888e-10
exon O 0 8.362261993966058e-09
16 O 0 4.8215571979426386e-08
, O 0 4.2699965785431004e-10
exon O 0 3.029905926155152e-08
33 O 0 3.6630343203114535e-08
or O 0 5.880097297961129e-09
exon O 0 2.3109835467494122e-07
35 O 0 7.158587891353818e-07
. O 0 1.874270161295044e-08

The O 0 1.7423022313778347e-07
others O 0 1.72504477369273e-09
were O 0 5.235193389907522e-10
minute O 0 5.472175246268307e-08
deletions O 0 3.454759811560848e-09
, O 0 5.7418743371062675e-11
4649delA O 0 6.9340924113703295e-09
in O 0 5.211859277487463e-10
exon O 0 1.1514053710470762e-08
33 O 0 1.698968610241991e-08
and O 0 1.687489176172008e-10
7883del5 O 0 1.3344284752747626e-06
in O 0 1.630659873796958e-08
exon O 0 3.760308118216926e-07
55 O 0 6.800716505495075e-07
. O 0 1.6325861551536036e-08

The O 0 2.3299618590044702e-07
mutations O 0 7.525611778191887e-08
4612del165 O 0 2.5380754777870607e-06
and O 0 9.221073904441823e-10
7883del5 O 0 1.4543338693329133e-05
were O 0 2.522940745208757e-10
found O 0 1.412500216617374e-12
in O 0 4.433086859298267e-14
more O 0 2.985960969177333e-15
than O 0 2.91747149442495e-14
two O 0 1.9695620053503463e-14
unrelated O 0 2.6775914927119893e-13
families O 0 1.861197522869725e-14
; O 0 2.2608041198683704e-13
44 O 0 5.041189687915448e-10
% O 0 4.505937636900548e-11
( O 0 3.357992486505146e-12
7 O 0 1.0211126166836948e-08
of O 0 3.827586025906271e-10
16 O 0 5.381970424878091e-10
) O 0 5.697141434828079e-13
of O 0 7.894780315598204e-12
the O 0 8.795612675693842e-12
mutant O 0 1.6269138813918005e-11
alleles O 0 3.3874164324237954e-12
had O 0 7.837975060653868e-12
one O 0 8.911178002099507e-13
of O 0 1.3104975438160693e-11
the O 0 5.373433642485992e-11
two O 0 6.456526285836262e-11
mutations O 0 8.116398220181509e-09
. O 0 4.165004696687902e-08

The O 0 3.4955661476487876e-07
4612del165 O 0 1.8651267964742146e-05
mutations O 0 1.2494257850548252e-09
in O 0 4.4900810500236865e-12
three O 0 1.6809395943315902e-13
different O 0 8.545500258480034e-15
families O 0 3.0822531484585303e-13
were O 0 3.4860968278760396e-12
all O 0 3.671343611066913e-12
ascribed O 0 3.3473107619030884e-10
to O 0 1.6205099762078845e-10
the O 0 9.259314148746256e-11
same O 0 2.415663225008302e-10
T O 0 5.004165526401039e-09
- O 0 4.344544279888396e-09
- O 0 4.3719428077793054e-09
> O 0 1.9753270130706824e-09
A O 0 1.6751883213927954e-09
substitution O 0 4.821936253063264e-11
at O 0 3.6759841698374984e-11
the O 0 4.298814776371174e-12
splice O 0 1.5701730193828922e-10
donor O 0 5.831550520252193e-11
site O 0 7.501929077946556e-10
in O 0 1.0004684858344604e-09
intron O 0 9.857384611677844e-06
33 O 0 4.596131475409493e-06
. O 0 1.8399271084490465e-07

Microsatellite O 0 5.200502982916078e-06
genotyping O 0 9.037212578277831e-08
around O 0 8.816865293415077e-11
the O 0 6.894469023466243e-11
ATM O 0 1.0190272803356493e-07
locus O 0 4.780694506933969e-09
also O 0 1.7762806199875247e-12
indicated O 0 2.352818113948718e-11
that O 0 1.053210050097099e-13
a O 0 3.993545511643548e-12
common O 0 1.9071407647563987e-11
haplotype O 0 1.7419674591678813e-08
was O 0 1.1550209677579915e-09
shared O 0 4.5112820271954457e-13
by O 0 3.485915440852583e-13
the O 0 3.948059934533177e-11
mutant O 0 9.357761787676111e-11
alleles O 0 1.9112484164751642e-11
in O 0 1.7646044347952028e-11
both O 0 1.3339490623209826e-10
mutations O 0 7.573504490210325e-08
. O 0 8.934107142977155e-08

This O 0 1.7142143260429066e-09
suggests O 0 7.580361893744225e-10
that O 0 4.725026793439557e-12
these O 0 2.4214963801477696e-12
two O 0 1.867359045171213e-11
founder O 0 9.42478184384754e-09
mutations O 0 1.167363983256564e-09
may O 0 2.103948126830346e-09
be O 0 4.615224036275123e-10
predominant O 0 3.802128389907011e-09
among O 0 1.1238130651763933e-12
Japanese O 0 4.3272577188169237e-10
ATM O 0 2.591246186511853e-07
mutant O 0 1.2451751629782848e-08
alleles O 0 5.374915623690413e-09
. O 0 5.4544684324753234e-09

W474C O 0 0.00016117653285618871
amino O 0 1.2573255503411929e-07
acid O 0 2.433979462423963e-09
substitution O 0 1.6836761151939328e-10
affects O 0 3.428250391901422e-11
early O 0 2.5433394279517074e-10
processing O 0 1.2083264944173777e-10
of O 0 6.450248668521397e-11
the O 0 2.938721141432232e-11
alpha O 0 3.652779814733442e-11
- O 0 2.253994083392663e-12
subunit O 0 1.228204257047727e-11
of O 0 6.226135926268306e-12
beta O 0 1.8126780632066186e-10
- O 0 7.076460251109751e-11
hexosaminidase O 0 1.130531002146995e-09
A O 0 9.641982351427103e-11
and O 0 2.4813414127231037e-13
is O 0 2.6535232886849835e-13
associated O 0 7.99958103231413e-12
with O 0 4.907387864128143e-12
subacute O 0 0.11362194269895554
G B-Disease 0 0.00011253963748458773
( I-Disease 0 1.0832489349965613e-09
M2 I-Disease 0 4.966346295987023e-06
) I-Disease 0 1.154153328464247e-09
gangliosidosis I-Disease 0 1.3238165593065787e-05
. O 0 1.3291825951000646e-07

Mutations O 0 9.586268134853526e-08
in O 0 1.2431857765449195e-09
the O 0 1.4191027908339038e-08
HEXA O 0 6.674283213214949e-06
gene O 0 8.635026027548065e-11
, O 0 3.499627454148224e-12
encoding O 0 2.6507728304037137e-12
the O 0 7.31782204277387e-11
alpha O 0 8.142004431777039e-11
- O 0 3.862593838527273e-12
subunit O 0 2.6163560901126814e-11
of O 0 2.917120017764674e-11
beta O 0 6.49177156475389e-10
- O 0 4.749409199256149e-10
hexosaminidase O 0 2.6726183932623826e-08
A O 0 1.9225636194164508e-08
( O 0 1.0769074521022048e-10
Hex O 0 5.526972657321494e-08
A O 0 1.7223266368660006e-08
) O 0 3.2921764273052823e-12
, O 0 1.1026947584202862e-12
that O 0 1.7257857469477056e-12
abolish O 0 2.102384577540306e-08
Hex O 0 2.7586663620127183e-08
A O 0 4.262087627271427e-10
enzyme O 0 3.654299085553703e-11
activity O 0 2.342417648737438e-10
cause O 0 0.0001393042621202767
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.4808669008002937e-10
TSD B-Disease 0 5.205688466958236e-06
) O 0 2.349426859657444e-12
, O 0 9.77017295192284e-13
the O 0 3.856956420911217e-11
fatal O 0 4.154214749974017e-08
infantile B-Disease 0 5.672066194506442e-08
form I-Disease 0 1.4884435906026283e-09
of I-Disease 0 1.4876461591484258e-06
G I-Disease 0 9.11194638320012e-06
( I-Disease 0 3.0989641408574187e-10
M2 I-Disease 0 4.4688755451716133e-07
) I-Disease 0 7.27504098629872e-11
gangliosidosis I-Disease 0 9.770661790753365e-08
, I-Disease 0 6.133916291561903e-11
Type I-Disease 0 1.6302525551736835e-08
1 I-Disease 0 2.1740313513873843e-06
. O 0 3.144288385215077e-08

Less O 0 8.038538368282389e-08
severe O 0 0.00014131792704574764
, O 0 9.618494889451767e-10
subacute O 0 0.18534383177757263
( O 0 1.7875594060523525e-10
juvenile O 0 1.4701084865009761e-06
- O 0 2.0863623717559676e-07
onset O 1 0.9998279809951782
) O 0 2.2439157476572547e-10
and O 0 4.022586264085248e-09
chronic O 1 0.9999998807907104
( O 0 5.418680504298834e-10
adult O 0 1.3741509974352084e-06
- O 0 1.370468339700892e-06
onset O 0 0.0012010157806798816
) O 0 1.5440138750877352e-11
variants O 0 4.013339660602355e-11
are O 0 2.0389476240202653e-13
characterized O 0 9.077719587309574e-13
by O 0 1.8021058278451518e-13
a O 0 9.926401714488442e-12
broad O 0 3.7629083182721956e-10
spectrum O 0 3.6955309923314417e-09
of O 0 1.5919698892474798e-10
clinical O 0 7.126716439209702e-10
manifestations O 0 1.3809006160769854e-09
and O 0 1.1695641200307194e-12
are O 0 5.020960589571105e-14
associated O 0 3.797911637959395e-12
with O 0 1.072722206202359e-12
residual O 0 1.4032048056833446e-06
levels O 0 4.65206504429716e-08
of O 0 1.5604713965444716e-08
Hex O 0 4.147288450440101e-07
A O 0 6.303818622654944e-08
enzyme O 0 3.1070741535188517e-09
activity O 0 2.9259494827016397e-09
. O 0 1.4239446288755175e-09

We O 0 2.9226379538727087e-08
identified O 0 1.7125673101858752e-09
a O 0 7.075060537431455e-10
1422 O 0 9.437059134143055e-07
G O 0 2.478836336194945e-07
- O 0 7.03908753507676e-08
- O 0 6.055481804878582e-08
> O 0 3.063342290943183e-08
C O 0 1.3611743554520217e-07
( O 0 2.083793727847283e-11
amino O 0 2.2295429391583355e-10
acid O 0 1.726847137506482e-11
W474C O 0 1.335295762849853e-10
) O 0 2.7576044864875996e-15
substitution O 0 1.2605393887987065e-13
in O 0 4.16846563505973e-14
the O 0 4.59411263371845e-13
first O 0 3.200358814764437e-12
position O 0 1.3868758919066693e-10
of O 0 1.4868198339179628e-10
exon O 0 1.674351435276833e-09
13 O 0 1.51616863508508e-09
of O 0 5.897863308845785e-10
HEXA O 0 7.727313459326979e-06
of O 0 3.9301956133996896e-10
a O 0 8.646071636420061e-10
non O 0 1.9668543416173634e-07
- O 0 1.6043908601659496e-07
Jewish O 0 2.435495218833239e-07
proband O 0 0.00042959777056239545
who O 0 1.7282382469563373e-10
manifested O 0 1.5561006649900122e-10
a O 0 5.803820618544009e-11
subacute O 0 3.9554007003061997e-07
variant O 0 2.5359161881510772e-08
of O 0 1.4468140761891846e-05
G B-Disease 0 0.0004922423977404833
( I-Disease 0 2.0073560591526984e-09
M2 I-Disease 0 7.595733677590033e-06
) I-Disease 0 9.673634115969776e-10
gangliosidosis I-Disease 0 1.1879404155479278e-05
. O 0 1.4346501586715021e-07

On O 0 1.1197530511708464e-06
the O 0 6.236176464113896e-09
second O 0 1.0586183485372658e-08
maternally O 0 1.2466912835407129e-08
inherited O 0 8.041694421478951e-09
allele O 0 7.45723749417948e-09
, O 0 7.58709588211115e-12
we O 0 5.127911550245612e-12
identified O 0 7.793894002405821e-12
the O 0 7.111176231200389e-12
common O 0 1.643759794944799e-08
infantile O 1 1.0
disease O 1 0.9999995231628418
- O 0 0.0002853701589629054
causing O 0 0.0003350529004819691
4 O 0 3.2775762520032004e-05
- O 0 5.633654609482619e-07
bp O 0 2.8555729159052134e-07
insertion O 0 2.5084908372718928e-08
, O 0 2.952678934686759e-10
+ O 0 4.099562467274609e-09
TATC O 0 4.761014679388609e-06
1278 O 0 3.510348562940635e-07
, O 0 9.421321361946511e-11
in O 0 2.293048806389919e-10
exon O 0 3.404575465992821e-08
11 O 0 3.3688152711874864e-08
. O 0 8.649754690281952e-09

Pulse O 0 3.397906766622327e-05
- O 0 3.775540449169057e-07
chase O 0 4.695234423479633e-09
analysis O 0 6.399939172369029e-12
using O 0 3.432738815423164e-11
proband O 0 4.053597137954057e-07
fibroblasts O 0 2.183908698327741e-08
revealed O 0 5.059233476600866e-09
that O 0 4.417622170849178e-11
the O 0 4.3215334089019564e-10
W474C O 0 4.037577028270789e-08
- O 0 1.1772491870232216e-09
containing O 0 1.0945774668591479e-11
alpha O 0 3.12620179743206e-10
- O 0 4.5693070854779805e-11
subunit O 0 2.5378540935427907e-10
precursor O 0 7.691310921487116e-10
was O 0 2.4838073264810134e-10
normally O 0 2.8355230489995886e-12
synthesized O 0 2.636643724532317e-12
, O 0 1.5286873329689588e-12
but O 0 1.0231185473483229e-12
not O 0 1.4893565547513532e-11
phosphorylated O 0 6.122277684816879e-10
or O 0 4.231719974434611e-10
secreted O 0 5.671776243110216e-11
, O 0 3.447013941643151e-12
and O 0 1.559528721439829e-11
the O 0 4.886470672538223e-10
mature O 0 6.2350111740272496e-09
lysosomal O 0 7.77420652298133e-08
alpha O 0 1.1222773821373266e-08
- O 0 7.444840854908819e-10
subunit O 0 2.929478881696923e-09
was O 0 2.011948163627153e-09
not O 0 4.823042520918364e-10
detected O 0 5.925141266516221e-09
. O 0 1.8296997250644154e-09

When O 0 8.803112017119474e-09
the O 0 3.4053662112398797e-09
W474C O 0 1.3947551735782326e-07
- O 0 8.890174152398345e-10
containing O 0 3.0992799472662202e-12
alpha O 0 3.2841503821989804e-11
- O 0 2.189534794791448e-12
subunit O 0 2.1484236265023604e-11
was O 0 1.5805151631909098e-10
transiently O 0 1.3265409881668688e-09
co O 0 1.657527934351144e-11
- O 0 3.993958636039352e-11
expressed O 0 5.544150642050605e-12
with O 0 4.0718586813946744e-13
the O 0 1.7657028617001913e-10
beta O 0 1.9786630667262273e-10
- O 0 9.056953104158438e-12
subunit O 0 1.9398583434027117e-11
to O 0 1.342967750894708e-11
produce O 0 2.6305669448278834e-11
Hex O 0 1.198679733249719e-08
A O 0 8.759296399318828e-09
( O 0 6.89620444083161e-11
alphabeta O 0 1.4156012184685096e-07
) O 0 2.1865228377881962e-11
in O 0 2.978744473303152e-10
COS O 0 1.0172595921176253e-06
- O 0 1.613520481669184e-07
7 O 0 9.425234992477272e-08
cells O 0 1.0025979352290548e-10
, O 0 2.885707948638294e-12
the O 0 1.7616920075513853e-11
mature O 0 1.800352228409352e-11
alpha O 0 1.3950226390724296e-11
- O 0 8.406991465828573e-13
subunit O 0 5.129124555636189e-12
was O 0 2.208519131463582e-11
present O 0 1.685685987497243e-12
, O 0 1.0710601242719386e-12
but O 0 1.7262335224449421e-12
its O 0 5.401339531890814e-12
level O 0 6.305388433602843e-10
was O 0 7.356870668218107e-10
much O 0 4.416172635912652e-11
lower O 0 2.5587543195371154e-10
than O 0 4.3206640522319706e-12
that O 0 1.2785604823137287e-12
from O 0 1.467707899660553e-10
normal O 0 2.8357654002775234e-09
alpha O 0 4.0045791682707943e-10
- O 0 3.626552530500149e-11
subunit O 0 1.6453828577400742e-10
transfections O 0 8.88028139911512e-09
, O 0 4.520049699113793e-13
although O 0 6.63624754107528e-13
higher O 0 3.096327361173934e-11
than O 0 2.1172133057162368e-12
in O 0 9.295193954816927e-12
those O 0 1.4982546453490286e-11
cells O 0 2.009660320101414e-11
transfected O 0 1.7768711849108776e-11
with O 0 1.8311405587364063e-14
an O 0 1.0382476128834028e-12
alpha O 0 9.338933099067859e-11
- O 0 1.0524882181062178e-11
subunit O 0 1.0736751071549477e-10
associated O 0 7.144705660433459e-11
with O 0 2.388142635034729e-11
infantile O 0 0.0005667749210260808
TSD B-Disease 0 0.0005824885447509587
. O 0 1.6620202814010554e-07

Furthermore O 0 4.37379421569517e-09
, O 0 6.124867280021817e-11
the O 0 1.7194791424035571e-10
precursor O 0 2.633772533400247e-09
level O 0 1.9977129284143302e-08
of O 0 2.6395965413428257e-09
the O 0 3.489907252074431e-09
W474C O 0 5.565733474099943e-08
alpha O 0 3.5042396762108297e-10
- O 0 1.3597782622110088e-11
subunit O 0 3.22035904887219e-11
was O 0 8.41338387846946e-11
found O 0 2.633325686413751e-13
to O 0 8.667544980356379e-12
accumulate O 0 5.629718045907506e-12
in O 0 4.691644208548729e-13
comparison O 0 1.4103479495375382e-10
to O 0 4.8822248466251494e-09
the O 0 1.0011066642334754e-08
normal O 0 5.408092818015575e-08
alpha O 0 7.351179664993879e-09
- O 0 5.297419169991713e-10
subunit O 0 1.593112752829029e-09
precursor O 0 2.218705219547701e-09
levels O 0 1.012091854768471e-09
. O 0 2.7039029348863153e-10

We O 0 6.486022385843171e-08
conclude O 0 2.984958484830713e-07
that O 0 3.073790874608129e-11
the O 0 2.713362312611878e-10
1422 O 0 4.7321344709416735e-07
G O 0 5.079948195430006e-08
- O 0 1.7365701765470476e-08
- O 0 1.18105969448834e-08
> O 0 2.6502005034956255e-09
C O 0 8.795005612682871e-09
mutation O 0 4.371869186114985e-12
is O 0 1.761205622259534e-14
the O 0 6.141589515597234e-13
cause O 0 5.034549999116678e-10
of O 0 1.2548023065050984e-08
Hex B-Disease 0 8.791197615209967e-05
A I-Disease 1 0.6526418328285217
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.4950502492137048e-09
the O 0 1.1642002917255923e-08
proband O 0 1.2724593034363352e-05
. O 0 9.626853625377407e-08

The O 0 1.1491724194456765e-07
resulting O 0 2.8720410938376517e-08
W474C O 0 4.2667552406783216e-06
substitution O 0 3.345692789480381e-08
clearly O 0 1.315442310634296e-09
interferes O 0 5.763932664493154e-10
with O 0 4.18897729004275e-12
alpha O 0 6.520972095636068e-10
- O 0 4.077520265877155e-11
subunit O 0 8.571178489180653e-11
processing O 0 1.4502233615376614e-11
, O 0 1.313429074702166e-13
but O 0 1.0569652520841383e-13
because O 0 1.701935169401772e-13
the O 0 3.2887231891758073e-13
base O 0 6.1454591415710524e-12
substitution O 0 2.411928295975585e-11
falls O 0 1.4239391887826969e-09
at O 0 9.820027430107459e-11
the O 0 1.0904223704533145e-11
first O 0 4.792348115567613e-11
position O 0 2.646503016734414e-09
of O 0 2.0216266438666253e-09
exon O 0 8.528200368118632e-09
13 O 0 6.067364388684382e-09
, O 0 3.56025035841423e-11
aberrant O 0 3.0730654132504753e-10
splicing O 0 3.5410185894590995e-10
may O 0 2.46706488571391e-10
also O 0 1.3818365939347044e-12
contribute O 0 1.2571624297130768e-11
to O 0 1.0984524401180806e-08
Hex B-Disease 0 0.0002289257972734049
A I-Disease 0 0.00028282302082516253
deficiency I-Disease 0 1.890725252451375e-05
in O 0 3.624355537912294e-10
this O 0 4.811355203138135e-10
proband O 0 8.140555110003334e-07
. O 0 2.288331302224833e-09
. O 0 1.0937442951330922e-08

Two O 0 9.234608633335029e-10
frequent O 0 4.761638638939303e-09
missense O 0 8.284868613372964e-07
mutations O 0 1.4526207792187051e-07
in O 0 1.2713229580185725e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0001850700209615752

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.9291930275500135e-09
an O 0 7.135359680887632e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 6.8626735405530326e-09
by O 0 2.093035120220854e-11
early O 0 1.1851069757540245e-05
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.685477077960968

A O 0 3.0835430209208425e-08
century O 0 1.9959940367186846e-09
after O 0 9.917700688477638e-11
its O 0 2.1314014735009795e-13
recognition O 0 8.764760835514029e-13
as O 0 1.2511390361236163e-11
a O 0 7.885066488633186e-10
syndrome O 0 5.833795313492374e-08
by O 0 3.1211536827280284e-11
Vaughan O 0 2.0148370083461487e-08
Pendred O 0 3.9455525779885647e-07
, O 0 1.7778677835478263e-11
the O 0 9.776357501323218e-10
disease O 0 2.4452791080875613e-07
gene O 0 1.6651028333924955e-09
( O 0 1.2455971809544053e-09
PDS O 0 6.785001460229978e-06
) O 0 3.574818913110178e-11
was O 0 9.528637878730706e-10
mapped O 0 1.804830507268207e-09
to O 0 4.1870267253329985e-09
chromosome O 0 4.70056465928792e-06
7q22 O 0 0.0002567233459558338
- O 0 2.6646921469364315e-05
q31 O 0 7.930477295303717e-05
. O 0 8.288774466791438e-08

1 O 0 3.161567292409018e-05
and O 0 4.137062248332768e-09
, O 0 2.0748642803880557e-09
recently O 0 8.882077295879753e-09
, O 0 1.3411127763873765e-10
found O 0 1.7948423997049545e-11
to O 0 4.3851022812901874e-10
encode O 0 1.291842882666927e-10
a O 0 1.893312173706363e-09
putative O 0 2.622816168695863e-07
sulfate O 0 3.426491446134605e-07
transporter O 0 1.5719533621449955e-05
. O 0 1.0166859709670462e-07

We O 0 2.635905005377026e-08
performed O 0 6.437957805749406e-11
mutation O 0 1.1705979935383581e-11
analysis O 0 2.5347215645843413e-12
of O 0 1.0712062487039375e-10
the O 0 2.6091229177183095e-09
PDS B-Disease 0 3.503244079183787e-05
gene O 0 1.2093270829183211e-10
in O 0 1.63253403850927e-11
patients O 0 7.887796318883922e-12
from O 0 2.165967752376652e-11
14 O 0 1.708039376602244e-09
Pendred B-Disease 0 2.1178234277385855e-08
families O 0 1.0161367190383852e-12
originating O 0 7.460640612244607e-12
from O 0 2.584696345842019e-11
seven O 0 1.07066846707915e-11
countries O 0 5.534364199560882e-13
and O 0 1.7182815933991513e-11
identified O 0 3.2165441421483365e-09
all O 0 9.147185231483945e-10
mutations O 0 1.015360062694981e-08
. O 0 1.3187338332443233e-08

The O 0 8.633654857703732e-08
mutations O 0 1.9774717419096532e-09
include O 0 7.647593495974103e-12
three O 0 1.5086668025965366e-11
single O 0 5.845526146464053e-11
base O 0 1.6348165043922336e-09
deletions O 0 5.093314658921599e-09
, O 0 4.637504824600569e-10
one O 0 6.131392060737539e-10
splice O 0 1.7954750575199796e-08
site O 0 5.595584551265631e-10
mutation O 0 1.5231793604186805e-10
and O 0 2.987312897051453e-10
10 O 0 8.206610857541818e-08
missense O 0 1.059431815519929e-05
mutations O 0 7.3403489295742474e-06
. O 0 7.270446076290682e-07

One O 0 7.176333127745238e-08
missense O 0 7.347544510594162e-07
mutation O 0 2.4097616346807627e-08
( O 0 1.6534744406992985e-10
L236P O 0 7.546402684965869e-07
) O 0 1.5709392120477617e-11
was O 0 3.712201657180003e-10
found O 0 6.960845203192456e-13
in O 0 5.160956297739494e-13
a O 0 4.571364467520489e-11
homozygous O 0 2.2472640068271765e-11
state O 0 2.003917864978888e-12
in O 0 1.0822209014355044e-12
two O 0 2.4936734534936056e-12
consanguineous O 0 2.559957756886888e-08
families O 0 7.858663372828367e-12
and O 0 4.575505772874688e-12
in O 0 4.199402978133371e-11
a O 0 4.054876434622656e-10
heterozygous O 0 2.9023242142933725e-11
state O 0 4.581470185865966e-12
in O 0 1.1785055353472074e-12
five O 0 1.5053605063874986e-12
additional O 0 5.426245824197151e-12
non O 0 1.0690886398379007e-08
- O 0 3.4849244912038557e-07
consanguineous O 0 1.7936835092768888e-06
families O 0 6.689812592775013e-10
. O 0 1.2645473113082062e-08

Another O 0 9.523049726567479e-08
missense O 0 1.8100597571901744e-06
mutation O 0 1.9375020698930712e-08
( O 0 1.232903779069261e-10
T416P O 0 4.793608354702883e-07
) O 0 4.834421057919869e-12
was O 0 1.282379064049266e-10
found O 0 1.9367138643679171e-13
in O 0 2.0862730488492576e-13
a O 0 7.047577799124127e-12
homozygous O 0 4.865818251792442e-12
state O 0 1.556378073294673e-12
in O 0 2.8493149679953422e-12
one O 0 6.040543065743975e-12
family O 0 4.614741748454332e-13
and O 0 7.831649825179587e-13
in O 0 1.0612692148692648e-11
a O 0 4.182028057186926e-10
heterozygous O 0 1.7566531562707155e-10
state O 0 7.149640601777918e-11
in O 0 3.096256584456114e-11
four O 0 4.7485553683612736e-11
families O 0 7.708225030489402e-11
. O 0 5.165753158564712e-09

Pendred B-Disease 0 0.003989746328443289
patients O 0 4.804647346645652e-08
in O 0 5.347610132488967e-10
three O 0 6.516185369065397e-10
non O 0 4.211264226228195e-08
- O 0 6.29263467999408e-08
consanguineous O 0 8.312933346132922e-07
families O 0 1.2989760656001437e-10
were O 0 4.060965105856518e-11
shown O 0 5.934270436158684e-12
to O 0 1.533402294029429e-10
be O 0 5.1152738295145994e-11
compound O 0 6.716751044244518e-10
heterozygotes O 0 3.1725627680501134e-10
for O 0 1.0518505511036835e-10
L236P O 0 1.2820119081879966e-06
and O 0 2.511908014923847e-09
T416P O 0 5.746409442508593e-05
. O 0 1.2807063853870204e-07

In O 0 8.717462307572532e-09
total O 0 2.64701771612863e-09
, O 0 1.7147129202643718e-11
one O 0 3.156999661690918e-11
or O 0 8.977550647326638e-11
both O 0 1.975460420244879e-11
of O 0 3.074167587158172e-10
these O 0 3.686514201545199e-12
mutations O 0 2.478694853536023e-11
were O 0 7.671524006325203e-12
found O 0 6.43061179392973e-13
in O 0 3.795128545192733e-13
nine O 0 2.540380926452368e-11
of O 0 1.3836385162613318e-11
the O 0 6.84979850618106e-11
14 O 0 3.5582445878645785e-09
families O 0 3.5395852915343085e-11
analyzed O 0 6.375167949101979e-09
. O 0 1.9439170273471973e-08

The O 0 2.0106900588956478e-09
identification O 0 4.894539218369687e-10
of O 0 4.549256249486433e-10
two O 0 3.2566543212153576e-11
frequent O 0 5.018579773974352e-09
PDS B-Disease 0 5.9412468544906005e-06
mutations O 0 1.6413840286944037e-09
will O 0 3.779926024960467e-11
facilitate O 0 1.5087021909554466e-10
the O 0 2.1229575042358562e-10
molecular O 0 2.357830730659316e-08
diagnosis O 0 9.494838195678312e-06
of O 0 9.920928505380289e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.857699317042716e-05

Insertional O 0 2.8121106879552826e-05
mutation O 0 1.9545192131431577e-09
by O 0 2.2774780325529598e-11
transposable O 0 4.871083802981957e-08
element O 0 5.083784060389007e-09
, O 0 2.1620313872539043e-10
L1 O 0 5.32151352672372e-06
, O 0 5.077983866730307e-11
in O 0 9.755974500480491e-11
the O 0 3.975389972765697e-08
DMD B-Disease 1 1.0
gene O 0 6.646024286460772e-10
results O 0 4.37577613032758e-11
in O 0 1.8939169676990275e-11
X B-Disease 1 0.9956992864608765
- I-Disease 1 0.9525055885314941
linked I-Disease 0 0.06898584961891174
dilated I-Disease 1 0.8824167847633362
cardiomyopathy I-Disease 1 1.0
. O 0 1.5685300240875222e-05

X B-Disease 0 0.28377965092658997
- I-Disease 0 0.05289033427834511
linked I-Disease 0 0.03256281465291977
dilated I-Disease 1 0.9999971389770508
cardiomyopathy I-Disease 1 1.0
( O 0 2.8882466196478163e-08
XLDCM B-Disease 1 0.9999972581863403
) O 0 2.2938350871526403e-11
is O 0 2.0074909616585312e-12
a O 0 1.5239837170000214e-11
clinical O 0 1.5368932793080603e-09
phenotype O 0 3.2823141538074196e-08
of O 0 1.069064214931359e-08
dystrophinopathy B-Disease 0 1.4098619658398093e-06
which O 0 1.3297137696488548e-11
is O 0 1.562696153034615e-12
characterized O 0 1.7449435993355245e-12
by O 0 2.6110905972098752e-12
preferential O 0 2.744998717219005e-08
myocardial B-Disease 0 9.268430403608363e-06
involvement I-Disease 0 6.39542196978482e-09
without O 0 8.551746116802761e-11
any O 0 4.6416349930300527e-11
overt O 0 2.2286128498194557e-09
clinical O 0 9.121614574780779e-09
signs O 0 1.896803825118809e-09
of O 0 2.001943499863046e-07
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.0001449945120839402

To O 0 6.556182263750543e-09
date O 0 3.680577975728738e-08
, O 0 4.09614833371541e-12
several O 0 9.784177591384835e-13
mutations O 0 1.3545802500514181e-11
in O 0 6.432283525259486e-12
the O 0 5.092382515670124e-09
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.028979508206248283
, O 0 1.525532411505992e-06
DMD O 1 1.0
, O 0 9.736353945299925e-09
have O 0 7.03765448695215e-11
been O 0 1.0848792350581782e-11
identified O 0 1.4987596667209724e-12
in O 0 3.124110670681135e-13
patients O 0 2.5030357560934524e-13
with O 0 3.1012890281019445e-13
XLDCM B-Disease 1 0.9935357570648193
, O 0 6.036492139482874e-11
but O 0 6.54984746994991e-12
a O 0 5.4163940693685575e-11
pathogenic O 0 1.600787696842687e-10
correlation O 0 9.03704888699508e-10
of O 0 4.1843817299991315e-10
these O 0 1.1741309313695325e-11
cardiospecific O 0 1.219757876924632e-07
mutations O 0 2.354530792558762e-09
in O 0 6.306699606994925e-10
DMD O 1 1.0
with O 0 3.9544811869518526e-11
the O 0 5.043625073142266e-09
XLDCM B-Disease 0 0.0003511974646244198
phenotype O 0 2.7963702109445876e-07
has O 0 2.2127831511564722e-10
remained O 0 4.2524897492235425e-10
to O 0 1.4825778105187482e-10
be O 0 3.9936789986150245e-10
elucidated O 0 2.681063904219627e-07
. O 0 2.4953676458494556e-08

We O 0 2.951527378058927e-08
report O 0 4.955094667913329e-11
here O 0 5.864642538960796e-12
the O 0 5.466218189892347e-12
identification O 0 8.21331284234228e-12
of O 0 1.34103778429151e-11
a O 0 4.7268321201610064e-11
unique O 0 3.1173640058224095e-11
de O 0 9.020988755992221e-08
novo O 0 7.223566171887796e-07
L1 O 0 6.058151029719738e-07
insertion O 0 2.1538746342031345e-09
in O 0 6.647643546742188e-11
the O 0 1.514439407213075e-10
muscle O 0 1.066834676155537e-10
exon O 0 2.113625496846794e-09
1 O 0 2.4909452278620847e-08
in O 0 1.3647417917983518e-10
DMD O 1 1.0
in O 0 1.65315372502306e-09
three O 0 2.2029753021790555e-10
XLDCM B-Disease 0 0.014204159379005432
patients O 0 1.1375603237162579e-10
from O 0 3.6361594291101085e-11
two O 0 3.8232771983059965e-12
unrelated O 0 1.716916331329088e-10
Japanese O 0 5.045489581689822e-10
families O 0 2.992072908880594e-11
. O 0 3.4373157653533326e-09

The O 0 1.1537466981792477e-08
insertion O 0 7.704234583627567e-09
was O 0 2.8581537137029045e-09
a O 0 1.797789694890639e-10
5 O 0 1.4761732947121686e-09
- O 0 1.5091712601833507e-10
truncated O 0 1.9683191188057947e-10
form O 0 3.725947328447887e-11
of O 0 3.070182719167036e-10
human O 0 5.1059059757996295e-11
L1 O 0 5.1976392967389984e-08
inversely O 0 1.0254884941218734e-08
integrated O 0 4.1979475451370263e-10
in O 0 1.92466684950654e-11
the O 0 1.1123411219893242e-10
5 O 0 7.763119924675266e-09
- O 0 6.95212909462839e-09
untranslated O 0 9.432946512788476e-07
region O 0 1.7789754114261314e-09
in O 0 8.467670314926679e-11
the O 0 4.3596912191468107e-10
muscle O 0 1.6988438433784836e-10
exon O 0 1.0956145990448363e-09
1 O 0 2.0022408619979615e-08
, O 0 4.773122543912101e-13
which O 0 1.0613490880433119e-13
affected O 0 1.7741948318480971e-12
the O 0 9.772992311252171e-12
transcription O 0 4.972418310433824e-12
or O 0 1.976608980658323e-12
the O 0 5.84273688458703e-12
stability O 0 4.404950709746558e-11
of O 0 6.15190051678205e-11
the O 0 6.048501283162366e-11
muscle O 0 9.980850347590664e-12
form O 0 1.6893761389802364e-10
of O 0 2.690405453975586e-09
dystrophin O 0 9.936432787682747e-10
transcripts O 0 3.0990704447120265e-10
but O 0 1.3266604611747446e-12
not O 0 8.733788432052636e-13
that O 0 1.7135113315226713e-13
of O 0 3.9247698840894074e-11
the O 0 1.239337937830598e-10
brain O 0 1.5228353689167307e-08
or O 0 5.458141938419203e-09
Purkinje O 0 1.581894366609049e-06
cell O 0 9.934375100328907e-08
form O 0 1.8202284124413382e-09
, O 0 2.681520838709872e-10
probably O 0 2.2187305326326623e-09
due O 0 3.0621855273693654e-08
to O 0 2.514869423819732e-10
its O 0 7.96491345100847e-12
unique O 0 3.4646244206903987e-13
site O 0 9.22483339715896e-11
of O 0 1.3190772085724944e-10
integration O 0 1.400137517038047e-08
. O 0 2.2284353917711996e-08

We O 0 9.747784446290098e-08
speculate O 0 2.3639190160906765e-08
that O 0 1.0444704996726006e-12
this O 0 7.222688701465085e-13
insertion O 0 1.167944629898443e-10
of O 0 7.442636784649181e-11
an O 0 1.0903308637899567e-11
L1 O 0 6.522135009845442e-08
sequence O 0 9.311861698391155e-11
in O 0 2.6927026580692015e-11
DMD O 1 1.0
is O 0 1.5924465912586783e-10
responsible O 0 1.0983738224501494e-10
for O 0 9.035983766780831e-13
some O 0 3.0466463228108476e-13
of O 0 9.136680127752594e-12
the O 0 3.564787137352865e-12
population O 0 6.880087455697972e-14
of O 0 2.216193808329825e-12
Japanese O 0 1.7064626101070957e-10
patients O 0 4.4105812752048834e-12
with O 0 1.6579824535858934e-12
XLDCM B-Disease 0 0.00029099025414325297
. O 0 8.082968072642416e-09
. O 0 1.867864085625115e-08

Severe O 0 0.00030338409123942256
early O 0 0.00045749187120236456
- O 1 0.9577949643135071
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 6.954969649086706e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 4.632077252608724e-05
red O 0 2.9744618586846627e-05
hair O 0 0.1808476746082306
pigmentation O 0 0.0023280747700482607
caused O 0 4.498891030380037e-06
by O 0 7.856729666855244e-08
POMC O 0 0.002260793698951602
mutations O 0 3.222748432563094e-07
in O 0 4.9152637515703645e-09
humans O 0 8.934034845253791e-09
. O 0 8.426368935943174e-09

Sequential O 0 1.7636304505685985e-07
cleavage O 0 6.446051656894269e-07
of O 0 3.856123598211525e-08
the O 0 7.995653583670048e-10
precursor O 0 1.9349372104571216e-10
protein O 0 1.909245539444271e-10
pre O 0 2.5488104071769158e-08
- O 0 2.642418550635739e-08
pro O 0 3.812224136368059e-08
- O 0 2.577739337539242e-07
opiomelanocortin O 0 2.3171880911831977e-06
( O 0 5.499730670877057e-10
POMC O 0 7.990170729499368e-07
) O 0 3.512011428202788e-12
generates O 0 1.1472604984075208e-11
the O 0 3.9789796457689874e-11
melanocortin O 0 2.0806592004873892e-08
peptides O 0 5.150186943581048e-10
adrenocorticotrophin O 0 2.1096255409247533e-07
( O 0 1.7915803562917887e-10
ACTH O 0 6.466210322741972e-08
) O 0 1.6172764516486637e-11
, O 0 2.3750420033441522e-11
melanocyte O 0 4.739351311400242e-08
- O 0 5.76130041451961e-08
stimulating O 0 1.6179043660358161e-09
hormones O 0 1.1961023838047424e-10
( O 0 1.9666135039897448e-12
MSH O 0 1.309152963813176e-08
) O 0 2.9124708287447953e-12
alpha O 0 7.176555877341784e-11
, O 0 3.320236609521271e-13
beta O 0 9.976745124484765e-11
and O 0 1.4112513241348879e-11
gamma O 0 1.677317618131724e-09
as O 0 1.3112276021909341e-11
well O 0 3.280279910547468e-12
as O 0 1.1669108387901694e-11
the O 0 3.418664656917869e-11
opioid O 0 3.98543953394892e-09
- O 0 8.353043257081083e-10
receptor O 0 3.3881694672110996e-10
ligand O 0 3.5855503011106293e-09
beta O 0 7.005294833106746e-08
- O 0 1.6752212061987848e-08
endorphin O 0 2.8113015559938503e-07
. O 0 1.5697725341823343e-09

While O 0 3.980585194796049e-09
a O 0 1.8776423471589254e-10
few O 0 4.353399238321565e-11
cases O 0 3.6581064566387766e-11
of O 0 4.71085215281164e-09
isolated O 0 2.6919808078673668e-05
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 6.012668762878093e-08
been O 0 2.795423892365534e-09
reported O 0 7.119597689175805e-10
( O 0 1.517099362802199e-10
OMIM O 0 3.088651965299505e-06
201400 O 0 5.08879267613338e-08
) O 0 2.3097619736983654e-12
, O 0 2.549116299987997e-12
an O 0 9.811172013707292e-11
inherited O 1 0.814784586429596
POMC O 1 1.0
defect O 1 0.999954342842102
has O 0 5.099127786678537e-09
not O 0 6.839436239580721e-10
been O 0 7.775233928919434e-11
described O 0 5.1709133502830795e-11
so O 0 5.33410728781325e-12
far O 0 2.562847156717396e-10
. O 0 1.95990246254496e-09

Recent O 0 6.581920786175033e-08
studies O 0 7.284570169296956e-10
in O 0 1.3502828195843808e-11
animal O 0 5.9176331369814594e-12
models O 0 2.7228625170544474e-12
elucidated O 0 6.191822055079399e-10
a O 0 1.7178916275617517e-11
central O 0 7.375669519582573e-10
role O 0 4.799824426804378e-10
of O 0 6.498837024082604e-09
alpha O 0 1.6585637752086768e-07
- O 0 7.497802556599709e-08
MSH O 0 2.379145598752075e-06
in O 0 9.26830695524572e-11
the O 0 9.013254725909192e-11
regulation O 0 1.8693199765884572e-10
of O 0 8.458690345380937e-12
food O 0 5.470450481492861e-13
intake O 0 2.7636662354229777e-14
by O 0 5.405887089154297e-15
activation O 0 1.8287636682767783e-10
of O 0 1.2195636722722725e-09
the O 0 9.039415438394371e-09
brain O 0 8.743223816054524e-07
melanocortin O 0 1.356601387669798e-06
- O 0 1.5787429674674058e-07
4 O 0 4.179623758204798e-08
- O 0 1.8330775786168374e-09
receptor O 0 3.4716018948444116e-10
( O 0 6.434173506486562e-12
MC4 O 0 9.309174942018217e-08
- O 0 3.1133622346857237e-09
R O 0 8.556057529141015e-10
; O 0 3.917408931963795e-12
refs O 0 5.83594839120849e-10
3 O 0 1.8169217519403702e-10
- O 0 3.227461353727534e-11
5 O 0 3.921238334037014e-11
) O 0 8.760373035440663e-15
and O 0 8.146218075100187e-14
the O 0 4.369018601763086e-12
linkage O 0 2.422104961041782e-09
of O 0 2.5225077582291533e-10
human O 0 5.377756018276614e-09
obesity B-Disease 1 1.0
to O 0 2.5069411435652e-08
chromosome O 0 2.1600411059807811e-07
2 O 0 2.7633146260086505e-07
in O 0 1.796137821807875e-10
close O 0 1.2094414358898575e-08
proximity O 0 1.0665284655431151e-08
to O 0 1.2182386210923823e-09
the O 0 1.0369588521186301e-09
POMC O 0 4.840017027163412e-07
locus O 0 3.506327672653242e-09
, O 0 3.983359215392612e-12
led O 0 1.1200467636696132e-12
to O 0 5.43376270627921e-13
the O 0 2.1053086574421287e-13
proposal O 0 4.015833672543767e-12
of O 0 6.071268054269607e-12
an O 0 1.4600476860512912e-12
association O 0 3.454321551021877e-11
of O 0 1.0450305509834834e-08
POMC O 0 0.0018337605288252234
with O 0 2.3963844797414424e-10
human O 0 1.4772549548069946e-06
obesity B-Disease 1 1.0
. O 0 1.23374988447722e-07

The O 0 2.4235466966615604e-09
dual O 0 6.967634469390305e-09
role O 0 7.374941990434536e-09
of O 0 3.4432761708558246e-07
alpha O 0 8.579451787227299e-06
- O 0 4.4972653086006176e-06
MSH O 0 2.2266112864599563e-05
in O 0 4.906203776577911e-10
regulating O 0 2.2020312240300655e-09
food O 0 3.681442997671702e-11
intake O 0 1.3622859784678809e-11
and O 0 1.1454603541724562e-12
influencing O 0 6.580963773927806e-09
hair O 0 2.0626962395908777e-06
pigmentation O 0 1.9305505247757537e-06
predicts O 0 1.9893655611724625e-09
that O 0 7.341132909899351e-13
the O 0 1.1756457786449293e-11
phenotype O 0 3.29237442864283e-10
associated O 0 1.6394646057404927e-11
with O 0 2.5808855378360585e-13
a O 0 6.726930679157306e-10
defect O 0 7.792050382704474e-08
in O 0 1.678175265418247e-09
POMC O 0 6.320026841422077e-06
function O 0 1.0221760105011413e-09
would O 0 5.095275312783087e-10
include O 0 1.4423737759727828e-09
obesity B-Disease 1 1.0
, O 0 1.040660002615823e-09
alteration O 0 1.4161403669277206e-05
in O 0 7.588187145302072e-07
pigmentation O 1 0.9992029070854187
and O 0 8.158262789947912e-05
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999986886978149
. O 0 1.969935965462355e-06

The O 0 4.1094914138284366e-08
observation O 0 8.05973797923798e-07
of O 0 4.8133884433809726e-08
these O 0 5.825627757971574e-10
symptoms O 0 2.277178055010154e-07
in O 0 2.880266858351632e-10
two O 0 1.3157903933080917e-10
probands O 0 6.299804340414994e-07
prompted O 0 1.9413037843918346e-09
us O 0 1.8510513954961283e-10
to O 0 7.505979726651901e-10
search O 0 2.9056487771406125e-10
for O 0 7.958035272426223e-12
mutations O 0 1.832402007906353e-10
within O 0 5.581418660582926e-10
their O 0 1.4220392641206558e-09
POMC O 0 1.4847808415652253e-05
genes O 0 2.2434171853547014e-08
. O 0 6.640731076146267e-09

Patient O 0 3.6134042602498084e-05
1 O 0 2.9308437206054805e-06
was O 0 2.047046265829522e-08
found O 0 6.551359281459224e-12
to O 0 2.5823751123588146e-11
be O 0 3.755598262933368e-12
a O 0 1.3968519049778472e-11
compound O 0 3.0274305284905267e-10
heterozygote O 0 3.1500357877689567e-10
for O 0 8.718080944658535e-12
two O 0 2.1145021497637195e-11
mutations O 0 1.0342759287906844e-10
in O 0 3.936617698485634e-10
exon O 0 1.2497720192072848e-08
3 O 0 1.7098159332817886e-07
( O 0 1.7319638778712232e-10
G7013T O 0 1.2039495231874753e-06
, O 0 1.7889270620408126e-10
C7133delta O 0 1.5490012827967803e-08
) O 0 8.18739119470141e-13
which O 0 5.190591879922213e-13
interfere O 0 5.26867568670375e-12
with O 0 2.2426532202482474e-14
appropriate O 0 1.0135048182646766e-11
synthesis O 0 2.753706151992219e-10
of O 0 9.483815954780539e-10
ACTH O 0 2.74586881232608e-07
and O 0 5.84775117218328e-09
alpha O 0 1.4619477042288054e-06
- O 0 3.7212373626971385e-07
MSH O 0 2.0801666323677637e-05
. O 0 1.0991943355520561e-08

Patient O 0 6.006845069350675e-06
2 O 0 2.8614013558581064e-07
was O 0 3.216090060931265e-09
homozygous O 0 1.928002896223191e-11
for O 0 1.7881986039483544e-12
a O 0 5.243214890038317e-11
mutation O 0 1.9308928067562903e-10
in O 0 1.1794555609956348e-10
exon O 0 1.1483086481689497e-08
2 O 0 4.0837849724084663e-07
( O 0 4.094871386417509e-10
C3804A O 0 1.0950489013339393e-06
) O 0 1.5868154012999014e-11
which O 0 6.768549609681429e-11
abolishes O 0 9.320337994722649e-07
POMC O 0 3.4931306345242774e-06
translation O 0 2.727671244429075e-08
. O 0 2.562185308363496e-08

These O 0 9.7207568383606e-11
findings O 0 3.197858644554685e-11
represent O 0 4.627471583001919e-12
the O 0 3.930896406989515e-12
first O 0 2.5582782420263683e-12
examples O 0 1.5994980947370285e-12
of O 0 2.7897805593424252e-11
a O 0 1.8996495487755283e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 3.1699394220652266e-09
the O 0 2.6652053897180394e-09
POMC O 0 4.960369324180647e-07
gene O 0 9.316813813498026e-12
and O 0 6.088903253126388e-13
define O 0 1.1696434099039976e-10
a O 0 3.222300551386503e-11
new O 0 7.41078198807088e-10
monogenic B-Disease 1 0.9908758401870728
endocrine I-Disease 1 0.9999998807907104
disorder I-Disease 0 3.4918384699267335e-06
resulting O 0 1.0774792169598868e-09
in O 0 8.578079913057479e-11
early O 0 5.680538379237987e-06
- O 0 5.94050798099488e-05
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 1.8800399175233906e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.900590970966732e-06
red O 0 1.8021538608081755e-06
hair O 0 1.6295382010866888e-05
pigmentation O 0 5.210049039305886e-06
. O 0 1.1534276644908914e-08
. O 0 4.3846217323562087e-08

A O 0 4.1750663370976326e-08
European O 0 4.1433483310981956e-09
multicenter O 0 3.461711912677856e-06
study O 0 9.623398966596142e-09
of O 0 5.185499389881443e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 6.255949647204773e-10
classification O 0 4.777540585365614e-09
of O 0 1.1866256421910748e-08
105 O 0 2.8897122916760054e-08
mutations O 0 9.158039604439949e-11
and O 0 3.9428811778041695e-12
a O 0 3.4903500228944395e-11
general O 0 1.0859210752833803e-10
system O 0 6.9286347492703015e-12
for O 0 4.4943476024128515e-12
genotype O 0 8.904327830627778e-10
- O 0 7.45908279586871e-10
based O 0 8.0924926482151e-11
prediction O 0 7.607106766727156e-08
of O 0 5.022640081620011e-09
metabolic O 0 3.9287265281018335e-06
phenotype O 0 6.153694016575173e-07
. O 0 1.9225014469270718e-08

Phenylketonuria B-Disease 0 0.007765968330204487
( O 0 5.689543769449301e-08
PKU B-Disease 0 8.152647205861285e-05
) O 0 7.190256723355049e-11
and O 0 7.627901088547162e-11
mild B-Disease 1 0.9999308586120605
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.770292510627769e-05
MHP B-Disease 1 1.0
) O 0 1.1300562569038775e-10
are O 0 2.1237905531434897e-11
allelic B-Disease 0 3.2847168540683924e-07
disorders I-Disease 0 8.336655810126103e-07
caused O 0 6.724856227435794e-09
by O 0 4.390439747870012e-11
mutations O 0 2.2141637134875936e-10
in O 0 5.145687001495425e-11
the O 0 3.137695381294492e-10
gene O 0 3.678985935340329e-11
encoding O 0 3.324590824860252e-09
phenylalanine O 0 7.725331670371816e-06
hydroxylase O 0 2.6892765163211152e-05
( O 0 1.3416896926798927e-08
PAH O 0 2.2959296984481625e-05
) O 0 4.443601597792224e-10
. O 0 6.782074457589715e-09

Previous O 0 5.218684009378194e-07
studies O 0 9.544389723004088e-10
have O 0 2.275735589557515e-12
suggested O 0 2.8869642787476835e-11
that O 0 3.145888226568222e-13
the O 0 2.001324236541868e-12
highly O 0 4.454017450000736e-12
variable O 0 3.7281207454498144e-08
metabolic O 0 0.0002661511243786663
phenotypes O 0 3.2906564229051583e-06
of O 0 0.007151416968554258
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 1.0832229236257263e-05
with O 0 4.719793977869813e-08
PAH O 1 0.9834287762641907
genotypes O 0 2.624151784402784e-05
. O 0 1.18219375622175e-07

We O 0 2.8694346454471997e-08
identified O 0 6.177454658917725e-10
both O 0 3.902651812826008e-11
causative O 0 5.757364807124077e-09
mutations O 0 1.092101076238805e-09
in O 0 9.72453992331701e-11
686 O 0 1.6073772712843493e-07
patients O 0 4.365774408654488e-10
from O 0 7.436694038354119e-10
seven O 0 1.4759762301252977e-09
European O 0 3.319673647084187e-09
centers O 0 9.933400768602496e-10
. O 0 2.5070641118674075e-09

On O 0 3.7215777126675675e-08
the O 0 6.519352419021018e-11
basis O 0 2.8523089445897654e-10
of O 0 2.2730990700825515e-11
the O 0 7.822980110927524e-12
phenotypic O 0 1.132568483441787e-09
characteristics O 0 2.4157048583717255e-10
of O 0 2.675441257427025e-10
297 O 0 3.668521264543756e-09
functionally O 0 2.6263396790682236e-08
hemizygous O 0 1.796569904399803e-06
patients O 0 1.0096586899877025e-09
, O 0 2.5970654446427766e-11
105 O 0 8.728476608155233e-09
of O 0 7.685855285544108e-10
the O 0 5.813107217811364e-10
mutations O 0 3.863818640037486e-11
were O 0 1.2724667673713608e-11
assigned O 0 1.1369674299266386e-11
to O 0 9.17093484487097e-12
one O 0 2.8041349624252643e-12
of O 0 6.518068203231753e-12
four O 0 2.033775058085663e-12
arbitrary O 0 6.272533603635111e-10
phenotype O 0 2.0087014718228602e-08
categories O 0 6.701028176792079e-09
. O 0 5.76706948862693e-09

We O 0 3.9140704899409684e-08
proposed O 0 7.877853924753708e-09
and O 0 5.741655415003599e-11
tested O 0 1.0265985110613496e-11
a O 0 6.835044140916791e-13
simple O 0 1.9344988393295293e-13
model O 0 4.902220664994295e-13
for O 0 5.876620804562416e-13
correlation O 0 2.498545120799278e-11
between O 0 5.693997010003393e-11
genotype O 0 4.888010884940286e-09
and O 0 5.638984765243826e-11
phenotypic O 0 2.2237438557226596e-08
outcome O 0 1.8298216275525192e-07
. O 0 4.405629283610324e-08

The O 0 3.5628502814688545e-08
observed O 0 1.405209393290363e-09
phenotype O 0 2.358621298270691e-09
matched O 0 1.7832754717339583e-10
the O 0 1.1164583146872076e-10
predicted O 0 3.4643541368950537e-09
phenotype O 0 6.265932772642202e-10
in O 0 1.586682348009294e-11
79 O 0 9.74192171376842e-10
% O 0 4.3767611063172396e-11
of O 0 1.5468052186329295e-11
the O 0 1.3997403063015224e-11
cases O 0 1.0056138213809795e-11
, O 0 1.3334923443242275e-12
and O 0 1.376289165098965e-12
in O 0 6.449999388757899e-12
only O 0 1.078070098470274e-11
5 O 0 1.9281591878694826e-09
of O 0 1.2243783764631644e-10
184 O 0 5.588641216469625e-10
patients O 0 2.0698897457149812e-11
was O 0 2.763814177519919e-10
the O 0 3.732533726541476e-11
observed O 0 3.7981742750936576e-11
phenotype O 0 7.70687264006753e-11
more O 0 4.5453786947421276e-14
than O 0 2.411815322109212e-13
one O 0 4.894634502393413e-13
category O 0 5.3504436992035664e-11
away O 0 3.501372108916101e-11
from O 0 5.598909790655027e-12
that O 0 2.7631579749970436e-12
expected O 0 8.042123411655666e-09
. O 0 1.8571464366345936e-08

Among O 0 2.5863641783807623e-10
the O 0 1.5963909361094153e-10
seven O 0 2.5063635195055056e-11
contributing O 0 1.9257316227760946e-11
centers O 0 3.217655959383836e-12
, O 0 6.805410185037331e-13
the O 0 4.097494565868942e-11
proportion O 0 1.7302272115049533e-10
of O 0 4.162165889720626e-10
patients O 0 1.8386257794045235e-11
for O 0 2.310032026775488e-11
whom O 0 3.167775597390232e-09
the O 0 1.5436915079547475e-09
observed O 0 2.9193589212717086e-10
phenotype O 0 9.510788823163807e-10
did O 0 7.55760662385363e-11
not O 0 2.27665698793178e-11
match O 0 8.327051270740071e-10
the O 0 1.057212858923684e-10
predicted O 0 3.6363154709562195e-09
phenotype O 0 6.053720857934763e-10
was O 0 5.932681013121055e-10
4 O 0 1.0648876225261006e-09
% O 0 3.838359838304051e-11
- O 0 6.406040142792335e-10
23 O 0 3.2437137420515683e-09
% O 0 1.446693320694692e-10
( O 0 2.844169344484726e-11
P O 0 6.948055215616478e-07
< O 0 4.230795980220137e-08
. O 0 7.52102338741345e-11
0001 O 0 3.222895372800849e-08
) O 0 9.156493922454767e-13
, O 0 8.460428538303866e-13
suggesting O 0 4.805244743777415e-11
that O 0 3.678717486882421e-12
differences O 0 4.8678075459385184e-11
in O 0 1.1797700837090641e-11
methods O 0 6.946926367490391e-11
used O 0 3.98774546370162e-12
for O 0 3.2096504273826376e-12
mutation O 0 6.213469322391418e-11
detection O 0 6.406727592889183e-09
or O 0 4.712394918726659e-10
phenotype O 0 3.765633138641533e-08
classification O 0 5.649863688006462e-09
may O 0 8.762830738806571e-11
account O 0 4.065789859734187e-13
for O 0 3.183778381991159e-13
a O 0 8.654461695900562e-12
considerable O 0 3.5691026523121394e-11
proportion O 0 5.119275489628983e-11
of O 0 3.202303699989528e-10
genotype O 0 6.232920668480801e-07
- O 0 9.626551218389068e-06
phenotype O 0 9.821293360801064e-07
inconsistencies O 0 4.5105704771231103e-07
. O 0 1.588880316205632e-08

Our O 0 1.8471565965683112e-07
data O 0 1.8620970321236996e-09
indicate O 0 9.255769484184384e-10
that O 0 1.0491811412716157e-11
the O 0 3.3645866648335243e-10
PAH O 0 1.1281975957899704e-06
- O 0 1.564154494815284e-08
mutation O 0 2.803526681638413e-11
genotype O 0 5.850712969657224e-11
is O 0 1.0611810367065766e-13
the O 0 3.7191980723459694e-13
main O 0 7.871778923140837e-11
determinant O 0 2.057936265842386e-09
of O 0 1.9118910621340746e-10
metabolic O 0 1.158114173449576e-06
phenotype O 0 4.0100097464801365e-08
in O 0 1.465962212732208e-10
most O 0 1.2174203312120824e-10
patients O 0 7.640019727972458e-10
with O 0 1.1630018725838909e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 9.037479321705177e-05

In O 0 1.127875459694394e-09
the O 0 2.0958323965203363e-10
present O 0 8.63583302090909e-11
study O 0 1.4347773837075639e-11
, O 0 6.520950229446654e-13
the O 0 2.8052171696657524e-11
classification O 0 6.3651688364529946e-09
of O 0 1.494258583534247e-08
105 O 0 3.03479328067624e-06
PAH O 0 0.00020486033463384956
mutations O 0 7.246243605152358e-09
may O 0 1.1686248635456309e-09
allow O 0 7.997311840535204e-11
the O 0 7.812545749219524e-11
prediction O 0 2.6868567370996743e-09
of O 0 1.0360055174851723e-10
the O 0 1.0662894178725679e-10
biochemical O 0 4.3812400929432727e-10
phenotype O 0 4.873126346893741e-09
in O 0 2.695427492316327e-10
> O 0 5.7508707129727554e-08
10 O 0 8.44877057204485e-09
, O 0 6.670785451801109e-11
000 O 0 7.139628332986092e-10
genotypes O 0 3.3357572259973267e-09
, O 0 2.3258981546314672e-12
which O 0 6.424935453455682e-13
may O 0 1.0473461681259622e-10
be O 0 5.6015487387428564e-12
useful O 0 1.82389910466374e-12
for O 0 4.576096988319345e-13
the O 0 2.162838658170685e-11
management O 0 2.905571339084645e-10
of O 0 1.0741018074966746e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.040941780023786e-07
newborns O 0 9.936421463407896e-08
. O 0 1.3442050139644834e-08

Somatic O 0 8.373532182304189e-05
instability O 0 0.0009852589573711157
of O 0 1.0788301551656332e-05
the O 0 5.1705596888496075e-06
CTG O 0 0.19983014464378357
repeat O 0 1.1198268339285278e-06
in O 0 1.510272018556691e-09
mice O 0 2.1256964244376064e-10
transgenic O 0 2.3878784366493377e-11
for O 0 9.192681338365816e-13
the O 0 8.730153822078535e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 6.42136437818408e-05
is O 0 2.3850315056250793e-09
age O 0 8.049827471268145e-09
dependent O 0 1.593215281925353e-10
but O 0 2.5180536909058526e-12
not O 0 6.2352865926040835e-12
correlated O 0 3.6939208636344034e-11
to O 0 5.715519030280447e-11
the O 0 9.36417193786454e-11
relative O 0 1.1337577987546865e-08
intertissue O 0 4.0436972881252586e-07
transcription O 0 2.7512205846846882e-08
levels O 0 6.293016330261025e-09
and O 0 5.960185123221606e-10
proliferative O 0 4.4343018089421093e-05
capacities O 0 3.2211016787186963e-07
. O 0 4.0182023042234505e-08

A O 0 5.2439958381000906e-05
( O 0 4.262189889914225e-08
CTG O 0 1.6370055163861252e-05
) O 0 4.310319115519157e-11
nexpansion O 0 4.062497893642103e-08
in O 0 2.4520234800928797e-11
the O 0 1.8918890065666716e-10
3 O 0 4.8879854830374825e-08
- O 0 7.546281466375149e-08
untranslated O 0 2.5264565920224413e-05
region O 0 2.6037849210069908e-08
( O 0 2.2053296688806512e-10
UTR O 0 2.965558451251127e-06
) O 0 7.827427941919929e-12
of O 0 3.323295805213178e-10
the O 0 4.98470331677936e-09
DM O 1 1.0
protein O 0 4.456575553035691e-08
kinase O 0 2.1551578299749963e-08
gene O 0 1.848640684976033e-11
( O 0 5.897460796620846e-13
DMPK O 0 3.782896556003834e-07
) O 0 1.8702229977358986e-13
is O 0 1.0109785458876225e-13
responsible O 0 1.4808586648595856e-11
for O 0 3.756388256004328e-11
causing O 0 0.005113705061376095
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.199599970888812e-06
DM B-Disease 1 1.0
) O 0 1.4318543684055385e-08
. O 0 3.3257911979944765e-08

Major O 0 0.00011233121040277183
instability O 1 0.9999654293060303
, O 0 2.8712834332367265e-09
with O 0 1.5779542603122643e-11
very O 0 1.2596353127225512e-10
large O 0 9.92440019054186e-11
expansions O 0 1.226651002994572e-09
between O 0 4.034688583232082e-09
generations O 0 3.9145145458441277e-10
and O 0 1.7145200190138432e-11
high O 0 1.2755929645891229e-09
levels O 0 1.7824593190329807e-10
of O 0 1.0472862854715714e-10
somatic O 0 3.27208802275436e-08
mosaicism O 0 1.5443688425875735e-06
, O 0 3.0484281765552623e-11
is O 0 1.3003388296684015e-11
observed O 0 1.5201581660129193e-10
in O 0 2.6388840765334542e-11
patients O 0 1.1648478015491293e-10
. O 0 3.030679263105185e-09

There O 0 6.268446650636861e-09
is O 0 8.4626645968644e-11
a O 0 1.7393197992987552e-10
good O 0 1.2577386354628572e-10
correlation O 0 8.684498675748387e-10
between O 0 6.324527568324356e-10
repeat O 0 4.07059319584846e-09
size O 0 5.595339191977189e-10
( O 0 6.701839777578655e-11
at O 0 1.2063535725914676e-09
least O 0 1.892497790423331e-11
in O 0 4.474726145176078e-12
leucocytes O 0 5.9937730334524986e-09
) O 0 1.5128500665748112e-12
, O 0 6.892660812767015e-13
clinical O 0 3.00806636543971e-11
severity O 0 2.885013117293056e-09
and O 0 8.787060488957277e-12
age O 0 5.790403267980082e-09
of O 0 3.79484710322231e-09
onset O 0 1.1584539606701583e-05
. O 0 2.2684295331032445e-08

The O 0 8.07471587904729e-06
trinucleotide O 0 0.06340302526950836
repeat O 0 1.159991029453522e-06
instability O 0 3.6238868688087678e-06
mechanisms O 0 3.2853268550070425e-08
involved O 0 4.556759414242606e-10
in O 0 2.73653921745165e-09
DM B-Disease 1 1.0
and O 0 7.308706528874609e-09
other O 0 4.696441568974308e-10
human O 0 9.74649992713239e-07
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.2098225199430601e-11
unknown O 0 2.5408826154205144e-09
. O 0 7.974088056528217e-10

We O 0 1.7542116381719097e-07
studied O 0 8.667132078699069e-08
somatic O 0 8.7541127413715e-07
instability O 0 4.6774852080488927e-07
by O 0 6.466733815102543e-10
measuring O 0 4.598534360411577e-06
the O 0 5.2577636466821787e-08
CTG O 0 4.293167421565158e-06
repeat O 0 2.358657269496689e-09
length O 0 1.513114217255307e-10
at O 0 1.4276306699312347e-11
several O 0 6.234781164656325e-14
ages O 0 2.0881942008887933e-11
in O 0 1.979461299733698e-12
various O 0 8.869671490330244e-12
tissues O 0 1.400540128315697e-09
of O 0 8.899848857879533e-09
transgenic O 0 9.378659626690933e-09
mice O 0 3.6108313561378225e-10
carrying O 0 1.5283092499873696e-11
a O 0 2.60122090534054e-10
( O 0 1.1301085622861251e-09
CTG O 0 4.568513759295456e-06
) O 0 5.526226004581858e-11
55expansion O 0 7.204915419833924e-08
surrounded O 0 5.692758764386241e-11
by O 0 1.8456343224559912e-12
45 O 0 2.231573370536921e-09
kb O 0 3.401991932605597e-08
of O 0 7.526795853252111e-10
the O 0 1.1323394444318069e-09
human O 0 2.6769956917860327e-08
DM B-Disease 1 1.0
region O 0 2.5649167127994588e-06
, O 0 1.5431636524176895e-10
using O 0 1.4892095889784684e-10
small O 0 4.0731384931547154e-10
- O 0 1.0397319449850784e-08
pool O 0 5.733822305842295e-10
PCR O 0 3.6510003909029365e-09
. O 0 3.765932898858182e-09

These O 0 1.57466359951286e-07
mice O 0 9.148341639786395e-09
have O 0 9.225181382688241e-12
been O 0 3.4034908138330655e-12
shown O 0 1.551264948744177e-13
to O 0 5.102330884187989e-12
reproduce O 0 6.646828920597869e-12
the O 0 9.486736916863858e-12
intergenerational O 0 7.720029060465095e-10
and O 0 1.3269427223683294e-10
somatic O 0 4.238825113134226e-07
instability O 0 2.8705719159916043e-05
of O 0 8.774464959060424e-07
the O 0 2.1134697192337626e-07
55 O 0 8.699441877979552e-07
CTG O 0 5.250911272014491e-06
repeat O 0 5.228111277233438e-09
suggesting O 0 2.8207455815554283e-10
that O 0 1.8715369965588424e-12
surrounding O 0 2.1389704243923724e-11
sequences O 0 5.811327981330994e-12
and O 0 6.919320802087348e-13
the O 0 5.596102140709158e-12
chromatin O 0 9.45880873626237e-11
environment O 0 1.5150201926328322e-10
are O 0 5.663273669465063e-13
involved O 0 4.193229964644107e-12
in O 0 8.599129741604372e-11
instability O 0 1.225334926857613e-06
mechanisms O 0 6.213762162587955e-07
. O 0 5.774435862804239e-08

As O 0 1.2856571807162709e-08
observed O 0 8.413517105232415e-10
in O 0 4.297945679909709e-12
some O 0 6.357584272399797e-13
of O 0 7.368298332588452e-11
the O 0 4.16346609966034e-11
tissues O 0 6.483292375181193e-11
of O 0 7.834355386648895e-09
DM B-Disease 1 1.0
patients O 0 5.659055801743307e-08
, O 0 9.61333096460848e-12
there O 0 3.3288241954587683e-12
is O 0 1.6266339403908647e-12
a O 0 2.457623514418028e-11
tendency O 0 9.93551699246531e-11
for O 0 8.045701258008187e-12
repeat O 0 7.779316635314615e-10
length O 0 5.834835392626303e-10
and O 0 2.309394064869963e-10
somatic O 0 5.255367341305828e-08
mosaicism O 0 3.542978674886399e-07
to O 0 1.5701910605070424e-10
increase O 0 1.1113311659816105e-11
with O 0 5.338192724229501e-14
the O 0 2.05009481613061e-11
age O 0 4.486763738320576e-10
of O 0 6.076553843437082e-11
the O 0 5.3498313418165466e-11
mouse O 0 3.59027207963436e-09
. O 0 7.012324498845146e-09

Furthermore O 0 9.170795323143466e-08
, O 0 1.4004305493031666e-09
we O 0 6.063959889779369e-10
observed O 0 2.2579892122731593e-10
no O 0 2.0524738159055644e-11
correlation O 0 5.0847392268904557e-11
between O 0 1.360853096876724e-10
the O 0 6.35968000484155e-10
somatic O 0 2.2716896808105957e-08
mutation O 0 1.3095600159829246e-08
rate O 0 2.344511784713177e-08
and O 0 3.4363303869078266e-10
tissue O 0 3.5854426982950827e-08
proliferation O 0 3.671778813441051e-06
capacity O 0 1.9922829608276516e-08
. O 0 2.605404603173156e-08

The O 0 3.0631616709797527e-07
somatic O 0 7.632918368472019e-07
mutation O 0 5.407411762803349e-08
rates O 0 1.397615467801927e-09
in O 0 6.554872096498077e-12
different O 0 1.3509983062820474e-12
tissues O 0 3.173813989398866e-11
were O 0 1.0128361691008614e-11
also O 0 5.978620918646593e-13
not O 0 1.2218250499893002e-12
correlated O 0 1.3830739505060752e-11
to O 0 3.483719215879866e-11
the O 0 6.552700049233806e-11
relative O 0 5.651224554981127e-08
inter O 0 4.070885552209802e-05
- O 0 5.665794446940708e-07
tissue O 0 2.6985049750294365e-09
difference O 0 1.508379948722549e-10
in O 0 4.6807327978848345e-12
transcriptional O 0 1.0751485812754424e-10
levels O 0 6.725028867116123e-11
of O 0 9.282614607530881e-12
the O 0 4.438988673166611e-12
three O 0 4.957001822902818e-12
genes O 0 2.522591727519008e-12
( O 0 2.41551787252825e-12
DMAHP O 0 4.789057584275724e-06
, O 0 3.509791624001224e-10
DMPK O 0 1.8877453840104863e-05
and O 0 8.26481827420622e-10
59 O 0 2.3422146000484645e-08
) O 0 4.666274311393437e-12
surrounding O 0 1.442851949029489e-10
the O 0 9.69613389578683e-10
repeat O 0 4.908649486878858e-09
. O 0 8.364330894572447e-10
. O 0 9.103434450707937e-09

A O 0 1.299178506997123e-07
novel O 0 1.8404390900172984e-08
missense O 0 1.6071212485258002e-06
mutation O 0 1.1863835247538645e-08
in O 0 8.975820781076393e-11
patients O 0 6.237466793068691e-11
from O 0 4.047239973714589e-11
a O 0 1.3410085264453642e-09
retinoblastoma B-Disease 0 1.1197242201888002e-05
pedigree O 0 5.413270720566743e-09
showing O 0 1.9054102046167642e-11
only O 0 1.2078304502394221e-11
mild O 0 3.309824947450579e-08
expression O 0 1.1302205837893098e-09
of O 0 1.8284517011579737e-08
the O 0 1.889091549855948e-09
tumor B-Disease 0 5.6438565820826625e-08
phenotype O 0 1.6154606896634505e-07
. O 0 9.200312511836728e-09

We O 0 5.6780301349590445e-08
have O 0 2.626055276011563e-11
used O 0 3.8929185396108235e-12
single O 0 3.2984994943752177e-12
strand O 0 2.715654610907503e-11
conformation O 0 9.37796628547316e-12
polymorphism O 0 1.323918578932659e-11
analysis O 0 9.24793770208654e-13
to O 0 1.0734677903523338e-11
study O 0 4.980191606329676e-12
the O 0 1.509069778860006e-11
27 O 0 4.025288102837976e-09
exons O 0 4.660571040204786e-09
of O 0 3.043026941540461e-10
the O 0 2.792087117065023e-10
RB1 O 0 5.7090996818942585e-08
gene O 0 5.677095078759908e-13
in O 0 1.0414045114540832e-13
individuals O 0 1.6747184422658684e-13
from O 0 1.8432888895802968e-11
a O 0 5.798755919883547e-10
family O 0 2.701890967904408e-11
showing O 0 1.65716138728067e-11
mild O 0 6.065145186084919e-08
expression O 0 6.39210506747645e-09
of O 0 9.144978463382358e-08
the O 0 1.459978182793975e-08
retinoblastoma B-Disease 0 1.9265705759607954e-06
phenotype O 0 1.2865791632066248e-06
. O 0 3.3526877274425715e-08

In O 0 7.915927913160203e-10
this O 0 6.958782161614607e-11
family O 0 1.6547357234442117e-11
affected O 0 1.194583321151299e-11
individuals O 0 4.493779751525012e-13
developed O 0 8.13499667629003e-09
unilateral B-Disease 1 1.0
tumors I-Disease 1 1.0
and O 0 1.3503157703098623e-08
, O 0 2.808718535529664e-11
as O 0 4.850862333344308e-12
a O 0 2.291202817750193e-11
result O 0 1.0218363655223328e-10
of O 0 5.97606464314282e-10
linkage O 0 2.908150831260059e-09
analysis O 0 1.5534376562875707e-10
, O 0 2.876861422695942e-11
unaffected O 0 6.640170080451924e-10
mutation O 0 6.387076978420225e-11
carriers O 0 1.860887095458952e-12
were O 0 1.6282883244858604e-12
also O 0 1.5537553611343763e-13
identified O 0 3.0342141559697167e-12
within O 0 2.5334758596562423e-11
the O 0 6.896889309659926e-11
pedigree O 0 4.682008114542668e-09
. O 0 7.61871987720042e-09

A O 0 9.836928711592918e-07
single O 0 8.120967009972446e-09
band O 0 3.515139734844297e-09
shift O 0 3.4750136101990847e-10
using O 0 4.516943416521535e-11
SSCP O 0 4.2842886614380404e-05
was O 0 1.6754448495248653e-08
identified O 0 1.768115931444214e-10
in O 0 4.0538610662776975e-11
exon O 0 1.6579597694743597e-09
21 O 0 8.540324003547539e-10
which O 0 1.1612882964279203e-12
resulted O 0 6.959684911711506e-11
in O 0 9.558297729694853e-12
a O 0 1.465512711185113e-09
missense O 0 2.530003655465407e-07
mutation O 0 8.860723710313323e-09
converting O 0 6.388972462190168e-09
a O 0 3.2313389741744913e-09
cys O 0 3.191667019564193e-07
- O 0 7.448796424114335e-08
- O 0 9.823956048649052e-08
> O 0 1.7278841468737483e-08
arg O 0 1.8507946286661081e-09
at O 0 3.761056743822877e-10
nucleotide O 0 6.994523710224243e-11
position O 0 2.0491812413592214e-10
28 O 0 5.699345440035586e-10
in O 0 2.172679050560511e-11
the O 0 1.2352016076633276e-09
exon O 0 4.454570046164008e-08
. O 0 2.1546810557993012e-08

The O 0 4.7205682562889706e-07
mutation O 0 2.3003314808534014e-08
destroyed O 0 6.150138176508335e-08
an O 0 2.516971353561104e-10
NdeI O 0 6.162873091852816e-07
restriction O 0 1.542409044930082e-08
enzyme O 0 4.961814514814478e-09
site O 0 7.432259696571464e-09
. O 0 2.596859616232905e-09

Analysis O 0 2.615529182126153e-10
of O 0 7.47144235369035e-10
all O 0 2.1069255715100432e-11
family O 0 8.694401101849714e-12
members O 0 6.492278502995275e-14
demonstrated O 0 1.0686827941683297e-12
that O 0 1.5260014389270604e-12
the O 0 1.8451541683450756e-10
missense O 0 6.133362973059775e-08
mutation O 0 6.004394492720166e-08
co O 0 1.9850494581419298e-08
- O 0 9.158699043609886e-08
segregated O 0 7.664770207416183e-11
with O 0 4.437488245780108e-13
patients O 0 4.325836217011769e-11
with O 0 2.549818967079176e-10
tumors B-Disease 1 1.0
or O 1 0.9998846054077148
who O 0 3.94877872622601e-07
, O 0 1.0563758201520557e-11
as O 0 5.158617023132139e-12
a O 0 2.499832285618453e-11
result O 0 2.912362573326277e-10
of O 0 3.4489266997894674e-09
linkage O 0 7.1931038903017e-09
analysis O 0 4.922166008114459e-10
had O 0 1.1079839268290925e-09
been O 0 7.337556257036582e-11
predicted O 0 5.514163015085671e-10
to O 0 6.175425448784466e-11
carry O 0 2.6003664499452128e-11
the O 0 1.0825770835332094e-10
predisposing O 0 1.6850785655719847e-08
mutation O 0 1.396915294549217e-08
. O 0 1.0316919762942689e-08

These O 0 3.1434113090256233e-09
observations O 0 1.6424497317757414e-08
point O 0 1.24511814192374e-08
to O 0 3.3613972716395324e-11
another O 0 1.5886991375224646e-11
region O 0 1.1510754571730786e-09
of O 0 9.64511359669018e-10
the O 0 3.832423711713773e-09
RB1 O 0 3.4486231470509665e-07
gene O 0 1.0298487063131745e-10
where O 0 7.143861197045354e-11
mutations O 0 2.862144028725755e-11
only O 0 4.411355395556038e-12
modify O 0 3.295081985044135e-10
the O 0 1.0107756298616266e-10
function O 0 1.1633290858403811e-10
of O 0 3.139928317352769e-10
the O 0 1.4980409968057273e-10
gene O 0 4.0446682461614536e-12
and O 0 2.324780559032069e-12
raise O 0 9.100317027721516e-11
important O 0 1.631699809989673e-11
questions O 0 5.557789645171951e-11
for O 0 4.093323249798608e-11
genetic O 0 1.719086539786474e-09
counseling O 0 1.1205794972490857e-11
in O 0 1.590689656816996e-13
families O 0 3.6095844873186914e-14
with O 0 2.329731764764368e-14
these O 0 6.670676923163643e-13
distinctive O 0 1.5159184671431625e-11
phenotypes O 0 7.134809409947707e-10
. O 0 6.956901166255136e-10
. O 0 4.438064138412301e-09

Maternal B-Disease 0 7.3512633207428735e-06
disomy I-Disease 0 5.044208955951035e-05
and O 0 8.214728950406425e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 8.849763162288582e-07
with O 0 1.6344531630907433e-11
gamete O 0 1.7752782355273666e-08
complementation O 0 6.771993810161803e-08
in O 0 9.59817902240756e-12
a O 0 2.3495219658720146e-11
case O 0 5.511786582701461e-10
of O 0 2.076637972692197e-09
familial O 0 1.6578782791043523e-08
translocation O 0 5.899089501326671e-07
( O 0 8.551811342405458e-11
3 O 0 9.439066417371578e-09
; O 0 1.1605559395444498e-11
15 O 0 3.24434501486337e-09
) O 0 5.792183573050114e-12
( O 0 1.4439826938328348e-11
p25 O 0 1.9426011022005696e-08
; O 0 1.525321362272347e-11
q11 O 0 1.1215802686592724e-07
. O 0 9.957657615133897e-11
2 O 0 6.663442242427209e-09
) O 0 5.1538395079431254e-11
. O 0 3.3914753228003747e-09

Maternal B-Disease 0 0.01311266515403986
uniparental I-Disease 1 0.9548354744911194
disomy I-Disease 1 0.7454646825790405
( I-Disease 0 1.3472278226345225e-07
UPD I-Disease 1 1.0
) I-Disease 0 4.797533897926698e-11
for I-Disease 0 3.125735087428083e-11
chromosome I-Disease 0 7.533869705866891e-08
15 I-Disease 0 3.2751585887780266e-09
is O 0 5.431462029269196e-13
responsible O 0 3.724730159720968e-12
for O 0 2.8771546234894474e-13
an O 0 1.897470462003392e-12
estimated O 0 1.2083120094763533e-11
30 O 0 5.087969975892115e-11
% O 0 2.2190617399164836e-12
of O 0 5.534606518746432e-13
cases O 0 2.0492650545239632e-12
of O 0 1.3188721226242706e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2826710644731065e-06
PWS B-Disease 1 1.0
) O 0 3.2260982774090508e-09
. O 0 1.8881813446114393e-08

We O 0 2.066295223812631e-08
report O 0 1.0472817925377687e-11
on O 0 7.71887692652129e-11
an O 0 7.668867575477342e-14
unusual O 0 1.689547617480039e-13
case O 0 1.909801830568547e-11
of O 0 8.001721507611137e-11
maternal B-Disease 0 3.304986506691421e-08
disomy I-Disease 0 8.713560418982524e-06
15 I-Disease 0 3.1993434390642506e-07
in O 0 5.902176525296454e-09
PWS B-Disease 1 1.0
that O 0 1.2159078188744843e-09
is O 0 4.457759161802244e-11
most O 0 3.981017718170804e-13
consistent O 0 9.266971955426695e-13
with O 0 5.385324940843225e-15
adjacent O 0 9.501789632881952e-11
- O 0 4.072953974088023e-09
1 O 0 3.5595840586211125e-07
segregation O 0 4.7999065833082e-10
of O 0 3.3407567077287093e-12
a O 0 4.029208910960591e-11
paternal O 0 3.6965182026449384e-09
t O 0 8.859163957986027e-10
( O 0 8.409369554873702e-12
3 O 0 2.2819763856318787e-09
; O 0 1.09330461350865e-11
15 O 0 2.4898798578476544e-09
) O 0 3.500415235446752e-12
( O 0 7.963850932879435e-12
p25 O 0 6.570691546414764e-09
; O 0 3.6983745059504525e-12
q11 O 0 2.3458403219933643e-08
. O 0 3.627180370294192e-12
2 O 0 1.1870522620416324e-10
) O 0 1.8734959330440892e-14
with O 0 2.3259490850285197e-14
simultaneous O 0 9.822294366745865e-11
maternal O 0 2.4729564174208463e-08
meiotic O 0 1.4401126691154786e-07
nondisjunction O 0 2.506389478185156e-07
for O 0 1.6265773172818854e-09
chromosome O 0 3.1040929115988547e-06
15 O 0 1.1438447700129473e-06
. O 0 1.4440619366951069e-08

The O 0 8.518255611988934e-08
patient O 0 1.68282365820005e-08
( O 0 3.764851971843619e-11
J O 0 1.0861836585718265e-07
. O 0 5.683515116872151e-11
B O 0 3.186865216164847e-09
. O 0 1.047273270708693e-12
) O 0 2.3987769778334445e-13
, O 0 5.606932561470768e-13
a O 0 3.100831050262265e-11
17 O 0 6.119510453928001e-10
- O 0 1.8853832384202462e-10
year O 0 5.202454023134351e-10
- O 0 3.5202121217992044e-09
old O 0 9.483598351067712e-10
white O 0 6.5219730657761765e-12
male O 0 7.273979595739943e-13
with O 0 7.775577463798797e-14
PWS B-Disease 1 1.0
, O 0 2.473907967370792e-09
was O 0 1.175205284198455e-07
found O 0 8.115522837082167e-11
to O 0 9.580922721852403e-10
have O 0 5.1835136877231847e-11
47 O 0 4.2551371315369124e-09
chromosomes O 0 9.545803730803826e-11
with O 0 2.6493157711041104e-13
a O 0 3.7454081502907854e-10
supernumerary O 0 3.6202555975251016e-07
, O 0 6.451429668263842e-11
paternal O 0 5.8082147091909064e-08
der O 0 3.0183871331246337e-06
( O 0 2.748735267177338e-11
15 O 0 1.9024453123961393e-09
) O 0 2.827194045280229e-13
consisting O 0 3.3959347920525795e-13
of O 0 1.5030258287973552e-11
the O 0 1.7299458740516194e-11
short O 0 1.0919630477612685e-10
arm O 0 1.3020227118687444e-09
and O 0 4.045804316565871e-11
the O 0 8.071839863177388e-10
proximal O 0 2.8167623895569704e-06
long O 0 3.130726344835466e-09
arm O 0 5.432612582012553e-09
of O 0 2.556530764863396e-09
chromosome O 0 1.3744455884534545e-07
15 O 0 2.1118195547842333e-07
, O 0 3.18258579212749e-11
and O 0 1.7936042928656803e-10
distal O 0 3.505001586745493e-05
chromosome O 0 0.0013615178177133203
arm O 0 0.00016525600221939385
3p O 0 0.002640895312651992
. O 0 5.310860160534503e-07

The O 0 4.775639013132604e-07
t O 0 7.455986050786123e-09
( O 0 2.688371227022035e-11
3 O 0 3.254925218243443e-09
; O 0 6.881039141259926e-12
15 O 0 9.782717969031296e-10
) O 0 6.345372903331092e-13
was O 0 4.237662304396039e-11
present O 0 3.899842959415728e-13
in O 0 6.124720956096619e-13
the O 0 1.929800937106041e-12
balanced O 0 5.6996764079275675e-12
state O 0 8.475162412147075e-12
in O 0 9.212520503398824e-12
the O 0 5.7947504433775165e-11
patients O 0 2.460249885760657e-11
father O 0 1.49524337356155e-10
and O 0 3.169192686058864e-11
a O 0 5.528994151404731e-09
sister O 0 5.910752634008531e-07
. O 0 9.628873698375173e-08

Fluorescent O 0 4.0914335386332823e-07
in O 0 2.2090365092708453e-08
situ O 0 3.0164247988295756e-08
hybridization O 0 5.144587880701046e-11
analysis O 0 1.6238439629404078e-12
demonstrated O 0 4.683016669761175e-13
that O 0 5.6165202968073286e-14
the O 0 1.2910072316740795e-11
PWS B-Disease 1 1.0
critical O 0 5.6016027372152166e-08
region O 0 2.768079809811752e-08
resided O 0 5.393451907309554e-09
on O 0 3.1571594227841615e-09
the O 0 7.511862659681512e-11
derivative O 0 4.958803367927089e-10
chromosome O 0 4.4589198999744895e-09
3 O 0 3.2147406958671354e-09
and O 0 8.778898289742154e-13
that O 0 3.8153348210813454e-13
there O 0 1.675042049509301e-12
was O 0 1.945958949534088e-10
no O 0 3.132037337816307e-11
deletion O 0 1.2144059091667714e-09
of O 0 1.6174622752274104e-10
the O 0 1.0332332767148955e-09
PWS B-Disease 1 1.0
region O 0 2.9824460057170654e-07
on O 0 7.888518638310416e-08
the O 0 5.340963782352048e-10
normal O 0 2.83497580966241e-09
pair O 0 3.326375980217122e-11
of O 0 5.123905466586365e-11
15s O 0 1.1396348043035687e-07
present O 0 2.208137006576294e-10
in O 0 2.1200208255578445e-09
J O 0 4.9864906031871215e-05
. O 0 7.475753704966337e-08

B O 0 0.0005272913840599358
. O 0 2.841002810782811e-07

Methylation O 0 7.430463000446252e-08
analysis O 0 1.5935383013143678e-09
at O 0 6.126006812934293e-09
exon O 0 4.258051689021158e-09
alpha O 0 1.562955631584373e-08
of O 0 1.7200760260571712e-10
the O 0 7.795710604829864e-11
small O 0 7.527438394827612e-11
nuclear O 0 4.722229789422272e-07
ribonucleoprotein O 0 7.368490742010181e-07
- O 0 1.9392217609492945e-07
associated O 0 1.3079125338322228e-08
polypeptide O 0 8.218905804824317e-07
N O 0 7.807835089579385e-08
( O 0 1.0521952233111254e-11
SNRPN O 0 1.0311390497008688e-06
) O 0 3.5624762688424294e-12
gene O 0 7.715100802142827e-13
showed O 0 1.553547871943617e-13
a O 0 6.411872985681577e-13
pattern O 0 8.830142866900204e-11
characteristic O 0 1.2893141415615261e-11
of O 0 1.4831143257953983e-11
only O 0 1.485566183956344e-11
the O 0 1.1488770351730793e-10
maternal O 0 1.7577946209712536e-08
chromosome O 0 6.375827297233627e-07
15 O 0 5.647743819281459e-07
in O 0 3.7044232126248744e-09
J O 0 0.00011592319788178429
. O 0 1.7245102412744018e-07

B O 0 0.0004485637182369828
. O 0 1.742652955272206e-07

Maternal B-Disease 0 0.0002591869269963354
disomy I-Disease 0 0.00030592703842557967
was O 0 2.2814559486050712e-07
confirmed O 0 9.034998305068598e-10
by O 0 1.824578509113106e-11
polymerase O 0 1.9383032956454826e-09
chain O 0 5.838951544490101e-11
reaction O 0 2.7634110277841017e-12
analysis O 0 2.185412658131658e-12
of O 0 1.161856721942911e-10
microsatellite O 0 1.1455784765246335e-08
repeats O 0 5.457642338058122e-09
at O 0 1.0582826837080006e-09
the O 0 1.706511321142301e-10
gamma O 0 2.928619835529389e-08
- O 0 1.1269921884604628e-08
aminobutyric O 0 5.10775493012261e-08
acid O 0 1.2536343074742717e-09
receptor O 0 2.9376295840322086e-10
beta3 O 0 1.1413866296550168e-08
subunit O 0 2.8685138708794966e-09
( O 0 1.4333713903302847e-11
GABRB3 O 0 1.125449784922239e-06
) O 0 5.171761630062832e-11
locus O 0 9.907520137630854e-09
. O 0 1.8708190552274573e-09

A O 0 2.531481186451856e-06
niece O 0 1.3744931948167505e-06
( O 0 2.1674566308416132e-10
B O 0 3.589137165249667e-08
. O 0 8.214628630098808e-12
B O 0 6.536151619940256e-10
. O 0 3.4078932709645515e-13
) O 0 5.767923709184067e-14
with O 0 3.586103582055994e-13
45 O 0 2.6902924332716793e-09
chromosomes O 0 1.0046788401218976e-10
and O 0 2.4645084150537455e-12
the O 0 1.2920812857142305e-11
derivative O 0 3.814538268587242e-11
3 O 0 4.5753772298651185e-11
but O 0 2.424129148283216e-13
without O 0 1.2297841564534728e-11
the O 0 2.440630475497585e-10
der O 0 1.0965547971863998e-06
( O 0 8.427099296159923e-11
15 O 0 5.89511106596774e-09
) O 0 2.4133902341849645e-12
demonstrated O 0 2.2303103374560207e-12
a O 0 1.1524539135499001e-11
phenotype O 0 3.5878741644346235e-10
consistent O 0 7.053736934825583e-12
with O 0 4.11295821077344e-15
that O 0 5.07431621135819e-14
reported O 0 3.186325552365088e-12
for O 0 2.292749106888592e-12
haploinsufficiency O 0 1.975985952640258e-07
of O 0 5.131816394055022e-08
distal O 0 0.00012921408051624894
3 O 0 0.0009645200334489346
p O 0 0.00012636477185878903
. O 0 1.1568553048846297e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999979734420776
associated O 0 1.0709662490171468e-08
with O 0 3.833721534673984e-11
unbalanced O 0 1.6906429664231837e-05
segregation O 0 1.0673388572968179e-07
of O 0 9.353792407296169e-09
non O 0 1.3649877672605726e-08
- O 0 3.819509331037807e-08
Robertsonian O 0 1.9049754200750613e-06
translocations O 0 9.629000032873591e-07
has O 0 2.6091826477170343e-09
been O 0 8.976505649904709e-11
reported O 0 9.410473789106533e-11
previously O 0 3.042596036229028e-11
but O 0 3.855674893943339e-12
has O 0 1.3484651763262523e-12
not O 0 8.241087499916144e-12
, O 0 2.9917804345025445e-12
to O 0 3.7685321530034344e-10
our O 0 2.681193600473364e-10
knowledge O 0 3.284409133552657e-10
, O 0 2.1233653724195278e-11
been O 0 3.027013709133719e-11
observed O 0 1.2290197505537837e-11
in O 0 3.3229734068551675e-13
a O 0 1.1151488586713665e-11
case O 0 4.6066758740970215e-10
of O 0 4.346948134781314e-09
PWS B-Disease 1 1.0
. O 0 8.973862577477121e-07

Furthermore O 0 1.713898768684885e-06
, O 0 1.0056288246573786e-08
our O 0 2.7019968484864876e-09
findings O 0 2.6754923276861575e-10
are O 0 6.990595710805458e-13
best O 0 1.227828927939656e-12
interpreted O 0 4.1147536766761306e-12
as O 0 9.49553044700402e-13
true O 0 1.0935381940246902e-11
gamete O 0 2.2844413027911514e-09
complementation O 0 3.547904370293509e-08
resulting O 0 1.2391324077931642e-10
in O 0 1.7777702920884764e-10
maternal B-Disease 0 4.2728966946015134e-05
UPD I-Disease 1 1.0
15 I-Disease 0 8.841101953294128e-05
and O 0 4.3031343466282124e-07
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9995286464691162
- I-Disease 1 0.9999998807907104
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 3.971657918100391e-07
2 I-Disease 0 1.7946213404229638e-07
and O 0 1.1220065848638328e-10
Stuve B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 2.5106073470171353e-11
a O 0 3.288475394769286e-11
case O 0 6.871363200655622e-11
for O 0 2.0330818625846625e-11
" O 0 5.087767984690572e-10
lumping O 0 1.5565823074936702e-09
" O 0 1.096413715373501e-08
. O 0 6.556632570209331e-09

Recent O 0 3.5980050050454793e-09
studies O 0 1.63589183865831e-10
demonstrated O 0 5.094651089887492e-11
the O 0 7.356895648236161e-11
existence O 0 4.2052242243961757e-10
of O 0 1.5870069147716492e-10
a O 0 3.0885019541848635e-10
genetically O 0 3.1526445343210696e-10
distinct O 0 9.437228559380784e-13
, O 0 7.113637478552148e-14
usually O 0 5.63958906971921e-14
lethal O 0 2.2170817699090906e-12
form O 0 1.9687855133069393e-13
of O 0 3.91218958270545e-12
the O 0 1.2972100824071298e-11
Schwartz B-Disease 0 2.52742538577877e-05
- I-Disease 1 0.999171257019043
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2459751008719877e-09
SJS B-Disease 0 0.00016416667494922876
) O 0 2.1342471193119827e-11
of O 0 3.358458844360257e-09
myotonia B-Disease 1 0.5575624704360962
and O 0 3.3139315291919047e-07
skeletal B-Disease 1 0.9999821186065674
dysplasia I-Disease 1 1.0
, O 0 1.6251894408014778e-07
which O 0 4.490115657063143e-08
we O 0 9.742375794985492e-08
called O 0 9.991323395297513e-07
SJS B-Disease 0 0.00017910735914483666
type I-Disease 0 4.698210886999732e-07
2 I-Disease 0 3.7685254028474446e-06
. O 0 2.5296991168488603e-08

This O 0 1.5815353471282378e-09
disorder O 0 3.583293619158212e-06
is O 0 1.0260935330574927e-11
reminiscent O 0 4.3802791949154596e-10
of O 0 3.9500658299829183e-10
another O 0 2.986103725399758e-11
rare O 0 1.751847451825217e-11
condition O 0 4.256754593257028e-08
, O 0 5.595547029196846e-12
the O 0 2.0409585133052133e-10
Stuve B-Disease 1 0.9936892986297607
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.735050313480315e-07
SWS B-Disease 1 0.6017534732818604
) O 0 1.3381964807102076e-11
, O 0 6.517207563547234e-13
which O 0 6.706295132934137e-13
comprises O 0 1.927641640059319e-12
campomelia B-Disease 0 1.1252443243847665e-07
at O 0 9.56834433907261e-09
birth O 0 3.1004674383439124e-09
with O 0 2.2018149456459746e-11
skeletal B-Disease 0 4.056516263517551e-05
dysplasia I-Disease 1 0.9999827146530151
, O 0 2.5072280251947632e-08
contractures B-Disease 0 1.3527356713893823e-05
, O 0 8.559910003036464e-10
and O 0 4.872063863459175e-10
early B-Disease 0 1.752898356244259e-06
death I-Disease 0 8.823815846881189e-07
. O 0 2.0780969833822382e-08

To O 0 6.139233010848955e-10
test O 0 6.155759495890534e-12
for O 0 1.0843858092284692e-13
possible O 0 2.7267930968744025e-11
nosologic O 0 3.0612574164479156e-07
identity O 0 1.1768175323112473e-10
between O 0 9.138396706021013e-10
these O 0 2.5749596899160565e-10
disorders O 0 4.681313825471989e-08
, O 0 1.3864177167421943e-11
we O 0 1.3410121971202393e-11
reviewed O 0 4.0994489053369776e-11
the O 0 6.698985550307457e-12
literature O 0 1.0579017046055683e-12
and O 0 7.728853093549176e-14
obtained O 0 8.713671060742167e-13
a O 0 3.2492446233600702e-12
follow O 0 4.591548061899653e-12
- O 0 2.3225079845423657e-11
up O 0 1.0968512556552845e-11
of O 0 3.3212391170600597e-12
the O 0 1.2477282661932376e-12
only O 0 2.8034703464935307e-13
two O 0 4.108470291405708e-13
surviving O 0 3.307593920975904e-10
patients O 0 1.4437210975326575e-11
, O 0 5.9658658221883876e-12
one O 0 4.786392462929889e-11
with O 0 1.0612732047332596e-11
SJS B-Disease 0 1.539413347018126e-06
type I-Disease 0 1.706991703542826e-08
2 I-Disease 0 3.134967982987291e-07
at O 0 1.3459695580309017e-09
age O 0 2.1309250197720786e-10
10 O 0 2.272700430627772e-11
years O 0 4.162733092255566e-12
and O 0 2.548434553661938e-13
another O 0 3.209333840348272e-11
with O 0 1.3840978710377705e-11
SWS B-Disease 0 9.664044227974955e-06
at O 0 7.920492706148252e-09
age O 0 5.244150447225593e-09
7 O 0 6.462769874815422e-08
years O 0 3.0424480712554214e-09
. O 0 2.5907647138723178e-09

Patients O 0 4.010744873994554e-07
reported O 0 7.739461294065109e-10
as O 0 3.441182408470134e-11
having O 0 6.016158404786864e-11
either O 0 8.65008509265408e-09
neonatal O 1 0.9999853372573853
SJS B-Disease 1 0.9996926784515381
or O 0 1.221746259716383e-07
SWS B-Disease 0 6.113873951107962e-06
presented O 0 6.380571852121486e-12
a O 0 1.0796190330619737e-12
combination O 0 1.5106990094646e-12
of O 0 5.463591818549718e-12
a O 0 1.357280347141776e-11
severe O 0 6.218801473778512e-08
, O 0 6.392097962049093e-11
prenatal O 0 1.5509042441408383e-06
- O 0 1.5030275335448096e-06
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 0.9999982118606567
( O 0 1.993184436943629e-11
with O 0 1.0579859210935183e-09
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9985170960426331
respiratory O 1 1.0
and O 0 0.09916601330041885
feeding O 0 0.0024792912881821394
difficulties O 0 1.0341497045374126e-06
, O 0 9.940711448441775e-11
tendency O 0 3.11164072286374e-09
to O 0 4.8900560045694874e-08
hyperthermia B-Disease 0 0.01863905042409897
, O 0 3.134870141252577e-11
and O 0 4.186844447529037e-12
frequent O 0 3.755313421338613e-11
death O 0 3.1899789476597107e-09
in O 0 9.278088713982058e-11
infancy O 0 1.6278910663913848e-08
) O 0 4.6136041493248514e-14
with O 0 8.542077398340179e-15
a O 0 2.0310780834975617e-11
distinct O 0 1.8552893943368787e-10
campomelic B-Disease 0 6.832989311078563e-05
- I-Disease 0 0.003749666502699256
metaphyseal I-Disease 1 0.9932215213775635
skeletal I-Disease 1 0.9995737671852112
dysplasia I-Disease 1 1.0
. O 0 5.609587606159039e-05

The O 0 3.997402231448177e-08
similarity O 0 3.16116199883254e-08
of O 0 2.415218780527084e-08
the O 0 2.9757984965073092e-09
clinical O 0 5.31998178843196e-09
and O 0 5.2631135560865516e-11
radiographic O 0 1.565247487178567e-07
findings O 0 4.217067584022516e-08
is O 0 8.746199597897686e-11
so O 0 3.968140052656999e-12
extensive O 0 2.0844824477617152e-10
that O 0 3.048509361613938e-11
these O 0 7.562653281389942e-11
disorders O 0 3.803914339073344e-08
appear O 0 3.393414715890941e-10
to O 0 2.34831348810971e-10
be O 0 7.044957499313664e-12
a O 0 1.2987970941791271e-11
single O 0 5.280751183556198e-11
entity O 0 6.176799871582261e-08
. O 0 1.880555089428526e-07

The O 0 2.4829050815355913e-08
follow O 0 2.7052249329528877e-09
- O 0 1.7438049892959384e-09
up O 0 3.669707246412024e-11
observation O 0 3.62734314807156e-10
of O 0 3.911428472780365e-12
an O 0 7.30422802320066e-14
identical O 0 1.3730634467953862e-13
and O 0 4.041332765940438e-14
unique O 0 1.4377756797634422e-13
pattern O 0 1.2969763041326132e-09
of O 0 1.4113611612742716e-08
progressive O 1 0.9999852180480957
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 9.932241482601967e-07
the O 0 9.371543683300843e-07
two O 0 3.748046761842261e-09
patients O 0 2.0101367792513258e-10
( O 0 5.139622668431931e-12
one O 0 4.374774500992551e-11
with O 0 4.8893371989988665e-12
SJS B-Disease 0 9.327605710041098e-08
type I-Disease 0 4.471456538368557e-09
2 I-Disease 0 6.935695040510836e-08
, O 0 7.880848751362635e-12
one O 0 1.8876131560596754e-11
with O 0 1.1560248418251984e-11
SWS B-Disease 0 5.972679900878575e-06
) O 0 6.243144196060868e-11
surviving O 0 6.310769684603201e-09
beyond O 0 1.1766643126520648e-07
infancy O 0 6.898556392798127e-08
adds O 0 1.0304946999883935e-11
to O 0 1.5093778657493395e-11
the O 0 3.0018977754953102e-12
evidence O 0 5.054034447893319e-13
in O 0 9.156977747674239e-14
favor O 0 2.1727538171423255e-11
of O 0 8.97125082555128e-11
identity O 0 2.3643492719216397e-10
. O 0 1.263943838480941e-09

The O 0 9.287857238859942e-08
hypothesis O 0 4.989924491383135e-07
that O 0 3.944993220983406e-09
SWS B-Disease 0 0.001119310618378222
and O 0 4.6108997509008987e-08
SJS B-Disease 0 0.0004894472658634186
type I-Disease 0 7.168276283664454e-08
2 I-Disease 0 9.153512081638837e-08
are O 0 9.641697162887652e-13
the O 0 7.12135602223829e-12
same O 0 1.461687437753767e-10
disorder O 0 4.910297501936611e-09
should O 0 7.963718573478218e-11
be O 0 1.6582815676180473e-10
testable O 0 3.0606892575946176e-09
by O 0 2.882881607046972e-11
molecular O 0 7.34358018839032e-10
methods O 0 4.692967126018743e-10
. O 0 7.282663361252162e-11
. O 0 1.3263639075944411e-09

A O 0 5.303022909686206e-09
mouse O 0 1.0322099945614394e-11
model O 0 6.890968264755548e-12
of O 0 2.2666743482169238e-11
severe O 1 0.8933888673782349
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.00040155163151212037
defects O 1 1.0
in O 0 1.887817597889807e-05
hemostasis O 1 0.9993591904640198
and O 0 6.49699450150365e-06
thrombosis B-Disease 1 1.0
. O 0 0.0021200336050242186

von B-Disease 1 0.9999994039535522
Willebrand I-Disease 1 0.9999997615814209
factor I-Disease 0 0.0003745107678696513
( I-Disease 0 2.3446908414825884e-08
vWf I-Disease 1 0.9998550415039062
) I-Disease 0 1.0499918801087915e-07
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9999923706054688
humans O 0 0.0007813493139110506
. O 0 1.4671182952952222e-06

We O 0 2.5412328241714022e-08
generated O 0 2.2969260174421358e-11
a O 0 8.286198116547183e-12
mouse O 0 3.019573306672907e-12
model O 0 1.7528426626833848e-12
for O 0 1.1865825162715726e-12
this O 0 2.8208680183383628e-11
disease O 0 1.0415769635674366e-10
by O 0 6.597791432118305e-13
using O 0 1.6525655843757647e-11
gene O 0 1.1382896014655586e-10
targeting O 0 6.973347455030421e-10
. O 0 1.736049415335117e-09

vWf B-Disease 0 0.02150914818048477
- I-Disease 1 0.9998867511749268
deficient I-Disease 0 0.0024227695539593697
mice O 0 1.247074550292382e-07
appeared O 0 6.762130411175349e-09
normal O 0 2.162619239243213e-08
at O 0 2.510006646971874e-09
birth O 0 1.8280663094394356e-10
; O 0 5.943547737308208e-12
they O 0 1.865693016744885e-11
were O 0 4.836748015990544e-11
viable O 0 6.696875498590771e-09
and O 0 2.861697823153264e-10
fertile O 0 3.2076061415864388e-06
. O 0 1.2526530213108344e-07

Neither O 0 5.6511339607823174e-06
vWf O 0 0.0003439424035605043
nor O 0 6.072326868888922e-06
vWf O 0 0.00035042990930378437
propolypeptide O 0 0.00015286289271898568
( O 0 3.6263350100540492e-09
von B-Disease 0 0.001119917375035584
Willebrand I-Disease 0 8.284227078547701e-06
antigen O 0 1.789584729294802e-07
II O 0 0.0033805575221776962
) O 0 6.615216152638936e-10
were O 0 1.151422401868274e-09
detectable O 0 2.59004977465338e-08
in O 0 3.6271771697293786e-10
plasma O 0 2.925365016892556e-08
, O 0 1.38184061415636e-10
platelets O 0 4.306247802787766e-09
, O 0 7.214848163350496e-11
or O 0 8.854332267382858e-10
endothelial O 0 1.3799021647553644e-10
cells O 0 9.050067639737591e-11
of O 0 3.373158419250899e-10
the O 0 6.184386336371972e-10
homozygous O 0 4.10157241503839e-09
mutant O 0 8.463047862505846e-08
mice O 0 4.4332018944714946e-08
. O 0 9.600811701204748e-09

The O 0 4.638349935248698e-07
mutant O 0 9.299925523009733e-07
mice O 0 1.505978275417874e-08
exhibited O 0 2.10427697489024e-09
defects O 0 4.502964202401927e-06
in O 0 2.0371131448371216e-09
hemostasis O 0 4.103132198451931e-07
with O 0 1.3677430715786087e-11
a O 0 5.179466633364882e-09
highly O 0 7.857431150171124e-09
prolonged O 0 0.3802245557308197
bleeding O 1 0.6984939575195312
time O 0 2.1280977762216935e-06
and O 0 1.3975494539408828e-08
spontaneous O 0 1.5398229891161463e-07
bleeding O 0 1.2084080935892416e-06
events O 0 8.188691912047741e-12
in O 0 3.430708408330707e-12
approximately O 0 4.397275946144141e-12
10 O 0 1.1886881756684176e-10
% O 0 9.972787179401976e-11
of O 0 3.284340022169374e-10
neonates O 0 1.7894140569296724e-07
. O 0 5.079269982388723e-08

As O 0 5.75982206374448e-10
in O 0 4.375375409204629e-11
the O 0 4.1448480758710105e-10
human O 0 1.1777815389635293e-09
disease O 0 1.5447879420094068e-08
, O 0 1.9427157365442538e-12
the O 0 9.062366829182267e-11
factor O 0 3.3285482703426794e-10
VIII O 0 5.188319846638478e-05
level O 0 4.394847201183438e-05
in O 0 1.667309312836096e-08
these O 0 6.71926236872622e-10
mice O 0 1.309489294776256e-09
was O 0 6.543236508171901e-10
reduced O 0 1.782326647381538e-10
strongly O 0 5.9539751601223045e-12
as O 0 8.975640326466805e-13
a O 0 5.5806678722625236e-12
result O 0 2.8782060068621718e-11
of O 0 9.23729912005733e-11
the O 0 6.224298854107246e-11
lack O 0 2.707660207157403e-10
of O 0 3.0747990958923666e-11
protection O 0 3.667698783571538e-11
provided O 0 3.397666262922039e-12
by O 0 1.0515135984157098e-10
vWf O 0 2.639666718096123e-06
. O 0 3.4238514245998886e-08

Defective O 0 0.0005652455729432404
thrombosis B-Disease 0 0.004120061174035072
in O 0 9.770509450390819e-07
mutant O 0 6.069971618671843e-07
mice O 0 5.198092623004413e-09
was O 0 5.810557590635312e-10
also O 0 1.185408433738988e-12
evident O 0 5.155252526950482e-12
in O 0 1.3193853561771496e-12
an O 0 4.415326340222875e-13
in O 0 1.7171897584433715e-12
vivo O 0 4.808288836533059e-11
model O 0 2.3901569959350333e-11
of O 0 1.054897502683616e-08
vascular B-Disease 1 0.9999538660049438
injury I-Disease 1 0.9999998807907104
. O 0 1.688031443336513e-05

In O 0 1.5641918316156023e-10
this O 0 4.3368299403045985e-12
model O 0 1.8194178802444227e-11
, O 0 5.202171159124358e-12
the O 0 1.2458865883413495e-10
exteriorized O 0 3.7091132298883167e-07
mesentery O 0 4.3668450189215946e-07
was O 0 3.063961528937398e-08
superfused O 0 1.4960686200993223e-07
with O 0 2.4936142040132836e-10
ferric O 0 3.214828723230312e-07
chloride O 0 1.0164838748494276e-08
and O 0 1.3739262172407507e-08
the O 0 1.1331496097000127e-07
accumulation O 0 6.461191901507846e-07
of O 0 2.3855997710597876e-07
fluorescently O 0 2.709750788199017e-07
labeled O 0 1.801216953367657e-08
platelets O 0 4.50773018911832e-09
was O 0 3.5977851808866035e-09
observed O 0 1.0007925044241972e-10
by O 0 2.4877317220117767e-11
intravital O 0 2.023976009013495e-07
microscopy O 0 1.052847622418085e-07
. O 0 6.798486396064618e-08

We O 0 7.04562864939362e-07
conclude O 0 1.2061378583894111e-05
that O 0 6.546607145274663e-10
these O 0 1.4475820542259044e-10
mice O 0 7.032411875051992e-10
very O 0 3.8203611281428795e-12
closely O 0 5.5882333482859536e-11
mimic O 0 6.721101897255721e-08
severe O 0 0.00042705031228251755
human O 0 2.0052537365700118e-05
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 9.410688107891474e-06
will O 0 5.176259776362713e-08
be O 0 5.927285884332889e-10
very O 0 1.1711109512702045e-12
useful O 0 2.514550200005683e-12
for O 0 3.1930404501001597e-13
investigating O 0 1.4991606914205313e-11
the O 0 1.7816085412514227e-11
role O 0 2.8216051023433053e-11
of O 0 1.560868656547143e-10
vWf O 0 3.261035175228244e-08
in O 0 3.0163643804925755e-10
normal O 0 1.353219403199546e-07
physiology O 0 3.3979890012858505e-09
and O 0 1.0008492298818616e-11
in O 0 5.067456870788689e-11
disease O 0 1.249363834610051e-09
models O 0 4.8417228559749503e-11
. O 0 2.3757862344098157e-10
. O 0 8.853931809937876e-09

Oral O 0 2.086753511321149e-06
contraceptives O 0 7.525597567337172e-08
and O 0 1.1547334269335074e-11
the O 0 4.8038517608262055e-11
risk O 0 2.028916945562287e-08
of O 0 3.1524548376182793e-06
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999656677246094

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 0.007975663058459759
Study O 0 1.4933104353076487e-07
Group O 0 1.9170251497335755e-10
. O 0 2.52750798068746e-09

BACKGROUND O 0 4.1790823956944223e-07
Women O 0 8.106395416040968e-11
with O 0 5.833724345608027e-13
mutations O 0 1.805341813543304e-11
in O 0 9.5995156268458e-12
either O 0 2.055311060233933e-10
the O 0 1.3457178704712192e-09
BRCA1 O 0 4.359236083217866e-09
or O 0 1.863415199920837e-09
the O 0 2.1305033293117503e-09
BRCA2 O 0 2.1166510766335023e-09
gene O 0 1.0388780981307466e-11
have O 0 2.951187471483818e-13
a O 0 1.2439240176104205e-12
high O 0 4.559834801409757e-11
lifetime O 0 1.0355752921853423e-09
risk O 0 4.047262223139114e-07
of O 1 0.6277714371681213
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0001952330203494057

Oral O 0 3.872675006277859e-05
contraceptives O 0 3.1206018320517614e-05
protect O 0 3.6949060699953407e-07
against O 1 0.9999905824661255
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0003883790341205895
general O 0 1.4294838592832093e-06
, O 0 3.700450709742675e-11
but O 0 1.861660998969672e-12
it O 0 6.725984244386474e-13
is O 0 3.0511124226098585e-13
not O 0 2.0332245002224747e-12
known O 0 8.963412477525079e-12
whether O 0 1.1506703576080746e-11
they O 0 7.443892507605354e-13
also O 0 2.455479667252264e-13
protect O 0 2.100752948333562e-12
against O 0 1.4063507303152534e-10
hereditary B-Disease 1 0.8883888125419617
forms I-Disease 0 0.0011503152782097459
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.700311496388167e-05

METHODS O 0 2.429964069960988e-07
We O 0 1.2903898782834489e-10
enrolled O 0 5.858943191716648e-11
207 O 0 1.1506879650513557e-11
women O 0 9.002193657398419e-14
with O 0 5.2142509060493225e-12
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.3125486475473735e-07
161 O 0 2.0307480141923406e-08
of O 0 2.3316137909290546e-09
their O 0 2.1636525904256132e-10
sisters O 0 2.4564672518323505e-10
as O 0 1.2819235256644745e-11
controls O 0 2.729198533835131e-10
in O 0 1.0303727489280323e-11
a O 0 1.7897701376501374e-10
case O 0 2.4939577070171026e-09
- O 0 2.6400710950724715e-08
control O 0 3.28868736687582e-08
study O 0 3.7347719361591203e-10
. O 0 1.4236730683236942e-09

All O 0 8.929844419469646e-09
the O 0 3.9336903179254534e-10
patients O 0 5.32797590768741e-12
carried O 0 1.1473693089375514e-12
a O 0 3.3906226350882696e-12
pathogenic O 0 6.945998637375439e-11
mutation O 0 1.1493636598025603e-10
in O 0 2.953443045683457e-11
either O 0 5.637847411144037e-10
BRCA1 O 0 4.821251398112736e-09
( O 0 6.851794305540171e-12
179 O 0 3.419703409335284e-10
women O 0 3.127055905882692e-13
) O 0 3.1814050634355884e-13
or O 0 9.98194027435062e-11
BRCA2 O 0 7.552685588052555e-09
( O 0 4.811912326929679e-11
28 O 0 9.583690285808188e-08
women O 0 1.685063200085324e-11
) O 0 4.318350538268234e-11
. O 0 3.93618382332761e-09

The O 0 4.965168542980791e-08
control O 0 1.0201801181608516e-08
women O 0 2.201612156471633e-12
were O 0 2.336578630232622e-12
enrolled O 0 9.770326908631333e-12
regardless O 0 2.366143739274129e-11
of O 0 4.76797733239831e-11
whether O 0 3.6216449977866105e-11
or O 0 2.9753599584125823e-10
not O 0 9.535982004038601e-10
they O 0 3.040983090341065e-11
had O 0 2.2979612657181292e-10
either O 0 5.226144517145315e-10
mutation O 0 1.1672464772516378e-08
. O 0 9.640796605481228e-09

Lifetime O 0 7.539369562437059e-06
histories O 0 7.828397201592452e-07
of O 0 1.0050403034256306e-06
oral O 0 1.5506026329603628e-06
- O 0 9.945068057959361e-08
contraceptive O 0 3.971704742866677e-09
use O 0 2.7043811634541726e-11
were O 0 1.1728188949525209e-12
obtained O 0 7.916791679683788e-13
by O 0 2.7732305926501943e-13
interview O 0 4.995997018863996e-11
or O 0 1.851872388075604e-12
by O 0 2.779362569087229e-13
written O 0 3.4123420235288027e-13
questionnaire O 0 1.2198922427764103e-12
and O 0 1.353680839297211e-12
were O 0 2.3452316477712287e-12
compared O 0 3.6188530470881997e-12
between O 0 1.949919670174438e-10
patients O 0 2.3299355500494556e-11
and O 0 4.557937360871733e-12
control O 0 6.185687517756833e-09
women O 0 2.1822540790476103e-13
, O 0 8.745836086593295e-14
after O 0 4.412045381818608e-12
adjustment O 0 3.863715597463013e-11
for O 0 3.169956972696314e-13
year O 0 6.726440238136178e-11
of O 0 2.3004390059533364e-10
birth O 0 1.1320501203115896e-09
and O 0 4.4024836554079627e-10
parity O 0 1.7471393221057951e-07
. O 0 6.974404698212311e-08

RESULTS O 0 2.6647040840543923e-07
The O 0 3.3346438943482326e-09
adjusted O 0 1.900461343851134e-09
odds O 0 3.1681681722517396e-09
ratio O 0 1.785692010924933e-10
for O 0 9.195190386890317e-09
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 4.1841065723247084e-08
with O 0 9.487026615684346e-12
any O 0 1.8961057168809248e-09
past O 0 4.440161849306179e-10
use O 0 1.810686843517484e-11
of O 0 8.026989489762215e-11
oral O 0 2.3349426836460907e-09
contraceptives O 0 3.23284474745833e-08
was O 0 1.1353808559988465e-08
0 O 0 6.118734319215946e-08
. O 0 6.548458664212831e-09

5 O 0 1.3155179203749867e-06
( O 0 5.163977023769917e-10
95 O 0 6.685315412369164e-08
percent O 0 1.6061170171610684e-08
confidence O 0 2.0463075678378573e-09
interval O 0 7.681257407909925e-09
, O 0 5.748668208127583e-11
0 O 0 8.344094859502604e-10
. O 0 1.1294825318086676e-11
3 O 0 1.1332210725356617e-09
to O 0 6.272509733840081e-10
0 O 0 1.4234775580490577e-09
. O 0 3.534431081142486e-11
8 O 0 7.621219211273456e-09
) O 0 1.7243069472261396e-10
. O 0 5.105803779770213e-09

The O 0 1.0446582621170819e-07
risk O 0 2.543128729826094e-08
decreased O 0 7.496165355114215e-10
with O 0 1.6417126176299784e-13
increasing O 0 8.846917642912899e-11
duration O 0 3.752267385692676e-09
of O 0 1.6717020823175943e-10
use O 0 1.1188480003587742e-10
( O 0 1.9631449243995291e-10
P O 0 1.6718682900318527e-06
for O 0 1.9073019552617865e-10
trend O 0 2.1072732447890985e-09
, O 0 2.1896361460105318e-11
< O 0 1.6064785057778863e-08
0 O 0 6.228933480123544e-10
. O 0 3.99801155723245e-12
001 O 0 3.723858721382811e-11
) O 0 2.2119811407886325e-14
; O 0 2.2312016736145482e-14
use O 0 6.220648995913791e-13
for O 0 1.290206548369699e-12
six O 0 5.822289698975691e-12
or O 0 1.2544480428380855e-12
more O 0 8.264911785559395e-14
years O 0 8.508398846585052e-12
was O 0 2.0160333472074576e-11
associated O 0 1.96003781781362e-12
with O 0 7.419705718965733e-14
a O 0 1.3519689534557955e-10
60 O 0 1.3823395761392021e-09
percent O 0 3.668883252760935e-10
reduction O 0 2.460280645877333e-09
in O 0 1.1143123090917584e-09
risk O 0 3.973961156589212e-06
. O 0 1.2360258097032784e-06

Oral O 0 1.454344965168275e-05
- O 0 3.4929533399008506e-07
contraceptive O 0 4.1412011597685705e-08
use O 0 3.515902291528761e-10
protected O 0 4.0208469442859496e-08
against O 0 0.002614063210785389
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 9.618728036286939e-11
for O 0 4.789841700353348e-12
carriers O 0 6.163110386619985e-13
of O 0 4.4699001444659103e-11
the O 0 8.296797970874792e-11
BRCA1 O 0 3.6741074072033086e-10
mutation O 0 3.211429733251947e-10
( O 0 2.7824457148051263e-12
odds O 0 3.4689693340084204e-09
ratio O 0 3.4160313466813363e-11
, O 0 2.0206828831720314e-12
0 O 0 1.376994213098115e-10
. O 0 2.8541940946119615e-12
5 O 0 1.825205819816489e-10
; O 0 1.6067264706209894e-12
95 O 0 8.891056779702922e-10
percent O 0 4.618623261620769e-10
confidence O 0 6.925388734702054e-11
interval O 0 2.333507831409065e-10
, O 0 1.1682336521767755e-11
0 O 0 1.4876481990722112e-10
. O 0 5.565318605266212e-12
3 O 0 2.7878935271452576e-10
to O 0 1.8951032410008395e-10
0 O 0 3.7991901291611896e-10
. O 0 7.576394372987849e-12
9 O 0 1.2081403655272993e-09
) O 0 3.229021596547893e-13
and O 0 2.0192717940445415e-13
for O 0 3.214832100615489e-13
carriers O 0 6.518960176359057e-13
of O 0 3.2882370437636865e-11
the O 0 1.5424016230891624e-10
BRCA2 O 0 1.4402130599222573e-09
mutation O 0 3.180693763926712e-10
( O 0 3.140446236393757e-12
odds O 0 3.4457900977002964e-09
ratio O 0 2.430678228138028e-11
, O 0 1.5669881841748334e-12
0 O 0 1.557906303961687e-10
. O 0 2.785031536986504e-12
4 O 0 2.760158213099828e-10
; O 0 2.8916636880121915e-12
95 O 0 1.1214551509652892e-09
percent O 0 4.2636816299790326e-10
confidence O 0 8.00636223985407e-11
interval O 0 2.6298510591438173e-10
, O 0 8.168039161704499e-12
0 O 0 1.1348340323014128e-10
. O 0 3.76093123657939e-12
2 O 0 3.7655575879647074e-10
to O 0 1.5577933387689313e-10
1 O 0 9.570899628386087e-09
. O 0 7.054871270506524e-11
1 O 0 5.210443632108763e-08
) O 0 4.218591864724175e-10
. O 0 6.3291651919428205e-09

CONCLUSIONS O 0 4.753391840495169e-05
Oral O 0 1.232947170137777e-06
- O 0 2.415301914027168e-08
contraceptive O 0 1.6243545397642833e-09
use O 0 1.6182970762057547e-12
may O 0 7.695441506250233e-12
reduce O 0 8.78669706438906e-11
the O 0 3.8838869620416716e-11
risk O 0 2.466728510341909e-08
of O 0 3.550328983692452e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.978743023935749e-08
women O 0 1.2407676882458807e-12
with O 0 8.733483635716896e-14
pathogenic O 0 2.6552373147414876e-11
mutations O 0 3.7274114350616117e-11
in O 0 1.1064243271574625e-11
the O 0 2.9832133985330245e-10
BRCA1 O 0 1.8837459592191408e-08
or O 0 1.9022961339487665e-07
BRCA2 O 0 5.59603995498037e-06
gene O 0 1.179394871542172e-06

A O 0 4.0845367266229005e-07
Japanese O 0 2.7095744314920012e-08
family O 0 3.556736016818718e-10
with O 0 5.2641981052037323e-11
adrenoleukodystrophy B-Disease 1 1.0
with O 0 6.495533971806466e-11
a O 0 3.897307365718916e-09
codon O 0 2.791812825364559e-08
291 O 0 2.9717317495681073e-09
deletion O 0 1.2529941528782729e-08
: O 0 2.781464078158158e-12
a O 0 4.6354330096587404e-11
clinical O 0 1.0592762222927377e-09
, O 0 2.3971786361487446e-11
biochemical O 0 6.6263581288694695e-09
, O 0 7.706700277942957e-10
pathological O 0 0.00023208615311887115
, O 0 9.671955458756543e-10
and O 0 1.17496556928387e-09
genetic O 0 2.9543715029944906e-08
report O 0 3.1284821400134888e-09
. O 0 1.4421270400077901e-08

We O 0 4.975878820090429e-09
report O 0 2.079846711522393e-11
a O 0 1.0579324742632235e-11
Japanese O 0 2.186657244163115e-10
family O 0 9.124907426882878e-12
with O 0 2.074458660406009e-11
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.9779516808048356e-06
ALD B-Disease 1 1.0
) O 0 1.9537533049729383e-11
with O 0 6.249094666212207e-13
a O 0 1.1280513328992825e-10
three O 0 2.4989170455125276e-11
base O 0 3.930757941361662e-10
pair O 0 8.736529555353201e-11
deletion O 0 4.597321190402681e-09
( O 0 4.324978222780551e-11
delGAG O 0 1.9158397890350898e-07
291 O 0 2.81543510727289e-10
) O 0 1.9912227249008208e-12
in O 0 5.646109274559663e-11
the O 0 2.8523007955527646e-08
ALD B-Disease 1 1.0
gene O 0 5.485404699356877e-07
. O 0 1.2733735843539762e-07

A O 0 2.679187787180126e-07
variety O 0 6.237291794164435e-10
of O 0 2.70619526787641e-09
phenotypes O 0 2.5599660169461913e-09
were O 0 6.408774205768353e-11
observed O 0 1.2305350315100494e-11
within O 0 5.338290139794699e-12
this O 0 2.293502714134643e-11
family O 0 3.9575015486903453e-10
. O 0 3.9008547503271984e-09

While O 0 5.749661191600808e-09
the O 0 3.3053313419628694e-09
proband O 0 7.436931355186971e-06
( O 0 2.603346427321185e-09
patient O 0 4.001540787612612e-07
1 O 0 1.4483273389487294e-06
) O 0 1.05376221637421e-10
was O 0 1.385666248410189e-08
classified O 0 1.831231555282642e-10
as O 0 1.625266934923708e-11
having O 0 7.423776003656624e-12
a O 0 2.1646791997786963e-11
rare O 0 8.17455391571853e-12
intermediate O 0 4.2352726881134117e-10
type O 0 4.1670111805558463e-10
of O 0 7.996568962553852e-10
adult O 0 9.306171833145527e-09
cerebral O 0 2.532752841943875e-05
and O 0 1.2341896393763818e-08
cerebello O 1 0.9976223111152649
- O 0 0.14407894015312195
brain O 0 2.7976822821074165e-05
stem O 0 5.096716382269051e-09
forms O 0 6.046863704201044e-11
, O 0 1.166416247443125e-12
his O 0 1.2308237762326257e-11
younger O 0 1.4029744380139597e-11
brother O 0 1.4781108281791688e-10
( O 0 5.381656925651512e-12
patient O 0 4.674652887004527e-10
2 O 0 3.294681638621455e-09
) O 0 2.807420745529199e-12
and O 0 3.3864362702917816e-11
nephew O 0 3.129648007416108e-07
( O 0 3.0697497321874323e-10
patient O 0 5.157407301226158e-08
3 O 0 7.378716304629052e-08
) O 0 1.9881726473491845e-11
had O 0 9.407608025924219e-10
a O 0 4.472992198856218e-09
childhood O 0 1.9379349396331236e-05
ALD B-Disease 1 1.0
type O 0 3.929743616026826e-05
. O 0 9.945122201315826e-07

Another O 0 1.588114457717893e-07
nephew O 0 4.689357865572674e-06
( O 0 1.3549434907389468e-09
patient O 0 2.494925865903497e-07
4 O 0 4.888129865321389e-07
) O 0 2.3764193737840777e-11
of O 0 1.7109675898296928e-09
patient O 0 2.9297819281737247e-08
1 O 0 6.887984795866942e-07
was O 0 2.011907085375242e-08
classified O 0 8.025136805089872e-11
as O 0 7.061840695543609e-12
having O 0 1.6592074936205847e-11
an O 0 3.321481631402001e-11
adolescent O 0 1.0011290685341123e-09
form O 0 1.5301182543225877e-10
. O 0 1.5278859066825135e-08

The O 0 4.589630719920024e-08
tau O 0 6.432210142293115e-08
level O 0 8.779703186689858e-09
in O 0 1.1410458689020686e-10
the O 0 1.455312204079462e-09
cerebrospinal O 0 5.728231400325967e-08
fluid O 0 7.857599371163815e-08
( O 0 4.444400403258442e-09
CSF O 0 2.3899519874248654e-05
) O 0 5.826169408029713e-11
in O 0 5.1494374736504867e-11
patient O 0 1.925116510648195e-09
1 O 0 3.322056940646689e-08
was O 0 1.4142006454775924e-09
as O 0 3.872360765377891e-12
high O 0 9.751546792280408e-11
as O 0 2.2386628141524145e-13
that O 0 5.524868621408982e-14
of O 0 2.0101461727789482e-12
patients O 0 2.010173060992826e-12
with O 0 2.2625580228807785e-11
Alzheimers B-Disease 1 1.0
disease I-Disease 0 5.6196702644228935e-05
( O 0 3.0029013997623366e-11
AD B-Disease 0 4.442233603185741e-07
) O 0 1.2540168903285576e-09
. O 0 1.734931487362701e-08

His O 0 2.2137148334877566e-05
brain O 0 2.3657610654481687e-05
magnetic O 0 9.3557730451721e-07
resonance O 0 6.527660900701449e-08
image O 0 5.163487415416057e-09
( O 0 3.1720120974298993e-10
MRI O 0 5.800276312584174e-07
) O 0 5.148789380959862e-11
showed O 0 5.861245516713964e-11
abnormalities B-Disease 0 3.0463964684201983e-09
in I-Disease 0 8.791134487040608e-12
the I-Disease 0 1.3254604358525768e-10
bilateral I-Disease 0 2.8069021027476992e-06
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9999947547912598
and O 0 2.7056034923589323e-06
brain O 0 0.0004125242994632572
stem O 0 9.300514136612037e-08
, O 0 4.01424119639282e-12
but O 0 8.78306867339862e-13
not O 0 1.521432827812641e-12
in O 0 1.1761903300280818e-12
the O 0 1.785507158791333e-11
cerebral O 0 7.239241881507041e-07
white O 0 2.6454682888754633e-09
matter O 0 4.412556986466143e-09
, O 0 2.5792677455643842e-12
where O 0 1.3544505144194585e-12
marked O 0 6.956748111602851e-12
reductions O 0 2.9429532144575887e-09
of O 0 1.0299298081051234e-09
the O 0 2.0320607418966574e-09
cerebral O 0 4.952928065904416e-06
blood O 0 5.4728431564399216e-08
flow O 0 2.2592148596345396e-08
and O 0 8.271930918013481e-10
oxygen O 0 4.261066166577621e-09
metabolism O 0 3.82067311122114e-09
were O 0 4.679750944397432e-12
clearly O 0 3.285865720140113e-12
demonstrated O 0 5.437722754714214e-13
by O 0 6.043723681237179e-12
positron O 0 1.353402723225372e-07
emission O 0 1.2245078551131883e-06
tomography O 0 3.018844836333301e-06
( O 0 6.226097859496349e-09
PET O 0 4.920950686937431e-07
) O 0 4.4116962860663023e-10
. O 0 5.793385771113435e-09

In O 0 2.995795256310885e-08
patients O 0 3.4309814989086362e-09
2 O 0 8.532483519729794e-08
and O 0 3.313036511798373e-10
3 O 0 1.0055505583750346e-07
, O 0 5.404743319559202e-11
the O 0 5.019687443486021e-10
autopsy O 0 3.541473114765381e-09
findings O 0 2.0964721625382765e-10
showed O 0 6.750860287452198e-11
massive O 0 3.589561714534284e-08
demyelination B-Disease 1 1.0
of I-Disease 0 1.821254591050092e-05
the I-Disease 0 4.205629409170797e-07
cerebral I-Disease 1 0.796914279460907
white I-Disease 0 7.549963321196174e-09
matter I-Disease 0 9.955117841187189e-10
with O 0 2.151579018032021e-13
sparing O 0 1.1564604829317204e-09
of O 0 3.1797995347915275e-08
the O 0 3.474082888033081e-08
U O 0 4.129670560359955e-05
- O 0 1.3334221193872509e-06
fibers O 0 1.6880251862971818e-08
, O 0 2.0745695092361238e-11
compatible O 0 1.2271487992432384e-10
with O 0 1.098714218564223e-12
the O 0 9.29867433052678e-11
findings O 0 1.8605587903675058e-10
of O 0 1.4504848433460893e-09
childhood O 0 1.6359987057512626e-05
ALD B-Disease 1 1.0
. O 0 8.92792104423279e-06

Oleic O 0 0.0010668106842786074
and O 0 3.3157252801174764e-06
erucic O 0 0.0023481962271034718
acids O 0 3.377261236892082e-06
( O 0 1.3869269066546508e-09
Lorenzos O 0 1.1954327874263981e-06
Oil O 0 1.8985933536441735e-07
) O 0 1.1701649198225805e-11
were O 0 6.244665808757821e-12
administered O 0 6.512066493685742e-12
to O 0 8.903422443751197e-11
patients O 0 6.1187457010836166e-12
1 O 0 1.222966838909656e-09
and O 0 5.064828764722584e-11
4 O 0 1.671850391460339e-08
, O 0 9.331983970295443e-12
but O 0 3.2115488653866597e-12
sufficient O 0 1.7929808679428838e-11
effectiveness O 0 1.6245014014537595e-11
was O 0 9.404983042360371e-11
not O 0 2.145450830881579e-11
obtained O 0 8.957150021693394e-10
. O 0 3.796758463181504e-09

The O 0 9.88106592103577e-08
findings O 0 8.09402489476696e-10
in O 0 5.269992341822016e-12
this O 0 4.434757682608703e-12
family O 0 5.335986643859036e-13
suggest O 0 5.774068289471357e-13
that O 0 8.840746467146318e-14
delGAG291 O 0 5.838241556865853e-10
is O 0 8.395229498560364e-13
part O 0 1.4423172725597233e-11
of O 0 2.672646270962531e-10
the O 0 1.7756895953624507e-10
cause O 0 3.660429470642157e-08
of O 0 9.965727798544322e-08
Japanese O 0 2.3075026547303423e-06
ALD B-Disease 1 1.0
with O 0 2.67936839382088e-10
phenotypic O 0 8.016153429935002e-08
variations O 0 1.2605335086846026e-07
. O 0 1.360875323541677e-08

Moreover O 0 4.365778494275219e-08
, O 0 1.4414207674673385e-11
although O 0 1.1903499019805253e-12
the O 0 8.87000976140806e-12
scale O 0 2.2704367275139248e-09
of O 0 8.708678916891088e-11
the O 0 3.146875815485117e-11
study O 0 4.431324664849745e-12
is O 0 3.5038335080561644e-13
limited O 0 3.77131832707267e-12
, O 0 6.669268002440498e-12
there O 0 8.923258833226644e-12
is O 0 1.983320799259225e-11
a O 0 6.060583701561484e-10
possibility O 0 9.570429426730698e-08
that O 0 2.9072690921339017e-09
PET O 0 8.879207484824292e-07
can O 0 1.872739741060059e-09
detect O 0 2.0022223168325581e-07
an O 0 3.418237914942779e-09
insidious B-Disease 0 2.5229459424735978e-05
lesion I-Disease 0 0.011234322562813759
which O 0 1.1365783869621282e-09
is O 0 2.521935438259959e-10
undetectable O 0 7.392768064384825e-10
by O 0 9.272175041652453e-12
computed O 0 2.7030496951852e-08
tomogram O 0 2.7229780243942514e-06
( O 0 2.3619617373071833e-09
CT O 0 1.19237374747172e-05
) O 0 8.276377500004983e-11
or O 0 2.3046112240798777e-10
MRI O 0 1.3749065885804157e-08
analysis O 0 5.498466699310756e-12
, O 0 3.9693620704781343e-14
and O 0 1.2763661655368352e-14
that O 0 9.82163755571452e-15
the O 0 1.234419603210815e-13
higher O 0 9.627625953412267e-12
level O 0 1.3452861047369424e-10
of O 0 2.8186198167134968e-11
tau O 0 4.1689826590918244e-10
reflects O 0 7.007496796371249e-13
the O 0 6.262314885402409e-13
process O 0 6.726234846876622e-11
of O 0 3.19073184540386e-10
neuronal B-Disease 0 1.4521874618367292e-06
degeneration I-Disease 1 0.9999921321868896
in O 0 8.13740371086169e-07
ALD B-Disease 1 1.0
. O 0 1.3659289379575057e-06

Lorenzos O 0 4.5272659917827696e-05
Oil O 0 3.8847340988468204e-07
should O 0 1.2230595702877878e-10
be O 0 3.2496414413552e-12
given O 0 6.350167245337823e-13
in O 0 3.278226485842889e-13
the O 0 3.3073697860291906e-12
early O 0 3.427114425580413e-10
stage O 0 1.5491651017551789e-10
. O 0 2.6955082263468988e-11
. O 0 3.4239016066806016e-09

Nonsense O 0 7.031048426142661e-06
mutation O 0 1.5029881339501117e-08
in O 0 2.561723055904963e-10
exon O 0 7.573082605460968e-09
4 O 0 1.4518916735539733e-08
of O 0 1.4291408334532463e-10
human O 0 5.64936257496651e-11
complement O 0 4.184956547970131e-10
C9 O 0 6.480287993326783e-06
gene O 0 3.941514128968926e-11
is O 0 5.68980030191818e-13
the O 0 1.2624096646512983e-12
major O 0 1.0199203287486469e-10
cause O 0 9.2834433473854e-09
of O 0 1.598885290832186e-08
Japanese O 0 5.23578798095059e-08
complement B-Disease 0 1.958721185246759e-07
C9 I-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9998053908348083
. O 0 1.0604977660477743e-06

Deficiency B-Disease 0 0.08297531306743622
of I-Disease 0 1.9497192624839954e-06
the I-Disease 0 2.1874069489058456e-07
ninth I-Disease 0 1.237916762875102e-06
component I-Disease 0 1.5094030914042378e-08
of I-Disease 0 3.4794060965737117e-09
human I-Disease 0 1.067934074505672e-10
complement I-Disease 0 4.3977502195424734e-10
( O 0 1.856188397431069e-10
C9 O 0 4.773860928253271e-05
) O 0 8.544567831059169e-12
is O 0 6.070245760041171e-13
the O 0 7.03741915002859e-13
most O 0 5.3596074112019845e-14
common O 0 3.1122443511222286e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.500467249395456e-09
Japan O 0 4.0436560766465846e-09
but O 0 4.341582648947906e-11
is O 0 7.146828701759533e-12
rare O 0 5.135017411284082e-12
in O 0 4.310522425110541e-12
other O 0 1.82755546807023e-12
countries O 0 1.5967503708136377e-10
. O 0 1.1386858567163927e-08

We O 0 6.785179529344987e-09
studied O 0 3.0448266130633783e-10
the O 0 1.6170575295459955e-11
molecular O 0 3.846957474795687e-11
basis O 0 2.5694352201455217e-10
of O 0 8.803896500708674e-10
C9 B-Disease 1 0.9999996423721313
deficiency I-Disease 0 0.0003993927384726703
in O 0 3.9634159842982797e-10
four O 0 8.233708159721687e-11
Japanese O 0 8.035836884801029e-09
C9 B-Disease 0 0.0021155138965696096
- I-Disease 0 1.2983135093236342e-05
deficient I-Disease 0 1.1372792414476862e-06
patients O 0 1.55687940317506e-09
who O 0 1.6976713090866014e-10
had O 0 2.5463116060109314e-09
suffered O 0 3.8402629343181616e-07
from O 0 9.09829680040275e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 5.540172423934564e-06

Direct O 0 6.145798892021048e-08
sequencing O 0 8.956796193615446e-09
of O 0 1.3253708353033744e-08
amplified O 0 1.1805867394798497e-08
C9 O 0 6.690215286653256e-06
cDNA O 0 1.338801070005502e-08
and O 0 2.302853602254018e-10
DNA O 0 3.9300004917031117e-10
revealed O 0 3.1651647969255237e-10
a O 0 5.961865029435742e-11
nonsense O 0 2.563474321704007e-09
substitution O 0 1.4983532192758275e-09
( O 0 3.227208777989432e-11
CGA O 0 1.1260768317811198e-08
- O 0 3.4651751690262245e-08
- O 0 2.868794268806596e-08
> O 0 4.743671677687189e-09
TGA O 0 3.4186291575366567e-09
) O 0 5.813031805045055e-13
at O 0 2.0945366968616597e-11
codon O 0 3.7720753603975865e-11
95 O 0 4.2498119606770857e-11
in O 0 4.104759501050159e-12
exon O 0 6.733438806527658e-10
4 O 0 1.0241548720202331e-09
in O 0 9.556456320725104e-12
the O 0 2.386140451893226e-10
four O 0 1.715470321350665e-09
C9 B-Disease 0 0.002296309918165207
- I-Disease 0 2.3610009520780295e-05
deficient I-Disease 0 3.8313226013997337e-07
individuals O 0 4.464738856402306e-10
. O 0 2.6290061683198473e-08

An O 0 2.4700463896465408e-09
allele O 0 2.421495226556658e-09
- O 0 2.6645292638960427e-09
specific O 0 1.584058439974001e-10
polymerase O 0 8.225820025131725e-09
chain O 0 7.460022044547543e-10
reaction O 0 4.567128966681544e-11
system O 0 5.578137951545159e-11
designed O 0 1.0289396418228236e-10
to O 0 1.0935351513197133e-09
detect O 0 1.3320149427897832e-09
exclusively O 0 3.294726904495837e-12
only O 0 2.193292422680848e-12
one O 0 4.881826280028756e-12
of O 0 9.494991598524294e-12
the O 0 1.387690223147997e-11
normal O 0 3.149615568354136e-10
and O 0 8.012087521214184e-12
mutant O 0 2.3796592474312206e-10
alleles O 0 2.0230438851909227e-11
indicated O 0 7.122501199940956e-11
that O 0 1.347732255657652e-12
all O 0 3.342860059943331e-12
the O 0 1.3720830895069813e-11
four O 0 2.4496476895563557e-12
patients O 0 2.0179394450998284e-13
were O 0 1.3575178307856373e-12
homozygous O 0 1.7049610421399075e-12
for O 0 5.7755918103641335e-12
the O 0 1.3360192119282743e-10
mutation O 0 9.640989395709454e-11
in O 0 1.7439538702035406e-10
exon O 0 3.941593273992794e-09
4 O 0 1.227658064095749e-08
and O 0 1.511301392191633e-12
that O 0 1.0952222202070816e-12
the O 0 4.0162650982722425e-11
parents O 0 1.8107109561738e-11
of O 0 1.7273880936752306e-10
patient O 0 1.19460275005423e-09
2 O 0 8.323819145061861e-08
were O 0 1.957836115451528e-09
heterozygous O 0 1.6307555306127597e-09
. O 0 5.988368467768623e-09

The O 0 2.630932272040809e-08
common O 0 3.2253293369421954e-09
mutation O 0 2.3292980877442915e-09
at O 0 2.2450983294675098e-09
codon O 0 2.549849442701202e-09
95 O 0 2.794171338749152e-09
in O 0 7.679579194785902e-11
exon O 0 3.593313868677228e-09
4 O 0 6.4353615769618955e-09
might O 0 2.134959743715914e-11
be O 0 9.728839261979871e-12
responsible O 0 4.5336536608209244e-11
for O 0 4.95161550650991e-12
most O 0 5.169641104085798e-11
Japanese O 0 1.7136586905053264e-07
C9 B-Disease 1 0.9999275207519531
deficiency I-Disease 0 0.0004877343599218875
. O 0 2.119027442404331e-08
. O 0 3.632304057532565e-08

BRCA1 O 0 4.162018996112238e-08
required O 0 2.2619646156130102e-09
for O 0 2.6561350341403056e-10
transcription O 0 1.6447131656605052e-08
- O 0 8.419817731919466e-08
coupled O 0 1.2431229379217257e-07
repair O 0 0.00010575560736469924
of O 0 2.2647220248472877e-05
oxidative O 0 2.852016950782854e-05
DNA O 0 3.1211820896714926e-05
damage O 1 0.6986373066902161
. O 0 9.563327694195323e-07

The O 0 1.4976509191910736e-05
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 0 8.571294074499747e-07
BRCA1 O 0 4.197135012873332e-07
encodes O 0 2.3672745985692245e-09
a O 0 1.187070997055173e-09
zinc O 0 9.12454112267369e-08
finger O 0 3.4342242827278824e-08
protein O 0 1.4093329170350444e-08
of O 0 1.1944979450007054e-09
unknown O 0 2.892434958212675e-09
function O 0 1.1826640777812258e-09
. O 0 1.8180738026174481e-09

Association O 0 5.0505782667187304e-08
of O 0 1.1160191348835724e-07
the O 0 6.60668533214448e-08
BRCA1 O 0 6.370439731284705e-09
protein O 0 4.3499484569942126e-10
with O 0 2.826983710058767e-13
the O 0 1.0134861005983709e-10
DNA O 0 9.236669762380245e-10
repair O 0 1.1402729427345548e-07
protein O 0 2.8632841875264603e-08
Rad51 O 0 2.757740524828023e-08
and O 0 3.090981637310364e-11
changes O 0 2.3382518143932884e-11
in O 0 2.7033859525960047e-11
the O 0 1.3565459866526908e-10
phosphorylation O 0 2.5000432279931317e-10
and O 0 1.0293126073701586e-10
cellular O 0 4.598932346056017e-10
localization O 0 1.663900306425603e-08
of O 0 7.170214644247608e-09
the O 0 2.7561299908995807e-09
protein O 0 5.293661620164869e-10
after O 0 7.005235835855217e-10
exposure O 0 2.0761625751930524e-09
to O 0 2.1167156916135355e-09
DNA O 0 3.2464742005799962e-09
- O 0 2.7802165014634284e-09
damaging O 0 3.3474334415473095e-09
agents O 0 2.8751662509152176e-11
are O 0 3.7040482443392864e-13
consistent O 0 1.924834640634754e-12
with O 0 1.3217919495750203e-14
a O 0 1.7731198453940777e-11
role O 0 5.0226923314911076e-11
for O 0 5.045024814576138e-11
BRCA1 O 0 7.478175412245491e-09
in O 0 8.574457588395035e-09
DNA O 0 1.1839330227303435e-06
repair O 0 0.0004836722509935498
. O 0 8.345166406797944e-07

Here O 0 2.4019513489292876e-08
, O 0 2.8803202878346923e-11
it O 0 2.6643166839424026e-12
is O 0 1.5151775233784859e-12
shown O 0 1.1576746505870261e-12
that O 0 4.7156631897971035e-12
mouse O 0 4.650182017229554e-09
embryonic O 0 2.050851577450885e-07
stem O 0 2.908680301061395e-07
cells O 0 1.1423623824668994e-08
deficient B-Disease 0 3.553057936755977e-08
in I-Disease 0 1.1634362362400452e-09
BRCA1 I-Disease 0 1.8712626115302555e-08
are O 0 5.535340588669335e-11
defective O 0 4.866679947923558e-09
in O 0 2.733094861540053e-10
the O 0 2.9975752435795755e-10
ability O 0 1.4400414020954155e-11
to O 0 1.1390626636353929e-10
carry O 0 3.874416412696924e-11
out O 0 1.8877031882080786e-11
transcription O 0 1.775029290218555e-10
- O 0 1.6374505085181568e-09
coupled O 0 5.452242213266345e-09
repair O 0 1.5586218751195702e-06
of O 0 1.0305747082384187e-06
oxidative O 0 1.3416075717032072e-06
DNA O 0 1.3784115253656637e-06
damage O 0 0.00038071369635872543
, O 0 5.025397320501668e-10
and O 0 2.9721783367797627e-10
are O 0 5.975298034144316e-11
hypersensitive O 0 1.6855774731538986e-07
to O 0 2.4488524559274083e-06
ionizing O 0 1.938095738296397e-05
radiation O 0 1.7562451830599457e-05
and O 0 1.420301654064815e-09
hydrogen O 0 7.239498445166248e-10
peroxide O 0 1.9303239895407387e-08
. O 0 4.220718885505903e-09

These O 0 1.7218758641135423e-09
results O 0 1.0584583209904963e-09
suggest O 0 2.649139130284084e-09
that O 0 2.358579442862663e-10
BRCA1 O 0 1.719825348800441e-08
participates O 0 1.0364857583322618e-10
, O 0 9.651761811654835e-13
directly O 0 1.5546225765050714e-11
or O 0 8.527606398800458e-11
indirectly O 0 1.253488424168836e-09
, O 0 1.818210512705143e-11
in O 0 1.0442782749642276e-10
transcription O 0 4.349967053229875e-09
- O 0 3.738980680623172e-08
coupled O 0 1.682586159290622e-08
repair O 0 6.379744377227325e-07
of O 0 2.6507282768761797e-07
oxidative O 0 2.140067891787112e-07
DNA O 0 4.0427565295431123e-07
damage O 0 6.713991751894355e-06
. O 0 4.325048319486768e-09
. O 0 9.057329997119723e-09

Truncation O 0 1.220081867359113e-05
mutations O 0 8.643356252946433e-09
in O 0 3.075174836997263e-11
the O 0 9.631211800309458e-11
transactivation O 0 5.80442701902939e-07
region O 0 1.5707264822140132e-07
of O 0 5.979388362220561e-08
PAX6 O 0 0.00014991298667155206
result O 0 1.4384184510163323e-08
in O 0 1.4388128466436e-09
dominant O 0 2.2281130895862589e-07
- O 0 1.5524521757015464e-07
negative O 0 3.1151042634292025e-08
mutants O 0 1.6578624695284816e-08
. O 0 5.876192310516615e-10

PAX6 O 0 0.0007022175705060363
is O 0 3.75477293701465e-09
a O 0 2.064529436296425e-09
transcription O 0 4.216888616070946e-09
factor O 0 5.244924980440935e-11
with O 0 4.288057878069386e-14
two O 0 1.7050586203354312e-12
DNA O 0 5.813392822684449e-11
- O 0 1.4028199435411892e-10
binding O 0 9.931682143360376e-09
domains O 0 8.123867445419819e-08
( O 0 2.1879787912015836e-11
paired O 0 2.919580202598304e-11
box O 0 8.960101410826482e-11
and O 0 2.5569185657658977e-11
homeobox O 0 1.6441602523897814e-09
) O 0 3.240406857771272e-12
and O 0 1.7511660524438533e-11
a O 0 1.730515286624268e-09
proline O 0 2.9985390170850224e-08
- O 0 8.743844404079937e-08
serine O 0 4.5555733407809385e-08
- O 0 1.3675160914772277e-07
threonine O 0 2.6139466058339167e-07
( O 0 2.469466020560418e-10
PST O 0 3.1944914553605486e-06
) O 0 1.2341366817381072e-10
- O 0 6.724496959265025e-09
rich O 0 2.630680118187456e-09
transactivation O 0 7.350985811171995e-07
domain O 0 2.3066634469159908e-07
. O 0 8.258850492381953e-09

PAX6 O 1 0.9987978935241699
regulates O 0 2.881059299397748e-05
eye O 0 0.0058971429243683815
development O 0 2.8594101308954123e-07
in O 0 5.0273749607754326e-09
animals O 0 2.070001253740017e-10
ranging O 0 1.4498881206748138e-08
from O 0 1.3261546527587598e-08
jellyfish O 0 6.400958652008626e-10
to O 0 4.303932321647608e-09
Drosophila O 0 1.4201012588088702e-09
to O 0 3.393511860405596e-10
humans O 0 3.6261393887571103e-10
. O 0 2.8352460379466038e-09

Heterozygous O 0 1.670623817062733e-07
mutations O 0 5.985581807976814e-09
in O 0 2.5297434286253306e-11
the O 0 1.523687981341837e-10
human O 0 4.975269085605305e-10
PAX6 O 0 6.7106243477610406e-06
gene O 0 3.849609242490004e-10
result O 0 1.2565828932942225e-10
in O 0 4.413105731543299e-12
various O 0 2.1101098299225463e-12
phenotypes O 0 4.325722557929623e-10
, O 0 1.1474349031689868e-12
including O 0 2.7741474482173567e-12
aniridia B-Disease 1 1.0
, O 0 5.481827969333608e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.3821996880380993e-09
autosomal B-Disease 0 3.6963231764275406e-07
dominant I-Disease 0 1.0975696795867407e-06
keratitis I-Disease 1 0.8736265897750854
, O 0 4.415554144543421e-09
and O 0 4.3804256222301774e-08
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999704360961914

It O 0 1.7435688448586006e-09
is O 0 5.483994855448593e-11
believed O 0 7.97402283092552e-11
that O 0 6.177279824812199e-13
the O 0 1.0675465719756083e-11
mutated O 0 2.6877767372868178e-11
allele O 0 5.884450260396079e-09
of O 0 1.1527942156419613e-08
PAX6 O 0 4.4272128434386104e-06
produces O 0 3.436002871115562e-10
an O 0 1.3939407961238715e-10
inactive O 0 1.022800066863283e-09
protein O 0 5.967283334129547e-10
and O 0 5.379278966710643e-11
aniridia B-Disease 1 1.0
is O 0 2.8696153009377667e-08
caused O 0 1.7996549672716355e-07
due O 0 2.0106542706344044e-06
to O 0 3.1415137868862075e-07
genetic O 0 1.807463831937639e-07
haploinsufficiency O 0 2.627959247547551e-06
. O 0 4.299479172686915e-08

However O 0 1.552358241951879e-08
, O 0 1.9085064084656267e-10
several O 0 5.548511650133037e-11
truncation O 0 1.0696356156358888e-07
mutations O 0 8.40550118397232e-09
have O 0 1.9528814329539124e-11
been O 0 6.3321496483748074e-12
found O 0 2.7500330029676945e-13
to O 0 5.694102307718385e-12
occur O 0 7.878774889447104e-12
in O 0 8.346218681454243e-12
the O 0 3.1597358063351066e-10
C O 0 4.606913535099011e-07
- O 0 2.7005039981986556e-08
terminal O 0 8.102080073513207e-08
half O 0 5.007160797099175e-10
of O 0 1.212530631455877e-10
PAX6 O 0 1.024814366701321e-07
in O 0 1.9947970358868972e-11
patients O 0 4.0701756201522166e-12
with O 0 2.1516211121813678e-12
Aniridia B-Disease 1 1.0
resulting O 0 2.6986917589510995e-08
in O 0 2.1371455716234777e-09
mutant O 0 4.162181710398727e-10
proteins O 0 1.989229744467358e-12
that O 0 3.356210708654883e-13
retain O 0 4.634794284474886e-12
the O 0 5.223946709237426e-12
DNA O 0 1.040972603255641e-11
- O 0 2.333537876819669e-11
binding O 0 1.4807471915290193e-09
domains O 0 3.4864411357915515e-09
but O 0 8.313082167088481e-11
have O 0 2.9090578904100717e-11
lost O 0 1.0112987114396788e-09
most O 0 1.2377421136633426e-12
of O 0 1.749643659121336e-11
the O 0 7.578927069262775e-11
transactivation O 0 9.306192794156232e-08
domain O 0 8.098695758462782e-08
. O 0 7.946398206115646e-09

It O 0 7.136401469765019e-10
is O 0 2.1136795438914113e-11
not O 0 3.027336714644946e-11
clear O 0 5.389613755291123e-10
whether O 0 2.66486711170133e-11
such O 0 3.684498539602288e-11
mutants O 0 2.7787024237113656e-07
really O 0 2.0481427664975627e-09
behave O 0 1.9833067133046e-10
as O 0 6.720130701909355e-11
loss O 0 6.756532000551374e-10
- O 0 3.50988926811624e-08
of O 0 6.08233747811937e-08
- O 0 2.482366028289107e-07
function O 0 3.0216287250084406e-09
mutants O 0 1.6025840376965306e-10
as O 0 2.3273626949260606e-12
predicted O 0 1.0328590205332944e-09
by O 0 6.853614897828209e-11
haploinsufficiency O 0 1.922318733704742e-05
. O 0 3.630586604685959e-07

Contrary O 0 4.368185813063974e-08
to O 0 1.5023911004163892e-09
this O 0 5.609463241129653e-11
theory O 0 1.6631033217251456e-09
, O 0 6.593429361517744e-12
our O 0 1.053878252027518e-11
data O 0 1.1618072823238457e-11
showed O 0 7.311176837554445e-12
that O 0 9.242453807498108e-13
these O 0 2.1094337214477843e-12
mutants O 0 1.6797051249906048e-10
are O 0 1.429589194419656e-12
dominant O 0 4.839823541935573e-10
- O 0 1.3441325830143569e-09
negative O 0 3.6843952888609977e-10
in O 0 1.0034780645318264e-10
transient O 0 2.766797102538021e-08
transfection O 0 2.1235093683458217e-09
assays O 0 1.8227046261198865e-10
when O 0 2.2287807016629912e-11
they O 0 1.3815072133147033e-12
are O 0 2.4615148786454044e-13
coexpressed O 0 1.4161502193132947e-08
with O 0 1.0073684941769301e-11
wild O 0 2.5643838164057797e-09
- O 0 2.8812863206439943e-08
type O 0 5.535591753869085e-07
PAX6 O 0 0.000425713078584522
. O 0 1.3928716668942798e-07

We O 0 1.8673405932645437e-08
found O 0 9.856295467292053e-12
that O 0 9.027991028365268e-13
the O 0 5.93017787653416e-11
dominant O 0 3.432114148438359e-09
- O 0 4.087553850951053e-09
negative O 0 4.525355645768059e-09
effects O 0 3.555328831339466e-08
result O 0 6.525364137921486e-10
from O 0 2.8353744352394017e-10
the O 0 3.488333233381269e-11
enhanced O 0 8.223062855639007e-12
DNA O 0 3.61098824452899e-11
binding O 0 5.918587286934951e-10
ability O 0 4.437061135176279e-11
of O 0 2.745257909886334e-10
these O 0 3.604004247814707e-11
mutants O 0 3.4394862513664748e-09
. O 0 1.136827743053459e-09

Kinetic O 0 2.1128471416886896e-07
studies O 0 4.4380280006528494e-10
of O 0 8.683483793126001e-11
binding O 0 5.531251456858399e-09
and O 0 6.318908729596728e-10
dissociation O 0 2.7386917622607143e-08
revealed O 0 5.1143783652563e-10
that O 0 9.325449483801873e-13
various O 0 5.366750338402226e-13
truncation O 0 1.492620604892636e-08
mutants O 0 6.107511163477852e-10
have O 0 3.352296955652645e-12
3 O 0 1.8273271784607914e-10
- O 0 4.5986345287296615e-10
5 O 0 1.997227938588253e-09
- O 0 6.023693766010751e-10
fold O 0 3.420962679800965e-10
higher O 0 1.0804977051970255e-10
affinity O 0 1.0809836532843509e-11
to O 0 4.5361013556455276e-11
various O 0 1.170139722964092e-12
DNA O 0 2.483766881403171e-12
- O 0 2.466140139323336e-12
binding O 0 1.4999673378368605e-11
sites O 0 5.0167921032684415e-12
when O 0 2.921750027248121e-13
compared O 0 8.766800761901561e-13
with O 0 6.357823881079916e-14
the O 0 1.2214719513625738e-10
wild O 0 6.726417756119929e-10
- O 0 3.2660505411286067e-09
type O 0 4.4830553491692626e-08
PAX6 O 0 0.00035274768015369773
. O 0 1.4252120195124007e-07

These O 0 3.9455930189724597e-10
results O 0 1.84128698399455e-10
provide O 0 9.63107805312946e-12
a O 0 3.230078357563393e-11
new O 0 4.215442665073121e-12
insight O 0 1.4048159337198829e-12
into O 0 3.931441760682275e-13
the O 0 4.698870958129431e-13
role O 0 1.282387499142168e-12
of O 0 7.942507762592754e-12
mutant O 0 8.257396988398114e-10
PAX6 O 0 9.579722473063157e-07
in O 0 5.618974729948434e-10
causing O 0 5.510025857802248e-07
aniridia B-Disease 1 1.0
. O 0 1.579241342142268e-07
. O 0 8.715404931081139e-08

Reversal O 0 1.3022810207985458e-07
of O 0 1.260258919444368e-08
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 3.650338476290926e-05
excellent O 0 1.5963125576945458e-07
neuropsychologic O 1 0.9999058246612549
outcome O 1 0.9992794394493103
in O 0 1.7931466800291673e-07
very B-Disease 0 5.24966736747956e-08
- I-Disease 0 4.587487637763843e-06
long I-Disease 0 3.4875071719397965e-08
- I-Disease 0 1.5152528121120667e-08
chain I-Disease 0 3.742130494366336e-10
acyl I-Disease 0 2.3926302605836725e-10
- I-Disease 0 6.640477501207442e-09
coenzyme I-Disease 0 8.044052091094045e-10
A I-Disease 0 9.107898222282529e-07
dehydrogenase I-Disease 0 8.706100743438583e-06
deficiency I-Disease 0 0.00043987223762087524
. O 0 2.9770103537885007e-07

Very B-Disease 0 3.673424657790747e-07
- I-Disease 0 3.245041625632439e-06
long I-Disease 0 5.1923876753789955e-08
- I-Disease 0 1.0425280194681363e-08
chain I-Disease 0 3.296609651926019e-10
acyl I-Disease 0 1.0359145485860921e-10
- I-Disease 0 1.18362028511676e-10
coenzyme I-Disease 0 2.5726804367409706e-11
A I-Disease 0 5.254781054730984e-10
dehydrogenase I-Disease 0 9.57078527541455e-10
( I-Disease 0 1.694836285204282e-11
VLCAD I-Disease 0 0.00015499640721827745
) I-Disease 0 2.48376930134242e-10
deficiency I-Disease 0 1.7832202559020516e-07
is O 0 1.901278787186378e-11
a O 0 2.1601032074158866e-09
disorder O 0 0.00023462343961000443
of O 0 0.00012832018546760082
fatty O 0 7.695066415180918e-06
acid O 0 1.2769991144523374e-06
beta O 0 1.5301789346722217e-07
oxidation O 0 1.3447845503833378e-08
that O 0 2.8893550746422747e-11
reportedly O 0 1.3307749346935793e-10
has O 0 3.9336920222912686e-13
high O 0 1.115853156402613e-11
rates O 0 4.814269642661184e-12
of O 0 4.092329773663916e-12
morbidity O 0 2.2392663723280748e-08
and O 0 4.118652641160736e-10
mortality O 0 2.2779991581955983e-07
. O 0 1.998989773710491e-08

We O 0 3.764238254433394e-09
describe O 0 2.759610873148688e-10
the O 0 2.902589973929892e-11
outcome O 0 2.595399006821708e-09
of O 0 3.40651881702847e-11
a O 0 1.3669919363135108e-11
5 O 0 1.2358514211996408e-10
- O 0 2.2467711718876515e-11
year O 0 3.7841604849653265e-11
- O 0 3.4677902216451173e-10
old O 0 2.445700586495292e-10
girl O 0 3.3624165951540164e-11
with O 0 1.0963737513344785e-12
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 5.742874691350153e-06
was O 0 6.756976489441513e-08
first O 0 1.6396685398323285e-10
seen O 0 2.5756704061241642e-11
at O 0 1.0681453117833417e-11
5 O 0 3.7273687608641026e-11
months O 0 2.913648489144549e-12
of O 0 7.050504928149404e-13
age O 0 1.8784680842071078e-12
with O 0 4.023680938132837e-14
severe O 0 0.3330673277378082
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 7.354104309342802e-05
hepatomegaly B-Disease 1 1.0
, O 0 0.010006044059991837
encephalopathy B-Disease 1 0.9998759031295776
, O 0 9.580839588352319e-08
and O 0 7.596897262374114e-07
hypotonia B-Disease 1 0.9969438910484314
. O 0 0.0002225951902801171

Biochemical O 0 3.439410249939101e-07
studies O 0 1.793968884555852e-08
indicated O 0 0.00013571372255682945
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 9.949273953679949e-05
by O 0 2.433704349158461e-10
a O 0 3.2994986742806987e-09
stable O 0 1.8369320287092705e-08
yet O 0 3.885128219138778e-09
inactive O 0 3.5715459034690866e-08
enzyme O 0 5.423163429441047e-08
. O 0 1.6968021654406584e-08

Molecular O 0 6.453321930166567e-07
genetic O 0 2.6599744629152156e-09
analysis O 0 3.6961194521678564e-11
of O 0 3.568888518046265e-09
her O 0 5.896100496727286e-09
VLCAD O 1 0.9994148015975952
gene O 0 4.3467491828153015e-09
revealed O 0 9.714427484652788e-09
a O 0 3.760585620682377e-09
T1372C O 0 8.460403478238732e-06
( O 0 1.3790187880502458e-09
F458L O 0 1.3288205991557334e-05
) O 0 7.049211769860619e-10
missense O 0 3.30581286789311e-07
mutation O 0 8.582048849348212e-09
and O 0 1.3726884906528625e-10
a O 0 5.029388905342103e-09
1668 O 0 2.788155325106345e-05
ACAG O 0 0.0027892575599253178
1669 O 0 2.8547328838612884e-05
splice O 0 1.8466332676325692e-06
site O 0 2.7454175821617355e-08
mutation O 0 8.892315328523637e-09
. O 0 5.77503866949769e-09

After O 0 5.208973163917108e-08
initial O 0 1.602824184487872e-08
treatment O 0 2.6807194242195465e-09
with O 0 3.152053965060908e-11
intravenous O 0 2.302678936416669e-09
glucose O 0 1.2235676649652305e-07
and O 0 1.3819090316502525e-10
carnitine O 0 2.4343460580666942e-09
, O 0 4.328625999305835e-11
the O 0 7.277820013307235e-10
patient O 0 3.3123244147503783e-09
has O 0 2.2747775885179067e-11
thrived O 0 6.251476558638558e-10
on O 0 1.2615594124909535e-09
a O 0 1.6132420954662052e-09
low O 0 6.523852675854869e-07
- O 0 2.424172862447449e-07
fat O 0 9.447246185345648e-08
diet O 0 4.1907072256819333e-10
supplemented O 0 3.051462945172223e-12
with O 0 2.593369854801686e-13
medium O 0 1.0253359938872109e-08
- O 0 3.80572160452175e-08
chain O 0 1.4970714445894373e-08
triglyceride O 0 6.162347521154743e-09
oil O 0 5.240863387712125e-08
and O 0 5.960136550964279e-11
carnitine O 0 1.4651654889341614e-10
and O 0 8.485773715649625e-12
avoidance O 0 3.850279206574214e-09
of O 0 9.411703416617456e-09
fasting O 0 3.109091721853474e-07
. O 0 3.2260305538045486e-09

Her O 0 8.487407399115909e-07
ventricular O 0 0.002622433705255389
hypertrophy O 1 0.998261034488678
resolved O 0 0.0002808844728861004
significantly O 0 4.7410960490879006e-08
over O 0 2.866676007684532e-09
1 O 0 5.147540349526025e-08
year O 0 2.4950794208500326e-10
, O 0 3.811430771688551e-12
and O 0 2.2032936239368972e-11
cognitively O 0 4.8543149944180186e-08
, O 0 2.2321757289778255e-11
she O 0 5.583052683361123e-12
is O 0 4.512744886976672e-13
in O 0 6.962147330001611e-13
the O 0 5.265360196460289e-12
superior O 0 3.4744770949224346e-10
range O 0 3.30247074131762e-09
for O 0 6.835980115305063e-10
age O 0 3.7753784454253037e-07
. O 0 6.897859350374347e-08

Clinical O 0 4.4586329295270843e-08
recognition O 0 1.1831205348755702e-08
of O 1 0.9982907176017761
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.2959081630015135e-07
important O 0 1.0900694236148922e-10
because O 0 2.499859477408939e-12
it O 0 1.674166041258987e-13
is O 0 1.1879292851051798e-13
one O 0 5.537541996128437e-13
of O 0 2.990057637250465e-12
the O 0 4.780486770328274e-12
few O 0 1.5751928841151175e-12
directly O 0 1.5248681484170135e-10
treatable O 0 0.11544536054134369
causes O 0 1.2839863927638362e-07
of O 0 1.3758570958088967e-06
cardiomyopathy B-Disease 1 1.0
in O 0 7.696182365179993e-06
children O 0 6.433373389569397e-09
. O 0 8.576578891528186e-10
. O 0 7.559026293790794e-09

Cloning O 0 1.229675250513651e-09
of O 0 3.589734412501322e-11
a O 0 5.1161882889949606e-12
novel O 0 5.2946286244193175e-11
member O 0 4.765995237354659e-11
of O 0 1.7409029773318707e-10
the O 0 5.426023519383705e-10
low O 0 1.4445143392549653e-07
- O 0 3.394253411670434e-08
density O 0 7.816817415573496e-09
lipoprotein O 0 7.6499654824147e-06
receptor O 0 0.00010750659566838294
family O 0 3.709685358899151e-08
. O 0 2.421491984705426e-08

A O 0 4.4995289272264927e-07
gene O 0 1.877545757755783e-10
encoding O 0 1.0595060245810473e-10
a O 0 1.7390644480030915e-10
novel O 0 2.3034256724230318e-09
transmembrane O 0 4.2185316573295495e-08
protein O 0 8.804920681448891e-10
was O 0 4.7335985825514015e-11
identified O 0 3.2067851520913015e-13
by O 0 4.2769000824617945e-14
DNA O 0 2.2356044966642674e-12
sequence O 0 3.276364097561102e-13
analysis O 0 3.276487425558222e-14
within O 0 3.473716269058319e-13
the O 0 4.409269390576176e-12
insulin B-Disease 0 4.734337380796205e-06
- I-Disease 0 0.05373875051736832
dependent I-Disease 1 0.9975392818450928
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.5634974426248505e-09
IDDM B-Disease 0 9.073705768969376e-06
) O 0 1.4420532476466796e-11
locus O 0 1.6779000411304423e-09
IDDM4 O 0 4.998892677576805e-07
on O 0 1.591048537363804e-08
chromosome O 0 1.0339514346924261e-06
11q13 O 0 1.8633312720339745e-05
. O 0 5.6316626029229155e-08

Based O 0 3.0420419516730135e-09
on O 0 1.3453746561253865e-08
its O 0 1.2676081018181407e-10
chromosomal O 0 2.504659448732127e-07
position O 0 1.7906003790812974e-07
, O 0 8.180948973812718e-12
this O 0 7.134652244000783e-12
gene O 0 1.9468740855566047e-12
is O 0 1.9814244646074175e-13
a O 0 2.603104364007347e-12
candidate O 0 9.622544427934088e-11
for O 0 1.504735572255278e-11
conferring O 0 1.4397633307794422e-08
susceptibility O 0 3.540385660016909e-05
to O 0 8.138620614772663e-06
diabetes B-Disease 1 1.0
. O 0 6.918301096447976e-06

The O 0 2.2557321699423483e-07
gene O 0 1.8660293310546194e-09
, O 0 1.49276438432544e-10
termed O 0 5.71116913761216e-08
low O 0 1.6495501995450468e-06
- O 0 1.2714939146007964e-07
density O 0 9.952312751693171e-09
lipoprotein O 0 2.1540733996516792e-07
receptor O 0 6.493412740837812e-08
related O 0 8.038780308083915e-09
protein O 0 3.381457114315367e-09
5 O 0 1.1708849445568603e-09
( O 0 3.4291447719575485e-12
LRP5 O 0 4.249948233336909e-07
) O 0 3.2031801256576786e-12
, O 0 2.276669087628025e-12
encodes O 0 7.508960900987072e-13
a O 0 2.3604999899173862e-11
protein O 0 2.1782776971068785e-10
of O 0 8.476933599510517e-10
1615 O 0 1.4254147799874772e-06
amino O 0 7.875544838498172e-08
acids O 0 5.254791046738205e-10
that O 0 1.6852230331695917e-12
contains O 0 1.4366443147964536e-12
conserved O 0 2.9772320025989174e-11
modules O 0 4.7774510042453144e-12
which O 0 9.380317296569032e-14
are O 0 5.156211083643704e-14
characteristic O 0 5.824688821542967e-12
of O 0 8.604983045557013e-12
the O 0 4.001995956848248e-11
low O 0 2.061146808784997e-08
- O 0 1.929407389411608e-08
density O 0 3.5869456294079782e-09
lipoprotein O 0 6.072681344448938e-07
( O 0 2.7247684108999692e-09
LDL O 0 7.862612619646825e-06
) O 0 2.7799498814040646e-10
receptor O 0 8.982255650380466e-08
family O 0 1.3600441883809822e-09
. O 0 2.2672863586592484e-09

These O 0 8.523123318227022e-10
modules O 0 1.7727159740132947e-09
include O 0 2.3336403989770993e-11
a O 0 1.2425693807216476e-09
putative O 0 2.764987527825724e-08
signal O 0 1.3729935410822236e-08
peptide O 0 4.340930670476695e-10
for O 0 1.0772978342732387e-10
protein O 0 2.0329357641735157e-10
export O 0 3.7264039076667643e-10
, O 0 5.4001859407792896e-12
four O 0 2.0447293164194136e-11
epidermal O 0 5.346286968688219e-09
growth O 0 5.584869233743461e-10
factor O 0 3.26340870993036e-10
( O 0 3.016800004251863e-11
EGF O 0 1.8523069300613315e-08
) O 0 5.362036335776477e-12
repeats O 0 7.037332522275008e-11
with O 0 1.3358820885427114e-13
associated O 0 1.3051101865890757e-10
spacer O 0 1.513984670964419e-08
domains O 0 8.34152125150922e-09
, O 0 2.8854999986616114e-11
three O 0 2.7667769117445395e-11
LDL O 0 1.2799262094631558e-07
- O 0 6.814935460397464e-08
receptor O 0 1.9056384914506452e-08
( O 0 8.631353271004727e-11
LDLR O 0 3.0992682695796248e-06
) O 0 1.006488902638436e-11
repeats O 0 1.010694722358707e-10
, O 0 2.6462049240207064e-13
a O 0 9.38147216161811e-12
single O 0 1.1740308725194382e-10
transmembrane O 0 1.5711751899516457e-08
spanning O 0 3.971393880419782e-09
domain O 0 2.337139370922614e-09
, O 0 9.293261472864689e-12
and O 0 6.520679829424836e-12
a O 0 9.101345788131709e-10
cytoplasmic O 0 1.9268759388069157e-07
domain O 0 2.717493998716236e-07
. O 0 1.2421530470874131e-08

The O 0 6.193481283389701e-08
encoded O 0 5.315556883545014e-10
protein O 0 1.4667654868461e-09
has O 0 1.4650402473202068e-13
a O 0 3.9503461808122753e-13
unique O 0 3.3656148072484793e-13
organization O 0 4.8570120148028195e-11
of O 0 1.8239435517486413e-09
EGF O 0 3.871693024848355e-06
and O 0 6.01216143536476e-09
LDLR O 1 0.9853728413581848
repeats O 0 6.859888657118063e-08
; O 0 1.2514112142369971e-11
therefore O 0 1.9943834084212853e-10
, O 0 1.8271835433569805e-11
LRP5 O 0 0.00013058002514299005
likely O 0 1.5929851882034995e-09
represents O 0 3.086025575707585e-12
a O 0 1.0806492419662694e-12
new O 0 9.51356831854766e-13
category O 0 4.625867744412204e-11
of O 0 4.731558894688348e-11
the O 0 2.789957431748036e-10
LDLR O 1 0.7336044907569885
family O 0 7.736793428136934e-09
. O 0 1.7100907356848438e-08

Both O 0 2.5311951645790032e-08
human O 0 2.605075044570526e-09
and O 0 3.801611525577897e-10
mouse O 0 5.792438528828825e-08
LRP5 O 0 0.21007631719112396
cDNAs O 0 8.938163227867335e-05
have O 0 2.0313049020614926e-09
been O 0 8.107884363894868e-10
isolated O 0 1.2776871782804733e-09
and O 0 1.5974745831703885e-11
the O 0 1.275161781721934e-10
encoded O 0 1.1538005273425966e-10
mature O 0 1.4905686684940633e-09
proteins O 0 3.5369515476169067e-12
are O 0 8.557835429884308e-14
95 O 0 8.90721107982273e-11
% O 0 1.5166992661796996e-11
identical O 0 2.8795496802985765e-12
, O 0 1.5000752376370663e-12
indicating O 0 4.0003476226013746e-11
a O 0 2.0191119609602737e-11
high O 0 4.486113425183902e-10
degree O 0 1.8470785789759248e-08
of O 0 5.565239380445064e-10
evolutionary O 0 1.276517891390938e-09
conservation O 0 2.2225245255302895e-10
. O 0 2.6106833708738897e-11
. O 0 1.3317837943560562e-09

The O 0 1.2345785194156633e-07
APC B-Disease 0 2.0795562605258056e-08
variants O 0 7.513169530959374e-10
I1307K O 0 6.340089271361649e-07
and O 0 9.594119942946122e-11
E1317Q O 0 9.203481567965355e-07
are O 0 1.1822156751814528e-12
associated O 0 4.193500213744983e-09
with O 0 1.7115286254920647e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 5.6298585349168206e-08
but O 0 1.043111257092999e-11
not O 0 4.781380152918402e-12
always O 0 8.68398438553207e-14
with O 0 1.896096169681197e-15
a O 0 5.006735477597335e-12
family O 0 7.0017819667200776e-12
history O 0 1.9270186835118608e-10
. O 0 3.1023483781922323e-09

Classical O 0 0.00026216107653453946
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.735772935442583e-08
FAP B-Disease 0 3.3402475452248837e-08
) O 0 5.386974503626685e-13
is O 0 1.767280440913288e-13
a O 0 2.0801086547672654e-11
high O 0 5.199721613280417e-07
- O 1 0.999629020690918
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
that O 0 9.765007691342475e-10
predisposes O 0 4.442470569188117e-08
to O 0 9.664566036349242e-09
hundreds O 0 3.4576699142752076e-11
or O 0 3.84225706806518e-11
thousands O 0 2.23698750495549e-11
of O 0 2.57749768195481e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999992847442627
carcinoma I-Disease 1 1.0
and O 0 1.3280576922625187e-06
that O 0 4.660900110309285e-09
results O 0 9.564471437073507e-10
from O 0 2.290750700240096e-09
truncating O 0 2.808894272732232e-08
mutations O 0 4.0410480517394376e-10
in O 0 1.2861021969623465e-10
the O 0 2.4534669851306035e-09
APC B-Disease 0 2.0996514749072048e-08
gene O 0 1.2820763339860264e-09
. O 0 6.217102832550836e-09

A O 0 3.527605541009393e-09
variant O 0 3.7185601264866364e-09
of O 0 3.5582714552617745e-09
FAP B-Disease 0 1.6467463126446091e-07
is O 0 2.389676012626296e-09
attenuated B-Disease 0 0.0015835115918889642
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999977350234985
coli I-Disease 1 1.0
, O 0 1.2906811175383837e-09
which O 0 2.295953531461503e-11
results O 0 5.643159203816417e-11
from O 0 2.456073677770121e-10
germ O 0 2.5959852223422786e-07
- O 0 7.394365564294958e-09
line O 0 2.5667032943488266e-09
mutations O 0 2.494764117511039e-11
in O 0 3.5708712462639847e-12
the O 0 2.5514720544683733e-11
5 O 0 3.4476357879675845e-10
and O 0 4.733325276867761e-12
3 O 0 2.1210078138267363e-09
regions O 0 9.029485492639822e-10
of O 0 6.258805473891016e-09
the O 0 1.8044561400643033e-08
APC B-Disease 0 8.607231904989021e-08
gene O 0 1.863098786358819e-09
. O 0 2.6756366011682076e-09

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.0006138286553323269
have O 0 2.272325660968022e-09
" O 0 2.65514876751638e-09
multiple O 0 5.898237898094294e-09
" O 0 0.0021534438710659742
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 3.1497251473666665e-09
typically O 0 4.311538348567012e-10
fewer O 0 4.760523572566733e-12
than O 0 1.769379022638351e-12
100 O 0 5.664098096797021e-12
) O 0 7.122883690204376e-14
without O 0 3.820696363454612e-12
the O 0 1.4104010494231378e-11
florid O 0 7.814297653396807e-09
phenotype O 0 2.7737652175119365e-09
of O 0 6.367193439160701e-10
classical O 0 1.4685858751306569e-08
FAP B-Disease 0 1.5734971725578362e-07
. O 0 7.372452870413326e-09

Another O 0 3.6635285916020166e-09
group O 0 4.707649547963655e-11
of O 0 3.0023933339506925e-10
patients O 0 3.2320261050822197e-11
with O 0 2.072345767212269e-12
multiple O 0 1.0246598947105667e-07
adenomas B-Disease 1 0.9999979734420776
has O 0 1.280186268104444e-07
no O 0 2.6614880965780685e-08
mutations O 0 6.541114871971843e-10
in O 0 3.638263024186017e-10
the O 0 3.2112106307380373e-09
APC B-Disease 0 3.7986565004644035e-09
gene O 0 3.5559274275120956e-11
, O 0 2.003008436196607e-12
and O 0 2.031778608205248e-12
their O 0 6.3426174035097205e-12
phenotype O 0 3.918862734320072e-10
probably O 0 1.5067179448546852e-10
results O 0 2.198491215466003e-11
from O 0 6.276168473817734e-11
variation O 0 3.1356253704650783e-10
at O 0 5.437396366492209e-11
a O 0 3.355431600973735e-12
locus O 0 2.9896314590605044e-11
, O 0 6.502382183040667e-13
or O 0 9.785713038501509e-12
loci O 0 6.204424196631919e-10
, O 0 4.228036323827844e-12
elsewhere O 0 1.6695025570334643e-11
in O 0 2.0841871631316344e-11
the O 0 4.1231640324213004e-10
genome O 0 3.885017196836316e-09
. O 0 6.144976527622248e-09

Recently O 0 1.2142970717832213e-07
, O 0 7.626169834518137e-11
however O 0 3.142017895862992e-11
, O 0 1.575721757934856e-12
a O 0 1.366574908789886e-11
missense O 0 1.3878742599615634e-09
variant O 0 1.6277069692094415e-09
of O 0 1.1729581217423402e-07
APC B-Disease 0 2.9386804101250164e-08
( O 0 1.3296866385736905e-10
I1307K O 0 3.142051809845725e-06
) O 0 5.987171262239466e-12
was O 0 9.331473094231768e-11
described O 0 2.4084699078857907e-12
that O 0 8.825735010441899e-14
confers O 0 7.221218414898978e-12
an O 0 1.4489056926903637e-13
increased O 0 6.889053216774244e-11
risk O 0 6.56989200820135e-08
of O 0 0.48896265029907227
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 8.773044868348734e-08
including O 0 2.940217860847305e-11
multiple O 0 4.4451295977410155e-09
adenomas B-Disease 0 1.55048710439587e-05
, O 0 4.115260354708994e-10
in O 0 7.927112299910277e-09
Ashkenazim O 0 2.1739277144661173e-05
. O 0 1.1402598687482168e-07

We O 0 4.8877247138534585e-08
have O 0 3.473573859102963e-11
studied O 0 6.76736236493447e-11
a O 0 1.7427458781638094e-11
set O 0 5.935982955174168e-11
of O 0 3.612646423331589e-12
164 O 0 1.3419904076883427e-10
patients O 0 5.669434106209126e-13
with O 0 7.55128761169982e-13
multiple O 0 1.4457204088103026e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9496954083442688
/ I-Disease 1 0.9999996423721313
or I-Disease 1 0.9987140893936157
carcinoma I-Disease 1 1.0
and O 0 9.260674005417968e-07
analyzed O 0 4.071542392125593e-08
codons O 0 1.1469694527477259e-07
1263 O 0 4.199056888865016e-07
- O 0 2.204129145866318e-08
1377 O 0 8.160938591572631e-08
( O 0 1.1845079084249477e-10
exon O 0 1.1420181245114236e-08
15G O 0 1.848309096885714e-07
) O 0 1.6362615472623188e-12
of O 0 5.605259659202666e-11
the O 0 2.7051461071181393e-10
APC B-Disease 0 4.788268892497172e-09
gene O 0 1.668331098270137e-11
for O 0 6.266934193810414e-11
germ O 0 4.2754047058224387e-07
- O 0 5.99058651573614e-08
line O 0 2.1568396846305404e-08
variants O 0 3.5245724117061172e-09
. O 0 8.053482325465211e-09

Three O 0 2.8973614618621468e-08
patients O 0 2.555315681274095e-10
with O 0 1.11346077757285e-12
the O 0 1.9311037213753934e-09
I1307K O 0 5.353988967726764e-07
allele O 0 6.004597707942594e-09
were O 0 3.2884020506607214e-10
detected O 0 1.1999046201083274e-10
, O 0 1.7168219428563558e-13
each O 0 3.549519890250902e-13
of O 0 8.74913613779782e-11
Ashkenazi O 0 5.513895118269829e-08
descent O 0 4.731904255095287e-07
. O 0 2.0106142528675264e-08

Four O 0 6.140877673033174e-08
patients O 0 3.3102274255014663e-09
had O 0 4.367808781324811e-09
a O 0 1.8332628748396473e-09
germ O 0 1.192888589685026e-06
- O 0 1.034766725638292e-07
line O 0 3.570837492361534e-08
E1317Q O 0 5.259971089799365e-07
missense O 0 7.559026293790794e-09
variant O 0 1.5895463834070256e-09
of O 0 4.948396536974542e-08
APC O 0 2.2271851030097878e-09
that O 0 3.832154645694308e-12
was O 0 6.80097991812012e-11
not O 0 2.4219120632607005e-12
present O 0 2.411177160710487e-12
in O 0 2.503065680073413e-12
controls O 0 2.378878760644909e-10
; O 0 5.806441698980036e-12
one O 0 3.669924086846521e-11
of O 0 3.9988293926151997e-11
these O 0 3.4146860686257163e-13
individuals O 0 2.091230183812187e-12
had O 0 3.96779553657467e-10
an O 0 9.48789571214581e-12
unusually O 0 2.689730382865463e-11
large O 0 3.817360490210309e-12
number O 0 1.5966306401993258e-11
of O 0 4.359918204244195e-09
metaplastic B-Disease 0 0.0006574935396201909
polyps I-Disease 0 9.586772648617625e-06
of I-Disease 0 5.541624403804235e-08
the I-Disease 0 4.4134008447827e-08
colorectum I-Disease 0 2.2044623619876802e-05
. O 0 1.4411212134746165e-07

There O 0 1.35086886121627e-09
is O 0 2.2616261294294837e-11
increasing O 0 1.2344420624588182e-11
evidence O 0 9.637527755013142e-12
that O 0 1.042633319091324e-12
there O 0 2.645035449347355e-12
exist O 0 4.522089647185368e-11
germ O 0 4.7916310919049465e-09
- O 0 1.1319242765317483e-10
line O 0 4.9448983102662325e-11
variants O 0 5.092432985714934e-12
of O 0 7.4522249482456e-11
the O 0 7.051991629536403e-11
APC B-Disease 0 2.07760766923748e-10
gene O 0 5.939986458432245e-13
that O 0 8.892021776014947e-14
predispose O 0 3.758640065854024e-10
to O 0 4.570684455917906e-11
the O 0 1.8062648599048714e-11
development O 0 1.3782291974351324e-10
of O 0 4.964159638909393e-10
multiple O 0 0.0018559896852821112
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 9.15576148230457e-09
but O 0 1.3772095963648923e-10
without O 0 9.871276018813546e-11
the O 0 1.5789364260498928e-10
florid O 0 2.6333206726292246e-09
phenotype O 0 1.660307891171442e-09
of O 0 5.168066530281124e-10
classical O 0 1.609372857203084e-09
FAP B-Disease 0 4.666548480969368e-09
, O 0 8.583996144104211e-13
and O 0 1.756228355017514e-13
possibly O 0 7.848806674037867e-12
with O 0 8.10898182911253e-14
importance O 0 7.149780767434777e-10
for O 0 1.3286366993270349e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.6630455255508423
in O 0 3.537400372621846e-10
the O 0 2.3888638289726316e-10
general O 0 1.887038164616328e-10
population O 0 1.3326983288632077e-13
. O 0 3.5666372199399943e-12
. O 0 3.791408575981592e-10

Genomic O 0 5.56009638330579e-09
structure O 0 5.259162549897667e-10
of O 0 3.6566034644636147e-09
the O 0 3.186593389159498e-08
human O 0 9.110121936828364e-06
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.848880128818564e-05
CLD B-Disease 1 0.999950647354126
) O 0 3.220485211841151e-09
gene O 0 3.435237871940444e-09
. O 0 4.824130428460194e-09

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 9.525694622425362e-06
CLD B-Disease 1 0.9999997615814209
) O 0 1.626927065290218e-10
is O 0 1.2328796837601796e-11
caused O 0 2.6680777032161984e-10
by O 0 2.739910208438001e-11
mutations O 0 3.263757319960092e-10
in O 0 2.989511416195967e-11
a O 0 1.1840718683320262e-10
gene O 0 5.646063477859897e-12
which O 0 4.010552306921156e-12
encodes O 0 3.719060129303564e-11
an O 0 4.960749519500318e-11
intestinal O 0 3.578972496143251e-07
anion O 0 4.649953950774943e-07
transporter O 0 1.8999018720933236e-05
. O 0 1.0341076972508745e-07

We O 0 1.6794954760257497e-08
report O 0 5.425131177627662e-11
here O 0 2.6498326102797343e-12
the O 0 2.45242476500096e-12
complete O 0 9.054500205163407e-12
genomic O 0 6.354729936708381e-11
organization O 0 3.09472170112457e-11
of O 0 1.3422105094029746e-10
the O 0 4.524024488361533e-10
human O 0 1.7316378331244664e-09
CLD B-Disease 0 0.00013287889305502176
gene O 0 1.1340767214207403e-10
which O 0 1.4110299300512663e-12
spans O 0 2.3614829536278137e-10
approximately O 0 2.3669111809399013e-11
39kb O 0 6.132462004870831e-08
, O 0 3.9750959468509706e-11
and O 0 1.272501409799176e-10
comprises O 0 2.986116631742419e-10
21 O 0 8.860186540005088e-08
exons O 0 6.004783585922269e-07
. O 0 2.471013793581278e-08

All O 0 1.0969097985480403e-07
exon O 0 9.247977317272671e-08
/ O 0 6.806880747944888e-08
intron O 0 2.0493549968136904e-08
boundaries O 0 2.24814833416076e-10
conform O 0 6.176909678190512e-11
to O 0 1.3518451635885498e-10
the O 0 2.89803292474744e-10
GT O 0 1.293207958497078e-07
/ O 0 1.358510985483008e-06
AG O 0 0.00014266319340094924
rule O 0 6.689077736155014e-07
. O 0 4.308024514898534e-08

An O 0 1.8255819078660807e-10
analysis O 0 4.6069724424224745e-11
of O 0 2.9295219028391273e-10
the O 0 1.2056428078111026e-09
putative O 0 1.5149342971199076e-06
promoter O 0 3.0587525543523952e-06
region O 0 6.10975448012141e-08
sequence O 0 4.1550922702526805e-09
shows O 0 1.0675389044978445e-10
a O 0 3.1883244933084143e-09
putative O 0 8.088057256827597e-06
TATA O 0 0.00018536020070314407
box O 0 7.769786591893535e-09
and O 0 4.731344205310961e-10
predicts O 0 1.7501735172231747e-08
multiple O 0 3.1253732934999334e-10
transcription O 0 3.369740753100814e-08
factor O 0 8.388104100198746e-10
binding O 0 1.3823032496418364e-08
sites O 0 1.2594779441599258e-08
. O 0 3.902767442554023e-09

The O 0 5.857767959582816e-08
genomic O 0 4.709863610230514e-09
structure O 0 6.064954649609433e-10
was O 0 1.0361442814854627e-09
determined O 0 5.999508528864439e-11
using O 0 2.2897599614990494e-12
DNA O 0 4.4586945247004905e-11
from O 0 1.6483968053385145e-12
several O 0 5.97249775135221e-14
sources O 0 2.993378548504788e-12
including O 0 2.5998366803034294e-14
multiple O 0 1.5774960547901284e-12
large O 0 1.2212088285057376e-10
- O 0 4.865380098806327e-09
insert O 0 3.684790472746613e-09
libaries O 0 9.961451752360517e-08
and O 0 5.95527308022703e-11
genomic O 0 1.789264986173933e-10
DNA O 0 3.71927488806989e-10
from O 0 9.051276395055652e-11
Finnish O 0 1.3162457435100805e-06
CLD B-Disease 1 0.9818865060806274
patients O 0 9.850595894533853e-09
and O 0 4.347642523772066e-10
controls O 0 1.7435904453577677e-07
. O 0 5.887596543630025e-08

Exon O 0 7.278688229916952e-08
- O 0 2.40816144803091e-09
specific O 0 4.483835525093127e-11
primers O 0 6.602484670104047e-10
developed O 0 6.4449331288463085e-12
in O 0 2.0034744262903414e-12
this O 0 5.673829028135513e-12
study O 0 2.9808328114860894e-12
will O 0 7.430416416702446e-13
facilitate O 0 8.779756435761676e-12
mutation O 0 2.265360468656219e-11
screening O 0 3.0532694428320184e-11
studies O 0 3.794870234025138e-12
of O 0 7.215738423438367e-12
patients O 0 2.6808737521588633e-12
with O 0 4.458690090313605e-13
the O 0 4.778087259182939e-09
disease O 0 4.117392791158636e-07
. O 0 1.3411652233230598e-08

Genomic O 0 1.5740907244321534e-08
sequencing O 0 1.54621682124656e-09
of O 0 2.17715312444966e-09
a O 0 6.336400293349698e-09
BAC O 0 0.0005092654610052705
clone O 0 6.232668965822086e-06
H O 1 1.0
_ O 0 3.959632621786113e-09
RG364P16 O 0 1.637072386984073e-06
revealed O 0 6.486399750649241e-10
the O 0 2.6577960318685534e-11
presence O 0 3.720931548989448e-12
of O 0 1.0872620165303104e-10
another O 0 1.6275726599790374e-10
, O 0 1.2902587852303693e-11
highly O 0 4.144593002131103e-11
homologous O 0 2.04077171828132e-10
gene O 0 1.3846319923960237e-10
3 O 0 3.558938388437127e-08
of O 0 5.800550706425156e-09
the O 0 2.0833436309430908e-08
CLD B-Disease 0 0.001699764165095985
gene O 0 6.44238329350344e-10
, O 0 2.0754548253620886e-12
with O 0 3.6964521206309456e-14
a O 0 8.85293921504271e-12
similar O 0 1.997331553621473e-12
genomic O 0 2.28346425101833e-10
structure O 0 3.1632696462224885e-10
, O 0 1.7132312278914097e-12
recently O 0 5.941904520495589e-12
identified O 0 4.5182850516578554e-12
as O 0 1.6393354772617497e-12
the O 0 5.080388887357401e-10
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 4.518164686828641e-08
( O 0 6.562484444749828e-10
PDS B-Disease 0 8.8970506340047e-07
) O 0 4.2708173803029936e-11
. O 0 3.096257972234895e-10
. O 0 5.0574970877903525e-09

The O 0 1.0004747252878587e-08
APCI1307K O 0 0.0002975283714476973
allele O 0 1.7922867812103505e-07
and O 0 1.9038572940388576e-09
cancer B-Disease 0 3.443257446633652e-05
risk O 0 2.136641263916772e-08
in O 0 1.1130791600921786e-11
a O 0 5.451435830527984e-11
community O 0 9.930397650015355e-12
- O 0 6.494121906897021e-11
based O 0 1.3708196903994274e-11
study O 0 1.3616208854871914e-11
of O 0 5.547685921758472e-11
Ashkenazi O 0 6.69388677820848e-09
Jews O 0 1.5530948749287177e-09
. O 0 2.7729927243314023e-09

Mutations O 0 3.2621176870861746e-08
in O 0 2.3057762643663438e-10
APC O 0 3.023704175930675e-09
are O 0 3.157598423182695e-13
classically O 0 3.4017938466135433e-10
associated O 0 2.355908801376927e-10
with O 0 8.37598546077345e-10
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.9875440787918706e-08
FAP B-Disease 0 7.1520211974984704e-09
) O 0 3.056202751809678e-13
, O 0 5.743026361545653e-14
a O 0 6.550797664733876e-12
highly O 0 6.671784902323452e-09
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 5.094020707474556e-06
by O 0 1.1586047676814815e-08
multiple O 0 1.3931347098150582e-07
intestinal O 1 0.9999867677688599
polyps B-Disease 0 2.43208364736347e-06
and O 0 1.7866595702908938e-10
, O 0 5.821076043063811e-13
without O 0 3.712920162296518e-12
surgical O 0 7.275492652780713e-09
intervention O 0 2.0636566233633857e-08
, O 0 9.268107982463025e-12
the O 0 1.392492510188248e-10
development O 0 1.1243046316167238e-07
of O 0 0.007858271710574627
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.1940187505388167e-06
CRC B-Disease 0 3.599859701353125e-05
) O 0 6.285420517393447e-10
. O 0 3.81972586893653e-09

APC B-Disease 0 1.932130771820084e-06
is O 0 3.140940563195471e-10
a O 0 3.483875188337038e-09
tumour O 1 1.0
- O 0 4.4607259042095393e-07
suppressor O 0 1.8768671949942473e-08
gene O 0 4.847202153546171e-11
, O 0 4.771359089078553e-12
and O 0 6.21927925825716e-11
somatic O 0 4.048256869282341e-06
loss O 0 2.0845674953307025e-05
occurs O 0 9.074423132915399e-07
in O 0 1.0993180694640614e-06
tumours B-Disease 1 1.0
. O 0 1.1159760106238537e-05

The O 0 1.9002413864654955e-06
germline O 0 6.052819571777945e-06
T O 0 3.0531342787298854e-08
- O 0 6.693194332108021e-10
to O 0 1.885196304618475e-10
- O 0 1.9933071859767892e-10
A O 0 1.0522523963274466e-09
transversion O 0 1.3426829426066433e-08
responsible O 0 1.198024873749759e-10
for O 0 1.1131130739361339e-11
the O 0 5.042353201645255e-10
APC O 0 4.811559595196968e-09
I1307K O 0 1.305434409459849e-07
allele O 0 9.707681325465956e-10
converts O 0 1.6935444713261916e-10
the O 0 3.6330535801987196e-11
wild O 0 9.23644841166471e-12
- O 0 8.283416487453454e-12
type O 0 3.095949538400866e-11
sequence O 0 1.6423782472907433e-11
to O 0 1.806781634028365e-11
a O 0 2.3465898668639795e-10
homopolymer O 0 7.384230684692739e-06
tract O 0 1.9173528471583268e-06
( O 0 6.597440371791663e-09
A8 O 0 5.101580427435692e-06
) O 0 1.1543855281404003e-11
that O 0 6.634036636005147e-12
is O 0 8.591522632217519e-11
genetically O 0 1.0657984716999636e-08
unstable O 0 6.283924449235201e-06
and O 0 1.090436452244603e-08
prone O 0 9.887954547593836e-06
to O 0 3.156051388941705e-05
somatic O 0 9.608225809643045e-05
mutation O 0 1.1752320460800547e-05
. O 0 2.5297600814155885e-07

The O 0 7.20076656079982e-08
I1307K O 0 2.4775840756774414e-06
allele O 0 1.3715069080433295e-08
was O 0 4.631028005519511e-09
found O 0 4.083903007434664e-11
in O 0 4.546027096430372e-11
6 O 0 3.1710177950117213e-07
. O 0 2.7477225827965412e-08

1 O 0 5.274063369142823e-06
% O 0 1.1514580400273644e-08
of O 0 3.3791425213536286e-09
unselected O 0 1.7138827388407663e-05
Ashkenazi O 0 2.6320273605051625e-07
Jews O 0 4.719987178880558e-10
and O 0 1.3248070175608806e-12
higher O 0 7.445888350332552e-11
proportions O 0 1.6133458458078564e-10
of O 0 5.431964947288925e-11
Ashkenazim O 0 9.946430346019497e-09
with O 0 5.836339983349148e-13
family O 0 2.2793161455481048e-11
or O 0 9.038923776127916e-11
personal O 0 1.9661214878397004e-09
histories O 0 2.233644025295689e-08
of O 0 5.2455311561061535e-06
CRC B-Disease 0 9.922404569806531e-05
( O 0 3.447742757956007e-09
ref O 0 3.5241148452769266e-06
. O 0 1.940807736744432e-09
2 O 0 6.417553777282592e-08
) O 0 9.99941518475822e-11
. O 0 3.4015879002424754e-09

To O 0 6.789102169335592e-09
evaluate O 0 8.047213451156665e-10
the O 0 4.430811620381725e-11
role O 0 1.4072175369417295e-10
of O 0 6.066193103393402e-10
I1307K O 0 1.7654423572821543e-05
in O 0 6.7935448377909324e-09
cancer B-Disease 0 1.2045067705912516e-05
, O 0 6.389566098441435e-10
we O 0 2.414747735102196e-09
genotyped O 0 1.3090414086036617e-06
5 O 0 2.5289085670010536e-07
, O 0 3.0416341667560687e-10
081 O 0 9.133236176239734e-07
Ashkenazi O 0 2.1676738626297265e-08
volunteers O 0 7.213110317372262e-12
in O 0 1.6236271225059107e-12
a O 0 1.0563703384258716e-10
community O 0 2.613220473346445e-10
survey O 0 3.8527692147738435e-09
. O 0 1.4774781398330106e-08

Risk O 0 2.545371899032034e-06
of O 0 9.187199623283959e-08
developing O 0 0.00016818319272715598
colorectal B-Disease 1 1.0
, I-Disease 1 0.9721567034721375
breast I-Disease 1 1.0
and I-Disease 0 0.00308908405713737
other I-Disease 0 5.241765848040814e-06
cancers I-Disease 1 0.999998927116394
were O 0 4.115829455031417e-08
compared O 0 9.132298250946747e-10
between O 0 2.5510851209276098e-09
genotyped O 0 2.3273678095847572e-07
I1307K O 0 2.3717410257972915e-08
carriers O 0 3.055085264630497e-12
and O 0 4.1021218540049365e-12
non O 0 2.8023293754952938e-11
- O 0 6.271306824540135e-12
carriers O 0 2.5286988215161843e-13
and O 0 3.6560939822502525e-13
their O 0 1.7751213910247032e-13
first O 0 3.1024028832038475e-12
- O 0 5.63519994556394e-11
degree O 0 6.2797913535916905e-09
relatives O 0 7.87028109350274e-10
. O 0 7.758290121451239e-10

Sperm O 0 1.3018944144960187e-08
DNA O 0 4.0358641428817066e-10
analysis O 0 5.643630094503971e-12
in O 0 3.213761071499399e-12
a O 0 3.205874454792479e-09
Friedreich B-Disease 1 0.9984879493713379
ataxia I-Disease 1 0.9999939203262329
premutation O 0 0.010835270397365093
carrier O 0 7.51317656977335e-07
suggests O 0 3.6027376637548514e-08
both O 0 3.85178305917222e-10
meiotic O 0 7.918003319673517e-08
and O 0 8.501111814496198e-09
mitotic O 0 8.954475561040454e-08
expansion O 0 5.1235517162240285e-08
in O 0 1.656461523502628e-09
the O 0 1.5681335341355407e-08
FRDA B-Disease 0 0.00012048350617988035
gene O 0 1.2903740298497723e-08
. O 0 1.0469157984971389e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 2.1391292648331728e-07
usually O 0 4.688457955204228e-10
caused O 0 2.789616870835232e-10
by O 0 3.663996460834956e-13
an O 0 1.0492606132908588e-12
expansion O 0 7.153845849039442e-10
of O 0 8.223353109571008e-10
a O 0 6.071881841762661e-08
GAA O 1 0.9987930059432983
trinucleotide O 0 0.00572826387360692
repeat O 0 8.641958260113825e-08
in O 0 7.375613453319829e-10
intron O 0 9.496893227378678e-08
1 O 0 2.440110051793454e-07
of O 0 4.7356527588249264e-09
the O 0 1.0846533449182516e-08
FRDA B-Disease 0 0.0003235721669625491
gene O 0 2.0456411675695563e-08
. O 0 2.072476235071008e-08

Occasionally O 0 9.815827439751956e-08
, O 0 1.9619696145500853e-10
a O 0 2.335903692696206e-10
fully O 0 2.3462362608306364e-10
expanded O 0 7.007984470508433e-11
allele O 0 2.8651785388689177e-09
has O 0 2.836530489658262e-11
been O 0 7.374115207348098e-12
found O 0 1.4114632856596088e-12
to O 0 1.3670180439018242e-11
arise O 0 1.1069947736253027e-10
from O 0 5.233622910050251e-11
a O 0 2.7565910665217075e-10
premutation O 0 2.2001353272571578e-07
of O 0 6.957515008565451e-09
100 O 0 5.820030013481414e-10
or O 0 1.685526856975983e-10
less O 0 8.101427084739043e-09
triplet O 0 6.571886387973791e-06
repeats O 0 3.0420255825447384e-06
. O 0 4.6166022116267413e-08

We O 0 1.3103975504691334e-07
have O 0 7.847478222799964e-11
examined O 0 6.707674415906695e-10
the O 0 6.155739112889691e-11
sperm O 0 2.765975122553943e-11
DNA O 0 4.2313708092933666e-11
of O 0 2.3166414966913074e-11
a O 0 1.3092439632433894e-10
premutation O 0 2.084913603539462e-06
carrier O 0 2.9961725545035733e-07
. O 0 3.022524310836161e-07

This O 0 1.0457383403661424e-08
mans O 0 6.238861374185944e-07
leucocyte O 0 2.797324896164355e-07
DNA O 0 4.177238999147903e-09
showed O 0 3.583672941731564e-11
one O 0 1.1590754397938774e-12
normal O 0 2.0376162562785183e-11
allele O 0 2.1889847573453025e-11
and O 0 1.2094804324735975e-12
one O 0 3.106920970497029e-12
allele O 0 3.205885001911213e-10
of O 0 3.6416095139379934e-10
approximately O 0 2.0977040937619762e-10
100 O 0 9.308935844387634e-10
repeats O 0 1.3138881982399653e-08
. O 0 5.3093480723021e-09

His O 0 7.554603485004918e-07
sperm O 0 7.056560225038311e-09
showed O 0 1.9799982833856866e-11
an O 0 4.846087723817116e-13
expanded O 0 3.2764279570690613e-12
allele O 0 3.307455143097826e-10
in O 0 4.234454800688958e-11
a O 0 1.4840892959000485e-09
tight O 0 1.3777732732478398e-08
range O 0 1.2644315816601193e-08
centering O 0 2.045496749758513e-08
on O 0 8.520977812231934e-10
a O 0 6.831935711604231e-11
size O 0 2.1294135899019295e-10
of O 0 5.472055031319201e-10
approximately O 0 3.760621591908375e-09
320 O 0 1.0251525139892692e-07
trinucleotide O 0 2.8557507903315127e-05
repeats O 0 6.029367227711191e-07
. O 0 5.842803929567708e-08

His O 0 1.57447448145831e-06
affected O 0 1.4184636256686645e-06
son O 0 4.915322278975509e-06
has O 0 5.498765887068657e-10
repeat O 0 1.8344592511709834e-09
sizes O 0 8.711756871448983e-10
of O 0 4.5579962026920384e-09
1040 O 0 1.7999914803112915e-07
and O 0 4.45844383634153e-09
540 O 0 1.6068929653556552e-07
. O 0 2.982505264981228e-08

These O 0 2.390139752783682e-10
data O 0 7.344991281854618e-11
suggest O 0 4.19860222977686e-11
that O 0 6.383124822977038e-13
expansion O 0 9.954201352080361e-11
occurs O 0 4.205500964832298e-12
in O 0 1.2917602100828707e-12
two O 0 6.92263466602755e-13
stages O 0 2.7057587073664457e-11
, O 0 7.187041218235934e-13
the O 0 1.733499802036853e-11
first O 0 4.2582017772963e-11
during O 0 5.983806505849287e-11
meiosis O 0 7.373144629563289e-12
followed O 0 1.5850088169039322e-12
by O 0 7.525492815713131e-13
a O 0 1.8979609550662246e-10
second O 0 1.5254159047017879e-09
mitotic O 0 8.34791880066632e-09
expansion O 0 1.0755253754268779e-07
. O 0 6.552458842179476e-08

We O 0 1.5552454613043665e-07
also O 0 1.6029721994215151e-10
show O 0 6.642016103786119e-11
that O 0 5.193662340474692e-13
in O 0 1.0254062139322673e-12
all O 0 9.44448512452123e-13
informative O 0 1.5543231632331178e-11
carrier O 0 1.9030829689903328e-10
father O 0 3.3793018383576623e-10
to O 0 5.471919028998684e-10
affected O 0 4.919256668678429e-10
child O 0 7.439305282908037e-10
transmissions O 0 1.0805017991444288e-10
, O 0 4.103121379987751e-13
with O 0 4.1859775330244445e-14
the O 0 1.00430280411401e-11
notable O 0 6.320248686388086e-13
exception O 0 2.0965630273539482e-11
of O 0 1.4247561463953673e-10
the O 0 8.851389760033967e-11
premutation O 0 2.154344080906867e-08
carrier O 0 5.049821671931909e-10
, O 0 1.7914152800058147e-11
the O 0 6.666270313537837e-11
expansion O 0 5.180313955577276e-10
size O 0 9.988955218531714e-10
decreases O 0 7.208582619711024e-09
. O 0 3.6522312951703384e-10
. O 0 1.808556504556691e-08

The O 0 4.176022372348598e-08
R496H O 0 9.98684572550701e-06
mutation O 0 1.020108086891014e-08
of O 0 8.062638334749295e-10
arylsulfatase O 0 3.5017828849959187e-06
A O 0 1.0526869687055296e-07
does O 0 2.3434856832871276e-10
not O 0 8.742467860756165e-10
cause O 0 1.7838943676906638e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.0379902732893243e-06

Deficiency B-Disease 1 0.9998075366020203
of I-Disease 0 1.2670393516600598e-05
arylsulfatase I-Disease 1 0.9999924898147583
A I-Disease 1 0.9998477697372437
( O 0 3.108403490159617e-08
ARSA O 0 0.0002222825714852661
) O 0 4.704579434355871e-11
enzyme O 0 3.3006047894801327e-10
activity O 0 5.604952613147418e-10
causes O 0 2.0229917652159202e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.2823874701316527e-07
MLD B-Disease 1 1.0
) O 0 2.120534414729036e-09
. O 0 4.571752754145564e-09

A O 0 1.25247311189014e-06
number O 0 2.2837356450366997e-09
of O 0 4.326310865110372e-09
ARSA O 0 2.237238732050173e-05
gene O 0 2.1693769003405805e-09
mutations O 0 4.9384936140484115e-09
responsible O 0 5.360336619020245e-09
for O 0 1.4120236535575259e-08
MLD B-Disease 1 1.0
have O 0 6.257160833911257e-08
been O 0 2.759564798893166e-09
identified O 0 8.790120853419126e-10
. O 0 7.736332130470203e-10

Recently O 0 2.0901023844999145e-07
, O 0 4.948165210905131e-10
the O 0 3.6957987781249813e-09
R496H O 0 6.625097739743069e-06
mutation O 0 1.928575876775085e-08
of O 0 1.3685905742022442e-08
ARSA O 0 1.991247154364828e-05
was O 0 1.1176584102656761e-09
proposed O 0 6.149144388123418e-11
to O 0 1.3942406257294593e-11
be O 0 5.195071803298923e-12
a O 0 5.150734352921127e-11
cause O 0 1.662958126757985e-08
of O 0 1.1435268731929682e-07
MLD B-Disease 1 1.0
( O 0 3.095303124922566e-09
Draghia O 0 1.6072500557129388e-06
et O 0 2.7308830752303948e-08
al O 0 1.0398351513174475e-08
. O 0 9.327623742838576e-12
, O 0 8.763561924751695e-12
1997 O 0 2.777999219549798e-10
) O 0 9.325405031512801e-11
. O 0 5.225100352390655e-09

We O 0 3.1859066496053856e-08
have O 0 3.222693986670855e-11
investigated O 0 4.31445074111636e-10
the O 0 1.3886970740006888e-10
R496H O 0 2.871427540185323e-08
mutation O 0 1.309637901597549e-11
and O 0 1.8964899095585963e-12
found O 0 1.4792854441392222e-12
this O 0 6.327296759450762e-12
mutation O 0 6.541611002885972e-11
at O 0 1.2654895187313997e-10
a O 0 1.2454866998856673e-11
relatively O 0 3.5211738039220286e-12
high O 0 9.725202414212486e-12
frequency O 0 1.1045602800463517e-11
in O 0 3.4877911106109827e-13
an O 0 4.455918056409103e-13
African O 0 9.734588352419693e-13
American O 0 4.558065079887652e-13
population O 0 1.3416299863601433e-13
( O 0 1.9475426046161592e-12
f O 0 6.898000837196605e-09
= O 0 4.42409137102473e-10
0 O 0 1.8964917136710113e-10
. O 0 4.437008052637914e-12
09 O 0 3.3497440932173106e-10
, O 0 1.8609697116644952e-11
n O 0 2.119386000032364e-09
= O 0 3.522254043986095e-09
61 O 0 1.5505255968051301e-09
subjects O 0 2.2396955123848983e-10
) O 0 6.39697739224232e-11
. O 0 3.0600237899136573e-09

The O 0 1.2612830460057012e-06
ARSA O 0 4.0178703784476966e-05
enzyme O 0 6.596923896040607e-09
activity O 0 5.585284457154671e-10
in O 0 1.6209606573669433e-11
subjects O 0 4.706177114677246e-11
with O 0 1.4681397102807997e-13
and O 0 6.171394992260382e-12
without O 0 1.0664399224813437e-10
the O 0 3.306023510507572e-10
R496H O 0 1.3748803873170345e-08
mutation O 0 3.229172831908933e-11
was O 0 1.1922553222465382e-10
determined O 0 6.735401125723683e-11
and O 0 2.838076778796661e-12
found O 0 4.907303296358689e-12
to O 0 2.2552862355418313e-10
be O 0 6.446562172968129e-10
normal O 0 4.386436813774708e-08
. O 0 1.7876123692417423e-08

It O 0 1.0625725854751522e-09
is O 0 1.9510273605027884e-11
therefore O 0 1.7977350164066763e-10
concluded O 0 3.646224433495604e-10
that O 0 9.764867733852434e-12
the O 0 2.876028859510882e-10
R496H O 0 1.5033227782623726e-06
mutation O 0 1.953603323556763e-08
of O 0 1.2728425424768375e-08
ARSA O 0 5.310353299137205e-05
does O 0 6.227849486117876e-11
not O 0 6.386635144350894e-12
negatively O 0 1.854449926952384e-11
influence O 0 7.90984153176133e-11
the O 0 2.216824987466559e-11
activity O 0 1.1602356575490802e-10
of O 0 8.395879130818074e-11
ARSA O 0 6.394692491085152e-07
and O 0 5.29897046380734e-12
is O 0 1.4422836839764197e-12
not O 0 9.365524848703455e-12
a O 0 3.109503210474429e-10
cause O 0 3.4915211699626525e-07
of O 0 3.112751755907084e-06
MLD B-Disease 1 1.0

Down O 0 1.528748043710948e-06
- O 0 1.8520102784691517e-08
regulation O 0 2.5299822237201397e-09
of O 0 4.1813281725922025e-09
transmembrane O 0 1.6638836086713127e-06
carbonic O 0 0.00019145449914503843
anhydrases O 0 0.0004408770182635635
in O 0 7.005335191934137e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999996423721313
lines O 0 2.0518746168818325e-07
by O 0 2.885205852010131e-09
wild O 0 6.8636420991197156e-09
- O 0 1.7403029017870608e-09
type O 0 6.761798232446381e-08
von B-Disease 1 0.9999985694885254
Hippel I-Disease 1 0.9993269443511963
- I-Disease 1 0.9705963730812073
Lindau I-Disease 0 0.33518216013908386
transgenes O 0 9.880520519800484e-05
. O 0 2.4884980120987166e-07

To O 0 2.3133384274842683e-07
discover O 0 5.995076879372618e-09
genes O 0 4.3511576286459075e-11
involved O 0 1.9603528869649445e-11
in O 0 5.469558486681514e-11
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 4.3880937994345004e-08
VHL B-Disease 0 9.22513208934106e-06
) O 0 1.7022300236035903e-10
- O 0 1.4169986073397922e-08
mediated O 0 9.414628038939554e-06
carcinogenesis O 1 0.986943244934082
, O 0 1.2809715510542219e-09
we O 0 7.152263226117839e-10
used O 0 1.0237218184272479e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 0.00020566509920172393
stably O 0 1.4468196241068654e-05
transfected O 0 1.390323660643844e-07
with O 0 1.3950811859897438e-11
wild O 0 2.4088411265665854e-09
- O 0 2.7634257104836024e-09
type O 0 4.901821881730939e-08
VHL O 0 4.475634705158882e-05
- O 0 1.0375221108915866e-06
expressing O 0 1.0100250413813683e-08
transgenes O 0 2.884233708755346e-06
. O 0 6.21129743194615e-08

Large O 0 4.466710734618573e-08
- O 0 6.222254000931571e-08
scale O 0 3.9841998500378395e-07
RNA O 0 7.951025793317967e-08
differential O 0 1.3910764096181083e-08
display O 0 3.9110648747398e-11
technology O 0 1.877330929600518e-10
applied O 0 2.7855920348152097e-10
to O 0 8.399130696501445e-11
these O 0 1.1637961644730965e-12
cell O 0 8.234791321060086e-11
lines O 0 1.09455240010492e-11
identified O 0 3.3733608354596933e-12
several O 0 2.2271041347915466e-13
differentially O 0 4.924664009919866e-10
expressed O 0 3.0552442520370704e-11
genes O 0 3.832332368114422e-11
, O 0 1.8889375740654968e-12
including O 0 1.2861255029722463e-12
an O 0 2.6682250853227174e-10
alpha O 0 2.2994724702130043e-07
carbonic O 0 2.164950728911208e-06
anhydrase O 0 6.37125651792303e-07
gene O 0 5.762393895381024e-10
, O 0 4.624526803165274e-11
termed O 0 5.031943572930686e-08
CA12 O 0 0.0030284507665783167
. O 0 1.6545746461815725e-07

The O 0 4.6002182330084906e-07
deduced O 0 7.55100373339701e-08
protein O 0 1.0030097863378273e-09
sequence O 0 3.224956759972919e-11
was O 0 5.949733067334151e-11
classified O 0 4.052745552346471e-12
as O 0 1.390386612266925e-12
a O 0 9.033201964214754e-11
one O 0 6.663514739990717e-10
- O 0 1.9376541615656606e-07
pass O 0 5.580108677349926e-07
transmembrane O 0 0.0005114392261020839
CA O 0 1.5236685612762813e-05
possessing O 0 4.525579910819033e-09
an O 0 3.065794007550693e-10
apparently O 0 1.8282310110251387e-09
intact O 0 8.275829466164453e-10
catalytic O 0 8.834982745398179e-10
domain O 0 2.0953347501517783e-08
in O 0 1.7420132003564959e-09
the O 0 2.16941113961866e-08
extracellular O 0 3.318141807540087e-06
CA O 0 0.00036701824865303934
module O 0 2.8887068310723407e-06
. O 0 1.7490190629132485e-08

Reintroduced O 0 7.505237135774223e-06
wild O 0 8.705054455049321e-08
- O 0 2.663915665834793e-08
type O 0 2.6478524262074643e-08
VHL B-Disease 0 2.7292330742056947e-06
strongly O 0 6.067780944363221e-09
inhibited O 0 3.1121512034104626e-09
the O 0 2.1656797188907007e-10
overexpression O 0 6.998397417135038e-10
of O 0 2.787792774405773e-10
the O 0 3.5415725907483875e-10
CA12 O 0 3.395721705601318e-06
gene O 0 9.596733130390334e-12
in O 0 3.973448740174357e-12
the O 0 2.8335037094429083e-10
parental O 0 2.4512241907359567e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.0009152857819572091
. O 0 2.4110640879371203e-06

Similar O 0 8.116178285000331e-10
results O 0 7.699603732369553e-10
were O 0 8.392869038642559e-11
obtained O 0 1.2050835329624476e-10
with O 0 4.638712157445379e-12
CA9 O 0 1.4069355529500172e-05
, O 0 1.4502267442484396e-10
encoding O 0 3.382281121844244e-10
another O 0 2.3783185199022228e-08
transmembrane O 0 1.8254291944685974e-06
CA O 0 3.474123104751925e-07
with O 0 8.971999358731164e-12
an O 0 2.351356886975964e-10
intact O 0 2.928685516323526e-09
catalytic O 0 7.281268032954813e-09
domain O 0 3.62729878133905e-07
. O 0 2.0078626761232954e-08

Although O 0 5.242317691056542e-10
both O 0 7.630549664350283e-11
domains O 0 7.734977991447067e-09
of O 0 7.159992154726069e-09
the O 0 5.645296674572364e-09
VHL B-Disease 0 1.51728087871561e-07
protein O 0 9.07233232982918e-10
contribute O 0 3.027267325705907e-11
to O 0 2.863887460513581e-10
regulation O 0 4.4148804612120784e-09
of O 0 2.3680919447599535e-09
CA12 O 0 0.00998377799987793
expression O 0 3.420662364472804e-10
, O 0 8.60980904626718e-12
the O 0 1.5816665685508546e-11
elongin O 0 8.946444141066934e-10
binding O 0 4.6583670254563e-09
domain O 0 9.721805582785237e-09
alone O 0 2.4156496247762504e-10
could O 0 1.2373563285095202e-10
effectively O 0 2.3601423038144276e-09
regulate O 0 2.5507459255891263e-08
CA9 O 0 0.00019180715025868267
expression O 0 5.10190290015089e-08
. O 0 6.671837837757266e-08

We O 0 1.3995853009873827e-07
mapped O 0 3.5809048881674244e-07
CA12 O 0 0.0005190139636397362
and O 0 4.901260908241056e-08
CA9 O 0 0.00021307457063812762
loci O 0 3.425614991670045e-08
to O 0 8.754068581140473e-09
chromosome O 0 3.3418533718077015e-08
bands O 0 1.4511330803657074e-08
15q22 O 0 1.3476857247951557e-06
and O 0 1.9809751616861604e-09
17q21 O 0 3.3161501050926745e-05
. O 0 9.566377201508658e-08

2 O 0 2.247157453894033e-06
respectively O 0 2.4205132120869166e-08
, O 0 6.061034452109482e-10
regions O 0 5.2148383389294395e-08
prone O 0 7.045386496429273e-07
to O 0 1.4307819640180242e-07
amplification O 0 3.2372383884649025e-07
in O 0 2.375198482340579e-09
some O 0 3.744186904963698e-10
human O 0 2.3464624021585223e-08
cancers B-Disease 0 0.000503373914398253
. O 0 1.1293101209730594e-07

Additional O 0 1.1846179859276162e-07
experiments O 0 1.2064508503328852e-08
are O 0 2.774978163921915e-12
needed O 0 4.3111909875381826e-11
to O 0 3.4717659302963e-11
define O 0 4.116437746226609e-10
the O 0 5.325397414712718e-11
role O 0 1.2152116812824687e-10
of O 0 4.5469747411708283e-10
CA O 0 4.993151492271863e-07
IX O 0 4.215987428324297e-05
and O 0 1.1998943172386589e-08
CA O 0 9.351687140224385e-07
XII O 0 8.902677564037731e-07
enzymes O 0 2.53298788194245e-11
in O 0 2.0286224956811427e-12
the O 0 1.1940844146796081e-11
regulation O 0 3.4164504558731323e-10
of O 0 9.362136066393134e-11
pH O 0 3.021543903969359e-08
in O 0 1.437144431237769e-10
the O 0 9.422026492345026e-10
extracellular O 0 1.9392397021533725e-08
microenvironment O 0 1.1413239064950176e-07
and O 0 3.12578296579602e-11
its O 0 4.3170741287346104e-11
potential O 0 2.4807583764996366e-10
impact O 0 8.765581149816626e-09
on O 0 1.4781976460653823e-06
cancer B-Disease 0 3.197601472493261e-05
cell O 0 1.7704514903016388e-06
growth O 0 1.0447335441199357e-08
. O 0 8.365548254118949e-09

A O 0 5.74163038891129e-07
gene O 0 5.246599266151009e-10
encoding O 0 6.827927112595944e-10
a O 0 2.4553115096637157e-09
transmembrane O 0 6.553265734510205e-07
protein O 0 4.772003681097203e-09
is O 0 8.218385824307339e-13
mutated O 0 3.844930884094877e-12
in O 0 2.0103905519486265e-13
patients O 0 5.0181317434727646e-12
with O 0 6.786592988972107e-12
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.8641968965530396
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.25260603427886963
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 9.167062109405322e-10
. O 0 5.268261382695982e-09

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.544192057030159e-07
WFS B-Disease 0 0.0015794293722137809
; O 0 2.439524138253546e-09
OMIM O 0 7.775973062962294e-05
222300 O 0 8.017162400619782e-08
) O 0 3.186196152835802e-13
is O 0 6.518363323063103e-13
an O 0 6.455122547599501e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9055824875831604
defined O 0 1.1000316109399666e-11
by O 0 9.58480148548213e-13
young O 0 6.908132399452427e-11
- O 0 1.2333288168520085e-07
onset O 1 1.0
non O 1 0.9999980926513672
- O 0 0.11524543911218643
immune O 0 2.4780756575637497e-06
insulin B-Disease 1 0.9999945163726807
- I-Disease 0 0.3009675443172455
dependent I-Disease 0 0.00010831901454366744
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 2.0162831049219676e-07
progressive O 1 0.9964025020599365
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999986886978149
. O 0 2.1892796212341636e-05

Linkage O 0 3.5013688375329366e-06
to O 0 3.1112744380834556e-08
markers O 0 5.821432225161516e-09
on O 0 1.9633381143080442e-08
chromosome O 0 8.473497246086481e-07
4p O 0 0.0010081863729283214
was O 0 7.54295292892948e-09
confirmed O 0 1.7802438689873412e-10
in O 0 1.3947566192273886e-11
five O 0 2.0832581493213098e-10
families O 0 8.693477188126408e-11
. O 0 1.2959384676491936e-08

On O 0 3.619730648551922e-08
the O 0 5.984331780117813e-11
basis O 0 5.454725560127827e-10
of O 0 1.5275813947113193e-10
meiotic O 0 9.407502147951163e-06
recombinants O 1 0.9518090486526489
and O 0 4.2179766523986473e-07
disease O 0 0.00043753787758760154
- O 0 8.744594026666164e-08
associated O 0 3.428020178830593e-08
haplotypes O 0 1.2901752199923067e-07
, O 0 4.0541026091744925e-10
the O 0 1.5456778967859464e-08
WFS B-Disease 0 1.8341664826948545e-06
gene O 0 1.5142026521530738e-10
was O 0 1.4013764593201472e-09
localized O 0 8.588074251747457e-09
to O 0 2.6819634513230994e-08
a O 0 1.8191279593793297e-07
BAC O 0 0.001836637849919498
/ O 0 1.1985836863459554e-05
P1 O 0 0.00012827834871131927
contig O 0 3.83507313017617e-06
of O 0 2.1616282097625117e-09
less O 0 1.8806207979782386e-10
than O 0 4.203505946098751e-11
250 O 0 1.544177452572626e-09
kb O 0 7.576769007755502e-07
. O 0 2.017382705332693e-08

Mutations O 0 1.111631675598801e-08
in O 0 2.8776571403543727e-11
a O 0 1.7530484008876357e-10
novel O 0 1.4970135131520124e-09
gene O 0 1.8990835293219988e-10
( O 0 5.145107950799144e-11
WFS1 O 0 1.323493506788509e-05
) O 0 4.6195550856831247e-11
encoding O 0 1.840233659899937e-10
a O 0 6.0132623325159784e-09
putative O 0 2.804954704060947e-07
transmembrane O 0 1.0024407259834334e-07
protein O 0 1.393266391147563e-09
were O 0 3.216845843520555e-12
found O 0 3.907330798432092e-14
in O 0 4.2250576003316845e-14
all O 0 6.41798829251021e-14
affected O 0 2.557345340267053e-13
individuals O 0 1.377105081443869e-13
in O 0 2.014711140974068e-11
six O 0 1.2765770662781506e-08
WFS B-Disease 0 9.467426571063697e-05
families O 0 8.21391288319262e-11
, O 0 1.367310084599005e-11
and O 0 1.3153205954963276e-11
these O 0 6.201223996110672e-12
mutations O 0 4.213877510816921e-11
were O 0 4.197166919572837e-12
associated O 0 4.907303296358689e-12
with O 0 1.2083182761649103e-12
the O 0 1.1708223279782715e-09
disease O 0 5.9038459454541226e-08
phenotype O 0 1.499973052432324e-07
. O 0 1.0067019218240603e-07

WFS1 O 0 0.18820855021476746
appears O 0 1.0522730242712441e-08
to O 0 4.0962308545111625e-10
function O 0 4.295874073134698e-11
in O 0 1.1286813497712878e-11
survival O 0 5.288255167101852e-09
of O 0 1.1359867491123055e-09
islet O 0 5.924301831328194e-07
beta O 0 4.500122031458886e-06
- O 0 1.4933986847154301e-07
cells O 0 1.2898264400984516e-10
and O 0 1.1190523334370095e-11
neurons O 0 3.261566849932507e-10
. O 0 4.912749651531101e-10
. O 0 3.281492633178118e-09

Stable O 0 2.2332685603032587e-06
interaction O 0 3.2875633326767684e-09
between O 0 4.3474455146963464e-09
the O 0 6.201029134622615e-10
products O 0 7.852599126501048e-11
of O 0 1.76705039489633e-10
the O 0 2.779435848143663e-10
BRCA1 O 0 2.361790540916786e-09
and O 0 6.078191283620527e-10
BRCA2 O 0 5.366006305962401e-08
tumor B-Disease 0 9.948954584615421e-07
suppressor O 0 1.4658971281278355e-07
genes O 0 6.685131337391681e-10
in O 0 1.6024617743859437e-10
mitotic O 0 2.7435747895765417e-08
and O 0 9.651284216261047e-09
meiotic O 0 2.4607345039839856e-05
cells O 0 2.8401839244907023e-06
. O 0 4.6972795075816975e-07

BRCA1 O 0 5.080694904791017e-07
and O 0 1.093676926799958e-09
BRCA2 O 0 3.073406862341699e-09
account O 0 2.849195705756369e-12
for O 0 3.8012212193010153e-13
most O 0 1.3046825447261823e-13
cases O 0 7.528047738132593e-13
of O 0 4.104260334369947e-11
familial O 0 5.030655003679385e-09
, O 0 1.1352735418412863e-10
early O 0 1.9921050409266172e-07
onset O 1 0.9753745198249817
breast B-Disease 0 0.0033485612366348505
and I-Disease 0 6.3839106587693095e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.3155734279735043e-08
encode O 0 3.6606544184802914e-11
products O 0 5.463612201550561e-12
that O 0 1.922016284192432e-13
each O 0 2.1675360345561195e-13
interact O 0 3.2142189842869484e-13
with O 0 2.3340652869664746e-13
hRAD51 O 0 6.571997346327407e-08
. O 0 2.549802147200353e-08

Results O 0 4.661584451781664e-09
presented O 0 4.0615560914503135e-10
here O 0 1.1341372979645215e-10
show O 0 5.747426406327305e-12
that O 0 2.6030881009747597e-13
BRCA1 O 0 1.286568351854811e-10
and O 0 8.833006548414346e-11
BRCA2 O 0 3.331435038944619e-08
coexist O 0 1.3161550738161054e-09
in O 0 1.8586673866671788e-11
a O 0 3.163486972379559e-10
biochemical O 0 5.5012443489488305e-09
complex O 0 6.048354039833725e-10
and O 0 4.282269677746697e-11
colocalize O 0 4.0175126514441217e-07
in O 0 1.1975183067391981e-09
subnuclear O 0 4.514754891715711e-06
foci O 0 3.030718573882041e-07
in O 0 5.875083197715014e-10
somatic O 0 7.029612447695399e-09
cells O 0 1.4728736286162558e-10
and O 0 2.9379125000839057e-12
on O 0 1.650147379850253e-10
the O 0 5.376383799965412e-12
axial O 0 5.486328405468477e-11
elements O 0 1.2638316608526434e-11
of O 0 9.679645973648121e-11
developing O 0 7.871842622186875e-10
synaptonemal O 0 1.3801530940327211e-06
complexes O 0 1.3839203560905844e-08
. O 0 1.5704083367040766e-08

Like O 0 1.4614819576763693e-07
BRCA1 O 0 7.491368592127401e-07
and O 0 1.1564896595928076e-08
RAD51 O 0 5.2713920013047755e-05
, O 0 9.330253902817276e-09
BRCA2 O 0 1.1438999081292422e-07
relocates O 0 2.200575366373414e-08
to O 0 8.83123085770876e-09
PCNA O 0 1.0735354294411081e-07
+ O 0 8.965952980055647e-10
replication O 0 4.1239955894667446e-11
sites O 0 4.130874028257514e-12
following O 0 6.482683313768778e-12
exposure O 0 1.4555731064902488e-09
of O 0 1.6893866305878191e-09
S O 0 8.411028034061019e-07
phase O 0 4.812782776753011e-07
cells O 0 8.458215239315336e-10
to O 0 4.781515183793772e-09
hydroxyurea O 0 8.58611315379676e-08
or O 0 3.024790373729047e-08
UV O 0 0.0001468079281039536
irradiation O 0 6.813777986280911e-07
. O 0 5.321625806686825e-09

Thus O 0 3.431618367244482e-08
, O 0 3.665162340293904e-10
BRCA1 O 0 1.0021721230657477e-09
and O 0 6.433636956515443e-11
BRCA2 O 0 7.186613526499741e-10
participate O 0 7.11158631983011e-11
, O 0 2.0748175313251016e-12
together O 0 2.877555236192181e-13
, O 0 3.6099996689881175e-13
in O 0 2.981128364998309e-12
a O 0 3.3287134160175924e-10
pathway O 0 3.50474960164604e-09
( O 0 1.6337861619142302e-11
s O 0 6.650424655418874e-10
) O 0 2.3163960441614784e-13
associated O 0 1.7333832936713978e-12
with O 0 5.985258810922364e-14
the O 0 1.89320191468223e-11
activation O 0 1.1004015754156882e-10
of O 0 3.955011318446111e-10
double O 0 2.7043657244152364e-11
- O 0 2.0048613880163657e-09
strand O 0 3.2633047375441038e-09
break O 0 5.208970144110481e-09
repair O 0 7.2717472043848375e-09
and O 0 5.832988536624839e-10
/ O 0 1.999140977204661e-07
or O 0 4.847320766998564e-08
homologous O 0 3.165856554687707e-08
recombination O 0 2.5396095892915582e-08
. O 0 1.4977397100324197e-08

Dysfunction O 0 0.003473869990557432
of O 0 4.0729179318077513e-07
this O 0 4.503106776354571e-09
pathway O 0 5.007013115232439e-08
may O 0 2.1345088196955686e-10
be O 0 2.913270753107655e-12
a O 0 5.475380131930718e-12
general O 0 9.042079585075413e-11
phenomenon O 0 4.715458926107807e-11
in O 0 7.650591314981026e-14
the O 0 3.201663652079023e-13
majority O 0 4.558419275184876e-14
of O 0 6.178316864190181e-13
cases O 0 1.400775762744333e-12
of O 0 1.375335401121447e-10
hereditary B-Disease 1 0.8991537094116211
breast I-Disease 1 0.9942895174026489
and I-Disease 0 9.522848267806694e-05
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0855887921934482e-06
. O 0 6.079147851778544e-08

A O 0 6.414139619437265e-08
novel O 0 6.0322857819983255e-09
Arg362Ser O 0 6.709803983540041e-07
mutation O 0 5.415807802222616e-10
in O 0 1.8305881116509326e-11
the O 0 1.3561761436076125e-10
sterol O 0 2.233218054925601e-08
27 O 0 3.358589140134427e-07
- O 0 1.0383471504837871e-07
hydroxylase O 0 1.8372006138633878e-07
gene O 0 6.53566534225547e-10
( O 0 9.272710377317139e-11
CYP27 O 0 0.00023285928182303905
) O 0 7.740342394813027e-11
: O 0 7.1255813749449e-12
its O 0 5.370544287064405e-11
effects O 0 1.5475475345638756e-09
on O 0 1.345077116354787e-08
pre O 0 3.9176185850919865e-08
- O 0 2.3027448836643316e-09
mRNA O 0 3.584754992846939e-10
splicing O 0 1.5216860757560902e-11
and O 0 5.221065008283177e-13
enzyme O 0 7.105020564945885e-12
activity O 0 1.8082857433654453e-10
. O 0 4.2782141718156197e-10

A O 0 5.304482186829773e-08
novel O 0 1.166869711966001e-09
C O 0 5.984180262430527e-08
to O 0 9.316854232555016e-11
A O 0 2.452236413930109e-09
mutation O 0 6.110165151618219e-11
in O 0 9.386985980186502e-12
the O 0 1.3673211174403122e-10
sterol O 0 5.8122897605983326e-09
27 O 0 1.3969743406505586e-07
- O 0 1.1236529218194846e-07
hydroxylase O 0 1.417172086348728e-07
gene O 0 3.3148506162206104e-10
( O 0 2.755459575787267e-11
CYP27 O 0 1.6039935871958733e-05
) O 0 1.855408882089904e-11
was O 0 2.8143826158455454e-10
identified O 0 2.010276493880081e-12
by O 0 1.2223844983103027e-12
sequencing O 0 5.8505124356234e-11
amplified O 0 1.706398244927243e-09
CYP27 O 0 5.665725439030211e-06
gene O 0 3.099648315796344e-11
products O 0 3.3683331731454436e-12
from O 0 8.57650495761364e-12
a O 0 4.867305863909266e-11
patient O 0 1.4889539601270485e-10
with O 0 1.3072769429467446e-11
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 5.169540884253365e-08
CTX B-Disease 0 9.759033855516464e-05
) O 0 1.548406736162633e-09
. O 0 5.538050018571994e-09

The O 0 5.6217675847847204e-08
mutation O 0 3.5998994896146996e-09
changed O 0 1.8842255533613184e-10
the O 0 9.202585221634862e-11
adrenodoxin O 0 7.151830239138235e-09
cofactor O 0 5.295177074593482e-10
binding O 0 2.594072734396491e-09
residue O 0 6.763188231673212e-09
362Arg O 0 2.3756685507692055e-10
to O 0 2.7708660366165816e-10
362Ser O 0 5.376845635396421e-08
( O 0 4.6070008918874805e-10
CGT O 0 1.1031576150344335e-06
362Arg O 0 1.7969037813259092e-08
to O 0 2.77508815926808e-09
AGT O 0 1.0664415128758264e-07
362Ser O 0 1.1297895952111503e-09
) O 0 8.692108447935776e-13
, O 0 1.0793343757815876e-13
and O 0 1.4228340185738764e-13
was O 0 3.53112428186364e-10
responsible O 0 6.203146329930576e-10
for O 0 1.2107194136135035e-09
deficiency O 0 1.1668473234749399e-05
in O 0 8.258302841568366e-08
the O 0 1.0994029935318395e-06
sterol O 0 7.331410643018899e-07
27 O 0 6.609775937249651e-06
- O 0 3.799173100560438e-07
hydroxylase O 0 6.204524538588885e-08
activity O 0 2.443534796725544e-08
, O 0 7.543690498656996e-12
as O 0 1.456448460099291e-12
confirmed O 0 3.395897495497846e-12
by O 0 1.9734813284412456e-13
expression O 0 1.653107858934355e-11
of O 0 3.6683583948260434e-10
mutant O 0 1.5017888321811057e-10
cDNA O 0 7.828839243551045e-10
into O 0 4.36274433246453e-10
COS O 0 2.8329718588793185e-06
- O 0 3.0141939078021096e-07
1 O 0 4.3074822997368756e-07
cells O 0 1.064440757758689e-09
. O 0 1.5470575931431085e-09

Quantitative O 0 4.119630858667733e-08
analysis O 0 2.0807008893619638e-10
showed O 0 2.6548927986591586e-11
that O 0 2.930478938938802e-13
the O 0 5.332408126168531e-12
expression O 0 2.0065464914620357e-11
of O 0 2.8472535440471347e-10
CYP27 O 0 7.803895414326689e-07
gene O 0 8.535461400172029e-12
mRNA O 0 1.237290270239555e-10
in O 0 1.1133971349053251e-12
the O 0 9.31514327479066e-12
patient O 0 5.029393221334111e-11
represented O 0 1.5818482634877284e-10
52 O 0 3.6281048210184963e-07
. O 0 4.9362547827058734e-08

5 O 0 1.974503476276368e-07
% O 0 2.285932110268618e-09
of O 0 7.84893428029676e-10
the O 0 1.888191158982977e-09
normal O 0 8.179841159972057e-08
level O 0 4.268470661372703e-07
. O 0 4.633168870782356e-08

As O 0 2.3231261359057953e-09
the O 0 4.5003056836634414e-10
mutation O 0 7.974600840787716e-11
occurred O 0 5.629938182316607e-10
at O 0 2.1732759689085945e-11
the O 0 4.256689185161422e-12
penultimate O 0 8.668578077575262e-10
nucleotide O 0 7.027822074290313e-11
of O 0 1.636300678287128e-10
exon O 0 6.553478870685581e-10
6 O 0 1.1689129664205211e-08
( O 0 6.108903313761793e-12
- O 0 5.599121610799784e-09
2 O 0 1.3171904456044103e-08
position O 0 4.254146812598947e-09
of O 0 1.124590975898343e-09
exon O 0 1.5996042268540123e-09
6 O 0 2.5797652014603045e-08
- O 0 1.3679042787373419e-08
intron O 0 5.6908131540467366e-08
6 O 0 1.5853899526518944e-08
splice O 0 3.506019918830816e-09
site O 0 1.0855587262437183e-10
) O 0 1.1966031464305527e-12
of O 0 1.5893243665576762e-10
the O 0 1.2259492310207065e-09
gene O 0 2.1098059410640246e-10
, O 0 1.5982920542612078e-10
we O 0 1.4118289870523881e-09
hypothesized O 0 1.1067193383951235e-08
that O 0 6.423606785377345e-11
the O 0 5.182883566767771e-10
mutation O 0 4.477445636474897e-10
may O 0 1.5312110468457263e-09
partially O 0 3.852622221245383e-09
affect O 0 4.515095852752893e-09
the O 0 2.6914523942878077e-09
normal O 0 3.8414107450535084e-09
splicing O 0 1.173764418993528e-10
efficiency O 0 5.514391721028744e-11
in O 0 7.732901992352215e-12
exon O 0 4.131508468674383e-10
6 O 0 2.358180539729915e-09
and O 0 5.017901892612198e-12
cause O 0 1.6907236721763752e-10
alternative O 0 3.677269322377441e-10
splicing O 0 5.312452561190284e-11
elsewhere O 0 3.913824125900689e-12
, O 0 2.292702872442199e-14
which O 0 2.4278296997044986e-14
resulted O 0 3.321746089995914e-12
in O 0 2.2887293189138846e-12
decreased O 0 1.0482975598691269e-10
transcript O 0 7.690367787027697e-11
in O 0 1.3527729283979717e-11
the O 0 1.5369334971371273e-10
patient O 0 4.288886579217888e-09
. O 0 9.34845889588587e-09

Transfection O 0 7.085545348672895e-06
of O 0 2.195640824709244e-08
constructed O 0 3.4807936533098882e-09
minigenes O 0 3.186022752288409e-07
, O 0 1.4275218160331171e-11
with O 0 8.619034576762968e-14
or O 0 1.1443980485470462e-10
without O 0 9.484141250126754e-10
the O 0 1.6716453776766116e-09
mutation O 0 3.435059181544631e-10
, O 0 2.968341197839841e-11
into O 0 1.1556247070387826e-09
COS O 0 7.126625860109925e-06
- O 0 1.1827931984953466e-06
1 O 0 1.8207886114396388e-06
cells O 0 1.9934591477532848e-10
confirmed O 0 3.6997995812859674e-12
that O 0 6.436523406275207e-14
the O 0 2.92810567459334e-12
mutant O 0 4.209732215598727e-11
minigene O 0 1.0981822562428079e-08
was O 0 4.2493764063067374e-10
responsible O 0 1.246304726087999e-10
for O 0 3.864917066942475e-11
a O 0 3.299120976407721e-09
mRNA O 0 2.2969995683297384e-08
species O 0 2.5237385098408893e-11
alternatively O 0 6.460693091625558e-10
spliced O 0 1.0659082505526385e-08
at O 0 6.4657261766853935e-09
an O 0 4.275163556499706e-10
activated O 0 2.4342506321772817e-07
cryptic O 0 1.709634886992717e-07
5 O 0 1.9850104138185998e-07
splice O 0 7.646368516134316e-08
site O 0 1.036551999789026e-08
88 O 0 1.0281364204445254e-08
bp O 0 8.960896913379202e-09
upstream O 0 2.5984898677222645e-09
from O 0 7.456319589538296e-11
the O 0 1.0954928630901861e-10
3 O 0 6.149290854295941e-09
end O 0 1.9608792811709463e-08
of O 0 2.185224001749475e-09
exon O 0 1.5238347472745772e-08
6 O 0 1.8431374826377578e-07
. O 0 5.130149638432613e-09

Our O 0 6.838059363190041e-08
data O 0 2.631762863192222e-10
suggest O 0 1.0450115772719926e-10
that O 0 3.8964990088652396e-12
the O 0 6.828118626067692e-11
C O 0 1.1831926549632499e-08
to O 0 6.554699838456912e-11
A O 0 3.8392573564749455e-09
mutation O 0 1.4390948155362793e-10
at O 0 9.658290833769456e-11
the O 0 1.657249858177945e-11
penultimate O 0 2.1366808322653696e-09
nucleotide O 0 2.855896075182329e-10
of O 0 1.1030218405316816e-10
exon O 0 1.3439479529253617e-09
6 O 0 1.1439082570063874e-08
of O 0 1.1626635765260573e-10
the O 0 1.5831642941055435e-10
CYP27 O 0 1.0086728252645116e-06
gene O 0 5.778600254552346e-12
not O 0 2.121457740381083e-12
only O 0 6.632012647389551e-12
causes O 0 2.1265815774995644e-09
the O 0 2.249427533129733e-09
deficiency B-Disease 0 2.995446948261815e-07
in I-Disease 0 2.4199946491165747e-09
the I-Disease 0 1.0796336269436324e-08
sterol I-Disease 0 3.236343104617845e-08
27 I-Disease 0 1.4523881475270173e-07
- I-Disease 0 1.937442917210319e-08
hydroxylase I-Disease 0 1.6590613327593928e-08
activity I-Disease 0 4.221056837394599e-09
, O 0 3.390053645788149e-12
but O 0 6.0891274661356576e-12
also O 0 7.212119790267479e-12
partially O 0 4.4089371042943526e-10
leads O 0 5.634949971911052e-12
to O 0 4.2857099813442545e-11
alternative O 0 2.6976595957073357e-10
pre O 0 8.888754621239059e-09
- O 0 3.9982747668254603e-10
mRNA O 0 1.5042370127282823e-10
splicing O 0 3.50604996424142e-11
of O 0 1.5123603758215864e-11
the O 0 3.0555533797604895e-11
gene O 0 5.563814686748714e-11
. O 0 1.0713538944884249e-09

To O 0 6.738954727580904e-09
our O 0 2.2493835960535336e-10
knowledge O 0 4.1516977355993134e-11
, O 0 4.2648298629634207e-13
this O 0 4.238660475126138e-13
is O 0 1.2306283379490135e-12
the O 0 6.841751557656872e-12
first O 0 4.252941748772443e-11
report O 0 1.5341738296426044e-11
regarding O 0 7.039547417209135e-11
effects O 0 2.5346915677459947e-09
on O 0 5.039567430031866e-09
pre O 0 5.983938233811159e-09
- O 0 3.301278417300324e-10
mRNA O 0 8.502043513658464e-11
splicing O 0 1.0077951494158466e-11
of O 0 1.0970097443288584e-12
a O 0 1.103300610594271e-12
mutation O 0 2.398590657690103e-12
at O 0 2.7476241767909748e-11
the O 0 1.0857113819096043e-11
- O 0 2.859504300012361e-10
2 O 0 9.579447457497281e-09
position O 0 1.0221296697920934e-08
of O 0 1.8310962746070913e-09
a O 0 4.679026055498525e-09
5 O 0 1.6585289586146246e-07
splice O 0 1.619990257495374e-07
site O 0 1.2926946624247648e-08
. O 0 4.711103507304415e-09

ATM O 0 0.00024409477191511542
germline O 0 1.0338427273381967e-05
mutations O 0 1.519997283594421e-08
in O 0 3.888979416277749e-11
classical O 0 5.5560994951520115e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 1.987149971682811e-06
in O 0 6.290825499410957e-11
the O 0 2.9002891754892346e-10
Dutch O 0 4.116424090483406e-09
population O 0 9.63802475328901e-12
. O 0 5.713429729325981e-10

Germline O 0 0.00013286038301885128
mutations O 0 2.5782744828006798e-08
in O 0 9.658732841311135e-11
the O 0 1.1089686807741472e-10
ATM O 0 1.0463129918036884e-08
gene O 0 1.6133433835847227e-13
are O 0 4.656911440434482e-16
responsible O 0 6.965172254062846e-14
for O 0 1.8817301774935735e-13
the O 0 1.5128991392998614e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.269752942789637e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.106125300358144e-09
. O 0 2.171273827400455e-08

In O 0 3.364615963619144e-08
our O 0 3.29203087012786e-09
study O 0 1.6298902505429425e-10
, O 0 1.0798873947837073e-11
we O 0 1.1579137822181895e-11
have O 0 6.519880121902411e-13
determined O 0 4.043474582937634e-11
the O 0 9.248294838282156e-12
ATM O 0 4.7793453639144445e-09
mutation O 0 3.4840578339023764e-11
spectrum O 0 6.128516027992248e-10
in O 0 1.1165685563641059e-11
19 O 0 1.1472440775150972e-09
classical O 0 3.956312610853274e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.012000675070794e-09
, O 0 4.2681499610661144e-13
including O 0 2.90599250392376e-14
some O 0 1.8043277646723893e-13
immigrant O 0 6.924754519799237e-11
populations O 0 1.182953366339612e-12
, O 0 1.9100839616578713e-13
as O 0 1.4683615651503445e-12
well O 0 1.0205381461778074e-12
as O 0 6.551946919036711e-12
12 O 0 1.589512271804594e-10
of O 0 2.6633121055774645e-11
Dutch O 0 1.1217247131156682e-09
ethnic O 0 1.9639802284476815e-10
origin O 0 9.387066679522604e-10
. O 0 2.0161201597090894e-09

Both O 0 1.593988940840063e-08
the O 0 1.3677033727788057e-08
protein O 0 1.181104103409325e-09
truncation O 0 3.121414593465488e-08
test O 0 1.096585222626345e-08
( O 0 1.4650089474876893e-10
PTT O 0 2.7084979592473246e-07
) O 0 2.4808031063444647e-12
and O 0 1.0606453866232601e-12
the O 0 4.215482997393938e-12
restriction O 0 2.3502212329051808e-11
endonuclease O 0 1.5497628735872127e-09
fingerprinting O 0 1.9825476815782395e-09
( O 0 2.5011772167293778e-11
REF O 0 2.8620773306897718e-08
) O 0 1.2253631269387721e-12
method O 0 3.4995225467460145e-11
were O 0 7.376306054678039e-13
used O 0 2.6939943873795225e-13
and O 0 2.607615187145973e-13
compared O 0 1.474463606765397e-11
for O 0 4.977257321570061e-12
their O 0 5.3179240525058624e-12
detection O 0 1.8702901727341015e-10
efficiency O 0 2.0998326341614693e-11
, O 0 4.4561901911543966e-13
identifying O 0 4.554686922758622e-12
76 O 0 2.327595755025058e-10
% O 0 2.507251567820945e-12
and O 0 3.289582419397502e-13
60 O 0 7.617985409158479e-11
% O 0 2.5742413409246545e-11
of O 0 3.171738219287512e-11
the O 0 3.264909176348141e-10
mutations O 0 6.270715613432287e-10
, O 0 1.6621573561970138e-10
respectively O 0 1.1650445053135172e-08
. O 0 2.2368244145809513e-08

Most O 0 2.8373356997235533e-08
patients O 0 1.8930088607760354e-09
were O 0 1.2935269522174053e-10
found O 0 7.019954929854411e-12
to O 0 1.1716327907862478e-10
be O 0 1.5821893795120445e-10
compound O 0 1.3553809630195701e-08
heterozygote O 0 8.773111659365895e-08
. O 0 1.741841337832284e-08

Seventeen O 0 6.721203931192576e-07
mutations O 0 2.1295933905207676e-09
were O 0 7.333190998881634e-11
distinct O 0 4.144519363119548e-12
, O 0 8.457110012294322e-12
of O 0 1.0983088744032088e-10
which O 0 2.013673776335434e-11
10 O 0 1.5293225574808389e-09
were O 0 3.404011794660988e-11
not O 0 2.3680907235146265e-10
reported O 0 1.4067431663988827e-09
previously O 0 2.956281219823609e-09
. O 0 5.165832206444065e-09

Mutations O 0 7.883958801357949e-07
are O 0 2.857687350643623e-11
small O 0 7.930159307001361e-11
deletions O 0 9.459756533658492e-09
or O 0 4.738447785257449e-07
point O 0 0.00012123063788749278
mutations O 0 3.1232609387643606e-08
frequently O 0 2.973192803068514e-10
affecting O 0 2.5010462589847293e-09
splice O 0 9.159310820905375e-08
sites O 0 8.776137150334762e-09
. O 0 5.437090777604681e-09

Moreover O 0 7.306535820816862e-08
, O 0 6.064387880755362e-10
a O 0 9.692792346527312e-09
16 O 0 2.4215941607508285e-07
. O 0 2.3584783903629614e-08

7 O 0 6.408840818039607e-06
- O 0 1.459912084555981e-07
kb O 0 1.449537592179695e-07
genomic O 0 2.2633026564022884e-09
deletion O 0 9.028094716256874e-09
of O 0 7.878677155126468e-10
the O 0 6.14065881476833e-11
3 O 0 2.3157471495949267e-09
end O 0 6.326726698091534e-09
of O 0 4.5619422128773124e-10
the O 0 2.0584887960861664e-10
gene O 0 5.920952096671872e-12
, O 0 6.270705526015274e-13
most O 0 2.664625247880692e-13
likely O 0 4.1395841615665674e-11
a O 0 5.433498442841689e-11
result O 0 2.6535881825218155e-10
of O 0 6.531066798487473e-10
recombination O 0 1.4973090475822737e-11
between O 0 1.5434550859616536e-10
two O 0 1.1687016805705941e-11
LINE O 0 1.0863054455967358e-08
elements O 0 9.027380232229376e-11
, O 0 1.0769090480478027e-11
was O 0 9.249115362486293e-10
identified O 0 5.794245083734495e-10
. O 0 1.1398544330631921e-09

The O 0 2.0286034185801327e-08
most O 0 1.046974226065478e-11
frequently O 0 1.0479971924992615e-11
found O 0 1.2947548849034929e-12
mutation O 0 2.8802637358493755e-12
, O 0 1.7624027508645473e-13
identified O 0 2.265959772249082e-12
in O 0 4.252191318238757e-13
three O 0 6.574350981149168e-13
unrelated O 0 1.0539989020452722e-11
Turkish O 0 2.8017814734937474e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 4.5559750416757083e-11
, O 0 6.6875728045590055e-12
was O 0 2.715309088685558e-10
previously O 0 2.8323879699976295e-12
described O 0 9.307354556118905e-14
to O 0 2.0704563009812244e-13
be O 0 8.598083047406044e-14
a O 0 7.503935623917601e-13
Turkish O 0 3.800844972090545e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 3.5019331789953867e-06
mutation O 0 2.7379188693998913e-08
. O 0 4.007560949759181e-09

The O 0 3.312627505636101e-09
presence O 0 1.1364369167932153e-10
of O 0 7.693936598940354e-10
a O 0 3.4957770012056244e-09
founder O 0 1.4275218518378097e-07
mutation O 0 5.828031390819888e-09
among O 0 4.067123699456887e-13
relatively O 0 5.700010775877562e-13
small O 0 2.333691237216967e-13
ethnic O 0 2.8185431419358586e-12
population O 0 4.6650952821884403e-14
groups O 0 5.39396272872944e-14
in O 0 1.5933991322561458e-12
Western O 0 3.4533960135973985e-09
Europe O 0 1.8930594869459583e-09
could O 0 2.616433736335466e-09
indicate O 0 4.690711707944217e-10
a O 0 1.622563750025563e-10
high O 0 3.947271398629937e-10
carrier O 0 4.727153998101974e-12
frequency O 0 5.165935040851721e-11
in O 0 1.3340189413194037e-12
such O 0 3.757819576344357e-12
communities O 0 1.643695318742644e-10
. O 0 1.1029072766177705e-08

In O 0 1.4919623314568753e-09
patients O 0 1.4707315920681197e-10
of O 0 2.7744409547558746e-10
Dutch O 0 4.824479926668346e-09
ethnic O 0 2.0695670177595105e-10
origin O 0 5.510606554404163e-11
, O 0 9.018387165521391e-13
however O 0 5.140622302834963e-12
, O 0 3.836206526053321e-12
no O 0 6.504261712558801e-11
significant O 0 3.91415622136293e-10
founder O 0 7.610978514094313e-09
effect O 0 9.369365727707191e-08
could O 0 9.113371390867542e-09
be O 0 1.1759340168282506e-09
identified O 0 4.029589550924584e-09
. O 0 4.332371794646406e-09

The O 0 2.58874095493411e-08
observed O 0 7.3740133998967394e-09
genetic O 0 6.581298839236638e-10
heterogeneity O 0 2.3269044469031996e-09
including O 0 1.0628729884068489e-12
the O 0 1.0612191680969829e-10
relative O 0 7.552324987614156e-09
high O 0 3.4001367055225273e-08
percentage O 0 1.1822407053330153e-08
of O 0 2.8342728164432174e-09
splice O 0 8.573218224228185e-08
- O 0 9.65837756439214e-08
site O 0 5.003039316164859e-09
mutations O 0 5.686326409737319e-10
had O 0 2.589533310004555e-10
no O 0 2.8616144176485392e-11
reflection O 0 6.594090273814857e-10
on O 0 1.632377610860658e-08
the O 0 1.3761389805466706e-09
phenotype O 0 1.4509620882563468e-07
. O 0 2.0418365664909288e-08

All O 0 4.047720769673191e-10
patients O 0 1.519096480551152e-11
manifested O 0 9.512034909731071e-11
classical O 0 3.263941295017503e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 1.3372589702242976e-09
increased O 0 2.901142659439415e-09
cellular O 0 6.47394138297841e-10
radioresistant O 0 3.102030277091217e-08
DNA O 0 1.7933522444835148e-09
synthesis O 0 1.2460534826175262e-09
. O 0 9.218998342497287e-10

Determination O 0 6.703830024434865e-08
of O 0 5.130433411437707e-09
the O 0 1.461325227491983e-10
genomic O 0 1.526847259736286e-10
structure O 0 3.0367520997831576e-11
of O 0 1.5761382476942032e-10
the O 0 1.5245978091105172e-10
COL4A4 O 0 1.6521618817932904e-05
gene O 0 6.948804379125484e-12
and O 0 4.5374812305924717e-13
of O 0 1.5626791527445505e-11
novel O 0 1.147791306443935e-09
mutations O 0 6.99333952525194e-07
causing O 0 2.371580012550112e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0023038554936647415

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 5.035308836554009e-10
a O 0 8.343521984421898e-10
progressive O 0 0.0002720588818192482
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 1.2692985364992637e-05
by O 0 2.2739533278581803e-07
glomerular B-Disease 1 0.9999709129333496
basement I-Disease 1 0.999991774559021
membrane I-Disease 0 0.0006340743857435882
abnormalities I-Disease 1 0.5796633362770081
and O 0 3.3307729907505745e-09
associated O 0 5.095044386393965e-09
with O 0 4.950588897156827e-11
mutations O 0 2.2867605586895934e-09
in O 0 3.114976332430075e-10
either O 0 4.0305483950398013e-10
the O 0 1.2484323574923906e-09
COL4A3 O 0 6.547420525748748e-06
or O 0 2.8739135515820635e-09
the O 0 3.1326261584752046e-09
COL4A4 O 0 1.0652187484083697e-05
gene O 0 7.338340352047723e-11
, O 0 1.5892559620742097e-12
which O 0 5.41538710575884e-13
encode O 0 1.0530023034083236e-11
the O 0 1.0263170868718419e-10
alpha3 O 0 1.475646769222294e-07
and O 0 2.36262703845469e-10
alpha4 O 0 7.968498607624497e-07
type O 0 2.7458767704047204e-07
IV O 0 0.262601763010025
collagen O 0 2.461620624671923e-06
chains O 0 5.352207210762572e-08
, O 0 2.8244009908640066e-10
respectively O 0 1.1200319782744828e-08
. O 0 1.2431651263966614e-08

To O 0 8.071570078982404e-08
date O 0 2.4016728161768697e-07
, O 0 6.233672605882035e-11
mutation O 0 4.8408457797854965e-11
screening O 0 1.7022690201873303e-10
in O 0 1.2129463232424254e-11
the O 0 7.503828808319568e-11
two O 0 2.148157346448798e-11
genes O 0 4.119262916879585e-11
has O 0 3.173406849799054e-12
been O 0 3.5178708904237688e-12
hampered O 0 4.413682752613113e-10
by O 0 4.115004777899278e-12
the O 0 1.675903305020654e-10
lack O 0 1.1153030721189339e-09
of O 0 5.949724601883588e-10
genomic O 0 6.595184398605625e-10
structure O 0 4.3892864343142435e-10
information O 0 1.330483223593859e-10
. O 0 3.899954581498832e-09

We O 0 1.542800376341802e-08
report O 0 4.5869984893753823e-11
here O 0 8.909857227012985e-12
the O 0 8.945787687009155e-12
complete O 0 2.542775712210954e-11
characterization O 0 6.508558691997735e-10
of O 0 2.2620152972940843e-10
the O 0 2.0223929475537972e-10
48 O 0 1.1127560206602993e-08
exons O 0 1.1528228149870756e-08
of O 0 2.767339246645406e-09
the O 0 3.3791873743638234e-09
COL4A4 O 0 0.0011570216156542301
gene O 0 5.461492369462917e-10
, O 0 1.0035713579603645e-11
a O 0 5.1170300635616783e-11
comprehensive O 0 6.023188614534547e-10
gene O 0 1.8583200950272882e-11
screen O 0 4.752889193326837e-10
, O 0 1.9230596282060475e-11
and O 0 9.676318774021198e-12
the O 0 3.641552337452225e-11
subsequent O 0 2.21092172347781e-11
detection O 0 2.9345997853980066e-10
of O 0 1.2840157756488502e-11
10 O 0 1.1362845560303203e-11
novel O 0 4.3256852093331855e-12
mutations O 0 2.7693416136675975e-12
in O 0 4.578192209017673e-13
eight O 0 3.2834741869880446e-11
patients O 0 5.69610435208201e-11
diagnosed O 0 1.2928076102980413e-06
with O 0 3.2097411395426434e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0010019438341259956

Furthermore O 0 1.4837792150501627e-07
, O 0 1.8627008824267932e-09
we O 0 6.691943665870781e-10
identified O 0 2.75747980005292e-10
a O 0 3.6940633885151897e-10
glycine O 0 2.514535024644715e-09
to O 0 6.568798838202383e-09
alanine O 0 1.1353375128919652e-08
substitution O 0 4.959817889726992e-09
in O 0 2.61623778197162e-10
the O 0 6.356696835574382e-10
collagenous O 0 6.400525620620101e-08
domain O 0 1.1412510936281706e-09
that O 0 4.771374810010054e-13
is O 0 7.131437909820015e-13
apparently O 0 1.738499795511661e-11
silent O 0 5.246136164371862e-11
in O 0 5.917099492672162e-13
the O 0 5.865234947027842e-12
heterozygous O 0 2.6776543222278848e-12
carriers O 0 5.020544310146979e-12
, O 0 5.495174627834221e-12
in O 0 1.2815819239175852e-10
11 O 0 6.76174636282667e-08
. O 0 1.988532183361258e-08

5 O 0 2.47982455903184e-07
% O 0 2.3630339907043663e-09
of O 0 1.6533735491819357e-10
all O 0 9.992126917546251e-12
control O 0 1.2155733364327403e-10
individuals O 0 9.407628755869757e-13
, O 0 2.4393622972268547e-12
and O 0 2.360183663091542e-12
in O 0 1.2758448811323042e-11
one O 0 1.123445000222878e-11
control O 0 4.261801328508952e-11
individual O 0 1.4370243276579098e-13
homozygous O 0 1.751108372888277e-12
for O 0 3.3592740134730237e-12
this O 0 8.674363310978705e-11
glycine O 0 2.1067439348598782e-08
substitution O 0 3.196497644353258e-08
. O 0 2.5463904762546008e-08

There O 0 1.1171517044772372e-08
has O 0 8.505644799594592e-11
been O 0 1.7016480238774e-11
no O 0 7.927765215132165e-12
previous O 0 4.9937484702944346e-11
finding O 0 2.7145362346825408e-11
of O 0 1.0103934182381646e-11
a O 0 2.5182474161500323e-11
glycine O 0 2.842348578724341e-10
substitution O 0 2.979818336523721e-10
that O 0 2.4500590358605967e-12
is O 0 5.404057735157453e-13
not O 0 1.6682539681275865e-12
associated O 0 2.4166239755846197e-12
with O 0 5.751905977338309e-14
any O 0 7.688182729337356e-11
obvious O 0 1.7814701103180397e-10
phenotype O 0 4.638487094421606e-10
in O 0 3.089861699834273e-11
homozygous O 0 7.165777693440845e-11
individuals O 0 3.7994565826870996e-11
. O 0 8.147853947093608e-09

Founder O 0 6.076949830458034e-06
BRCA1 O 0 1.225771484314464e-07
and O 0 8.663817441245669e-10
BRCA2 O 0 7.938914414751252e-09
mutations O 0 3.115057864433446e-11
in O 0 8.672004629152463e-13
French O 0 5.222377530422762e-10
Canadian O 0 1.510295106754711e-07
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4133583135844674e-05
. O 0 3.6246294143893465e-07

We O 0 4.9158264125992446e-09
have O 0 6.554471809055995e-12
identified O 0 1.2129046898790019e-11
four O 0 1.525983251435617e-13
mutations O 0 1.6612674235381986e-13
in O 0 9.262443514002766e-14
each O 0 1.0715607004149752e-12
of O 0 7.290408277071947e-10
the O 0 5.699916627577295e-08
breast B-Disease 1 0.9999734163284302
cancer I-Disease 1 0.9999996423721313
- O 1 0.9997264742851257
susceptibility O 1 0.9161874055862427
genes O 0 4.70307952582516e-08
, O 0 8.072020135641012e-11
BRCA1 O 0 6.149334930150019e-10
and O 0 1.17074155925323e-10
BRCA2 O 0 2.7886075670835453e-09
, O 0 2.791054876365856e-13
in O 0 1.82917618768777e-13
French O 0 2.2221262330202052e-10
Canadian O 0 7.972297488834101e-09
breast B-Disease 0 8.566661563236266e-05
cancer I-Disease 0 0.33970963954925537
and O 0 0.001040670438669622
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.143848677997994e-07
from O 0 2.70368403221255e-08
Quebec O 0 4.2174701775365975e-07
. O 0 3.271888360245612e-08

To O 0 4.266777580141934e-07
identify O 0 6.228891606951947e-07
founder O 0 6.7283558564668056e-06
effects O 0 4.2282434151275083e-05
, O 0 1.066945087835336e-09
we O 0 2.0294296798617495e-10
examined O 0 7.1482771091258e-11
independently O 0 1.8366629397914558e-11
ascertained O 0 3.9932826489952333e-10
French O 0 6.963136317539309e-11
Canadian O 0 3.491563427271416e-10
cancer B-Disease 0 2.0151282864588893e-09
families O 0 2.686297907207591e-13
for O 0 2.2070431419940473e-13
the O 0 1.1925752919916821e-11
distribution O 0 5.390638976865425e-11
of O 0 2.9185223682226535e-11
these O 0 8.084974530142564e-12
eight O 0 1.2789184156147826e-09
mutations O 0 9.555322755261386e-09
. O 0 3.7563648191962784e-08

Mutations O 0 2.2647768105343857e-07
were O 0 6.297792287668358e-10
found O 0 4.926350126444046e-12
in O 0 9.153460107935718e-12
41 O 0 2.089909578728566e-09
of O 0 4.2741526984357847e-10
97 O 0 2.206013505201554e-08
families O 0 4.3212694533778517e-10
. O 0 2.3099957502381585e-08

Six O 0 6.353539561132493e-08
of O 0 1.6709385874946747e-08
eight O 0 8.776857463033139e-09
mutations O 0 1.3592661440853249e-09
were O 0 7.788477085490797e-10
observed O 0 7.457233719421197e-10
at O 0 1.0192867661018568e-09
least O 0 3.197128395360238e-10
twice O 0 1.196304388884073e-08
. O 0 1.2535488203013756e-08

The O 0 7.214478614514519e-07
BRCA1 O 0 7.649474582649418e-07
C4446T O 0 1.5234651073114946e-05
mutation O 0 1.9880467050370498e-08
was O 0 6.292941723273771e-10
the O 0 1.7211385094917375e-11
most O 0 5.677918530309911e-13
common O 0 2.6354685794816035e-11
mutation O 0 4.07293671011999e-10
found O 0 2.5892010757644357e-11
, O 0 6.732722018787385e-13
followed O 0 1.460003125342002e-12
by O 0 3.901846293979938e-12
the O 0 8.688922359390006e-10
BRCA2 O 0 5.4470167043518813e-08
8765delAG O 0 3.619679205257853e-07
mutation O 0 6.500674203380186e-07
. O 0 5.2204512712705764e-08

Together O 0 9.9952304211115e-09
, O 0 3.5332467507309673e-10
these O 0 1.846473494937495e-11
mutations O 0 9.132955502977325e-11
were O 0 2.378877476949537e-11
found O 0 1.9132024523665914e-12
in O 0 2.9403341740563693e-12
28 O 0 1.4616323706917456e-09
of O 0 3.0888905322434823e-10
41 O 0 1.6275579772795368e-09
families O 0 2.1327078558036616e-12
identified O 0 1.5496550223592642e-11
to O 0 4.4235598517516905e-10
have O 0 1.3474328597329333e-10
a O 0 4.046919688249773e-09
mutation O 0 4.952758914100741e-08
. O 0 2.3786180136653456e-08

The O 0 3.231340528486726e-08
odds O 0 2.0572826997522498e-07
of O 0 1.2307381780374271e-09
detection O 0 6.0127347545346765e-09
of O 0 4.41513076099298e-10
any O 0 8.71850591721568e-10
of O 0 5.4671858151778e-09
the O 0 1.1908399821791704e-09
four O 0 1.21316443002506e-10
BRCA1 O 0 2.470889715056046e-09
mutations O 0 5.923469270641135e-09
was O 0 2.2125785648086094e-08
18 O 0 1.0592105326168166e-07
. O 0 9.970971603934231e-09

7x O 0 0.0007980052614584565
greater O 0 5.644459477593955e-08
if O 0 5.855463669490746e-09
one O 0 2.110867557136853e-11
or O 0 2.305105759048409e-12
more O 0 6.864606403927595e-14
cases O 0 1.55711537414005e-11
of O 0 5.996771079708196e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 2.7574195371471433e-08
also O 0 4.550605118419648e-12
present O 0 3.935164694102156e-12
in O 0 7.418157234317935e-12
the O 0 1.5636666961249546e-10
family O 0 1.7101184357493082e-10
. O 0 3.69470676275796e-09

The O 0 2.5896348176956963e-08
odds O 0 6.720281220395918e-08
of O 0 3.939855108825441e-10
detection O 0 1.7789211215202272e-09
of O 0 9.258960265157157e-11
any O 0 1.9137627593757145e-10
of O 0 2.786294972523251e-09
the O 0 5.891488408238388e-10
four O 0 1.690691336930783e-10
BRCA2 O 0 1.6512164080495495e-08
mutations O 0 1.0247025450382807e-08
was O 0 4.31801154832101e-08
5 O 0 2.1026897911724518e-07
. O 0 1.525731008200637e-08

3x O 0 5.0548649596748874e-05
greater O 0 4.1795598093585795e-08
if O 0 6.572471455967843e-09
there O 0 4.383327381618507e-11
were O 0 1.5738303021928246e-11
at O 0 4.740281951687297e-12
least O 0 3.1151676290613883e-13
five O 0 1.5925687147071849e-13
cases O 0 1.847687042429158e-13
of O 0 6.334194280199767e-11
breast B-Disease 0 2.671362835826585e-06
cancer I-Disease 0 2.5947083486244082e-06
in O 0 5.556523685612547e-09
the O 0 1.7415165132206312e-07
family O 0 9.524081079348434e-09
. O 0 3.201476417302729e-08

Interestingly O 0 4.4058143799929894e-08
, O 0 1.2051293296622134e-10
the O 0 8.03015987038691e-11
presence O 0 6.520583378799572e-11
of O 0 1.2214212974370753e-09
a O 0 3.4164798989877454e-08
breast B-Disease 0 1.8150716641684994e-05
cancer I-Disease 0 4.735104994324502e-06
case O 0 8.332921197506948e-08
< O 0 5.233384399616625e-06
36 O 0 1.7499466764547833e-08
years O 0 8.806209234046847e-11
of O 0 4.274378767599174e-11
age O 0 1.1771138230809441e-10
was O 0 1.3369872049751041e-11
strongly O 0 5.920655675797915e-13
predictive O 0 9.187116345454882e-11
of O 0 1.755962215910234e-11
the O 0 2.068491428489083e-12
presence O 0 6.174782365107878e-13
of O 0 8.091994088688104e-12
any O 0 6.197585500355984e-11
of O 0 1.2738661514521965e-10
the O 0 1.0540115308321774e-10
eight O 0 8.781268073798643e-11
mutations O 0 3.071436438517594e-10
screened O 0 5.84274539860985e-09
. O 0 2.5676631931759175e-09

Carriers O 0 4.6282352950122174e-10
of O 0 3.462106434870549e-10
the O 0 3.793207761781936e-11
same O 0 2.016433374441018e-11
mutation O 0 1.6742411276804425e-11
, O 0 9.41430161366559e-14
from O 0 5.089304086665358e-13
different O 0 5.5686046594206895e-14
families O 0 2.6342399398956995e-13
, O 0 3.268661654277222e-13
shared O 0 1.3444433283674173e-12
similar O 0 5.52665552211451e-12
haplotypes O 0 2.532362319840331e-09
, O 0 3.2538603755849493e-11
indicating O 0 2.7880639463795376e-10
that O 0 1.3580106657251623e-11
the O 0 1.6827836346600122e-10
mutant O 0 1.4787143731709307e-10
alleles O 0 2.2101036278865394e-11
were O 0 2.902543873653518e-12
likely O 0 6.8984904594282526e-12
to O 0 3.93157121442167e-12
be O 0 1.3274526877021797e-12
identical O 0 2.283839892376627e-13
by O 0 6.0230298396316e-13
descent O 0 6.336989266664261e-10
for O 0 7.544204518906972e-13
a O 0 1.7106068297967347e-11
mutation O 0 2.250815853144239e-11
in O 0 5.530377805013087e-12
the O 0 2.0621238050466673e-10
founder O 0 1.5979340517446872e-08
population O 0 1.9427204636657258e-11
. O 0 7.639787136248799e-10

The O 0 1.7494118376149004e-09
identification O 0 4.1060554956118267e-10
of O 0 6.972177279962466e-10
common O 0 3.388287872496676e-09
BRCA1 O 0 1.3384212138589646e-07
and O 0 4.257006480656855e-08
BRCA2 O 0 2.7074725039710756e-07
mutations O 0 5.888458609604186e-09
will O 0 2.9033483950335892e-11
facilitate O 0 1.57794229072028e-11
carrier O 0 3.0011076089520028e-12
detection O 0 1.514433717320074e-10
in O 0 4.629022859470311e-13
French O 0 3.049197005999815e-10
Canadian O 0 6.100924654361961e-09
breast B-Disease 0 4.594413894665195e-06
cancer I-Disease 0 4.88897567265667e-05
and O 0 6.450506589317229e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.1547224352834746e-06
. O 0 2.2872333715895365e-07

Are O 0 3.675665105618009e-09
Dp71 O 0 2.9843269658158533e-05
and O 0 1.4452716357027384e-08
Dp140 O 0 0.0019468683749437332
brain O 0 2.3924242213979596e-06
dystrophin O 0 3.5031607836799594e-08
isoforms O 0 1.456519488352015e-10
related O 0 2.7287287013288974e-11
to O 0 2.12681469657916e-11
cognitive B-Disease 0 1.1026069302033648e-07
impairment I-Disease 0 0.004123024642467499
in O 0 1.1882630133186467e-06
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9995166063308716

Molecular O 0 1.4847987586108502e-06
study O 0 1.3891560124434932e-09
and O 0 6.359374138398266e-11
neuropsychological O 0 8.579556509680231e-10
analysis O 0 3.3348122874254926e-11
were O 0 5.0514158828063316e-12
performed O 0 5.5372332695598214e-14
concurrently O 0 1.6527592825148901e-13
on O 0 1.6061513230525293e-11
49 O 0 3.860594621762914e-10
patients O 0 1.4030272169757163e-12
with O 0 4.097133222968896e-12
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.516379926324589e-06
DMD B-Disease 1 1.0
) O 0 7.137214430574801e-11
in O 0 1.7335792523720528e-11
order O 0 2.473509071176938e-11
to O 0 3.706469159370229e-11
find O 0 8.366939086013048e-12
a O 0 6.100543247650192e-12
molecular O 0 4.853048518604908e-11
explanation O 0 9.946187103093695e-12
for O 0 9.142148843510611e-13
the O 0 1.3355504202561264e-10
cognitive B-Disease 0 2.671523304798029e-07
impairment I-Disease 0 1.1968635590164922e-05
observed O 0 1.0781560533246193e-08
in O 0 1.2121144365995207e-10
most O 0 5.803447167274101e-10
DMD B-Disease 1 1.0
patients O 0 6.108565742124483e-08
. O 0 1.646882097361413e-08

Complete O 0 3.8336686714046664e-08
analysis O 0 4.109408924257707e-10
of O 0 3.4574492158157e-09
the O 0 2.999887671606416e-09
dystrophin O 0 4.357575633662236e-08
gene O 0 1.0634586544711055e-09
was O 0 4.525459118553954e-09
performed O 0 9.335277342814585e-12
to O 0 9.563991959504747e-11
define O 0 1.756225276317025e-09
the O 0 5.176442052778896e-10
localization O 0 8.492785497082878e-08
of O 0 1.2084729661410165e-08
deletions O 0 1.2791337766770994e-08
and O 0 3.7695960242167814e-10
duplications O 0 4.3269463567696675e-09
in O 0 5.031254579623834e-11
relation O 0 7.98839772109261e-10
to O 0 8.959115116446981e-10
the O 0 4.1416550744521885e-10
different O 0 8.027253861619954e-10
DMD B-Disease 1 1.0
promoters O 0 6.066892819944769e-05
. O 0 1.2278118788344727e-07

Qualitative O 0 4.933638209081437e-08
analysis O 0 5.71888092437689e-10
of O 0 5.062235519659453e-09
the O 0 3.7066565372612104e-09
Dp71 O 0 3.212597619040025e-07
transcript O 0 3.8830094695185835e-09
and O 0 2.2319117040647818e-11
testing O 0 3.3002869100767773e-12
for O 0 2.1338909372142778e-13
the O 0 4.073740476895349e-12
specific O 0 1.5486355253724327e-11
first O 0 4.022200628117645e-10
exon O 0 3.873947385102383e-09
of O 0 1.4503693357426073e-08
Dp140 O 0 1.3531953300116584e-06
were O 0 4.909330164615255e-10
also O 0 1.6261568480668842e-11
carried O 0 2.4119695823943132e-11
out O 0 3.442718679580459e-11
. O 0 3.0155936081577295e-10

Neuropsychological O 0 6.931674647603359e-07
analysis O 0 2.8964706189071876e-09
assessed O 0 1.0086047552704258e-07
verbal O 0 8.679092644570119e-08
and O 0 6.139037278529713e-09
visuospatial O 0 1.9903882275684737e-07
intelligence O 0 3.219158495326724e-09
, O 0 9.029377939784311e-11
verbal O 0 2.814960176067416e-08
memory O 0 2.0860483118667617e-07
, O 0 1.897997176092403e-10
and O 0 8.708944676527608e-11
reading O 0 8.042920995876557e-09
skills O 0 3.4932705617052306e-09
. O 0 3.403703763282806e-09

Comparison O 0 7.386199172287888e-07
of O 0 6.912095500410942e-07
molecular O 0 1.2724777320727299e-07
and O 0 4.275025056177384e-10
psychometric O 0 1.8052845973670628e-07
findings O 0 4.285926724634237e-09
demonstrated O 0 1.0351363516347689e-10
that O 0 7.71930002557708e-12
deletions O 0 4.194329883411285e-10
and O 0 1.1046304149164854e-10
duplications O 0 1.7328570800501097e-09
that O 0 1.656731522803323e-11
were O 0 1.877734599753378e-11
localized O 0 2.0218271501448726e-09
in O 0 5.592572932533457e-11
the O 0 5.728029162099801e-10
distal O 0 2.3595459879288683e-06
part O 0 2.7003599356589802e-08
of O 0 1.2192664371468709e-06
the O 0 2.8114195060879865e-07
gene O 0 1.0887795109937315e-09
seemed O 0 7.029354320842174e-10
to O 0 3.355356617551486e-11
be O 0 2.691920688094318e-12
preferentially O 0 3.3625963125061276e-11
associated O 0 2.484492993282128e-11
with O 0 1.2701098853207249e-11
cognitive B-Disease 0 1.191726914839819e-05
impairment I-Disease 0 0.3384455740451813
. O 0 4.621510015567765e-06

Two O 0 1.769288360264909e-08
altered O 0 3.870862030908029e-08
Dp71 O 0 4.112136593903415e-06
transcripts O 0 4.440090251023321e-08
and O 0 5.905912425774318e-10
two O 0 1.502075269721459e-10
deleted O 0 2.0353692065100404e-09
Dp140 O 0 3.05430489788705e-08
DNA O 0 3.613420326842309e-11
sequences O 0 4.709566612561e-13
were O 0 6.616793023868014e-14
found O 0 5.809013785675141e-15
in O 0 6.026563186749094e-15
four O 0 9.536691098280259e-14
patients O 0 1.6809685967397042e-13
with O 0 5.426057281439356e-13
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.19187131524085999

These O 0 4.46857484348584e-09
findings O 0 3.6476941467356028e-09
suggest O 0 5.020683313539109e-10
that O 0 5.687524236297481e-12
some O 0 1.252456471867447e-12
sequences O 0 2.049007231247346e-12
located O 0 6.416195266062408e-12
in O 0 1.1626402965370097e-12
the O 0 1.935209284487094e-11
distal O 0 5.6065193376753086e-08
part O 0 8.69746163978391e-10
of O 0 9.124885735900534e-09
the O 0 2.8025992637736863e-09
gene O 0 3.8806065999485995e-11
and O 0 1.6550955050931293e-11
, O 0 1.9753502219360675e-12
in O 0 2.8625519923192178e-12
particular O 0 6.70698011018267e-11
, O 0 7.953240496738623e-12
some O 0 3.083644103951677e-11
DMD B-Disease 1 1.0
isoforms O 0 1.4034582385136218e-08
expressed O 0 6.021152326729506e-11
in O 0 5.086261967157668e-11
the O 0 6.470509128497781e-10
brain O 0 3.2613836964401344e-08
may O 0 9.820270985283486e-11
be O 0 2.7454434125412375e-12
related O 0 5.448938609348142e-12
to O 0 1.9384454111315286e-11
the O 0 3.805527074018933e-11
cognitive B-Disease 0 1.3934610798571612e-08
impairment I-Disease 0 4.2091283347645e-08
associated O 0 3.888568134158277e-09
with O 0 8.036782905840312e-10
DMD B-Disease 1 1.0
. O 0 5.983004314202844e-08
. O 0 1.5478404336022322e-08

I1307K O 0 6.478394061559811e-05
APC O 0 1.0489990387441139e-07
and O 0 2.3919091707291784e-10
hMLH1 O 0 3.214276134144711e-08
mutations O 0 5.809912273502249e-11
in O 0 3.415728257964018e-13
a O 0 4.02428351059525e-12
non O 0 3.1492669583244037e-10
- O 0 1.5764507754756352e-10
Jewish O 0 2.0232340802728288e-10
family O 0 2.715703909580286e-13
with O 0 1.6556368906059382e-13
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999995231628418

We O 0 6.468288127337019e-10
describe O 0 1.2207959469712204e-11
a O 0 2.1436173149036453e-12
French O 0 2.68041616680037e-10
Canadian O 0 7.9846236289427e-09
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.684072776697576e-05
HNPCC B-Disease 1 0.999994158744812
) O 0 1.5010900855649822e-10
kindred O 0 2.087045425369638e-09
which O 0 1.006714893739269e-12
carries O 0 1.9978040489282423e-12
a O 0 1.7462021412173456e-12
novel O 0 5.252533824551264e-11
truncating O 0 2.0900062125406293e-08
mutation O 0 6.74628131136501e-10
in O 0 3.3405181398826755e-10
hMLH1 O 0 3.283642513451923e-07
. O 0 9.221169960937914e-08

Interestingly O 0 7.76146507064368e-08
, O 0 3.459123265603381e-10
the O 0 7.662070422576051e-10
I1307K O 0 1.6856755280514335e-07
APC O 0 1.5269878694823547e-09
polymorphism O 0 4.009936827031879e-10
, O 0 1.6566327303013662e-12
associated O 0 2.114822802556232e-13
with O 0 1.47147431805788e-15
an O 0 9.781429409928127e-14
increased O 0 6.281605791080835e-11
risk O 0 4.683653642700847e-08
of O 0 0.011231261305510998
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.0829173646698109e-07
is O 0 3.893410246980089e-11
also O 0 6.668870100243196e-13
present O 0 5.340853627411324e-13
in O 0 1.5268865815806776e-12
this O 0 4.6453018515135724e-11
family O 0 1.4572613948882207e-10
. O 0 2.1472377209619253e-09

The O 0 8.040731103164944e-08
I1307K O 0 1.3075992683297954e-05
polymorphism O 0 2.4590582370365155e-07
has O 0 8.13669548405116e-11
previously O 0 4.1262835162592104e-12
only O 0 1.940048734725211e-13
been O 0 7.710565313404777e-14
identified O 0 3.8666146022839354e-14
in O 0 5.632093590465662e-15
individuals O 0 8.410932134149743e-14
of O 0 7.536963414489506e-11
self O 0 8.529567274706551e-09
- O 0 4.071146619821775e-08
reported O 0 2.5919113522121506e-09
Ashkenazi O 0 3.429622452699732e-08
Jewish O 0 1.6257120094564925e-09
origins O 0 5.6297051465037384e-09
. O 0 1.9807708806496294e-09

In O 0 7.69859009874807e-10
addition O 0 1.995101479856931e-11
, O 0 4.487974662042982e-12
in O 0 3.0047735133376108e-12
this O 0 2.8999502452164982e-11
family O 0 2.7812956798767274e-11
, O 0 2.3097795377735597e-12
there O 0 3.6030260806146908e-12
appears O 0 1.7160741577759708e-11
to O 0 4.0792317440585535e-11
be O 0 4.776187431665413e-11
no O 0 3.6555401067284166e-11
relationship O 0 1.5467285438552913e-11
between O 0 2.202084764535428e-10
the O 0 1.0400563049683953e-10
I1307K O 0 2.6006465869699014e-09
polymorphism O 0 2.739304096055495e-11
and O 0 5.837163977000237e-13
the O 0 2.227309265842581e-12
presence O 0 1.691663844595459e-12
or O 0 1.975540703247347e-10
absence O 0 1.355011303161291e-08
of O 0 4.608172066156158e-09
cancer B-Disease 0 7.250545763781702e-08
. O 0 8.894940894954573e-10
. O 0 9.674893775013516e-09

Identification O 0 1.7881467417879549e-09
of O 0 3.3329827786587884e-10
a O 0 2.5415345175638926e-11
novel O 0 2.901683615608164e-10
mutation O 0 4.576985457305227e-10
of O 0 5.50853140879326e-09
the O 0 1.382535419480746e-08
CPO O 0 3.8795948057668284e-05
gene O 0 1.384451667890696e-11
in O 0 4.445089261950752e-12
a O 0 1.9834049680422794e-10
Japanese O 0 3.602854903306252e-08
hereditary B-Disease 1 0.9999023675918579
coproporphyria I-Disease 1 0.9998693466186523
family O 0 6.713555222859213e-08
. O 0 3.59380898373729e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 2.9935935685898585e-07
HCP B-Disease 1 0.9999991655349731
) O 0 3.898002060021e-11
is O 0 1.6859567561477995e-11
an O 0 7.360463905037307e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 7.523050515878538e-10
by O 0 3.691089447976914e-11
a O 0 1.4151376959148365e-08
deficiency B-Disease 0 0.002590087242424488
of I-Disease 0 0.021928470581769943
coproporphyrinogen I-Disease 0 0.00022765205358155072
oxidase I-Disease 0 1.5056571101013105e-06
( O 0 4.721970814358656e-09
CPO O 0 4.779557912115706e-06
) O 0 7.565939194598137e-12
caused O 0 3.9759147363316316e-11
by O 0 2.7278632911548195e-12
a O 0 8.563563053121115e-11
mutation O 0 1.2227353851645972e-10
in O 0 1.3508089091729403e-10
the O 0 9.233186659685089e-09
CPO O 0 2.5697750970721245e-05
gene O 0 6.820836340182268e-09
. O 0 8.947506735523802e-09

Only O 0 2.3230299461829418e-08
11 O 0 5.95010476445168e-08
mutations O 0 9.765921404891742e-10
of O 0 9.346617924066436e-10
the O 0 1.1784982989482273e-09
gene O 0 5.398973282333408e-11
have O 0 1.4503561546197474e-11
been O 0 2.2632918109111166e-11
reported O 0 2.2694948351165145e-11
in O 0 1.642150443403878e-10
HCP B-Disease 1 0.9999969005584717
patients O 0 4.528595809460967e-07
. O 0 8.493399263898027e-07

We O 0 4.411361942402436e-09
report O 0 2.146465817587373e-11
another O 0 2.1468589059270293e-11
mutation O 0 1.1345304903875864e-11
in O 0 8.500527213552156e-13
a O 0 7.253025263720403e-11
Japanese O 0 3.883372290403031e-09
family O 0 3.1876418171705723e-10
. O 0 6.893634552085359e-09

Polymerase O 0 1.4661682712358015e-07
chain O 0 1.4504627499078993e-09
reaction O 0 2.7324054477362303e-11
- O 0 7.658632755758177e-11
single O 0 1.6217949292546274e-12
strand O 0 2.1420202417354872e-11
conformational O 0 3.1581320891760356e-11
polymorphism O 0 1.7211910716130596e-11
and O 0 1.732659263460612e-12
direct O 0 8.810695228955723e-11
sequence O 0 3.42378070339322e-11
analyses O 0 3.6089549317747105e-12
demonstrated O 0 3.2241800375365504e-12
a O 0 9.550575608141543e-11
C O 0 7.612360519715367e-08
to O 0 2.0046777571280927e-09
T O 0 2.9604962925589007e-09
substitution O 0 1.0557699853253055e-10
in O 0 3.2120896220622086e-11
exon O 0 7.886389874478539e-10
1 O 0 2.236602725247394e-08
of O 0 1.302748020570732e-09
the O 0 3.4584584085450842e-09
CPO O 0 5.99091833919374e-07
gene O 0 1.0187416014939554e-11
at O 0 6.112414741021865e-11
nucleotide O 0 4.3542457833778414e-11
position O 0 4.3420900208701596e-10
85 O 0 4.796237296211814e-10
, O 0 5.285784288565354e-13
which O 0 8.664564833844868e-13
lies O 0 8.717125909996071e-10
in O 0 4.4943670313157824e-11
the O 0 7.56288809355965e-10
putative O 0 2.427086975842485e-08
presequence O 0 1.968050789002973e-08
for O 0 4.297726410862346e-11
targeting O 0 1.490614187638073e-09
to O 0 1.1522138798625292e-08
mitochondria O 0 2.2899916629626205e-08
. O 0 7.615901687074711e-09

This O 0 3.2759082113642535e-09
mutation O 0 6.165330468377306e-10
changes O 0 2.6436800665274873e-11
the O 0 8.958016967097748e-11
codon O 0 3.1385932741656575e-10
for O 0 2.2770002897076758e-11
glutamine O 0 2.9160184683574286e-11
to O 0 1.2136829041775599e-10
a O 0 3.110250390570002e-10
termination O 0 2.6109763240356187e-08
codon O 0 2.801489173975824e-08
at O 0 3.5988577451462334e-08
amino O 0 9.845332327174106e-10
acid O 0 2.6503912953224074e-10
position O 0 7.291339199078095e-10
29 O 0 9.270671341710113e-08
. O 0 3.644494928067843e-09

MaeI O 0 1.5133635315578431e-05
restriction O 0 1.2893727863172444e-08
analysis O 0 7.221208353502817e-11
showed O 0 2.626150512330394e-11
two O 0 2.727331435779107e-13
other O 0 4.3720317080206406e-14
carriers O 0 4.248843301930122e-13
in O 0 4.974315230554804e-12
the O 0 3.9566711018679257e-10
family O 0 2.703645085588846e-10
. O 0 4.251032414970268e-09

The O 0 1.3090185291275702e-07
C O 0 9.215342288371176e-05
- O 0 2.4082872187136672e-05
T O 0 1.2782772955688415e-06
mutation O 0 9.444462989449676e-10
is O 0 1.7063045854720515e-12
located O 0 4.809799693944461e-12
within O 0 1.0452204206312654e-11
a O 0 6.081053022244376e-11
recently O 0 9.078854334987341e-11
proposed O 0 5.523636548154798e-10
putative O 0 2.541008514711507e-09
alternative O 0 3.105923018775769e-10
translation O 0 1.6504622668556124e-10
initiation O 0 3.420466687664714e-10
codon O 0 1.0436556063808666e-09
( O 0 6.312156526633306e-12
TIC O 0 7.624414433138327e-10
- O 0 2.790613518044438e-09
1 O 0 7.026448756164427e-09
) O 0 5.16729942254962e-13
, O 0 5.570753277076013e-13
supporting O 0 6.891428400157551e-12
that O 0 7.538109025873041e-12
TIC O 0 2.9324305206301915e-09
- O 0 1.020238471483026e-08
1 O 0 2.8384180339457998e-08
is O 0 1.4320105864995547e-11
the O 0 1.214461031739944e-10
real O 0 1.7741442093210935e-08
TIC O 0 4.1336722489404565e-08
rather O 0 4.083040294755591e-10
than O 0 4.707777501167243e-10
TIC O 0 2.1351583612272407e-08
- O 0 7.949918767735653e-08
2 O 0 4.408588338833397e-08
. O 0 1.958761486342553e-10
. O 0 1.241981850697016e-09

Human B-Disease 0 2.148961703030139e-10
complement I-Disease 0 2.179754154951752e-09
factor I-Disease 0 8.427077773376368e-07
H I-Disease 1 1.0
deficiency I-Disease 1 0.9990391731262207
associated O 0 8.8715502499781e-08
with O 0 1.2107550162454572e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999809265136719

This O 0 2.1378305792296715e-09
study O 0 4.202912323725272e-11
reports O 0 2.9273740549673466e-12
on O 0 5.825757931621212e-11
six O 0 1.9211301386518054e-12
cases O 0 4.3903032251324525e-12
of O 0 7.985914707298036e-10
deficiency B-Disease 0 5.7333909353474155e-06
in I-Disease 0 2.782794883415818e-09
the I-Disease 0 4.802665820591301e-09
human I-Disease 0 3.3727898945956625e-11
complement I-Disease 0 6.736733566825581e-12
regulatory I-Disease 0 6.75209999023707e-10
protein I-Disease 0 6.178235256726339e-09
Factor I-Disease 0 1.9683876750775653e-09
H I-Disease 0 0.009259619750082493
( O 0 4.405200596663272e-12
FH O 0 5.579665174337833e-09
) O 0 4.656185427319567e-15
in O 0 8.340505262112929e-16
the O 0 1.5142160240928055e-15
context O 0 4.8004552129178243e-14
of O 0 2.2190350956480948e-13
an O 0 1.1509513828111828e-11
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.099672878510319e-06

Five O 0 2.2585600945035367e-08
of O 0 2.777808538745319e-10
the O 0 1.2963369960816706e-11
cases O 0 1.7086755187828429e-12
were O 0 1.5197969835747949e-12
observed O 0 1.5393729043203241e-12
in O 0 4.665006174322389e-14
children O 0 4.963733010775531e-14
presenting O 0 1.2619882352668532e-12
with O 0 6.977082800396772e-11
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.8451282812748104e-05
HUS B-Disease 1 1.0
) O 0 2.4197099435241398e-08
. O 0 2.1865474764126702e-07

Two O 0 2.410724397883257e-10
of O 0 2.064504678322976e-10
the O 0 4.084993454611663e-11
children O 0 8.519404257577301e-13
exhibited O 0 8.869993281535038e-12
a O 0 3.037872842170941e-09
homozygous O 0 1.8807416779509367e-07
deficiency O 1 0.6784452199935913
characterized O 0 1.2057140841292835e-09
by O 0 7.918853073274335e-11
the O 0 2.495286821613263e-08
absence O 0 4.508196482788662e-08
of O 0 3.6579428375205225e-09
the O 0 1.6854015405520784e-10
150 O 0 2.538971463628137e-11
- O 0 1.7564245197165818e-11
kD O 0 1.7076606795285443e-10
form O 0 1.217744221432282e-12
of O 0 2.2014338962872415e-10
Factor O 0 1.8738224305536733e-09
H O 1 0.9563730359077454
and O 0 7.686257880168412e-12
the O 0 2.2456828063788237e-11
presence O 0 7.563352071374152e-13
, O 0 1.5318272366705854e-13
upon O 0 8.200226955801249e-12
immunoblotting O 0 2.0053214200288494e-08
, O 0 6.6817332916579986e-12
of O 0 8.474650148304619e-11
the O 0 2.4967075629156454e-10
42 O 0 1.0121015137087852e-09
- O 0 8.133845263991191e-10
kD O 0 2.446440205972067e-08
Factor O 0 7.348764929915319e-10
H O 0 0.00013583878171630204
- O 0 9.159359493082775e-09
like O 0 5.606927769297165e-11
protein O 0 3.9933820139559373e-10
1 O 0 4.628714300736192e-09
( O 0 6.322543183445717e-12
FHL O 0 1.3413000488071702e-07
- O 0 1.7595992218844003e-08
1 O 0 2.857026792923989e-08
) O 0 2.2695025112678957e-12
and O 0 3.1203546690949935e-12
other O 0 6.7465837604030465e-12
FH O 0 1.4346652221775003e-07
- O 0 1.5351236948291103e-09
related O 0 6.050904777232802e-10
protein O 0 3.543836335495598e-10
( O 0 2.7217982642019356e-12
FHR O 0 1.0520341220399132e-06
) O 0 4.449672227901935e-11
bands O 0 4.984104684524482e-09
. O 0 4.218698723690295e-09

Southern O 0 8.161870823641948e-07
blot O 0 1.179803234663268e-06
and O 0 7.316132422108268e-11
PCR O 0 2.121005454602809e-11
analysis O 0 6.548944871641316e-13
of O 0 2.4256289251484153e-12
DNA O 0 3.86489321449468e-12
of O 0 1.032739215325873e-12
one O 0 4.0744377273124743e-13
patient O 0 8.453884293990743e-12
with O 0 1.3867079142956817e-12
homozygous O 0 3.668284875857353e-08
deficiency O 1 0.9968794584274292
ruled O 0 9.569327630742919e-06
out O 0 7.541856583692663e-10
the O 0 7.202418522700427e-11
presence O 0 2.577634937092621e-12
of O 0 3.5902822381750354e-11
a O 0 1.0480451576033722e-11
large O 0 6.840708121486072e-12
deletion O 0 1.3735061976660745e-09
of O 0 1.9886070568020386e-09
the O 0 1.3885255167878086e-09
FH O 0 2.2673400223993667e-07
gene O 0 4.813084826527092e-12
as O 0 8.698676002595607e-13
the O 0 5.744829091602899e-12
underlying O 0 4.197499292590834e-10
defect O 0 1.4062664810410297e-08
for O 0 1.189936371659428e-09
the O 0 5.431594445326482e-07
deficiency O 1 0.99998939037323
. O 0 2.4740971639403142e-05

The O 0 9.742967321813012e-09
other O 0 7.00461390279461e-12
four O 0 2.930558573588371e-12
children O 0 1.5694280456387405e-13
presented O 0 5.901492402399233e-12
with O 0 1.5041501030821358e-11
heterozygous O 0 4.155618569257058e-07
deficiency O 1 0.999451220035553
and O 0 1.4294960770655507e-09
exhibited O 0 2.0969678771187716e-10
a O 0 2.6132067620920907e-09
normal O 0 1.383767909146627e-07
immunoblotting O 0 5.284356348056463e-07
pattern O 0 7.904887411314121e-09
of O 0 1.431113783034732e-09
proteins O 0 9.314895209333596e-12
of O 0 1.1386869225304963e-10
the O 0 3.770530832003516e-10
FH O 0 4.76793047710089e-06
family O 0 5.370260347525857e-10
. O 0 1.958190942730198e-09

Factor B-Disease 0 0.03293673321604729
H I-Disease 1 1.0
deficiency I-Disease 1 0.9596127867698669
is O 0 5.359983290542658e-11
the O 0 6.934746527020863e-11
only O 0 7.668078949585322e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 9.045282922670594e-08
with O 0 1.5291388155702634e-09
HUS B-Disease 1 1.0
. O 0 2.462912334522116e-06

These O 0 4.970519551505959e-09
observations O 0 3.125227365785577e-08
suggest O 0 6.789603324008908e-10
a O 0 1.0688265550395926e-10
role O 0 7.417198799597458e-11
for O 0 3.188880756677115e-11
FH O 0 1.3898294355385588e-06
and O 0 8.956483887878619e-10
/ O 0 3.2722195442147495e-07
or O 0 1.3298933509986455e-08
FH O 0 1.2892346603621263e-06
receptors O 0 3.18371662366701e-10
in O 0 3.22883256589912e-12
the O 0 1.646763454765665e-11
pathogenesis O 0 3.5942873122252195e-09
of O 0 2.8396501816629893e-10
idiopathic O 0 0.0003493922995403409
HUS B-Disease 1 1.0
. O 0 2.099411311462518e-08
. O 0 2.4603568959946642e-08

Further O 0 1.8178309968419626e-09
evidence O 0 1.5070024395047454e-10
for O 0 1.9158938758395694e-12
a O 0 2.041884196446464e-11
major O 0 8.889356611918586e-11
ancient O 0 1.3035428292340612e-10
mutation O 0 8.01006727613185e-09
underlying O 0 4.811406029148202e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 4.067631209636602e-07
linkage O 0 1.2369939668133156e-06
disequilibrium O 0 5.562548608395446e-07
studies O 0 3.3481453720618504e-11
in O 0 9.842575973001422e-13
the O 0 3.961439683231038e-12
Japanese O 0 7.227050902169907e-11
population O 0 8.806486356122134e-13
. O 0 6.436558230848988e-11

The O 0 8.210460578084167e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.061255923370481e-08
DM B-Disease 1 1.0
) O 0 2.3007680483022597e-10
mutation O 0 3.5043065671480633e-10
is O 0 7.081763127303464e-12
an O 0 6.780851574683666e-11
unstable O 0 6.623314448006568e-07
( O 0 7.833682147406762e-09
CTG O 0 9.591793059371412e-06
) O 0 5.096441602070456e-10
n O 0 4.670431152931087e-09
repeat O 0 1.2469426602379485e-09
, O 0 3.4744071768927354e-12
present O 0 5.090646220534678e-12
at O 0 3.5548827770348623e-11
a O 0 1.9151668098627006e-12
copy O 0 1.0949490446277022e-11
number O 0 1.967799187485575e-12
of O 0 1.511022557076913e-11
5 O 0 1.103723334949791e-09
- O 0 7.722889883154949e-09
37 O 0 3.366334322407738e-09
repeats O 0 7.947152380616274e-10
on O 0 8.279575247627236e-09
normal O 0 7.491195219699875e-09
chromosomes O 0 4.716999013609779e-10
but O 0 2.1139860695296164e-11
amplified O 0 5.5450626729180996e-11
to O 0 2.2312998670948048e-10
50 O 0 5.92333015969615e-10
- O 0 1.591811960022227e-10
3000 O 0 1.0176734455136227e-11
copies O 0 8.395137883476789e-12
on O 0 1.6622795584453343e-08
DM B-Disease 1 0.9999996423721313
chromosomes O 0 9.42834219586075e-07
. O 0 1.9942369533509918e-08

Previous O 0 3.9766867132584593e-08
findings O 0 3.982086882459157e-10
in O 0 1.3976540411131388e-11
Caucasian O 0 8.601976908551023e-09
populations O 0 3.2870772076476484e-11
of O 0 8.640561877104602e-11
a O 0 1.553314810109896e-08
DM B-Disease 1 1.0
founder O 0 3.8151756598381326e-05
chromosome O 0 1.1228574976485106e-06
raise O 0 2.5047650620280137e-09
a O 0 1.3642420526593924e-10
question O 0 1.1177175157639496e-10
about O 0 1.8228140351295163e-12
the O 0 7.400293919324064e-12
molecular O 0 2.5378142295973127e-11
events O 0 2.0780562871598046e-13
involved O 0 1.0306395493986376e-12
in O 0 5.644835727319775e-12
the O 0 2.145648103635267e-10
expansion O 0 1.6319667395237047e-08
mutation O 0 6.684142306312424e-08
. O 0 2.2390782561387823e-08

To O 0 1.5270178010950985e-08
investigate O 0 3.215807842238405e-09
whether O 0 1.4600992637170407e-10
a O 0 1.7781298655705768e-10
founder O 0 9.060261985105456e-10
chromosome O 0 1.5640135853089987e-09
for O 0 5.671105599014403e-11
the O 0 4.357523675224684e-09
DM B-Disease 1 1.0
mutation O 0 2.850516978014639e-08
exists O 0 3.12730952245488e-11
in O 0 7.092343747884533e-13
the O 0 6.955951873527377e-12
Japanese O 0 2.7237939334567862e-11
population O 0 5.712058972519307e-13
, O 0 2.0361739638125043e-12
we O 0 7.896561182718642e-11
genotyped O 0 1.5577927570120664e-07
families O 0 1.3376070216730707e-11
using O 0 3.8883635894437774e-11
polymorphic O 0 1.0178943909977534e-08
markers O 0 1.3838544532518426e-08
near O 0 9.079472818029899e-08
the O 0 7.2520922600460835e-09
( O 0 1.7492449710942992e-09
CTG O 0 3.4225565741508035e-06
) O 0 1.8524605460701338e-10
n O 0 5.569054106757676e-09
repeat O 0 3.2029527918808753e-09
region O 0 1.825349649209329e-09
and O 0 1.4701510842041188e-10
constructed O 0 4.0838930459585754e-08
haplotypes O 0 3.7208539538369223e-07
. O 0 2.6948235642976215e-08

Six O 0 3.159944483854815e-08
different O 0 2.232976130389641e-11
haplotypes O 0 3.4084852718052616e-09
were O 0 1.460898763072649e-10
found O 0 1.070956517912336e-11
and O 0 8.695715675299809e-11
DM B-Disease 1 1.0
alleles O 0 1.0123313298748826e-09
were O 0 6.151466835913055e-11
always O 0 4.36702132788902e-11
haplotype O 0 3.5884937688024365e-08
A O 0 3.941295574350079e-07
. O 0 4.0700907533164354e-08

To O 0 1.3692322831104775e-09
find O 0 3.618537414151746e-11
an O 0 6.675959156147993e-13
origin O 0 1.677370395358757e-11
of O 0 1.2689239936580776e-10
the O 0 3.6898453736888825e-10
( O 0 5.866147012589806e-10
CTG O 0 1.7349599374938407e-06
) O 0 1.1922529630226109e-10
n O 0 1.1690640677741726e-09
repeat O 0 7.624094133795722e-10
mutation O 0 9.84866528608297e-12
and O 0 1.6746833412205342e-13
to O 0 3.169245248180186e-12
investigate O 0 6.802053278270881e-12
the O 0 2.485122134118778e-12
mechanism O 0 2.166653662039053e-11
of O 0 1.0096016904437288e-11
the O 0 6.3993896987080134e-12
expansion O 0 1.0033115310781326e-10
mutation O 0 1.4802938388958076e-11
in O 0 2.9934813308707398e-12
the O 0 1.0772376914103265e-11
Japanese O 0 6.60862961576747e-11
population O 0 4.3033241900469754e-13
we O 0 2.1693653817767e-12
have O 0 1.096482605232596e-12
studied O 0 3.111495089358485e-11
90 O 0 4.435946332481677e-10
Japanese O 0 7.494821430142906e-10
DM B-Disease 1 0.9999998807907104
families O 0 2.7631856872045724e-11
comprising O 0 2.5343394917387574e-12
190 O 0 7.616983432878754e-11
affected O 0 4.68675653841899e-11
and O 0 2.7092394300209932e-11
130 O 0 5.850618656211282e-09
unaffected O 0 9.841285475431505e-08
members O 0 2.835769119524656e-10
. O 0 7.979843452687874e-09

The O 0 3.2177851494452625e-08
results O 0 1.0800614846928625e-09
suggest O 0 5.315424767005084e-10
that O 0 3.0665511362854003e-12
a O 0 2.2296395632559474e-11
few O 0 8.29239541616511e-12
common O 0 1.304820747977109e-11
ancestral O 0 1.3632802664531596e-09
mutations O 0 1.7302964616661143e-10
in O 0 1.096503964015394e-11
both O 0 7.411132124657271e-11
Caucasian O 0 7.791991407657406e-08
and O 0 5.965939964269751e-10
Japanese O 0 3.297045303440882e-09
populations O 0 2.7182858828439516e-12
have O 0 9.601537907842975e-14
originated O 0 2.8748946040609014e-13
by O 0 7.572601264582354e-14
expansion O 0 9.541271939195184e-11
of O 0 8.348388647050342e-11
an O 0 3.157589814617445e-11
ancestral O 0 8.712371379893113e-10
n O 0 2.140988941690125e-09
= O 0 1.8208637930783311e-09
5 O 0 4.3441135133548414e-09
repeat O 0 6.603303459584708e-10
to O 0 2.4772319751065197e-09
n O 0 6.291684062631475e-09
= O 0 3.938677384240918e-09
19 O 0 6.305740374301649e-09
- O 0 3.69689878709778e-09
37 O 0 1.129518034659327e-09
copies O 0 5.916191148092054e-11
. O 0 8.036123988475197e-10

These O 0 2.4476978777165925e-10
data O 0 2.4029098155686768e-11
support O 0 1.1451223649872055e-11
multistep O 0 2.4300469192439778e-08
models O 0 2.00504102210175e-09
of O 0 2.3192844977870664e-08
triplet O 0 3.400997456992627e-06
repeat O 0 6.417235454136971e-08
expansion O 0 5.188553586776834e-09
that O 0 6.987587158197028e-12
have O 0 4.2010329676794855e-13
been O 0 9.821904709906085e-14
proposed O 0 6.428993080086209e-13
for O 0 4.3438064018137823e-13
both O 0 4.9023566456307677e-11
DM B-Disease 1 1.0
and O 0 1.3303703916278664e-08
Friedreichs B-Disease 0 0.0008103699656203389
ataxia I-Disease 0 0.0016920722555369139
. O 0 4.662707198122007e-08
. O 0 1.1526913112902548e-07

The O 0 3.762551159525174e-09
molecular O 0 3.3874087979057776e-09
basis O 0 1.6601376273683854e-08
of O 0 4.77319872516091e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.2525977466946188e-09
the O 0 8.713451626896074e-10
western O 0 1.6113264056372145e-09
Cape O 0 1.4117651048195512e-08
, O 0 1.662952588132871e-11
South O 0 3.4556807415597746e-10
Africa O 0 7.137133245516125e-11
. O 0 4.800080888323066e-10

Deficiency B-Disease 0 0.0021356530487537384
of I-Disease 0 2.105343810399063e-06
the I-Disease 0 1.6050873341555416e-07
sixth I-Disease 0 2.632002349400864e-07
component I-Disease 0 1.3099696438700903e-08
of I-Disease 0 5.714315243210422e-09
human I-Disease 0 2.371096374798043e-10
complement I-Disease 0 9.648057908151486e-10
( O 0 4.384341500962563e-10
C6 O 0 3.2918662327574566e-05
) O 0 6.956817760750411e-11
has O 0 9.474584311552903e-12
been O 0 2.384277454289818e-12
reported O 0 2.744243092316079e-13
in O 0 1.2337481263122087e-14
a O 0 2.1447939453113352e-13
number O 0 4.523221329281492e-14
of O 0 2.0466546751633785e-13
families O 0 1.2735963677993137e-14
from O 0 1.927935675688497e-12
the O 0 7.817699612666651e-12
western O 0 6.773977490048821e-10
Cape O 0 1.1665632015933625e-08
, O 0 1.0965291175057956e-11
South O 0 2.993518488647595e-10
Africa O 0 1.6878559661037684e-10
. O 0 7.16330772476681e-10

Meningococcal B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999990463256836
is O 0 1.0140395190205709e-09
endemic O 0 1.2513212688247677e-10
in O 0 1.1233935656718153e-11
the O 0 1.4479852039617214e-10
Cape O 0 2.369600959895024e-09
and O 0 1.7869848396162569e-12
almost O 0 1.0660266072659574e-11
all O 0 1.2145963488446876e-12
pedigrees O 0 7.313104982697993e-11
of O 0 5.114885737178554e-10
total O 0 5.170448389435478e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 4.162566824561509e-08
C6Q0 O 0 0.019468683749437332
) O 0 2.412149126274077e-11
have O 0 1.102955509042769e-12
been O 0 1.5243259128897013e-12
ascertained O 0 5.732947450098891e-10
because O 0 6.0333348560204225e-12
of O 0 1.2742210064864423e-10
recurrent O 0 0.003520593512803316
disease O 0 0.28415602445602417
. O 0 2.1620009249545546e-07

We O 0 2.988570102502308e-08
have O 0 3.919922372808138e-11
sequenced O 0 7.257398154658645e-11
the O 0 9.603874119579192e-12
expressed O 0 2.3825648051700732e-11
exons O 0 1.4299493145131237e-08
of O 0 3.8686236436547006e-09
the O 0 4.372776363226194e-09
C6 O 0 1.013738256006036e-06
gene O 0 4.485101526285895e-11
from O 0 1.3264662805656524e-11
selected O 0 8.727859472472399e-13
cases O 0 3.202836216728566e-13
and O 0 9.647712316540602e-13
have O 0 2.4586723715996905e-12
found O 0 3.9781125442395204e-12
three O 0 1.3331776654856853e-11
molecular O 0 2.1643769443357996e-08
defects O 0 4.471852207643678e-06
leading O 0 1.0534035865816804e-08
to O 0 3.139889770409354e-08
total O 0 1.0689890928006207e-07
deficiency O 0 2.648018744366709e-05
879delG O 0 1.8660358591660042e-06
, O 0 3.064307488309659e-11
which O 0 4.256218207737694e-12
is O 0 1.8980459565165475e-12
the O 0 9.802656950053112e-12
common O 0 7.6391559744593e-11
defect O 0 1.4723105401515113e-08
in O 0 2.5447854934412817e-10
the O 0 1.8664139123103496e-09
Cape O 0 3.074710264172609e-08
and O 0 1.0300824776487971e-10
hitherto O 0 8.64691784840943e-09
unreported O 0 3.226301448222557e-09
, O 0 1.908806663078466e-12
and O 0 3.0882514427676977e-12
1195delC O 0 2.1517065906806465e-09
and O 0 7.624104819692334e-11
1936delG O 0 1.72270127052343e-08
, O 0 1.9905325651659034e-11
which O 0 4.0006964754923935e-12
have O 0 1.964229343412449e-12
been O 0 5.393659477381796e-12
previously O 0 5.530884344268072e-12
reported O 0 1.6122706468502113e-12
in O 0 2.43906457531029e-12
African O 0 9.727749161747568e-11
- O 0 1.6373598032970449e-09
Americans O 0 8.112582827735082e-11
. O 0 2.80258860563265e-09

We O 0 1.0081854640020538e-07
also O 0 5.137978584257574e-11
show O 0 1.088755648137596e-11
that O 0 9.430637829899516e-14
the O 0 1.707320266067236e-12
879delG O 0 1.2404287597078678e-09
and O 0 1.0435038250156126e-10
1195delC O 0 1.4030150850885548e-05
defects O 1 0.5814914703369141
are O 0 5.216720111445028e-11
associated O 0 1.9922439253861057e-09
with O 0 3.5880520776743197e-10
characteristic O 0 4.363033440313302e-06
C6 O 1 0.9999979734420776
/ O 1 0.9998937845230103
C7 O 0 0.0043592872098088264
region O 0 2.7521527954377234e-06
DNA O 0 8.260476391797056e-08
marker O 0 1.0108576198319952e-08
haplotypes O 0 6.507594019211638e-09
, O 0 6.705172875265397e-12
although O 0 1.609585186489182e-12
small O 0 1.3343250115926963e-11
variations O 0 2.603718796123644e-09
were O 0 2.5982171969474166e-09
observed O 0 2.926419817583792e-08
. O 0 2.091657336222852e-08

The O 0 3.076951315961196e-08
1936delG O 0 5.373697717914183e-07
defect O 0 2.2616050046053715e-06
was O 0 6.384600936826246e-08
observed O 0 5.064541563903902e-10
only O 0 1.5892811372486548e-11
once O 0 2.65183604242214e-11
in O 0 5.087112588814113e-12
the O 0 5.91732010613022e-11
Cape O 0 4.939595843467259e-09
, O 0 1.7205075255113944e-12
but O 0 2.0161786736666576e-12
its O 0 7.641440431804813e-12
associated O 0 1.4246040458409936e-10
haplotype O 0 1.4296308847860928e-07
could O 0 3.5156244138079273e-08
be O 0 5.531325175667234e-09
deduced O 0 1.399227613774201e-07
. O 0 6.550432196661404e-09

The O 0 3.359857458917759e-08
data O 0 4.711927514833292e-10
from O 0 1.982168318370725e-10
the O 0 2.729776127363692e-10
haplotypes O 0 2.2067783156387577e-09
indicate O 0 4.0761696795676983e-10
that O 0 9.580035549572319e-12
these O 0 6.586705139643989e-12
three O 0 4.645780288248247e-11
molecular O 0 1.6126984192510463e-08
defects O 0 6.608525637830098e-08
account O 0 2.1221142898486534e-11
for O 0 5.277329684361121e-10
the O 0 5.30074999005592e-07
defects O 0 0.06406760215759277
in O 0 5.671316749555899e-09
all O 0 7.84531217767892e-10
the O 0 2.594046644155412e-10
38 O 0 1.095052604149771e-09
unrelated O 0 9.449288573826209e-11
C6Q0 O 0 2.5381241357536055e-06
individuals O 0 5.3987984222070295e-11
we O 0 6.172389821479385e-10
have O 0 2.4630764441924136e-11
studied O 0 5.138941494564619e-10
from O 0 2.255600289879922e-10
the O 0 2.0990928439879042e-10
Cape O 0 2.706041613009802e-08
. O 0 1.7263284135538015e-09

We O 0 3.6140875181445153e-08
have O 0 3.561513584049436e-11
also O 0 2.5732582297627316e-12
observed O 0 8.783357721697804e-12
the O 0 4.56407871565756e-12
879delG O 0 2.1594690480242207e-09
defect O 0 2.04998751307528e-09
in O 0 2.5934714445452478e-11
two O 0 1.8278221991518961e-10
Dutch O 0 0.001139720086939633
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 1.9595502180891344e-06
, O 0 3.8584409105257844e-12
but O 0 1.507501155156854e-12
the O 0 3.393445247024118e-11
879delG O 0 4.693649469089678e-09
defect O 0 2.472418536569876e-08
in O 0 6.49893194815121e-10
the O 0 1.575256192154484e-08
Cape O 0 8.991683841941267e-08
probably O 0 1.7214587533231906e-09
did O 0 1.9204653145532546e-10
not O 0 4.698436778527437e-11
come O 0 1.6853202861044636e-11
from O 0 2.3090935413749847e-11
The O 0 1.8297127701849547e-10
Netherlands O 0 5.482314047178249e-10
. O 0 1.6184344142633478e-10
. O 0 1.8039056470797732e-08

Complement B-Disease 1 0.8911591172218323
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.4475690646165162e-09
seven O 0 3.9311401356378894e-10
further O 0 2.0142596479644226e-09
molecular O 0 7.120160034901346e-07
defects O 0 3.397336331545375e-05
and O 0 8.167517773216559e-10
their O 0 1.0077769729832653e-09
associated O 0 8.99682639499133e-09
marker O 0 2.4347056637452624e-07
haplotypes O 0 6.833925567661936e-07
. O 0 7.679751945488533e-08

Seven O 0 1.9319262634098777e-08
further O 0 5.774716815842851e-10
molecular O 0 8.892214076183791e-09
bases O 0 4.569242317842281e-09
of O 0 2.8393544198479503e-05
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.073571809229179e-08
described O 0 1.7319557343853376e-08
. O 0 7.067672669336389e-09

All O 0 1.1853039660891795e-09
these O 0 6.9555671985965795e-12
new O 0 9.99941518475822e-11
molecular O 0 5.009590076099357e-09
defects O 0 6.921565542938879e-09
involve O 0 2.460268794246545e-11
single O 0 1.0108681947063047e-10
- O 0 2.133374366053431e-09
nucleotide O 0 7.962537296180017e-10
events O 0 3.6945405068600223e-11
, O 0 8.778467536219026e-12
deletions O 0 3.342570387143695e-10
and O 0 5.756944365664651e-10
substitutions O 0 8.357441960704648e-10
, O 0 8.25666358200694e-12
some O 0 1.695152156665214e-12
of O 0 6.880439273881933e-11
which O 0 1.6116503964713758e-11
alter O 0 2.540791754768179e-08
splice O 0 1.3057040781916385e-08
sites O 0 8.383061605998776e-11
, O 0 3.4653666654976822e-12
and O 0 2.3867720300163597e-11
others O 0 7.187984096823641e-10
codons O 0 2.0692854718618037e-07
. O 0 4.2026062629929584e-08

They O 0 1.0163457853096247e-09
are O 0 7.885626288235692e-13
distributed O 0 9.367396181653165e-13
along O 0 4.458838853693692e-11
the O 0 8.815541074902455e-10
C7 O 0 2.0786260392924305e-06
gene O 0 5.1870938100329056e-11
, O 0 7.683073469967605e-13
but O 0 4.3090655826513724e-13
predominantly O 0 9.092829570886418e-13
towards O 0 7.760565107206574e-11
the O 0 2.0483996443498853e-10
3 O 0 6.15358786149045e-08
end O 0 4.6938936293372535e-07
. O 0 6.312216527248893e-08

All O 0 1.0185954302244227e-08
were O 0 1.6350401588205443e-10
found O 0 2.1125661983645294e-12
in O 0 9.109981649255139e-13
compound O 0 1.4600101683193145e-10
heterozygous O 0 5.2118073745610616e-11
individuals O 0 1.541383340408764e-11
. O 0 5.958619819779187e-09

The O 0 7.92430273577338e-06
C6 O 0 0.1938115507364273
/ O 0 0.007407426368445158
C7 O 0 0.0005524164880625904
marker O 0 1.8827586245606653e-07
haplotypes O 0 2.3733701226547055e-08
associated O 0 1.4118909374971622e-09
with O 0 7.849828426165217e-11
most O 0 3.927104685885752e-08
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999996423721313
are O 0 1.5894169536068148e-08
tabulated O 0 1.8880985663827232e-08
. O 0 1.3943961540974215e-09
. O 0 8.403481466245921e-09

A O 0 1.2057074627591646e-06
genome O 0 3.272136339660392e-09
- O 0 1.6974583960660539e-09
wide O 0 3.202340337349341e-10
search O 0 1.1578237674170211e-10
for O 0 3.5108461277078007e-12
chromosomal O 0 5.516335477295797e-08
loci O 0 2.2729899740170367e-08
linked O 0 1.7265662677345972e-08
to O 0 1.4009229332145878e-08
mental O 1 0.9998914003372192
health O 0 8.034090797082172e-07
wellness O 0 1.0121503919435781e-06
in O 0 9.977049048037756e-11
relatives O 0 2.424743184015199e-10
at O 0 7.51365358819811e-11
high O 0 3.2335567556884826e-10
risk O 0 3.58344937056998e-10
for O 0 1.475286670604703e-09
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 8.43311753762066e-10
the O 0 5.221364673957396e-09
Old O 0 1.1115235842851234e-08
Order O 0 6.062317869925948e-10
Amish O 0 4.243716933416408e-09
. O 0 3.652558810962603e-10

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 5.305632821972495e-09
BPAD B-Disease 1 1.0
; O 0 5.704543218598701e-05
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.0392697253068803e-10
is O 0 9.089904176584618e-12
characterized O 0 4.907677562948631e-12
by O 0 1.2187114165063129e-11
episodes O 0 2.3004620430810974e-09
of O 0 1.2223162482172256e-09
mania B-Disease 0 3.602057674356729e-08
and O 0 6.382063211241018e-10
/ O 0 1.3209814824222121e-06
or O 0 5.412829295892152e-08
hypomania B-Disease 0 1.1406766134314239e-05
interspersed O 0 2.168424328985452e-10
with O 0 5.808266736496981e-13
periods O 0 3.0469196055094017e-09
of O 0 1.8466478346468307e-09
depression B-Disease 0 3.7411107314255787e-06
. O 0 2.9082022123816387e-08

Compelling O 0 2.2687755674155596e-08
evidence O 0 1.5764396454898133e-09
supports O 0 1.3449423519329429e-10
a O 0 2.2632411222911486e-10
significant O 0 4.227226624298197e-10
genetic O 0 9.980746229487636e-10
component O 0 6.556729048590171e-10
in O 0 2.4722262431664532e-11
the O 0 6.071436131627195e-10
susceptibility O 0 4.44057306481227e-08
to O 0 3.7067572122850834e-08
develop O 0 2.0939296518918127e-05
BPAD B-Disease 1 1.0
. O 0 4.88207078888081e-05

To O 0 1.2253281056473497e-08
date O 0 1.0907822201033923e-07
, O 0 5.6652241925414515e-11
however O 0 1.0701300262594415e-10
, O 0 1.658199272336347e-10
linkage O 0 1.146409100982737e-08
studies O 0 7.91355314611053e-11
have O 0 8.378880814001455e-13
attempted O 0 3.004489990132697e-10
only O 0 1.2011536513686916e-12
to O 0 2.3510282262662052e-11
identify O 0 3.978410656468867e-11
chromosomal O 0 1.1495428964281018e-07
loci O 0 3.180145213832475e-08
that O 0 3.767049866487682e-11
cause O 0 1.0189665999860154e-08
or O 0 1.2482127831336953e-10
increase O 0 3.299925055433306e-10
the O 0 1.3775879048605333e-10
risk O 0 9.240792575582191e-10
of O 0 1.2364085311133977e-09
developing O 0 6.541570769513783e-07
BPAD B-Disease 1 1.0
. O 0 7.174032361945137e-06

To O 0 1.4341645737658837e-07
determine O 0 2.947510502337991e-08
whether O 0 3.234605361335241e-10
there O 0 4.06746893111265e-11
could O 0 3.150678884455971e-10
be O 0 7.027929627145824e-11
protective O 0 2.1899045077322654e-10
alleles O 0 4.9031772565710785e-12
that O 0 5.85310662784555e-13
prevent O 0 1.1195284282949913e-11
or O 0 2.285920931710539e-11
reduce O 0 1.386413761572669e-09
the O 0 1.2983344954697884e-10
risk O 0 1.6123224977349082e-09
of O 0 2.160919221338986e-09
developing O 0 1.3060224546279642e-06
BPAD B-Disease 1 1.0
, O 0 8.52466292000642e-11
similar O 0 8.181975062748759e-13
to O 0 1.3804068131617608e-11
what O 0 1.373629264804152e-13
is O 0 5.735101521291142e-14
observed O 0 5.524071326236391e-13
in O 0 2.2091321285298837e-13
other O 0 8.008042146068206e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 3.761693734283256e-11
we O 0 6.741978069574328e-12
used O 0 2.3140052374248654e-11
mental O 0 1.8777201660213905e-07
health O 0 3.847913099264133e-10
wellness O 0 1.8828398840042837e-09
( O 0 6.717842428172194e-13
absence O 0 2.955168887375237e-10
of O 0 6.962419529799035e-11
any O 0 5.116401080584865e-09
psychiatric B-Disease 1 0.9999775886535645
disorder I-Disease 0 2.2072306819609366e-05
) O 0 1.1764550921986028e-12
as O 0 3.200248876664147e-12
the O 0 3.376620164030619e-11
phenotype O 0 3.073184151602959e-09
in O 0 2.1873079736334233e-10
our O 0 5.568360772478798e-10
genome O 0 1.3785506070007614e-09
- O 0 3.151445326921021e-08
wide O 0 2.550891942121325e-08
linkage O 0 1.9605022316682152e-07
scan O 0 7.889396442806174e-07
of O 0 1.2410943384111306e-08
several O 0 3.1211006001896635e-11
large O 0 6.392975732127937e-11
multigeneration O 0 3.8823193904136133e-07
Old O 0 2.5297570260818247e-08
Order O 0 2.3823445438608815e-09
Amish O 0 4.232957095950951e-09
pedigrees O 0 3.413727633905239e-10
exhibiting O 0 1.0246814681480476e-11
an O 0 2.8151743089455117e-12
extremely O 0 1.3085874051022017e-10
high O 0 1.2900619594802265e-07
incidence O 0 0.0003715490165632218
of O 0 2.312458491360303e-05
BPAD B-Disease 1 1.0
. O 0 6.22256557107903e-05

We O 0 2.5347324594804377e-07
have O 0 1.6651116596655413e-10
found O 0 1.4062052737517927e-11
strong O 0 2.0697150590609503e-12
evidence O 0 2.345965435801567e-12
for O 0 7.589044952356627e-13
a O 0 5.693171281628828e-11
locus O 0 1.3101488782751858e-09
on O 0 4.85355355905881e-09
chromosome O 0 3.795088048264006e-07
4p O 0 0.0010505274403840303
at O 0 2.302166279832818e-08
D4S2949 O 0 1.4044402973922843e-07
( O 0 5.47180920365542e-12
maximum O 0 8.955463037807476e-09
GENEHUNTER O 0 4.603062109254097e-07
- O 0 7.59996865440371e-09
PLUS O 0 7.211480301805295e-10
nonparametric O 0 6.746461722606512e-10
linkage O 0 1.6107477851523555e-10
score O 0 4.201790651525705e-11
= O 0 1.8315135866253662e-11
4 O 0 9.829415753559445e-11
. O 0 9.901134816539536e-13
05 O 0 1.3653100872090818e-09
, O 0 1.91797151077866e-11
P O 0 8.191879175001304e-08
= O 0 1.1670872601676763e-10
5 O 0 1.2552031636303695e-10
. O 0 2.542899159470313e-13
22 O 0 3.772831005943722e-11
x O 0 3.145977089946683e-10
10 O 0 3.255736791274444e-10
( O 0 8.751468300038923e-12
- O 0 5.7571227785047085e-09
4 O 0 4.720853929995883e-09
) O 0 1.6872683805679856e-12
; O 0 1.118045326459205e-11
SIBPAL O 0 4.007390089100227e-06
Pempirical O 0 6.958062215289829e-08
value O 0 1.464735138734241e-10
< O 0 2.278470967453927e-09
3 O 0 1.2615757050138399e-10
x O 0 1.4099175993376178e-10
10 O 0 1.153620116101095e-10
( O 0 2.599284069232377e-12
- O 0 2.8313009714509008e-09
5 O 0 3.5284939414736982e-09
) O 0 3.5526375678079924e-12
) O 0 1.6558334564598098e-12
and O 0 3.3637105687628344e-12
suggestive O 0 8.29160906601345e-11
evidence O 0 4.5470831960825464e-12
for O 0 2.315314010393338e-13
a O 0 2.510214605622174e-11
locus O 0 5.427017168990744e-10
on O 0 4.779546092237297e-09
chromosome O 0 7.128802508304943e-07
4q O 0 4.1143171074509155e-06
at O 0 2.5924800084453636e-09
D4S397 O 0 9.14803166551792e-08
( O 0 7.994943249101105e-12
maximum O 0 2.0137651546292545e-08
GENEHUNTER O 0 5.275896910461597e-07
- O 0 3.4819753746972992e-09
PLUS O 0 5.788236001613711e-10
nonparametric O 0 9.835084968656815e-10
linkage O 0 4.0655945277023875e-10
score O 0 8.673469581443882e-11
= O 0 3.23462853724088e-11
3 O 0 8.723341493599435e-11
. O 0 2.3388437454113786e-12
29 O 0 1.7743700952976837e-09
, O 0 1.622569092973869e-11
P O 0 1.8663546086372662e-07
= O 0 2.4651833352429264e-10
2 O 0 2.4892043981594725e-10
. O 0 7.399725905805898e-13
57 O 0 6.239977978772515e-11
x O 0 3.1133487454759745e-10
10 O 0 4.678631371213271e-10
( O 0 1.2291229666006043e-11
- O 0 9.449297344588103e-09
3 O 0 6.3831619989684896e-09
) O 0 3.2530581960815708e-12
; O 0 2.264928349038353e-11
SIBPAL O 0 5.6333019529120065e-06
Pempirical O 0 1.1219075446433635e-07
value O 0 2.690137279603988e-10
< O 0 4.696147914984294e-09
1 O 0 7.01411317916012e-10
x O 0 6.654344852918825e-10
10 O 0 6.422139486872425e-10
( O 0 6.121407200576634e-12
- O 0 2.6958810739330374e-09
3 O 0 1.839181917873134e-09
) O 0 2.8455227540566397e-13
) O 0 3.5851170936043036e-14
that O 0 4.179204996391378e-14
are O 0 5.94103759243847e-14
linked O 0 1.492126838753549e-10
to O 0 2.827577283426308e-09
mental O 0 0.0003542827907949686
health O 0 3.086238393734675e-07
wellness O 0 3.523402483551763e-06
. O 0 3.045102658916221e-08

These O 0 3.598052744635538e-09
findings O 0 2.7502800037382258e-09
are O 0 2.5214372690457454e-12
consistent O 0 1.2282791971018892e-11
with O 0 6.73164052712033e-14
the O 0 2.3763380152530544e-11
hypothesis O 0 8.488465486067298e-11
that O 0 2.4780871799023885e-13
certain O 0 1.3422046460376258e-11
alleles O 0 6.245157169182391e-11
could O 0 2.370368346049645e-10
prevent O 0 6.114155293168722e-10
or O 0 3.1682453882631023e-10
modify O 0 3.5018898891792105e-09
the O 0 1.0619905649322803e-10
clinical O 0 7.766477461146337e-10
manifestations O 0 1.3084439309807294e-08
of O 0 1.090652812507642e-08
BPAD B-Disease 1 1.0
and O 0 4.470735934236636e-11
perhaps O 0 2.0134203332355938e-11
other O 0 6.049513320838251e-12
related O 0 1.4727801556091435e-07
affective B-Disease 1 0.9999996423721313
disorders I-Disease 1 0.9999996423721313
. O 0 5.095002052257769e-06

Segregation O 0 3.1812603538128315e-06
distortion O 0 3.645464312285185e-05
in O 0 6.33462633459203e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0008372853044420481

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.811690814676695e-07
DM B-Disease 1 1.0
) O 0 5.2873826844601624e-11
is O 0 3.639494955409717e-12
an O 0 2.4814194102273923e-11
autosomal B-Disease 1 0.9940648674964905
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9961639642715454
which O 0 1.8204800514287633e-11
, O 0 1.5212181557824889e-12
in O 0 2.4769212288860976e-12
the O 0 1.819619108167636e-11
typical O 0 1.230080343139761e-10
pedigree O 0 8.903236481394572e-11
, O 0 1.1083246950413517e-12
shows O 0 1.7928740089767636e-12
a O 0 6.154987630679898e-11
three O 0 4.6750606857992594e-11
generation O 0 5.020916127307373e-09
anticipation O 0 1.0136340655719778e-08
cascade O 0 1.4586871657229494e-05
. O 0 7.002743132034084e-07

This O 0 3.4992689301738267e-11
results O 0 2.3780246868887467e-11
in O 0 8.52855008837139e-11
infertility B-Disease 1 0.993796706199646
and O 0 1.6773877860032371e-06
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.8922360324231704e-08
CDM B-Disease 0 2.4585660867160186e-06
) O 0 3.246207827285047e-13
with O 0 4.88342310654092e-14
the O 0 1.480057465474971e-10
disappearance O 0 1.2997357856647795e-08
of O 0 3.1725160276607767e-09
DM B-Disease 1 1.0
in O 0 4.089035776644323e-09
that O 0 5.907444533548301e-10
pedigree O 0 1.726539977653374e-08
. O 0 5.372537525971666e-09

The O 0 1.1206469086033621e-09
concept O 0 6.932845963980583e-10
of O 0 4.563545985547535e-09
segregation O 0 1.585568476514254e-08
distortion O 0 6.165183776829508e-07
, O 0 2.571807176943164e-11
where O 0 4.305731986231631e-12
there O 0 7.71021647135578e-13
is O 0 2.2904412741442393e-12
preferential O 0 1.2182431730067833e-09
transmission O 0 9.345459961451752e-10
of O 0 4.632799005532817e-11
the O 0 3.423792282672422e-12
larger O 0 4.1580671197860575e-12
allele O 0 1.7631854309918538e-10
at O 0 5.193946939208161e-10
the O 0 1.4426758399022077e-10
DM B-Disease 1 0.9999998807907104
locus O 0 1.7955230191546434e-08
, O 0 1.0537215197614636e-11
has O 0 1.2160312904199722e-12
been O 0 2.2466969690909666e-12
put O 0 1.0367165459435057e-11
forward O 0 9.750653756634975e-11
to O 0 7.109281219275232e-11
explain O 0 3.128945991193177e-10
partially O 0 8.672282891808436e-10
the O 0 9.155524255399783e-11
maintenance O 0 9.549236956729601e-09
of O 0 5.4547908412416746e-09
DM B-Disease 1 1.0
in O 0 1.888421641282889e-09
the O 0 1.2000974658477048e-09
population O 0 6.562703071949505e-12
. O 0 2.724465375525398e-10

In O 0 2.233259577266722e-09
a O 0 6.876034186475977e-10
survey O 0 3.4915501045951203e-10
of O 0 2.343804039739439e-09
DM B-Disease 1 1.0
in O 0 7.156851999923219e-09
Northern O 0 8.573136511813573e-08
Ireland O 0 3.4420786221289745e-09
, O 0 3.531158143665891e-10
59 O 0 3.5920272978273715e-08
pedigrees O 0 4.667973119154567e-09
were O 0 1.1276926059622383e-09
ascertained O 0 5.24956760727946e-07
. O 0 1.024882312350428e-08

Sibships O 0 1.2316766515141353e-05
where O 0 8.314291477518054e-10
the O 0 1.1282406259249811e-10
status O 0 4.3940526217589593e-10
of O 0 4.706430800638373e-10
all O 0 1.5591004182136103e-11
the O 0 6.895126830608334e-11
members O 0 3.837538360002002e-12
had O 0 1.988825909515768e-10
been O 0 6.211384184773294e-11
identified O 0 4.503600617433712e-11
were O 0 5.172055058538794e-12
examined O 0 1.952218421641394e-11
to O 0 5.037467318280697e-11
determine O 0 7.297722842691812e-11
the O 0 3.743113458076763e-11
transmission O 0 6.678402275639428e-10
of O 0 6.405844743540001e-10
the O 0 5.3263780053214305e-09
DM B-Disease 1 1.0
expansion O 0 2.5559651817275153e-07
from O 0 3.730473263630074e-09
affected O 0 1.326675214130546e-09
parents O 0 2.1106784722779715e-11
to O 0 8.625071212797764e-10
their O 0 1.2116428693698111e-10
offspring O 0 6.876847424841515e-10
. O 0 2.6689186416462007e-09

Where O 0 5.326388219373257e-09
the O 0 4.58563603755735e-10
transmitting O 0 8.117791772122018e-09
parent O 0 2.0566766067986464e-09
was O 0 1.7541305297186227e-08
male O 0 3.8006833791293104e-10
, O 0 6.015550557680882e-11
58 O 0 5.696558247336725e-08
. O 0 2.16765734251112e-08

3 O 0 2.510133526811842e-06
% O 0 1.4686810878572487e-08
of O 0 1.9082198043918197e-09
the O 0 3.6185412444211806e-09
offspring O 0 6.9763843590919805e-09
were O 0 1.692666146135835e-10
affected O 0 2.9660279787790955e-10
, O 0 4.0063781285570865e-12
and O 0 1.8559669860002126e-12
in O 0 1.7868689384040182e-12
the O 0 7.359332761247561e-12
case O 0 2.199707603567358e-11
of O 0 5.572956159050069e-12
a O 0 1.444663052380113e-11
female O 0 1.318502945713007e-11
transmitting O 0 1.402777782821829e-09
parent O 0 3.4788023572929205e-09
, O 0 2.8186495359960873e-09
68 O 0 1.7035882819982362e-06
. O 0 1.0999455923865753e-07

7 O 0 1.1215561244171113e-05
% O 0 5.6677944115790524e-08
were O 0 6.763701265732891e-10
affected O 0 7.322855211100432e-09
. O 0 2.3654974867781675e-08

Studies O 0 1.2058572806949996e-08
on O 0 9.199873751697396e-09
meiotic O 0 1.6109252953810937e-07
drive O 0 3.436602824535839e-08
in O 0 2.3653472513984752e-09
DM B-Disease 1 1.0
have O 0 7.477111985121354e-11
shown O 0 2.5658479247542276e-12
increased O 0 1.352391202497083e-11
transmission O 0 4.681056930966321e-11
of O 0 2.5161621917957344e-12
the O 0 3.680357884769392e-13
larger O 0 6.533624010741923e-13
allele O 0 2.256050901650042e-11
at O 0 1.8340443747044688e-11
the O 0 1.8609164556537827e-11
DM B-Disease 1 0.9999324083328247
locus O 0 6.915043537780718e-10
in O 0 2.539295683445797e-11
non O 0 3.6124191638009506e-08
- O 0 7.631229550497665e-07
DM O 1 1.0
heterozygotes O 0 1.4458782615633936e-08
for O 0 1.8568684090336518e-10
CTGn O 0 3.0336761938087875e-06
. O 0 1.0595940125313064e-08

This O 0 3.700553419250241e-09
study O 0 1.5234931372010152e-10
provides O 0 1.3100121031353607e-12
further O 0 1.5075161605149212e-11
evidence O 0 7.538487195590804e-11
that O 0 1.687082765156056e-11
the O 0 1.8698915749126854e-09
DM B-Disease 1 1.0
expansion O 0 5.07644244862604e-07
tends O 0 1.2677447536191266e-08
to O 0 6.15191564357076e-10
be O 0 3.782170687749442e-10
transmitted O 0 1.5222884064414188e-09
preferentially O 0 7.320425599033342e-09
. O 0 2.22609775057947e-09

Diagnosis O 1 0.9999918937683105
of O 0 0.0010638842359185219
hemochromatosis B-Disease 1 1.0
. O 0 0.00048701127525418997

If O 0 3.723745248862542e-05
untreated O 1 0.995790958404541
, O 0 3.145882665478439e-09
hemochromatosis B-Disease 1 1.0
can O 0 6.50335252316836e-08
cause O 1 0.9393166899681091
serious O 1 0.9999896287918091
illness O 1 0.9999744892120361
and O 0 6.41283692814909e-10
early B-Disease 0 9.917033594319946e-08
death I-Disease 0 1.4791727842577984e-08
, O 0 1.2974692934625276e-12
but O 0 1.9049802967713303e-12
the O 0 1.168548452445961e-10
disease O 0 1.0511450598826855e-09
is O 0 6.220364392843514e-13
still O 0 1.3942824759333172e-12
substantially O 0 1.8986054395320195e-10
under O 0 1.1949290410484537e-06
- O 1 0.9999165534973145
diagnosed O 0 0.015064354054629803
. O 0 1.8136591961592785e-07

The O 0 4.2067846095505956e-08
cornerstone O 0 5.821224249302759e-07
of O 0 4.894887162265604e-09
screening O 0 1.00497977995051e-10
and O 0 1.931881737915475e-12
case O 0 4.736307873676182e-11
detection O 0 1.2311371921924774e-09
is O 0 3.341215542088105e-12
the O 0 3.856412064684456e-11
measurement O 0 1.6822966353302604e-09
of O 0 1.3884937644093043e-09
serum O 0 6.515464834322415e-10
transferrin O 0 6.431827515029909e-09
saturation O 0 5.221045817904724e-09
and O 0 5.476155987005349e-11
the O 0 1.2422181339122318e-10
serum O 0 1.249740422260004e-09
ferritin O 0 8.889504954368022e-08
level O 0 2.6187015222944865e-08
. O 0 4.861855362747747e-09

Once O 0 7.583464167737475e-08
the O 0 1.1176498615483865e-09
diagnosis O 0 2.059790858766064e-06
is O 0 6.121246565182759e-11
suspected O 0 1.830189155782591e-08
, O 0 4.843034306922789e-11
physicians O 0 8.266694551117837e-10
must O 0 5.10595965508287e-09
use O 0 9.314553572892237e-09
serum O 0 2.3140269433952199e-07
ferritin O 0 3.478420921965153e-06
levels O 0 9.231798969722149e-08
and O 0 2.9209423768605802e-09
hepatic O 0 0.0024769301526248455
iron O 0 0.0002604187175165862
stores O 0 7.21964852345991e-08
on O 0 7.406492841255385e-07
liver O 0 4.2491947738199087e-07
biopsy O 0 1.686109669662983e-07
specimens O 0 9.541035322913061e-11
to O 0 3.9353564851296596e-10
assess O 0 5.117982038171931e-09
patients O 0 1.5887536078396103e-11
for O 0 8.048786463710211e-12
the O 0 1.7924416118031417e-10
presence O 0 1.6199383501280806e-10
of O 0 7.18672978905488e-08
iron B-Disease 0 0.00017213869432453066
overload I-Disease 0 3.599948831833899e-05
. O 0 1.237773403772735e-07

Liver O 1 0.9039337038993835
biopsy O 0 0.1629132181406021
is O 0 5.0999253708994274e-09
also O 0 9.211097162786785e-12
used O 0 1.0399520871187673e-12
to O 0 3.3225460577268606e-11
establish O 0 3.256008657137599e-11
the O 0 2.026434575697067e-11
presence O 0 7.415341778116424e-12
or O 0 1.9758392699742444e-09
absence O 0 2.5256113644900324e-07
of O 0 1.2625378076336347e-07
cirrhosis B-Disease 1 0.9999997615814209
, O 0 3.692173997094095e-11
which O 0 6.118255208020784e-12
can O 0 3.7967979454878176e-11
affect O 0 1.693504181332628e-08
prognosis O 0 1.795164826035034e-05
and O 0 3.049303476387877e-09
management O 0 9.94275382026899e-08
. O 0 2.3438053275981474e-08

A O 0 3.0171963771863375e-07
DNA O 0 1.4843497542216255e-09
- O 0 1.774271146670614e-10
based O 0 4.425783524386606e-12
test O 0 5.451537658796024e-12
for O 0 7.730213496225102e-13
the O 0 2.9504210186104274e-10
HFE O 0 1.6513713489985093e-06
gene O 0 2.593383563453955e-10
is O 0 7.546553659754096e-12
commercially O 0 3.602231013477564e-11
available O 0 9.285927062008259e-12
, O 0 3.098618150260135e-12
but O 0 7.602634884487647e-13
its O 0 1.0472952800127944e-12
place O 0 2.2509532432435364e-11
in O 0 6.076744467863049e-13
the O 0 1.9985063950955784e-11
diagnosis O 0 7.313407763831492e-07
of O 0 2.4763263439808725e-08
hemochromatosis B-Disease 1 1.0
is O 0 1.0549417339689171e-08
still O 0 1.8644950861013143e-10
being O 0 5.894992133326227e-11
evaluated O 0 1.4150208782481855e-09
. O 0 2.366186580005092e-09

Currently O 0 1.256411685801595e-08
, O 0 1.3388788688839526e-10
the O 0 1.293043450090181e-10
most O 0 1.3041507977706868e-12
useful O 0 3.3862862600791965e-12
role O 0 2.6357488240591476e-12
for O 0 8.800542217711482e-13
this O 0 3.036680715912121e-12
test O 0 3.096349348793992e-12
is O 0 4.16045100931281e-14
in O 0 1.2500764312584067e-13
the O 0 4.630084943918478e-12
detection O 0 2.17851559014548e-09
of O 0 4.6982799872807846e-09
hemochromatosis B-Disease 1 1.0
in O 0 1.1673038091686294e-09
the O 0 3.4732661191583247e-09
family O 0 3.4887925881577075e-11
members O 0 1.1351988142907499e-12
of O 0 4.2083031503992174e-11
patients O 0 7.331757271612782e-13
with O 0 2.7637348450917053e-14
a O 0 7.11066414083028e-11
proven O 0 1.0686517226687897e-09
case O 0 2.0018341151395447e-10
of O 0 1.0379362924695101e-09
the O 0 3.51452311697642e-09
disease O 0 8.681923446829387e-08
. O 0 9.149405677533196e-09

It O 0 6.40705433152533e-10
is O 0 5.6012094268309554e-11
crucial O 0 3.2919429404643097e-09
to O 0 2.5602410858027724e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999998807907104
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 9.353313856763634e-08
because O 0 7.717261274464704e-10
phlebotomy O 0 8.045177537496784e-07
therapy O 0 1.5964162214388011e-09
can O 0 4.0860922284613466e-11
avert O 0 0.004649240989238024
serious O 1 1.0
chronic O 1 1.0
disease O 1 0.9999996423721313
and O 0 5.528601465520921e-10
can O 0 2.951271171891534e-10
even O 0 3.430410677740525e-10
lead O 0 4.184276189422853e-11
to O 0 1.280072020604095e-10
normal O 0 2.320132752586801e-09
life O 0 1.055459955545679e-10
expectancy O 0 4.047458201927867e-10
. O 0 1.9110662705101866e-11
. O 0 2.098001106176639e-09

Prevalence O 0 2.708792089833878e-05
of O 0 2.8990863043532045e-08
the O 0 1.9362385472732058e-08
I1307K O 0 2.1680105419363827e-05
APC B-Disease 0 1.6313784101384954e-08
gene O 0 1.0277598000082988e-12
variant O 0 1.774113625105378e-12
in O 0 3.428233716872009e-13
Israeli O 0 4.772711115208494e-10
Jews O 0 1.2456292074192188e-11
of O 0 1.2687962659685414e-13
differing O 0 2.1679898070466226e-14
ethnic O 0 1.168272564192746e-13
origin O 0 2.096332954231936e-13
and O 0 5.597604085978702e-13
risk O 0 9.424758751208628e-10
for O 0 1.0939408667809403e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0017879554070532322

BACKGROUND O 0 1.0124209381956462e-07
& O 0 6.2781739806894166e-09
AIMS O 0 1.319448372782972e-08
Israeli O 0 2.18525038064854e-08
Jews O 0 1.0802159167155878e-09
of O 0 2.1542104211569324e-10
European O 0 2.9651470168090555e-09
birth O 0 1.4653812741016736e-07
, O 0 3.2707370145601544e-10
i O 0 3.1783604637070084e-09
. O 0 2.3373598195819412e-11
e O 0 1.9304904896877417e-11
. O 0 6.43503262828804e-12
, O 0 5.473103741049368e-12
Ashkenazim O 0 9.526246458335663e-08
, O 0 2.946779539131361e-12
have O 0 1.7279564281172388e-12
the O 0 1.1412679135069936e-10
highest O 0 0.0002262811321998015
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.00030458741821348667
of O 0 6.565751831111299e-10
any O 0 1.663340298829752e-10
Israeli O 0 3.541724780120603e-08
ethnic O 0 1.6071274311357797e-09
group O 0 4.616014168123961e-11
. O 0 6.847882261240557e-10

The O 0 4.939136601933569e-07
I1307K O 0 1.7344475054414943e-05
APC B-Disease 0 1.4265060244156302e-08
gene O 0 6.949122700883326e-12
variant O 0 1.1223832974138759e-10
was O 0 1.10017961407749e-09
found O 0 5.467615509652246e-12
in O 0 5.1203492834606124e-11
6 O 0 4.841111831410672e-07
. O 0 3.632733580616332e-08

1 O 0 3.70426647577915e-07
% O 0 7.306347193924978e-10
of O 0 3.4426135553378145e-11
American O 0 1.2118039210973208e-11
Jews O 0 1.0151073037700797e-10
, O 0 1.4323157460430225e-12
28 O 0 4.98068086773884e-10
% O 0 6.595181345492307e-11
of O 0 6.123722362527673e-11
their O 0 1.1229213114916092e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.9655733467516256e-06
, O 0 1.0299248433265351e-11
but O 0 1.3699511360390493e-12
not O 0 4.790244156199774e-12
in O 0 1.7608756466835906e-11
non O 0 7.901872045579239e-09
- O 0 2.506281226999363e-08
Jews O 0 1.2207698851796067e-08
. O 0 8.102633231032996e-09

We O 0 3.6853126772484757e-08
assessed O 0 2.427763376999792e-07
the O 0 1.6337192709769965e-09
I1307K O 0 3.0739884095964953e-06
prevalence O 0 5.784571710520936e-10
in O 0 7.369551881719269e-14
Israeli O 0 8.22607884587434e-11
Jews O 0 8.740708677679176e-12
of O 0 1.6528286714539292e-13
differing O 0 6.700231190183426e-14
ethnic O 0 2.930613108957647e-13
origin O 0 1.0107033482711913e-12
and O 0 1.0924702982528789e-12
risk O 0 1.6947021563851195e-09
for O 0 2.0574611880874727e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.006279595196247101

METHODS O 0 5.884811571377213e-07
DNA O 0 3.4166280915570724e-09
samples O 0 3.3080510986743805e-12
from O 0 1.7638228117650145e-12
500 O 0 1.0689946107131365e-12
unrelated O 0 4.433827437144711e-12
Jews O 0 2.084811316638291e-11
of O 0 1.3184049338366144e-11
European O 0 5.214571829892378e-11
or O 0 1.695567852788571e-10
non O 0 3.723990005255473e-09
- O 0 5.318718035440817e-11
European O 0 1.3141619736867227e-11
origin O 0 4.576579566706318e-12
, O 0 1.0145438769692053e-14
with O 0 1.6927965362278013e-16
or O 0 1.0113700783971613e-13
without O 0 3.779266125308184e-13
a O 0 7.235014995964073e-13
personal O 0 8.335968634115565e-13
and O 0 5.487717051610996e-12
/ O 0 6.435560351292224e-08
or O 0 4.802958919469802e-09
family O 0 8.980701599048402e-11
history O 0 5.969773286818025e-11
of O 0 1.5458474778018427e-10
neoplasia B-Disease 0 3.3982701097556856e-07
, O 0 2.032602419710372e-10
were O 0 5.90579599113461e-11
examined O 0 1.3957365818662026e-10
for O 0 1.8474033067206186e-11
the O 0 2.43010472855687e-10
I1307K O 0 5.80945291872581e-09
variant O 0 6.818081255827169e-12
by O 0 3.2868683903092277e-12
the O 0 2.111648876590433e-11
allele O 0 2.2894641044102215e-11
- O 0 6.895797127759451e-11
specific O 0 5.3994676785240614e-11
oligonucleotide O 0 1.7560587650677917e-08
( O 0 6.093455739986098e-10
ASO O 0 1.4639185792475473e-05
) O 0 3.858324770789068e-11
method O 0 4.340932946433895e-09
. O 0 9.838349024349213e-10

RESULTS O 0 1.4048032426217105e-07
In O 0 2.1865405319676512e-10
persons O 0 2.8652082442737203e-11
at O 0 1.6365558214159748e-11
average O 0 1.6031028934881952e-11
risk O 0 4.265584829798996e-10
for O 0 6.565457510987471e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.576232193656324e-07
I1307K O 0 5.12748010805808e-06
was O 0 5.087702703576724e-09
found O 0 5.1623371376263716e-12
in O 0 1.4620967631051585e-11
5 O 0 8.825976394177815e-09
. O 0 2.9533446799234753e-09

0 O 0 3.5000093134840427e-07
% O 0 1.2966127060920485e-09
of O 0 2.657751796419916e-10
120 O 0 4.675295151024272e-10
European O 0 5.525385704530095e-10
and O 0 1.1039296143877664e-09
1 O 0 3.542023023328511e-06
. O 0 2.5035864936739927e-08

6 O 0 6.486708912234462e-07
% O 0 1.6197075902724123e-09
of O 0 2.964150314088698e-10
188 O 0 3.024521744166009e-10
non O 0 1.3013896627001031e-09
- O 0 4.2539338718228237e-10
European O 0 5.204230935085263e-10
Jews O 0 3.0608293677403253e-09
( O 0 1.0599528199595198e-10
P O 0 9.073358455680136e-07
= O 0 3.4759881084589495e-10
0 O 0 2.862991788088465e-10
. O 0 6.702999266749998e-12
08 O 0 3.074871191000028e-10
) O 0 1.1182286867306157e-11
. O 0 6.874499858255945e-10

It O 0 2.9614564134305965e-09
occurred O 0 4.062156833128938e-08
in O 0 2.658197828520059e-10
15 O 0 3.359485845066956e-08
. O 0 6.372894656436756e-09

4 O 0 2.8962080023120507e-07
% O 0 6.023912479946603e-10
of O 0 1.3245278485118916e-10
52 O 0 1.4085367316951647e-09
Ashkenazi O 0 1.1216860773544113e-09
Israelis O 0 1.6759585941272803e-09
with O 0 3.8962019374699786e-12
familial O 0 1.1511468983371742e-05
cancer B-Disease 1 0.9991992115974426
( O 0 1.0150806861730644e-09
P O 0 8.6886166172917e-06
= O 0 3.8199132745830866e-10
0 O 0 2.3303634022475705e-10
. O 0 2.2032336892408022e-12
02 O 0 3.717776433931341e-11
) O 0 2.840360596462893e-13
and O 0 4.226754363179097e-12
was O 0 6.036368627171385e-10
not O 0 3.444873206137622e-11
detected O 0 1.7075989233727995e-10
in O 0 3.657560799369408e-12
51 O 0 1.6337380337461127e-09
non O 0 1.943749161625874e-09
- O 0 1.0593813604131697e-09
European O 0 9.550107371580907e-10
Jews O 0 2.2819417466735104e-09
at O 0 1.335619836950741e-09
increased O 0 2.832878376324288e-09
cancer B-Disease 0 2.933644225322496e-07
risk O 0 3.88759850977749e-08
. O 0 2.103732477110043e-08

Colorectal B-Disease 1 0.5010303854942322
neoplasia I-Disease 0 0.08586916327476501
occurred O 0 9.173852595267817e-05
personally O 0 1.0006445450017054e-08
or O 0 3.2510563685583804e-11
in O 0 1.5920685993500716e-12
the O 0 5.874000938432822e-12
families O 0 1.728750823049019e-12
of O 0 1.1788596487871672e-10
13 O 0 2.8602205048855467e-09
of O 0 1.2408924998652537e-09
20 O 0 8.072983170848147e-09
Ashkenazi O 0 3.3980862568228076e-09
I1307K O 0 7.74181163620824e-09
carriers O 0 1.9623493368453593e-12
, O 0 1.259585968513277e-12
8 O 0 6.482714365318998e-10
of O 0 4.201470074627345e-11
whom O 0 2.3302420756876607e-11
also O 0 5.473020474322521e-12
had O 0 4.9562288301219226e-11
a O 0 2.547513588968542e-11
personal O 0 1.5740651837514719e-10
or O 0 1.130837312679489e-09
family O 0 8.413432450726788e-11
history O 0 2.52780102405481e-10
of O 0 3.5495135719543214e-09
noncolonic O 0 2.514519655960612e-05
neoplasia B-Disease 1 0.8525781631469727
. O 0 4.6547465899493545e-06

CONCLUSIONS O 0 1.7345200831186958e-05
The O 0 1.0880830103587869e-07
I1307K O 0 1.6801810488686897e-05
APC O 0 2.4749757798758765e-08
variant O 0 2.862376335954764e-09
may O 0 3.572702356180457e-09
represent O 0 7.643571886539746e-11
a O 0 8.047305044556197e-10
susceptibility O 0 5.6406928905516907e-08
gene O 0 9.92065249394436e-11
for O 0 1.5336076852889846e-09
colorectal B-Disease 1 1.0
, I-Disease 0 1.0345104783482384e-05
or I-Disease 0 1.4082941561355256e-05
other I-Disease 0 9.098192421674867e-09
, I-Disease 0 1.196550192261725e-09
cancers I-Disease 0 3.7222635000944138e-06
in O 0 5.164590533013325e-09
Ashkenazi O 0 1.931150791278924e-06
Jews O 0 8.03310840069571e-09
, O 0 8.97809344230227e-12
and O 0 7.396145328131265e-12
partially O 0 2.364882734084972e-09
explains O 0 4.992234403644602e-11
the O 0 4.593282351694761e-12
higher O 0 3.8741743146886165e-10
incidence O 0 7.91836441749183e-07
of O 0 5.613452458419488e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.3192313847175683e-08
European O 0 2.4107130514039454e-08
Israelis O 0 5.302494514580758e-07
. O 0 4.15539567200085e-08

Systematic O 0 4.789127316939812e-09
analysis O 0 1.2726494857950854e-10
of O 0 9.447994608891008e-10
coproporphyrinogen O 0 5.002831130695995e-06
oxidase O 0 2.7504762556418427e-07
gene O 0 7.875780916322128e-09
defects O 0 7.487111588488915e-07
in O 0 9.223641850297781e-10
hereditary B-Disease 1 0.9999178647994995
coproporphyria I-Disease 1 0.9440401792526245
and O 0 1.5139188747070875e-07
mutation O 0 1.2927949910590542e-07
update O 0 1.0319541132730592e-07
. O 0 8.12126472737873e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999991655349731
( O 0 1.957766784244086e-07
HC B-Disease 1 1.0
) O 0 2.952858790816748e-10
is O 0 8.337217721754442e-11
an O 0 4.962304456235245e-10
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 1.2177719099781825e-06
autosomal O 1 1.0
dominant O 1 0.9999974966049194
inheritance O 0 0.00039416394429281354
caused O 0 2.05486412596656e-06
by O 0 1.5867859803897488e-10
deficient B-Disease 0 5.0912586146978356e-08
activity I-Disease 0 5.309621631255368e-09
of I-Disease 0 1.877798361249461e-08
coproporphyrinogen I-Disease 0 7.701783033553511e-07
III I-Disease 0 0.0002327265392523259
oxidase I-Disease 0 4.722603819118376e-07
( O 0 2.4203270498901475e-09
CPO O 0 3.4659667562664254e-06
) O 0 1.114690145742614e-10
. O 0 1.3148603317247876e-09

Clinical O 0 2.495342596375849e-05
manifestations O 0 0.0006088028312660754
of O 0 1.4347050409924123e-06
the O 0 2.4293615297210636e-07
disease O 0 0.0009061222663149238
are O 0 2.213113183381979e-13
characterized O 0 1.0986472148699633e-12
by O 0 5.828297371633651e-13
acute O 0 4.0822118307914934e-07
attacks O 0 4.835869162889139e-07
of O 0 0.27243632078170776
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 4.486885973875587e-09
precipitated O 0 1.576614061526982e-09
by O 0 4.504783698844328e-12
drugs O 0 4.8159067012054635e-11
, O 0 2.707378592148313e-12
fasting O 0 2.4741815263240596e-09
, O 0 5.5308872065618075e-11
cyclical O 0 5.433775527308171e-07
hormonal O 0 2.171649384763441e-07
changes O 0 5.689681614740039e-09
, O 0 1.9932777650666367e-09
or O 0 1.0174178896704689e-05
infectious B-Disease 0 0.008554871194064617
diseases I-Disease 0 5.101431816001423e-05
. O 0 6.249705819527662e-08

Skin O 1 0.9999996423721313
photosensitivity O 1 0.9997832179069519
may O 0 1.9456627342151478e-05
also O 0 2.5537432168931673e-09
be O 0 4.6235415496198584e-10
present O 0 1.1228120655459861e-09
. O 0 7.434429072361581e-09

The O 0 9.102187448206678e-08
seven O 0 8.479363877711421e-09
exons O 0 2.0246760712439027e-08
, O 0 8.675190427132051e-11
the O 0 1.4201337883434917e-09
exon O 0 7.989315875533975e-09
/ O 0 5.8316370399325024e-08
intron O 0 4.827381872019032e-08
boundaries O 0 1.1129401844556241e-09
and O 0 1.9153867727994545e-11
part O 0 8.340180213117776e-10
of O 0 1.492313117523736e-08
3 O 0 1.951916743792026e-07
noncoding O 0 6.576073019459727e-08
sequence O 0 1.5626478999664073e-09
of O 0 5.76582648292856e-09
the O 0 1.6438475469726654e-08
CPO O 0 6.87993633619044e-06
gene O 0 2.719512393056789e-10
were O 0 8.298206566337285e-11
systematically O 0 1.827919760000185e-10
analyzed O 0 1.9984519681465196e-12
by O 0 4.713700133343601e-13
an O 0 7.786493672057304e-12
exon O 0 5.538361089185706e-11
- O 0 5.787783030619664e-10
by O 0 3.701730311167495e-10
- O 0 7.285368752718568e-08
exon O 0 1.2506399471590157e-08
denaturing O 0 1.3142525858711451e-06
gradient O 0 5.947925956206745e-07
gel O 0 3.872257181569694e-08
electrophoresis O 0 5.013442105905597e-09
( O 0 1.3765891204720049e-11
DGGE O 0 4.948614105160232e-07
) O 0 1.0591311898691669e-12
strategy O 0 1.1509645667096002e-11
followed O 0 2.7740768124458193e-13
by O 0 4.338091097824161e-14
direct O 0 9.399544510790836e-12
sequencing O 0 2.3981105729681262e-12
in O 0 1.2067820701067156e-12
seven O 0 4.653333707943519e-12
unrelated O 0 4.6207003501219646e-11
heterozygous O 0 3.9663125561695267e-10
HC B-Disease 1 0.9997439980506897
patients O 0 5.119201951231389e-09
from O 0 1.0204890266152233e-09
France O 0 1.2227919787832775e-09
, O 0 7.97696977916651e-12
Holland O 0 3.467505726995057e-10
, O 0 2.7092121948624204e-12
and O 0 8.905032093664556e-12
Czech O 0 1.5414421739023965e-07
Republic O 0 2.7592300284595694e-06
. O 0 1.8510903601054451e-06

Seven O 0 6.1408638174498265e-09
novel O 0 3.335450249331018e-10
mutations O 0 6.46083811450815e-11
and O 0 8.10187854305422e-12
two O 0 9.166545994476749e-12
new O 0 2.1085870549608643e-10
polymorphisms O 0 1.5905632366752798e-08
were O 0 1.4627383393417404e-07
detected O 0 7.147522751438373e-07
. O 0 2.5707613815484365e-08

Among O 0 7.912214772254345e-10
these O 0 3.653644053969174e-11
mutations O 0 1.0530008115461342e-10
two O 0 1.8985826799600147e-11
are O 0 5.576539664070568e-12
missense O 0 5.9000523577878994e-08
( O 0 7.948486313580361e-10
G197W O 0 1.5238589185173623e-05
, O 0 5.823406201699299e-10
W427R O 0 1.272592044188059e-06
) O 0 3.4245255936538044e-11
, O 0 1.3854844355121188e-11
two O 0 3.70235526264695e-12
are O 0 2.0133463039112565e-12
nonsense O 0 4.086626148591677e-09
( O 0 1.1323043891398044e-10
Q306X O 0 1.3857477370038396e-06
, O 0 1.2032803919925783e-10
Q385X O 0 3.9761297898621706e-07
) O 0 3.30478595877981e-11
, O 0 1.3722139743932438e-11
two O 0 4.942538132240992e-12
are O 0 9.948610945470504e-13
small O 0 2.342528081233919e-11
deletions O 0 3.016607408312666e-09
( O 0 3.5931610464778885e-10
662de14bp O 0 1.1175820873177145e-06
; O 0 1.0050621446211494e-10
1168del3bp O 0 1.7878876690247125e-07
removing O 0 5.0805755158478405e-09
a O 0 6.865000790057252e-10
glycine O 0 3.146542804088881e-09
at O 0 5.1355146801768115e-09
position O 0 7.326652062822347e-10
390 O 0 6.493093562820462e-11
) O 0 1.6319167154763004e-12
, O 0 5.980331789674775e-13
and O 0 8.819933715667472e-13
one O 0 1.6990559350074652e-12
is O 0 1.8088978665647959e-12
a O 0 1.0689039930955602e-10
splicing O 0 2.7255467327513827e-10
mutation O 0 1.1155961571196471e-10
( O 0 8.604256630101448e-13
IVS1 O 0 3.6307596928963903e-07
- O 0 6.9447341211059666e-09
15c O 0 2.171651232174554e-07
- O 0 2.9097930731580846e-09
- O 0 1.7280910036276964e-09
> O 0 1.6379845257930015e-09
g O 0 4.3554750084329186e-11
) O 0 1.3351580447793984e-14
which O 0 2.2151349832644392e-14
creates O 0 3.194138530060453e-12
a O 0 3.9975557586391375e-11
new O 0 1.0847225201393584e-10
acceptor O 0 2.035233537256431e-09
splice O 0 4.6909313766718697e-08
site O 0 2.244259222905498e-09
. O 0 1.6746261044531252e-09

The O 0 4.2090800178584686e-08
pathological O 0 2.64212235379091e-06
significance O 0 1.0428502505988035e-08
of O 0 7.678078617345818e-09
the O 0 1.3324825687277553e-09
point O 0 4.4415216393645096e-08
mutations O 0 7.641243748857107e-10
G197W O 0 4.644113005269901e-07
, O 0 3.5272923470941464e-11
W427R O 0 3.1881488666840596e-06
, O 0 4.579183560116107e-11
and O 0 1.8253338077145465e-11
the O 0 1.3117586183941654e-10
in O 0 2.8359732964777784e-11
- O 0 4.848573209592644e-10
frame O 0 1.840690821985902e-09
deletion O 0 3.5860150404687374e-09
390delGly O 0 1.137183458510549e-09
were O 0 5.500438646222072e-12
assessed O 0 9.079719615057158e-11
by O 0 5.028170262967591e-13
their O 0 2.932694235027733e-12
respective O 0 2.4449810231974567e-11
expression O 0 8.153019058487754e-12
in O 0 1.3734157908174005e-11
a O 0 6.395464019481878e-11
prokaryotic O 0 4.865976545309625e-12
system O 0 1.5563611163726954e-11
using O 0 2.212228230463742e-12
site O 0 5.26038414216945e-11
- O 0 3.120993047334153e-11
directed O 0 1.244180800052952e-11
mutagenesis O 0 2.378822756554655e-07
. O 0 1.1779393460642495e-08

These O 0 1.0816488815734715e-09
mutations O 0 8.304021359428759e-10
resulted O 0 2.2704703395159953e-10
in O 0 2.1090325666439647e-11
the O 0 3.693007011307259e-10
absence O 0 2.3190620535018525e-09
or O 0 3.467816589441952e-10
a O 0 8.413420515829273e-10
dramatic O 0 1.1436486424543091e-08
decrease O 0 3.5539940768103406e-07
of O 0 1.1952309932894423e-06
CPO O 0 0.0008065254660323262
activity O 0 4.129433932575921e-07
. O 0 3.508965207288384e-08

The O 0 1.6620925080701454e-08
two O 0 9.102104486791163e-11
polymorphisms O 0 1.7632468818362668e-09
were O 0 4.91093221643979e-10
localized O 0 1.6562916371754e-08
in O 0 4.5927264769041187e-10
noncoding O 0 1.553593342862314e-08
part O 0 1.7236041482959763e-09
of O 0 7.515395417101445e-09
the O 0 8.880158275381689e-10
gene O 0 6.810920317318336e-12
1 O 0 2.729819481572804e-09
) O 0 1.1254390431744699e-12
a O 0 3.413786198169788e-10
C O 0 1.1488502593692829e-07
/ O 0 7.859934036957839e-09
G O 0 1.8506075560864588e-09
polymorphism O 0 5.998593982647904e-11
in O 0 3.5688420534779608e-12
the O 0 5.88467954920624e-11
promotor O 0 5.236497031546605e-07
region O 0 3.7082848791669676e-08
, O 0 1.4673476878002134e-09
142 O 0 1.069123278796269e-08
bp O 0 1.834288632096559e-08
upstream O 0 2.4761785955007554e-09
from O 0 2.6025794366835164e-11
the O 0 1.3855742941881743e-11
transcriptional O 0 2.5035064299405718e-11
initiation O 0 1.7126342011231088e-11
site O 0 3.979918825058881e-12
( O 0 1.177534225725932e-13
- O 0 2.730406178930167e-10
142C O 0 4.061784864006768e-08
/ O 0 2.794784181858745e-09
G O 0 2.416987054942865e-09
) O 0 1.1465423879405967e-12
, O 0 1.355497203196776e-12
and O 0 1.5044484755200038e-11
2 O 0 8.77836381363295e-09
) O 0 1.5294173913438236e-11
a O 0 4.8557664555914926e-09
6 O 0 5.3392376742067427e-08
bp O 0 3.828916739223587e-09
deletion O 0 6.857459045050973e-11
polymorphism O 0 1.992705479791912e-11
in O 0 7.303427827787257e-12
the O 0 5.509051201335602e-11
3 O 0 3.2548754802519397e-09
noncoding O 0 7.1550774194406586e-09
part O 0 5.257858592955245e-10
of O 0 1.1557443002629952e-08
the O 0 5.411910919406182e-08
CPO O 0 3.146780363749713e-05
gene O 0 1.6670954616770928e-09
, O 0 2.324818254573202e-10
574 O 0 5.2654712590083363e-08
bp O 0 1.07615747424461e-07
downstream O 0 1.8564097814532943e-08
of O 0 2.9173660709425064e-10
the O 0 4.7683409304388746e-11
last O 0 2.263366161159297e-10
base O 0 2.094597550961197e-10
of O 0 3.875702189737318e-11
the O 0 2.8471327725987372e-11
normal O 0 7.820034064742742e-10
termination O 0 1.4279325277755106e-08
codon O 0 1.624999867999577e-08
( O 0 2.2193347160026633e-10
+ O 0 7.538609736457147e-09
574 O 0 1.3847284208168276e-08
delATTCTT O 0 1.208634614613402e-07
) O 0 1.3646948848755613e-10
. O 0 3.241573676149301e-09

Five O 0 6.784781447777277e-08
intragenic O 0 8.49073057906935e-06
dimorphisms O 0 4.801473914994858e-05
are O 0 6.314110345684298e-11
now O 0 1.3815710728226627e-11
well O 0 6.301062644743782e-13
characterized O 0 5.710024467142638e-12
and O 0 7.096064729740503e-13
the O 0 3.64694429169643e-12
high O 0 5.965937466267945e-11
degree O 0 1.368924196221144e-09
of O 0 7.693287673582461e-11
allelic O 0 4.841820278045361e-09
heterogeneity O 0 1.1365594687617886e-08
in O 0 3.120304292725251e-10
HC B-Disease 1 0.9999938011169434
is O 0 5.970778316211067e-10
demonstrated O 0 1.1621087772639704e-11
with O 0 1.0321735463949058e-13
seven O 0 3.235540091059419e-12
new O 0 9.383592264756296e-14
different O 0 2.6129309626350336e-14
mutations O 0 9.17922638940527e-13
making O 0 8.041661954394375e-13
a O 0 3.0701229752905235e-11
total O 0 4.770454031799432e-10
of O 0 6.015946851789522e-09
nineteen O 0 5.56135682927561e-06
CPO O 1 0.9321877956390381
gene B-Disease 0 5.010824224882526e-06
defects I-Disease 0 0.38872626423835754
reported O 0 2.7917435474478225e-08
so O 0 3.618235711044804e-10
far O 0 9.59963553093246e-10
. O 0 2.667339682460579e-10
. O 0 5.871713781857579e-09

Coincidence O 0 8.020249993023754e-07
of O 0 3.8497871557297e-09
two O 0 5.9317698322680634e-12
novel O 0 1.5927170693430526e-10
arylsulfatase O 0 1.2558371054183226e-07
A O 0 1.7814073771660333e-08
alleles O 0 2.0290037705539277e-10
and O 0 1.7372242533397753e-10
mutation O 0 1.3400675014096919e-09
459 O 0 7.248870392828621e-09
+ O 0 4.9040265182043186e-09
1G O 0 8.573398702083068e-08
> O 0 1.3991917624522898e-09
A O 0 4.2198150529415557e-10
within O 0 3.1014697754461196e-11
a O 0 4.850744458884115e-11
family O 0 2.909590623989544e-11
with O 0 2.8909315913372424e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 3.566314188407915e-10
molecular O 0 1.0846361586658304e-09
basis O 0 3.828695693819384e-10
of O 0 1.8627177578167675e-10
phenotypic O 0 8.52524451033787e-08
heterogeneity O 0 2.8572558221640065e-06
. O 0 1.0522011706370904e-07

In O 0 4.1454645272054336e-10
a O 0 1.5220177895791664e-10
family O 0 9.012511223427389e-12
with O 0 1.894009038147515e-13
three O 0 5.343253617340338e-11
siblings O 0 1.3350315297699922e-09
, O 0 1.617864913219802e-12
one O 0 1.1520555559876855e-12
developed O 0 1.6018436577169837e-11
classical O 0 1.897932921934853e-09
late O 0 2.8465825380408205e-05
infantile O 1 0.9996272325515747
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 6.436269739396039e-09
MLD B-Disease 1 1.0
) O 0 5.8070097341822446e-11
, O 0 1.3052788017109407e-11
fatal O 0 3.932327352629272e-09
at O 0 1.531470950055791e-09
age O 0 1.8565575743423324e-09
5 O 0 9.232007158743727e-09
years O 0 3.1902205877010203e-10
, O 0 4.794933547436209e-12
with O 0 3.226825490837415e-12
deficient O 0 9.034385328732242e-08
arylsulfatase O 0 1.8419161733618239e-06
A O 0 1.1789348945967504e-06
( O 0 7.457461315141245e-10
ARSA O 0 5.72523788378021e-07
) O 0 2.8312482566739128e-12
activity O 0 1.732610756255415e-11
and O 0 1.155684597499429e-12
increased O 0 2.1645853165441764e-10
galactosylsulfatide O 0 2.2674501565234095e-07
( O 0 3.562617756358577e-09
GS O 0 0.02361561544239521
) O 0 1.656486725565287e-09
excretion O 0 1.8695205383778557e-09
. O 0 2.47845965972715e-10

The O 0 1.2284123052097584e-08
two O 0 4.2329369176474785e-11
other O 0 6.9773323403687915e-12
siblings O 0 7.214933650523392e-10
, O 0 5.937624697471833e-11
apparently O 0 2.4157625233556246e-08
healthy O 0 2.832336587488271e-10
at O 0 9.09853881125855e-09
12 O 0 6.853935197170813e-09
( O 0 4.2267890576486167e-11
1 O 0 1.431468717782991e-06
/ O 0 3.38905223884467e-08
2 O 0 3.557519789865182e-08
) O 0 3.4483620386244196e-12
and O 0 5.149798122661142e-12
15 O 0 1.7501450289003628e-10
years O 0 1.8236356869039128e-11
, O 0 5.629693759778842e-13
respectively O 0 1.7763289103522872e-11
, O 0 1.0262417001263846e-12
and O 0 1.70225107880978e-12
their O 0 6.079054360591529e-12
father O 0 1.5948640186280727e-09
, O 0 7.812456931377554e-11
apparently O 0 2.504417651039148e-08
healthy O 0 1.6146287432072803e-11
as O 0 1.263180315555501e-12
well O 0 1.4800673707460188e-12
, O 0 1.4721052068317197e-12
presented O 0 3.937909442974785e-10
ARSA O 0 4.4038920350431e-06
and O 0 2.4760216099650734e-10
GS O 0 0.31489887833595276
values O 0 1.9553265256933017e-11
within O 0 4.046666647605779e-12
the O 0 2.9469592998515592e-12
range O 0 5.907692668394304e-10
of O 0 3.2896205759413988e-09
MLD B-Disease 1 1.0
patients O 0 3.642877643983411e-08
. O 0 9.827251901128875e-09

Mutation O 0 1.0473352851647633e-08
screening O 0 3.651339508525808e-10
and O 0 2.1388470421851435e-12
sequence O 0 8.021154920823115e-12
analysis O 0 4.719494109753364e-13
disclosed O 0 1.1796963406141003e-10
the O 0 8.409562109179536e-12
involvement O 0 2.842652224721576e-10
of O 0 2.5180468821162094e-10
three O 0 1.9587605842863454e-11
different O 0 9.035402634416378e-12
ARSA O 0 5.259105819277465e-06
mutations O 0 2.4489505978664283e-09
being O 0 2.2868193449987473e-11
the O 0 1.5514383180925684e-11
molecular O 0 4.9789117273491e-11
basis O 0 3.1216496054753406e-10
of O 0 1.6338555508532693e-10
intrafamilial O 0 6.671837695648719e-07
phenotypic O 0 1.7091180097850156e-06
heterogeneity O 0 1.7092523194151e-05
. O 0 1.0022035468182366e-07

The O 0 1.762197943122601e-09
late O 0 4.5775138346471067e-07
infantile O 0 0.000538818771019578
patient O 0 6.932031055839616e-07
inherited O 0 4.6787340579612646e-07
from O 0 4.37655067742071e-08
his O 0 1.6079260944934504e-07
mother O 0 1.0601479694116733e-08
the O 0 6.0987139782753275e-09
frequent O 0 1.28116217634755e-09
0 O 0 4.4991059766630315e-09
- O 0 5.045357021060681e-09
type O 0 2.084142458613769e-08
mutation O 0 5.832835547892046e-09
459 O 0 1.9292996089603776e-09
+ O 0 3.378477220206122e-10
1G O 0 3.538967785488012e-09
> O 0 2.3054949616074794e-10
A O 0 3.65119351419807e-10
, O 0 8.683922179432424e-13
and O 0 2.3229841986625865e-13
from O 0 1.3700930147353407e-11
his O 0 1.1708263525367357e-10
father O 0 3.675773574407515e-11
a O 0 2.463173762179416e-12
novel O 0 1.8823484437824334e-12
, O 0 4.782764353832014e-13
single O 0 1.126178230531627e-11
basepair O 0 7.0261968687646e-08
microdeletion O 0 1.0146189310944465e-07
of O 0 2.614005722989532e-08
guanine O 0 1.9448236077135306e-10
at O 0 2.8710973598577993e-09
nucleotide O 0 3.946646898178585e-10
7 O 0 3.631332345932492e-09
in O 0 1.7418054845674824e-11
exon O 0 4.5875958587515697e-10
1 O 0 1.9141589646665125e-08
( O 0 4.7891773879982225e-11
7delG O 0 4.15539567200085e-08
) O 0 2.0420956592381856e-10
. O 0 3.840209483740864e-09

The O 0 1.2687540618117055e-07
two O 0 4.298566835814199e-09
clinically O 0 7.416596417897381e-06
unaffected O 0 3.8193567775124393e-07
siblings O 0 5.704938743633647e-09
carried O 0 7.533054735553435e-11
the O 0 4.5010267735179355e-10
maternal O 0 2.7869980101513647e-08
mutation O 0 3.6528253755108153e-09
459 O 0 2.1107538827891403e-08
+ O 0 5.623051801961765e-09
1G O 0 2.28365450993806e-07
> O 0 1.1227655249967938e-08
A O 0 1.4903477563166234e-08
and O 0 4.499136133095938e-11
, O 0 1.3490009456718077e-11
on O 0 5.988182172345091e-10
their O 0 2.7778163883690477e-12
paternal O 0 1.9694795794222841e-10
allele O 0 3.083681088256185e-10
, O 0 2.244063225173565e-12
a O 0 2.483502639649693e-11
novel O 0 1.2561564288748883e-10
cytosine O 0 1.130726692832873e-10
to O 0 1.9154462738146805e-10
thymidine O 0 2.357596962099251e-08
transition O 0 2.0604549177960507e-08
at O 0 5.514355194691234e-09
nucleotide O 0 4.002809195213786e-09
2435 O 0 6.14732371673199e-08
in O 0 1.9528292177772855e-11
exon O 0 1.3170665669193227e-09
8 O 0 1.9872419265709595e-09
, O 0 8.909648734935216e-13
resulting O 0 6.0753685068859475e-12
in O 0 1.4897997765994653e-11
substitution O 0 1.6022906612622734e-10
of O 0 4.78052819552488e-10
alanine O 0 1.881683919791044e-09
464 O 0 1.475292221719826e-09
by O 0 1.654086312363745e-10
valine O 0 2.0059467260580277e-06
( O 0 1.3480607741200856e-09
A464V O 0 6.628624305449193e-06
) O 0 5.684407389239254e-10
. O 0 6.685261677574772e-09

The O 0 4.041105583496574e-08
fathers O 0 3.6062082209298296e-09
genotype O 0 2.0784449716870768e-09
thus O 0 2.2732521420820717e-10
was O 0 4.047089774417145e-09
7delG O 0 5.908047455704946e-07
/ O 0 1.3657342606165912e-05
A464V O 0 0.00017142470460385084
. O 0 1.2001031279851304e-07

Mutation O 0 1.4482955066341674e-06
A464V O 0 1.7537078747409396e-05
was O 0 5.115571077851655e-09
not O 0 1.4141830068092887e-11
found O 0 9.895244346136423e-13
in O 0 1.564921261153207e-12
18 O 0 2.7393538548636798e-09
unrelated O 0 6.838894961447295e-08
MLD B-Disease 1 1.0
patients O 0 5.492524124406373e-08
and O 0 1.6456223050909102e-09
50 O 0 3.396992909188157e-08
controls O 0 7.27480227169508e-08
. O 0 1.809598515478683e-08

A464V O 0 0.0019509743433445692
, O 0 4.522868191081386e-10
although O 0 2.1723558715769364e-11
clearly O 0 3.257364100672788e-10
modifying O 0 5.751481957361193e-09
ARSA O 0 0.000253933307249099
and O 0 5.917622658557775e-08
GS O 1 1.0
levels O 0 3.5763076766670565e-07
, O 0 1.0360608204695865e-10
apparently O 0 4.892497074138191e-09
bears O 0 1.3047045388514533e-10
little O 0 2.982902987114233e-12
significance O 0 3.5390570682358735e-12
for O 0 1.2299102708501763e-12
clinical O 0 1.482827305387957e-09
manifestation O 0 1.1561505175450293e-07
of O 0 5.727127359023143e-07
MLD B-Disease 1 1.0
, O 0 3.4547993355005246e-09
mimicking O 0 1.8110487332023695e-08
the O 0 1.495221502167965e-09
frequent O 0 3.904643719465639e-09
ARSA O 0 0.00013063556980341673
pseudodeficiency O 0 9.520617823000066e-06
allele O 0 9.655168469180353e-07
. O 0 7.828472803339537e-08

Our O 0 3.154416106099234e-08
results O 0 5.520687795801393e-10
demonstrate O 0 8.774989762594387e-11
that O 0 7.546391896789961e-13
in O 0 1.9563549998741214e-12
certain O 0 9.273364715012278e-11
genetic O 0 1.1933326327095983e-08
conditions O 0 1.9372823771846015e-06
MLD B-Disease 1 1.0
- O 0 0.07466616481542587
like O 0 9.37733624084558e-09
ARSA O 0 0.0001745210465742275
and O 0 2.8760904768887485e-09
GS O 1 0.9998394250869751
values O 0 4.247123763789773e-10
need O 0 1.759036145909665e-11
not O 0 7.072972307668735e-13
be O 0 2.081193832721706e-13
paralleled O 0 3.3396738065988307e-12
by O 0 3.730039009868652e-13
clinical O 0 8.83908324311733e-09
disease O 0 7.20960002809079e-09
, O 0 8.252314847093101e-13
a O 0 1.4785696972330342e-11
finding O 0 7.472435864519511e-11
with O 0 4.1851973817987054e-13
serious O 0 2.1335544886369462e-08
diagnostic O 0 1.8713981475571018e-08
and O 0 1.903835533667575e-09
prognostic O 0 0.0011116977548226714
implications O 0 9.871391739579849e-06
. O 0 2.486002586010727e-07

Moreover O 0 4.242639022322692e-07
, O 0 3.0546238871664855e-09
further O 0 3.0569335507379947e-08
ARSA O 0 5.336990943760611e-05
alleles O 0 9.45466993584887e-09
functionally O 0 7.997835171913437e-10
similar O 0 1.1997798587959352e-12
to O 0 2.2352442119455418e-10
A464V O 0 4.6965089950390393e-07
might O 0 3.95375926443009e-10
exist O 0 3.678431864662102e-11
which O 0 2.4774646310149473e-12
, O 0 1.4112668282259544e-12
together O 0 3.5568390680668083e-13
with O 0 5.169034688126684e-13
0 O 0 5.9861644530201374e-09
- O 0 5.356269205947228e-09
type O 0 8.132918338787931e-09
mutations O 0 4.661353525392542e-09
, O 0 2.6309282877279294e-11
may O 0 6.363845450607641e-09
cause O 0 2.4239770937128924e-06
pathological O 0 0.0011653132969513535
ARSA O 0 0.0001328895305050537
and O 0 2.5839410611183666e-08
GS O 1 1.0
levels O 0 2.0462382011032787e-08
, O 0 4.4911920319898324e-13
but O 0 3.639505417960681e-14
not O 0 2.034744172197539e-13
clinical O 0 1.3449416060018482e-11
outbreak O 0 2.271534522979568e-11
of O 0 9.828290958857622e-11
the O 0 6.355945214586711e-10
disease O 0 3.390590919138958e-08
. O 0 2.8959057374322583e-10
. O 0 9.602606709790962e-09

Human O 0 0.0002193997788708657
MLH1 O 1 1.0
deficiency O 1 0.9999998807907104
predisposes O 0 1.7829011994763277e-05
to O 0 4.150588210904971e-07
hematological B-Disease 1 0.999607264995575
malignancy I-Disease 1 0.9999598264694214
and O 0 5.616159537424892e-09
neurofibromatosis B-Disease 1 0.9908595681190491
type I-Disease 0 0.0007781553431414068
1 I-Disease 0 0.40520521998405457
. O 0 3.15435642050943e-07

Heterozygous O 0 3.1141954792701654e-08
germ O 0 1.315289523518004e-06
- O 0 2.0111743381789893e-08
line O 0 4.6106247708621595e-09
mutations O 0 6.737482793894856e-11
in O 0 5.286815690092039e-12
the O 0 4.822607591048467e-11
DNA O 0 1.8609892515897286e-09
mismatch O 0 2.337507339689182e-06
repair O 0 6.8072126850893255e-06
genes O 0 6.827422627253554e-09
lead O 0 1.5240548822959e-09
to O 0 1.9456196653777624e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999816417694092

The O 0 2.6180973833334065e-08
disease O 0 6.177789657613175e-08
susceptibility O 0 2.1470587086014348e-08
of O 0 2.1389887638889604e-09
individuals O 0 1.4479355214813694e-10
who O 0 1.1812933564669947e-07
constitutionally O 0 4.4396092562237754e-06
lack O 0 3.690437324621598e-07
both O 0 4.371398798497239e-10
wild O 0 4.633393668740382e-10
- O 0 1.2931371251578838e-10
type O 0 1.625177908914921e-10
alleles O 0 9.847374304872147e-11
is O 0 7.85063333785807e-12
unknown O 0 1.4435352913011457e-09
. O 0 1.0281162587943982e-09

We O 0 8.279322116777621e-09
have O 0 1.1606999215929559e-11
identified O 0 1.1170136864080416e-11
three O 0 3.96131668049457e-13
offspring O 0 1.1785954157073064e-12
in O 0 6.864030421523462e-14
a O 0 1.2399409277108475e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9846463799476624
who O 0 8.343875812499846e-09
developed O 0 6.7098908651530564e-09
hematological B-Disease 0 0.0003561191842891276
malignancy I-Disease 1 0.9490363001823425
at O 0 2.010361122017912e-08
a O 0 1.9523228519946478e-11
very O 0 6.974015549082724e-13
early O 0 4.862873437261328e-10
age O 0 1.013695349882937e-09
, O 0 1.076920779115309e-12
and O 0 9.208088935439007e-13
at O 0 8.258322498067017e-11
least O 0 1.2084663998657152e-11
two O 0 1.761624049759214e-12
of O 0 4.824233460626326e-12
them O 0 1.8019272055372348e-13
displayed O 0 3.784706922860259e-12
signs O 0 1.0943838890664637e-10
of O 0 2.502657803216124e-10
neurofibromatosis B-Disease 0 0.00010126995766768232
type I-Disease 0 2.3395054995489772e-06
1 I-Disease 0 6.298865628195927e-05
( O 0 2.3396145021337134e-09
NF1 B-Disease 0 8.17084037407767e-06
) O 0 1.2375361846395094e-09
. O 0 7.581985705940042e-09

DNA O 0 3.083141741910822e-09
sequence O 0 4.668253283934831e-11
analysis O 0 3.8705567613830927e-13
and O 0 4.5469070132295175e-13
allele O 0 8.810758546362596e-12
- O 0 1.0893746842099983e-11
specific O 0 3.4821826411929324e-12
amplification O 0 2.0411299039846398e-10
in O 0 1.4019686453425884e-11
two O 0 5.3648929049243677e-11
siblings O 0 2.4353399297183387e-09
revealed O 0 2.3578565766513293e-09
a O 0 3.436410933588263e-09
homozygous O 0 1.2742611410487825e-08
MLH1 O 0 2.8991007638978772e-05
mutation O 0 2.8818744723935197e-08
( O 0 7.994063050409395e-11
C676T O 0 6.193517378960678e-07
- O 0 1.2193601151011535e-07
- O 0 2.3732779652618774e-07
> O 0 2.075550753488642e-07
Arg226Stop O 0 1.0535924275245634e-06
) O 0 8.984813587575857e-11
. O 0 2.028416545840628e-09

Thus O 0 1.8962403203204303e-08
, O 0 3.6806585557158655e-10
a O 0 1.5810347475664344e-09
homozygous O 0 2.75656097947774e-09
germ O 0 8.867817200552963e-07
- O 0 5.753756227022677e-08
line O 0 2.2843465785626904e-08
MLH1 O 0 6.674691121588694e-06
mutation O 0 5.598715713261981e-09
and O 0 1.283137485152963e-10
consequent O 0 4.02328405471053e-05
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 1.947777406030582e-07
in O 0 1.079591860353446e-09
a O 0 1.059765275535085e-09
mutator O 0 4.2557073243187915e-07
phenotype O 0 2.323888415034503e-09
characterized O 0 6.271270829028008e-12
by O 0 9.82250955919306e-13
leukemia B-Disease 0 0.0001026817990350537
and O 0 2.23328608939255e-08
/ O 1 0.9999617338180542
or O 1 0.9998859167098999
lymphoma B-Disease 1 1.0
associated O 0 1.0705500244512223e-05
with O 0 3.8897898790857255e-10
neurofibromatosis B-Disease 0 0.07855387032032013
type I-Disease 0 1.0258511792926583e-05
1 I-Disease 0 2.8716396627714857e-05
. O 0 2.9875768525755575e-09
. O 0 7.827394732373705e-09

Missense O 0 0.00011504521535243839
mutations O 0 6.950858733034693e-07
in O 0 1.7937284990665603e-09
the O 0 2.9956619407300877e-09
most O 0 3.6609545256416354e-11
ancient O 0 9.382985499684082e-10
residues O 0 7.961967440905937e-08
of O 0 2.7520521972412837e-10
the O 0 5.332475017105764e-10
PAX6 O 0 1.9741673895623535e-06
paired O 0 1.320136777671621e-10
domain O 0 2.4173976154173715e-09
underlie O 0 1.1065014460243106e-09
a O 0 3.2702736352252515e-11
spectrum O 0 9.44339149100415e-08
of O 0 2.6513445661180413e-08
human O 0 0.0011427673744037747
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.045813847333192825

Mutations O 0 1.129080757777956e-07
of O 0 4.565983591220402e-09
the O 0 6.136282593161013e-10
human O 0 3.016019101131917e-10
PAX6 O 0 7.7835993579356e-06
gene O 0 1.2333237542350162e-08
underlie O 0 0.00041645573219284415
aniridia B-Disease 1 1.0
( O 1 0.9999897480010986
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999998807907104
of I-Disease 0 0.47477447986602783
the I-Disease 0 7.566616204712773e-07
iris I-Disease 0 6.976652571211162e-07
) O 0 7.037623955818972e-12
, O 0 3.641104074064011e-13
a O 0 1.3080801199161218e-11
rare O 0 5.245778256224298e-10
dominant O 1 0.8817387223243713
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9999761581420898
eye I-Disease 1 0.999930739402771
. O 0 2.3357781628874363e-06

The O 0 4.300816058844248e-08
spectrum O 0 5.03397870943445e-07
of O 0 6.311795175406587e-08
PAX6 O 0 0.0004091752925887704
mutations O 0 1.557388600303966e-07
in O 0 4.6458557001471945e-09
aniridia B-Disease 1 1.0
patients O 0 2.2438074154251808e-07
is O 0 2.177890333354693e-11
highly O 0 3.834597136348483e-12
biased O 0 9.529395328389256e-11
, O 0 2.861153154676277e-13
with O 0 8.111766195816744e-14
92 O 0 1.4034308160049136e-09
% O 0 8.849972144009399e-11
of O 0 8.881339413902012e-11
all O 0 3.0383393717636764e-11
reported O 0 1.027579021872782e-09
mutations O 0 1.1213310280311362e-09
leading O 0 3.6374792067306316e-10
to O 0 8.395018569196111e-10
premature O 0 4.920481444514735e-08
truncation O 0 3.793554128606047e-07
of O 0 1.2863654319517082e-07
the O 0 1.6026040938754704e-08
protein O 0 2.2709087943439954e-09
( O 0 2.1778237199732153e-11
nonsense O 0 4.14407530513472e-09
, O 0 2.713552646471662e-11
splicing O 0 3.6973181460897564e-11
, O 0 1.4926488864364096e-12
insertions O 0 2.616096748953023e-11
and O 0 7.753356116857457e-12
deletions O 0 2.239597257647219e-10
) O 0 4.8608465343102925e-12
and O 0 1.3708353029107112e-11
just O 0 1.2666782067682902e-09
2 O 0 1.662869308916015e-08
% O 0 1.631258739198671e-10
leading O 0 2.2618417555575476e-11
to O 0 4.2796325511185174e-11
substitution O 0 2.1972768049494107e-10
of O 0 5.903400546181103e-10
one O 0 1.902687313259932e-10
amino O 0 1.1679134048758755e-10
acid O 0 2.979889121915158e-12
by O 0 2.8192354592330993e-13
another O 0 7.123329703873083e-11
( O 0 4.975287959396724e-10
missense O 0 5.768149549112422e-07
) O 0 3.0063256328816124e-09
. O 0 1.4860784602888089e-08

The O 0 1.3261091780236711e-08
extraordinary O 0 5.685993453852234e-09
conservation O 0 3.3158640277974882e-09
of O 0 1.5266092834309575e-09
the O 0 3.057445185916663e-09
PAX6 O 0 2.0039772152813384e-06
protein O 0 9.694566927009873e-09
at O 0 5.088867549574161e-09
the O 0 1.3277434707248403e-09
amino O 0 7.277671354444237e-09
acid O 0 1.2430631635140799e-08
level O 0 2.302684620758555e-08
amongst O 0 5.283362636276934e-10
vertebrates O 0 1.6454471563065454e-08
predicts O 0 1.162478895366803e-07
that O 0 1.2092884471570642e-09
pathological O 0 9.828029578784481e-05
missense O 0 2.0520659745670855e-05
mutations O 0 3.1549279810860753e-07
should O 0 7.183872385851942e-10
in O 0 3.274767956806812e-11
fact O 0 2.601090696996433e-11
be O 0 2.3339875171446423e-11
common O 0 3.3021335665850415e-11
even O 0 8.855252468797925e-12
though O 0 1.8028527889318857e-12
they O 0 9.381790049695082e-13
are O 0 2.1445566405608324e-13
hardly O 0 1.9545069729343112e-10
ever O 0 1.6625156806782115e-10
seen O 0 3.275337778774201e-10
in O 0 6.437445021489907e-10
aniridia B-Disease 1 1.0
patients O 0 1.8678272795114026e-07
. O 0 1.5757360927182162e-07

This O 0 5.9582787592660225e-09
indicates O 0 4.4396561982296134e-09
that O 0 4.035275152219908e-12
there O 0 1.7071053771966493e-12
is O 0 6.234332169431644e-13
a O 0 1.3455367896264558e-11
heavy O 0 2.530422804625232e-08
ascertainment O 0 3.7510099559767696e-07
bias O 0 7.4347128453666755e-09
in O 0 1.2232852751592471e-11
the O 0 2.845205494816927e-11
selection O 0 3.260688247186394e-11
of O 0 3.327302669497989e-11
patients O 0 3.3046267545328023e-12
for O 0 6.897635240754596e-12
PAX6 O 0 2.0810051637454308e-07
mutation O 0 3.888766531012777e-10
analysis O 0 3.30119980830601e-12
and O 0 2.1090945559031765e-13
that O 0 8.057490764011577e-13
the O 0 2.164019935468886e-10
missing O 0 3.226153566515677e-09
PAX6 O 0 2.9350139811867848e-05
missense O 0 9.176845196634531e-06
mutations O 0 6.83042102878062e-08
frequently O 0 6.222886095308411e-11
may O 0 9.96094873251252e-10
underlie O 0 8.165936549175967e-08
phenotypes O 0 2.2209576400200604e-09
distinct O 0 7.3513651763224e-12
from O 0 4.49673354108171e-11
textbook O 0 1.4779861601255107e-07
aniridia B-Disease 1 1.0
. O 0 2.5619050347813754e-07

Here O 0 1.4174203144534658e-08
we O 0 7.464515811017591e-11
present O 0 5.995284563936609e-12
four O 0 4.951622336983597e-13
novel O 0 1.2461051634993225e-10
PAX6 O 0 1.5425465562657337e-06
missense O 0 8.858443720782816e-07
mutations O 0 2.1359731761094736e-08
, O 0 2.294587610196519e-11
two O 0 5.502264442680538e-12
in O 0 1.2464657778155086e-11
association O 0 8.803031220638857e-12
with O 0 3.7119786411299316e-12
atypical O 0 1.800597573264895e-07
phenotypes O 0 1.724235545452757e-07
ectopia B-Disease 0 4.083070962224156e-06
pupillae I-Disease 0 1.0105358114742558e-06
( O 0 7.590974723803434e-12
displaced B-Disease 0 2.1824532459024937e-10
pupils I-Disease 0 1.0533884875485455e-10
) O 0 2.155023035022019e-11
and O 0 2.1768636671026798e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 0 0.0010827606311067939
( O 0 4.32585495202531e-10
searching B-Disease 0 1.9413603169482485e-08
gaze I-Disease 0 1.5064578917645122e-08
) O 0 8.615422828275876e-13
, O 0 3.1193770439960633e-13
and O 0 3.2749269875814724e-13
two O 0 5.116644412848925e-13
in O 0 2.9234123802290846e-12
association O 0 7.556059944402449e-12
with O 0 1.089559106999538e-12
more O 0 5.8049832302176085e-11
recognizable O 0 9.961964053673e-08
aniridia B-Disease 1 1.0
phenotypes O 0 1.8644989268068457e-06
. O 0 9.044109816613854e-08

Strikingly O 0 1.280003090187165e-07
, O 0 1.077053890519153e-09
all O 0 1.3891951478051112e-10
four O 0 4.5798913272943054e-11
mutations O 0 1.2896099466086497e-10
are O 0 5.740313281134279e-13
located O 0 5.227437580024308e-11
within O 0 2.95946156469995e-10
the O 0 5.56566659426494e-09
PAX6 O 0 3.3272681321250275e-06
paired O 0 3.2999016852386376e-09
domain O 0 1.316060238565342e-08
and O 0 6.531017393562877e-10
affect O 0 2.0598340810806803e-08
amino O 0 3.099487599911299e-08
acids O 0 2.813341504204203e-10
which O 0 1.686901703393251e-12
are O 0 6.221538583796316e-13
highly O 0 3.248141772910218e-12
conserved O 0 3.4505218127200976e-11
in O 0 4.654026296291303e-12
all O 0 9.772413780972933e-12
known O 0 9.858932420447886e-11
paired O 0 1.5078448212246798e-10
domain O 0 4.392889607629513e-09
proteins O 0 4.9729893814021153e-11
. O 0 1.4625269051382617e-10

Our O 0 7.256201861594036e-09
results O 0 1.2342991906333367e-10
support O 0 5.899222083050049e-11
the O 0 1.0029078262308033e-10
hypothesis O 0 9.182107157945651e-11
that O 0 2.1700335281417578e-14
the O 0 1.497661586760679e-13
under O 0 3.1215752639007777e-12
- O 0 2.6998663721355953e-11
representation O 0 9.480338736267413e-11
of O 0 7.350110520221165e-10
missense O 0 1.8514434714234085e-06
mutations O 0 2.0923123145166755e-07
is O 0 2.8346375594012763e-11
caused O 0 1.0279392614886973e-10
by O 0 2.7516256634330105e-11
ascertainment O 0 6.896950708323857e-06
bias O 0 3.7281532172528387e-07
and O 0 3.3177207509060835e-11
suggest O 0 1.653290698788723e-11
that O 0 7.266682101967487e-14
a O 0 1.6069472141833074e-12
substantial O 0 2.06863554064185e-10
burden O 0 1.936098215082893e-08
of O 0 2.2886075257133598e-08
PAX6 B-Disease 1 0.9999972581863403
- I-Disease 1 0.9999977350234985
related I-Disease 1 0.9999948740005493
disease I-Disease 1 1.0
remains O 0 2.5067594222605294e-08
to O 0 2.1191919330476594e-09
be O 0 7.268636803559048e-10
uncovered O 0 2.8436311083623877e-08
. O 0 3.594895492398109e-10
. O 0 4.239857798182811e-09

The O 0 3.941037274302062e-09
chromosomal O 0 2.1630404489769717e-07
order O 0 8.421002561931346e-09
of O 0 6.912016914384367e-08
genes O 0 2.153899281154281e-09
controlling O 0 2.419221232230484e-07
the O 0 8.141888940826902e-09
major O 0 1.490555803229654e-07
histocompatibility O 0 8.1669058999978e-06
complex O 0 6.086050774456453e-08
, O 0 8.29669839774727e-12
properdin O 0 1.8231922638278775e-09
factor O 0 1.4260204128646592e-10
B O 0 4.315440449431662e-09
, O 0 3.867944376248489e-13
and O 0 8.929557614167916e-12
deficiency B-Disease 0 2.1043308606749633e-07
of I-Disease 0 8.714039267943008e-07
the I-Disease 0 6.421471709927573e-08
second I-Disease 0 1.7061909218796245e-08
component I-Disease 0 1.885581912830503e-09
of I-Disease 0 3.1761122620821425e-09
complement I-Disease 0 2.5600539466097416e-09
. O 0 3.192335995549911e-08

The O 0 9.622738161851885e-09
relationship O 0 3.4485978517295734e-09
of O 0 1.6599477348222536e-08
the O 0 1.8799906076338857e-09
genes O 0 1.464879779977668e-11
coding O 0 1.1514306175186562e-10
for O 0 6.17401199609624e-11
HLA O 0 1.4396315251019587e-08
to O 0 1.9367168979655958e-10
those O 0 1.7502635625554763e-12
coding O 0 1.5652713500347026e-11
for O 0 1.121543287928295e-12
properdin O 0 2.648714803044072e-09
Factor O 0 5.3248797732274866e-11
B O 0 4.796987251864948e-10
allotypes O 0 6.558780740739678e-10
and O 0 8.472540160772701e-13
for O 0 7.897343889951003e-11
deficiency B-Disease 0 2.043984324018311e-07
of I-Disease 0 3.0213311674742727e-07
the I-Disease 0 6.52885390195479e-09
second I-Disease 0 1.6496950472344452e-09
component I-Disease 0 4.6256054542226366e-10
of I-Disease 0 9.148685697901726e-10
complement I-Disease 0 6.002304764329836e-10
( O 0 2.265115317534594e-10
C2 O 0 2.1767563396224432e-07
) O 0 6.171465682242028e-12
was O 0 3.9453350308971125e-11
studied O 0 1.0260146681914661e-12
in O 0 4.418239049359257e-14
families O 0 2.0682931821218442e-13
of O 0 1.3465227197140273e-11
patients O 0 3.6529258784501195e-11
with O 0 1.2355404199748676e-10
connective O 1 0.999993085861206
tissue O 1 1.0
disorders O 1 1.0
. O 0 7.577147334814072e-05

Patients O 0 1.913919959406485e-06
were O 0 8.004717444443088e-10
selected O 0 3.5030284228909636e-11
because O 0 1.0276486259175321e-11
they O 0 2.880901246726797e-12
were O 0 1.9158023691762116e-12
heterozygous O 0 2.384882439102065e-12
or O 0 9.01769076078196e-11
homozygous O 0 4.114791174458787e-09
for O 0 3.039434091078874e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 8.049336429394316e-06

12 O 0 2.942765036095807e-07
families O 0 1.1234413399563437e-10
with O 0 1.2755382687579253e-11
15 O 0 3.678879423318904e-08
matings O 0 5.986943278912804e-07
informative O 0 3.0068491696511046e-08
for O 0 5.329124519448669e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 1.0740802025566154e-07
found O 0 1.1302292435289019e-09
. O 0 2.6473814251914973e-09

Of O 0 3.610371322793071e-06
57 O 0 5.992952765154769e-07
informative O 0 1.3573756341145327e-08
meioses O 0 1.326384449384932e-06
, O 0 7.56112394917352e-11
two O 0 8.996710494646454e-12
crossovers O 0 1.368187368955276e-10
were O 0 1.1617807410546632e-11
noted O 0 6.804765084744702e-12
between O 0 6.150812636995795e-10
the O 0 2.3087982015113084e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 7.935303802941718e-11
and O 0 1.759824751201844e-11
the O 0 2.3312568542266376e-10
HLA O 0 7.154667969189177e-09
- O 0 1.409612515601566e-08
B O 0 5.7402846920240336e-08
gene O 0 5.456319532477771e-13
, O 0 2.2671941364224568e-14
with O 0 5.1750663758627635e-15
a O 0 1.7880086300436915e-11
recombinant O 0 5.4068438094800886e-12
fraction O 0 1.855538056538819e-09
of O 0 2.5073509934969707e-09
0 O 0 1.1438355329573824e-07
. O 0 9.401763811922592e-09

035 O 0 0.0038225145544856787
. O 0 2.709445652726572e-06

A O 0 3.2318772014150454e-07
lod O 0 4.694019935413962e-06
score O 0 1.7627963533328739e-09
of O 0 1.3535039755652178e-10
13 O 0 1.1767413432561824e-10
was O 0 1.3999591416680168e-11
calculated O 0 4.7184728346749694e-11
for O 0 6.8251207636926825e-12
linkage O 0 1.0778563108715389e-07
between O 0 0.00016131738084368408
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.2141152911103745e-08
HLA O 0 5.1719275973027834e-08
- O 0 3.5385223640105323e-09
B O 0 1.3575458535086682e-09
at O 0 5.801800012639191e-13
a O 0 5.704162457046552e-14
maximum O 0 1.309443005415023e-11
likelihood O 0 1.2895797277256982e-11
value O 0 8.29995881052037e-12
of O 0 2.0789741456139765e-11
the O 0 1.784584459374461e-11
recombinant O 0 9.678843013519178e-13
fraction O 0 9.977277337647195e-11
of O 0 1.814857708559714e-10
0 O 0 1.4148299420924104e-08
. O 0 3.2007421157942417e-09

04 O 0 0.0012471493100747466
. O 0 1.5129013490877696e-06

18 O 0 7.312724505936785e-07
families O 0 1.4072631948636172e-10
with O 0 5.300647941408609e-12
21 O 0 6.865370494324452e-09
informative O 0 2.2117663256437936e-10
matings O 0 2.4957579114470718e-08
for O 0 2.914066904446955e-11
both O 0 6.34380603603546e-11
properdin O 0 3.120197789030499e-07
Factor O 0 2.9984230653923305e-09
B O 0 7.946595381724819e-09
allotype O 0 1.2111450509166843e-08
and O 0 1.2090503598294333e-10
HLA O 0 1.265744309364436e-08
- O 0 1.6446564998773283e-08
B O 0 6.093531368378535e-08
were O 0 1.9692532327031387e-11
found O 0 1.0875187035630507e-11
. O 0 2.1989621235007917e-10

Of O 0 1.0306857802788727e-05
72 O 0 2.582869910838781e-06
informative O 0 1.0616352241754612e-08
meioses O 0 4.558582531899447e-06
, O 0 6.603404489879949e-10
three O 0 2.517888397779444e-10
recombinants O 0 1.4451497918344103e-06
were O 0 1.9905650461282676e-09
found O 0 2.209033130029514e-11
, O 0 1.6994060238889608e-12
giving O 0 1.0685726392276051e-12
a O 0 7.711254551567848e-11
recombinant O 0 2.244338222212594e-11
fraction O 0 2.811562094251485e-09
of O 0 5.911956257875772e-09
0 O 0 2.2918864317489351e-07
. O 0 1.5572247491490998e-08

042 O 0 0.007248523645102978
. O 0 4.546468971966533e-06

A O 0 6.632062081735057e-07
lod O 0 9.125476935878396e-06
score O 0 2.7926849721637836e-09
of O 0 6.611016178936779e-10
16 O 0 1.0446115084050689e-09
between O 0 4.2130676725093963e-10
HLA O 0 3.805707038395667e-08
- O 0 8.00262967004528e-09
B O 0 5.481835874121543e-09
and O 0 6.375617265033662e-13
Factor O 0 1.2219747783093204e-11
B O 0 4.1877029621772976e-10
allotypes O 0 8.5075635425369e-10
was O 0 4.5058946157583435e-11
calculated O 0 6.210909564430267e-11
at O 0 3.8655346284999226e-12
a O 0 1.3270730001013753e-12
maximum O 0 2.483059036162416e-10
likelihood O 0 1.3171538859602094e-10
value O 0 3.5309543483519334e-11
of O 0 8.815367880110614e-11
the O 0 1.0795830895915515e-10
recombinant O 0 3.784649243304683e-12
fraction O 0 2.3138031768343836e-10
of O 0 2.4796606434840385e-10
0 O 0 1.183592157616431e-08
. O 0 1.9578287879795653e-09

04 O 0 0.0010759476572275162
. O 0 2.247521706522093e-06

A O 0 1.0362638391825385e-07
crossover O 0 9.246352128400304e-09
was O 0 1.7034780253055715e-09
shown O 0 3.2003709578287687e-12
to O 0 3.3589873937867054e-11
have O 0 1.8092842762190697e-12
occurred O 0 1.3599449344425807e-10
between O 0 1.595708287727149e-11
genes O 0 3.0179190309981285e-13
for O 0 2.02962782214558e-13
Factor O 0 2.0859399277317614e-12
B O 0 1.0192902771821721e-10
and O 0 1.7173403541251298e-12
HLA O 0 4.9596380335970025e-09
- O 0 1.0246555603998786e-08
D O 0 1.7422623344032218e-09
, O 0 1.3013727465441272e-12
in O 0 1.101500726567728e-12
which O 0 7.721965428197919e-12
HLA O 0 5.6924602809260705e-09
- O 0 3.06636871449939e-09
D O 0 4.2004302813758443e-10
segregared O 0 2.2611494898683304e-09
with O 0 2.955718352362635e-12
HLA O 0 5.162778649037136e-09
- O 0 5.853696416480147e-10
A O 0 2.2518142905880723e-09
and O 0 3.074160023763817e-11
B O 0 9.114191357184609e-08
. O 0 7.72161945494787e-10

These O 0 6.813551389761585e-10
studies O 0 1.3059069103871224e-10
suggest O 0 2.7767902560649205e-11
that O 0 8.506933764189373e-13
the O 0 3.880670958189558e-12
genes O 0 1.0322365656461815e-13
for O 0 1.3707267200631368e-13
Factor O 0 3.705069584469811e-11
B O 0 1.6877216069133283e-07
and O 0 3.283704330669934e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 4.877975454120609e-11
located O 0 3.845402121727126e-11
outside O 0 1.3864441712752029e-11
those O 0 2.2139660439159103e-13
for O 0 6.9963219245794406e-12
HLA O 0 6.7228040911970766e-09
, O 0 3.5722997910464516e-13
that O 0 1.877377207414998e-14
the O 0 2.580629666123352e-13
order O 0 1.5241950496874823e-12
of O 0 4.8556111388597945e-12
genese O 0 5.888615817184473e-09
is O 0 1.9305492968135773e-11
HLA O 0 3.393746617064153e-09
- O 0 6.905105376375786e-10
A O 0 9.23892962134687e-09
, O 0 5.129124555636189e-12
- O 0 3.154575212160893e-10
B O 0 6.190314039145051e-09
, O 0 2.198121242316664e-12
- O 0 3.3413211086852357e-10
D O 0 4.876443138179809e-10
, O 0 9.019458790948676e-12
Factor O 0 1.2898658530158258e-10
B O 0 1.2437840979373505e-08
allotype O 0 1.1156993195982068e-06
, O 0 5.041608375222495e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 5.7145819326587244e-11
that O 0 1.991625397587682e-12
the O 0 1.5957934626498194e-11
genes O 0 2.30916718038654e-12
coding O 0 3.4815220151251935e-10
for O 0 1.1576940517343814e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.0632697772526853e-09
Factor O 0 1.6023525839514718e-09
B O 0 7.385865696818428e-09
allotypes O 0 2.526148845660714e-09
are O 0 6.856298027154567e-14
approximately O 0 1.2092404985328264e-12
3 O 0 2.815530274202782e-11
- O 0 1.9803610140645134e-11
- O 0 1.0230805785882424e-10
5 O 0 1.4060182185193781e-10
centimorgans O 0 5.975928085710791e-10
from O 0 2.6566745765094213e-12
the O 0 1.0538180571229017e-11
HLA O 0 1.4225540190260233e-10
- O 0 2.537906343413887e-11
A O 0 3.478428933778588e-10
and O 0 7.6622380315583e-12
HLA O 0 3.308937845947213e-10
- O 0 1.6981245576364046e-10
B O 0 9.75986957918451e-10
loci O 0 2.7409962320701364e-12
, O 0 8.657650808828292e-15
and O 0 1.888761711390922e-15
that O 0 6.389549838932505e-15
the O 0 1.9899166949638447e-12
apparent O 0 1.8739583218518874e-09
lack O 0 1.0902674318913341e-09
of O 0 4.496110150853383e-10
recombinants O 0 2.8768875282025874e-08
between O 0 6.358758519731111e-10
the O 0 1.3066899784419661e-09
Factor O 0 3.6633451827583485e-10
B O 0 1.7525852769040284e-08
gene O 0 2.333214177419052e-10
and O 0 3.598171005592121e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.8993164818681407e-09
suggests O 0 6.088247961333337e-11
that O 0 4.872010455660158e-13
these O 0 2.4604024872164343e-13
two O 0 5.9798554996604025e-12
genes O 0 3.889357932940207e-11
lie O 0 2.6122899399183552e-09
in O 0 7.177975661770697e-12
close O 0 2.3683945915564664e-09
proximity O 0 6.390056928040622e-09
to O 0 4.743943460283617e-09
one O 0 1.0669003458474435e-09
another O 0 3.5230669492847255e-09
. O 0 2.2505702190755983e-08

Distribution O 0 1.2709114649567255e-08
of O 0 6.0609801622035775e-09
emerin O 0 1.2198445801914204e-05
and O 0 4.182413082531866e-09
lamins O 0 1.2248792700120248e-05
in O 0 7.534149970567228e-10
the O 0 1.5266325981144746e-09
heart O 0 8.402840201426898e-09
and O 0 1.511976828461048e-11
implications O 0 1.1180251169307098e-09
for O 0 9.146727125708409e-11
Emery B-Disease 1 0.9965882301330566
- I-Disease 1 0.9999996423721313
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.000269956944976002

Emerin O 0 0.0002533954393584281
is O 0 4.248778662230279e-09
a O 0 2.6498518934658932e-09
nuclear O 0 2.829297898188088e-07
membrane O 0 3.132865078470104e-09
protein O 0 1.9189567990185452e-10
which O 0 4.127532734002348e-13
is O 0 3.134605422450143e-12
missing O 0 4.870565409320626e-11
or O 0 3.668167505854747e-11
defective O 0 9.123528599275232e-09
in O 0 7.912632354889482e-11
Emery B-Disease 0 0.20449189841747284
- I-Disease 1 0.9999994039535522
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3640270708492608e-06
EDMD B-Disease 1 1.0
) O 0 3.0114350124677e-08
. O 0 9.386465649185993e-08

It O 0 8.414599746153772e-12
is O 0 8.807225782003769e-13
one O 0 7.457677054026335e-13
member O 0 4.569601207843332e-12
of O 0 4.5138344451078893e-11
a O 0 1.569584018312753e-09
family O 0 6.3959100238264455e-09
of O 0 1.7782544148303714e-07
lamina O 1 0.9999728202819824
- O 1 0.6583483815193176
associated O 0 2.406322039405495e-07
proteins O 0 4.366305234038137e-11
which O 0 1.8117775075349174e-12
includes O 0 9.823671823921964e-13
LAP1 O 0 1.3004721949982923e-05
, O 0 5.542379888368032e-10
LAP2 O 0 0.00013460639456752688
and O 0 1.3119249686610601e-08
lamin O 0 1.0575139640423004e-05
B O 0 2.0847210180363618e-06
receptor O 0 3.8681983483002114e-07
( O 0 2.1768706837121954e-09
LBR O 0 1.4955579672459862e-06
) O 0 1.8479294483508824e-10
. O 0 2.9927211819824606e-09

A O 0 4.659214482671814e-06
panel O 0 2.3749105082515598e-07
of O 0 2.6156067534088834e-08
16 O 0 9.767900266410834e-09
monoclonal O 0 3.8151148906706567e-10
antibodies O 0 9.986497184755194e-10
( O 0 1.245235581315285e-10
mAbs O 0 3.6291599059268265e-08
) O 0 2.0169872716468973e-11
has O 0 7.339778090864613e-12
been O 0 8.430680632776077e-12
mapped O 0 6.826166021323132e-11
to O 0 3.693955905048618e-11
six O 0 5.564575709937625e-12
specific O 0 2.3038309541340007e-12
sites O 0 1.3918413296898358e-11
throughout O 0 9.53622684291e-12
the O 0 5.733538088747991e-10
emerin O 0 6.405556973732018e-08
molecule O 0 2.262593584712036e-10
using O 0 3.726046554630713e-11
phage O 0 4.449587226451612e-11
- O 0 3.693934741422211e-11
displayed O 0 1.6399170433070709e-12
peptide O 0 2.0940731787488787e-11
libraries O 0 2.19060099920787e-11
and O 0 1.505722976857804e-11
has O 0 1.7069630431354454e-11
been O 0 2.5306976566413786e-12
used O 0 1.1323269795762703e-12
to O 0 4.4711453289769665e-11
localize O 0 1.427430618150538e-07
emerin O 0 8.772021828917786e-07
in O 0 1.389420384301232e-10
human O 0 3.2654945414378744e-10
and O 0 2.938139731512024e-10
rabbit O 0 2.427844663088763e-07
heart O 0 9.357503927276412e-07
. O 0 2.6851989787246566e-07

Several O 0 2.7070521380068158e-09
mAbs O 0 1.3113175612033956e-07
against O 0 1.2857006570499152e-09
different O 0 5.3295839963496405e-11
emerin O 0 6.481521381829225e-07
epitopes O 0 1.410748069474721e-07
did O 0 1.0823505425250346e-09
not O 0 9.62151747163631e-11
recognize O 0 1.938686711167037e-10
intercalated O 0 4.881684834145972e-09
discs O 0 1.8576672644599057e-08
in O 0 2.938688736797701e-10
the O 0 2.9945368407169326e-09
heart O 0 4.0401193501793387e-08
, O 0 1.5116106283352693e-11
though O 0 2.183729325838657e-12
they O 0 2.8638955356513618e-12
recognized O 0 2.360977385817975e-11
cardiomyocyte O 0 1.0175666886880208e-07
nuclei O 0 1.2939136695422349e-07
strongly O 0 7.550841729653257e-09
, O 0 1.2963302653545838e-10
both O 0 3.379673971237729e-11
at O 0 1.4807987724907434e-08
the O 0 3.886979349498887e-10
rim O 0 1.1193272086984507e-08
and O 0 1.3528710270105382e-11
in O 0 1.0596899746584398e-10
intranuclear O 0 9.942107226379449e-07
spots O 0 1.4392884217784285e-08
or O 0 4.0234149345508285e-09
channels O 0 1.0174599651691096e-07
. O 0 2.8749568059538433e-08

A O 0 2.8072931854694616e-06
polyclonal O 0 1.6973610854620347e-06
rabbit O 0 1.621581624533519e-08
antiserum O 0 3.8203253893698275e-08
against O 0 1.0735882405299435e-08
emerin O 0 8.99863152881153e-06
did O 0 3.268270631906489e-08
recognize O 0 7.066082829965126e-09
both O 0 1.647091796286304e-09
nuclear O 0 1.6021783721953398e-06
membrane O 0 4.926329566501408e-09
and O 0 1.2194467657877794e-10
intercalated O 0 3.930885339453738e-10
discs O 0 9.154114688492143e-10
but O 0 3.200470097275421e-11
, O 0 2.9901432892220914e-12
after O 0 3.177308763313569e-11
affinity O 0 1.3515299122912605e-11
purification O 0 1.1198188210048698e-11
against O 0 2.0810847836671975e-11
a O 0 4.7324158480854805e-11
pure O 0 1.010460048966877e-09
- O 0 2.261779208367898e-09
emerin O 0 9.416429946895732e-08
band O 0 2.737425008891847e-10
on O 0 4.609013726231126e-10
a O 0 8.238876247901317e-11
western O 0 3.6570637629296243e-09
blot O 0 2.47046818913077e-06
, O 0 3.074324475549339e-11
it O 0 4.216609266610716e-12
stained O 0 4.260058084071261e-09
only O 0 8.094040437889305e-10
the O 0 6.248058959101854e-09
nuclear O 0 3.6812841699429555e-06
membrane O 0 4.201308172468998e-07
. O 0 1.640999869323423e-08

These O 0 4.0279432567125184e-10
results O 0 1.7614273928323598e-10
would O 0 7.962902004443606e-10
not O 0 1.748380051846965e-10
be O 0 5.427014740377878e-11
expected O 0 1.6212962083983484e-09
if O 0 8.199609324854862e-10
immunostaining O 0 2.7985416295450705e-07
at O 0 2.3863661269274417e-08
intercalated O 0 1.3760392825190593e-09
discs O 0 1.1577742320412199e-08
were O 0 6.766768395616296e-11
due O 0 1.2265831683677675e-09
to O 0 4.2004125871963893e-11
a O 0 1.7271104685301353e-11
product O 0 3.8266494140071217e-11
of O 0 6.47282713539532e-11
the O 0 1.7863120704841862e-10
emerin O 0 1.1269454347484498e-07
gene O 0 5.4876363869693634e-11
and O 0 1.661959979359917e-11
, O 0 8.352956347434937e-12
therefore O 0 2.4203627990715404e-10
, O 0 1.4137730049157415e-11
cast O 0 3.76371746269033e-11
some O 0 3.226343617181854e-13
doubt O 0 2.7623793877329383e-11
upon O 0 1.4761773400873146e-11
the O 0 5.638315335454447e-12
hypothesis O 0 3.2227753798963477e-10
that O 0 1.8187621547705035e-11
cardiac B-Disease 0 4.519937283475883e-05
defects I-Disease 0 1.803886152629275e-05
in O 0 3.946748705629943e-08
EDMD B-Disease 1 1.0
are O 0 1.8301326010217167e-09
caused O 0 1.1925953558034053e-08
by O 0 1.0776410319657259e-10
absence O 0 7.515068745078679e-08
of O 0 6.884504699655736e-08
emerin O 0 5.511777999345213e-06
from O 0 1.8385765088169137e-07
intercalated O 0 1.0026431027654326e-06
discs O 0 3.162134817102924e-06
. O 0 1.5939501452066906e-07

Although O 0 1.7513022143589296e-08
emerin O 0 3.906935307895765e-05
was O 0 2.697467493817385e-07
abundant O 0 9.609087969764118e-10
in O 0 4.8707791272528667e-11
the O 0 5.040680095547145e-10
membranes O 0 1.0650095250142044e-09
of O 0 4.931735464452913e-09
cardiomyocyte O 0 3.8136425928314566e-07
nuclei O 0 5.530240514417528e-07
, O 0 5.797735208590282e-11
it O 0 7.519470289485408e-12
was O 0 1.0602505540191487e-09
absent O 0 9.561553770964792e-10
from O 0 4.105161002798674e-11
many O 0 2.0341942106455457e-12
non O 0 4.016269095075131e-09
- O 0 1.4701834416541715e-08
myocyte O 0 1.943727845343801e-08
cells O 0 2.1859056231754437e-11
in O 0 6.07827807183603e-12
the O 0 2.614491956265397e-10
heart O 0 3.082243438257137e-08
. O 0 5.1393588051951156e-08

This O 0 4.033078593312922e-10
distribution O 0 2.949483102199224e-09
of O 0 7.961838410786015e-10
emerin O 0 8.948156278165698e-07
was O 0 1.5059601343736517e-09
similar O 0 2.1037481652552703e-12
to O 0 5.734530211798372e-11
that O 0 2.2242695966318005e-12
of O 0 3.7309413891684073e-10
lamin O 0 9.447982733945537e-07
A O 0 2.1219191737031906e-08
, O 0 1.7286989548170872e-11
a O 0 6.895429366382544e-11
candidate O 0 9.559802949254959e-10
gene O 0 6.51468462509186e-13
for O 0 4.799652428971735e-13
an O 0 2.0195423024865766e-12
autosomal O 0 1.6339186670322192e-09
form O 0 4.527974084567177e-08
of O 1 0.8797075748443604
EDMD B-Disease 1 1.0
. O 0 6.894205580465496e-05

In O 0 1.7851215616815352e-08
contrast O 0 1.6503221900165954e-08
, O 0 1.7615738201470776e-08
lamin O 0 0.0002644742780830711
B1 O 0 0.00011579549754969776
was O 0 1.394280531030745e-07
absent O 0 2.501600881998911e-08
from O 0 1.8546111313355595e-09
cardiomyocyte O 0 1.2816464050047216e-06
nuclei O 0 2.1401608591986587e-06
, O 0 5.505188527266114e-10
showing O 0 7.820183389739555e-10
that O 0 1.1599176064081007e-09
lamin O 0 5.7488914535497315e-06
B1 O 0 8.765431971369253e-07
is O 0 1.6713441394755613e-11
not O 0 1.3503755405541717e-11
essential O 0 1.635313932879523e-11
for O 0 1.2253495960956595e-11
localization O 0 3.155710004421053e-08
of O 0 1.2183971165313778e-08
emerin O 0 3.271601940468827e-07
to O 0 2.6077511705580037e-08
the O 0 1.6355814480562003e-08
nuclear O 0 2.668725574039854e-05
lamina O 1 0.9983075857162476
. O 0 4.7072256847968674e-07

Lamin O 1 0.927251935005188
B1 O 0 0.008362830616533756
is O 0 4.767543027028864e-10
also O 0 1.7248915837320133e-11
almost O 0 2.578901259209232e-10
completely O 0 7.410503766180909e-09
absent O 0 3.8815819891624415e-08
from O 0 1.1770836749747104e-08
skeletal O 0 7.087303401931422e-07
muscle O 0 3.239764794216171e-07
nuclei O 0 0.0011181191075593233
. O 0 3.7898760183452396e-06

In O 0 6.490193271702083e-08
EDMD B-Disease 1 1.0
, O 0 1.6197415630969658e-09
the O 0 1.3434091339359355e-10
additional O 0 3.451818691990738e-11
absence O 0 6.460992185708392e-09
of O 0 2.0193537508816917e-08
lamin O 0 5.3965159168001264e-05
B1 O 0 3.549821121850982e-05
from O 0 2.8400211959933586e-08
heart O 0 0.00023221143055707216
and O 0 1.951438264313765e-07
skeletal O 0 0.0002644457563292235
muscle O 0 1.0213024324912112e-05
nuclei O 1 0.9980912804603577
which O 0 2.979828082061431e-07
already O 0 2.1223968360573053e-08
lack O 0 2.4041145962883093e-08
emerin O 0 9.588042360064719e-08
may O 0 1.1408500533161003e-10
offer O 0 4.796186451466733e-12
an O 0 4.4428152021040723e-13
alternative O 0 7.74434405492741e-11
explanation O 0 1.9299170594955228e-10
of O 0 2.391840892013164e-10
why O 0 1.0508519748819722e-10
these O 0 6.858842053342196e-12
tissues O 0 1.8833667958517708e-10
are O 0 2.272989739135478e-12
particularly O 0 1.3113427010935652e-11
affected O 0 3.582868446372345e-10
. O 0 4.430416034040263e-10
. O 0 8.848091148649928e-09

Genetic O 0 2.3715607255780924e-07
mapping O 0 1.245103220526289e-07
of O 0 2.823823024300509e-07
the O 0 9.388757860051555e-08
copper B-Disease 0 2.110071136485203e-06
toxicosis I-Disease 0 0.0002736079040914774
locus O 0 9.11320086061096e-08
in O 0 3.3305631585989204e-09
Bedlington O 0 6.635946760980005e-07
terriers O 0 4.473301373764116e-08
to O 0 5.4053876930026945e-09
dog O 0 7.512901412098927e-09
chromosome O 0 1.32323947354962e-07
10 O 0 9.28744547934457e-09
, O 0 2.212527903944217e-12
in O 0 2.2567126119199532e-12
a O 0 1.2609237265426287e-10
region O 0 2.187193359759476e-08
syntenic O 0 3.100675485256943e-06
to O 0 1.6053819607009245e-08
human O 0 3.0273283879722612e-09
chromosome O 0 7.121836006263038e-06
region O 0 2.055707000181428e-06
2p13 O 0 0.00013336911797523499
- O 0 4.820279173145536e-06
p16 O 0 5.262324407340202e-07
. O 0 7.432586102140704e-09

Abnormal O 1 0.9999996423721313
hepatic B-Disease 1 1.0
copper I-Disease 0 0.0021922739688307047
accumulation I-Disease 0 1.1846979759866372e-05
is O 0 1.0066156241883562e-11
recognized O 0 7.603026281471914e-13
as O 0 5.89156924201556e-13
an O 0 8.666457829153984e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.784129722182115e-06
man O 0 1.4989196643000469e-05
, O 0 2.9700644721408764e-10
mouse O 0 5.194864272084487e-08
, O 0 9.55098578003799e-09
rat O 0 1.0796891274367226e-06
and O 0 3.84176246370771e-09
dog O 0 8.202923709177412e-07
. O 0 8.92858764700577e-08

The O 0 1.5554078913737612e-08
major O 0 1.793719519582737e-07
cause O 0 0.02202628180384636
of O 1 0.9996981620788574
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 1.0
in O 0 1.1326756975904573e-05
man O 0 2.529282028262969e-05
is O 0 5.468619654336315e-11
a O 0 1.8084650443839223e-10
dysfunctional O 0 2.0754391982791276e-08
ATP7B O 0 0.0001733866665745154
gene O 0 4.868942471425441e-10
, O 0 4.4153139477920433e-11
causing O 0 4.4418186462280573e-07
Wilson B-Disease 0 8.438822987955064e-06
disease I-Disease 0 0.0008227594662457705
( O 0 1.765942836406964e-09
WD B-Disease 0 0.00011632726818788797
) O 0 4.408148956969171e-09
. O 0 2.7617883091579642e-08

Mutations O 0 1.4073027898575674e-07
in O 0 9.00243490864483e-10
the O 0 8.023981479254871e-09
ATP7B O 1 0.9944214224815369
genes O 0 1.601009103069373e-08
have O 0 3.724767716484223e-11
also O 0 2.8734161317683915e-12
been O 0 3.707414583664637e-12
demonstrated O 0 6.184640039680334e-12
in O 0 1.5997430810599234e-11
mouse O 0 2.26760743515797e-08
and O 0 1.4061591890879299e-08
rat O 0 2.016701728280168e-06
. O 0 2.093205786479757e-08

The O 0 4.4228056594874943e-07
ATP7B O 1 0.8415709137916565
gene O 0 2.1447081888226194e-09
has O 0 4.116090454586718e-11
been O 0 1.7017552297882155e-11
excluded O 0 2.2041100888881004e-10
in O 0 4.9775231679427545e-12
the O 0 4.024669486568655e-11
much O 0 3.425650874078201e-10
rarer O 0 9.249861818716454e-07
human O 0 2.127278975194713e-07
copper B-Disease 0 6.237394700292498e-05
overload I-Disease 1 0.9983035326004028
disease O 0 0.009684538468718529
non B-Disease 0 3.2340693678634125e-07
- I-Disease 0 6.220770387699304e-08
Indian I-Disease 0 6.363105153894821e-09
childhood I-Disease 0 2.207676601528874e-07
cirrhosis I-Disease 1 0.9977812170982361
, O 0 1.9316331867358372e-10
indicating O 0 9.408652523745786e-09
genetic O 0 1.5192472346825525e-07
heterogeneity O 0 2.4096939341688994e-06
. O 0 1.0442678188837817e-07

By O 0 1.4962620031866436e-10
investigating O 0 6.495490811886384e-09
the O 0 2.7433382232544545e-09
common O 0 1.6427215143721696e-07
autosomal O 0 0.06191624328494072
recessive O 1 0.9999562501907349
copper B-Disease 1 0.9999994039535522
toxicosis I-Disease 1 0.9999996423721313
( O 0 3.776249357656525e-08
CT B-Disease 1 0.8711928725242615
) O 0 2.5219593080549885e-10
in O 0 4.080994653321568e-09
Bedlington O 0 1.5078346223162953e-05
terriers O 0 6.529397751364741e-07
, O 0 3.405741244577598e-10
we O 0 3.555683178446678e-11
have O 0 1.6662623429468393e-13
identified O 0 1.5774469404317149e-13
a O 0 2.2093333157955156e-14
new O 0 1.1176256690676855e-14
locus O 0 1.0315639401708987e-12
involved O 0 1.521060566996718e-13
in O 0 8.917967059263177e-12
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.796402158215642e-05

We O 0 7.182330818977789e-08
examined O 0 8.97923690956759e-09
whether O 0 3.518129676471915e-10
the O 0 8.554327246557136e-10
WD B-Disease 0 2.2962979073781753e-06
gene O 0 2.670079490840749e-09
ATP7B O 0 0.0006677639321424067
was O 0 6.994360290946133e-08
also O 0 8.586133193322354e-11
causative O 0 8.600199996600111e-10
for O 0 1.0654802734544333e-10
CT B-Disease 0 2.8038019195264496e-07
by O 0 4.012819243559562e-11
investigating O 0 1.1098832963796212e-09
the O 0 2.737792215157242e-09
chromosomal O 0 4.9233074150834e-07
co O 0 2.3879687560679486e-08
- O 0 3.999026176870757e-08
localization O 0 5.846666226716479e-07
of O 0 4.081129816313478e-07
ATP7B O 0 0.0009835942182689905
and O 0 8.482194502335005e-09
C04107 O 0 5.82088489409216e-07
, O 0 8.95526708344363e-11
using O 0 9.796156941188627e-11
fluorescence O 0 2.2783754882738094e-09
in O 0 3.693924277570204e-09
situ O 0 5.246794287927514e-08
hybridization O 0 4.456080393566708e-09
( O 0 2.608215865507191e-10
FISH O 0 2.2277044209317864e-08
) O 0 5.686182774633508e-11
. O 0 8.055905387216455e-10

C04107 O 0 0.0004950204165652394
is O 0 3.3191907555796263e-10
an O 0 2.7340426797528572e-11
anonymous O 0 3.605559739661146e-10
microsatellite O 0 1.5207534431738168e-07
marker O 0 6.659023199517833e-08
closely O 0 6.156587462058383e-10
linked O 0 5.394164404037838e-08
to O 0 1.5805762814125046e-06
CT B-Disease 1 0.9999929666519165
. O 0 7.503004326281371e-06

However O 0 2.8868981871710275e-07
, O 0 2.132443910340953e-08
BAC O 0 7.733946404187009e-05
clones O 0 3.2757597523414006e-08
containing O 0 2.2064824967138463e-10
ATP7B O 0 1.5963223631842993e-05
and O 0 9.459967253988566e-10
C04107 O 0 8.639780730845814e-07
mapped O 0 3.474849963325255e-09
to O 0 1.228955381904484e-09
the O 0 2.777448548929584e-10
canine O 0 3.122395453303284e-09
chromosome O 0 3.3714893987735195e-08
regions O 0 1.3004201271371585e-08
CFA22q11 O 0 4.129193769131234e-07
and O 0 3.7718689283039453e-10
CFA10q26 O 0 1.920679778777412e-06
, O 0 1.9047424748563913e-10
respectively O 0 1.3661618503135742e-09
, O 0 4.573597056634071e-11
demonstrating O 0 8.18457385198812e-11
that O 0 1.7765254545221154e-11
WD B-Disease 0 3.648336530659435e-07
cannot O 0 9.709500758958711e-09
be O 0 5.544821823910695e-10
homologous O 0 6.29398588802843e-10
to O 0 1.9813388263401066e-08
CT B-Disease 0 5.2606705139623955e-05
. O 0 8.91621496634798e-08

The O 0 8.68566712597385e-06
copper O 0 1.6419255643995712e-06
transport O 0 1.2167581076028e-07
genes O 0 2.345364791267457e-09
CTR1 O 0 6.250794740481069e-06
and O 0 7.119271838718078e-10
CTR2 O 0 0.00023902890097815543
were O 0 1.3808506560408773e-09
also O 0 2.4852181076950863e-11
excluded O 0 3.972247808459173e-10
as O 0 1.7479925493169013e-11
candidate O 0 2.9965478987037386e-09
genes O 0 8.75160638402761e-11
for O 0 2.0644101705880047e-10
CT B-Disease 0 0.00017872080206871033
since O 0 4.9018410663848044e-08
they O 0 5.4948004479804524e-11
both O 0 5.192426349998058e-12
mapped O 0 1.8334237461559155e-09
to O 0 3.2160287766203055e-09
canine O 0 1.8399884993414162e-07
chromosome O 0 1.0077053957502358e-05
region O 0 8.560407877666876e-06
CFA11q22 O 0 0.0031162924133241177
. O 0 1.1922608109671273e-06

2 O 0 2.3732496629236266e-05
- O 0 3.899911916960264e-06
22 O 0 9.689399576018332e-07
. O 0 2.1145538653399854e-08

5 O 0 4.561954119708389e-05
. O 0 3.7665529362129746e-07

A O 0 8.281755867756146e-07
transcribed O 0 4.934670450040812e-09
sequence O 0 2.5500523914701034e-10
identified O 0 2.975631199775286e-11
from O 0 1.4858154637198417e-11
the O 0 8.239174620339185e-11
C04107 O 0 3.6347572063277767e-08
- O 0 2.1482620127244445e-09
containing O 0 8.702435300156353e-11
BAC O 0 7.336838621085917e-07
was O 0 1.0047234155763363e-09
found O 0 9.887885865991763e-13
to O 0 1.17741415575634e-11
be O 0 8.805180543025592e-12
homologous O 0 1.049339261316451e-11
to O 0 5.970650363007479e-11
a O 0 9.961229063826238e-11
gene O 0 3.115450258883712e-11
expressed O 0 1.848478488331029e-11
from O 0 2.714682367788157e-10
human O 0 1.853846104404866e-10
chromosome O 0 2.77668931403241e-07
2p13 O 0 1.6385795333917486e-06
- O 0 2.6066670599789177e-08
p16 O 0 2.1263910632285388e-09
, O 0 3.3039131326628723e-13
a O 0 2.7285398333104505e-12
region O 0 2.394451859011326e-10
devoid O 0 7.397126799979503e-10
of O 0 2.2762186233094006e-11
any O 0 9.625665542412065e-11
positional O 0 1.4762866484829829e-08
candidate O 0 7.26161772490741e-07
genes O 0 1.2837655383179936e-08
. O 0 4.744105996934422e-09

Molecular O 0 1.8987485361776635e-08
analysis O 0 7.560994191857517e-11
of O 0 8.196888723333018e-10
the O 0 1.483579814554048e-09
APC B-Disease 0 4.584781443384145e-09
gene O 0 1.976209343737545e-12
in O 0 2.373682196979421e-12
205 O 0 3.3864234333380594e-11
families O 0 1.919555226576053e-12
: O 0 9.27045549700689e-13
extended O 0 1.581837105746331e-09
genotype O 0 5.2459437682728094e-08
- O 0 1.0074991507735831e-07
phenotype O 0 8.22633783315041e-09
correlations O 0 9.476044837697373e-09
in O 0 5.648392517598744e-11
FAP B-Disease 0 1.3349391037031921e-10
and O 0 4.50727400281431e-13
evidence O 0 1.300809503515521e-12
for O 0 2.32465522526093e-13
the O 0 6.6856342510746014e-12
role O 0 2.541330861027813e-11
of O 0 8.470129597704101e-10
APC B-Disease 0 2.848428382051793e-09
amino O 0 2.4295359057902033e-09
acid O 0 8.950147845077083e-10
changes O 0 2.2918507369684704e-10
in O 0 2.0467386718792113e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 6.686982669634745e-05

BACKGROUND O 0 5.8251004020348773e-08
/ O 0 8.873089996086492e-08
AIMS O 0 1.4086145938563277e-07
The O 0 5.097102184770108e-10
development O 0 7.277880076372867e-09
of O 0 3.922294581570895e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.550752942198642e-10
a O 0 6.891454421009691e-12
variable O 0 4.388647778519328e-11
range O 0 7.289348291639186e-11
of O 0 3.8556619702534434e-11
extracolonic O 0 5.482596066030965e-07
manifestations O 0 1.7557994169692392e-06
in O 0 2.2314281977742212e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.4003664894346457e-09
FAP B-Disease 0 7.145527503027438e-10
) O 0 1.9715689652155706e-14
is O 0 6.786168357803121e-15
the O 0 1.1788466524557256e-13
result O 0 2.9659625450095817e-12
of O 0 5.0013933966530644e-11
the O 0 1.5644424644634114e-10
dominant O 0 1.901804047577116e-08
inheritance O 0 3.023832732651499e-06
of O 0 2.5812820240389556e-05
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 1.0
( O 0 4.8050572409863435e-09
APC B-Disease 0 4.343800696915423e-08
) O 0 9.058875871659211e-11
gene O 0 2.6817253973021593e-10
mutations O 0 7.100750654132071e-09
. O 0 9.000018508231733e-09

In O 0 1.0587691834373913e-09
this O 0 3.103493503853194e-11
study O 0 6.6420254712928894e-12
, O 0 7.296625733092463e-14
direct O 0 5.647808175995861e-12
mutation O 0 6.536144889213169e-12
analysis O 0 2.758892073129182e-12
of O 0 1.6553834691901415e-10
the O 0 4.887178439716422e-10
APC B-Disease 0 2.110603913862974e-09
gene O 0 3.837122980465679e-11
was O 0 2.9554170222212406e-10
performed O 0 6.809123577478093e-13
to O 0 1.471207877745684e-11
determine O 0 5.2751539247886114e-11
genotype O 0 2.2868913429618942e-09
- O 0 9.567176384450704e-09
phenotype O 0 1.928762483061064e-09
correlations O 0 1.87618653946231e-09
for O 0 2.361887248281125e-11
nine O 0 1.870147370297559e-10
extracolonic O 0 5.969076255496475e-08
manifestations O 0 1.0771283420751843e-08
and O 0 8.06470602104925e-12
to O 0 4.2931547206137566e-11
investigate O 0 2.4937557227544538e-11
the O 0 7.327371348564427e-12
incidence O 0 2.3875803556450137e-09
of O 0 3.679816173995931e-10
APC B-Disease 0 3.5763567662883133e-09
mutations O 0 7.288906145319629e-10
in O 0 5.340209940918328e-10
non O 1 0.9421861171722412
- O 1 1.0
FAP O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.7757048883358948e-05

METHODS O 0 6.3681259234726895e-06
The O 0 7.632846887872802e-08
APC B-Disease 0 4.578098966590005e-08
gene O 0 8.601705459021503e-11
was O 0 3.562602435280837e-10
analysed O 0 2.537533377866552e-11
in O 0 1.2418235927416643e-12
190 O 0 6.525634893561616e-11
unrelated O 0 1.4310339024881102e-10
FAP B-Disease 0 8.3338513867659e-10
and O 0 1.974160765416677e-11
15 O 0 1.2792123982308112e-07
non O 0 0.49483585357666016
- O 1 0.9999998807907104
FAP O 1 0.9999966621398926
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 9.180963900234929e-08
using O 0 4.852998003457287e-09
denaturing O 0 9.82744950306369e-07
gradient O 0 1.473638633342489e-07
gel O 0 4.048418045243807e-09
electrophoresis O 0 8.341039525738836e-10
, O 0 1.5274378983853865e-11
the O 0 1.1332463439872598e-10
protein O 0 4.933771793891317e-11
truncation O 0 1.793844850439541e-09
test O 0 5.201737304783016e-11
, O 0 2.810253386335143e-13
and O 0 1.3988533638722989e-12
direct O 0 1.7806184304802741e-09
sequencing O 0 8.053267386287644e-09
. O 0 1.585009101745527e-08

RESULTS O 0 4.660112153942464e-06
Chain O 0 1.361358670237678e-07
terminating O 0 4.6059597025305266e-08
signals O 0 1.2878949018357844e-09
were O 0 8.446953206342478e-12
only O 0 8.972679912434833e-13
identified O 0 9.41682062188809e-13
in O 0 2.113298549826989e-13
patients O 0 2.9124025782180374e-13
belonging O 0 9.60852274481394e-13
to O 0 7.405211860378458e-11
the O 0 6.47453424207356e-10
FAP B-Disease 0 9.912926479671569e-09
group O 0 1.581993147592442e-10
( O 0 1.4498534317564093e-10
105 O 0 3.5983913448944804e-07
patients O 0 1.0503996561439521e-09
) O 0 2.336469628883009e-10
. O 0 1.4071224185840947e-08

Amino O 0 1.4260876923799515e-07
acid O 0 2.6235849048816817e-09
changes O 0 8.10769073406048e-12
were O 0 1.4124490422748326e-12
identified O 0 6.666530391954972e-13
in O 0 9.829813964754366e-14
four O 0 2.6673661109727353e-13
patients O 0 2.441018036574566e-13
, O 0 3.6329439619380705e-14
three O 0 5.808997488761236e-13
of O 0 1.3012897703834625e-10
whom O 0 8.796724459969596e-11
belonged O 0 3.1789049170782846e-10
to O 0 3.1589647564445045e-10
the O 0 1.098171220625943e-09
non O 0 1.8608841401146492e-07
- O 0 3.71315479696932e-07
FAP O 0 5.827634197430598e-08
group O 0 1.5708419009996533e-09
of O 0 6.317772204056382e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 4.4132466427981853e-05

Genotype O 0 2.396694071649108e-05
- O 0 3.136136456305394e-06
phenotype O 0 9.009021795236549e-08
correlations O 0 1.924757775384478e-08
identified O 0 1.4393225500342055e-10
significant O 0 3.450857655185047e-11
differences O 0 2.146585548201685e-10
in O 0 4.654276963833581e-11
the O 0 4.01666533367262e-10
nature O 0 1.2440627694676465e-10
of O 0 5.5360799278147965e-11
certain O 0 1.0095695113232495e-10
extracolonic O 0 3.906899905814498e-07
manifestations O 0 2.078989069786985e-08
in O 0 1.7804409335742122e-10
FAP B-Disease 0 2.858508096892365e-09
patients O 0 6.921515877805762e-12
belonging O 0 2.063388522544063e-12
to O 0 8.410015045479113e-11
three O 0 1.02423250436523e-10
mutation O 0 2.0891175012138774e-08
subgroups O 0 2.5773854872568336e-07
. O 0 2.7835980631607526e-08

CONCLUSIONS O 0 5.4164979701454286e-06
Extended O 0 1.4977788964642968e-07
genotype O 0 6.387804774021788e-08
- O 0 2.171990409749469e-08
phenotype O 0 3.2469200661466857e-09
correlations O 0 2.476570726273053e-09
made O 0 3.951638669064117e-11
in O 0 2.4338794868405955e-11
this O 0 2.8134420140824012e-11
study O 0 3.568136064391325e-11
may O 0 1.6398436775144631e-10
have O 0 5.296625985029557e-12
the O 0 1.430956655251725e-11
potential O 0 1.3920138479395217e-11
to O 0 4.5901490941524514e-11
determine O 0 1.8173308691249446e-10
the O 0 3.3182710051926634e-11
most O 0 3.4317861052901577e-13
appropriate O 0 1.2767406923352986e-11
surveillance O 0 2.348833350040991e-10
and O 0 6.470654567714007e-11
prophylactic O 0 5.103370767756132e-06
treatment O 0 1.788338721553373e-08
regimens O 0 2.2007411171198754e-10
for O 0 1.2996240368601253e-12
those O 0 1.5163571353421501e-12
patients O 0 2.1019221519563702e-13
with O 0 9.35408976839025e-14
mutations O 0 6.295759746866025e-11
associated O 0 1.0331638322647052e-10
with O 0 5.184836067428922e-12
life O 0 1.11280429315741e-09
threatening O 0 1.9380257754164631e-07
conditions O 0 1.8207962057203986e-05
. O 0 3.0367075964932155e-07

This O 0 2.089208139821608e-09
study O 0 6.695438647952301e-11
also O 0 7.039926638603006e-14
provided O 0 7.950319683191001e-14
evidence O 0 1.798401813753181e-12
for O 0 1.8309817637757186e-12
the O 0 8.60695681392798e-11
pathological O 0 2.445013365104387e-07
nature O 0 2.126784304223861e-09
of O 0 9.111702503616925e-09
amino O 0 1.1105567576663589e-09
acid O 0 8.974725129728967e-11
changes O 0 2.1806825008935382e-12
in O 0 1.2639714795648072e-11
APC O 0 5.476680220439789e-10
associated O 0 5.802456171793979e-12
with O 0 3.832479852135945e-14
both O 0 2.2059418094272365e-12
FAP B-Disease 0 7.274351121466793e-10
and O 0 2.36141967091541e-10
non O 1 0.5379348993301392
- O 1 1.0
FAP O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.0958779007050907e-07
. O 0 4.527332730930311e-09
. O 0 9.60139789896175e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.0014437971403822303
cancer B-Disease 1 1.0
risk O 1 0.7541208863258362
of O 0 0.0007700781570747495
the O 0 1.150768184743356e-05
APC O 0 1.7735354731485131e-06
I1307K O 0 9.90477292361902e-06
polymorphism O 0 5.890033776267956e-07
. O 0 8.724868649778728e-08

Germ O 0 6.0389611462596804e-05
- O 0 3.809614952388074e-07
line O 0 2.566802592696149e-08
and O 0 3.719246299827006e-10
somatic O 0 1.1754369033667444e-08
truncating O 0 1.1556874568441344e-07
mutations O 0 2.2772979058061082e-09
of O 0 1.8996495487755283e-09
the O 0 1.086715273324046e-09
APC B-Disease 0 1.4811369908329652e-09
gene O 0 6.780382245247241e-12
are O 0 1.7458383100733138e-13
thought O 0 7.551186780897778e-13
to O 0 3.511048743409795e-11
initiate O 0 5.8181605311347084e-08
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999841451644897
formation O 0 5.57596149519668e-06
in O 0 7.089262908266392e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.01692606508731842
sporadic O 1 0.9999407529830933
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 4.4566652945832175e-07
respectively O 0 2.4687344080120965e-07
. O 0 1.1132616606346346e-07

Recently O 0 1.4455314101269323e-07
, O 0 7.843037885812976e-10
an O 0 1.4989134378140534e-09
isoleucine O 0 1.399899247189751e-06
- O 0 5.59509885533771e-07
- O 0 3.0940418582758866e-07
> O 0 6.609975145011049e-08
lysine O 0 3.316352703564007e-08
polymorphism O 0 2.050533770558971e-10
at O 0 4.964595401446559e-10
codon O 0 2.988030933792629e-10
1307 O 0 5.230993860294575e-09
( O 0 1.5396789745936168e-11
I1307K O 0 7.850469074810462e-08
) O 0 4.229899850521912e-12
of O 0 7.365881515841721e-11
the O 0 2.4848781365882644e-10
APC B-Disease 0 6.923678075310136e-09
gene O 0 1.8005720178737583e-11
has O 0 4.986091292451256e-13
been O 0 3.2054277309713497e-13
identified O 0 3.2698339478762217e-13
in O 0 7.223129971749287e-13
6 O 0 4.349832161132383e-10
% O 0 3.38653965981095e-11
- O 0 3.13195552825718e-10
7 O 0 9.670834799635486e-09
% O 0 7.040164978766583e-11
of O 0 4.633285421995481e-11
the O 0 9.46119016465019e-11
Ashkenazi O 0 7.378684774295152e-09
Jewish O 0 4.1755479629479453e-10
population O 0 4.399339399718816e-12
. O 0 3.8065670060483114e-10

To O 0 1.6953302761635314e-08
assess O 0 3.0808504192236796e-08
the O 0 3.453308472511907e-10
risk O 0 1.1086794815540202e-09
of O 0 5.111918527367365e-11
this O 0 3.813474275943252e-12
common O 0 5.529874474996532e-11
APC B-Disease 0 1.8703623094751265e-09
allelic O 0 1.3505211393649574e-09
variant O 0 3.1702536151811955e-09
in O 0 1.7813631458807322e-08
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 1.5281634659913834e-06
we O 0 2.6092388694110014e-08
have O 0 2.29604113499704e-11
analyzed O 0 1.411735919137902e-11
a O 0 1.8369635240017557e-12
large O 0 4.792391743863034e-12
cohort O 0 1.7729720469539245e-10
of O 0 1.0135209338457685e-10
unselected O 0 3.133658879050927e-07
Ashkenazi O 0 3.313728669240845e-08
Jewish O 0 3.933024572688737e-09
subjects O 0 7.65593477503046e-10
with O 0 3.0563225561497376e-11
adenomatous B-Disease 0 5.082825282443082e-06
polyps I-Disease 0 3.527349008436431e-07
and O 0 1.5979720324743596e-10
. O 0 9.553968727260553e-10
or O 1 0.9994008541107178
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.4806237125242205e-08
for O 0 1.6031962424278845e-09
the O 0 7.362282161693656e-08
APC O 0 8.466035694709717e-08
I1307K O 0 1.4359835631694295e-06
polymorphism O 0 1.1737044758319826e-07
. O 0 4.068282422053926e-08

The O 0 1.275905674447131e-07
APC O 0 9.311714421755823e-08
I1307K O 0 5.25677137375169e-07
allele O 0 1.602428967295566e-09
was O 0 4.490025573566925e-10
identified O 0 7.500190572773402e-12
in O 0 1.4118167572518825e-11
48 O 0 4.4703818424807196e-09
( O 0 1.3098727831561963e-11
10 O 0 7.342403907095729e-10
. O 0 1.2783244948688655e-11
1 O 0 1.6822653492454265e-08
% O 0 2.45499204298838e-10
) O 0 5.378517076159994e-12
of O 0 1.7913548422399117e-10
476 O 0 7.633222054437283e-09
patients O 0 8.332897705187747e-10
. O 0 2.596275416877347e-09

Compared O 0 1.923057935115935e-09
with O 0 5.448520324149997e-13
the O 0 2.298937776257226e-11
frequency O 0 4.691998178874002e-11
in O 0 2.2267472967515273e-13
two O 0 1.8320524744074203e-14
separate O 0 4.294753165297663e-14
population O 0 4.393884480433444e-14
control O 0 2.20634990312496e-12
groups O 0 8.0465826059542e-14
, O 0 1.8225358288520566e-12
the O 0 1.1005169692213101e-10
APC O 0 6.441845723514916e-09
I1307K O 0 3.4908211432593816e-08
allele O 0 2.7685839731894646e-10
is O 0 2.344116925307588e-13
associated O 0 1.9144717278499201e-13
with O 0 3.4143051070873592e-15
an O 0 5.222430018818336e-13
estimated O 0 2.970040186012213e-11
relative O 0 1.5507060080466317e-09
risk O 0 1.4230656653069218e-08
of O 0 1.067196393478298e-07
1 O 0 0.0004537627683021128
. O 0 3.5446788615445257e-07

5 O 0 2.1952107999823056e-05
- O 0 2.1259354525682284e-06
1 O 0 5.05477919432451e-06
. O 0 3.4211943500395137e-08

7 O 0 2.1910448140260996e-06
for O 0 9.608855044973552e-09
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.02331993728876114
( O 0 2.1259245475135913e-09
both O 0 6.106070316036494e-09
P O 0 6.028196003171615e-05
= O 0 4.06668210217731e-09
. O 0 5.2540971573478146e-11
01 O 0 1.1706438041159117e-09
) O 0 3.8894169135383905e-11
. O 0 1.4901109235410104e-09

Furthermore O 0 4.427413458074625e-08
, O 0 6.030496241260508e-11
compared O 0 8.687874031299003e-11
with O 0 4.2576146601358555e-12
noncarriers O 0 3.529563400661573e-06
, O 0 1.444667385719356e-09
APC O 0 1.0026873553670157e-07
I1307K O 0 7.616716857228312e-07
carriers O 0 5.881100467730604e-11
had O 0 1.4852949425936401e-10
increased O 0 1.9004015375245764e-11
numbers O 0 1.4732345118145806e-12
of O 0 9.995238664517458e-11
adenomas B-Disease 0 1.8213553630630486e-05
and O 0 7.47648755350383e-07
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 7.945725883473642e-06
patient O 0 2.6000364528044884e-07
( O 0 1.8446404126404303e-10
P O 0 2.0462266547838226e-06
= O 0 4.841826939383509e-10
. O 0 9.13518132666935e-12
03 O 0 8.452550465110065e-11
) O 0 9.626316670868773e-13
, O 0 1.5621180564362458e-12
as O 0 1.1979824684343887e-12
well O 0 5.111708582458685e-13
as O 0 7.07537381548079e-13
a O 0 2.1787294191000228e-11
younger O 0 9.344153922841159e-11
age O 0 1.0103000658290284e-09
at O 0 3.0739226719589396e-09
diagnosis O 0 4.942402256347123e-07
. O 0 8.36918623292604e-09

We O 0 2.8468656765312517e-08
conclude O 0 1.656098049807042e-07
that O 0 2.8379321462268514e-11
the O 0 3.532592829369463e-10
APC O 0 2.9051529182311242e-08
I1307K O 0 2.805197993893671e-07
variant O 0 4.392236352401824e-09
leads O 0 9.742479045726782e-10
to O 0 1.6560119941999574e-10
increased O 0 5.6676077164752314e-09
adenoma B-Disease 1 1.0
formation O 0 1.3846536717210256e-07
and O 0 2.0116326659991302e-10
directly O 0 3.6619760002132296e-10
contributes O 0 3.540584492256471e-11
to O 0 1.612444622267617e-10
3 O 0 1.2847103381119496e-09
% O 0 1.8321670569587667e-11
- O 0 3.2285878831528336e-11
4 O 0 1.1556858942052273e-10
% O 0 1.603542385680834e-12
of O 0 2.2114592329678523e-13
all O 0 4.99765051391321e-13
Ashkenazi O 0 5.690270654667984e-08
Jewish O 0 4.143594196648337e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.197901711857412e-07

The O 0 2.8313998257090134e-08
estimated O 0 5.3210675865500434e-09
relative O 0 2.4298428158431307e-08
risk O 0 1.826422124651117e-09
for O 0 1.866725177213091e-11
carriers O 0 7.228952852988968e-11
may O 0 1.695950269109403e-09
justify O 0 7.272714097616984e-10
specific O 0 2.2771565882928613e-11
clinical O 0 2.009054901608298e-11
screening O 0 6.329493353052218e-12
for O 0 6.972885268317908e-13
the O 0 2.7020248885567533e-11
360 O 0 7.788253930662847e-10
, O 0 1.887764250474433e-11
000 O 0 1.624737705485657e-10
Americans O 0 1.6761061939415955e-12
expected O 0 4.0711656268399565e-10
to O 0 4.251824725631792e-10
harbor O 0 1.2826077977479144e-08
this O 0 7.997994627695348e-12
allele O 0 4.5555403199726285e-11
, O 0 1.1555039694174929e-12
and O 0 2.0737218366095878e-12
genetic O 0 3.4864624208486017e-12
testing O 0 6.92100998907208e-13
in O 0 8.870880511277837e-14
the O 0 1.780724439431891e-12
setting O 0 3.674596044112022e-11
of O 0 5.3103455660563625e-11
long O 0 3.968158579503722e-10
- O 0 4.100829453790311e-09
term O 0 4.2706364666855734e-08
- O 0 1.3478378413367409e-08
outcome O 0 5.662032620534774e-09
studies O 0 1.5023723584639548e-11
may O 0 1.6369272257121814e-11
impact O 0 2.6302171551861875e-10
significantly O 0 6.902449278811673e-09
on O 0 0.00037877075374126434
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.1754905244742986e-06
in O 0 8.826232279768309e-12
this O 0 1.698632380586762e-11
population O 0 1.0481450776755885e-11
. O 0 7.593617401546737e-10

Localization O 0 3.2450882372359047e-06
of O 0 1.2869445242813526e-07
human O 0 1.7067823820937633e-09
BRCA1 O 0 5.715764750391372e-09
and O 0 2.5789493804384556e-11
its O 0 1.2826033637947098e-11
loss O 0 5.433405114718681e-11
in O 0 1.4446411081281418e-11
high O 0 4.713963974722901e-08
- O 0 7.292417336657309e-08
grade O 0 1.9946902796164068e-07
, O 0 3.718962637844214e-10
non B-Disease 0 0.09040205925703049
- I-Disease 1 0.9999967813491821
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.010162786580622196

Although O 0 1.2622815015461697e-09
the O 0 2.435645296561262e-10
link O 0 5.884323583948969e-10
between O 0 1.0610212708428435e-09
the O 0 3.979332863224272e-09
BRCA1 O 0 5.14016242902926e-08
tumour B-Disease 1 1.0
- O 0 6.231862670347255e-08
suppressor O 0 1.2689350015193668e-08
gene O 0 4.4146908351194725e-11
and O 0 1.4601996001228912e-10
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 2.942840637842892e-07
established O 0 1.6834289517930756e-10
, O 0 6.881507625018657e-13
the O 0 3.990012313603852e-12
role O 0 2.2963816178472873e-12
, O 0 8.579212508593934e-14
if O 0 7.296211703387845e-13
any O 0 2.4750994656597136e-11
, O 0 5.453160058926931e-12
of O 0 1.5898882210763077e-10
BRCA1 O 0 6.860501056138446e-09
in O 0 1.0354015422819884e-09
non B-Disease 0 0.0007059374474920332
- I-Disease 1 0.9999097585678101
familial I-Disease 1 0.9999997615814209
cancers I-Disease 1 1.0
is O 0 4.118106744499528e-08
unclear O 0 2.0606404405043577e-07
. O 0 1.3256792108506943e-08

BRCA1 O 0 1.1965519661316648e-05
mutations O 0 9.047146676266493e-08
are O 0 2.860021247608202e-11
rare O 0 6.636115268410236e-11
in O 0 6.924731343893598e-10
sporadic B-Disease 0 6.641279469477013e-05
cancers I-Disease 1 1.0
, O 0 1.0585476495350576e-08
but O 0 6.241198224898881e-09
loss O 0 8.462144762688695e-08
of O 0 1.8814914426457108e-07
BRCA1 O 0 8.919119665051767e-09
resulting O 0 8.081082469857392e-10
from O 0 2.5892715749264994e-10
reduced O 0 7.124053014173626e-10
expression O 0 5.02084138154224e-12
or O 0 6.222577314529687e-11
incorrect O 0 8.891056779702922e-10
subcellular O 0 1.8669629398004872e-08
localization O 0 2.5585713103737362e-08
is O 0 2.6287463525398458e-11
postulated O 0 5.672449732152529e-10
to O 0 2.992067357765471e-11
be O 0 3.0150495815284284e-12
important O 0 2.662721605706242e-12
in O 0 1.3536169581052082e-11
non B-Disease 0 2.1507842120627174e-06
- I-Disease 0 0.0008656855789013207
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9999418258666992

Epigenetic O 0 0.0003149476833641529
loss O 0 0.00013201353431213647
, O 0 1.387715498069042e-09
however O 0 4.3040285224726915e-10
, O 0 4.878028536658974e-12
has O 0 2.861262388045155e-13
not O 0 3.751758289888968e-13
received O 0 1.3900339213002155e-12
general O 0 1.5006548781393292e-10
acceptance O 0 7.093924336842861e-10
due O 0 2.6565569744008144e-09
to O 0 2.752844896480866e-10
controversy O 0 1.8711178439989595e-10
regarding O 0 8.574023435681255e-11
the O 0 2.275412358532236e-10
subcellular O 0 5.185439988508733e-08
localization O 0 2.9544391821900717e-08
of O 0 3.0854654387013625e-09
BRCA1 O 0 1.3634466888845509e-09
proteins O 0 3.4985462877418216e-12
, O 0 2.6985613179805745e-13
reports O 0 8.056261820849064e-13
of O 0 6.005596627639553e-12
which O 0 1.0309914814238264e-12
have O 0 2.996983303887868e-12
ranged O 0 3.4439830987054165e-09
from O 0 1.591811960022227e-10
exclusively O 0 4.12571886376778e-11
nuclear O 0 1.1081391448897193e-07
, O 0 2.6225315322148113e-11
to O 0 3.1340827155723616e-10
conditionally O 0 7.523014033949948e-08
nuclear O 0 2.2230106822007656e-07
, O 0 4.2364584063037114e-11
to O 0 1.659437254275531e-09
the O 0 1.2453556408331679e-08
ER O 0 1.4520956938213203e-05
/ O 0 1.2836044049890916e-07
golgi O 0 2.2787509124100325e-07
, O 0 3.533029077629202e-11
to O 0 2.8119037653873136e-10
cytoplasmic O 0 3.9629586723322063e-08
invaginations O 0 1.9859439248648414e-07
into O 0 1.2028612550452067e-09
the O 0 6.248174755363323e-10
nucleus O 0 2.2512056219170518e-08
. O 0 9.398608113997398e-09

In O 0 3.0292344188609377e-09
an O 0 6.107508943031803e-11
attempt O 0 7.352764619383834e-09
to O 0 1.978437635941077e-09
resolve O 0 2.488732064875876e-08
this O 0 3.6216327159444006e-10
issue O 0 1.2464772325415652e-08
, O 0 1.5922796414713503e-10
we O 0 3.3306760127693735e-10
have O 0 5.071199016271066e-11
comprehensively O 0 1.3581758828706825e-08
characterized O 0 2.027163548135036e-09
19 O 0 4.9154536441164964e-08
anti O 0 1.1243518116543783e-07
- O 0 4.3109344005642924e-07
BRCA1 O 0 5.587140972096449e-09
antibodies O 0 1.014985762104459e-09
. O 0 2.69788746898314e-09

These O 0 1.5673110809188984e-08
reagents O 0 1.3643109753047611e-08
detect O 0 9.482051410714121e-08
a O 0 1.2479950406429907e-08
220 O 0 8.356234815209973e-09
- O 0 1.3184874525506984e-08
kD O 0 6.746029868054393e-08
protein O 0 4.5993711617065003e-10
localized O 0 2.5477395748652043e-09
in O 0 8.397576384266969e-11
discrete O 0 1.590411535801195e-08
nuclear O 0 2.913963044193224e-06
foci O 0 2.2594784354623698e-07
in O 0 1.3315926139512158e-10
all O 0 1.6537014813078343e-10
epithelial O 0 9.037623094343417e-09
cell O 0 1.8205176033347925e-08
lines O 0 9.745262236071639e-11
, O 0 4.501371877237842e-13
including O 0 4.536016608982715e-14
those O 0 4.218537411754264e-13
derived O 0 1.53778899336654e-11
from O 0 1.3364200857068909e-09
breast B-Disease 0 1.8567982351669343e-07
malignancies I-Disease 0 2.13599082599103e-06
. O 0 1.1373330011110738e-07

Immunohistochemical O 0 6.707470674882643e-06
staining O 0 1.033604348776862e-06
of O 0 4.146529306581215e-07
human O 0 4.765766448144859e-08
breast O 0 1.9742747099371627e-06
specimens O 0 3.413078042413531e-09
also O 0 1.208039002165151e-09
revealed O 0 5.074176456787427e-08
BRCA1 O 0 2.2962950652072323e-07
nuclear O 0 0.00015752845501992851
foci O 0 9.126234544964973e-06
in O 0 1.2283882799835055e-09
benign O 1 0.9999719858169556
breast O 1 1.0
, O 0 2.0782772480743006e-06
invasive B-Disease 1 0.999993085861206
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 1 0.8205199837684631
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 0.9999998807907104
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.00016671905177645385

Conversely O 0 8.048016297834693e-07
, O 0 1.0168925701492526e-09
BRCA1 O 0 1.5084267168674614e-09
expression O 0 8.981540511321384e-11
was O 0 2.552067168704042e-10
reduced O 0 1.0172237357997105e-10
or O 0 2.1421631829499077e-11
undetectable O 0 7.563287496292759e-11
in O 0 2.1226464054328875e-13
the O 0 9.371649506775825e-13
majority O 0 4.872837159816679e-13
of O 0 1.674440031074198e-10
high O 0 2.652564319305384e-07
- O 0 6.321461114566773e-06
grade O 0 1.070658163371263e-05
, O 0 1.5394494567999573e-08
ductal B-Disease 1 0.9995834231376648
carcinomas I-Disease 1 1.0
, O 0 8.45139402905204e-10
suggesting O 0 7.814874858347309e-10
that O 0 6.734014040832292e-11
absence O 0 7.968800730395742e-09
of O 0 1.2085881628820516e-08
BRCA1 O 0 7.975217819478075e-09
may O 0 9.174023762881234e-10
contribute O 0 6.346020930969587e-11
to O 0 8.626107605991251e-10
the O 0 5.75222480758697e-10
pathogenesis O 0 2.3630443379829558e-08
of O 0 6.418952869235994e-11
a O 0 1.0198303139474785e-11
significant O 0 8.973270043677317e-11
percentage O 0 1.0439089592750861e-08
of O 0 1.3357351669185391e-08
sporadic B-Disease 0 0.06429870426654816
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 7.368993010459235e-06
. O 0 1.475880594625778e-06

